activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	393576	CHEMBL814453	Inhibition of Transforming growth factor beta-1 receptor (TbetaRI)	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	30000.0	CHEMBL4439	Homo sapiens	IC50	uM	30.0
	393576	CHEMBL814453	Inhibition of Transforming growth factor beta-1 receptor (TbetaRI)	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	30000.0	CHEMBL4439	Homo sapiens	IC50	uM	30.0
	411577	CHEMBL814454	Inhibition of Transforming growth factor beta-1 receptor (TbetaRI) autophosphorylation	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	IC50	nM	27000.0	CHEMBL4439	Homo sapiens	IC50	uM	27.0
	411578	CHEMBL814455	Dissociation constant for TGF-beta receptor type I	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Kd	nM	5.0	CHEMBL4439	Homo sapiens	Kd	nM	5.0
	829600	CHEMBL814457	In vitro inhibitory activity against human Transforming growth factor beta-1 receptor kinase (TGF-beta RIK)	B	Cc1cccc(-c2[nH]ncc2-c2ccnc3ccccc23)n1		CHEMBL129677	=	IC50	nM	34.0	CHEMBL4439	Homo sapiens	IC50	uM	0.034
	829601	CHEMBL728561	In vitro inhibition of transforming growth factor- beta dependent luciferase production in mink lung cells (p3TP Lux)	F	Cc1cccc(-c2[nH]ncc2-c2ccnc3ccccc23)n1		CHEMBL129677	=	IC50	nM	2.9	CHEMBL4439	Homo sapiens	IC50	uM	0.0029
	829602	CHEMBL740149	In vitro inhibition of transforming growth factor- beta dependent luciferase growth in mouse fibroblasts (NIH 3T3)	F	Cc1cccc(-c2[nH]ncc2-c2ccnc3ccccc23)n1		CHEMBL129677	=	IC50	nM	7.1	CHEMBL4439	Homo sapiens	IC50	uM	0.0071
	829604	CHEMBL814457	In vitro inhibitory activity against human Transforming growth factor beta-1 receptor kinase (TGF-beta RIK)	B	Cc1cccc(-c2n[nH]cc2-c2ccc(O)cc2)n1		CHEMBL118928	=	IC50	nM	31.0	CHEMBL4439	Homo sapiens	IC50	uM	0.031
	829605	CHEMBL728561	In vitro inhibition of transforming growth factor- beta dependent luciferase production in mink lung cells (p3TP Lux)	F	Cc1cccc(-c2n[nH]cc2-c2ccc(O)cc2)n1		CHEMBL118928	=	IC50	nM	44.0	CHEMBL4439	Homo sapiens	IC50	uM	0.044
	829606	CHEMBL740149	In vitro inhibition of transforming growth factor- beta dependent luciferase growth in mouse fibroblasts (NIH 3T3)	F	Cc1cccc(-c2n[nH]cc2-c2ccc(O)cc2)n1		CHEMBL118928	=	IC50	nM	32.0	CHEMBL4439	Homo sapiens	IC50	uM	0.032
	831890	CHEMBL814457	In vitro inhibitory activity against human Transforming growth factor beta-1 receptor kinase (TGF-beta RIK)	B	Cc1cccc(-c2[nH]ncc2-c2ccc(F)c(F)c2)n1		CHEMBL126789	=	IC50	nM	151.0	CHEMBL4439	Homo sapiens	IC50	uM	0.151
	831891	CHEMBL728561	In vitro inhibition of transforming growth factor- beta dependent luciferase production in mink lung cells (p3TP Lux)	F	Cc1cccc(-c2[nH]ncc2-c2ccc(F)c(F)c2)n1		CHEMBL126789	=	IC50	nM	788.0	CHEMBL4439	Homo sapiens	IC50	uM	0.788
	831892	CHEMBL740149	In vitro inhibition of transforming growth factor- beta dependent luciferase growth in mouse fibroblasts (NIH 3T3)	F	Cc1cccc(-c2[nH]ncc2-c2ccc(F)c(F)c2)n1		CHEMBL126789	=	IC50	nM	683.0	CHEMBL4439	Homo sapiens	IC50	uM	0.683
	831894	CHEMBL814457	In vitro inhibitory activity against human Transforming growth factor beta-1 receptor kinase (TGF-beta RIK)	B	COc1ccc(-c2cn(C)nc2-c2cccc(C)n2)cc1		CHEMBL129760	=	IC50	nM	44.0	CHEMBL4439	Homo sapiens	IC50	uM	0.044
	831895	CHEMBL728561	In vitro inhibition of transforming growth factor- beta dependent luciferase production in mink lung cells (p3TP Lux)	F	COc1ccc(-c2cn(C)nc2-c2cccc(C)n2)cc1		CHEMBL129760	=	IC50	nM	47.0	CHEMBL4439	Homo sapiens	IC50	uM	0.047
	831896	CHEMBL740149	In vitro inhibition of transforming growth factor- beta dependent luciferase growth in mouse fibroblasts (NIH 3T3)	F	COc1ccc(-c2cn(C)nc2-c2cccc(C)n2)cc1		CHEMBL129760	=	IC50	nM	61.0	CHEMBL4439	Homo sapiens	IC50	uM	0.061
	832937	CHEMBL814457	In vitro inhibitory activity against human Transforming growth factor beta-1 receptor kinase (TGF-beta RIK)	B	Brc1cccc(-c2[nH]ncc2-c2ccnc3ccccc23)n1		CHEMBL341280	=	IC50	nM	31.0	CHEMBL4439	Homo sapiens	IC50	uM	0.031
	832938	CHEMBL728561	In vitro inhibition of transforming growth factor- beta dependent luciferase production in mink lung cells (p3TP Lux)	F	Brc1cccc(-c2[nH]ncc2-c2ccnc3ccccc23)n1		CHEMBL341280	=	IC50	nM	2.9	CHEMBL4439	Homo sapiens	IC50	uM	0.0029
	832939	CHEMBL740149	In vitro inhibition of transforming growth factor- beta dependent luciferase growth in mouse fibroblasts (NIH 3T3)	F	Brc1cccc(-c2[nH]ncc2-c2ccnc3ccccc23)n1		CHEMBL341280	=	IC50	nM	1.2	CHEMBL4439	Homo sapiens	IC50	uM	0.0012
	834145	CHEMBL814457	In vitro inhibitory activity against human Transforming growth factor beta-1 receptor kinase (TGF-beta RIK)	B	Clc1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL341534	=	IC50	nM	1760.0	CHEMBL4439	Homo sapiens	IC50	uM	1.76
	834146	CHEMBL728561	In vitro inhibition of transforming growth factor- beta dependent luciferase production in mink lung cells (p3TP Lux)	F	Clc1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL341534	>	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	IC50	uM	10.0
	834147	CHEMBL740149	In vitro inhibition of transforming growth factor- beta dependent luciferase growth in mouse fibroblasts (NIH 3T3)	F	Clc1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL341534	=	IC50	nM	4670.0	CHEMBL4439	Homo sapiens	IC50	uM	4.67
	837825	CHEMBL814457	In vitro inhibitory activity against human Transforming growth factor beta-1 receptor kinase (TGF-beta RIK)	B	Cc1cccc(-c2[nH]nc(C)c2-c2ccnc3ccccc23)n1		CHEMBL129153	=	IC50	nM	82.0	CHEMBL4439	Homo sapiens	IC50	uM	0.082
	837826	CHEMBL728561	In vitro inhibition of transforming growth factor- beta dependent luciferase production in mink lung cells (p3TP Lux)	F	Cc1cccc(-c2[nH]nc(C)c2-c2ccnc3ccccc23)n1		CHEMBL129153	=	IC50	nM	24.0	CHEMBL4439	Homo sapiens	IC50	uM	0.024
	837827	CHEMBL740149	In vitro inhibition of transforming growth factor- beta dependent luciferase growth in mouse fibroblasts (NIH 3T3)	F	Cc1cccc(-c2[nH]nc(C)c2-c2ccnc3ccccc23)n1		CHEMBL129153	=	IC50	nM	148.0	CHEMBL4439	Homo sapiens	IC50	uM	0.148
	837829	CHEMBL814457	In vitro inhibitory activity against human Transforming growth factor beta-1 receptor kinase (TGF-beta RIK)	B	Cc1cccc(-c2[nH]ncc2-c2ccccc2)n1		CHEMBL129553	=	IC50	nM	543.0	CHEMBL4439	Homo sapiens	IC50	uM	0.543
	837830	CHEMBL728561	In vitro inhibition of transforming growth factor- beta dependent luciferase production in mink lung cells (p3TP Lux)	F	Cc1cccc(-c2[nH]ncc2-c2ccccc2)n1		CHEMBL129553	=	IC50	nM	3370.0	CHEMBL4439	Homo sapiens	IC50	uM	3.37
	837831	CHEMBL740149	In vitro inhibition of transforming growth factor- beta dependent luciferase growth in mouse fibroblasts (NIH 3T3)	F	Cc1cccc(-c2[nH]ncc2-c2ccccc2)n1		CHEMBL129553	=	IC50	nM	2160.0	CHEMBL4439	Homo sapiens	IC50	uM	2.16
	840227	CHEMBL814457	In vitro inhibitory activity against human Transforming growth factor beta-1 receptor kinase (TGF-beta RIK)	B	FC(F)(F)c1cccc(-c2n[nH]cc2-c2ccnc3ccccc23)c1		CHEMBL129678	=	IC50	nM	217.0	CHEMBL4439	Homo sapiens	IC50	uM	0.217
	840228	CHEMBL728561	In vitro inhibition of transforming growth factor- beta dependent luciferase production in mink lung cells (p3TP Lux)	F	FC(F)(F)c1cccc(-c2n[nH]cc2-c2ccnc3ccccc23)c1		CHEMBL129678	=	IC50	nM	355.0	CHEMBL4439	Homo sapiens	IC50	uM	0.355
	840229	CHEMBL740149	In vitro inhibition of transforming growth factor- beta dependent luciferase growth in mouse fibroblasts (NIH 3T3)	F	FC(F)(F)c1cccc(-c2n[nH]cc2-c2ccnc3ccccc23)c1		CHEMBL129678	=	IC50	nM	524.0	CHEMBL4439	Homo sapiens	IC50	uM	0.524
	840231	CHEMBL814457	In vitro inhibitory activity against human Transforming growth factor beta-1 receptor kinase (TGF-beta RIK)	B	c1ccc(Cn2cc(-c3ccnc4ccccc34)c(-c3ccccn3)n2)cc1		CHEMBL126180	=	IC50	nM	369.0	CHEMBL4439	Homo sapiens	IC50	uM	0.369
	840232	CHEMBL728561	In vitro inhibition of transforming growth factor- beta dependent luciferase production in mink lung cells (p3TP Lux)	F	c1ccc(Cn2cc(-c3ccnc4ccccc34)c(-c3ccccn3)n2)cc1		CHEMBL126180	=	IC50	nM	399.0	CHEMBL4439	Homo sapiens	IC50	uM	0.399
	840233	CHEMBL740149	In vitro inhibition of transforming growth factor- beta dependent luciferase growth in mouse fibroblasts (NIH 3T3)	F	c1ccc(Cn2cc(-c3ccnc4ccccc34)c(-c3ccccn3)n2)cc1		CHEMBL126180	=	IC50	nM	1340.0	CHEMBL4439	Homo sapiens	IC50	uM	1.34
	842725	CHEMBL814457	In vitro inhibitory activity against human Transforming growth factor beta-1 receptor kinase (TGF-beta RIK)	B	Fc1ccc(-c2c[nH]nc2-c2ccccn2)cc1		CHEMBL337978	=	IC50	nM	275.0	CHEMBL4439	Homo sapiens	IC50	uM	0.275
	842726	CHEMBL728561	In vitro inhibition of transforming growth factor- beta dependent luciferase production in mink lung cells (p3TP Lux)	F	Fc1ccc(-c2c[nH]nc2-c2ccccn2)cc1		CHEMBL337978	=	IC50	nM	3530.0	CHEMBL4439	Homo sapiens	IC50	uM	3.53
	842727	CHEMBL740149	In vitro inhibition of transforming growth factor- beta dependent luciferase growth in mouse fibroblasts (NIH 3T3)	F	Fc1ccc(-c2c[nH]nc2-c2ccccn2)cc1		CHEMBL337978	=	IC50	nM	2590.0	CHEMBL4439	Homo sapiens	IC50	uM	2.59
	848684	CHEMBL814457	In vitro inhibitory activity against human Transforming growth factor beta-1 receptor kinase (TGF-beta RIK)	B	c1ccc(-c2c[nH]nc2-c2ccccn2)cc1		CHEMBL129280	=	IC50	nM	3990.0	CHEMBL4439	Homo sapiens	IC50	uM	3.99
	848685	CHEMBL728561	In vitro inhibition of transforming growth factor- beta dependent luciferase production in mink lung cells (p3TP Lux)	F	c1ccc(-c2c[nH]nc2-c2ccccn2)cc1		CHEMBL129280	>	IC50	nM	9000.0	CHEMBL4439	Homo sapiens	IC50	uM	9.0
	848686	CHEMBL740149	In vitro inhibition of transforming growth factor- beta dependent luciferase growth in mouse fibroblasts (NIH 3T3)	F	c1ccc(-c2c[nH]nc2-c2ccccn2)cc1		CHEMBL129280	=	IC50	nM	9540.0	CHEMBL4439	Homo sapiens	IC50	uM	9.54
	848688	CHEMBL814457	In vitro inhibitory activity against human Transforming growth factor beta-1 receptor kinase (TGF-beta RIK)	B	Cc1cccc(-c2[nH]ncc2-c2ccc(F)cc2)n1		CHEMBL125846	=	IC50	nM	70.0	CHEMBL4439	Homo sapiens	IC50	uM	0.07
	848689	CHEMBL728561	In vitro inhibition of transforming growth factor- beta dependent luciferase production in mink lung cells (p3TP Lux)	F	Cc1cccc(-c2[nH]ncc2-c2ccc(F)cc2)n1		CHEMBL125846	=	IC50	nM	139.0	CHEMBL4439	Homo sapiens	IC50	uM	0.139
	848690	CHEMBL740149	In vitro inhibition of transforming growth factor- beta dependent luciferase growth in mouse fibroblasts (NIH 3T3)	F	Cc1cccc(-c2[nH]ncc2-c2ccc(F)cc2)n1		CHEMBL125846	=	IC50	nM	41.0	CHEMBL4439	Homo sapiens	IC50	uM	0.041
	850971	CHEMBL814457	In vitro inhibitory activity against human Transforming growth factor beta-1 receptor kinase (TGF-beta RIK)	B	Cc1cccc(-c2[nH]ncc2-c2ccc(Cl)cc2)n1		CHEMBL125738	=	IC50	nM	57.0	CHEMBL4439	Homo sapiens	IC50	uM	0.057
	850972	CHEMBL728561	In vitro inhibition of transforming growth factor- beta dependent luciferase production in mink lung cells (p3TP Lux)	F	Cc1cccc(-c2[nH]ncc2-c2ccc(Cl)cc2)n1		CHEMBL125738	=	IC50	nM	551.0	CHEMBL4439	Homo sapiens	IC50	uM	0.551
	850973	CHEMBL740149	In vitro inhibition of transforming growth factor- beta dependent luciferase growth in mouse fibroblasts (NIH 3T3)	F	Cc1cccc(-c2[nH]ncc2-c2ccc(Cl)cc2)n1		CHEMBL125738	=	IC50	nM	421.0	CHEMBL4439	Homo sapiens	IC50	uM	0.421
	852085	CHEMBL814457	In vitro inhibitory activity against human Transforming growth factor beta-1 receptor kinase (TGF-beta RIK)	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)cc1		CHEMBL126676	=	IC50	nM	382.0	CHEMBL4439	Homo sapiens	IC50	uM	0.382
	852086	CHEMBL728561	In vitro inhibition of transforming growth factor- beta dependent luciferase production in mink lung cells (p3TP Lux)	F	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)cc1		CHEMBL126676	=	IC50	nM	1200.0	CHEMBL4439	Homo sapiens	IC50	uM	1.2
	852087	CHEMBL740149	In vitro inhibition of transforming growth factor- beta dependent luciferase growth in mouse fibroblasts (NIH 3T3)	F	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)cc1		CHEMBL126676	=	IC50	nM	2920.0	CHEMBL4439	Homo sapiens	IC50	uM	2.92
	856558	CHEMBL814457	In vitro inhibitory activity against human Transforming growth factor beta-1 receptor kinase (TGF-beta RIK)	B	Fc1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL340203	=	IC50	nM	91.0	CHEMBL4439	Homo sapiens	IC50	uM	0.091
	856559	CHEMBL728561	In vitro inhibition of transforming growth factor- beta dependent luciferase production in mink lung cells (p3TP Lux)	F	Fc1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL340203	=	IC50	nM	94.0	CHEMBL4439	Homo sapiens	IC50	uM	0.094
	856560	CHEMBL740149	In vitro inhibition of transforming growth factor- beta dependent luciferase growth in mouse fibroblasts (NIH 3T3)	F	Fc1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL340203	=	IC50	nM	76.0	CHEMBL4439	Homo sapiens	IC50	uM	0.076
	857655	CHEMBL814457	In vitro inhibitory activity against human Transforming growth factor beta-1 receptor kinase (TGF-beta RIK)	B	c1ccc(-c2n[nH]c(C3CC3)c2-c2ccnc3ccccc23)nc1		CHEMBL338196	=	IC50	nM	203.0	CHEMBL4439	Homo sapiens	IC50	uM	0.203
	857656	CHEMBL728561	In vitro inhibition of transforming growth factor- beta dependent luciferase production in mink lung cells (p3TP Lux)	F	c1ccc(-c2n[nH]c(C3CC3)c2-c2ccnc3ccccc23)nc1		CHEMBL338196	=	IC50	nM	94.0	CHEMBL4439	Homo sapiens	IC50	uM	0.094
	857657	CHEMBL740149	In vitro inhibition of transforming growth factor- beta dependent luciferase growth in mouse fibroblasts (NIH 3T3)	F	c1ccc(-c2n[nH]c(C3CC3)c2-c2ccnc3ccccc23)nc1		CHEMBL338196	=	IC50	nM	538.0	CHEMBL4439	Homo sapiens	IC50	uM	0.538
	860100	CHEMBL814457	In vitro inhibitory activity against human Transforming growth factor beta-1 receptor kinase (TGF-beta RIK)	B	c1ccc(-c2c[nH]nc2-c2ccnc3ccccc23)nc1		CHEMBL338713	=	IC50	nM	150.0	CHEMBL4439	Homo sapiens	IC50	uM	0.15
	860101	CHEMBL728561	In vitro inhibition of transforming growth factor- beta dependent luciferase production in mink lung cells (p3TP Lux)	F	c1ccc(-c2c[nH]nc2-c2ccnc3ccccc23)nc1		CHEMBL338713	=	IC50	nM	683.0	CHEMBL4439	Homo sapiens	IC50	uM	0.683
	860102	CHEMBL740149	In vitro inhibition of transforming growth factor- beta dependent luciferase growth in mouse fibroblasts (NIH 3T3)	F	c1ccc(-c2c[nH]nc2-c2ccnc3ccccc23)nc1		CHEMBL338713	=	IC50	nM	1680.0	CHEMBL4439	Homo sapiens	IC50	uM	1.68
	863492	CHEMBL814457	In vitro inhibitory activity against human Transforming growth factor beta-1 receptor kinase (TGF-beta RIK)	B	c1csc(-c2n[nH]cc2-c2ccnc3ccccc23)c1		CHEMBL130025	=	IC50	nM	353.0	CHEMBL4439	Homo sapiens	IC50	uM	0.353
	863493	CHEMBL728561	In vitro inhibition of transforming growth factor- beta dependent luciferase production in mink lung cells (p3TP Lux)	F	c1csc(-c2n[nH]cc2-c2ccnc3ccccc23)c1		CHEMBL130025	=	IC50	nM	1660.0	CHEMBL4439	Homo sapiens	IC50	uM	1.66
	863494	CHEMBL740149	In vitro inhibition of transforming growth factor- beta dependent luciferase growth in mouse fibroblasts (NIH 3T3)	F	c1csc(-c2n[nH]cc2-c2ccnc3ccccc23)c1		CHEMBL130025	=	IC50	nM	2810.0	CHEMBL4439	Homo sapiens	IC50	uM	2.81
	864842	CHEMBL814456	Inhibition of human Transforming growth factor (TGF) beta-1 receptor (T204D mutation) autophosphorylation in Sf9 cells	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	IC50	nM	51.0	CHEMBL4439	Homo sapiens	IC50	uM	0.051
	864843	CHEMBL728561	In vitro inhibition of transforming growth factor- beta dependent luciferase production in mink lung cells (p3TP Lux)	F	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	IC50	nM	47.0	CHEMBL4439	Homo sapiens	IC50	uM	0.047
	864844	CHEMBL740149	In vitro inhibition of transforming growth factor- beta dependent luciferase growth in mouse fibroblasts (NIH 3T3)	F	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	IC50	nM	89.0	CHEMBL4439	Homo sapiens	IC50	uM	0.089
	953914	CHEMBL642728	Inhibition of Activin like receptor kinase 5, TGF beta type I receptor	B	O=C(O)c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccccn3)[nH]2)cc1		CHEMBL269339	=	IC50	nM	1500.0	CHEMBL4439	Homo sapiens	IC50	uM	1.5
	957905	CHEMBL642728	Inhibition of Activin like receptor kinase 5, TGF beta type I receptor	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	IC50	nM	260.0	CHEMBL4439	Homo sapiens	IC50	uM	0.26
	960325	CHEMBL642728	Inhibition of Activin like receptor kinase 5, TGF beta type I receptor	B	Fc1ccc(-c2c(-c3ccccn3)nc3n2CCS3)cc1		CHEMBL266706	=	IC50	nM	1600.0	CHEMBL4439	Homo sapiens	IC50	uM	1.6
	964135	CHEMBL642728	Inhibition of Activin like receptor kinase 5, TGF beta type I receptor	B	O=C(O)c1ccc(-c2nc(-c3ccc4c(c3)OCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL6250	=	IC50	nM	170.0	CHEMBL4439	Homo sapiens	IC50	uM	0.17
	968092	CHEMBL642728	Inhibition of Activin like receptor kinase 5, TGF beta type I receptor	B	Fc1ccc(-c2c(-c3ccccn3)nc3n2CCC3)cc1		CHEMBL6304	=	IC50	nM	5800.0	CHEMBL4439	Homo sapiens	IC50	uM	5.8
	969280	CHEMBL642728	Inhibition of Activin like receptor kinase 5, TGF beta type I receptor	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	>	IC50	nM	50000.0	CHEMBL4439	Homo sapiens	IC50	uM	50.0
	973099	CHEMBL642728	Inhibition of Activin like receptor kinase 5, TGF beta type I receptor	B	Fc1ccc(-c2c(-c3cccnc3)nc3n2CCC3)cc1		CHEMBL6294	>	IC50	nM	50000.0	CHEMBL4439	Homo sapiens	IC50	uM	50.0
	974334	CHEMBL642728	Inhibition of Activin like receptor kinase 5, TGF beta type I receptor	B	O=C(O)c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL6252	=	IC50	nM	400.0	CHEMBL4439	Homo sapiens	IC50	uM	0.4
	977939	CHEMBL642728	Inhibition of Activin like receptor kinase 5, TGF beta type I receptor	B	N#Cc1ccc(-c2nc(-c3ccc4c(c3)OCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL269341	=	IC50	nM	2950.0	CHEMBL4439	Homo sapiens	IC50	uM	2.95
	980574	CHEMBL642728	Inhibition of Activin like receptor kinase 5, TGF beta type I receptor	B	COc1ccc(-c2c(-c3ccccn3)nc3n2CCC3)cc1		CHEMBL6204	=	IC50	nM	5100.0	CHEMBL4439	Homo sapiens	IC50	uM	5.1
	981817	CHEMBL642728	Inhibition of Activin like receptor kinase 5, TGF beta type I receptor	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	IC50	nM	94.0	CHEMBL4439	Homo sapiens	IC50	uM	0.094
	985557	CHEMBL642728	Inhibition of Activin like receptor kinase 5, TGF beta type I receptor	B	c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL268889	=	IC50	nM	460.0	CHEMBL4439	Homo sapiens	IC50	uM	0.46
	986813	CHEMBL642728	Inhibition of Activin like receptor kinase 5, TGF beta type I receptor	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	6000.0	CHEMBL4439	Homo sapiens	IC50	uM	6.0
	1442965	CHEMBL832530	Binding affinity to Activin A receptor type II-like kinase (ALK5) in fluorescence polarization binding assay; Range is (0.095-5.521)	B	Nc1nc(-c2ccccn2)c(-c2ccnc3ccccc23)s1		CHEMBL181640	=	IC50	nM	720.0	CHEMBL4439	Homo sapiens	IC50	uM	0.72
	1442966	CHEMBL829583	Stimulation of Transforming growth factor beta receptor I kinase in HepG2 cells	F	Nc1nc(-c2ccccn2)c(-c2ccnc3ccccc23)s1		CHEMBL181640	=	IC50	nM	420.0	CHEMBL4439	Homo sapiens	IC50	uM	0.42
	1442967	CHEMBL831006	Binding affinity to Activin A receptor type II-like kinase (ALK5) in fluorescence polarization binding assay; Range is (2.423-6.540)	B	Nc1nc(-c2cccnc2)c(-c2ccnc3ccccc23)s1		CHEMBL359724	=	IC50	nM	3980.0	CHEMBL4439	Homo sapiens	IC50	uM	3.98
	1442968	CHEMBL829583	Stimulation of Transforming growth factor beta receptor I kinase in HepG2 cells	F	Nc1nc(-c2cccnc2)c(-c2ccnc3ccccc23)s1		CHEMBL359724	>	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	IC50	uM	10.0
	1442975	CHEMBL830168	Binding affinity to Activin A receptor type II-like kinase (ALK5) in fluorescence polarization binding assay; Range is (0.356-4.455)	B	Nc1nc(-c2ccccc2F)c(-c2ccnc3ccccc23)s1		CHEMBL184746	=	IC50	nM	1250.0	CHEMBL4439	Homo sapiens	IC50	uM	1.25
	1442976	CHEMBL829583	Stimulation of Transforming growth factor beta receptor I kinase in HepG2 cells	F	Nc1nc(-c2ccccc2F)c(-c2ccnc3ccccc23)s1		CHEMBL184746	=	IC50	nM	6670.0	CHEMBL4439	Homo sapiens	IC50	uM	6.67
	1442977	CHEMBL829080	Binding affinity for Activin A receptor type II-like kinase (ALK5) in fluorescence polarization binding assay	B	COc1ccccc1-c1nc(N)sc1-c1ccnc2ccccc12		CHEMBL185237	>	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	IC50	uM	10.0
	1442978	CHEMBL829583	Stimulation of Transforming growth factor beta receptor I kinase in HepG2 cells	F	COc1ccccc1-c1nc(N)sc1-c1ccnc2ccccc12		CHEMBL185237	>	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	IC50	uM	10.0
	1442985	CHEMBL830167	Binding affinity to Activin A receptor type II-like kinase (ALK5) in fluorescence polarization binding assay; Range is (0.289-3.621)	B	Nc1nc(-c2cc(Cl)ccn2)c(-c2ccnc3ccccc23)s1		CHEMBL182678	=	IC50	nM	1020.0	CHEMBL4439	Homo sapiens	IC50	uM	1.02
	1442986	CHEMBL829583	Stimulation of Transforming growth factor beta receptor I kinase in HepG2 cells	F	Nc1nc(-c2cc(Cl)ccn2)c(-c2ccnc3ccccc23)s1		CHEMBL182678	>	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	IC50	uM	10.0
	1442987	CHEMBL829080	Binding affinity for Activin A receptor type II-like kinase (ALK5) in fluorescence polarization binding assay	B	Cc1ccc(-c2nc(N)sc2-c2ccnc3ccccc23)nc1		CHEMBL359611	>	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	IC50	uM	10.0
	1442988	CHEMBL829583	Stimulation of Transforming growth factor beta receptor I kinase in HepG2 cells	F	Cc1ccc(-c2nc(N)sc2-c2ccnc3ccccc23)nc1		CHEMBL359611	>	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	IC50	uM	10.0
	1442990	CHEMBL831015	Binding affinity to Activin A receptor type II-like kinase (ALK5) in fluorescence polarization binding assay; Range is (3.221-19.588)	B	Nc1nc(-c2ccccn2)c(-c2ccnc3ncccc23)s1		CHEMBL181958	=	IC50	nM	7940.0	CHEMBL4439	Homo sapiens	IC50	uM	7.94
	1442991	CHEMBL829583	Stimulation of Transforming growth factor beta receptor I kinase in HepG2 cells	F	Nc1nc(-c2ccccn2)c(-c2ccnc3ncccc23)s1		CHEMBL181958	>	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	IC50	uM	10.0
	1442992	CHEMBL831713	Binding affinity to Activin A receptor type II-like kinase (ALK5) in fluorescence polarization binding assay; Range is (0.038-0.042)	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	IC50	nM	40.0	CHEMBL4439	Homo sapiens	IC50	uM	0.04
	1443105	CHEMBL831120	Inhibition of recombinant Activin A receptor type II-like kinase (ALK5) expressed in baculovirus/Sf9 cells	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	IC50	nM	20.0	CHEMBL4439	Homo sapiens	IC50	uM	0.02
	1443106	CHEMBL829583	Stimulation of Transforming growth factor beta receptor I kinase in HepG2 cells	F	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	IC50	nM	120.0	CHEMBL4439	Homo sapiens	IC50	uM	0.12
	1443114	CHEMBL829080	Binding affinity for Activin A receptor type II-like kinase (ALK5) in fluorescence polarization binding assay	B	CCOc1ccc2nc(-c3sc(N)nc3-c3ccccn3)ccc2n1		CHEMBL360613	>	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	IC50	uM	10.0
	1443115	CHEMBL829583	Stimulation of Transforming growth factor beta receptor I kinase in HepG2 cells	F	CCOc1ccc2nc(-c3sc(N)nc3-c3ccccn3)ccc2n1		CHEMBL360613	>	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	IC50	uM	10.0
	1443116	CHEMBL831711	Binding affinity to Activin A receptor type II-like kinase (ALK5) in fluorescence polarization binding assay; Range is (0.021-0.042)	B	Cc1ccnc2ccc(-c3sc(N)nc3-c3ccccn3)nc12		CHEMBL182354	=	IC50	nM	30.0	CHEMBL4439	Homo sapiens	IC50	uM	0.03
	1443117	CHEMBL829583	Stimulation of Transforming growth factor beta receptor I kinase in HepG2 cells	F	Cc1ccnc2ccc(-c3sc(N)nc3-c3ccccn3)nc12		CHEMBL182354	=	IC50	nM	220.0	CHEMBL4439	Homo sapiens	IC50	uM	0.22
	1443124	CHEMBL831709	Binding affinity to Activin A receptor type II-like kinase (ALK5) in fluorescence polarization binding assay; Range is (0.019-0.032)	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)n1		CHEMBL360034	=	IC50	nM	20.0	CHEMBL4439	Homo sapiens	IC50	uM	0.02
	1443125	CHEMBL831120	Inhibition of recombinant Activin A receptor type II-like kinase (ALK5) expressed in baculovirus/Sf9 cells	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)n1		CHEMBL360034	=	IC50	nM	6.0	CHEMBL4439	Homo sapiens	IC50	uM	0.006
	1443126	CHEMBL829583	Stimulation of Transforming growth factor beta receptor I kinase in HepG2 cells	F	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)n1		CHEMBL360034	=	IC50	nM	10.0	CHEMBL4439	Homo sapiens	IC50	uM	0.01
	1443128	CHEMBL832529	Binding affinity to Activin A receptor type II-like kinase (ALK5) in fluorescence polarization binding assay; Range is (0.040-0.044)	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	IC50	nM	40.0	CHEMBL4439	Homo sapiens	IC50	uM	0.04
	1443129	CHEMBL831120	Inhibition of recombinant Activin A receptor type II-like kinase (ALK5) expressed in baculovirus/Sf9 cells	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	IC50	nM	10.0	CHEMBL4439	Homo sapiens	IC50	uM	0.01
	1443130	CHEMBL829583	Stimulation of Transforming growth factor beta receptor I kinase in HepG2 cells	F	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	IC50	nM	30.0	CHEMBL4439	Homo sapiens	IC50	uM	0.03
	1443133	CHEMBL831712	Binding affinity to Activin A receptor type II-like kinase (ALK5) in fluorescence polarization binding assay; Range is (0.029-0.032)	B	c1ccc(-c2n[nH]cc2-c2ccc3ncccc3n2)nc1		CHEMBL183354	=	IC50	nM	30.0	CHEMBL4439	Homo sapiens	IC50	uM	0.03
	1443247	CHEMBL831120	Inhibition of recombinant Activin A receptor type II-like kinase (ALK5) expressed in baculovirus/Sf9 cells	B	c1ccc(-c2n[nH]cc2-c2ccc3ncccc3n2)nc1		CHEMBL183354	=	IC50	nM	10.0	CHEMBL4439	Homo sapiens	IC50	uM	0.01
	1443248	CHEMBL829583	Stimulation of Transforming growth factor beta receptor I kinase in HepG2 cells	F	c1ccc(-c2n[nH]cc2-c2ccc3ncccc3n2)nc1		CHEMBL183354	=	IC50	nM	50.0	CHEMBL4439	Homo sapiens	IC50	uM	0.05
	1443252	CHEMBL831710	Binding affinity to Activin A receptor type II-like kinase (ALK5) in fluorescence polarization binding assay; Range is (0.020-0.026)	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	IC50	nM	20.0	CHEMBL4439	Homo sapiens	IC50	uM	0.02
	1443256	CHEMBL831120	Inhibition of recombinant Activin A receptor type II-like kinase (ALK5) expressed in baculovirus/Sf9 cells	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	IC50	nM	4.0	CHEMBL4439	Homo sapiens	IC50	uM	0.004
	1443257	CHEMBL829583	Stimulation of Transforming growth factor beta receptor I kinase in HepG2 cells	F	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	IC50	nM	10.0	CHEMBL4439	Homo sapiens	IC50	uM	0.01
	1466655	CHEMBL830169	Binding affinity to Activin A receptor type II-like kinase (ALK5) in fluorescence polarization binding assay; Range is (0.783-1.764)	B	Nc1nc(-c2nccs2)c(-c2ccnc3ccccc23)s1		CHEMBL362710	=	IC50	nM	1170.0	CHEMBL4439	Homo sapiens	IC50	uM	1.17
	1466656	CHEMBL829583	Stimulation of Transforming growth factor beta receptor I kinase in HepG2 cells	F	Nc1nc(-c2nccs2)c(-c2ccnc3ccccc23)s1		CHEMBL362710	=	IC50	nM	6580.0	CHEMBL4439	Homo sapiens	IC50	uM	6.58
	1466657	CHEMBL831004	Binding affinity to Activin A receptor type II-like kinase (ALK5) in fluorescence polarization binding assay; Range is (0.864-3.661)	B	Nc1nc(-c2ccc(Cl)cn2)c(-c2ccnc3ccccc23)s1		CHEMBL447486	=	IC50	nM	1770.0	CHEMBL4439	Homo sapiens	IC50	uM	1.77
	1466658	CHEMBL829583	Stimulation of Transforming growth factor beta receptor I kinase in HepG2 cells	F	Nc1nc(-c2ccc(Cl)cn2)c(-c2ccnc3ccccc23)s1		CHEMBL447486	>	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	IC50	uM	10.0
	1466659	CHEMBL831016	Binding affinity to Activin A receptor type II-like kinase (ALK5) in fluorescence polarization binding assay; Range is (5.326-22.574)	B	Nc1nc(-c2ccccn2)c(-c2cccc3ccccc23)s1		CHEMBL365918	=	IC50	nM	10960.0	CHEMBL4439	Homo sapiens	IC50	uM	10.96
	1466660	CHEMBL829583	Stimulation of Transforming growth factor beta receptor I kinase in HepG2 cells	F	Nc1nc(-c2ccccn2)c(-c2cccc3ccccc23)s1		CHEMBL365918	>	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	IC50	uM	10.0
	1466661	CHEMBL831005	Binding affinity to Activin A receptor type II-like kinase (ALK5) in fluorescence polarization binding assay; Range is (1.375-9.154)	B	Nc1nc(-c2ccccn2)c(-c2ccc3ccccc3n2)s1		CHEMBL186966	=	IC50	nM	3540.0	CHEMBL4439	Homo sapiens	IC50	uM	3.54
	1466662	CHEMBL829583	Stimulation of Transforming growth factor beta receptor I kinase in HepG2 cells	F	Nc1nc(-c2ccccn2)c(-c2ccc3ccccc3n2)s1		CHEMBL186966	>	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	IC50	uM	10.0
	1466663	CHEMBL830166	Binding affinity to Activin A receptor type II-like kinase (ALK5) in fluorescence polarization binding assay; Range is (0.180-0.790)	B	Cc1ccc2nccc(-c3sc(N)nc3-c3ccccn3)c2n1		CHEMBL425177	=	IC50	nM	380.0	CHEMBL4439	Homo sapiens	IC50	uM	0.38
	1466664	CHEMBL829583	Stimulation of Transforming growth factor beta receptor I kinase in HepG2 cells	F	Cc1ccc2nccc(-c3sc(N)nc3-c3ccccn3)c2n1		CHEMBL425177	=	IC50	nM	260.0	CHEMBL4439	Homo sapiens	IC50	uM	0.26
	1466665	CHEMBL831710	Binding affinity to Activin A receptor type II-like kinase (ALK5) in fluorescence polarization binding assay; Range is (0.020-0.026)	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	IC50	nM	20.0	CHEMBL4439	Homo sapiens	IC50	uM	0.02
	1466666	CHEMBL831120	Inhibition of recombinant Activin A receptor type II-like kinase (ALK5) expressed in baculovirus/Sf9 cells	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	IC50	nM	10.0	CHEMBL4439	Homo sapiens	IC50	uM	0.01
	1466667	CHEMBL829583	Stimulation of Transforming growth factor beta receptor I kinase in HepG2 cells	F	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	IC50	nM	10.0	CHEMBL4439	Homo sapiens	IC50	uM	0.01
	1691981	CHEMBL861562	Inhibition of recombinant human TGFbeta R1 expressed in Sf9 cells	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	IC50	nM	59.0	CHEMBL4439	Homo sapiens	IC50	uM	0.059
	1691984	CHEMBL861567	Inhibition of TGFbeta R1 induced transcriptional activation of p3TP-Lux in mink Mv1Lu lung cells	F	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	IC50	nM	40.0	CHEMBL4439	Homo sapiens	IC50	uM	0.04
	1691986	CHEMBL861562	Inhibition of recombinant human TGFbeta R1 expressed in Sf9 cells	B	c1ccc(-c2nn3c(c2-c2ccc4c(c2)ncn4CCCOC2CCCCO2)CCC3)nc1		CHEMBL204158	=	IC50	nM	6580.0	CHEMBL4439	Homo sapiens	IC50	uM	6.58
	1691987	CHEMBL861562	Inhibition of recombinant human TGFbeta R1 expressed in Sf9 cells	B	Cc1cccc(-c2nn3c(c2-c2ccc4c(c2)ncn4CCCOC2CCCCO2)CCC3)n1		CHEMBL202625	=	IC50	nM	1830.0	CHEMBL4439	Homo sapiens	IC50	uM	1.83
	1691988	CHEMBL861562	Inhibition of recombinant human TGFbeta R1 expressed in Sf9 cells	B	Cn1cnc2cc(-c3c(-c4ccccn4)nn4c3CCC4)ccc21		CHEMBL203214	=	IC50	nM	4740.0	CHEMBL4439	Homo sapiens	IC50	uM	4.74
	1691989	CHEMBL861562	Inhibition of recombinant human TGFbeta R1 expressed in Sf9 cells	B	c1ccc(-c2nn3c(c2-c2ccc4[nH]cnc4c2)CCC3)nc1		CHEMBL204139	=	IC50	nM	1700.0	CHEMBL4439	Homo sapiens	IC50	uM	1.7
	1691990	CHEMBL861562	Inhibition of recombinant human TGFbeta R1 expressed in Sf9 cells	B	c1ccc(-c2nn3c(c2-c2ccc4ncn(CCCN5CCCC5)c4c2)CCC3)nc1		CHEMBL378167	=	IC50	nM	246.0	CHEMBL4439	Homo sapiens	IC50	uM	0.246
	1691991	CHEMBL861562	Inhibition of recombinant human TGFbeta R1 expressed in Sf9 cells	B	CN(C)CCCn1cnc2ccc(-c3c(-c4ccccn4)nn4c3CCC4)cc21		CHEMBL202730	=	IC50	nM	398.0	CHEMBL4439	Homo sapiens	IC50	uM	0.398
	1691992	CHEMBL861562	Inhibition of recombinant human TGFbeta R1 expressed in Sf9 cells	B	Cc1cccc(-c2nn3c(c2-c2ccc4ncn(CCCN5CCCCC5)c4c2)CCC3)n1		CHEMBL377711	=	IC50	nM	155.0	CHEMBL4439	Homo sapiens	IC50	uM	0.155
	1691993	CHEMBL861562	Inhibition of recombinant human TGFbeta R1 expressed in Sf9 cells	B	Cc1cccc(-c2nn3c(c2-c2ccc4ncn(CCCN5CCCC5)c4c2)CCC3)n1		CHEMBL206233	=	IC50	nM	74.0	CHEMBL4439	Homo sapiens	IC50	uM	0.074
	1691994	CHEMBL861562	Inhibition of recombinant human TGFbeta R1 expressed in Sf9 cells	B	Cc1cccc(-c2nn3c(c2-c2ccc4ncn(CCCN5CCOCC5)c4c2)CCC3)n1		CHEMBL381532	=	IC50	nM	69.0	CHEMBL4439	Homo sapiens	IC50	uM	0.069
	1691995	CHEMBL861562	Inhibition of recombinant human TGFbeta R1 expressed in Sf9 cells	B	CCN(CC)CCCn1cnc2ccc(-c3c(-c4cccc(C)n4)nn4c3CCC4)cc21		CHEMBL203791	=	IC50	nM	122.0	CHEMBL4439	Homo sapiens	IC50	uM	0.122
	1691996	CHEMBL861562	Inhibition of recombinant human TGFbeta R1 expressed in Sf9 cells	B	Cc1cccc(-c2nn3c(c2-c2ccc4ncn(CCCN(C)C)c4c2)CCC3)n1		CHEMBL441176	=	IC50	nM	85.0	CHEMBL4439	Homo sapiens	IC50	uM	0.085
	1691997	CHEMBL861562	Inhibition of recombinant human TGFbeta R1 expressed in Sf9 cells	B	OCCCn1cnc2ccc(-c3c(-c4ccccn4)nn4c3CCC4)cc21		CHEMBL203619	=	IC50	nM	79.0	CHEMBL4439	Homo sapiens	IC50	uM	0.079
	1691998	CHEMBL861562	Inhibition of recombinant human TGFbeta R1 expressed in Sf9 cells	B	Cc1cccc(-c2nn3c(c2-c2ccc4ncn(CCCO)c4c2)CCC3)n1		CHEMBL204063	=	IC50	nM	41.0	CHEMBL4439	Homo sapiens	IC50	uM	0.041
	1691999	CHEMBL861562	Inhibition of recombinant human TGFbeta R1 expressed in Sf9 cells	B	Cn1cnc2ccc(-c3c(-c4ccccn4)nn4c3CCC4)cc21		CHEMBL204170	=	IC50	nM	75.0	CHEMBL4439	Homo sapiens	IC50	uM	0.075
	1692000	CHEMBL861562	Inhibition of recombinant human TGFbeta R1 expressed in Sf9 cells	B	Cc1cccc(-c2nn3c(c2-c2ccc4ncn(C)c4c2)CCC3)n1		CHEMBL204966	=	IC50	nM	22.0	CHEMBL4439	Homo sapiens	IC50	uM	0.022
	1692002	CHEMBL861562	Inhibition of recombinant human TGFbeta R1 expressed in Sf9 cells	B	Cc1cccc(-c2nn3c(c2-c2ccc4[nH]cnc4c2)CCC3)n1		CHEMBL382838	=	IC50	nM	47.0	CHEMBL4439	Homo sapiens	IC50	uM	0.047
	1692003	CHEMBL861562	Inhibition of recombinant human TGFbeta R1 expressed in Sf9 cells	B	Cn1ccc2cc(-c3c(-c4ccccn4)nn4c3CCC4)ccc21		CHEMBL427211	=	IC50	nM	12230.0	CHEMBL4439	Homo sapiens	IC50	uM	12.23
	1692004	CHEMBL861562	Inhibition of recombinant human TGFbeta R1 expressed in Sf9 cells	B	Cc1cccc(-c2nn3c(c2-c2ccc4c(ccn4C)c2)CCC3)n1		CHEMBL377717	=	IC50	nM	4100.0	CHEMBL4439	Homo sapiens	IC50	uM	4.1
	1692005	CHEMBL861562	Inhibition of recombinant human TGFbeta R1 expressed in Sf9 cells	B	c1ccc(-c2nn3c(c2-c2ccc4[nH]ccc4c2)CCC3)nc1		CHEMBL204061	>	IC50	nM	20000.0	CHEMBL4439	Homo sapiens	IC50	uM	20.0
	1692047	CHEMBL861567	Inhibition of TGFbeta R1 induced transcriptional activation of p3TP-Lux in mink Mv1Lu lung cells	F	c1ccc(-c2nn3c(c2-c2ccc4c(c2)ncn4CCCOC2CCCCO2)CCC3)nc1		CHEMBL204158	=	IC50	nM	5890.0	CHEMBL4439	Homo sapiens	IC50	uM	5.89
	1692048	CHEMBL861567	Inhibition of TGFbeta R1 induced transcriptional activation of p3TP-Lux in mink Mv1Lu lung cells	F	Cc1cccc(-c2nn3c(c2-c2ccc4c(c2)ncn4CCCOC2CCCCO2)CCC3)n1		CHEMBL202625	=	IC50	nM	2430.0	CHEMBL4439	Homo sapiens	IC50	uM	2.43
	1692049	CHEMBL861567	Inhibition of TGFbeta R1 induced transcriptional activation of p3TP-Lux in mink Mv1Lu lung cells	F	Cn1cnc2cc(-c3c(-c4ccccn4)nn4c3CCC4)ccc21		CHEMBL203214	=	IC50	nM	1373.0	CHEMBL4439	Homo sapiens	IC50	uM	1.373
	1692050	CHEMBL861567	Inhibition of TGFbeta R1 induced transcriptional activation of p3TP-Lux in mink Mv1Lu lung cells	F	c1ccc(-c2nn3c(c2-c2ccc4[nH]cnc4c2)CCC3)nc1		CHEMBL204139	=	IC50	nM	422.0	CHEMBL4439	Homo sapiens	IC50	uM	0.422
	1692051	CHEMBL861567	Inhibition of TGFbeta R1 induced transcriptional activation of p3TP-Lux in mink Mv1Lu lung cells	F	c1ccc(-c2nn3c(c2-c2ccc4ncn(CCCN5CCCC5)c4c2)CCC3)nc1		CHEMBL378167	=	IC50	nM	226.0	CHEMBL4439	Homo sapiens	IC50	uM	0.226
	1692052	CHEMBL861567	Inhibition of TGFbeta R1 induced transcriptional activation of p3TP-Lux in mink Mv1Lu lung cells	F	CN(C)CCCn1cnc2ccc(-c3c(-c4ccccn4)nn4c3CCC4)cc21		CHEMBL202730	=	IC50	nM	104.0	CHEMBL4439	Homo sapiens	IC50	uM	0.104
	1692053	CHEMBL861567	Inhibition of TGFbeta R1 induced transcriptional activation of p3TP-Lux in mink Mv1Lu lung cells	F	Cc1cccc(-c2nn3c(c2-c2ccc4ncn(CCCN5CCCCC5)c4c2)CCC3)n1		CHEMBL377711	=	IC50	nM	51.0	CHEMBL4439	Homo sapiens	IC50	uM	0.051
	1692054	CHEMBL861567	Inhibition of TGFbeta R1 induced transcriptional activation of p3TP-Lux in mink Mv1Lu lung cells	F	Cc1cccc(-c2nn3c(c2-c2ccc4ncn(CCCN5CCCC5)c4c2)CCC3)n1		CHEMBL206233	=	IC50	nM	117.0	CHEMBL4439	Homo sapiens	IC50	uM	0.117
	1692055	CHEMBL861567	Inhibition of TGFbeta R1 induced transcriptional activation of p3TP-Lux in mink Mv1Lu lung cells	F	Cc1cccc(-c2nn3c(c2-c2ccc4ncn(CCCN5CCOCC5)c4c2)CCC3)n1		CHEMBL381532	=	IC50	nM	186.0	CHEMBL4439	Homo sapiens	IC50	uM	0.186
	1692056	CHEMBL861567	Inhibition of TGFbeta R1 induced transcriptional activation of p3TP-Lux in mink Mv1Lu lung cells	F	CCN(CC)CCCn1cnc2ccc(-c3c(-c4cccc(C)n4)nn4c3CCC4)cc21		CHEMBL203791	=	IC50	nM	100.0	CHEMBL4439	Homo sapiens	IC50	uM	0.1
	1692057	CHEMBL861567	Inhibition of TGFbeta R1 induced transcriptional activation of p3TP-Lux in mink Mv1Lu lung cells	F	Cc1cccc(-c2nn3c(c2-c2ccc4ncn(CCCN(C)C)c4c2)CCC3)n1		CHEMBL441176	=	IC50	nM	53.0	CHEMBL4439	Homo sapiens	IC50	uM	0.053
	1692058	CHEMBL861567	Inhibition of TGFbeta R1 induced transcriptional activation of p3TP-Lux in mink Mv1Lu lung cells	F	OCCCn1cnc2ccc(-c3c(-c4ccccn4)nn4c3CCC4)cc21		CHEMBL203619	=	IC50	nM	79.0	CHEMBL4439	Homo sapiens	IC50	uM	0.079
	1692059	CHEMBL861567	Inhibition of TGFbeta R1 induced transcriptional activation of p3TP-Lux in mink Mv1Lu lung cells	F	Cc1cccc(-c2nn3c(c2-c2ccc4ncn(CCCO)c4c2)CCC3)n1		CHEMBL204063	=	IC50	nM	78.0	CHEMBL4439	Homo sapiens	IC50	uM	0.078
	1692060	CHEMBL861567	Inhibition of TGFbeta R1 induced transcriptional activation of p3TP-Lux in mink Mv1Lu lung cells	F	Cn1cnc2ccc(-c3c(-c4ccccn4)nn4c3CCC4)cc21		CHEMBL204170	=	IC50	nM	8.0	CHEMBL4439	Homo sapiens	IC50	uM	0.008
	1692061	CHEMBL861567	Inhibition of TGFbeta R1 induced transcriptional activation of p3TP-Lux in mink Mv1Lu lung cells	F	Cc1cccc(-c2nn3c(c2-c2ccc4ncn(C)c4c2)CCC3)n1		CHEMBL204966	=	IC50	nM	29.0	CHEMBL4439	Homo sapiens	IC50	uM	0.029
	1692062	CHEMBL861567	Inhibition of TGFbeta R1 induced transcriptional activation of p3TP-Lux in mink Mv1Lu lung cells	F	Cc1cccc(-c2nn3c(c2-c2ccc4[nH]cnc4c2)CCC3)n1		CHEMBL382838	=	IC50	nM	15.0	CHEMBL4439	Homo sapiens	IC50	uM	0.015
Not Determined	1692063	CHEMBL861567	Inhibition of TGFbeta R1 induced transcriptional activation of p3TP-Lux in mink Mv1Lu lung cells	F	Cn1ccc2cc(-c3c(-c4ccccn4)nn4c3CCC4)ccc21		CHEMBL427211		IC50			CHEMBL4439	Homo sapiens	IC50		
Not Determined	1692064	CHEMBL861567	Inhibition of TGFbeta R1 induced transcriptional activation of p3TP-Lux in mink Mv1Lu lung cells	F	Cc1cccc(-c2nn3c(c2-c2ccc4c(ccn4C)c2)CCC3)n1		CHEMBL377717		IC50			CHEMBL4439	Homo sapiens	IC50		
Not Determined	1692065	CHEMBL861567	Inhibition of TGFbeta R1 induced transcriptional activation of p3TP-Lux in mink Mv1Lu lung cells	F	c1ccc(-c2nn3c(c2-c2ccc4[nH]ccc4c2)CCC3)nc1		CHEMBL204061		IC50			CHEMBL4439	Homo sapiens	IC50		
	1695705	CHEMBL861566	Inhibition of TGFbeta R1 in human Calu6 cells implanted in nude mouse at 50 mg/kg, po	F	c1ccc(-c2nn3c(c2-c2ccc4[nH]cnc4c2)CCC3)nc1		CHEMBL204139	=	Inhibition	%	65.0	CHEMBL4439	Homo sapiens	Inhibition	%	65.0
	1699494	CHEMBL860750	Displacement of rhodamine green fluorescently labeled ATP from recombinant GST-ALK5 by FP assay	B	c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL205736	=	IC50	nM	107.0	CHEMBL4439	Homo sapiens	IC50	uM	0.107
	1699495	CHEMBL860750	Displacement of rhodamine green fluorescently labeled ATP from recombinant GST-ALK5 by FP assay	B	O=C(Nc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1)C1CCOCC1		CHEMBL206017	=	IC50	nM	112.0	CHEMBL4439	Homo sapiens	IC50	uM	0.112
	1699496	CHEMBL860750	Displacement of rhodamine green fluorescently labeled ATP from recombinant GST-ALK5 by FP assay	B	CN(C(=O)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1)C1CCOCC1		CHEMBL205271	=	IC50	nM	214.0	CHEMBL4439	Homo sapiens	IC50	uM	0.214
	1699497	CHEMBL860750	Displacement of rhodamine green fluorescently labeled ATP from recombinant GST-ALK5 by FP assay	B	O=C(NC1CCOCC1)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202887	=	IC50	nM	18.0	CHEMBL4439	Homo sapiens	IC50	uM	0.018
	1699498	CHEMBL860750	Displacement of rhodamine green fluorescently labeled ATP from recombinant GST-ALK5 by FP assay	B	O=C(c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1)N1CCOCC1		CHEMBL436944	=	IC50	nM	123.0	CHEMBL4439	Homo sapiens	IC50	uM	0.123
	1699499	CHEMBL860750	Displacement of rhodamine green fluorescently labeled ATP from recombinant GST-ALK5 by FP assay	B	O=C(c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1)N1CCCC1		CHEMBL380916	=	IC50	nM	110.0	CHEMBL4439	Homo sapiens	IC50	uM	0.11
	1699500	CHEMBL860750	Displacement of rhodamine green fluorescently labeled ATP from recombinant GST-ALK5 by FP assay	B	COCCNC(=O)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL205151	=	IC50	nM	91.0	CHEMBL4439	Homo sapiens	IC50	uM	0.091
	1699501	CHEMBL860750	Displacement of rhodamine green fluorescently labeled ATP from recombinant GST-ALK5 by FP assay	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(CNC4CCOCC4)cc3)c2)nc1		CHEMBL204211	=	IC50	nM	47.0	CHEMBL4439	Homo sapiens	IC50	uM	0.047
	1699502	CHEMBL860750	Displacement of rhodamine green fluorescently labeled ATP from recombinant GST-ALK5 by FP assay	B	Cl.c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(CN4CCOCC4)cc3)c2)nc1		CHEMBL1237161	=	IC50	nM	42.0	CHEMBL4439	Homo sapiens	IC50	uM	0.042
	1699503	CHEMBL860750	Displacement of rhodamine green fluorescently labeled ATP from recombinant GST-ALK5 by FP assay	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(CN4CCCC4)cc3)c2)nc1		CHEMBL205570	=	IC50	nM	19.0	CHEMBL4439	Homo sapiens	IC50	uM	0.019
	1699504	CHEMBL860750	Displacement of rhodamine green fluorescently labeled ATP from recombinant GST-ALK5 by FP assay	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	IC50	nM	30.0	CHEMBL4439	Homo sapiens	IC50	uM	0.03
	1699505	CHEMBL860750	Displacement of rhodamine green fluorescently labeled ATP from recombinant GST-ALK5 by FP assay	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	IC50	nM	12.0	CHEMBL4439	Homo sapiens	IC50	uM	0.012
	1699506	CHEMBL860750	Displacement of rhodamine green fluorescently labeled ATP from recombinant GST-ALK5 by FP assay	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCCC4)cc3)c2)nc1		CHEMBL202994	=	IC50	nM	40.0	CHEMBL4439	Homo sapiens	IC50	uM	0.04
	1699507	CHEMBL860750	Displacement of rhodamine green fluorescently labeled ATP from recombinant GST-ALK5 by FP assay	B	CN(C)CCOc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL424676	=	IC50	nM	15.0	CHEMBL4439	Homo sapiens	IC50	uM	0.015
	1699508	CHEMBL860750	Displacement of rhodamine green fluorescently labeled ATP from recombinant GST-ALK5 by FP assay	B	CC(=O)COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202943	=	IC50	nM	25.0	CHEMBL4439	Homo sapiens	IC50	uM	0.025
	1699509	CHEMBL860750	Displacement of rhodamine green fluorescently labeled ATP from recombinant GST-ALK5 by FP assay	B	ClCCOc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL204575	=	IC50	nM	19.0	CHEMBL4439	Homo sapiens	IC50	uM	0.019
	1699510	CHEMBL860750	Displacement of rhodamine green fluorescently labeled ATP from recombinant GST-ALK5 by FP assay	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCC4CCCCC4)cc3)c2)nc1		CHEMBL379700	=	IC50	nM	81.0	CHEMBL4439	Homo sapiens	IC50	uM	0.081
	1699511	CHEMBL860750	Displacement of rhodamine green fluorescently labeled ATP from recombinant GST-ALK5 by FP assay	B	N#Cc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL437118	=	IC50	nM	35.0	CHEMBL4439	Homo sapiens	IC50	uM	0.035
	1699512	CHEMBL860750	Displacement of rhodamine green fluorescently labeled ATP from recombinant GST-ALK5 by FP assay	B	COC(=O)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL203436	=	IC50	nM	27.0	CHEMBL4439	Homo sapiens	IC50	uM	0.027
	1699513	CHEMBL860750	Displacement of rhodamine green fluorescently labeled ATP from recombinant GST-ALK5 by FP assay	B	Clc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL204838	=	IC50	nM	43.0	CHEMBL4439	Homo sapiens	IC50	uM	0.043
	1699514	CHEMBL860750	Displacement of rhodamine green fluorescently labeled ATP from recombinant GST-ALK5 by FP assay	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	IC50	nM	32.0	CHEMBL4439	Homo sapiens	IC50	uM	0.032
	1699515	CHEMBL860750	Displacement of rhodamine green fluorescently labeled ATP from recombinant GST-ALK5 by FP assay	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	IC50	nM	48.0	CHEMBL4439	Homo sapiens	IC50	uM	0.048
	1699516	CHEMBL860750	Displacement of rhodamine green fluorescently labeled ATP from recombinant GST-ALK5 by FP assay	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	IC50	nM	24.0	CHEMBL4439	Homo sapiens	IC50	uM	0.024
	1699517	CHEMBL860750	Displacement of rhodamine green fluorescently labeled ATP from recombinant GST-ALK5 by FP assay	B	FC(F)(F)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL383523	=	IC50	nM	24.0	CHEMBL4439	Homo sapiens	IC50	uM	0.024
	1699518	CHEMBL860750	Displacement of rhodamine green fluorescently labeled ATP from recombinant GST-ALK5 by FP assay	B	Cc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL205156	=	IC50	nM	28.0	CHEMBL4439	Homo sapiens	IC50	uM	0.028
	1699519	CHEMBL860750	Displacement of rhodamine green fluorescently labeled ATP from recombinant GST-ALK5 by FP assay	B	COc1cccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)c1		CHEMBL382799	=	IC50	nM	115.0	CHEMBL4439	Homo sapiens	IC50	uM	0.115
	1699520	CHEMBL860750	Displacement of rhodamine green fluorescently labeled ATP from recombinant GST-ALK5 by FP assay	B	FC(F)(F)c1cccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)c1		CHEMBL382466	=	IC50	nM	240.0	CHEMBL4439	Homo sapiens	IC50	uM	0.24
	1699521	CHEMBL860750	Displacement of rhodamine green fluorescently labeled ATP from recombinant GST-ALK5 by FP assay	B	Cc1cccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)c1		CHEMBL205260	=	IC50	nM	191.0	CHEMBL4439	Homo sapiens	IC50	uM	0.191
	1699522	CHEMBL860750	Displacement of rhodamine green fluorescently labeled ATP from recombinant GST-ALK5 by FP assay	B	FC(F)(F)c1ccccc1-c1cc(-c2c[nH]nc2-c2ccccn2)ccn1		CHEMBL426852	=	IC50	nM	9333.0	CHEMBL4439	Homo sapiens	IC50	uM	9.333
	1699523	CHEMBL860750	Displacement of rhodamine green fluorescently labeled ATP from recombinant GST-ALK5 by FP assay	B	Cc1ccccc1-c1cc(-c2c[nH]nc2-c2ccccn2)ccn1		CHEMBL383433	=	IC50	nM	3981.0	CHEMBL4439	Homo sapiens	IC50	uM	3.981
	1699524	CHEMBL860750	Displacement of rhodamine green fluorescently labeled ATP from recombinant GST-ALK5 by FP assay	B	Fc1ccccc1-c1cc(-c2c[nH]nc2-c2ccccn2)ccn1		CHEMBL205427	=	IC50	nM	59.0	CHEMBL4439	Homo sapiens	IC50	uM	0.059
	1812464	CHEMBL910218	Inhibition of Alk5	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	<	IC50	nM	5011.87	CHEMBL4439	Homo sapiens	Log IC50		-5.3
	1904533	CHEMBL889560	Inhibition of human recombinant ALK5 phosphorylation expressed in Sf9 cells	B	Cc1cccc(-c2[nH]c(CNc3cccc(C#N)c3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL387747	=	IC50	nM	46.0	CHEMBL4439	Homo sapiens	IC50	uM	0.046
	1904534	CHEMBL889560	Inhibition of human recombinant ALK5 phosphorylation expressed in Sf9 cells	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	IC50	nM	1542.0	CHEMBL4439	Homo sapiens	IC50	uM	1.542
	1904535	CHEMBL889560	Inhibition of human recombinant ALK5 phosphorylation expressed in Sf9 cells	B	Cc1cccc(-c2[nH]c(NCc3ccc(C#N)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL445934	=	IC50	nM	153.0	CHEMBL4439	Homo sapiens	IC50	uM	0.153
	1904536	CHEMBL889560	Inhibition of human recombinant ALK5 phosphorylation expressed in Sf9 cells	B	Cc1cccc(-c2[nH]c(NCc3cccc(C#N)c3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226734	=	IC50	nM	24.0	CHEMBL4439	Homo sapiens	IC50	uM	0.024
	1904537	CHEMBL889560	Inhibition of human recombinant ALK5 phosphorylation expressed in Sf9 cells	B	CCc1cccc(-c2[nH]c(CNc3ccc(C(N)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL226733	=	IC50	nM	92.0	CHEMBL4439	Homo sapiens	IC50	uM	0.092
	1904538	CHEMBL889560	Inhibition of human recombinant ALK5 phosphorylation expressed in Sf9 cells	B	CCc1cccc(-c2[nH]c(CNc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL376119	=	IC50	nM	15.0	CHEMBL4439	Homo sapiens	IC50	uM	0.015
	1904539	CHEMBL889560	Inhibition of human recombinant ALK5 phosphorylation expressed in Sf9 cells	B	Cc1cccc(-c2[nH]c(CNc3ccc(C(N)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL229654	=	IC50	nM	75.0	CHEMBL4439	Homo sapiens	IC50	uM	0.075
	1904540	CHEMBL889560	Inhibition of human recombinant ALK5 phosphorylation expressed in Sf9 cells	B	Cc1cccc(-c2[nH]c(CNc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL229599	=	IC50	nM	10.0	CHEMBL4439	Homo sapiens	IC50	uM	0.01
	1904541	CHEMBL889560	Inhibition of human recombinant ALK5 phosphorylation expressed in Sf9 cells	B	CCc1cccc(-c2[nH]c(CNc3ccc(C(N)=O)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL389079	=	IC50	nM	385.0	CHEMBL4439	Homo sapiens	IC50	uM	0.385
	1904542	CHEMBL889560	Inhibition of human recombinant ALK5 phosphorylation expressed in Sf9 cells	B	CCc1cccc(-c2[nH]c(CNc3cccc(C(N)=O)c3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL229598	=	IC50	nM	46.0	CHEMBL4439	Homo sapiens	IC50	uM	0.046
	1904543	CHEMBL889560	Inhibition of human recombinant ALK5 phosphorylation expressed in Sf9 cells	B	Cc1cccc(-c2[nH]c(CNc3ccc(C(N)=O)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL229597	=	IC50	nM	262.0	CHEMBL4439	Homo sapiens	IC50	uM	0.262
	1904544	CHEMBL889560	Inhibition of human recombinant ALK5 phosphorylation expressed in Sf9 cells	B	Cc1cccc(-c2[nH]c(CNc3cccc(C(N)=O)c3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL389078	=	IC50	nM	21.0	CHEMBL4439	Homo sapiens	IC50	uM	0.021
	1904545	CHEMBL889560	Inhibition of human recombinant ALK5 phosphorylation expressed in Sf9 cells	B	CCc1cccc(-c2[nH]c(CNc3ccc(C#N)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL229548	=	IC50	nM	47.0	CHEMBL4439	Homo sapiens	IC50	uM	0.047
	1904546	CHEMBL889560	Inhibition of human recombinant ALK5 phosphorylation expressed in Sf9 cells	B	CCc1cccc(-c2[nH]c(CNc3cccc(C#N)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL229547	=	IC50	nM	119.0	CHEMBL4439	Homo sapiens	IC50	uM	0.119
	1904547	CHEMBL889560	Inhibition of human recombinant ALK5 phosphorylation expressed in Sf9 cells	B	Cc1cccc(-c2[nH]c(CNc3ccc(C#N)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL229546	=	IC50	nM	42.0	CHEMBL4439	Homo sapiens	IC50	uM	0.042
	1904548	CHEMBL889560	Inhibition of human recombinant ALK5 phosphorylation expressed in Sf9 cells	B	Cc1cccc(-c2[nH]c(CNc3cccc(C#N)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL387748	=	IC50	nM	12.0	CHEMBL4439	Homo sapiens	IC50	uM	0.012
	1904549	CHEMBL889560	Inhibition of human recombinant ALK5 phosphorylation expressed in Sf9 cells	B	CCc1cccc(-c2[nH]c(CNc3ccc(C#N)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL229497	=	IC50	nM	360.0	CHEMBL4439	Homo sapiens	IC50	uM	0.36
	1904550	CHEMBL889560	Inhibition of human recombinant ALK5 phosphorylation expressed in Sf9 cells	B	CCc1cccc(-c2[nH]c(CNc3cccc(C#N)c3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL229496	=	IC50	nM	73.0	CHEMBL4439	Homo sapiens	IC50	uM	0.073
	1904551	CHEMBL889560	Inhibition of human recombinant ALK5 phosphorylation expressed in Sf9 cells	B	Cc1cccc(-c2[nH]c(CNc3ccc(C#N)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL229495	=	IC50	nM	174.0	CHEMBL4439	Homo sapiens	IC50	uM	0.174
	1904552	CHEMBL889561	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as p3TP-luciferase reporter activity at 0.1 uM relative to control	F	Cc1cccc(-c2[nH]c(CNc3cccc(C#N)c3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL387747	=	Activity	%	14.0	CHEMBL4439	Homo sapiens	Activity	%	14.0
	1904553	CHEMBL889561	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as p3TP-luciferase reporter activity at 0.1 uM relative to control	F	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	Activity	%	69.0	CHEMBL4439	Homo sapiens	Activity	%	69.0
	1904554	CHEMBL889561	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as p3TP-luciferase reporter activity at 0.1 uM relative to control	F	Cc1cccc(-c2[nH]c(NCc3ccc(C#N)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL445934	=	Activity	%	61.0	CHEMBL4439	Homo sapiens	Activity	%	61.0
	1904555	CHEMBL889561	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as p3TP-luciferase reporter activity at 0.1 uM relative to control	F	Cc1cccc(-c2[nH]c(NCc3cccc(C#N)c3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226734	=	Activity	%	33.0	CHEMBL4439	Homo sapiens	Activity	%	33.0
	1904556	CHEMBL889561	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as p3TP-luciferase reporter activity at 0.1 uM relative to control	F	CCc1cccc(-c2[nH]c(CNc3ccc(C(N)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL226733	=	Activity	%	104.0	CHEMBL4439	Homo sapiens	Activity	%	104.0
	1904557	CHEMBL889561	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as p3TP-luciferase reporter activity at 0.1 uM relative to control	F	CCc1cccc(-c2[nH]c(CNc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL376119	=	Activity	%	67.0	CHEMBL4439	Homo sapiens	Activity	%	67.0
	1904558	CHEMBL889561	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as p3TP-luciferase reporter activity at 0.1 uM relative to control	F	Cc1cccc(-c2[nH]c(CNc3ccc(C(N)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL229654	=	Activity	%	84.0	CHEMBL4439	Homo sapiens	Activity	%	84.0
	1904559	CHEMBL889561	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as p3TP-luciferase reporter activity at 0.1 uM relative to control	F	Cc1cccc(-c2[nH]c(CNc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL229599	=	Activity	%	63.0	CHEMBL4439	Homo sapiens	Activity	%	63.0
	1904560	CHEMBL889561	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as p3TP-luciferase reporter activity at 0.1 uM relative to control	F	CCc1cccc(-c2[nH]c(CNc3ccc(C(N)=O)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL389079	=	Activity	%	125.0	CHEMBL4439	Homo sapiens	Activity	%	125.0
	1904561	CHEMBL889561	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as p3TP-luciferase reporter activity at 0.1 uM relative to control	F	CCc1cccc(-c2[nH]c(CNc3cccc(C(N)=O)c3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL229598	=	Activity	%	30.0	CHEMBL4439	Homo sapiens	Activity	%	30.0
	1904562	CHEMBL889561	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as p3TP-luciferase reporter activity at 0.1 uM relative to control	F	Cc1cccc(-c2[nH]c(CNc3ccc(C(N)=O)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL229597	=	Activity	%	55.0	CHEMBL4439	Homo sapiens	Activity	%	55.0
	1904563	CHEMBL889561	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as p3TP-luciferase reporter activity at 0.1 uM relative to control	F	Cc1cccc(-c2[nH]c(CNc3cccc(C(N)=O)c3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL389078	=	Activity	%	28.0	CHEMBL4439	Homo sapiens	Activity	%	28.0
	1904564	CHEMBL889561	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as p3TP-luciferase reporter activity at 0.1 uM relative to control	F	CCc1cccc(-c2[nH]c(CNc3ccc(C#N)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL229548	=	Activity	%	32.0	CHEMBL4439	Homo sapiens	Activity	%	32.0
	1904565	CHEMBL889561	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as p3TP-luciferase reporter activity at 0.1 uM relative to control	F	CCc1cccc(-c2[nH]c(CNc3cccc(C#N)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL229547	=	Activity	%	33.0	CHEMBL4439	Homo sapiens	Activity	%	33.0
	1904566	CHEMBL889561	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as p3TP-luciferase reporter activity at 0.1 uM relative to control	F	Cc1cccc(-c2[nH]c(CNc3ccc(C#N)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL229546	=	Activity	%	16.0	CHEMBL4439	Homo sapiens	Activity	%	16.0
	1904567	CHEMBL889561	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as p3TP-luciferase reporter activity at 0.1 uM relative to control	F	Cc1cccc(-c2[nH]c(CNc3cccc(C#N)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL387748	=	Activity	%	7.0	CHEMBL4439	Homo sapiens	Activity	%	7.0
	1904568	CHEMBL889561	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as p3TP-luciferase reporter activity at 0.1 uM relative to control	F	CCc1cccc(-c2[nH]c(CNc3ccc(C#N)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL229497	=	Activity	%	67.0	CHEMBL4439	Homo sapiens	Activity	%	67.0
	1904569	CHEMBL889561	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as p3TP-luciferase reporter activity at 0.1 uM relative to control	F	CCc1cccc(-c2[nH]c(CNc3cccc(C#N)c3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL229496	=	Activity	%	21.0	CHEMBL4439	Homo sapiens	Activity	%	21.0
	1904570	CHEMBL889561	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as p3TP-luciferase reporter activity at 0.1 uM relative to control	F	Cc1cccc(-c2[nH]c(CNc3ccc(C#N)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL229495	=	Activity	%	43.0	CHEMBL4439	Homo sapiens	Activity	%	43.0
	1904571	CHEMBL889562	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as SBE luciferase reporter activity at 0.1 uM relative to control	F	Cc1cccc(-c2[nH]c(CNc3cccc(C#N)c3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL387747	=	Activity	%	36.0	CHEMBL4439	Homo sapiens	Activity	%	36.0
	1904572	CHEMBL889562	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as SBE luciferase reporter activity at 0.1 uM relative to control	F	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	Activity	%	68.0	CHEMBL4439	Homo sapiens	Activity	%	68.0
	1904573	CHEMBL889562	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as SBE luciferase reporter activity at 0.1 uM relative to control	F	Cc1cccc(-c2[nH]c(NCc3ccc(C#N)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL445934	=	Activity	%	66.0	CHEMBL4439	Homo sapiens	Activity	%	66.0
	1904574	CHEMBL889562	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as SBE luciferase reporter activity at 0.1 uM relative to control	F	Cc1cccc(-c2[nH]c(NCc3cccc(C#N)c3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226734	=	Activity	%	52.0	CHEMBL4439	Homo sapiens	Activity	%	52.0
	1904575	CHEMBL889562	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as SBE luciferase reporter activity at 0.1 uM relative to control	F	CCc1cccc(-c2[nH]c(CNc3ccc(C(N)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL226733	=	Activity	%	112.0	CHEMBL4439	Homo sapiens	Activity	%	112.0
	1904576	CHEMBL889562	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as SBE luciferase reporter activity at 0.1 uM relative to control	F	CCc1cccc(-c2[nH]c(CNc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL376119	=	Activity	%	95.0	CHEMBL4439	Homo sapiens	Activity	%	95.0
	1904577	CHEMBL889562	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as SBE luciferase reporter activity at 0.1 uM relative to control	F	Cc1cccc(-c2[nH]c(CNc3ccc(C(N)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL229654	=	Activity	%	101.0	CHEMBL4439	Homo sapiens	Activity	%	101.0
	1904578	CHEMBL889562	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as SBE luciferase reporter activity at 0.1 uM relative to control	F	Cc1cccc(-c2[nH]c(CNc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL229599	=	Activity	%	95.0	CHEMBL4439	Homo sapiens	Activity	%	95.0
	1904579	CHEMBL889562	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as SBE luciferase reporter activity at 0.1 uM relative to control	F	CCc1cccc(-c2[nH]c(CNc3ccc(C(N)=O)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL389079	=	Activity	%	96.0	CHEMBL4439	Homo sapiens	Activity	%	96.0
	1904580	CHEMBL889562	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as SBE luciferase reporter activity at 0.1 uM relative to control	F	CCc1cccc(-c2[nH]c(CNc3cccc(C(N)=O)c3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL229598	=	Activity	%	59.0	CHEMBL4439	Homo sapiens	Activity	%	59.0
	1904581	CHEMBL889562	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as SBE luciferase reporter activity at 0.1 uM relative to control	F	Cc1cccc(-c2[nH]c(CNc3ccc(C(N)=O)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL229597	=	Activity	%	67.0	CHEMBL4439	Homo sapiens	Activity	%	67.0
	1904582	CHEMBL889562	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as SBE luciferase reporter activity at 0.1 uM relative to control	F	Cc1cccc(-c2[nH]c(CNc3cccc(C(N)=O)c3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL389078	=	Activity	%	54.0	CHEMBL4439	Homo sapiens	Activity	%	54.0
	1904583	CHEMBL889562	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as SBE luciferase reporter activity at 0.1 uM relative to control	F	CCc1cccc(-c2[nH]c(CNc3ccc(C#N)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL229548	=	Activity	%	40.0	CHEMBL4439	Homo sapiens	Activity	%	40.0
	1904584	CHEMBL889562	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as SBE luciferase reporter activity at 0.1 uM relative to control	F	CCc1cccc(-c2[nH]c(CNc3cccc(C#N)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL229547	=	Activity	%	62.0	CHEMBL4439	Homo sapiens	Activity	%	62.0
	1904585	CHEMBL889562	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as SBE luciferase reporter activity at 0.1 uM relative to control	F	Cc1cccc(-c2[nH]c(CNc3ccc(C#N)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL229546	=	Activity	%	23.0	CHEMBL4439	Homo sapiens	Activity	%	23.0
	1904586	CHEMBL889562	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as SBE luciferase reporter activity at 0.1 uM relative to control	F	Cc1cccc(-c2[nH]c(CNc3cccc(C#N)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL387748	=	Activity	%	25.0	CHEMBL4439	Homo sapiens	Activity	%	25.0
	1904587	CHEMBL889562	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as SBE luciferase reporter activity at 0.1 uM relative to control	F	CCc1cccc(-c2[nH]c(CNc3ccc(C#N)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL229497	=	Activity	%	99.0	CHEMBL4439	Homo sapiens	Activity	%	99.0
	1904588	CHEMBL889562	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as SBE luciferase reporter activity at 0.1 uM relative to control	F	CCc1cccc(-c2[nH]c(CNc3cccc(C#N)c3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL229496	=	Activity	%	33.0	CHEMBL4439	Homo sapiens	Activity	%	33.0
	1904589	CHEMBL889562	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as SBE luciferase reporter activity at 0.1 uM relative to control	F	Cc1cccc(-c2[nH]c(CNc3ccc(C#N)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL229495	=	Activity	%	35.0	CHEMBL4439	Homo sapiens	Activity	%	35.0
	1904590	CHEMBL889563	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as ARE-luciferase reporter activity at 0.1 uM relative to control	F	Cc1cccc(-c2[nH]c(CNc3cccc(C#N)c3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL387747	=	Activity	%	62.0	CHEMBL4439	Homo sapiens	Activity	%	62.0
	1904591	CHEMBL889563	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as ARE-luciferase reporter activity at 0.1 uM relative to control	F	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	Activity	%	128.0	CHEMBL4439	Homo sapiens	Activity	%	128.0
	1904592	CHEMBL889563	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as ARE-luciferase reporter activity at 0.1 uM relative to control	F	Cc1cccc(-c2[nH]c(NCc3ccc(C#N)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL445934	=	Activity	%	129.0	CHEMBL4439	Homo sapiens	Activity	%	129.0
	1904593	CHEMBL889563	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as ARE-luciferase reporter activity at 0.1 uM relative to control	F	Cc1cccc(-c2[nH]c(NCc3cccc(C#N)c3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226734	=	Activity	%	95.0	CHEMBL4439	Homo sapiens	Activity	%	95.0
	1904594	CHEMBL889563	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as ARE-luciferase reporter activity at 0.1 uM relative to control	F	CCc1cccc(-c2[nH]c(CNc3ccc(C(N)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL226733	=	Activity	%	98.0	CHEMBL4439	Homo sapiens	Activity	%	98.0
	1904595	CHEMBL889563	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as ARE-luciferase reporter activity at 0.1 uM relative to control	F	CCc1cccc(-c2[nH]c(CNc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL376119	=	Activity	%	96.0	CHEMBL4439	Homo sapiens	Activity	%	96.0
	1904596	CHEMBL889563	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as ARE-luciferase reporter activity at 0.1 uM relative to control	F	Cc1cccc(-c2[nH]c(CNc3ccc(C(N)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL229654	=	Activity	%	127.0	CHEMBL4439	Homo sapiens	Activity	%	127.0
	1904597	CHEMBL889563	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as ARE-luciferase reporter activity at 0.1 uM relative to control	F	Cc1cccc(-c2[nH]c(CNc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL229599	=	Activity	%	99.0	CHEMBL4439	Homo sapiens	Activity	%	99.0
	1904598	CHEMBL889563	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as ARE-luciferase reporter activity at 0.1 uM relative to control	F	CCc1cccc(-c2[nH]c(CNc3ccc(C(N)=O)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL389079	=	Activity	%	133.0	CHEMBL4439	Homo sapiens	Activity	%	133.0
	1904599	CHEMBL889563	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as ARE-luciferase reporter activity at 0.1 uM relative to control	F	CCc1cccc(-c2[nH]c(CNc3cccc(C(N)=O)c3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL229598	=	AD50	%	64.0	CHEMBL4439	Homo sapiens	AD50	%	64.0
	1904600	CHEMBL889563	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as ARE-luciferase reporter activity at 0.1 uM relative to control	F	Cc1cccc(-c2[nH]c(CNc3ccc(C(N)=O)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL229597	=	Activity	%	119.0	CHEMBL4439	Homo sapiens	Activity	%	119.0
	1904601	CHEMBL889563	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as ARE-luciferase reporter activity at 0.1 uM relative to control	F	Cc1cccc(-c2[nH]c(CNc3cccc(C(N)=O)c3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL389078	=	Activity	%	79.0	CHEMBL4439	Homo sapiens	Activity	%	79.0
	1904602	CHEMBL889563	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as ARE-luciferase reporter activity at 0.1 uM relative to control	F	CCc1cccc(-c2[nH]c(CNc3ccc(C#N)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL229548	=	Activity	%	61.0	CHEMBL4439	Homo sapiens	Activity	%	61.0
	1904603	CHEMBL889563	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as ARE-luciferase reporter activity at 0.1 uM relative to control	F	CCc1cccc(-c2[nH]c(CNc3cccc(C#N)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL229547	=	Activity	%	79.0	CHEMBL4439	Homo sapiens	Activity	%	79.0
	1904604	CHEMBL889563	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as ARE-luciferase reporter activity at 0.1 uM relative to control	F	Cc1cccc(-c2[nH]c(CNc3ccc(C#N)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL229546	=	Activity	%	55.0	CHEMBL4439	Homo sapiens	Activity	%	55.0
	1904605	CHEMBL889563	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as ARE-luciferase reporter activity at 0.1 uM relative to control	F	Cc1cccc(-c2[nH]c(CNc3cccc(C#N)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL387748	=	Activity	%	13.0	CHEMBL4439	Homo sapiens	Activity	%	13.0
	1904606	CHEMBL889563	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as ARE-luciferase reporter activity at 0.1 uM relative to control	F	CCc1cccc(-c2[nH]c(CNc3ccc(C#N)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL229497	=	Activity	%	136.0	CHEMBL4439	Homo sapiens	Activity	%	136.0
	1904607	CHEMBL889563	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as ARE-luciferase reporter activity at 0.1 uM relative to control	F	CCc1cccc(-c2[nH]c(CNc3cccc(C#N)c3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL229496	=	Activity	%	75.0	CHEMBL4439	Homo sapiens	Activity	%	75.0
	1904608	CHEMBL889563	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as ARE-luciferase reporter activity at 0.1 uM relative to control	F	Cc1cccc(-c2[nH]c(CNc3ccc(C#N)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL229495	=	Activity	%	123.0	CHEMBL4439	Homo sapiens	Activity	%	123.0
	1904647	CHEMBL889564	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as p3TP-luciferase reporter activity at 0.05 uM relative to control	F	Cc1cccc(-c2[nH]c(CNc3cccc(C#N)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL387748	>	Inhibition	%	90.0	CHEMBL4439	Homo sapiens	Inhibition	%	90.0
Not Active	1904648	CHEMBL889564	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as p3TP-luciferase reporter activity at 0.05 uM relative to control	F	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084		Activity			CHEMBL4439	Homo sapiens	Activity		
	1904649	CHEMBL889564	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as p3TP-luciferase reporter activity at 0.05 uM relative to control	F	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Inhibition	%	23.0	CHEMBL4439	Homo sapiens	Inhibition	%	23.0
	1904650	CHEMBL889564	Inhibition of TGF-beta induced ALK5 activity in HaCaT cells assessed as p3TP-luciferase reporter activity at 0.05 uM relative to control	F	Cc1cccc(C2NC(C(C)(C)C)=NC2c2ccc3nccnc3c2)n1		CHEMBL226632	=	Inhibition	%	9.0	CHEMBL4439	Homo sapiens	Inhibition	%	9.0
	1964235	CHEMBL897072	Inhibition of Alk5	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	<	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	pIC50		5.0
	1964244	CHEMBL897072	Inhibition of Alk5	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	<	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	pIC50		5.0
	1965877	CHEMBL897419	Inhibition of TGFBR1	B	Fc1ccc(Cl)cc1-c1nc(Nc2ccncc2)c2nccnc2n1		CHEMBL238125	=	IC50	nM	53.0	CHEMBL4439	Homo sapiens	IC50	nM	53.0
	1965878	CHEMBL897419	Inhibition of TGFBR1	B	O=C(NCCCN1CCCC1=O)c1cnccc1Nc1nc(-c2cc(Br)ccc2F)nc2nccnc12		CHEMBL234655	=	IC50	nM	3.2	CHEMBL4439	Homo sapiens	IC50	nM	3.2
	1986222	CHEMBL899823	Inhibition of ALK5	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	IC50	nM	296.0	CHEMBL4439	Homo sapiens	IC50	nM	296.0
	2109496	CHEMBL935200	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as p3TP-luciferase activity at 0.1 uM	B	N#Cc1cccc(CNc2nc(-c3ccc4c(c3)OCO4)c(-c3ccccn3)s2)c1		CHEMBL255219	=	Activity	%	8.0	CHEMBL4439	Homo sapiens	Activity	%	8.0
	2109497	CHEMBL935201	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as ARE-luciferase activity at 0.1 uM	B	N#Cc1cccc(CNc2nc(-c3ccc4c(c3)OCO4)c(-c3ccccn3)s2)c1		CHEMBL255219	=	Activity	%	12.0	CHEMBL4439	Homo sapiens	Activity	%	12.0
	2109498	CHEMBL935199	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as SBE-luciferase activity at 0.1 uM	B	N#Cc1cccc(CNc2nc(-c3ccc4c(c3)OCO4)c(-c3ccccn3)s2)c1		CHEMBL255219	=	Activity	%	39.0	CHEMBL4439	Homo sapiens	Activity	%	39.0
	2109499	CHEMBL935200	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as p3TP-luciferase activity at 0.1 uM	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3nccnc3c2)n1		CHEMBL401570	=	Activity	%	95.0	CHEMBL4439	Homo sapiens	Activity	%	95.0
	2109500	CHEMBL935200	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as p3TP-luciferase activity at 0.1 uM	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Activity	%	97.0	CHEMBL4439	Homo sapiens	Activity	%	97.0
	2109501	CHEMBL935200	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as p3TP-luciferase activity at 0.1 uM	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	Activity	%	75.0	CHEMBL4439	Homo sapiens	Activity	%	75.0
	2109502	CHEMBL935200	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as p3TP-luciferase activity at 0.1 uM	B	CCc1cccc(-c2sc(NCc3ccc(C(N)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL257950	=	Activity	%	9.0	CHEMBL4439	Homo sapiens	Activity	%	9.0
	2109503	CHEMBL935200	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as p3TP-luciferase activity at 0.1 uM	B	CCc1cccc(-c2sc(NCc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL257954	=	Activity	%	98.0	CHEMBL4439	Homo sapiens	Activity	%	98.0
	2109504	CHEMBL935200	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as p3TP-luciferase activity at 0.1 uM	B	Cc1cccc(-c2sc(NCc3ccc(C(N)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL440403	=	Activity	%	9.0	CHEMBL4439	Homo sapiens	Activity	%	9.0
	2109505	CHEMBL935200	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as p3TP-luciferase activity at 0.1 uM	B	Cc1cccc(-c2sc(NCc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL403472	=	Activity	%	98.0	CHEMBL4439	Homo sapiens	Activity	%	98.0
	2109506	CHEMBL935200	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as p3TP-luciferase activity at 0.1 uM	B	NC(=O)c1ccc(CNc2nc(-c3ccc4nccnc4c3)c(-c3ccccn3)s2)cc1		CHEMBL403473	=	Activity	%	26.0	CHEMBL4439	Homo sapiens	Activity	%	26.0
	2109507	CHEMBL935200	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as p3TP-luciferase activity at 0.1 uM	B	NC(=O)c1cccc(CNc2nc(-c3ccc4nccnc4c3)c(-c3ccccn3)s2)c1		CHEMBL429735	=	Activity	%	10.0	CHEMBL4439	Homo sapiens	Activity	%	10.0
	2109508	CHEMBL935200	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as p3TP-luciferase activity at 0.1 uM	B	CCc1cccc(-c2sc(NCc3ccc(C(N)=O)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL270600	=	Activity	%	26.0	CHEMBL4439	Homo sapiens	Activity	%	26.0
	2109509	CHEMBL935200	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as p3TP-luciferase activity at 0.1 uM	B	CCc1cccc(-c2sc(NCc3cccc(C(N)=O)c3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL255986	=	Activity	%	9.0	CHEMBL4439	Homo sapiens	Activity	%	9.0
	2109510	CHEMBL935200	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as p3TP-luciferase activity at 0.1 uM	B	Cc1cccc(-c2sc(NCc3ccc(C(N)=O)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL438155	=	Activity	%	9.0	CHEMBL4439	Homo sapiens	Activity	%	9.0
	2109511	CHEMBL935200	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as p3TP-luciferase activity at 0.1 uM	B	Cc1cccc(-c2sc(NCc3cccc(C(N)=O)c3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL255987	=	Activity	%	7.0	CHEMBL4439	Homo sapiens	Activity	%	7.0
	2109512	CHEMBL935200	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as p3TP-luciferase activity at 0.1 uM	B	NC(=O)c1ccc(CNc2nc(-c3ccc4c(c3)OCO4)c(-c3ccccn3)s2)cc1		CHEMBL403733	=	Activity	%	56.0	CHEMBL4439	Homo sapiens	Activity	%	56.0
	2109513	CHEMBL935200	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as p3TP-luciferase activity at 0.1 uM	B	NC(=O)c1cccc(CNc2nc(-c3ccc4c(c3)OCO4)c(-c3ccccn3)s2)c1		CHEMBL271243	=	Activity	%	17.0	CHEMBL4439	Homo sapiens	Activity	%	17.0
	2109514	CHEMBL935200	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as p3TP-luciferase activity at 0.1 uM	B	CCc1cccc(-c2sc(NCc3ccc(C#N)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL271245	=	Activity	%	8.0	CHEMBL4439	Homo sapiens	Activity	%	8.0
	2109515	CHEMBL935200	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as p3TP-luciferase activity at 0.1 uM	B	CCc1cccc(-c2sc(NCc3cccc(C#N)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL271244	=	Activity	%	4.0	CHEMBL4439	Homo sapiens	Activity	%	4.0
	2109516	CHEMBL935200	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as p3TP-luciferase activity at 0.1 uM	B	Cc1cccc(-c2sc(NCc3ccc(C#N)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL271728	=	Activity	%	2.0	CHEMBL4439	Homo sapiens	Activity	%	2.0
	2109517	CHEMBL935200	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as p3TP-luciferase activity at 0.1 uM	B	Cc1cccc(-c2sc(NCc3cccc(C#N)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL411292	=	Activity	%	2.0	CHEMBL4439	Homo sapiens	Activity	%	2.0
	2109518	CHEMBL935200	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as p3TP-luciferase activity at 0.1 uM	B	N#Cc1ccc(CNc2nc(-c3ccc4nccnc4c3)c(-c3ccccn3)s2)cc1		CHEMBL271937	=	Activity	%	9.0	CHEMBL4439	Homo sapiens	Activity	%	9.0
	2109519	CHEMBL935200	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as p3TP-luciferase activity at 0.1 uM	B	N#Cc1cccc(CNc2nc(-c3ccc4nccnc4c3)c(-c3ccccn3)s2)c1		CHEMBL272590	=	Activity	%	5.0	CHEMBL4439	Homo sapiens	Activity	%	5.0
	2109520	CHEMBL935200	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as p3TP-luciferase activity at 0.1 uM	B	CCc1cccc(-c2sc(NCc3ccc(C#N)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL257843	=	Activity	%	27.0	CHEMBL4439	Homo sapiens	Activity	%	27.0
	2109521	CHEMBL935200	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as p3TP-luciferase activity at 0.1 uM	B	CCc1cccc(-c2sc(NCc3cccc(C#N)c3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL404157	=	Activity	%	11.0	CHEMBL4439	Homo sapiens	Activity	%	11.0
	2109522	CHEMBL935200	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as p3TP-luciferase activity at 0.1 uM	B	Cc1cccc(-c2sc(NCc3ccc(C#N)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL256487	=	Activity	%	13.0	CHEMBL4439	Homo sapiens	Activity	%	13.0
	2109523	CHEMBL935200	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as p3TP-luciferase activity at 0.1 uM	B	Cc1cccc(-c2sc(NCc3cccc(C#N)c3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL257718	=	Activity	%	5.0	CHEMBL4439	Homo sapiens	Activity	%	5.0
	2109524	CHEMBL935200	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as p3TP-luciferase activity at 0.1 uM	B	N#Cc1ccc(CNc2nc(-c3ccc4c(c3)OCO4)c(-c3ccccn3)s2)cc1		CHEMBL404546	=	Activity	%	33.0	CHEMBL4439	Homo sapiens	Activity	%	33.0
	2109525	CHEMBL935201	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as ARE-luciferase activity at 0.1 uM	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3nccnc3c2)n1		CHEMBL401570	=	Activity	%	71.0	CHEMBL4439	Homo sapiens	Activity	%	71.0
	2109526	CHEMBL935201	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as ARE-luciferase activity at 0.1 uM	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Activity	%	84.0	CHEMBL4439	Homo sapiens	Activity	%	84.0
	2109527	CHEMBL935201	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as ARE-luciferase activity at 0.1 uM	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	Activity	%	18.0	CHEMBL4439	Homo sapiens	Activity	%	18.0
	2109528	CHEMBL935201	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as ARE-luciferase activity at 0.1 uM	B	CCc1cccc(-c2sc(NCc3ccc(C(N)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL257950	=	Activity	%	27.0	CHEMBL4439	Homo sapiens	Activity	%	27.0
	2109529	CHEMBL935201	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as ARE-luciferase activity at 0.1 uM	B	CCc1cccc(-c2sc(NCc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL257954	=	Activity	%	99.0	CHEMBL4439	Homo sapiens	Activity	%	99.0
	2109530	CHEMBL935201	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as ARE-luciferase activity at 0.1 uM	B	Cc1cccc(-c2sc(NCc3ccc(C(N)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL440403	=	Activity	%	14.0	CHEMBL4439	Homo sapiens	Activity	%	14.0
	2109531	CHEMBL935201	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as ARE-luciferase activity at 0.1 uM	B	NC(=O)c1ccc(CNc2nc(-c3ccc4nccnc4c3)c(-c3ccccn3)s2)cc1		CHEMBL403473	=	Activity	%	47.0	CHEMBL4439	Homo sapiens	Activity	%	47.0
	2109532	CHEMBL935201	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as ARE-luciferase activity at 0.1 uM	B	NC(=O)c1cccc(CNc2nc(-c3ccc4nccnc4c3)c(-c3ccccn3)s2)c1		CHEMBL429735	=	Activity	%	15.0	CHEMBL4439	Homo sapiens	Activity	%	15.0
	2109533	CHEMBL935201	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as ARE-luciferase activity at 0.1 uM	B	CCc1cccc(-c2sc(NCc3ccc(C(N)=O)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL270600	=	Activity	%	74.0	CHEMBL4439	Homo sapiens	Activity	%	74.0
	2109534	CHEMBL935201	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as ARE-luciferase activity at 0.1 uM	B	CCc1cccc(-c2sc(NCc3cccc(C(N)=O)c3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL255986	=	Activity	%	32.0	CHEMBL4439	Homo sapiens	Activity	%	32.0
	2109535	CHEMBL935201	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as ARE-luciferase activity at 0.1 uM	B	Cc1cccc(-c2sc(NCc3ccc(C(N)=O)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL438155	=	Activity	%	39.0	CHEMBL4439	Homo sapiens	Activity	%	39.0
	2109536	CHEMBL935201	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as ARE-luciferase activity at 0.1 uM	B	Cc1cccc(-c2sc(NCc3cccc(C(N)=O)c3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL255987	=	Activity	%	17.0	CHEMBL4439	Homo sapiens	Activity	%	17.0
	2109537	CHEMBL935201	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as ARE-luciferase activity at 0.1 uM	B	NC(=O)c1ccc(CNc2nc(-c3ccc4c(c3)OCO4)c(-c3ccccn3)s2)cc1		CHEMBL403733	=	Activity	%	84.0	CHEMBL4439	Homo sapiens	Activity	%	84.0
	2109538	CHEMBL935201	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as ARE-luciferase activity at 0.1 uM	B	NC(=O)c1cccc(CNc2nc(-c3ccc4c(c3)OCO4)c(-c3ccccn3)s2)c1		CHEMBL271243	=	Activity	%	37.0	CHEMBL4439	Homo sapiens	Activity	%	37.0
	2109539	CHEMBL935201	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as ARE-luciferase activity at 0.1 uM	B	CCc1cccc(-c2sc(NCc3ccc(C#N)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL271245	=	Activity	%	26.0	CHEMBL4439	Homo sapiens	Activity	%	26.0
	2109540	CHEMBL935201	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as ARE-luciferase activity at 0.1 uM	B	CCc1cccc(-c2sc(NCc3cccc(C#N)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL271244	=	Activity	%	13.0	CHEMBL4439	Homo sapiens	Activity	%	13.0
	2109541	CHEMBL935201	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as ARE-luciferase activity at 0.1 uM	B	Cc1cccc(-c2sc(NCc3ccc(C#N)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL271728	=	Activity	%	5.0	CHEMBL4439	Homo sapiens	Activity	%	5.0
	2109542	CHEMBL935201	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as ARE-luciferase activity at 0.1 uM	B	Cc1cccc(-c2sc(NCc3cccc(C#N)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL411292	=	Activity	%	4.0	CHEMBL4439	Homo sapiens	Activity	%	4.0
	2109543	CHEMBL935201	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as ARE-luciferase activity at 0.1 uM	B	N#Cc1ccc(CNc2nc(-c3ccc4nccnc4c3)c(-c3ccccn3)s2)cc1		CHEMBL271937	=	Activity	%	16.0	CHEMBL4439	Homo sapiens	Activity	%	16.0
	2109544	CHEMBL935201	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as ARE-luciferase activity at 0.1 uM	B	N#Cc1cccc(CNc2nc(-c3ccc4nccnc4c3)c(-c3ccccn3)s2)c1		CHEMBL272590	=	Activity	%	5.0	CHEMBL4439	Homo sapiens	Activity	%	5.0
	2109545	CHEMBL935201	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as ARE-luciferase activity at 0.1 uM	B	CCc1cccc(-c2sc(NCc3ccc(C#N)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL257843	=	Activity	%	84.0	CHEMBL4439	Homo sapiens	Activity	%	84.0
	2109546	CHEMBL935201	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as ARE-luciferase activity at 0.1 uM	B	CCc1cccc(-c2sc(NCc3cccc(C#N)c3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL404157	=	Activity	%	45.0	CHEMBL4439	Homo sapiens	Activity	%	45.0
	2109547	CHEMBL935201	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as ARE-luciferase activity at 0.1 uM	B	Cc1cccc(-c2sc(NCc3ccc(C#N)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL256487	=	Activity	%	46.0	CHEMBL4439	Homo sapiens	Activity	%	46.0
	2109548	CHEMBL935201	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as ARE-luciferase activity at 0.1 uM	B	Cc1cccc(-c2sc(NCc3cccc(C#N)c3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL257718	=	Activity	%	6.0	CHEMBL4439	Homo sapiens	Activity	%	6.0
	2109549	CHEMBL935201	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as ARE-luciferase activity at 0.1 uM	B	N#Cc1ccc(CNc2nc(-c3ccc4c(c3)OCO4)c(-c3ccccn3)s2)cc1		CHEMBL404546	=	Activity	%	68.0	CHEMBL4439	Homo sapiens	Activity	%	68.0
	2109550	CHEMBL935199	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as SBE-luciferase activity at 0.1 uM	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3nccnc3c2)n1		CHEMBL401570	=	Activity	%	74.0	CHEMBL4439	Homo sapiens	Activity	%	74.0
	2109551	CHEMBL935199	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as SBE-luciferase activity at 0.1 uM	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Activity	%	75.0	CHEMBL4439	Homo sapiens	Activity	%	75.0
	2109552	CHEMBL935199	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as SBE-luciferase activity at 0.1 uM	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	Activity	%	51.0	CHEMBL4439	Homo sapiens	Activity	%	51.0
	2109553	CHEMBL935199	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as SBE-luciferase activity at 0.1 uM	B	CCc1cccc(-c2sc(NCc3ccc(C(N)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL257950	=	Activity	%	31.0	CHEMBL4439	Homo sapiens	Activity	%	31.0
	2109554	CHEMBL935199	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as SBE-luciferase activity at 0.1 uM	B	CCc1cccc(-c2sc(NCc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL257954	=	Activity	%	68.0	CHEMBL4439	Homo sapiens	Activity	%	68.0
	2109555	CHEMBL935199	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as SBE-luciferase activity at 0.1 uM	B	Cc1cccc(-c2sc(NCc3ccc(C(N)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL440403	=	Activity	%	29.0	CHEMBL4439	Homo sapiens	Activity	%	29.0
	2109556	CHEMBL935199	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as SBE-luciferase activity at 0.1 uM	B	Cc1cccc(-c2sc(NCc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL403472	=	Activity	%	78.0	CHEMBL4439	Homo sapiens	Activity	%	78.0
	2109557	CHEMBL935199	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as SBE-luciferase activity at 0.1 uM	B	NC(=O)c1ccc(CNc2nc(-c3ccc4nccnc4c3)c(-c3ccccn3)s2)cc1		CHEMBL403473	=	Activity	%	45.0	CHEMBL4439	Homo sapiens	Activity	%	45.0
	2109558	CHEMBL935199	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as SBE-luciferase activity at 0.1 uM	B	NC(=O)c1cccc(CNc2nc(-c3ccc4nccnc4c3)c(-c3ccccn3)s2)c1		CHEMBL429735	=	Activity	%	41.0	CHEMBL4439	Homo sapiens	Activity	%	41.0
	2109559	CHEMBL935199	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as SBE-luciferase activity at 0.1 uM	B	CCc1cccc(-c2sc(NCc3ccc(C(N)=O)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL270600	=	Activity	%	59.0	CHEMBL4439	Homo sapiens	Activity	%	59.0
	2109560	CHEMBL935199	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as SBE-luciferase activity at 0.1 uM	B	CCc1cccc(-c2sc(NCc3cccc(C(N)=O)c3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL255986	=	Activity	%	34.0	CHEMBL4439	Homo sapiens	Activity	%	34.0
	2109561	CHEMBL935199	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as SBE-luciferase activity at 0.1 uM	B	Cc1cccc(-c2sc(NCc3ccc(C(N)=O)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL438155	=	Activity	%	34.0	CHEMBL4439	Homo sapiens	Activity	%	34.0
	2109562	CHEMBL935199	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as SBE-luciferase activity at 0.1 uM	B	Cc1cccc(-c2sc(NCc3cccc(C(N)=O)c3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL255987	=	Activity	%	36.0	CHEMBL4439	Homo sapiens	Activity	%	36.0
	2109563	CHEMBL935199	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as SBE-luciferase activity at 0.1 uM	B	NC(=O)c1ccc(CNc2nc(-c3ccc4c(c3)OCO4)c(-c3ccccn3)s2)cc1		CHEMBL403733	=	Activity	%	82.0	CHEMBL4439	Homo sapiens	Activity	%	82.0
	2109564	CHEMBL935199	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as SBE-luciferase activity at 0.1 uM	B	NC(=O)c1cccc(CNc2nc(-c3ccc4c(c3)OCO4)c(-c3ccccn3)s2)c1		CHEMBL271243	=	Activity	%	40.0	CHEMBL4439	Homo sapiens	Activity	%	40.0
	2109565	CHEMBL935199	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as SBE-luciferase activity at 0.1 uM	B	CCc1cccc(-c2sc(NCc3ccc(C#N)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL271245	=	Activity	%	35.0	CHEMBL4439	Homo sapiens	Activity	%	35.0
	2109566	CHEMBL935199	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as SBE-luciferase activity at 0.1 uM	B	CCc1cccc(-c2sc(NCc3cccc(C#N)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL271244	=	Activity	%	35.0	CHEMBL4439	Homo sapiens	Activity	%	35.0
	2109567	CHEMBL935199	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as SBE-luciferase activity at 0.1 uM	B	Cc1cccc(-c2sc(NCc3ccc(C#N)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL271728	=	Activity	%	33.0	CHEMBL4439	Homo sapiens	Activity	%	33.0
	2109568	CHEMBL935199	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as SBE-luciferase activity at 0.1 uM	B	Cc1cccc(-c2sc(NCc3cccc(C#N)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL411292	=	Activity	%	32.0	CHEMBL4439	Homo sapiens	Activity	%	32.0
	2109569	CHEMBL935199	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as SBE-luciferase activity at 0.1 uM	B	N#Cc1ccc(CNc2nc(-c3ccc4nccnc4c3)c(-c3ccccn3)s2)cc1		CHEMBL271937	=	Activity	%	40.0	CHEMBL4439	Homo sapiens	Activity	%	40.0
	2109570	CHEMBL935199	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as SBE-luciferase activity at 0.1 uM	B	N#Cc1cccc(CNc2nc(-c3ccc4nccnc4c3)c(-c3ccccn3)s2)c1		CHEMBL272590	=	Activity	%	47.0	CHEMBL4439	Homo sapiens	Activity	%	47.0
	2109571	CHEMBL935199	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as SBE-luciferase activity at 0.1 uM	B	CCc1cccc(-c2sc(NCc3ccc(C#N)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL257843	=	Activity	%	57.0	CHEMBL4439	Homo sapiens	Activity	%	57.0
	2109572	CHEMBL935199	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as SBE-luciferase activity at 0.1 uM	B	CCc1cccc(-c2sc(NCc3cccc(C#N)c3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL404157	=	Activity	%	41.0	CHEMBL4439	Homo sapiens	Activity	%	41.0
	2109573	CHEMBL935199	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as SBE-luciferase activity at 0.1 uM	B	Cc1cccc(-c2sc(NCc3ccc(C#N)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL256487	=	Activity	%	39.0	CHEMBL4439	Homo sapiens	Activity	%	39.0
	2109574	CHEMBL935199	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as SBE-luciferase activity at 0.1 uM	B	Cc1cccc(-c2sc(NCc3cccc(C#N)c3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL257718	=	Activity	%	35.0	CHEMBL4439	Homo sapiens	Activity	%	35.0
	2109575	CHEMBL935199	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as SBE-luciferase activity at 0.1 uM	B	N#Cc1ccc(CNc2nc(-c3ccc4c(c3)OCO4)c(-c3ccccn3)s2)cc1		CHEMBL404546	=	Activity	%	64.0	CHEMBL4439	Homo sapiens	Activity	%	64.0
	2109576	CHEMBL935201	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as ARE-luciferase activity at 0.1 uM	B	Cc1cccc(-c2sc(NCc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL403472	=	Activity	%	96.0	CHEMBL4439	Homo sapiens	Activity	%	96.0
Dose-dependent effect	2109577	CHEMBL935202	Inhibition of TGF-beta-induced ALK5 in human HaCaT cells assessed as p3TP-luciferase activity	B	Cc1cccc(-c2sc(NCc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL403472		Activity			CHEMBL4439	Homo sapiens	Activity		
	2136860	CHEMBL937181	Inhibition of ALK5	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	IC50	nM	500.0	CHEMBL4439	Homo sapiens	IC50	nM	500.0
Not Evaluated	2149614	CHEMBL931311	Inhibition of human TGFbeta R1	B	NC(=O)c1c(NC(=O)C2CC2)sc2c1CCCC2		CHEMBL379367		Activity			CHEMBL4439	Homo sapiens	Activity		
	2153574	CHEMBL928261	Inhibition of TGFbeta type receptor 1 ALK5 (T204D) expressed in Sf9 cells	B	Clc1cc(-c2c(-c3ccccn3)nn3c2CCC3)c2ccccc2n1		CHEMBL406407	=	IC50	nM	19800.0	CHEMBL4439	Homo sapiens	IC50	uM	19.8
	2153575	CHEMBL928261	Inhibition of TGFbeta type receptor 1 ALK5 (T204D) expressed in Sf9 cells	B	CN(C)C(=O)c1ccc(Oc2ccc3c(-c4c(-c5ccccn5)nn5c4CCC5)ccnc3c2)cc1		CHEMBL261702	=	IC50	nM	1100.0	CHEMBL4439	Homo sapiens	IC50	uM	1.1
	2153576	CHEMBL928261	Inhibition of TGFbeta type receptor 1 ALK5 (T204D) expressed in Sf9 cells	B	O=C(O)c1ccc(Oc2ccc3c(-c4c(-c5ccccn5)nn5c4CCC5)ccnc3c2)cc1		CHEMBL261701	=	IC50	nM	4800.0	CHEMBL4439	Homo sapiens	IC50	uM	4.8
	2153577	CHEMBL928261	Inhibition of TGFbeta type receptor 1 ALK5 (T204D) expressed in Sf9 cells	B	NC(=O)c1ccc(Oc2ccc3c(-c4c(-c5ccccn5)nn5c4CCC5)ccnc3c2)cc1		CHEMBL260729	=	IC50	nM	1100.0	CHEMBL4439	Homo sapiens	IC50	uM	1.1
	2153578	CHEMBL928261	Inhibition of TGFbeta type receptor 1 ALK5 (T204D) expressed in Sf9 cells	B	N#Cc1ccc(Oc2ccc3c(-c4c(-c5ccccn5)nn5c4CCC5)ccnc3c2)cc1		CHEMBL258641	=	IC50	nM	1200.0	CHEMBL4439	Homo sapiens	IC50	uM	1.2
	2153579	CHEMBL928261	Inhibition of TGFbeta type receptor 1 ALK5 (T204D) expressed in Sf9 cells	B	CN1CCCC1CCCOc1ccc2c(-c3c(-c4ccccn4)nn4c3CCC4)ccnc2c1		CHEMBL406411	=	IC50	nM	72.0	CHEMBL4439	Homo sapiens	IC50	uM	0.072
	2153580	CHEMBL928261	Inhibition of TGFbeta type receptor 1 ALK5 (T204D) expressed in Sf9 cells	B	c1ccc(-c2nn3c(c2-c2ccnc4cc(OCC5CCCO5)ccc24)CCC3)nc1		CHEMBL409158	=	IC50	nM	130.0	CHEMBL4439	Homo sapiens	IC50	uM	0.13
	2153581	CHEMBL928261	Inhibition of TGFbeta type receptor 1 ALK5 (T204D) expressed in Sf9 cells	B	CN1CCN(C(=O)COc2ccc3c(-c4c(-c5ccccn5)nn5c4CCC5)ccnc3c2)CC1		CHEMBL409356	=	IC50	nM	49.0	CHEMBL4439	Homo sapiens	IC50	uM	0.049
	2153582	CHEMBL928261	Inhibition of TGFbeta type receptor 1 ALK5 (T204D) expressed in Sf9 cells	B	CN(C)CCCCCOc1ccc2c(-c3c(-c4ccccn4)nn4c3CCC4)ccnc2c1		CHEMBL411855	=	IC50	nM	47.0	CHEMBL4439	Homo sapiens	IC50	uM	0.047
	2153583	CHEMBL928261	Inhibition of TGFbeta type receptor 1 ALK5 (T204D) expressed in Sf9 cells	B	c1ccc(-c2nn3c(c2-c2ccnc4cc(OCCN5CCOCC5)ccc24)CCC3)nc1		CHEMBL260015	=	IC50	nM	69.0	CHEMBL4439	Homo sapiens	IC50	uM	0.069
	2153584	CHEMBL928261	Inhibition of TGFbeta type receptor 1 ALK5 (T204D) expressed in Sf9 cells	B	CN1CCN(CCOc2ccc3c(-c4c(-c5ccccn5)nn5c4CCC5)ccnc3c2)CC1		CHEMBL409331	=	IC50	nM	100.0	CHEMBL4439	Homo sapiens	IC50	uM	0.1
	2153585	CHEMBL928261	Inhibition of TGFbeta type receptor 1 ALK5 (T204D) expressed in Sf9 cells	B	CCN(C)CCOc1ccc2c(-c3c(-c4ccccn4)nn4c3CCC4)ccnc2c1		CHEMBL411297	=	IC50	nM	85.0	CHEMBL4439	Homo sapiens	IC50	uM	0.085
	2153586	CHEMBL928261	Inhibition of TGFbeta type receptor 1 ALK5 (T204D) expressed in Sf9 cells	B	CN(C)CCOc1ccc2c(-c3c(-c4ccccn4)nn4c3CCC4)ccnc2c1		CHEMBL409525	=	IC50	nM	24.0	CHEMBL4439	Homo sapiens	IC50	uM	0.024
	2153587	CHEMBL928261	Inhibition of TGFbeta type receptor 1 ALK5 (T204D) expressed in Sf9 cells	B	ClCCOc1ccc2c(-c3c(-c4ccccn4)nn4c3CCC4)ccnc2c1		CHEMBL261762	=	IC50	nM	33.0	CHEMBL4439	Homo sapiens	IC50	uM	0.033
	2153588	CHEMBL928261	Inhibition of TGFbeta type receptor 1 ALK5 (T204D) expressed in Sf9 cells	B	CN1CCN(CCCOc2ccc3c(-c4c(-c5ccccn5)nn5c4CCC5)ccnc3c2)CC1		CHEMBL261674	=	IC50	nM	74.0	CHEMBL4439	Homo sapiens	IC50	uM	0.074
	2153589	CHEMBL928261	Inhibition of TGFbeta type receptor 1 ALK5 (T204D) expressed in Sf9 cells	B	Oc1ccc2c(-c3c(-c4ccccn4)nn4c3CCC4)ccnc2c1		CHEMBL260147	=	IC50	nM	160.0	CHEMBL4439	Homo sapiens	IC50	uM	0.16
	2153590	CHEMBL928261	Inhibition of TGFbeta type receptor 1 ALK5 (T204D) expressed in Sf9 cells	B	c1ccc(-c2nn3c(c2-c2cc(N4CCCC4)nc4ccccc24)CCC3)nc1		CHEMBL258964	>	IC50	nM	20000.0	CHEMBL4439	Homo sapiens	IC50	uM	20.0
	2153591	CHEMBL928261	Inhibition of TGFbeta type receptor 1 ALK5 (T204D) expressed in Sf9 cells	B	CCSc1cc(-c2c(-c3ccccn3)nn3c2CCC3)c2ccccc2n1		CHEMBL259169	>	IC50	nM	20000.0	CHEMBL4439	Homo sapiens	IC50	uM	20.0
	2153592	CHEMBL928261	Inhibition of TGFbeta type receptor 1 ALK5 (T204D) expressed in Sf9 cells	B	COc1cc(-c2c(-c3ccccn3)nn3c2CCC3)c2ccccc2n1		CHEMBL409515	>	IC50	nM	20000.0	CHEMBL4439	Homo sapiens	IC50	uM	20.0
	2153593	CHEMBL928261	Inhibition of TGFbeta type receptor 1 ALK5 (T204D) expressed in Sf9 cells	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(=O)NCCN(C)C)cc24)CCC3)n1		CHEMBL410308	=	IC50	nM	193.0	CHEMBL4439	Homo sapiens	IC50	uM	0.193
	2153594	CHEMBL928261	Inhibition of TGFbeta type receptor 1 ALK5 (T204D) expressed in Sf9 cells	B	COC(=O)c1ccc2nccc(-c3c(-c4cccc(C)n4)nn4c3CCC4)c2c1		CHEMBL408181	=	IC50	nM	526.0	CHEMBL4439	Homo sapiens	IC50	uM	0.526
	2153595	CHEMBL928261	Inhibition of TGFbeta type receptor 1 ALK5 (T204D) expressed in Sf9 cells	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(OC(F)(F)F)cc24)CCC3)n1		CHEMBL260240	=	IC50	nM	141.0	CHEMBL4439	Homo sapiens	IC50	uM	0.141
	2153596	CHEMBL928261	Inhibition of TGFbeta type receptor 1 ALK5 (T204D) expressed in Sf9 cells	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(Br)cc24)CCC3)n1		CHEMBL260923	=	IC50	nM	89.0	CHEMBL4439	Homo sapiens	IC50	uM	0.089
	2153597	CHEMBL928261	Inhibition of TGFbeta type receptor 1 ALK5 (T204D) expressed in Sf9 cells	B	Cc1cccc(-c2nn3c(c2-c2ccnc4c(F)cccc24)CCC3)n1		CHEMBL411741	=	IC50	nM	928.0	CHEMBL4439	Homo sapiens	IC50	uM	0.928
	2153598	CHEMBL928261	Inhibition of TGFbeta type receptor 1 ALK5 (T204D) expressed in Sf9 cells	B	COc1cc(OC)c2nccc(-c3c(-c4cccc(C)n4)nn4c3CCC4)c2c1		CHEMBL261625	=	IC50	nM	3810.0	CHEMBL4439	Homo sapiens	IC50	uM	3.81
	2153599	CHEMBL928261	Inhibition of TGFbeta type receptor 1 ALK5 (T204D) expressed in Sf9 cells	B	CN(C)Cc1ccc(Oc2ccc3c(-c4c(-c5ccccn5)nn5c4CCC5)ccnc3c2)cc1		CHEMBL260239	=	IC50	nM	750.0	CHEMBL4439	Homo sapiens	IC50	uM	0.75
	2153681	CHEMBL928261	Inhibition of TGFbeta type receptor 1 ALK5 (T204D) expressed in Sf9 cells	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	IC50	nM	59.0	CHEMBL4439	Homo sapiens	IC50	uM	0.059
	2341246	CHEMBL1002714	Inhibition of ALK5 by filter binding assay	B	COc1cc2nccc(Oc3ccccc3C(=O)c3ccccc3)c2cc1OC		CHEMBL482728	=	IC50	nM	16000.0	CHEMBL4439	Homo sapiens	IC50	uM	16.0
	2341248	CHEMBL1002714	Inhibition of ALK5 by filter binding assay	B	COc1cc2nccc(Oc3ccc(C)cc3C(=O)c3ccccc3)c2cc1OC.Cl		CHEMBL482729	=	IC50	nM	2700.0	CHEMBL4439	Homo sapiens	IC50	uM	2.7
	2341250	CHEMBL1002714	Inhibition of ALK5 by filter binding assay	B	COc1cc2nccc(Oc3ccc(C)cc3C(C)=O)c2cc1OC		CHEMBL484907	=	IC50	nM	4400.0	CHEMBL4439	Homo sapiens	IC50	uM	4.4
	2341252	CHEMBL1002714	Inhibition of ALK5 by filter binding assay	B	COc1cc2nccc(Oc3cc(C)c(C)cc3C(C)=O)c2cc1OC		CHEMBL500149	=	IC50	nM	630.0	CHEMBL4439	Homo sapiens	IC50	uM	0.63
	2403437	CHEMBL963229	Inhibition of human ALK5 activity in human HaCaT cells assessed as p3TP-luciferase reporter activity at 0.5 uM	B	NS(=O)(=O)c1ccc(Cc2nc(-c3ccc4nccnc4c3)c(-c3ccccn3)[nH]2)cc1		CHEMBL477657	=	Activity	%	47.0	CHEMBL4439	Homo sapiens	Activity	%	47.0
	2403438	CHEMBL963229	Inhibition of human ALK5 activity in human HaCaT cells assessed as p3TP-luciferase reporter activity at 0.5 uM	B	Cc1cccc(-c2[nH]c(Cc3ccc(S(N)(=O)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL477451	=	Activity	%	7.0	CHEMBL4439	Homo sapiens	Activity	%	7.0
	2403439	CHEMBL963229	Inhibition of human ALK5 activity in human HaCaT cells assessed as p3TP-luciferase reporter activity at 0.5 uM	B	CCc1cccc(-c2[nH]c(Cc3ccc(S(N)(=O)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL514542	=	Activity	%	6.0	CHEMBL4439	Homo sapiens	Activity	%	6.0
	2403440	CHEMBL963229	Inhibition of human ALK5 activity in human HaCaT cells assessed as p3TP-luciferase reporter activity at 0.5 uM	B	CCCc1cccc(-c2[nH]c(Cc3ccc(S(N)(=O)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL477661	=	Activity	%	40.0	CHEMBL4439	Homo sapiens	Activity	%	40.0
	2403441	CHEMBL963229	Inhibition of human ALK5 activity in human HaCaT cells assessed as p3TP-luciferase reporter activity at 0.5 uM	B	CC(C)c1cccc(-c2[nH]c(Cc3ccc(S(N)(=O)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL515486	=	Activity	%	88.0	CHEMBL4439	Homo sapiens	Activity	%	88.0
	2403442	CHEMBL963229	Inhibition of human ALK5 activity in human HaCaT cells assessed as p3TP-luciferase reporter activity at 0.5 uM	B	CCCCc1cccc(-c2[nH]c(Cc3ccc(S(N)(=O)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL477663	=	Activity	%	70.0	CHEMBL4439	Homo sapiens	Activity	%	70.0
	2403443	CHEMBL963229	Inhibition of human ALK5 activity in human HaCaT cells assessed as p3TP-luciferase reporter activity at 0.5 uM	B	NS(=O)(=O)c1ccc(CCc2nc(-c3ccc4nccnc4c3)c(-c3ccccn3)[nH]2)cc1		CHEMBL477664	=	Activity	%	60.0	CHEMBL4439	Homo sapiens	Activity	%	60.0
	2403444	CHEMBL963229	Inhibition of human ALK5 activity in human HaCaT cells assessed as p3TP-luciferase reporter activity at 0.5 uM	B	Cc1cccc(-c2[nH]c(CCc3ccc(S(N)(=O)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL514700	=	Activity	%	13.0	CHEMBL4439	Homo sapiens	Activity	%	13.0
	2403445	CHEMBL963229	Inhibition of human ALK5 activity in human HaCaT cells assessed as p3TP-luciferase reporter activity at 0.5 uM	B	CCc1cccc(-c2[nH]c(CCc3ccc(S(N)(=O)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL477453	=	Activity	%	9.0	CHEMBL4439	Homo sapiens	Activity	%	9.0
	2403446	CHEMBL963229	Inhibition of human ALK5 activity in human HaCaT cells assessed as p3TP-luciferase reporter activity at 0.5 uM	B	CCCc1cccc(-c2[nH]c(CCc3ccc(S(N)(=O)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL477454	=	Activity	%	16.0	CHEMBL4439	Homo sapiens	Activity	%	16.0
	2403447	CHEMBL963229	Inhibition of human ALK5 activity in human HaCaT cells assessed as p3TP-luciferase reporter activity at 0.5 uM	B	CC(C)c1cccc(-c2[nH]c(CCc3ccc(S(N)(=O)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL477866	=	Activity	%	102.0	CHEMBL4439	Homo sapiens	Activity	%	102.0
	2403448	CHEMBL963229	Inhibition of human ALK5 activity in human HaCaT cells assessed as p3TP-luciferase reporter activity at 0.5 uM	B	CCCCc1cccc(-c2[nH]c(CCc3ccc(S(N)(=O)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL514539	=	Activity	%	123.0	CHEMBL4439	Homo sapiens	Activity	%	123.0
	2403449	CHEMBL963229	Inhibition of human ALK5 activity in human HaCaT cells assessed as p3TP-luciferase reporter activity at 0.5 uM	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	Activity	%	25.0	CHEMBL4439	Homo sapiens	Activity	%	25.0
	2403450	CHEMBL963230	Inhibition of human ALK5 activity in human HaCaT cells assessed as ARE-luciferase reporter activity at 0.5 uM	B	NS(=O)(=O)c1ccc(Cc2nc(-c3ccc4nccnc4c3)c(-c3ccccn3)[nH]2)cc1		CHEMBL477657	=	Activity	%	90.0	CHEMBL4439	Homo sapiens	Activity	%	90.0
	2403451	CHEMBL963230	Inhibition of human ALK5 activity in human HaCaT cells assessed as ARE-luciferase reporter activity at 0.5 uM	B	Cc1cccc(-c2[nH]c(Cc3ccc(S(N)(=O)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL477451	=	Activity	%	40.0	CHEMBL4439	Homo sapiens	Activity	%	40.0
	2403452	CHEMBL963230	Inhibition of human ALK5 activity in human HaCaT cells assessed as ARE-luciferase reporter activity at 0.5 uM	B	CCc1cccc(-c2[nH]c(Cc3ccc(S(N)(=O)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL514542	=	Activity	%	38.0	CHEMBL4439	Homo sapiens	Activity	%	38.0
	2403453	CHEMBL963230	Inhibition of human ALK5 activity in human HaCaT cells assessed as ARE-luciferase reporter activity at 0.5 uM	B	CCCc1cccc(-c2[nH]c(Cc3ccc(S(N)(=O)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL477661	=	Activity	%	107.0	CHEMBL4439	Homo sapiens	Activity	%	107.0
	2403454	CHEMBL963230	Inhibition of human ALK5 activity in human HaCaT cells assessed as ARE-luciferase reporter activity at 0.5 uM	B	CC(C)c1cccc(-c2[nH]c(Cc3ccc(S(N)(=O)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL515486	=	Activity	%	128.0	CHEMBL4439	Homo sapiens	Activity	%	128.0
	2403455	CHEMBL963230	Inhibition of human ALK5 activity in human HaCaT cells assessed as ARE-luciferase reporter activity at 0.5 uM	B	CCCCc1cccc(-c2[nH]c(Cc3ccc(S(N)(=O)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL477663	=	Activity	%	109.0	CHEMBL4439	Homo sapiens	Activity	%	109.0
	2403456	CHEMBL963230	Inhibition of human ALK5 activity in human HaCaT cells assessed as ARE-luciferase reporter activity at 0.5 uM	B	NS(=O)(=O)c1ccc(CCc2nc(-c3ccc4nccnc4c3)c(-c3ccccn3)[nH]2)cc1		CHEMBL477664	=	Activity	%	93.0	CHEMBL4439	Homo sapiens	Activity	%	93.0
	2403457	CHEMBL963230	Inhibition of human ALK5 activity in human HaCaT cells assessed as ARE-luciferase reporter activity at 0.5 uM	B	Cc1cccc(-c2[nH]c(CCc3ccc(S(N)(=O)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL514700	=	Activity	%	64.0	CHEMBL4439	Homo sapiens	Activity	%	64.0
	2403458	CHEMBL963230	Inhibition of human ALK5 activity in human HaCaT cells assessed as ARE-luciferase reporter activity at 0.5 uM	B	CCc1cccc(-c2[nH]c(CCc3ccc(S(N)(=O)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL477453	=	Activity	%	46.0	CHEMBL4439	Homo sapiens	Activity	%	46.0
	2403459	CHEMBL963230	Inhibition of human ALK5 activity in human HaCaT cells assessed as ARE-luciferase reporter activity at 0.5 uM	B	CCCc1cccc(-c2[nH]c(CCc3ccc(S(N)(=O)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL477454	=	Activity	%	68.0	CHEMBL4439	Homo sapiens	Activity	%	68.0
	2403460	CHEMBL963230	Inhibition of human ALK5 activity in human HaCaT cells assessed as ARE-luciferase reporter activity at 0.5 uM	B	CC(C)c1cccc(-c2[nH]c(CCc3ccc(S(N)(=O)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL477866	=	Activity	%	114.0	CHEMBL4439	Homo sapiens	Activity	%	114.0
	2403461	CHEMBL963230	Inhibition of human ALK5 activity in human HaCaT cells assessed as ARE-luciferase reporter activity at 0.5 uM	B	CCCCc1cccc(-c2[nH]c(CCc3ccc(S(N)(=O)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL514539	=	Activity	%	147.0	CHEMBL4439	Homo sapiens	Activity	%	147.0
	2403462	CHEMBL963230	Inhibition of human ALK5 activity in human HaCaT cells assessed as ARE-luciferase reporter activity at 0.5 uM	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	Activity	%	76.0	CHEMBL4439	Homo sapiens	Activity	%	76.0
Dose-dependent effect	2403476	CHEMBL963231	Inhibition of human ALK5 activity in human HaCaT cells assessed as p3TP-luciferase reporter activity	B	Cc1cccc(-c2[nH]c(Cc3ccc(S(N)(=O)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL477451		Activity			CHEMBL4439	Homo sapiens	Activity		
Dose-dependent effect	2403477	CHEMBL963232	Inhibition of human ALK5 activity in human HaCaT cells assessed as ARE-luciferase reporter activity	B	Cc1cccc(-c2[nH]c(Cc3ccc(S(N)(=O)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL477451		Activity			CHEMBL4439	Homo sapiens	Activity		
Dose-dependent effect	2403478	CHEMBL963231	Inhibition of human ALK5 activity in human HaCaT cells assessed as p3TP-luciferase reporter activity	B	CCc1cccc(-c2[nH]c(Cc3ccc(S(N)(=O)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL514542		Activity			CHEMBL4439	Homo sapiens	Activity		
Dose-dependent effect	2403479	CHEMBL963232	Inhibition of human ALK5 activity in human HaCaT cells assessed as ARE-luciferase reporter activity	B	CCc1cccc(-c2[nH]c(Cc3ccc(S(N)(=O)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL514542		Activity			CHEMBL4439	Homo sapiens	Activity		
	2452936	CHEMBL1013161	Inhibition of GST fused human recombinant ALK5 expressed in Sf9 cells by radioisotopic protein kinase assay	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL492634	=	IC50	nM	36.0	CHEMBL4439	Homo sapiens	IC50	nM	36.0
	2452939	CHEMBL1013161	Inhibition of GST fused human recombinant ALK5 expressed in Sf9 cells by radioisotopic protein kinase assay	B	COc1ccc(CNc2nccc(-c3ncn(Cc4cccc(C#N)c4)c3-c3ccc(F)cc3)n2)cc1		CHEMBL492848	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	2452940	CHEMBL1013161	Inhibition of GST fused human recombinant ALK5 expressed in Sf9 cells by radioisotopic protein kinase assay	B	COc1nccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc(F)cc2)n1		CHEMBL479987	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	2452941	CHEMBL1013161	Inhibition of GST fused human recombinant ALK5 expressed in Sf9 cells by radioisotopic protein kinase assay	B	NC(=O)c1cccc(Cc2nc(-c3ccc(F)cc3)c(-c3ccnc(NC4CC4)n3)[nH]2)c1		CHEMBL519620	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	2452942	CHEMBL1013161	Inhibition of GST fused human recombinant ALK5 expressed in Sf9 cells by radioisotopic protein kinase assay	B	C[C@H](Nc1nccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc(F)cc2)n1)c1ccccc1		CHEMBL481761	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	2452943	CHEMBL1013161	Inhibition of GST fused human recombinant ALK5 expressed in Sf9 cells by radioisotopic protein kinase assay	B	COc1nccc(-c2[nH]c(Cc3cccc(C#N)c3)nc2-c2ccc(F)cc2)n1		CHEMBL480787	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	2452944	CHEMBL1013161	Inhibition of GST fused human recombinant ALK5 expressed in Sf9 cells by radioisotopic protein kinase assay	B	N#Cc1cccc(Cc2nc(-c3ccc(F)cc3)c(-c3ccnc(NC4CC4)n3)[nH]2)c1		CHEMBL520437	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	2452945	CHEMBL1013161	Inhibition of GST fused human recombinant ALK5 expressed in Sf9 cells by radioisotopic protein kinase assay	B	C[C@H](Nc1nccc(-c2[nH]c(Cc3cccc(C#N)c3)nc2-c2ccc(F)cc2)n1)c1ccccc1		CHEMBL481752	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	2452946	CHEMBL1013161	Inhibition of GST fused human recombinant ALK5 expressed in Sf9 cells by radioisotopic protein kinase assay	B	N#Cc1cccc(Cc2nc(-c3ccc(F)cc3)c(-c3ccnc(N)n3)[nH]2)c1		CHEMBL519294	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	2452947	CHEMBL1013161	Inhibition of GST fused human recombinant ALK5 expressed in Sf9 cells by radioisotopic protein kinase assay	B	COc1ccc(CNc2nccc(-c3[nH]c(Cc4cccc(C#N)c4)nc3-c3ccc(F)cc3)n2)cc1		CHEMBL480940	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	2452948	CHEMBL1013161	Inhibition of GST fused human recombinant ALK5 expressed in Sf9 cells by radioisotopic protein kinase assay	B	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2Cc2ccc(C(N)=O)cc2)n1		CHEMBL480933	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	2452949	CHEMBL1013161	Inhibition of GST fused human recombinant ALK5 expressed in Sf9 cells by radioisotopic protein kinase assay	B	C[C@H](Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2Cc2ccc(C(N)=O)cc2)n1)c1ccccc1		CHEMBL480945	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	2452950	CHEMBL1013161	Inhibition of GST fused human recombinant ALK5 expressed in Sf9 cells by radioisotopic protein kinase assay	B	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2Cc2cccc(C(N)=O)c2)n1		CHEMBL480944	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	2452951	CHEMBL1013161	Inhibition of GST fused human recombinant ALK5 expressed in Sf9 cells by radioisotopic protein kinase assay	B	NC(=O)c1cccc(Cn2cnc(-c3ccc(F)cc3)c2-c2ccnc(NC3CC3)n2)c1		CHEMBL521424	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	2452952	CHEMBL1013161	Inhibition of GST fused human recombinant ALK5 expressed in Sf9 cells by radioisotopic protein kinase assay	B	C[C@H](Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2Cc2cccc(C(N)=O)c2)n1)c1ccccc1		CHEMBL481354	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	2452953	CHEMBL1013161	Inhibition of GST fused human recombinant ALK5 expressed in Sf9 cells by radioisotopic protein kinase assay	B	NC(=O)c1cccc(Cn2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)c1		CHEMBL481347	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	2452954	CHEMBL1013161	Inhibition of GST fused human recombinant ALK5 expressed in Sf9 cells by radioisotopic protein kinase assay	B	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2Cc2ccc(C#N)cc2)n1		CHEMBL481513	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	2452955	CHEMBL1013161	Inhibition of GST fused human recombinant ALK5 expressed in Sf9 cells by radioisotopic protein kinase assay	B	C[C@H](Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2Cc2ccc(C#N)cc2)n1)c1ccccc1		CHEMBL481339	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	2452956	CHEMBL1013161	Inhibition of GST fused human recombinant ALK5 expressed in Sf9 cells by radioisotopic protein kinase assay	B	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2Cc2cccc(C#N)c2)n1		CHEMBL481338	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	2452957	CHEMBL1013161	Inhibition of GST fused human recombinant ALK5 expressed in Sf9 cells by radioisotopic protein kinase assay	B	N#Cc1cccc(Cn2cnc(-c3ccc(F)cc3)c2-c2ccnc(NC3CC3)n2)c1		CHEMBL482301	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	2452958	CHEMBL1013161	Inhibition of GST fused human recombinant ALK5 expressed in Sf9 cells by radioisotopic protein kinase assay	B	C[C@H](Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2Cc2cccc(C#N)c2)n1)c1ccccc1		CHEMBL482300	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	2452959	CHEMBL1013161	Inhibition of GST fused human recombinant ALK5 expressed in Sf9 cells by radioisotopic protein kinase assay	B	N#Cc1cccc(Cn2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)c1		CHEMBL520949	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	2452960	CHEMBL1013161	Inhibition of GST fused human recombinant ALK5 expressed in Sf9 cells by radioisotopic protein kinase assay	B	COc1ccc(CNc2nccc(-c3c(-c4ccc(F)cc4)ncn3Cc3cccc(C#N)c3)n2)cc1		CHEMBL482129	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	2452961	CHEMBL1013161	Inhibition of GST fused human recombinant ALK5 expressed in Sf9 cells by radioisotopic protein kinase assay	B	COc1nccc(-c2ncn(Cc3ccc(C(N)=O)cc3)c2-c2ccc(F)cc2)n1		CHEMBL481764	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	2452962	CHEMBL1013161	Inhibition of GST fused human recombinant ALK5 expressed in Sf9 cells by radioisotopic protein kinase assay	B	C[C@H](Nc1nccc(-c2ncn(Cc3ccc(C(N)=O)cc3)c2-c2ccc(F)cc2)n1)c1ccccc1		CHEMBL481917	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	2452963	CHEMBL1013161	Inhibition of GST fused human recombinant ALK5 expressed in Sf9 cells by radioisotopic protein kinase assay	B	COc1nccc(-c2ncn(Cc3cccc(C(N)=O)c3)c2-c2ccc(F)cc2)n1		CHEMBL481757	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	2452964	CHEMBL1013161	Inhibition of GST fused human recombinant ALK5 expressed in Sf9 cells by radioisotopic protein kinase assay	B	NC(=O)c1cccc(Cn2cnc(-c3ccnc(NC4CC4)n3)c2-c2ccc(F)cc2)c1		CHEMBL520919	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	2452965	CHEMBL1013161	Inhibition of GST fused human recombinant ALK5 expressed in Sf9 cells by radioisotopic protein kinase assay	B	C[C@H](Nc1nccc(-c2ncn(Cc3cccc(C(N)=O)c3)c2-c2ccc(F)cc2)n1)c1ccccc1		CHEMBL480936	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	2452966	CHEMBL1013161	Inhibition of GST fused human recombinant ALK5 expressed in Sf9 cells by radioisotopic protein kinase assay	B	NC(=O)c1cccc(Cn2cnc(-c3ccnc(N)n3)c2-c2ccc(F)cc2)c1		CHEMBL492858	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	2452967	CHEMBL1013161	Inhibition of GST fused human recombinant ALK5 expressed in Sf9 cells by radioisotopic protein kinase assay	B	COc1nccc(-c2ncn(Cc3ccc(C#N)cc3)c2-c2ccc(F)cc2)n1		CHEMBL493686	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	2452968	CHEMBL1013161	Inhibition of GST fused human recombinant ALK5 expressed in Sf9 cells by radioisotopic protein kinase assay	B	C[C@H](Nc1nccc(-c2ncn(Cc3ccc(C#N)cc3)c2-c2ccc(F)cc2)n1)c1ccccc1		CHEMBL493685	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	2452969	CHEMBL1013161	Inhibition of GST fused human recombinant ALK5 expressed in Sf9 cells by radioisotopic protein kinase assay	B	COc1nccc(-c2ncn(Cc3cccc(C#N)c3)c2-c2ccc(F)cc2)n1		CHEMBL522003	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	2452970	CHEMBL1013161	Inhibition of GST fused human recombinant ALK5 expressed in Sf9 cells by radioisotopic protein kinase assay	B	N#Cc1cccc(Cn2cnc(-c3ccnc(NC4CC4)n3)c2-c2ccc(F)cc2)c1		CHEMBL495301	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	2452971	CHEMBL1013161	Inhibition of GST fused human recombinant ALK5 expressed in Sf9 cells by radioisotopic protein kinase assay	B	C[C@H](Nc1nccc(-c2ncn(Cc3cccc(C#N)c3)c2-c2ccc(F)cc2)n1)c1ccccc1		CHEMBL493055	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	2452972	CHEMBL1013161	Inhibition of GST fused human recombinant ALK5 expressed in Sf9 cells by radioisotopic protein kinase assay	B	N#Cc1cccc(Cn2cnc(-c3ccnc(N)n3)c2-c2ccc(F)cc2)c1		CHEMBL492849	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	2470409	CHEMBL981791	Inhibition of TGFBR1 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL4439	Homo sapiens	INH	%	10.0
Not Evaluated	2476597	CHEMBL1035861	Binding affinity to human TGFBR1 at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167		Activity			CHEMBL4439	Homo sapiens	Activity		
Not Evaluated	2476800	CHEMBL1035861	Binding affinity to human TGFBR1 at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL4439	Homo sapiens	Activity		
Not Evaluated	2478639	CHEMBL1035861	Binding affinity to human TGFBR1 at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL4439	Homo sapiens	Activity		
Not Evaluated	2478842	CHEMBL1035861	Binding affinity to human TGFBR1 at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755		Activity			CHEMBL4439	Homo sapiens	Activity		
	2479585	CHEMBL1025772	Inhibition of TGFBR1	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	IC50	nM	27.0	CHEMBL4439	Homo sapiens	IC50	nM	27.0
Not Evaluated	2479697	CHEMBL1035861	Binding affinity to human TGFBR1 at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL4439	Homo sapiens	Activity		
Active	2480696	CHEMBL1035861	Binding affinity to human TGFBR1 at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409		Activity			CHEMBL4439	Homo sapiens	Activity		
	2500615	CHEMBL985076	Binding affinity to human TGFBR1	B	Cc1cccc(-c2nc(N)sc2-c2ccc3nccnc3c2)n1		CHEMBL519948	=	Ki	nM	0.33	CHEMBL4439	Homo sapiens	Ki	nM	0.33
	2500618	CHEMBL985076	Binding affinity to human TGFBR1	B	Cc1nc(-c2nc(N)[nH]c2-c2ccc3nccnc3c2)ccc1F		CHEMBL480742	=	Ki	nM	0.7	CHEMBL4439	Homo sapiens	Ki	nM	0.7
	2500619	CHEMBL985076	Binding affinity to human TGFBR1	B	CC(=O)Nc1nc(-c2ccc(F)c(C)n2)c(-c2ccc3ncnn3c2)[nH]1		CHEMBL517068	=	Ki	nM	2.07	CHEMBL4439	Homo sapiens	Ki	nM	2.07
	2500620	CHEMBL985076	Binding affinity to human TGFBR1	B	CC(=O)Nc1nc(-c2cccc(C)n2)c(-c2ccc3ncnn3c2)[nH]1		CHEMBL450161	=	Ki	nM	2.95	CHEMBL4439	Homo sapiens	Ki	nM	2.95
	2500621	CHEMBL985076	Binding affinity to human TGFBR1	B	Cc1nc(-c2nc(N3CCN(S(C)(=O)=O)CC3)[nH]c2-c2ccc3ncnn3c2)ccc1F		CHEMBL480583	=	Ki	nM	3.0	CHEMBL4439	Homo sapiens	Ki	nM	3.0
	2500622	CHEMBL985076	Binding affinity to human TGFBR1	B	CC(=O)Nc1nc(-c2ccc(F)c(C)n2)c(-c2ccc3nccnc3c2)[nH]1		CHEMBL519939	=	Ki	nM	7.1	CHEMBL4439	Homo sapiens	Ki	nM	7.1
	2500624	CHEMBL985076	Binding affinity to human TGFBR1	B	COCC(=O)Nc1nc(-c2ccc(F)c(C)n2)c(-c2ccc3nccnc3c2)[nH]1		CHEMBL479262	=	Ki	nM	7.2	CHEMBL4439	Homo sapiens	Ki	nM	7.2
	2500627	CHEMBL985076	Binding affinity to human TGFBR1	B	CCC(=O)Nc1nc(-c2ccc(F)c(C)n2)c(-c2ccc3nccnc3c2)[nH]1		CHEMBL521441	=	Ki	nM	8.8	CHEMBL4439	Homo sapiens	Ki	nM	8.8
	2500635	CHEMBL985076	Binding affinity to human TGFBR1	B	Cc1nc(-c2nc(N3CCOCC3)[nH]c2-c2ccc3ncnn3c2)ccc1F		CHEMBL520104	=	Ki	nM	15.0	CHEMBL4439	Homo sapiens	Ki	nM	15.0
	2500637	CHEMBL985076	Binding affinity to human TGFBR1	B	CC(=O)N1CCN(c2nc(-c3ccc(F)c(C)n3)c(-c3ccc4ncnn4c3)[nH]2)CC1		CHEMBL480582	=	Ki	nM	15.2	CHEMBL4439	Homo sapiens	Ki	nM	15.2
	2500638	CHEMBL985076	Binding affinity to human TGFBR1	B	Cc1nc(-c2nc(N3CCN(C)CC3)[nH]c2-c2ccc3ncnn3c2)ccc1F		CHEMBL480581	=	Ki	nM	16.4	CHEMBL4439	Homo sapiens	Ki	nM	16.4
	2500639	CHEMBL985076	Binding affinity to human TGFBR1	B	COCCC(=O)Nc1nc(-c2ccc(F)c(C)n2)c(-c2ccc3nccnc3c2)[nH]1		CHEMBL480731	=	Ki	nM	19.0	CHEMBL4439	Homo sapiens	Ki	nM	19.0
	2500644	CHEMBL985077	Inhibition of TGFBR1 transfected in human HepG2 cells after 24 hrs by plasminogen activator inhibitor-luciferase reporter gene assay	B	Cc1nc(-c2nc(N)[nH]c2-c2ccc3nccnc3c2)ccc1F		CHEMBL480742	=	IC50	nM	33.5	CHEMBL4439	Homo sapiens	IC50	nM	33.5
	2500648	CHEMBL985076	Binding affinity to human TGFBR1	B	Cc1nc(-c2nc(N3CCCCC3)[nH]c2-c2ccc3ncnn3c2)ccc1F		CHEMBL481546	=	Ki	nM	53.2	CHEMBL4439	Homo sapiens	Ki	nM	53.2
	2500650	CHEMBL985077	Inhibition of TGFBR1 transfected in human HepG2 cells after 24 hrs by plasminogen activator inhibitor-luciferase reporter gene assay	B	COCC(=O)Nc1nc(-c2ccc(F)c(C)n2)c(-c2ccc3nccnc3c2)[nH]1		CHEMBL479262	=	EC50	nM	61.0	CHEMBL4439	Homo sapiens	EC50	nM	61.0
	2500652	CHEMBL985077	Inhibition of TGFBR1 transfected in human HepG2 cells after 24 hrs by plasminogen activator inhibitor-luciferase reporter gene assay	B	Cc1cccc(-c2nc(N)sc2-c2ccc3nccnc3c2)n1		CHEMBL519948	=	EC50	nM	80.0	CHEMBL4439	Homo sapiens	EC50	nM	80.0
	2500655	CHEMBL985077	Inhibition of TGFBR1 transfected in human HepG2 cells after 24 hrs by plasminogen activator inhibitor-luciferase reporter gene assay	B	CC(=O)Nc1nc(-c2ccc(F)c(C)n2)c(-c2ccc3ncnn3c2)[nH]1		CHEMBL517068	=	EC50	nM	111.0	CHEMBL4439	Homo sapiens	EC50	nM	111.0
	2500656	CHEMBL985077	Inhibition of TGFBR1 transfected in human HepG2 cells after 24 hrs by plasminogen activator inhibitor-luciferase reporter gene assay	B	COCCC(=O)Nc1nc(-c2ccc(F)c(C)n2)c(-c2ccc3nccnc3c2)[nH]1		CHEMBL480731	=	EC50	nM	148.0	CHEMBL4439	Homo sapiens	EC50	nM	148.0
	2500657	CHEMBL985077	Inhibition of TGFBR1 transfected in human HepG2 cells after 24 hrs by plasminogen activator inhibitor-luciferase reporter gene assay	B	CCC(=O)Nc1nc(-c2ccc(F)c(C)n2)c(-c2ccc3nccnc3c2)[nH]1		CHEMBL521441	=	EC50	nM	156.0	CHEMBL4439	Homo sapiens	EC50	nM	156.0
	2500658	CHEMBL985077	Inhibition of TGFBR1 transfected in human HepG2 cells after 24 hrs by plasminogen activator inhibitor-luciferase reporter gene assay	B	CC(=O)Nc1nc(-c2cccc(C)n2)c(-c2ccc3ncnn3c2)[nH]1		CHEMBL450161	=	EC50	nM	165.0	CHEMBL4439	Homo sapiens	EC50	nM	165.0
	2500659	CHEMBL985077	Inhibition of TGFBR1 transfected in human HepG2 cells after 24 hrs by plasminogen activator inhibitor-luciferase reporter gene assay	B	CC(=O)Nc1nc(-c2ccc(F)c(C)n2)c(-c2ccc3nccnc3c2)[nH]1		CHEMBL519939	=	EC50	nM	180.0	CHEMBL4439	Homo sapiens	EC50	nM	180.0
	2500660	CHEMBL985077	Inhibition of TGFBR1 transfected in human HepG2 cells after 24 hrs by plasminogen activator inhibitor-luciferase reporter gene assay	B	Cc1nc(-c2nc(N3CCN(C)CC3)[nH]c2-c2ccc3ncnn3c2)ccc1F		CHEMBL480581	=	EC50	nM	344.0	CHEMBL4439	Homo sapiens	EC50	nM	344.0
	2500661	CHEMBL985077	Inhibition of TGFBR1 transfected in human HepG2 cells after 24 hrs by plasminogen activator inhibitor-luciferase reporter gene assay	B	Cc1nc(-c2nc(N3CCN(S(C)(=O)=O)CC3)[nH]c2-c2ccc3ncnn3c2)ccc1F		CHEMBL480583	=	EC50	nM	414.0	CHEMBL4439	Homo sapiens	EC50	nM	414.0
	2500662	CHEMBL985077	Inhibition of TGFBR1 transfected in human HepG2 cells after 24 hrs by plasminogen activator inhibitor-luciferase reporter gene assay	B	Cc1nc(-c2nc(N3CCOCC3)[nH]c2-c2ccc3ncnn3c2)ccc1F		CHEMBL520104	=	EC50	nM	513.0	CHEMBL4439	Homo sapiens	EC50	nM	513.0
	2500663	CHEMBL985077	Inhibition of TGFBR1 transfected in human HepG2 cells after 24 hrs by plasminogen activator inhibitor-luciferase reporter gene assay	B	CC(=O)N1CCN(c2nc(-c3ccc(F)c(C)n3)c(-c3ccc4ncnn4c3)[nH]2)CC1		CHEMBL480582	=	EC50	nM	1220.0	CHEMBL4439	Homo sapiens	EC50	nM	1220.0
	2500664	CHEMBL985076	Binding affinity to human TGFBR1	B	Cc1nc(-c2nc(NC(=O)C(C)C)[nH]c2-c2ccc3nccnc3c2)ccc1F		CHEMBL482207	>	Ki	nM	28000.0	CHEMBL4439	Homo sapiens	Ki	nM	28000.0
Not Determined	2500665	CHEMBL985077	Inhibition of TGFBR1 transfected in human HepG2 cells after 24 hrs by plasminogen activator inhibitor-luciferase reporter gene assay	B	Cc1nc(-c2nc(NC(=O)C(C)C)[nH]c2-c2ccc3nccnc3c2)ccc1F		CHEMBL482207		EC50			CHEMBL4439	Homo sapiens	EC50		
Not Determined	2500666	CHEMBL985077	Inhibition of TGFBR1 transfected in human HepG2 cells after 24 hrs by plasminogen activator inhibitor-luciferase reporter gene assay	B	Cc1nc(-c2nc(N3CCCCC3)[nH]c2-c2ccc3ncnn3c2)ccc1F		CHEMBL481546		EC50			CHEMBL4439	Homo sapiens	EC50		
Not Evaluated	2577318	CHEMBL1035861	Binding affinity to human TGFBR1 at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL4439	Homo sapiens	Activity		
Not Evaluated	2577521	CHEMBL1035861	Binding affinity to human TGFBR1 at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL4439	Homo sapiens	Activity		
Not Evaluated	2593523	CHEMBL1035861	Binding affinity to human TGFBR1 at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878		Activity			CHEMBL4439	Homo sapiens	Activity		
Active	2593726	CHEMBL1035861	Binding affinity to human TGFBR1 at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097		Activity			CHEMBL4439	Homo sapiens	Activity		
	2593992	CHEMBL1035861	Binding affinity to human TGFBR1 at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519	=	Activity	%	0.75	CHEMBL4439	Homo sapiens	Activity	%	0.75
Not Evaluated	2594935	CHEMBL1035861	Binding affinity to human TGFBR1 at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL4439	Homo sapiens	Activity		
Not Evaluated	2595138	CHEMBL1035861	Binding affinity to human TGFBR1 at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL4439	Homo sapiens	Activity		
Not Evaluated	2595204	CHEMBL1035861	Binding affinity to human TGFBR1 at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL4439	Homo sapiens	Activity		
Not Evaluated	2596335	CHEMBL1035861	Binding affinity to human TGFBR1 at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342		Activity			CHEMBL4439	Homo sapiens	Activity		
Not Evaluated	2597604	CHEMBL1035861	Binding affinity to human TGFBR1 at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL4439	Homo sapiens	Activity		
Active	2597807	CHEMBL1035861	Binding affinity to human TGFBR1 at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL4439	Homo sapiens	Activity		
	2651565	CHEMBL1030214	Inhibition of human ALK5 kinase expressed in Sf9 cells	B	c1ccc(-c2nc(Nc3ccncc3)c3ccccc3n2)cc1		CHEMBL564660	=	IC50	nM	194.0	CHEMBL4439	Homo sapiens	IC50	uM	0.194
	2651566	CHEMBL1030214	Inhibition of human ALK5 kinase expressed in Sf9 cells	B	Clc1cccc(-c2nc(Nc3ccncc3)c3ccccc3n2)c1		CHEMBL571451	=	IC50	nM	49.0	CHEMBL4439	Homo sapiens	IC50	uM	0.049
	2651567	CHEMBL1030214	Inhibition of human ALK5 kinase expressed in Sf9 cells	B	Cc1csc(-c2nc(Nc3ccncc3)c3ccccc3n2)n1		CHEMBL541777	=	IC50	nM	20.0	CHEMBL4439	Homo sapiens	IC50	uM	0.02
	2651568	CHEMBL1030214	Inhibition of human ALK5 kinase expressed in Sf9 cells	B	Cc1cccc(-c2nc(Nc3ccncc3)c3ccccc3n2)n1		CHEMBL570533	=	IC50	nM	25.0	CHEMBL4439	Homo sapiens	IC50	uM	0.025
	2651569	CHEMBL1030214	Inhibition of human ALK5 kinase expressed in Sf9 cells	B	Cc1cc(Nc2nc(-c3cccc(C)n3)nc3ccccc23)ccn1		CHEMBL560415	=	IC50	nM	199.0	CHEMBL4439	Homo sapiens	IC50	uM	0.199
	2651570	CHEMBL1030214	Inhibition of human ALK5 kinase expressed in Sf9 cells	B	Cc1cccc(-c2nc(Nc3cccc(C(N)=O)c3)c3ccccc3n2)n1		CHEMBL563421	=	IC50	nM	263.0	CHEMBL4439	Homo sapiens	IC50	uM	0.263
	2651571	CHEMBL1030214	Inhibition of human ALK5 kinase expressed in Sf9 cells	B	Cc1cccc(-c2nc(Nc3ccncn3)c3ccccc3n2)n1		CHEMBL571452	=	IC50	nM	40.0	CHEMBL4439	Homo sapiens	IC50	uM	0.04
	2651572	CHEMBL1030214	Inhibition of human ALK5 kinase expressed in Sf9 cells	B	Cc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)n1		CHEMBL537968	=	IC50	nM	25.0	CHEMBL4439	Homo sapiens	IC50	uM	0.025
	2651573	CHEMBL1030214	Inhibition of human ALK5 kinase expressed in Sf9 cells	B	Cc1cccc(-c2nc(Nc3ccc4c(cnn4C)c3)c3ccccc3n2)n1		CHEMBL550482	=	IC50	nM	588.0	CHEMBL4439	Homo sapiens	IC50	uM	0.588
	2651574	CHEMBL1030214	Inhibition of human ALK5 kinase expressed in Sf9 cells	B	Cc1cccc(-c2nc(Nc3ccc4ncsc4c3)c3ccccc3n2)n1		CHEMBL550483	=	IC50	nM	646.0	CHEMBL4439	Homo sapiens	IC50	uM	0.646
	2651575	CHEMBL1030214	Inhibition of human ALK5 kinase expressed in Sf9 cells	B	Cc1cccc(-c2nc(Nc3ccc4nn[nH]c4c3)c3ccccc3n2)n1		CHEMBL563207	=	IC50	nM	3715.0	CHEMBL4439	Homo sapiens	IC50	uM	3.715
	2651576	CHEMBL1030214	Inhibition of human ALK5 kinase expressed in Sf9 cells	B	Cc1cccc(-c2nc(C)cc(Nc3ccncc3)n2)n1		CHEMBL552232	=	IC50	nM	93.0	CHEMBL4439	Homo sapiens	IC50	uM	0.093
	2651577	CHEMBL1030214	Inhibition of human ALK5 kinase expressed in Sf9 cells	B	Cc1cccc(-c2nc(Nc3ccncc3)c3c(C)csc3n2)n1		CHEMBL564250	=	IC50	nM	16.0	CHEMBL4439	Homo sapiens	IC50	uM	0.016
	2651578	CHEMBL1030214	Inhibition of human ALK5 kinase expressed in Sf9 cells	B	Cc1cccc(-c2nc(Nc3ccncc3)c3sccc3n2)n1		CHEMBL556871	=	IC50	nM	22.0	CHEMBL4439	Homo sapiens	IC50	uM	0.022
	2651579	CHEMBL1030214	Inhibition of human ALK5 kinase expressed in Sf9 cells	B	Cc1cccc(-c2cc(Nc3ccncc3)c3ccccc3n2)n1		CHEMBL560815	=	IC50	nM	22.0	CHEMBL4439	Homo sapiens	IC50	uM	0.022
	2651584	CHEMBL1030216	Inhibition of TGF-beta-induced ALK5 in human HepG2 cells by luciferase assay	B	c1ccc(-c2nc(Nc3ccncc3)c3ccccc3n2)cc1		CHEMBL564660	=	IC50	nM	2465.0	CHEMBL4439	Homo sapiens	IC50	uM	2.465
	2651585	CHEMBL1030216	Inhibition of TGF-beta-induced ALK5 in human HepG2 cells by luciferase assay	B	Clc1cccc(-c2nc(Nc3ccncc3)c3ccccc3n2)c1		CHEMBL571451	=	IC50	nM	1612.0	CHEMBL4439	Homo sapiens	IC50	uM	1.612
	2651586	CHEMBL1030216	Inhibition of TGF-beta-induced ALK5 in human HepG2 cells by luciferase assay	B	Cc1csc(-c2nc(Nc3ccncc3)c3ccccc3n2)n1		CHEMBL541777	=	IC50	nM	342.0	CHEMBL4439	Homo sapiens	IC50	uM	0.342
	2651587	CHEMBL1030216	Inhibition of TGF-beta-induced ALK5 in human HepG2 cells by luciferase assay	B	Cc1cccc(-c2nc(Nc3ccncc3)c3ccccc3n2)n1		CHEMBL570533	=	IC50	nM	95.0	CHEMBL4439	Homo sapiens	IC50	uM	0.095
	2651588	CHEMBL1030216	Inhibition of TGF-beta-induced ALK5 in human HepG2 cells by luciferase assay	B	Cc1cc(Nc2nc(-c3cccc(C)n3)nc3ccccc23)ccn1		CHEMBL560415	=	IC50	nM	1017.0	CHEMBL4439	Homo sapiens	IC50	uM	1.017
	2651589	CHEMBL1030216	Inhibition of TGF-beta-induced ALK5 in human HepG2 cells by luciferase assay	B	Cc1cccc(-c2nc(Nc3cccc(C(N)=O)c3)c3ccccc3n2)n1		CHEMBL563421	=	IC50	nM	545.0	CHEMBL4439	Homo sapiens	IC50	uM	0.545
	2651590	CHEMBL1030216	Inhibition of TGF-beta-induced ALK5 in human HepG2 cells by luciferase assay	B	Cc1cccc(-c2nc(Nc3ccncn3)c3ccccc3n2)n1		CHEMBL571452	=	IC50	nM	60.0	CHEMBL4439	Homo sapiens	IC50	uM	0.06
	2651591	CHEMBL1030216	Inhibition of TGF-beta-induced ALK5 in human HepG2 cells by luciferase assay	B	Cc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)n1		CHEMBL537968	=	IC50	nM	90.0	CHEMBL4439	Homo sapiens	IC50	uM	0.09
	2651592	CHEMBL1030216	Inhibition of TGF-beta-induced ALK5 in human HepG2 cells by luciferase assay	B	Cc1cccc(-c2nc(Nc3ccc4c(cnn4C)c3)c3ccccc3n2)n1		CHEMBL550482	=	IC50	nM	794.0	CHEMBL4439	Homo sapiens	IC50	uM	0.794
	2651593	CHEMBL1030216	Inhibition of TGF-beta-induced ALK5 in human HepG2 cells by luciferase assay	B	Cc1cccc(-c2nc(Nc3ccc4ncsc4c3)c3ccccc3n2)n1		CHEMBL550483	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	uM	5.0
	2651594	CHEMBL1030216	Inhibition of TGF-beta-induced ALK5 in human HepG2 cells by luciferase assay	B	Cc1cccc(-c2nc(Nc3ccc4nn[nH]c4c3)c3ccccc3n2)n1		CHEMBL563207	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	uM	5.0
	2651595	CHEMBL1030216	Inhibition of TGF-beta-induced ALK5 in human HepG2 cells by luciferase assay	B	Cc1cccc(-c2nc(C)cc(Nc3ccncc3)n2)n1		CHEMBL552232	=	IC50	nM	745.0	CHEMBL4439	Homo sapiens	IC50	uM	0.745
	2651596	CHEMBL1030216	Inhibition of TGF-beta-induced ALK5 in human HepG2 cells by luciferase assay	B	Cc1cccc(-c2nc(Nc3ccncc3)c3c(C)csc3n2)n1		CHEMBL564250	=	IC50	nM	318.0	CHEMBL4439	Homo sapiens	IC50	uM	0.318
	2651597	CHEMBL1030216	Inhibition of TGF-beta-induced ALK5 in human HepG2 cells by luciferase assay	B	Cc1cccc(-c2nc(Nc3ccncc3)c3sccc3n2)n1		CHEMBL556871	=	IC50	nM	60.0	CHEMBL4439	Homo sapiens	IC50	uM	0.06
	2651598	CHEMBL1030216	Inhibition of TGF-beta-induced ALK5 in human HepG2 cells by luciferase assay	B	Cc1cccc(-c2cc(Nc3ccncc3)c3ccccc3n2)n1		CHEMBL560815	=	IC50	nM	58.0	CHEMBL4439	Homo sapiens	IC50	uM	0.058
	2724651	CHEMBL1062753	Inhibition of ALK5 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 1 uM after 3 hrs	B	NC(=O)c1ccc(-c2cc(-c3ccc(O)c(O)c3)n(-c3ccccc3O)n2)cc1		CHEMBL551021	=	Inhibition	%	30.3	CHEMBL4439	Homo sapiens	INH	%	30.3
	2724652	CHEMBL1062753	Inhibition of ALK5 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 1 uM after 3 hrs	B	NC(=O)c1ccc(-c2cc(-c3ccccc3F)n(-c3ccc4c(c3)OCO4)n2)cc1		CHEMBL560287	=	Inhibition	%	55.4	CHEMBL4439	Homo sapiens	INH	%	55.4
	2724653	CHEMBL1062753	Inhibition of ALK5 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 1 uM after 3 hrs	B	COc1ccc(-c2cc(-c3ccc(C(N)=O)cc3)nn2-c2ccccc2F)cc1OC		CHEMBL559618	=	Inhibition	%	42.8	CHEMBL4439	Homo sapiens	INH	%	42.8
	2724654	CHEMBL1062753	Inhibition of ALK5 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 1 uM after 3 hrs	B	Cc1cccc(-n2nc(-c3ccc(C(N)=O)cc3)cc2-c2ccc3c(c2)OCO3)n1		CHEMBL560347	=	Inhibition	%	91.2	CHEMBL4439	Homo sapiens	INH	%	91.2
	2724655	CHEMBL1062753	Inhibition of ALK5 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 1 uM after 3 hrs	B	Cc1cccc(-n2nc(-c3ccc(C#N)cc3)cc2-c2ccc3c(c2)OCO3)n1		CHEMBL549312	=	Inhibition	%	45.2	CHEMBL4439	Homo sapiens	INH	%	45.2
	2724656	CHEMBL1062753	Inhibition of ALK5 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 1 uM after 3 hrs	B	NC(=O)c1ccc(-c2cc(-c3ccc4c(c3)OCO4)n(-c3ccccc3F)n2)cc1		CHEMBL560346	=	Inhibition	%	24.5	CHEMBL4439	Homo sapiens	INH	%	24.5
	2724657	CHEMBL1062753	Inhibition of ALK5 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 1 uM after 3 hrs	B	NC(=O)c1ccc(-c2cc(-c3ccc4c(c3)OCO4)n(-c3ccccn3)n2)cc1		CHEMBL565038	=	Inhibition	%	17.2	CHEMBL4439	Homo sapiens	INH	%	17.2
	2724658	CHEMBL1062752	Inhibition of ALK5 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 0.1 uM after 3 hrs	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	Inhibition	%	14.6	CHEMBL4439	Homo sapiens	INH	%	14.6
	2724659	CHEMBL1062752	Inhibition of ALK5 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 0.1 uM after 3 hrs	B	N#Cc1ccc(-c2cn(-c3ccc4c(c3)OCO4)c(-c3ccccc3F)n2)cc1		CHEMBL552429	=	Inhibition	%	2.7	CHEMBL4439	Homo sapiens	INH	%	2.7
	2724660	CHEMBL1062752	Inhibition of ALK5 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 0.1 uM after 3 hrs	B	Cc1cccc(-c2nc(-c3ccc(C(N)=O)cc3)cn2-c2ccc3c(c2)OCCO3)n1		CHEMBL562347	=	Inhibition	%	3.5	CHEMBL4439	Homo sapiens	INH	%	3.5
	2724661	CHEMBL1062752	Inhibition of ALK5 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 0.1 uM after 3 hrs	B	Cc1cccc(-c2nc(-c3ccc(C(N)=O)cc3)cn2-c2ccc(F)cc2)n1		CHEMBL551283	=	Inhibition	%	0.4	CHEMBL4439	Homo sapiens	INH	%	0.4
	2724662	CHEMBL1062752	Inhibition of ALK5 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 0.1 uM after 3 hrs	B	Cc1cccc(-c2nc(-c3ccc(C(N)=O)cc3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL551623	=	Inhibition	%	32.7	CHEMBL4439	Homo sapiens	INH	%	32.7
	2724663	CHEMBL1062752	Inhibition of ALK5 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 0.1 uM after 3 hrs	B	Cc1cccc(-c2nc(-c3ccc(C#N)cc3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL560207	=	Inhibition	%	2.5	CHEMBL4439	Homo sapiens	INH	%	2.5
	2724664	CHEMBL1062752	Inhibition of ALK5 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 0.1 uM after 3 hrs	B	NC(=O)c1ccc(-c2cn(-c3ccc4c(c3)OCO4)c(-c3ccccn3)n2)cc1		CHEMBL558665	=	Inhibition	%	5.3	CHEMBL4439	Homo sapiens	INH	%	5.3
	2724665	CHEMBL1062752	Inhibition of ALK5 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 0.1 uM after 3 hrs	B	NC(=O)c1ccc(-c2cc(-c3ccc(O)c(O)c3)n(-c3ccccc3O)n2)cc1		CHEMBL551021	=	Inhibition	%	8.8	CHEMBL4439	Homo sapiens	INH	%	8.8
	2724666	CHEMBL1062752	Inhibition of ALK5 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 0.1 uM after 3 hrs	B	NC(=O)c1ccc(-c2cc(-c3ccccc3F)n(-c3ccc4c(c3)OCO4)n2)cc1		CHEMBL560287	=	Inhibition	%	30.7	CHEMBL4439	Homo sapiens	INH	%	30.7
	2724667	CHEMBL1062752	Inhibition of ALK5 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 0.1 uM after 3 hrs	B	COc1ccc(-c2cc(-c3ccc(C(N)=O)cc3)nn2-c2ccccc2F)cc1OC		CHEMBL559618	=	Inhibition	%	6.2	CHEMBL4439	Homo sapiens	INH	%	6.2
	2724668	CHEMBL1062752	Inhibition of ALK5 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 0.1 uM after 3 hrs	B	Cc1cccc(-n2nc(-c3ccc(C(N)=O)cc3)cc2-c2ccc3c(c2)OCO3)n1		CHEMBL560347	=	Inhibition	%	53.9	CHEMBL4439	Homo sapiens	INH	%	53.9
	2724669	CHEMBL1062752	Inhibition of ALK5 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 0.1 uM after 3 hrs	B	Cc1cccc(-n2nc(-c3ccc(C#N)cc3)cc2-c2ccc3c(c2)OCO3)n1		CHEMBL549312	=	Inhibition	%	24.6	CHEMBL4439	Homo sapiens	INH	%	24.6
	2724670	CHEMBL1062752	Inhibition of ALK5 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 0.1 uM after 3 hrs	B	NC(=O)c1ccc(-c2cc(-c3ccc4c(c3)OCO4)n(-c3ccccc3F)n2)cc1		CHEMBL560346	=	Inhibition	%	9.9	CHEMBL4439	Homo sapiens	INH	%	9.9
	2724671	CHEMBL1062752	Inhibition of ALK5 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 0.1 uM after 3 hrs	B	NC(=O)c1ccc(-c2cc(-c3ccc4c(c3)OCO4)n(-c3ccccn3)n2)cc1		CHEMBL565038	=	Inhibition	%	6.9	CHEMBL4439	Homo sapiens	INH	%	6.9
	2724725	CHEMBL1062748	Inhibition of ALK5 expressed in CHO cells assessed as inhibition of TGF-beta-induced Smad2 phosphorylation at 0.1 uM	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	Inhibition	%	24.2	CHEMBL4439	Homo sapiens	INH	%	24.2
	2724726	CHEMBL1062746	Inhibition of ALK5 expressed in CHO cells assessed as inhibition of TGF-beta-induced Smad2 phosphorylation at 1 uM	B	N#Cc1ccc(-c2cn(-c3ccc4c(c3)OCO4)c(-c3ccccc3F)n2)cc1		CHEMBL552429	=	Inhibition	%	42.4	CHEMBL4439	Homo sapiens	INH	%	42.4
	2724727	CHEMBL1062746	Inhibition of ALK5 expressed in CHO cells assessed as inhibition of TGF-beta-induced Smad2 phosphorylation at 1 uM	B	NC(=O)c1ccc(-c2cn(-c3ccc4c(c3)OCO4)c(-c3ccccc3F)n2)cc1		CHEMBL552428	=	Inhibition	%	15.8	CHEMBL4439	Homo sapiens	INH	%	15.8
Not Active	2724728	CHEMBL1062746	Inhibition of ALK5 expressed in CHO cells assessed as inhibition of TGF-beta-induced Smad2 phosphorylation at 1 uM	B	COc1ccc(-n2cc(C(C)(C)C)nc2-c2cccc(C)n2)cc1F		CHEMBL558208		Activity			CHEMBL4439	Homo sapiens	Activity		
	2724729	CHEMBL1062746	Inhibition of ALK5 expressed in CHO cells assessed as inhibition of TGF-beta-induced Smad2 phosphorylation at 1 uM	B	COc1ccc(-n2cc(-c3ccc(C(N)=O)cc3)nc2-c2cccc(C)n2)cc1F		CHEMBL551686	=	Inhibition	%	10.8	CHEMBL4439	Homo sapiens	INH	%	10.8
	2724730	CHEMBL1062746	Inhibition of ALK5 expressed in CHO cells assessed as inhibition of TGF-beta-induced Smad2 phosphorylation at 1 uM	B	COc1ccc(-n2cc(-c3ccc(C#N)cc3)nc2-c2cccc(C)n2)cc1F		CHEMBL562348	=	Inhibition	%	10.5	CHEMBL4439	Homo sapiens	INH	%	10.5
Not Active	2724731	CHEMBL1062746	Inhibition of ALK5 expressed in CHO cells assessed as inhibition of TGF-beta-induced Smad2 phosphorylation at 1 uM	B	Cc1cccc(-c2nc(C(C)(C)C)cn2-c2ccc3c(c2)OCCO3)n1		CHEMBL564480		Activity			CHEMBL4439	Homo sapiens	Activity		
	2724732	CHEMBL1062746	Inhibition of ALK5 expressed in CHO cells assessed as inhibition of TGF-beta-induced Smad2 phosphorylation at 1 uM	B	Cc1cccc(-c2nc(-c3ccc(C(N)=O)cc3)cn2-c2ccc3c(c2)OCCO3)n1		CHEMBL562347	=	Inhibition	%	28.2	CHEMBL4439	Homo sapiens	INH	%	28.2
	2724733	CHEMBL1062746	Inhibition of ALK5 expressed in CHO cells assessed as inhibition of TGF-beta-induced Smad2 phosphorylation at 1 uM	B	Cc1cccc(-c2nc(-c3ccc(C#N)cc3)cn2-c2ccc3c(c2)OCCO3)n1		CHEMBL561008	=	Inhibition	%	21.1	CHEMBL4439	Homo sapiens	INH	%	21.1
Not Active	2724734	CHEMBL1062746	Inhibition of ALK5 expressed in CHO cells assessed as inhibition of TGF-beta-induced Smad2 phosphorylation at 1 uM	B	Cc1cccc(-c2nc(C(C)(C)C)cn2-c2ccc(F)cc2)n1		CHEMBL564982		Activity			CHEMBL4439	Homo sapiens	Activity		
	2724735	CHEMBL1062746	Inhibition of ALK5 expressed in CHO cells assessed as inhibition of TGF-beta-induced Smad2 phosphorylation at 1 uM	B	Cc1cccc(-c2nc(-c3ccc(C(N)=O)cc3)cn2-c2ccc(F)cc2)n1		CHEMBL551283	=	Inhibition	%	37.8	CHEMBL4439	Homo sapiens	INH	%	37.8
Not Active	2724736	CHEMBL1062746	Inhibition of ALK5 expressed in CHO cells assessed as inhibition of TGF-beta-induced Smad2 phosphorylation at 1 uM	B	Cc1cccc(-c2nc(-c3ccc(C#N)cc3)cn2-c2ccc(F)cc2)n1		CHEMBL559262		Activity			CHEMBL4439	Homo sapiens	Activity		
	2724737	CHEMBL1062746	Inhibition of ALK5 expressed in CHO cells assessed as inhibition of TGF-beta-induced Smad2 phosphorylation at 1 uM	B	Cc1cccc(-c2nc(C(C)(C)C)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL564561	=	Inhibition	%	24.7	CHEMBL4439	Homo sapiens	INH	%	24.7
	2724738	CHEMBL1062746	Inhibition of ALK5 expressed in CHO cells assessed as inhibition of TGF-beta-induced Smad2 phosphorylation at 1 uM	B	Cc1cccc(-c2nc(-c3ccc(C(N)=O)cc3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL551623	=	Inhibition	%	69.0	CHEMBL4439	Homo sapiens	INH	%	69.0
	2724739	CHEMBL1062746	Inhibition of ALK5 expressed in CHO cells assessed as inhibition of TGF-beta-induced Smad2 phosphorylation at 1 uM	B	Cc1cccc(-c2nc(-c3ccc(C#N)cc3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL560207	=	Inhibition	%	41.4	CHEMBL4439	Homo sapiens	INH	%	41.4
	2724740	CHEMBL1062746	Inhibition of ALK5 expressed in CHO cells assessed as inhibition of TGF-beta-induced Smad2 phosphorylation at 1 uM	B	NC(=O)c1ccc(-c2cn(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)n2)cc1		CHEMBL560686	=	Inhibition	%	8.1	CHEMBL4439	Homo sapiens	INH	%	8.1
	2724741	CHEMBL1062746	Inhibition of ALK5 expressed in CHO cells assessed as inhibition of TGF-beta-induced Smad2 phosphorylation at 1 uM	B	NC(=O)c1ccc(-c2cn(-c3ccc4c(c3)OCO4)c(-c3ccccn3)n2)cc1		CHEMBL558665	=	Inhibition	%	20.9	CHEMBL4439	Homo sapiens	INH	%	20.9
	2724742	CHEMBL1062746	Inhibition of ALK5 expressed in CHO cells assessed as inhibition of TGF-beta-induced Smad2 phosphorylation at 1 uM	B	NC(=O)c1ccc(-c2cc(-c3ccc(O)c(O)c3)n(-c3ccccc3O)n2)cc1		CHEMBL551021	=	Inhibition	%	21.0	CHEMBL4439	Homo sapiens	INH	%	21.0
	2724743	CHEMBL1062746	Inhibition of ALK5 expressed in CHO cells assessed as inhibition of TGF-beta-induced Smad2 phosphorylation at 1 uM	B	NC(=O)c1ccc(-c2cc(-c3ccc(F)cc3)n(-c3ccccc3F)n2)cc1		CHEMBL563547	=	Inhibition	%	24.4	CHEMBL4439	Homo sapiens	INH	%	24.4
Not Active	2724744	CHEMBL1062746	Inhibition of ALK5 expressed in CHO cells assessed as inhibition of TGF-beta-induced Smad2 phosphorylation at 1 uM	B	NC(=O)c1ccc(-c2cc(-c3ccc(F)cc3)n(-c3ccccc3O)n2)cc1		CHEMBL563042		Activity			CHEMBL4439	Homo sapiens	Activity		
Not Active	2724745	CHEMBL1062746	Inhibition of ALK5 expressed in CHO cells assessed as inhibition of TGF-beta-induced Smad2 phosphorylation at 1 uM	B	COc1ccccc1-n1nc(-c2ccc(C(N)=O)cc2)cc1-c1ccc(F)cc1		CHEMBL563823		Activity			CHEMBL4439	Homo sapiens	Activity		
Not Active	2724746	CHEMBL1062746	Inhibition of ALK5 expressed in CHO cells assessed as inhibition of TGF-beta-induced Smad2 phosphorylation at 1 uM	B	NC(=O)c1ccc(-c2cc(-c3ccc(F)cc3)n(-c3ccccn3)n2)cc1		CHEMBL564502		Activity			CHEMBL4439	Homo sapiens	Activity		
	2724747	CHEMBL1062746	Inhibition of ALK5 expressed in CHO cells assessed as inhibition of TGF-beta-induced Smad2 phosphorylation at 1 uM	B	NC(=O)c1ccc(-c2cc(-c3ccccc3F)n(-c3ccc4c(c3)OCO4)n2)cc1		CHEMBL560287	=	Inhibition	%	19.0	CHEMBL4439	Homo sapiens	INH	%	19.0
	2724748	CHEMBL1062746	Inhibition of ALK5 expressed in CHO cells assessed as inhibition of TGF-beta-induced Smad2 phosphorylation at 1 uM	B	N#Cc1ccc(-c2cc(-c3ccccc3F)n(-c3ccc4c(c3)OCO4)n2)cc1		CHEMBL550676	=	Inhibition	%	6.0	CHEMBL4439	Homo sapiens	INH	%	6.0
Not Active	2724749	CHEMBL1062746	Inhibition of ALK5 expressed in CHO cells assessed as inhibition of TGF-beta-induced Smad2 phosphorylation at 1 uM	B	NC(=O)c1ccc(-c2cc(-c3ccccn3)n(-c3ccc4c(c3)OCO4)n2)cc1		CHEMBL559024		Activity			CHEMBL4439	Homo sapiens	Activity		
	2724750	CHEMBL1062746	Inhibition of ALK5 expressed in CHO cells assessed as inhibition of TGF-beta-induced Smad2 phosphorylation at 1 uM	B	COc1ccc(-c2cc(-c3ccc(C(N)=O)cc3)nn2-c2ccccc2F)cc1OC		CHEMBL559618	=	Inhibition	%	33.9	CHEMBL4439	Homo sapiens	INH	%	33.9
	2724751	CHEMBL1062746	Inhibition of ALK5 expressed in CHO cells assessed as inhibition of TGF-beta-induced Smad2 phosphorylation at 1 uM	B	COc1ccc(-c2cc(-c3ccc(C#N)cc3)nn2-c2ccccc2F)cc1OC		CHEMBL549929	=	Inhibition	%	8.3	CHEMBL4439	Homo sapiens	INH	%	8.3
	2724752	CHEMBL1062746	Inhibition of ALK5 expressed in CHO cells assessed as inhibition of TGF-beta-induced Smad2 phosphorylation at 1 uM	B	COc1ccc(-c2cc(-c3ccc(C(N)=O)cc3)nn2-c2ccccn2)cc1OC		CHEMBL549928	=	Inhibition	%	14.7	CHEMBL4439	Homo sapiens	INH	%	14.7
Not Active	2724753	CHEMBL1062746	Inhibition of ALK5 expressed in CHO cells assessed as inhibition of TGF-beta-induced Smad2 phosphorylation at 1 uM	B	COc1ccc(-c2cc(-c3ccc(C#N)cc3)nn2-c2ccccn2)cc1OC		CHEMBL559420		Activity			CHEMBL4439	Homo sapiens	Activity		
Not Active	2724754	CHEMBL1062746	Inhibition of ALK5 expressed in CHO cells assessed as inhibition of TGF-beta-induced Smad2 phosphorylation at 1 uM	B	COc1ccccc1-n1nc(-c2ccc(C(N)=O)cc2)cc1-c1ccc2c(c1)OCO2		CHEMBL560945		Activity			CHEMBL4439	Homo sapiens	Activity		
Not Active	2724755	CHEMBL1062746	Inhibition of ALK5 expressed in CHO cells assessed as inhibition of TGF-beta-induced Smad2 phosphorylation at 1 uM	B	NC(=O)c1ccc(-c2cc(-c3ccc4c(c3)OCO4)n(-c3ccccc3)n2)cc1		CHEMBL564429		Activity			CHEMBL4439	Homo sapiens	Activity		
Not Active	2724756	CHEMBL1062746	Inhibition of ALK5 expressed in CHO cells assessed as inhibition of TGF-beta-induced Smad2 phosphorylation at 1 uM	B	NC(=O)c1ccc(-c2cc(-c3ccc4c(c3)OCO4)n(-c3ccccc3C(F)(F)F)n2)cc1		CHEMBL564604		Activity			CHEMBL4439	Homo sapiens	Activity		
Not Active	2724757	CHEMBL1062746	Inhibition of ALK5 expressed in CHO cells assessed as inhibition of TGF-beta-induced Smad2 phosphorylation at 1 uM	B	NC(=O)c1ccc(-c2cc(-c3ccc4c(c3)OCO4)n(-c3nccs3)n2)cc1		CHEMBL560543		Activity			CHEMBL4439	Homo sapiens	Activity		
	2724758	CHEMBL1062746	Inhibition of ALK5 expressed in CHO cells assessed as inhibition of TGF-beta-induced Smad2 phosphorylation at 1 uM	B	Cc1cccc(-n2nc(-c3ccc(C(N)=O)cc3)cc2-c2ccc3c(c2)OCO3)n1		CHEMBL560347	=	Inhibition	%	45.3	CHEMBL4439	Homo sapiens	INH	%	45.3
	2724759	CHEMBL1062746	Inhibition of ALK5 expressed in CHO cells assessed as inhibition of TGF-beta-induced Smad2 phosphorylation at 1 uM	B	Cc1cccc(-n2nc(-c3ccc(C#N)cc3)cc2-c2ccc3c(c2)OCO3)n1		CHEMBL549312	=	Inhibition	%	32.0	CHEMBL4439	Homo sapiens	INH	%	32.0
Not Active	2724760	CHEMBL1062746	Inhibition of ALK5 expressed in CHO cells assessed as inhibition of TGF-beta-induced Smad2 phosphorylation at 1 uM	B	OCc1ccc(-c2cc(-c3ccc4c(c3)OCO4)n(-c3ccccc3F)n2)cc1		CHEMBL549311		Activity			CHEMBL4439	Homo sapiens	Activity		
	2724761	CHEMBL1062746	Inhibition of ALK5 expressed in CHO cells assessed as inhibition of TGF-beta-induced Smad2 phosphorylation at 1 uM	B	O=C(O)c1ccc(-c2cc(-c3ccc4c(c3)OCO4)n(-c3ccccc3F)n2)cc1		CHEMBL561811	=	Inhibition	%	9.6	CHEMBL4439	Homo sapiens	INH	%	9.6
	2724762	CHEMBL1062746	Inhibition of ALK5 expressed in CHO cells assessed as inhibition of TGF-beta-induced Smad2 phosphorylation at 1 uM	B	NC(=O)c1ccc(-c2cc(-c3ccc4c(c3)OCO4)n(-c3ccccc3F)n2)cc1		CHEMBL560346	=	Inhibition	%	26.0	CHEMBL4439	Homo sapiens	INH	%	26.0
	2724763	CHEMBL1062746	Inhibition of ALK5 expressed in CHO cells assessed as inhibition of TGF-beta-induced Smad2 phosphorylation at 1 uM	B	N#Cc1ccc(-c2cc(-c3ccc4c(c3)OCO4)n(-c3ccccc3F)n2)cc1		CHEMBL556513	=	Inhibition	%	9.0	CHEMBL4439	Homo sapiens	INH	%	9.0
	2724764	CHEMBL1062746	Inhibition of ALK5 expressed in CHO cells assessed as inhibition of TGF-beta-induced Smad2 phosphorylation at 1 uM	B	NC(=O)c1ccc(-c2cc(-c3ccc4c(c3)OCO4)n(-c3ccccn3)n2)cc1		CHEMBL565038	=	Inhibition	%	15.4	CHEMBL4439	Homo sapiens	INH	%	15.4
Not Active	2724765	CHEMBL1062746	Inhibition of ALK5 expressed in CHO cells assessed as inhibition of TGF-beta-induced Smad2 phosphorylation at 1 uM	B	N#Cc1ccc(-c2cc(-c3ccc4c(c3)OCO4)n(-c3ccccn3)n2)cc1		CHEMBL554070		Activity			CHEMBL4439	Homo sapiens	Activity		
	2724766	CHEMBL1062753	Inhibition of ALK5 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 1 uM after 3 hrs	B	NC(=O)c1ccc(-c2cn(-c3ccc4c(c3)OCO4)c(-c3ccccn3)n2)cc1		CHEMBL558665	=	Inhibition	%	11.7	CHEMBL4439	Homo sapiens	INH	%	11.7
	2724767	CHEMBL1062753	Inhibition of ALK5 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 1 uM after 3 hrs	B	Cc1cccc(-c2nc(-c3ccc(C#N)cc3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL560207	=	Inhibition	%	21.0	CHEMBL4439	Homo sapiens	INH	%	21.0
	2724768	CHEMBL1062753	Inhibition of ALK5 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 1 uM after 3 hrs	B	Cc1cccc(-c2nc(-c3ccc(C(N)=O)cc3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL551623	=	Inhibition	%	67.2	CHEMBL4439	Homo sapiens	INH	%	67.2
	2724769	CHEMBL1062753	Inhibition of ALK5 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 1 uM after 3 hrs	B	Cc1cccc(-c2nc(-c3ccc(C(N)=O)cc3)cn2-c2ccc(F)cc2)n1		CHEMBL551283	=	Inhibition	%	15.5	CHEMBL4439	Homo sapiens	INH	%	15.5
	2724770	CHEMBL1062753	Inhibition of ALK5 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 1 uM after 3 hrs	B	Cc1cccc(-c2nc(-c3ccc(C(N)=O)cc3)cn2-c2ccc3c(c2)OCCO3)n1		CHEMBL562347	=	Inhibition	%	12.7	CHEMBL4439	Homo sapiens	INH	%	12.7
	2724771	CHEMBL1062753	Inhibition of ALK5 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 1 uM after 3 hrs	B	N#Cc1ccc(-c2cn(-c3ccc4c(c3)OCO4)c(-c3ccccc3F)n2)cc1		CHEMBL552429	=	Inhibition	%	14.1	CHEMBL4439	Homo sapiens	INH	%	14.1
	2724772	CHEMBL1062753	Inhibition of ALK5 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 1 uM after 3 hrs	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	Inhibition	%	75.1	CHEMBL4439	Homo sapiens	INH	%	75.1
	2724802	CHEMBL1062747	Inhibition of ALK5 assessed as inhibition of immobilized Smad3 phosphorylation	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	IC50	nM	47.0	CHEMBL4439	Homo sapiens	IC50	nM	47.0
	2724803	CHEMBL1062747	Inhibition of ALK5 assessed as inhibition of immobilized Smad3 phosphorylation	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	IC50	nM	94.0	CHEMBL4439	Homo sapiens	IC50	nM	94.0
	2892475	CHEMBL1061989	Selectivity for TGFBR1 as proportion of 290 kinases in screen with similar potency; non-selective = 1 highly selective = 0	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	Selectivity		0.0104	CHEMBL4439	Homo sapiens	Selectivity		0.0104
	2904251	CHEMBL1051314	Binding constant for TGFBR1 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	uM	10.0
	2904252	CHEMBL1051314	Binding constant for TGFBR1 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	uM	10.0
	2904253	CHEMBL1051314	Binding constant for TGFBR1 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	uM	10.0
	2904254	CHEMBL1051314	Binding constant for TGFBR1 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	uM	10.0
	2904255	CHEMBL1051314	Binding constant for TGFBR1 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	uM	10.0
	2904256	CHEMBL1051314	Binding constant for TGFBR1 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	uM	10.0
	2904257	CHEMBL1051314	Binding constant for TGFBR1 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	uM	10.0
	2904258	CHEMBL1051314	Binding constant for TGFBR1 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	uM	10.0
	2904259	CHEMBL1051314	Binding constant for TGFBR1 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	9600.0	CHEMBL4439	Homo sapiens	Kd	nM	9600.0
	2904260	CHEMBL1051314	Binding constant for TGFBR1 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	uM	10.0
	2904261	CHEMBL1051314	Binding constant for TGFBR1 kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	uM	10.0
	2904262	CHEMBL1051314	Binding constant for TGFBR1 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	230.0	CHEMBL4439	Homo sapiens	Kd	nM	230.0
	2904263	CHEMBL1051314	Binding constant for TGFBR1 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	uM	10.0
	2904264	CHEMBL1051314	Binding constant for TGFBR1 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	uM	10.0
	2904265	CHEMBL1051314	Binding constant for TGFBR1 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	uM	10.0
	2904266	CHEMBL1051314	Binding constant for TGFBR1 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	uM	10.0
	2904267	CHEMBL1051314	Binding constant for TGFBR1 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	uM	10.0
	2904268	CHEMBL1051314	Binding constant for TGFBR1 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	uM	10.0
	2904269	CHEMBL1051314	Binding constant for TGFBR1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	uM	10.0
	2904270	CHEMBL1051314	Binding constant for TGFBR1 kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	uM	10.0
	2904271	CHEMBL1051314	Binding constant for TGFBR1 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	uM	10.0
	2904272	CHEMBL1051314	Binding constant for TGFBR1 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	uM	10.0
	2904273	CHEMBL1051314	Binding constant for TGFBR1 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	uM	10.0
	2904274	CHEMBL1051314	Binding constant for TGFBR1 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	uM	10.0
	2904275	CHEMBL1051314	Binding constant for TGFBR1 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	uM	10.0
	2904276	CHEMBL1051314	Binding constant for TGFBR1 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	uM	10.0
	2904277	CHEMBL1051314	Binding constant for TGFBR1 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	uM	10.0
	2904278	CHEMBL1051314	Binding constant for TGFBR1 kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	uM	10.0
	2904279	CHEMBL1051314	Binding constant for TGFBR1 kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	uM	10.0
	2904280	CHEMBL1051314	Binding constant for TGFBR1 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	7100.0	CHEMBL4439	Homo sapiens	Kd	nM	7100.0
	2904281	CHEMBL1051314	Binding constant for TGFBR1 kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	Kd	nM	170.0	CHEMBL4439	Homo sapiens	Kd	nM	170.0
	2904282	CHEMBL1051314	Binding constant for TGFBR1 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	uM	10.0
	2904283	CHEMBL1051314	Binding constant for TGFBR1 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	2000.0	CHEMBL4439	Homo sapiens	Kd	nM	2000.0
	2904284	CHEMBL1051314	Binding constant for TGFBR1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	uM	10.0
	2904285	CHEMBL1051314	Binding constant for TGFBR1 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	uM	10.0
	2904286	CHEMBL1051314	Binding constant for TGFBR1 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	uM	10.0
	2904287	CHEMBL1051314	Binding constant for TGFBR1 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	uM	10.0
	2904288	CHEMBL1051314	Binding constant for TGFBR1 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	uM	10.0
	2922016	CHEMBL1059375	Inhibition of TGFBR1 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	89.0	CHEMBL4439	Homo sapiens	Activity	%	89.0
	2927139	CHEMBL1041189	Inhibition of 6His-tagged human ALK5 expressed in baculovirus-infected SF21 cells after 30 mins by fluorescence polarization assay	B	COc1cc(Nc2cc(Oc3cc(C)c(C)nc3-c3ccccn3)ccn2)cc(OC)c1OC		CHEMBL575099	=	IC50	nM	44.0	CHEMBL4439	Homo sapiens	IC50	nM	44.0
	2927140	CHEMBL1041189	Inhibition of 6His-tagged human ALK5 expressed in baculovirus-infected SF21 cells after 30 mins by fluorescence polarization assay	B	COc1cc(Nc2cc(Oc3ccc(C)nc3-c3ccccn3)ccn2)cc(OC)c1OC		CHEMBL583964	=	IC50	nM	13.0	CHEMBL4439	Homo sapiens	IC50	nM	13.0
	2927141	CHEMBL1041189	Inhibition of 6His-tagged human ALK5 expressed in baculovirus-infected SF21 cells after 30 mins by fluorescence polarization assay	B	COc1cc(Nc2cc(Oc3ccc(C)nc3C)ccn2)cc(OC)c1OC		CHEMBL574415	=	IC50	nM	35.0	CHEMBL4439	Homo sapiens	IC50	nM	35.0
	2927142	CHEMBL1041189	Inhibition of 6His-tagged human ALK5 expressed in baculovirus-infected SF21 cells after 30 mins by fluorescence polarization assay	B	COc1cc(Nc2cc(Oc3cccnc3)ccn2)cc(OC)c1OC		CHEMBL574621	=	IC50	nM	227.0	CHEMBL4439	Homo sapiens	IC50	nM	227.0
	2927143	CHEMBL1041189	Inhibition of 6His-tagged human ALK5 expressed in baculovirus-infected SF21 cells after 30 mins by fluorescence polarization assay	B	COc1cc(Nc2cc(Oc3ccc(C)nc3)ccn2)cc(OC)c1OC		CHEMBL573735	=	IC50	nM	108.0	CHEMBL4439	Homo sapiens	IC50	nM	108.0
	2927144	CHEMBL1041189	Inhibition of 6His-tagged human ALK5 expressed in baculovirus-infected SF21 cells after 30 mins by fluorescence polarization assay	B	COc1cc(Nc2cc(Oc3cccnc3C)ccn2)cc(OC)c1OC		CHEMBL572823	=	IC50	nM	107.0	CHEMBL4439	Homo sapiens	IC50	nM	107.0
	2927145	CHEMBL1041189	Inhibition of 6His-tagged human ALK5 expressed in baculovirus-infected SF21 cells after 30 mins by fluorescence polarization assay	B	COc1ccccc1Nc1cc(Oc2cc(C)c(C)nc2-c2ccccn2)ccn1		CHEMBL575492	=	IC50	nM	7.0	CHEMBL4439	Homo sapiens	IC50	nM	7.0
	2927146	CHEMBL1041189	Inhibition of 6His-tagged human ALK5 expressed in baculovirus-infected SF21 cells after 30 mins by fluorescence polarization assay	B	Cc1cc(Oc2ccnc(Nc3ccccc3N3CCOCC3)c2)c(-c2ccccn2)nc1C		CHEMBL575720	=	IC50	nM	739.0	CHEMBL4439	Homo sapiens	IC50	nM	739.0
	2927147	CHEMBL1041189	Inhibition of 6His-tagged human ALK5 expressed in baculovirus-infected SF21 cells after 30 mins by fluorescence polarization assay	B	COc1cccc(Nc2cc(Oc3cc(C)c(C)nc3-c3ccccn3)ccn2)c1		CHEMBL575721	=	IC50	nM	4.0	CHEMBL4439	Homo sapiens	IC50	nM	4.0
	2927148	CHEMBL1041189	Inhibition of 6His-tagged human ALK5 expressed in baculovirus-infected SF21 cells after 30 mins by fluorescence polarization assay	B	Cc1cc(Oc2ccnc(Nc3cccc(N4CCOCC4)c3)c2)c(-c2ccccn2)nc1C		CHEMBL574413	=	IC50	nM	6.0	CHEMBL4439	Homo sapiens	IC50	nM	6.0
	2927149	CHEMBL1041189	Inhibition of 6His-tagged human ALK5 expressed in baculovirus-infected SF21 cells after 30 mins by fluorescence polarization assay	B	COc1ccc(Nc2cc(Oc3cc(C)c(C)nc3-c3ccccn3)ccn2)cc1		CHEMBL573287	=	IC50	nM	30.0	CHEMBL4439	Homo sapiens	IC50	nM	30.0
	2927150	CHEMBL1041189	Inhibition of 6His-tagged human ALK5 expressed in baculovirus-infected SF21 cells after 30 mins by fluorescence polarization assay	B	Cc1cc(Oc2ccnc(Nc3ccc(N4CCOCC4)cc3)c2)c(-c2ccccn2)nc1C		CHEMBL575311	=	IC50	nM	109.0	CHEMBL4439	Homo sapiens	IC50	nM	109.0
	2927151	CHEMBL1041189	Inhibition of 6His-tagged human ALK5 expressed in baculovirus-infected SF21 cells after 30 mins by fluorescence polarization assay	B	Cc1cc(Oc2ccnc(Nc3ccc(S(N)(=O)=O)cc3)c2)c(-c2ccccn2)nc1C		CHEMBL578235	=	IC50	nM	21.0	CHEMBL4439	Homo sapiens	IC50	nM	21.0
	2927152	CHEMBL1041189	Inhibition of 6His-tagged human ALK5 expressed in baculovirus-infected SF21 cells after 30 mins by fluorescence polarization assay	B	Cc1cc(Oc2ccnc(Nc3ccc(C(=O)N(C)C)cc3)c2)c(-c2ccccn2)nc1C		CHEMBL575923	=	IC50	nM	12.0	CHEMBL4439	Homo sapiens	IC50	nM	12.0
	2927153	CHEMBL1041189	Inhibition of 6His-tagged human ALK5 expressed in baculovirus-infected SF21 cells after 30 mins by fluorescence polarization assay	B	Cc1cc(Oc2ccnc(Nc3ccc(F)cc3)c2)c(-c2ccccn2)nc1C		CHEMBL574199	=	IC50	nM	129.0	CHEMBL4439	Homo sapiens	IC50	nM	129.0
	2927154	CHEMBL1041189	Inhibition of 6His-tagged human ALK5 expressed in baculovirus-infected SF21 cells after 30 mins by fluorescence polarization assay	B	Cc1ccc(Oc2ccnc(Nc3ccc(S(N)(=O)=O)cc3)c2)c(C)n1		CHEMBL585367	=	IC50	nM	72.0	CHEMBL4439	Homo sapiens	IC50	nM	72.0
	2927155	CHEMBL1041190	Inhibition of ALK5 in human MDA-MB-468 cells assessed as inhibition of nuclear translocation of GFP-2/Smad2 fusion reporter gene after 90 mins by Hoechst 3342 staining-based cellomics arrayscan imaging analysis	B	COc1cc(Nc2cc(Oc3cc(C)c(C)nc3-c3ccccn3)ccn2)cc(OC)c1OC		CHEMBL575099	=	IC50	nM	55.0	CHEMBL4439	Homo sapiens	IC50	nM	55.0
	2927156	CHEMBL1041190	Inhibition of ALK5 in human MDA-MB-468 cells assessed as inhibition of nuclear translocation of GFP-2/Smad2 fusion reporter gene after 90 mins by Hoechst 3342 staining-based cellomics arrayscan imaging analysis	B	COc1cc(Nc2cc(Oc3ccc(C)nc3-c3ccccn3)ccn2)cc(OC)c1OC		CHEMBL583964	=	IC50	nM	20.0	CHEMBL4439	Homo sapiens	IC50	nM	20.0
	2927157	CHEMBL1041190	Inhibition of ALK5 in human MDA-MB-468 cells assessed as inhibition of nuclear translocation of GFP-2/Smad2 fusion reporter gene after 90 mins by Hoechst 3342 staining-based cellomics arrayscan imaging analysis	B	COc1cc(Nc2cc(Oc3ccc(C)nc3C)ccn2)cc(OC)c1OC		CHEMBL574415	=	IC50	nM	21.0	CHEMBL4439	Homo sapiens	IC50	nM	21.0
	2927158	CHEMBL1041190	Inhibition of ALK5 in human MDA-MB-468 cells assessed as inhibition of nuclear translocation of GFP-2/Smad2 fusion reporter gene after 90 mins by Hoechst 3342 staining-based cellomics arrayscan imaging analysis	B	COc1cc(Nc2cc(Oc3cccnc3)ccn2)cc(OC)c1OC		CHEMBL574621	>	IC50	nM	5800.0	CHEMBL4439	Homo sapiens	IC50	nM	5800.0
	2927159	CHEMBL1041190	Inhibition of ALK5 in human MDA-MB-468 cells assessed as inhibition of nuclear translocation of GFP-2/Smad2 fusion reporter gene after 90 mins by Hoechst 3342 staining-based cellomics arrayscan imaging analysis	B	COc1cc(Nc2cc(Oc3ccc(C)nc3)ccn2)cc(OC)c1OC		CHEMBL573735	=	IC50	nM	282.0	CHEMBL4439	Homo sapiens	IC50	nM	282.0
	2927160	CHEMBL1041190	Inhibition of ALK5 in human MDA-MB-468 cells assessed as inhibition of nuclear translocation of GFP-2/Smad2 fusion reporter gene after 90 mins by Hoechst 3342 staining-based cellomics arrayscan imaging analysis	B	COc1cc(Nc2cc(Oc3cccnc3C)ccn2)cc(OC)c1OC		CHEMBL572823	=	IC50	nM	628.0	CHEMBL4439	Homo sapiens	IC50	nM	628.0
	2927161	CHEMBL1041190	Inhibition of ALK5 in human MDA-MB-468 cells assessed as inhibition of nuclear translocation of GFP-2/Smad2 fusion reporter gene after 90 mins by Hoechst 3342 staining-based cellomics arrayscan imaging analysis	B	COc1ccccc1Nc1cc(Oc2cc(C)c(C)nc2-c2ccccn2)ccn1		CHEMBL575492	=	IC50	nM	114.0	CHEMBL4439	Homo sapiens	IC50	nM	114.0
	2927162	CHEMBL1041190	Inhibition of ALK5 in human MDA-MB-468 cells assessed as inhibition of nuclear translocation of GFP-2/Smad2 fusion reporter gene after 90 mins by Hoechst 3342 staining-based cellomics arrayscan imaging analysis	B	Cc1cc(Oc2ccnc(Nc3ccccc3N3CCOCC3)c2)c(-c2ccccn2)nc1C		CHEMBL575720	>	IC50	nM	3000.0	CHEMBL4439	Homo sapiens	IC50	nM	3000.0
	2927163	CHEMBL1041190	Inhibition of ALK5 in human MDA-MB-468 cells assessed as inhibition of nuclear translocation of GFP-2/Smad2 fusion reporter gene after 90 mins by Hoechst 3342 staining-based cellomics arrayscan imaging analysis	B	COc1cccc(Nc2cc(Oc3cc(C)c(C)nc3-c3ccccn3)ccn2)c1		CHEMBL575721	=	IC50	nM	32.0	CHEMBL4439	Homo sapiens	IC50	nM	32.0
	2927164	CHEMBL1041190	Inhibition of ALK5 in human MDA-MB-468 cells assessed as inhibition of nuclear translocation of GFP-2/Smad2 fusion reporter gene after 90 mins by Hoechst 3342 staining-based cellomics arrayscan imaging analysis	B	Cc1cc(Oc2ccnc(Nc3cccc(N4CCOCC4)c3)c2)c(-c2ccccn2)nc1C		CHEMBL574413	=	IC50	nM	62.0	CHEMBL4439	Homo sapiens	IC50	nM	62.0
	2927165	CHEMBL1041190	Inhibition of ALK5 in human MDA-MB-468 cells assessed as inhibition of nuclear translocation of GFP-2/Smad2 fusion reporter gene after 90 mins by Hoechst 3342 staining-based cellomics arrayscan imaging analysis	B	COc1ccc(Nc2cc(Oc3cc(C)c(C)nc3-c3ccccn3)ccn2)cc1		CHEMBL573287	=	IC50	nM	35.0	CHEMBL4439	Homo sapiens	IC50	nM	35.0
	2927166	CHEMBL1041190	Inhibition of ALK5 in human MDA-MB-468 cells assessed as inhibition of nuclear translocation of GFP-2/Smad2 fusion reporter gene after 90 mins by Hoechst 3342 staining-based cellomics arrayscan imaging analysis	B	Cc1cc(Oc2ccnc(Nc3ccc(N4CCOCC4)cc3)c2)c(-c2ccccn2)nc1C		CHEMBL575311	=	IC50	nM	146.0	CHEMBL4439	Homo sapiens	IC50	nM	146.0
	2927167	CHEMBL1041190	Inhibition of ALK5 in human MDA-MB-468 cells assessed as inhibition of nuclear translocation of GFP-2/Smad2 fusion reporter gene after 90 mins by Hoechst 3342 staining-based cellomics arrayscan imaging analysis	B	Cc1cc(Oc2ccnc(Nc3ccc(S(N)(=O)=O)cc3)c2)c(-c2ccccn2)nc1C		CHEMBL578235	=	IC50	nM	27.0	CHEMBL4439	Homo sapiens	IC50	nM	27.0
	2927168	CHEMBL1041190	Inhibition of ALK5 in human MDA-MB-468 cells assessed as inhibition of nuclear translocation of GFP-2/Smad2 fusion reporter gene after 90 mins by Hoechst 3342 staining-based cellomics arrayscan imaging analysis	B	Cc1cc(Oc2ccnc(Nc3ccc(C(=O)N(C)C)cc3)c2)c(-c2ccccn2)nc1C		CHEMBL575923	=	IC50	nM	31.0	CHEMBL4439	Homo sapiens	IC50	nM	31.0
	2927169	CHEMBL1041190	Inhibition of ALK5 in human MDA-MB-468 cells assessed as inhibition of nuclear translocation of GFP-2/Smad2 fusion reporter gene after 90 mins by Hoechst 3342 staining-based cellomics arrayscan imaging analysis	B	Cc1cc(Oc2ccnc(Nc3ccc(F)cc3)c2)c(-c2ccccn2)nc1C		CHEMBL574199	=	IC50	nM	63.0	CHEMBL4439	Homo sapiens	IC50	nM	63.0
	2927170	CHEMBL1041190	Inhibition of ALK5 in human MDA-MB-468 cells assessed as inhibition of nuclear translocation of GFP-2/Smad2 fusion reporter gene after 90 mins by Hoechst 3342 staining-based cellomics arrayscan imaging analysis	B	Cc1ccc(Oc2ccnc(Nc3ccc(S(N)(=O)=O)cc3)c2)c(C)n1		CHEMBL585367	=	IC50	nM	22.0	CHEMBL4439	Homo sapiens	IC50	nM	22.0
	2928501	CHEMBL1045669	Binding affinity to TGFBR1 assessed as percentage of kinase remaining bound to the bead at 1 uM by T7 phage display based binding assay	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	3.6	CHEMBL4439	Homo sapiens	Activity	%	3.6
	3009934	CHEMBL1048115	Inhibition of TGFR1	B	Cc1cccc(-c2[nH]c(CNc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL229599	=	IC50	nM	10.0	CHEMBL4439	Homo sapiens	IC50	nM	10.0
	3009935	CHEMBL1048115	Inhibition of TGFR1	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	IC50	nM	13.0	CHEMBL4439	Homo sapiens	IC50	nM	13.0
	3009936	CHEMBL1048115	Inhibition of TGFR1	B	Cc1cccnc1-c1nc(N)sc1-c1ccc2ncccc2n1		CHEMBL576062	=	IC50	nM	6.0	CHEMBL4439	Homo sapiens	IC50	nM	6.0
	3009937	CHEMBL1048115	Inhibition of TGFR1	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	IC50	nM	4.0	CHEMBL4439	Homo sapiens	IC50	nM	4.0
	3009938	CHEMBL1048115	Inhibition of TGFR1	B	CN(C)CCNC(=O)Nc1ccc2c(-c3c(-c4ccccn4)nn4c3CCC4)ccnc2c1		CHEMBL565814	=	IC50	nM	18.0	CHEMBL4439	Homo sapiens	IC50	nM	18.0
	3009939	CHEMBL1048115	Inhibition of TGFR1	B	Cc1cccc(-c2[nH]c(NCc3ccc(C#N)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL445934	=	IC50	nM	24.0	CHEMBL4439	Homo sapiens	IC50	nM	24.0
	3009940	CHEMBL1048115	Inhibition of TGFR1	B	Cc1cccc(-c2n[nH]cc2-c2ccc(O)cc2)n1		CHEMBL118928	=	IC50	nM	31.0	CHEMBL4439	Homo sapiens	IC50	nM	31.0
	3009941	CHEMBL1048115	Inhibition of TGFR1	B	Cc1cccc(-c2nn3c(c2-c2ccc(O)cc2)CCC3)n1		CHEMBL330814	=	IC50	nM	47.0	CHEMBL4439	Homo sapiens	IC50	nM	47.0
	3009942	CHEMBL1048115	Inhibition of TGFR1	B	Cc1cccc(-c2nn3c(c2-c2ccc4ncn(CCCN5CCOCC5)c4c2)CCC3)n1		CHEMBL381532	=	IC50	nM	69.0	CHEMBL4439	Homo sapiens	IC50	nM	69.0
	3009943	CHEMBL1048115	Inhibition of TGFR1	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccccc24)CCC3)n1		CHEMBL119976	=	IC50	nM	78.0	CHEMBL4439	Homo sapiens	IC50	nM	78.0
	3009944	CHEMBL1048115	Inhibition of TGFR1	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	IC50	nM	94.0	CHEMBL4439	Homo sapiens	IC50	nM	94.0
	3009945	CHEMBL1048115	Inhibition of TGFR1	B	Fc1ccc(-c2nn3c(c2-c2ccnc4ccccc24)CCC3)nc1		CHEMBL325405	=	IC50	nM	151.0	CHEMBL4439	Homo sapiens	IC50	nM	151.0
	3009946	CHEMBL1048115	Inhibition of TGFR1	B	c1ccc(-c2nn3c(c2-c2ccc4ncn(CCCN5CCCC5)c4c2)CCC3)nc1		CHEMBL378167	=	IC50	nM	246.0	CHEMBL4439	Homo sapiens	IC50	nM	246.0
	3009947	CHEMBL1048115	Inhibition of TGFR1	B	CCc1cccc(-c2[nH]c(CNc3ccc(C#N)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL229497	=	IC50	nM	360.0	CHEMBL4439	Homo sapiens	IC50	nM	360.0
	3009948	CHEMBL1048115	Inhibition of TGFR1	B	c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL268889	=	IC50	nM	460.0	CHEMBL4439	Homo sapiens	IC50	nM	460.0
	3009949	CHEMBL1048115	Inhibition of TGFR1	B	Fc1ccc(-c2c(-c3cccc(C(F)(F)F)n3)nn3c2CCC3)cc1		CHEMBL333798	=	IC50	nM	877.0	CHEMBL4439	Homo sapiens	IC50	nM	877.0
	3009950	CHEMBL1048115	Inhibition of TGFR1	B	Nc1nc(-c2cc(Cl)ccn2)c(-c2ccnc3ccccc23)s1		CHEMBL182678	=	IC50	nM	1023.0	CHEMBL4439	Homo sapiens	IC50	nM	1023.0
	3009951	CHEMBL1048115	Inhibition of TGFR1	B	c1ccc(-c2c[nH]nc2-c2ccccn2)cc1		CHEMBL129280	=	IC50	nM	3990.0	CHEMBL4439	Homo sapiens	IC50	nM	3990.0
	3009952	CHEMBL1048115	Inhibition of TGFR1	B	COc1ccc(-c2c(-c3ccccn3)nc3n2CCC3)cc1		CHEMBL6204	=	IC50	nM	5100.0	CHEMBL4439	Homo sapiens	IC50	nM	5100.0
	3009953	CHEMBL1048115	Inhibition of TGFR1	B	CS(=O)(=O)c1ccc(-c2c(-c3ccccn3)nn3c2CCC3)cc1		CHEMBL566256	=	IC50	nM	19500.0	CHEMBL4439	Homo sapiens	IC50	nM	19500.0
	3009954	CHEMBL1048115	Inhibition of TGFR1	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	IC50	nM	30000.0	CHEMBL4439	Homo sapiens	IC50	nM	30000.0
	3009955	CHEMBL1048115	Inhibition of TGFR1	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	IC50	nM	11.0	CHEMBL4439	Homo sapiens	IC50	nM	11.0
	3009956	CHEMBL1048115	Inhibition of TGFR1	B	CN(C)CCCc1cccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)c1		CHEMBL567706	=	IC50	nM	15.0	CHEMBL4439	Homo sapiens	IC50	nM	15.0
	3009957	CHEMBL1048115	Inhibition of TGFR1	B	O=C(NC1CCOCC1)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202887	=	IC50	nM	18.0	CHEMBL4439	Homo sapiens	IC50	nM	18.0
	3009958	CHEMBL1048115	Inhibition of TGFR1	B	c1ccc(-c2n[nH]cc2-c2ccc3ncccc3n2)nc1		CHEMBL183354	=	IC50	nM	19.0	CHEMBL4439	Homo sapiens	IC50	nM	19.0
	3009959	CHEMBL1048115	Inhibition of TGFR1	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	IC50	nM	20.0	CHEMBL4439	Homo sapiens	IC50	nM	20.0
	3009960	CHEMBL1048115	Inhibition of TGFR1	B	Cc1cccc(-c2[nH]c(CNc3ccc(C(N)=O)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL229597	=	IC50	nM	21.0	CHEMBL4439	Homo sapiens	IC50	nM	21.0
	3009961	CHEMBL1048115	Inhibition of TGFR1	B	FC(F)(F)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL383523	=	IC50	nM	24.0	CHEMBL4439	Homo sapiens	IC50	nM	24.0
	3009962	CHEMBL1048115	Inhibition of TGFR1	B	CC(=O)COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202943	=	IC50	nM	25.0	CHEMBL4439	Homo sapiens	IC50	nM	25.0
	3009963	CHEMBL1048115	Inhibition of TGFR1	B	Cc1cccc(-c2nc(C(C)C)[nH]c2-c2ccnc(-c3ccc(C(=O)NC4CCOCC4)cc3)c2)n1		CHEMBL585505	=	IC50	nM	25.0	CHEMBL4439	Homo sapiens	IC50	nM	25.0
	3009964	CHEMBL1048115	Inhibition of TGFR1	B	O=C(O)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL568357	=	IC50	nM	27.0	CHEMBL4439	Homo sapiens	IC50	nM	27.0
	3009965	CHEMBL1048115	Inhibition of TGFR1	B	Cc1cccc2ccc(-c3sc(N)nc3-c3ccccn3)nc12		CHEMBL565643	=	IC50	nM	30.0	CHEMBL4439	Homo sapiens	IC50	nM	30.0
	3009966	CHEMBL1048115	Inhibition of TGFR1	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	IC50	nM	30.0	CHEMBL4439	Homo sapiens	IC50	nM	30.0
	3009967	CHEMBL1048115	Inhibition of TGFR1	B	O=C(CCO)Nc1ccc2c(-c3c(-c4ccccn4)nn4c3CCC4)ccnc2c1		CHEMBL585117	=	IC50	nM	32.0	CHEMBL4439	Homo sapiens	IC50	nM	32.0
	3009968	CHEMBL1048115	Inhibition of TGFR1	B	COCCC(=O)Nc1ccc2c(-c3c(-c4ccccn4)nn4c3CCC4)ccnc2c1		CHEMBL565645	=	IC50	nM	34.0	CHEMBL4439	Homo sapiens	IC50	nM	34.0
	3009969	CHEMBL1048115	Inhibition of TGFR1	B	N#Cc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL437118	=	IC50	nM	35.0	CHEMBL4439	Homo sapiens	IC50	nM	35.0
	3009970	CHEMBL1048115	Inhibition of TGFR1	B	COC(=O)Nc1ccc2c(-c3c(-c4ccccn4)nn4c3CCC4)ccnc2c1		CHEMBL584928	=	IC50	nM	40.0	CHEMBL4439	Homo sapiens	IC50	nM	40.0
	3009971	CHEMBL1048115	Inhibition of TGFR1	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCCC4)cc3)c2)nc1		CHEMBL202994	=	IC50	nM	40.0	CHEMBL4439	Homo sapiens	IC50	nM	40.0
	3009972	CHEMBL1048115	Inhibition of TGFR1	B	Cc1cccc(-c2nn3c(c2-c2ccc4ncn(CCCO)c4c2)CCC3)n1		CHEMBL204063	=	IC50	nM	41.0	CHEMBL4439	Homo sapiens	IC50	nM	41.0
	3009973	CHEMBL1048115	Inhibition of TGFR1	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(CN4CCOCC4)cc3)c2)nc1		CHEMBL203162	=	IC50	nM	42.0	CHEMBL4439	Homo sapiens	IC50	nM	42.0
	3009974	CHEMBL1048115	Inhibition of TGFR1	B	Clc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL204838	=	IC50	nM	43.0	CHEMBL4439	Homo sapiens	IC50	nM	43.0
	3009975	CHEMBL1048115	Inhibition of TGFR1	B	Cc1cccc(-c2[nH]c(CNc3ccc(C#N)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL229495	=	IC50	nM	46.0	CHEMBL4439	Homo sapiens	IC50	nM	46.0
	3009976	CHEMBL1048115	Inhibition of TGFR1	B	CCc1cccc(-c2[nH]c(CNc3ccc(C(N)=O)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL389079	=	IC50	nM	46.0	CHEMBL4439	Homo sapiens	IC50	nM	46.0
	3009977	CHEMBL1048115	Inhibition of TGFR1	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(CNC4CCCOC4)cc3)c2)nc1		CHEMBL566234	=	IC50	nM	47.0	CHEMBL4439	Homo sapiens	IC50	nM	47.0
	3009978	CHEMBL1048115	Inhibition of TGFR1	B	CCc1cccc(-c2[nH]c(CNc3ccc(C#N)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL229548	=	IC50	nM	47.0	CHEMBL4439	Homo sapiens	IC50	nM	47.0
	3009979	CHEMBL1048115	Inhibition of TGFR1	B	Cc1cccc(-c2nn3c(c2-c2ccnc4cc(Cl)ccc24)CCC3)n1		CHEMBL332344	=	IC50	nM	48.0	CHEMBL4439	Homo sapiens	IC50	nM	48.0
	3009980	CHEMBL1048115	Inhibition of TGFR1	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	IC50	nM	48.0	CHEMBL4439	Homo sapiens	IC50	nM	48.0
	3009981	CHEMBL1048115	Inhibition of TGFR1	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	IC50	nM	51.0	CHEMBL4439	Homo sapiens	IC50	nM	51.0
	3009982	CHEMBL1048115	Inhibition of TGFR1	B	Clc1ccc2c(-c3c(-c4ccccn4)nn4c3CCC4)ccnc2c1		CHEMBL121554	=	IC50	nM	54.0	CHEMBL4439	Homo sapiens	IC50	nM	54.0
	3009983	CHEMBL1048115	Inhibition of TGFR1	B	Fc1ccccc1-c1cc(-c2c[nH]nc2-c2ccccn2)ccn1		CHEMBL205427	=	IC50	nM	59.0	CHEMBL4439	Homo sapiens	IC50	nM	59.0
	3009984	CHEMBL1048115	Inhibition of TGFR1	B	Nc1ccc2c(-c3c(-c4ccccn4)nn4c3CCC4)ccnc2c1		CHEMBL585700	=	IC50	nM	59.0	CHEMBL4439	Homo sapiens	IC50	nM	59.0
	3009985	CHEMBL1048115	Inhibition of TGFR1	B	CN(C)CC(=O)Nc1ccc2c(-c3c(-c4ccccn4)nn4c3CCC4)ccnc2c1		CHEMBL259821	=	IC50	nM	64.0	CHEMBL4439	Homo sapiens	IC50	nM	64.0
	3009986	CHEMBL1048115	Inhibition of TGFR1	B	CCc1cccc(-c2nn3c(c2-c2ccnc4ccccc24)CCC3)n1		CHEMBL122583	=	IC50	nM	71.0	CHEMBL4439	Homo sapiens	IC50	nM	71.0
	3009987	CHEMBL1048115	Inhibition of TGFR1	B	CCc1cccc(-c2[nH]c(CNc3cccc(C#N)c3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL229496	=	IC50	nM	73.0	CHEMBL4439	Homo sapiens	IC50	nM	73.0
	3009988	CHEMBL1048115	Inhibition of TGFR1	B	Cc1cccc(-c2[nH]c(CNc3ccc(C(N)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL229654	=	IC50	nM	75.0	CHEMBL4439	Homo sapiens	IC50	nM	75.0
	3009989	CHEMBL1048115	Inhibition of TGFR1	B	O=C(Nc1ccc2c(-c3c(-c4ccccn4)nn4c3CCC4)ccnc2c1)OCCO		CHEMBL566439	=	IC50	nM	79.0	CHEMBL4439	Homo sapiens	IC50	nM	79.0
	3009990	CHEMBL1048115	Inhibition of TGFR1	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCC4CCCCC4)cc3)c2)nc1		CHEMBL379700	=	IC50	nM	81.0	CHEMBL4439	Homo sapiens	IC50	nM	81.0
	3009991	CHEMBL1048115	Inhibition of TGFR1	B	CC(=O)Nc1ccc2c(-c3c(-c4ccccn4)nn4c3CCC4)ccnc2c1		CHEMBL565815	=	IC50	nM	87.0	CHEMBL4439	Homo sapiens	IC50	nM	87.0
	3009992	CHEMBL1048115	Inhibition of TGFR1	B	CCOc1ccc2c(-c3c(-c4cccc(C)n4)nn4c3CCC4)ccnc2c1		CHEMBL120587	=	IC50	nM	88.0	CHEMBL4439	Homo sapiens	IC50	nM	88.0
	3009993	CHEMBL1048115	Inhibition of TGFR1	B	Fc1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL340203	=	IC50	nM	91.0	CHEMBL4439	Homo sapiens	IC50	nM	91.0
	3009994	CHEMBL1048115	Inhibition of TGFR1	B	COCCNC(=O)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL205151	=	IC50	nM	91.0	CHEMBL4439	Homo sapiens	IC50	nM	91.0
	3009995	CHEMBL1048115	Inhibition of TGFR1	B	CCc1cccc(-c2[nH]c(CNc3ccc(C(N)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL226733	=	IC50	nM	92.0	CHEMBL4439	Homo sapiens	IC50	nM	92.0
	3009996	CHEMBL1048115	Inhibition of TGFR1	B	c1ccc(-c2nn3c(c2-c2ccnc4ccccc24)CCC3)nc1		CHEMBL121795	=	IC50	nM	104.0	CHEMBL4439	Homo sapiens	IC50	nM	104.0
	3009997	CHEMBL1048115	Inhibition of TGFR1	B	c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL205736	=	IC50	nM	107.0	CHEMBL4439	Homo sapiens	IC50	nM	107.0
	3009998	CHEMBL1048115	Inhibition of TGFR1	B	O=C(CN1CCCC1)Nc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL567287	=	IC50	nM	110.0	CHEMBL4439	Homo sapiens	IC50	nM	110.0
	3009999	CHEMBL1048115	Inhibition of TGFR1	B	CCSc1ccc2c(-c3c(-c4ccccn4)nn4c3CCC4)ccnc2c1		CHEMBL119936	=	IC50	nM	110.0	CHEMBL4439	Homo sapiens	IC50	nM	110.0
	3010000	CHEMBL1048115	Inhibition of TGFR1	B	O=C(Nc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1)C1CCOCC1		CHEMBL206017	=	IC50	nM	112.0	CHEMBL4439	Homo sapiens	IC50	nM	112.0
	3010001	CHEMBL1048115	Inhibition of TGFR1	B	COc1cccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)c1		CHEMBL382799	=	IC50	nM	115.0	CHEMBL4439	Homo sapiens	IC50	nM	115.0
	3010002	CHEMBL1048115	Inhibition of TGFR1	B	C#Cc1cccc(NCc2nc(-c3ccc4nccnc4c3)c(-c3cccc(CC)n3)[nH]2)c1		CHEMBL3707019	=	IC50	nM	119.0	CHEMBL4439	Homo sapiens	IC50	nM	119.0
	3010003	CHEMBL1048115	Inhibition of TGFR1	B	CCN(CC)CCCn1cnc2ccc(-c3c(-c4cccc(C)n4)nn4c3CCC4)cc21		CHEMBL203791	=	IC50	nM	122.0	CHEMBL4439	Homo sapiens	IC50	nM	122.0
	3010004	CHEMBL1048115	Inhibition of TGFR1	B	c1ccc(-c2c[nH]nc2-c2ccnc3ccccc23)nc1		CHEMBL338713	=	IC50	nM	150.0	CHEMBL4439	Homo sapiens	IC50	nM	150.0
	3010005	CHEMBL1048115	Inhibition of TGFR1	B	C#Cc1ccc(CNc2nc(-c3ccc4c(c3)OCO4)c(-c3cccc(C)n3)[nH]2)cc1		CHEMBL3707020	=	IC50	nM	153.0	CHEMBL4439	Homo sapiens	IC50	nM	153.0
	3010006	CHEMBL1048115	Inhibition of TGFR1	B	O=C(O)c1ccc(-c2nc(-c3ccc4c(c3)OCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL6250	=	IC50	nM	170.0	CHEMBL4439	Homo sapiens	IC50	nM	170.0
	3010007	CHEMBL1048115	Inhibition of TGFR1	B	C#Cc1ccc(NCc2nc(-c3ccc4c(c3)OCO4)c(-c3cccc(C)n3)[nH]2)cc1		CHEMBL3707023	=	IC50	nM	174.0	CHEMBL4439	Homo sapiens	IC50	nM	174.0
	3010008	CHEMBL1048115	Inhibition of TGFR1	B	c1ccc(-c2n[nH]c(C3CC3)c2-c2ccnc3ccccc23)nc1		CHEMBL338196	=	IC50	nM	203.0	CHEMBL4439	Homo sapiens	IC50	nM	203.0
	3010009	CHEMBL1048115	Inhibition of TGFR1	B	CN(C(=O)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1)C1CCOCC1		CHEMBL205271	=	IC50	nM	214.0	CHEMBL4439	Homo sapiens	IC50	nM	214.0
	3010010	CHEMBL1048115	Inhibition of TGFR1	B	FC(F)(F)c1cccc(-c2n[nH]cc2-c2ccnc3ccccc23)c1		CHEMBL129678	=	IC50	nM	217.0	CHEMBL4439	Homo sapiens	IC50	nM	217.0
	3010011	CHEMBL1048115	Inhibition of TGFR1	B	FC(F)(F)c1cccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)c1		CHEMBL382466	=	IC50	nM	240.0	CHEMBL4439	Homo sapiens	IC50	nM	240.0
	3010012	CHEMBL1048115	Inhibition of TGFR1	B	CN(C)CCCNC(=O)Nc1ccc2c(-c3c(-c4ccccn4)nn4c3CCC4)ccnc2c1		CHEMBL585109	=	IC50	nM	255.0	CHEMBL4439	Homo sapiens	IC50	nM	255.0
	3011073	CHEMBL1048115	Inhibition of TGFR1	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	IC50	nM	260.0	CHEMBL4439	Homo sapiens	IC50	nM	260.0
	3011074	CHEMBL1048115	Inhibition of TGFR1	B	Nc1nc(-c2ccccn2)c(-c2ccnc3ccccc23)s1		CHEMBL181640	=	IC50	nM	274.0	CHEMBL4439	Homo sapiens	IC50	nM	274.0
	3011075	CHEMBL1048115	Inhibition of TGFR1	B	Cc1cccc(-c2nn3c(c2-c2ccc(F)c(F)c2)CCC3)n1		CHEMBL120718	=	IC50	nM	343.0	CHEMBL4439	Homo sapiens	IC50	nM	343.0
	3011076	CHEMBL1048115	Inhibition of TGFR1	B	c1csc(-c2n[nH]cc2-c2ccnc3ccccc23)c1		CHEMBL130025	=	IC50	nM	353.0	CHEMBL4439	Homo sapiens	IC50	nM	353.0
	3011077	CHEMBL1048115	Inhibition of TGFR1	B	c1ccc(Cn2cc(-c3ccnc4ccccc34)c(-c3ccccn3)n2)cc1		CHEMBL126180	=	IC50	nM	369.0	CHEMBL4439	Homo sapiens	IC50	nM	369.0
	3011078	CHEMBL1048115	Inhibition of TGFR1	B	Cc1ccc2nccc(-c3sc(N)nc3-c3ccccn3)c2n1		CHEMBL425177	=	IC50	nM	380.0	CHEMBL4439	Homo sapiens	IC50	nM	380.0
	3011079	CHEMBL1048115	Inhibition of TGFR1	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)cc1		CHEMBL126676	=	IC50	nM	382.0	CHEMBL4439	Homo sapiens	IC50	nM	382.0
	3011080	CHEMBL1048115	Inhibition of TGFR1	B	CN(C)CCCn1cnc2cc(-c3c(-c4ccccn4)nn4c3CCC4)ccc21		CHEMBL565644	=	IC50	nM	398.0	CHEMBL4439	Homo sapiens	IC50	nM	398.0
	3011081	CHEMBL1048115	Inhibition of TGFR1	B	COc1ccc(-c2c(-c3ccccn3)nn3c2CCC3)cc1		CHEMBL120907	=	IC50	nM	646.0	CHEMBL4439	Homo sapiens	IC50	nM	646.0
	3011082	CHEMBL1048115	Inhibition of TGFR1	B	Nc1nc(-c2nccs2)c(-c2ccnc3ccccc23)s1		CHEMBL362710	=	IC50	nM	1175.0	CHEMBL4439	Homo sapiens	IC50	nM	1175.0
	3011083	CHEMBL1048115	Inhibition of TGFR1	B	Nc1nc(-c2ccccc2F)c(-c2ccnc3ccccc23)s1		CHEMBL184746	=	IC50	nM	1259.0	CHEMBL4439	Homo sapiens	IC50	nM	1259.0
	3011084	CHEMBL1048115	Inhibition of TGFR1	B	CC(C)c1cccc(-c2nn3c(c2-c2ccnc4ccccc24)CCC3)n1		CHEMBL120245	=	IC50	nM	1300.0	CHEMBL4439	Homo sapiens	IC50	nM	1300.0
	3011085	CHEMBL1048115	Inhibition of TGFR1	B	Cc1cccc(-c2nn3c(c2-c2ccc(F)cc2)CCC3)n1		CHEMBL121790	=	IC50	nM	1320.0	CHEMBL4439	Homo sapiens	IC50	nM	1320.0
	3011086	CHEMBL1048115	Inhibition of TGFR1	B	O=C(O)c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccccn3)[nH]2)cc1		CHEMBL269339	=	IC50	nM	1500.0	CHEMBL4439	Homo sapiens	IC50	nM	1500.0
	3011087	CHEMBL1048115	Inhibition of TGFR1	B	Fc1ccc(-c2c(-c3ccccn3)nc3n2CCS3)cc1		CHEMBL266706	=	IC50	nM	1600.0	CHEMBL4439	Homo sapiens	IC50	nM	1600.0
	3011088	CHEMBL1048115	Inhibition of TGFR1	B	Cc1cccc(-c2nn3c(c2-c2ccc4c(c2)ncn4C)CCC3)n1		CHEMBL584901	=	IC50	nM	1700.0	CHEMBL4439	Homo sapiens	IC50	nM	1700.0
	3011089	CHEMBL1048115	Inhibition of TGFR1	B	Clc1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL341534	=	IC50	nM	1760.0	CHEMBL4439	Homo sapiens	IC50	nM	1760.0
	3011090	CHEMBL1048115	Inhibition of TGFR1	B	Nc1nc(-c2cccc(Cl)n2)c(-c2ccnc3ccccc23)s1		CHEMBL582791	=	IC50	nM	1778.0	CHEMBL4439	Homo sapiens	IC50	nM	1778.0
	3011091	CHEMBL1048115	Inhibition of TGFR1	B	OCc1cccc(-c2nn3c(c2-c2ccc(F)cc2)CCC3)n1		CHEMBL122414	=	IC50	nM	2620.0	CHEMBL4439	Homo sapiens	IC50	nM	2620.0
	3011092	CHEMBL1048115	Inhibition of TGFR1	B	Nc1nc(-c2cccnc2)c(-c2ccnc3ccccc23)s1		CHEMBL359724	=	IC50	nM	3981.0	CHEMBL4439	Homo sapiens	IC50	nM	3981.0
	3011093	CHEMBL1048115	Inhibition of TGFR1	B	Cc1ccc(-c2c(-c3cccc(C)n3)nn3c2CCC3)cc1		CHEMBL118339	=	IC50	nM	4000.0	CHEMBL4439	Homo sapiens	IC50	nM	4000.0
	3011094	CHEMBL1048115	Inhibition of TGFR1	B	C[S+]([O-])c1ccc(C2=NC(c3ccc(F)cc3)C(c3ccncc3)N2)cc1		CHEMBL566254	=	IC50	nM	6000.0	CHEMBL4439	Homo sapiens	IC50	nM	6000.0
	3011095	CHEMBL1048115	Inhibition of TGFR1	B	CCS(=O)(=O)c1ccc2c(-c3c(-c4ccccn4)nn4c3CCC4)ccnc2c1		CHEMBL331703	=	IC50	nM	9290.0	CHEMBL4439	Homo sapiens	IC50	nM	9290.0
	3011096	CHEMBL1048115	Inhibition of TGFR1	B	Nc1nc(-c2ccccn2)c(-c2cccc3ccccc23)s1		CHEMBL365918	=	IC50	nM	10965.0	CHEMBL4439	Homo sapiens	IC50	nM	10965.0
	3011097	CHEMBL1048115	Inhibition of TGFR1	B	Fc1ccc(C2C(c3ccncc3)NC3SCCN32)cc1		CHEMBL566440	=	IC50	nM	50000.0	CHEMBL4439	Homo sapiens	IC50	nM	50000.0
	3052496	CHEMBL1072534	Residual activity of TGFB-R1 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	96.0	CHEMBL4439	Homo sapiens	Residual activity	%	96.0
	3052748	CHEMBL1043827	Residual activity of TGFB-R1 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	107.0	CHEMBL4439	Homo sapiens	Residual activity	%	107.0
	3054057	CHEMBL1071986	Residual activity of TGFB-R1 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	94.0	CHEMBL4439	Homo sapiens	Residual activity	%	94.0
	3055344	CHEMBL1072534	Residual activity of TGFB-R1 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	102.0	CHEMBL4439	Homo sapiens	Residual activity	%	102.0
	3055596	CHEMBL1043827	Residual activity of TGFB-R1 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	103.0	CHEMBL4439	Homo sapiens	Residual activity	%	103.0
	3056901	CHEMBL1071986	Residual activity of TGFB-R1 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	94.0	CHEMBL4439	Homo sapiens	Residual activity	%	94.0
	3057153	CHEMBL1072534	Residual activity of TGFB-R1 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	90.0	CHEMBL4439	Homo sapiens	Residual activity	%	90.0
	3058473	CHEMBL1043827	Residual activity of TGFB-R1 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	98.0	CHEMBL4439	Homo sapiens	Residual activity	%	98.0
	3059757	CHEMBL1071986	Residual activity of TGFB-R1 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	100.0	CHEMBL4439	Homo sapiens	Residual activity	%	100.0
	3063560	CHEMBL1050475	Binding affinity to human TGFBR1 at 200 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CSSC[C@@H](C(=O)NCC(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595545	=	Activity	%	100.0	CHEMBL4439	Homo sapiens	Activity	%	100.0
	3063650	CHEMBL1043379	Binding affinity to human TGFBR1 at 500 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(N)=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595546	=	Activity	%	75.0	CHEMBL4439	Homo sapiens	Activity	%	75.0
	3063740	CHEMBL1045146	Binding affinity to human TGFBR1 at 50 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CNC(=O)C[C@@H](C(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL609010	=	Activity	%	100.0	CHEMBL4439	Homo sapiens	Activity	%	100.0
	3066898	CHEMBL1066104	Inhibition of TGFBR1 at 10 uM	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Inhibition	%	0.0	CHEMBL4439	Homo sapiens	INH	%	0.0
	3066988	CHEMBL1066104	Inhibition of TGFBR1 at 10 uM	B	O=C1Nc2ccccc2/C1=C1\C(=O)N(CCCc2ccccc2)c2ccccc21		CHEMBL607196	=	Inhibition	%	0.0	CHEMBL4439	Homo sapiens	INH	%	0.0
	3081377	CHEMBL1070008	Displacement of [3H]HTS446284 from human recombinant His-tagged TGFbetaR1 after 1 hr by scintillation counting	B	Cn1c(-c2ccc3nccnc3c2)c(-c2ccccn2)c(=O)n1C		CHEMBL593725	=	Ki	nM	11.0	CHEMBL4439	Homo sapiens	Ki	uM	0.011
	3081378	CHEMBL1070009	Inhibition of TGFR-1 in human HepG2 cells expressing PAI-luciferase by luciferase reporter gene assay	B	Cn1c(-c2ccc3nccnc3c2)c(-c2ccccn2)c(=O)n1C		CHEMBL593725	=	IC50	nM	1700.0	CHEMBL4439	Homo sapiens	IC50	uM	1.7
	3081379	CHEMBL1070008	Displacement of [3H]HTS446284 from human recombinant His-tagged TGFbetaR1 after 1 hr by scintillation counting	B	Cc1cccc(-c2c(-c3ccc4nccnc4c3)n(C)n(C)c2=O)n1		CHEMBL606632	=	Ki	nM	5.0	CHEMBL4439	Homo sapiens	Ki	uM	0.005
	3081380	CHEMBL1070009	Inhibition of TGFR-1 in human HepG2 cells expressing PAI-luciferase by luciferase reporter gene assay	B	Cc1cccc(-c2c(-c3ccc4nccnc4c3)n(C)n(C)c2=O)n1		CHEMBL606632	=	IC50	nM	1030.0	CHEMBL4439	Homo sapiens	IC50	uM	1.03
	3081381	CHEMBL1070008	Displacement of [3H]HTS446284 from human recombinant His-tagged TGFbetaR1 after 1 hr by scintillation counting	B	Cn1c(-c2ccc3nccnc3c2)c(-c2cccnc2)c(=O)n1C		CHEMBL593470	>	Ki	nM	2800.0	CHEMBL4439	Homo sapiens	Ki	uM	2.8
	3081382	CHEMBL1070008	Displacement of [3H]HTS446284 from human recombinant His-tagged TGFbetaR1 after 1 hr by scintillation counting	B	Cc1cc(-c2c(-c3ccc4nccnc4c3)n(C)n(C)c2=O)ccn1		CHEMBL593012	>	Ki	nM	2800.0	CHEMBL4439	Homo sapiens	Ki	uM	2.8
	3081383	CHEMBL1070008	Displacement of [3H]HTS446284 from human recombinant His-tagged TGFbetaR1 after 1 hr by scintillation counting	B	Cn1c(-c2ccc3nccnc3c2)c(-c2ccccc2)c(=O)n1C		CHEMBL592999	=	Ki	nM	78.0	CHEMBL4439	Homo sapiens	Ki	uM	0.078
	3081384	CHEMBL1070009	Inhibition of TGFR-1 in human HepG2 cells expressing PAI-luciferase by luciferase reporter gene assay	B	Cn1c(-c2ccc3nccnc3c2)c(-c2ccccc2)c(=O)n1C		CHEMBL592999	>	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	IC50	uM	10.0
	3081385	CHEMBL1070008	Displacement of [3H]HTS446284 from human recombinant His-tagged TGFbetaR1 after 1 hr by scintillation counting	B	Cc1cccc(-c2c(-c3ccc4nccnc4c3)n(C)n(C)c2=O)c1		CHEMBL604261	=	Ki	nM	20.0	CHEMBL4439	Homo sapiens	Ki	uM	0.02
	3081386	CHEMBL1070009	Inhibition of TGFR-1 in human HepG2 cells expressing PAI-luciferase by luciferase reporter gene assay	B	Cc1cccc(-c2c(-c3ccc4nccnc4c3)n(C)n(C)c2=O)c1		CHEMBL604261	=	IC50	nM	3050.0	CHEMBL4439	Homo sapiens	IC50	uM	3.05
	3081387	CHEMBL1070008	Displacement of [3H]HTS446284 from human recombinant His-tagged TGFbetaR1 after 1 hr by scintillation counting	B	Cn1c(-c2ccc3nccnc3c2)c(-c2ccccc2O)c(=O)n1C		CHEMBL605302	=	Ki	nM	77000.0	CHEMBL4439	Homo sapiens	Ki	uM	77.0
	3081388	CHEMBL1070009	Inhibition of TGFR-1 in human HepG2 cells expressing PAI-luciferase by luciferase reporter gene assay	B	Cn1c(-c2ccc3nccnc3c2)c(-c2ccccc2O)c(=O)n1C		CHEMBL605302	>	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	IC50	uM	10.0
	3081389	CHEMBL1070008	Displacement of [3H]HTS446284 from human recombinant His-tagged TGFbetaR1 after 1 hr by scintillation counting	B	Cn1c(-c2ccc3nccnc3c2)c(-c2cccc(O)c2)c(=O)n1C		CHEMBL593965	=	Ki	nM	53000.0	CHEMBL4439	Homo sapiens	Ki	uM	53.0
	3081390	CHEMBL1070009	Inhibition of TGFR-1 in human HepG2 cells expressing PAI-luciferase by luciferase reporter gene assay	B	Cn1c(-c2ccc3nccnc3c2)c(-c2cccc(O)c2)c(=O)n1C		CHEMBL593965	>	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	IC50	uM	10.0
	3081391	CHEMBL1070008	Displacement of [3H]HTS446284 from human recombinant His-tagged TGFbetaR1 after 1 hr by scintillation counting	B	Cn1c(-c2ccc3nccnc3c2)c(-c2ccc(O)cc2)c(=O)n1C	Outside typical range	CHEMBL603423	=	Ki	nM	950000.0	CHEMBL4439	Homo sapiens	Ki	uM	950.0
	3081392	CHEMBL1070008	Displacement of [3H]HTS446284 from human recombinant His-tagged TGFbetaR1 after 1 hr by scintillation counting	B	Cn1c(-c2ccc3nccnc3c2)c(-c2ccccc2N)c(=O)n1C	Outside typical range	CHEMBL606695	=	Ki	nM	952000.0	CHEMBL4439	Homo sapiens	Ki	uM	952.0
	3081393	CHEMBL1070008	Displacement of [3H]HTS446284 from human recombinant His-tagged TGFbetaR1 after 1 hr by scintillation counting	B	Cn1c(-c2ccc3nccnc3c2)c(-c2cccc(N)c2)c(=O)n1C	Outside typical range	CHEMBL603851	=	Ki	nM	130000.0	CHEMBL4439	Homo sapiens	Ki	uM	130.0
	3081394	CHEMBL1070009	Inhibition of TGFR-1 in human HepG2 cells expressing PAI-luciferase by luciferase reporter gene assay	B	Cn1c(-c2ccc3nccnc3c2)c(-c2cccc(N)c2)c(=O)n1C		CHEMBL603851	>	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	IC50	uM	10.0
	3081395	CHEMBL1070008	Displacement of [3H]HTS446284 from human recombinant His-tagged TGFbetaR1 after 1 hr by scintillation counting	B	Cn1c(-c2ccc3nccnc3c2)c(-c2ccc(N)cc2)c(=O)n1C	Outside typical range	CHEMBL594372	=	Ki	nM	640000.0	CHEMBL4439	Homo sapiens	Ki	uM	640.0
	3081396	CHEMBL1070008	Displacement of [3H]HTS446284 from human recombinant His-tagged TGFbetaR1 after 1 hr by scintillation counting	B	Cn1c(-c2ccc3nccnc3c2)c(-c2ccccc2C#N)c(=O)n1C	Outside typical range	CHEMBL603853	=	Ki	nM	450000.0	CHEMBL4439	Homo sapiens	Ki	uM	450.0
	3081397	CHEMBL1070009	Inhibition of TGFR-1 in human HepG2 cells expressing PAI-luciferase by luciferase reporter gene assay	B	Cn1c(-c2ccc3nccnc3c2)c(-c2ccccc2C#N)c(=O)n1C		CHEMBL603853	>	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	IC50	uM	10.0
	3081398	CHEMBL1070008	Displacement of [3H]HTS446284 from human recombinant His-tagged TGFbetaR1 after 1 hr by scintillation counting	B	Cn1c(-c2ccc3nccnc3c2)c(-c2cccc(C#N)c2)c(=O)n1C		CHEMBL605942	=	Ki	nM	45000.0	CHEMBL4439	Homo sapiens	Ki	uM	45.0
	3081399	CHEMBL1070009	Inhibition of TGFR-1 in human HepG2 cells expressing PAI-luciferase by luciferase reporter gene assay	B	Cn1c(-c2ccc3nccnc3c2)c(-c2cccc(C#N)c2)c(=O)n1C		CHEMBL605942	>	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	IC50	uM	10.0
	3081400	CHEMBL1070008	Displacement of [3H]HTS446284 from human recombinant His-tagged TGFbetaR1 after 1 hr by scintillation counting	B	CCc1cccc(-c2c(-c3ccc4nccnc4c3)n(C)n(C)c2=O)c1		CHEMBL594371	=	Ki	nM	6.0	CHEMBL4439	Homo sapiens	Ki	uM	0.006
	3081401	CHEMBL1070009	Inhibition of TGFR-1 in human HepG2 cells expressing PAI-luciferase by luciferase reporter gene assay	B	CCc1cccc(-c2c(-c3ccc4nccnc4c3)n(C)n(C)c2=O)c1		CHEMBL594371	=	IC50	nM	390.0	CHEMBL4439	Homo sapiens	IC50	uM	0.39
	3081402	CHEMBL1070008	Displacement of [3H]HTS446284 from human recombinant His-tagged TGFbetaR1 after 1 hr by scintillation counting	B	C=Cc1cccc(-c2c(-c3ccc4nccnc4c3)n(C)n(C)c2=O)c1		CHEMBL593708	=	Ki	nM	12.0	CHEMBL4439	Homo sapiens	Ki	uM	0.012
	3081403	CHEMBL1070009	Inhibition of TGFR-1 in human HepG2 cells expressing PAI-luciferase by luciferase reporter gene assay	B	C=Cc1cccc(-c2c(-c3ccc4nccnc4c3)n(C)n(C)c2=O)c1		CHEMBL593708	=	IC50	nM	560.0	CHEMBL4439	Homo sapiens	IC50	uM	0.56
	3081404	CHEMBL1070008	Displacement of [3H]HTS446284 from human recombinant His-tagged TGFbetaR1 after 1 hr by scintillation counting	B	CC(C)c1cccc(-c2c(-c3ccc4nccnc4c3)n(C)n(C)c2=O)c1	Outside typical range	CHEMBL595351	>	Ki	nM	2800000.0	CHEMBL4439	Homo sapiens	Ki	uM	2800.0
	3081405	CHEMBL1070008	Displacement of [3H]HTS446284 from human recombinant His-tagged TGFbetaR1 after 1 hr by scintillation counting	B	CSc1cccc(-c2c(-c3ccc4nccnc4c3)n(C)n(C)c2=O)c1		CHEMBL595578	=	Ki	nM	60.0	CHEMBL4439	Homo sapiens	Ki	uM	0.06
	3081406	CHEMBL1070009	Inhibition of TGFR-1 in human HepG2 cells expressing PAI-luciferase by luciferase reporter gene assay	B	CSc1cccc(-c2c(-c3ccc4nccnc4c3)n(C)n(C)c2=O)c1		CHEMBL595578	>	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	IC50	uM	10.0
	3081407	CHEMBL1070008	Displacement of [3H]HTS446284 from human recombinant His-tagged TGFbetaR1 after 1 hr by scintillation counting	B	COc1cccc(-c2c(-c3ccc4nccnc4c3)n(C)n(C)c2=O)c1		CHEMBL606376	=	Ki	nM	20.0	CHEMBL4439	Homo sapiens	Ki	uM	0.02
	3081408	CHEMBL1070009	Inhibition of TGFR-1 in human HepG2 cells expressing PAI-luciferase by luciferase reporter gene assay	B	COc1cccc(-c2c(-c3ccc4nccnc4c3)n(C)n(C)c2=O)c1		CHEMBL606376	=	IC50	nM	1400.0	CHEMBL4439	Homo sapiens	IC50	uM	1.4
	3081409	CHEMBL1070008	Displacement of [3H]HTS446284 from human recombinant His-tagged TGFbetaR1 after 1 hr by scintillation counting	B	Cn1c(-c2ccc3nccnc3c2)c(-c2cccc(C(F)(F)F)c2)c(=O)n1C		CHEMBL594867	=	Ki	nM	111.0	CHEMBL4439	Homo sapiens	Ki	uM	0.111
	3081410	CHEMBL1070009	Inhibition of TGFR-1 in human HepG2 cells expressing PAI-luciferase by luciferase reporter gene assay	B	Cn1c(-c2ccc3nccnc3c2)c(-c2cccc(C(F)(F)F)c2)c(=O)n1C		CHEMBL594867	=	IC50	nM	1100.0	CHEMBL4439	Homo sapiens	IC50	uM	1.1
	3081411	CHEMBL1070008	Displacement of [3H]HTS446284 from human recombinant His-tagged TGFbetaR1 after 1 hr by scintillation counting	B	COCc1cccc(-c2c(-c3ccc4nccnc4c3)n(C)n(C)c2=O)c1		CHEMBL606919	=	Ki	nM	35.0	CHEMBL4439	Homo sapiens	Ki	uM	0.035
	3081412	CHEMBL1070009	Inhibition of TGFR-1 in human HepG2 cells expressing PAI-luciferase by luciferase reporter gene assay	B	COCc1cccc(-c2c(-c3ccc4nccnc4c3)n(C)n(C)c2=O)c1		CHEMBL606919	=	IC50	nM	3690.0	CHEMBL4439	Homo sapiens	IC50	uM	3.69
	3081413	CHEMBL1070008	Displacement of [3H]HTS446284 from human recombinant His-tagged TGFbetaR1 after 1 hr by scintillation counting	B	Cn1c(-c2ccc3nccnc3c2)c(-c2cccc(CO)c2)c(=O)n1C		CHEMBL595332	=	Ki	nM	370.0	CHEMBL4439	Homo sapiens	Ki	uM	0.37
	3081414	CHEMBL1070008	Displacement of [3H]HTS446284 from human recombinant His-tagged TGFbetaR1 after 1 hr by scintillation counting	B	Cn1c(-c2ccc3nccnc3c2)c(-c2cccc(CN)c2)c(=O)n1C	Outside typical range	CHEMBL596468	>	Ki	nM	2800000.0	CHEMBL4439	Homo sapiens	Ki	uM	2800.0
	3081415	CHEMBL1070008	Displacement of [3H]HTS446284 from human recombinant His-tagged TGFbetaR1 after 1 hr by scintillation counting	B	Cn1c(-c2ccc3nccnc3c2)c(-c2cccc(CC#N)c2)c(=O)n1C		CHEMBL593710	=	Ki	nM	24.0	CHEMBL4439	Homo sapiens	Ki	uM	0.024
	3081416	CHEMBL1070009	Inhibition of TGFR-1 in human HepG2 cells expressing PAI-luciferase by luciferase reporter gene assay	B	Cn1c(-c2ccc3nccnc3c2)c(-c2cccc(CC#N)c2)c(=O)n1C		CHEMBL593710	=	IC50	nM	4400.0	CHEMBL4439	Homo sapiens	IC50	uM	4.4
	3081417	CHEMBL1070008	Displacement of [3H]HTS446284 from human recombinant His-tagged TGFbetaR1 after 1 hr by scintillation counting	B	CC(=O)c1cccc(-c2c(-c3ccc4nccnc4c3)n(C)n(C)c2=O)c1		CHEMBL603433	=	Ki	nM	410.0	CHEMBL4439	Homo sapiens	Ki	uM	0.41
	3081418	CHEMBL1070008	Displacement of [3H]HTS446284 from human recombinant His-tagged TGFbetaR1 after 1 hr by scintillation counting	B	Cn1c(-c2ccc3nccnc3c2)c(-c2cccc(C(N)=O)c2)c(=O)n1C	Outside typical range	CHEMBL593227	>	Ki	nM	2800000.0	CHEMBL4439	Homo sapiens	Ki	uM	2800.0
	3081419	CHEMBL1070008	Displacement of [3H]HTS446284 from human recombinant His-tagged TGFbetaR1 after 1 hr by scintillation counting	B	COC(=O)c1cccc(-c2c(-c3ccc4nccnc4c3)n(C)n(C)c2=O)c1		CHEMBL593950	=	Ki	nM	440.0	CHEMBL4439	Homo sapiens	Ki	uM	0.44
	3081420	CHEMBL1070008	Displacement of [3H]HTS446284 from human recombinant His-tagged TGFbetaR1 after 1 hr by scintillation counting	B	Cn1c(-c2ccc3nccnc3c2)c(-c2cccc(F)c2)c(=O)n1C		CHEMBL593000	=	Ki	nM	78.0	CHEMBL4439	Homo sapiens	Ki	uM	0.078
	3081421	CHEMBL1070009	Inhibition of TGFR-1 in human HepG2 cells expressing PAI-luciferase by luciferase reporter gene assay	B	Cn1c(-c2ccc3nccnc3c2)c(-c2cccc(F)c2)c(=O)n1C		CHEMBL593000	=	IC50	nM	990.0	CHEMBL4439	Homo sapiens	IC50	uM	0.99
	3081422	CHEMBL1070008	Displacement of [3H]HTS446284 from human recombinant His-tagged TGFbetaR1 after 1 hr by scintillation counting	B	Cn1c(-c2ccc3nccnc3c2)c(-c2cccc(Cl)c2)c(=O)n1C		CHEMBL592977	=	Ki	nM	19.0	CHEMBL4439	Homo sapiens	Ki	uM	0.019
	3081423	CHEMBL1070009	Inhibition of TGFR-1 in human HepG2 cells expressing PAI-luciferase by luciferase reporter gene assay	B	Cn1c(-c2ccc3nccnc3c2)c(-c2cccc(Cl)c2)c(=O)n1C		CHEMBL592977	=	IC50	nM	1900.0	CHEMBL4439	Homo sapiens	IC50	uM	1.9
	3081424	CHEMBL1070008	Displacement of [3H]HTS446284 from human recombinant His-tagged TGFbetaR1 after 1 hr by scintillation counting	B	Cn1c(-c2ccc3nccnc3c2)c(-c2cccc(Br)c2)c(=O)n1C		CHEMBL595556	=	Ki	nM	12.0	CHEMBL4439	Homo sapiens	Ki	uM	0.012
	3081425	CHEMBL1070009	Inhibition of TGFR-1 in human HepG2 cells expressing PAI-luciferase by luciferase reporter gene assay	B	Cn1c(-c2ccc3nccnc3c2)c(-c2cccc(Br)c2)c(=O)n1C		CHEMBL595556	=	IC50	nM	220.0	CHEMBL4439	Homo sapiens	IC50	uM	0.22
	3081426	CHEMBL1070008	Displacement of [3H]HTS446284 from human recombinant His-tagged TGFbetaR1 after 1 hr by scintillation counting	B	Cn1c(-c2ccc3nccnc3c2)c(-c2cccc(NS(C)(=O)=O)c2)c(=O)n1C		CHEMBL607429	=	Ki	nM	19.0	CHEMBL4439	Homo sapiens	Ki	uM	0.019
	3081427	CHEMBL1070009	Inhibition of TGFR-1 in human HepG2 cells expressing PAI-luciferase by luciferase reporter gene assay	B	Cn1c(-c2ccc3nccnc3c2)c(-c2cccc(NS(C)(=O)=O)c2)c(=O)n1C		CHEMBL607429	>	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	IC50	uM	10.0
	3081428	CHEMBL1070008	Displacement of [3H]HTS446284 from human recombinant His-tagged TGFbetaR1 after 1 hr by scintillation counting	B	CC(=O)Nc1cccc(-c2c(-c3ccc4nccnc4c3)n(C)n(C)c2=O)c1		CHEMBL593945	=	Ki	nM	920.0	CHEMBL4439	Homo sapiens	Ki	uM	0.92
	3081429	CHEMBL1070008	Displacement of [3H]HTS446284 from human recombinant His-tagged TGFbetaR1 after 1 hr by scintillation counting	B	CCS(=O)(=O)Nc1cccc(-c2c(-c3ccc4nccnc4c3)n(C)n(C)c2=O)c1	Outside typical range	CHEMBL594409	>	Ki	nM	2800000.0	CHEMBL4439	Homo sapiens	Ki	uM	2800.0
	3081430	CHEMBL1070008	Displacement of [3H]HTS446284 from human recombinant His-tagged TGFbetaR1 after 1 hr by scintillation counting	B	CNC(=O)Nc1cccc(-c2c(-c3ccc4nccnc4c3)n(C)n(C)c2=O)c1	Outside typical range	CHEMBL593458	>	Ki	nM	2800000.0	CHEMBL4439	Homo sapiens	Ki	uM	2800.0
	3081431	CHEMBL1070008	Displacement of [3H]HTS446284 from human recombinant His-tagged TGFbetaR1 after 1 hr by scintillation counting	B	Cn1c(-c2ccc3nccnc3c2)c(-c2ccco2)c(=O)n1C		CHEMBL610195	=	Ki	nM	190.0	CHEMBL4439	Homo sapiens	Ki	uM	0.19
	3081432	CHEMBL1070009	Inhibition of TGFR-1 in human HepG2 cells expressing PAI-luciferase by luciferase reporter gene assay	B	Cn1c(-c2ccc3nccnc3c2)c(-c2ccco2)c(=O)n1C		CHEMBL610195	>	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	IC50	uM	10.0
	3081433	CHEMBL1070008	Displacement of [3H]HTS446284 from human recombinant His-tagged TGFbetaR1 after 1 hr by scintillation counting	B	Cn1c(-c2ccc3nccnc3c2)c(-c2ccoc2)c(=O)n1C		CHEMBL609582	=	Ki	nM	73.0	CHEMBL4439	Homo sapiens	Ki	uM	0.073
	3081434	CHEMBL1070009	Inhibition of TGFR-1 in human HepG2 cells expressing PAI-luciferase by luciferase reporter gene assay	B	Cn1c(-c2ccc3nccnc3c2)c(-c2ccoc2)c(=O)n1C		CHEMBL609582	>	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	IC50	uM	10.0
	3081435	CHEMBL1070008	Displacement of [3H]HTS446284 from human recombinant His-tagged TGFbetaR1 after 1 hr by scintillation counting	B	Cn1c(-c2ccc3nccnc3c2)c(-c2cccs2)c(=O)n1C		CHEMBL593704	=	Ki	nM	365.0	CHEMBL4439	Homo sapiens	Ki	uM	0.365
	3081436	CHEMBL1070008	Displacement of [3H]HTS446284 from human recombinant His-tagged TGFbetaR1 after 1 hr by scintillation counting	B	Cn1c(-c2ccc3nccnc3c2)c(-c2ccsc2)c(=O)n1C		CHEMBL593951	=	Ki	nM	54.0	CHEMBL4439	Homo sapiens	Ki	uM	0.054
	3081437	CHEMBL1070009	Inhibition of TGFR-1 in human HepG2 cells expressing PAI-luciferase by luciferase reporter gene assay	B	Cn1c(-c2ccc3nccnc3c2)c(-c2ccsc2)c(=O)n1C		CHEMBL593951	>	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	IC50	uM	10.0
	3081438	CHEMBL1070008	Displacement of [3H]HTS446284 from human recombinant His-tagged TGFbetaR1 after 1 hr by scintillation counting	B	Cn1c(-c2ccc3nccnc3c2)c(-c2ccc3nonc3c2)c(=O)n1C		CHEMBL594600	=	Ki	nM	640.0	CHEMBL4439	Homo sapiens	Ki	uM	0.64
	3081439	CHEMBL1070008	Displacement of [3H]HTS446284 from human recombinant His-tagged TGFbetaR1 after 1 hr by scintillation counting	B	Cn1c(-c2ccc3nccnc3c2)c(-c2csc3ccccc23)c(=O)n1C		CHEMBL603642	=	Ki	nM	1870.0	CHEMBL4439	Homo sapiens	Ki	uM	1.87
	3081440	CHEMBL1070008	Displacement of [3H]HTS446284 from human recombinant His-tagged TGFbetaR1 after 1 hr by scintillation counting	B	Cn1c(-c2ccc3nccnc3c2)c(-c2ccc3[nH]ccc3c2)c(=O)n1C		CHEMBL605726	=	Ki	nM	1120.0	CHEMBL4439	Homo sapiens	Ki	uM	1.12
Not Determined	3081446	CHEMBL1070009	Inhibition of TGFR-1 in human HepG2 cells expressing PAI-luciferase by luciferase reporter gene assay	B	Cn1c(-c2ccc3nccnc3c2)c(-c2cccnc2)c(=O)n1C		CHEMBL593470		IC50			CHEMBL4439	Homo sapiens	IC50		
Not Determined	3081447	CHEMBL1070009	Inhibition of TGFR-1 in human HepG2 cells expressing PAI-luciferase by luciferase reporter gene assay	B	Cn1c(-c2ccc3nccnc3c2)c(-c2ccc3[nH]ccc3c2)c(=O)n1C		CHEMBL605726		IC50			CHEMBL4439	Homo sapiens	IC50		
Not Determined	3081448	CHEMBL1070009	Inhibition of TGFR-1 in human HepG2 cells expressing PAI-luciferase by luciferase reporter gene assay	B	Cn1c(-c2ccc3nccnc3c2)c(-c2csc3ccccc23)c(=O)n1C		CHEMBL603642		IC50			CHEMBL4439	Homo sapiens	IC50		
Not Determined	3081449	CHEMBL1070009	Inhibition of TGFR-1 in human HepG2 cells expressing PAI-luciferase by luciferase reporter gene assay	B	Cn1c(-c2ccc3nccnc3c2)c(-c2ccc3nonc3c2)c(=O)n1C		CHEMBL594600		IC50			CHEMBL4439	Homo sapiens	IC50		
Not Determined	3081450	CHEMBL1070009	Inhibition of TGFR-1 in human HepG2 cells expressing PAI-luciferase by luciferase reporter gene assay	B	Cn1c(-c2ccc3nccnc3c2)c(-c2cccs2)c(=O)n1C		CHEMBL593704		IC50			CHEMBL4439	Homo sapiens	IC50		
Not Determined	3081451	CHEMBL1070009	Inhibition of TGFR-1 in human HepG2 cells expressing PAI-luciferase by luciferase reporter gene assay	B	CNC(=O)Nc1cccc(-c2c(-c3ccc4nccnc4c3)n(C)n(C)c2=O)c1		CHEMBL593458		IC50			CHEMBL4439	Homo sapiens	IC50		
Not Determined	3081452	CHEMBL1070009	Inhibition of TGFR-1 in human HepG2 cells expressing PAI-luciferase by luciferase reporter gene assay	B	CCS(=O)(=O)Nc1cccc(-c2c(-c3ccc4nccnc4c3)n(C)n(C)c2=O)c1		CHEMBL594409		IC50			CHEMBL4439	Homo sapiens	IC50		
Not Determined	3081453	CHEMBL1070009	Inhibition of TGFR-1 in human HepG2 cells expressing PAI-luciferase by luciferase reporter gene assay	B	CC(=O)Nc1cccc(-c2c(-c3ccc4nccnc4c3)n(C)n(C)c2=O)c1		CHEMBL593945		IC50			CHEMBL4439	Homo sapiens	IC50		
Not Determined	3081454	CHEMBL1070009	Inhibition of TGFR-1 in human HepG2 cells expressing PAI-luciferase by luciferase reporter gene assay	B	COC(=O)c1cccc(-c2c(-c3ccc4nccnc4c3)n(C)n(C)c2=O)c1		CHEMBL593950		IC50			CHEMBL4439	Homo sapiens	IC50		
Not Determined	3081455	CHEMBL1070009	Inhibition of TGFR-1 in human HepG2 cells expressing PAI-luciferase by luciferase reporter gene assay	B	Cn1c(-c2ccc3nccnc3c2)c(-c2cccc(C(N)=O)c2)c(=O)n1C		CHEMBL593227		IC50			CHEMBL4439	Homo sapiens	IC50		
Not Determined	3081456	CHEMBL1070009	Inhibition of TGFR-1 in human HepG2 cells expressing PAI-luciferase by luciferase reporter gene assay	B	CC(=O)c1cccc(-c2c(-c3ccc4nccnc4c3)n(C)n(C)c2=O)c1		CHEMBL603433		IC50			CHEMBL4439	Homo sapiens	IC50		
Not Determined	3081457	CHEMBL1070009	Inhibition of TGFR-1 in human HepG2 cells expressing PAI-luciferase by luciferase reporter gene assay	B	Cn1c(-c2ccc3nccnc3c2)c(-c2cccc(CN)c2)c(=O)n1C		CHEMBL596468		IC50			CHEMBL4439	Homo sapiens	IC50		
Not Determined	3081458	CHEMBL1070009	Inhibition of TGFR-1 in human HepG2 cells expressing PAI-luciferase by luciferase reporter gene assay	B	Cn1c(-c2ccc3nccnc3c2)c(-c2cccc(CO)c2)c(=O)n1C		CHEMBL595332		IC50			CHEMBL4439	Homo sapiens	IC50		
Not Determined	3081459	CHEMBL1070009	Inhibition of TGFR-1 in human HepG2 cells expressing PAI-luciferase by luciferase reporter gene assay	B	CC(C)c1cccc(-c2c(-c3ccc4nccnc4c3)n(C)n(C)c2=O)c1		CHEMBL595351		IC50			CHEMBL4439	Homo sapiens	IC50		
Not Determined	3081460	CHEMBL1070009	Inhibition of TGFR-1 in human HepG2 cells expressing PAI-luciferase by luciferase reporter gene assay	B	Cn1c(-c2ccc3nccnc3c2)c(-c2ccc(N)cc2)c(=O)n1C		CHEMBL594372		IC50			CHEMBL4439	Homo sapiens	IC50		
Not Determined	3081461	CHEMBL1070009	Inhibition of TGFR-1 in human HepG2 cells expressing PAI-luciferase by luciferase reporter gene assay	B	Cn1c(-c2ccc3nccnc3c2)c(-c2ccccc2N)c(=O)n1C		CHEMBL606695		IC50			CHEMBL4439	Homo sapiens	IC50		
Not Determined	3081462	CHEMBL1070009	Inhibition of TGFR-1 in human HepG2 cells expressing PAI-luciferase by luciferase reporter gene assay	B	Cn1c(-c2ccc3nccnc3c2)c(-c2ccc(O)cc2)c(=O)n1C		CHEMBL603423		IC50			CHEMBL4439	Homo sapiens	IC50		
Not Determined	3081463	CHEMBL1070009	Inhibition of TGFR-1 in human HepG2 cells expressing PAI-luciferase by luciferase reporter gene assay	B	Cc1cc(-c2c(-c3ccc4nccnc4c3)n(C)n(C)c2=O)ccn1		CHEMBL593012		IC50			CHEMBL4439	Homo sapiens	IC50		
	3081464	CHEMBL1070008	Displacement of [3H]HTS446284 from human recombinant His-tagged TGFbetaR1 after 1 hr by scintillation counting	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	Ki	nM	17.0	CHEMBL4439	Homo sapiens	Ki	nM	17.0
	3081465	CHEMBL1070009	Inhibition of TGFR-1 in human HepG2 cells expressing PAI-luciferase by luciferase reporter gene assay	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	IC50	nM	250.0	CHEMBL4439	Homo sapiens	IC50	nM	250.0
	3188376	CHEMBL1107780	Antagonistic activity at TGFBR1	F	Cc1cccc(-c2[nH]c(CNc3cccc(C#N)c3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL387747	=	IC50	nM	46.0	CHEMBL4439	Homo sapiens	IC50	uM	0.046
	3188377	CHEMBL1107780	Antagonistic activity at TGFBR1	F	Cc1cccc(-c2[nH]c(CNc3ccc(C#N)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL229495	=	IC50	nM	171.0	CHEMBL4439	Homo sapiens	IC50	uM	0.171
	3188378	CHEMBL1107780	Antagonistic activity at TGFBR1	F	CCc1cccc(-c2[nH]c(CNc3cccc(C#N)c3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL229496	=	IC50	nM	73.0	CHEMBL4439	Homo sapiens	IC50	uM	0.073
	3188379	CHEMBL1107780	Antagonistic activity at TGFBR1	F	CCc1cccc(-c2[nH]c(CNc3ccc(C#N)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL229497	=	IC50	nM	360.0	CHEMBL4439	Homo sapiens	IC50	uM	0.36
	3188380	CHEMBL1107780	Antagonistic activity at TGFBR1	F	Cc1cccc(-c2[nH]c(CNc3cccc(C#N)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL387748	=	IC50	nM	12.0	CHEMBL4439	Homo sapiens	IC50	uM	0.012
	3188381	CHEMBL1107780	Antagonistic activity at TGFBR1	F	Cc1cccc(-c2[nH]c(CNc3ccc(C#N)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL229546	=	IC50	nM	42.0	CHEMBL4439	Homo sapiens	IC50	uM	0.042
	3188382	CHEMBL1107780	Antagonistic activity at TGFBR1	F	CCc1cccc(-c2[nH]c(CNc3cccc(C#N)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL229547	=	IC50	nM	119.0	CHEMBL4439	Homo sapiens	IC50	uM	0.119
	3188383	CHEMBL1107780	Antagonistic activity at TGFBR1	F	CCc1cccc(-c2[nH]c(CNc3ccc(C#N)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL229548	=	IC50	nM	47.0	CHEMBL4439	Homo sapiens	IC50	uM	0.047
	3188384	CHEMBL1107780	Antagonistic activity at TGFBR1	F	Cc1cccc(-c2[nH]c(CNc3cccc(C(N)=O)c3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL389078	=	IC50	nM	21.0	CHEMBL4439	Homo sapiens	IC50	uM	0.021
	3188385	CHEMBL1107780	Antagonistic activity at TGFBR1	F	Cc1cccc(-c2[nH]c(CNc3ccc(C(N)=O)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL229597	=	IC50	nM	262.0	CHEMBL4439	Homo sapiens	IC50	uM	0.262
	3188386	CHEMBL1107780	Antagonistic activity at TGFBR1	F	CCc1cccc(-c2[nH]c(CNc3cccc(C(N)=O)c3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL229598	=	IC50	nM	46.0	CHEMBL4439	Homo sapiens	IC50	uM	0.046
	3188387	CHEMBL1107780	Antagonistic activity at TGFBR1	F	CCc1cccc(-c2[nH]c(CNc3ccc(C(N)=O)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL389079	=	IC50	nM	385.0	CHEMBL4439	Homo sapiens	IC50	uM	0.385
	3188388	CHEMBL1107780	Antagonistic activity at TGFBR1	F	Cc1cccc(-c2[nH]c(CNc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL229599	=	IC50	nM	10.0	CHEMBL4439	Homo sapiens	IC50	uM	0.01
	3188389	CHEMBL1107780	Antagonistic activity at TGFBR1	F	Cc1cccc(-c2[nH]c(CNc3ccc(C(N)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL229654	=	IC50	nM	75.0	CHEMBL4439	Homo sapiens	IC50	uM	0.075
	3188390	CHEMBL1107780	Antagonistic activity at TGFBR1	F	CCc1cccc(-c2[nH]c(CNc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL376119	=	IC50	nM	15.0	CHEMBL4439	Homo sapiens	IC50	uM	0.015
	3188391	CHEMBL1107780	Antagonistic activity at TGFBR1	F	CCc1cccc(-c2[nH]c(CNc3ccc(C(N)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL226733	=	IC50	nM	92.0	CHEMBL4439	Homo sapiens	IC50	uM	0.092
	3188392	CHEMBL1107780	Antagonistic activity at TGFBR1	F	Cc1cccc(-c2[nH]c(NCc3cccc(C#N)c3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226734	=	IC50	nM	24.0	CHEMBL4439	Homo sapiens	IC50	uM	0.024
	3188393	CHEMBL1107780	Antagonistic activity at TGFBR1	F	Cc1cccc(-c2[nH]c(NCc3ccc(C#N)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL445934	=	IC50	nM	153.0	CHEMBL4439	Homo sapiens	IC50	uM	0.153
	3188394	CHEMBL1107780	Antagonistic activity at TGFBR1	F	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	logIC50		-1.328	CHEMBL4439	Homo sapiens	logIC50		-1.328
	3188395	CHEMBL1107780	Antagonistic activity at TGFBR1	F	O=C(O)c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccccn3)[nH]2)cc1		CHEMBL269339	=	IC50	nM	1500.0	CHEMBL4439	Homo sapiens	IC50	uM	1.5
	3188396	CHEMBL1107780	Antagonistic activity at TGFBR1	F	O=C(O)c1ccc(-c2nc(-c3ccc4c(c3)OCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL6250	=	IC50	nM	170.0	CHEMBL4439	Homo sapiens	IC50	uM	0.17
	3188397	CHEMBL1107780	Antagonistic activity at TGFBR1	F	N#Cc1ccc(-c2nc(-c3ccc4c(c3)OCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL269341	=	IC50	nM	2950.0	CHEMBL4439	Homo sapiens	IC50	uM	2.95
	3188398	CHEMBL1107780	Antagonistic activity at TGFBR1	F	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	IC50	nM	260.0	CHEMBL4439	Homo sapiens	IC50	uM	0.26
	3188399	CHEMBL1107780	Antagonistic activity at TGFBR1	F	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	IC50	nM	94.0	CHEMBL4439	Homo sapiens	IC50	uM	0.094
	3188400	CHEMBL1107780	Antagonistic activity at TGFBR1	F	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	logKi		-0.585	CHEMBL4439	Homo sapiens	logKi		-0.585
	3188401	CHEMBL1107780	Antagonistic activity at TGFBR1	F	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	logKi		-1.027	CHEMBL4439	Homo sapiens	logKi		-1.027
	3188402	CHEMBL1107780	Antagonistic activity at TGFBR1	F	CCc1cccc(-c2[nH]c(CNc3ccc(C#N)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL229548	=	logKi		-1.32	CHEMBL4439	Homo sapiens	logKi		-1.32
	3188403	CHEMBL1107780	Antagonistic activity at TGFBR1	F	Cc1cccc(-c2[nH]c(CNc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL229599	=	logKi		-2.0	CHEMBL4439	Homo sapiens	logKi		-2.0
	3188404	CHEMBL1107780	Antagonistic activity at TGFBR1	F	O=C(O)c1ccc(-c2nc(-c3ccc4c(c3)OCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL6250	=	logIC50		-0.77	CHEMBL4439	Homo sapiens	logIC50		-0.77
	3188405	CHEMBL1107780	Antagonistic activity at TGFBR1	F	N#Cc1ccc(-c2nc(-c3ccc4c(c3)OCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL269341	=	logIC50		0.4698	CHEMBL4439	Homo sapiens	logIC50		0.4698
	3188406	CHEMBL1107780	Antagonistic activity at TGFBR1	F	Cc1cccc(-c2[nH]c(CNc3cccc(C#N)c3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL387747	=	logIC50		-1.337	CHEMBL4439	Homo sapiens	logIC50		-1.337
	3188407	CHEMBL1107780	Antagonistic activity at TGFBR1	F	Cc1cccc(-c2[nH]c(CNc3ccc(C#N)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL229495	=	logIC50		-0.759	CHEMBL4439	Homo sapiens	logIC50		-0.759
	3188408	CHEMBL1107780	Antagonistic activity at TGFBR1	F	CCc1cccc(-c2[nH]c(CNc3cccc(C#N)c3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL229496	=	logIC50		-1.137	CHEMBL4439	Homo sapiens	logIC50		-1.137
	3188409	CHEMBL1107780	Antagonistic activity at TGFBR1	F	CCc1cccc(-c2[nH]c(CNc3ccc(C#N)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL229497	=	logIC50		-0.4434	CHEMBL4439	Homo sapiens	logIC50		-0.4434
	3188410	CHEMBL1107780	Antagonistic activity at TGFBR1	F	Cc1cccc(-c2[nH]c(CNc3cccc(C#N)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL387748	=	logIC50		-1.921	CHEMBL4439	Homo sapiens	logIC50		-1.921
	3188411	CHEMBL1107780	Antagonistic activity at TGFBR1	F	Cc1cccc(-c2[nH]c(CNc3ccc(C#N)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL229546	=	logIC50		-1.377	CHEMBL4439	Homo sapiens	logIC50		-1.377
	3188412	CHEMBL1107780	Antagonistic activity at TGFBR1	F	CCc1cccc(-c2[nH]c(CNc3cccc(C#N)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL229547	=	logIC50		-0.924	CHEMBL4439	Homo sapiens	logIC50		-0.924
	3188413	CHEMBL1107780	Antagonistic activity at TGFBR1	F	Cc1cccc(-c2[nH]c(CNc3cccc(C(N)=O)c3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL389078	=	logIC50		-1.678	CHEMBL4439	Homo sapiens	logIC50		-1.678
	3188414	CHEMBL1107780	Antagonistic activity at TGFBR1	F	Cc1cccc(-c2[nH]c(CNc3ccc(C(N)=O)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL229597	=	logIC50		-0.582	CHEMBL4439	Homo sapiens	logIC50		-0.582
	3188415	CHEMBL1107780	Antagonistic activity at TGFBR1	F	CCc1cccc(-c2[nH]c(CNc3cccc(C(N)=O)c3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL229598	=	logIC50		-1.337	CHEMBL4439	Homo sapiens	logIC50		-1.337
	3188416	CHEMBL1107780	Antagonistic activity at TGFBR1	F	CCc1cccc(-c2[nH]c(CNc3ccc(C(N)=O)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL389079	=	logIC50		-0.415	CHEMBL4439	Homo sapiens	logIC50		-0.415
	3188417	CHEMBL1107780	Antagonistic activity at TGFBR1	F	Cc1cccc(-c2[nH]c(CNc3ccc(C(N)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL229654	=	logIC50		-1.125	CHEMBL4439	Homo sapiens	logIC50		-1.125
	3188418	CHEMBL1107780	Antagonistic activity at TGFBR1	F	CCc1cccc(-c2[nH]c(CNc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL376119	=	logIC50		-1.824	CHEMBL4439	Homo sapiens	logIC50		-1.824
	3188419	CHEMBL1107780	Antagonistic activity at TGFBR1	F	Cc1cccc(-c2[nH]c(NCc3cccc(C#N)c3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226734	=	logIC50		-1.62	CHEMBL4439	Homo sapiens	logIC50		-1.62
	3188420	CHEMBL1107780	Antagonistic activity at TGFBR1	F	Cc1cccc(-c2[nH]c(NCc3ccc(C#N)cc3)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL445934	=	logIC50		-0.815	CHEMBL4439	Homo sapiens	logIC50		-0.815
	3329147	CHEMBL1166745	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced p3TP-luciferase reporter activity at 0.05 uM relative to control	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3nccnc3c2)n1		CHEMBL401570	=	Inhibition	%	44.0	CHEMBL4439	Homo sapiens	INH	%	44.0
	3329148	CHEMBL1166745	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced p3TP-luciferase reporter activity at 0.05 uM relative to control	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Inhibition	%	44.0	CHEMBL4439	Homo sapiens	INH	%	44.0
	3329149	CHEMBL1166745	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced p3TP-luciferase reporter activity at 0.05 uM relative to control	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3ncccc3c2)n1		CHEMBL1164957	=	Inhibition	%	66.0	CHEMBL4439	Homo sapiens	INH	%	66.0
Dose-dependent effect	3329150	CHEMBL1166744	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced p3TP-luciferase reporter activity relative to control	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3ncccc3c2)n1		CHEMBL1164957		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
	3329153	CHEMBL1166742	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced ARE-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL492634	=	Inhibition	%	21.0	CHEMBL4439	Homo sapiens	INH	%	21.0
	3329154	CHEMBL1166742	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced ARE-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3nccnc3c2)n1		CHEMBL401570	=	Inhibition	%	55.0	CHEMBL4439	Homo sapiens	INH	%	55.0
	3329155	CHEMBL1166742	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced ARE-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Inhibition	%	47.0	CHEMBL4439	Homo sapiens	INH	%	47.0
	3329156	CHEMBL1166742	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced ARE-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2cn(Cc3cccc(C(N)=O)c3)nc2-c2ccc3ncccc3c2)n1		CHEMBL1165063	=	Inhibition	%	50.0	CHEMBL4439	Homo sapiens	INH	%	50.0
	3329157	CHEMBL1166742	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced ARE-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2cn(Cc3cccc(C#N)c3)nc2-c2ccc3ncccc3c2)n1		CHEMBL1164971	=	Inhibition	%	63.0	CHEMBL4439	Homo sapiens	INH	%	63.0
	3329158	CHEMBL1166742	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced ARE-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2c(-c3ccc4ncccc4n3)cnn2Cc2cccc(C(N)=O)c2)n1		CHEMBL1164023	=	Inhibition	%	85.0	CHEMBL4439	Homo sapiens	INH	%	85.0
	3329159	CHEMBL1166742	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced ARE-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2nn(Cc3cccc(C(N)=O)c3)cc2-c2ccc3ncccc3n2)n1		CHEMBL1164843	=	Inhibition	%	43.0	CHEMBL4439	Homo sapiens	INH	%	43.0
	3329160	CHEMBL1166742	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced ARE-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2c(-c3ccc4ncccc4c3)cnn2Cc2cccc(C(N)=O)c2)n1		CHEMBL1165405	=	Inhibition	%	87.0	CHEMBL4439	Homo sapiens	INH	%	87.0
	3329161	CHEMBL1166742	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced ARE-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2nn(Cc3cccc(C(N)=O)c3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1164022	=	Inhibition	%	22.0	CHEMBL4439	Homo sapiens	INH	%	22.0
	3329162	CHEMBL1166742	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced ARE-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2c(-c3ccc4ncccc4n3)cnn2Cc2cccc(C#N)c2)n1		CHEMBL1165055	=	Inhibition	%	86.0	CHEMBL4439	Homo sapiens	INH	%	86.0
	3329163	CHEMBL1166742	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced ARE-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2nn(Cc3cccc(C#N)c3)cc2-c2ccc3ncccc3n2)n1		CHEMBL1165694	=	Inhibition	%	38.0	CHEMBL4439	Homo sapiens	INH	%	38.0
	3329164	CHEMBL1166742	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced ARE-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2c(-c3ccc4ncccc4c3)cnn2Cc2cccc(C#N)c2)n1		CHEMBL1163956	=	Inhibition	%	86.0	CHEMBL4439	Homo sapiens	INH	%	86.0
	3329165	CHEMBL1166742	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced ARE-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2nn(Cc3cccc(C#N)c3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1163955	=	Inhibition	%	35.0	CHEMBL4439	Homo sapiens	INH	%	35.0
	3329166	CHEMBL1166742	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced ARE-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3ncccc3n2)n1		CHEMBL1165041	=	Inhibition	%	74.0	CHEMBL4439	Homo sapiens	INH	%	74.0
	3329167	CHEMBL1166742	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced ARE-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3ncccc3c2)n1		CHEMBL1164957	=	Inhibition	%	22.0	CHEMBL4439	Homo sapiens	INH	%	22.0
	3329168	CHEMBL1166742	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced ARE-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2[nH]c(Cc3cccc(C#N)c3)nc2-c2ccc3ncccc3n2)n1		CHEMBL1164092	=	Inhibition	%	87.0	CHEMBL4439	Homo sapiens	INH	%	87.0
	3329169	CHEMBL1166742	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced ARE-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2[nH]c(Cc3cccc(C#N)c3)nc2-c2ccc3ncccc3c2)n1		CHEMBL1165374	=	Inhibition	%	13.0	CHEMBL4439	Homo sapiens	INH	%	13.0
	3329170	CHEMBL1166741	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced SBE-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL492634	=	Inhibition	%	16.0	CHEMBL4439	Homo sapiens	INH	%	16.0
	3329171	CHEMBL1166741	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced SBE-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3nccnc3c2)n1		CHEMBL401570	=	Inhibition	%	26.0	CHEMBL4439	Homo sapiens	INH	%	26.0
	3329172	CHEMBL1166741	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced SBE-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Inhibition	%	22.0	CHEMBL4439	Homo sapiens	INH	%	22.0
	3329173	CHEMBL1166741	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced SBE-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2cn(Cc3cccc(C(N)=O)c3)nc2-c2ccc3ncccc3c2)n1		CHEMBL1165063	=	Inhibition	%	80.0	CHEMBL4439	Homo sapiens	INH	%	80.0
	3329174	CHEMBL1166741	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced SBE-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2cn(Cc3cccc(C#N)c3)nc2-c2ccc3ncccc3c2)n1		CHEMBL1164971	=	Inhibition	%	74.0	CHEMBL4439	Homo sapiens	INH	%	74.0
	3329175	CHEMBL1166741	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced SBE-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2c(-c3ccc4ncccc4n3)cnn2Cc2cccc(C(N)=O)c2)n1		CHEMBL1164023	=	Inhibition	%	105.0	CHEMBL4439	Homo sapiens	INH	%	105.0
	3329176	CHEMBL1166741	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced SBE-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2nn(Cc3cccc(C(N)=O)c3)cc2-c2ccc3ncccc3n2)n1		CHEMBL1164843	=	Inhibition	%	30.0	CHEMBL4439	Homo sapiens	INH	%	30.0
	3329177	CHEMBL1166741	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced SBE-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2c(-c3ccc4ncccc4c3)cnn2Cc2cccc(C(N)=O)c2)n1		CHEMBL1165405	=	Inhibition	%	106.0	CHEMBL4439	Homo sapiens	INH	%	106.0
	3329178	CHEMBL1166741	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced SBE-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2nn(Cc3cccc(C(N)=O)c3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1164022	=	Inhibition	%	18.0	CHEMBL4439	Homo sapiens	INH	%	18.0
	3329179	CHEMBL1166741	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced SBE-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2c(-c3ccc4ncccc4n3)cnn2Cc2cccc(C#N)c2)n1		CHEMBL1165055	=	Inhibition	%	94.0	CHEMBL4439	Homo sapiens	INH	%	94.0
	3329180	CHEMBL1166741	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced SBE-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2nn(Cc3cccc(C#N)c3)cc2-c2ccc3ncccc3n2)n1		CHEMBL1165694	=	Inhibition	%	29.0	CHEMBL4439	Homo sapiens	INH	%	29.0
	3329181	CHEMBL1166741	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced SBE-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2c(-c3ccc4ncccc4c3)cnn2Cc2cccc(C#N)c2)n1		CHEMBL1163956	=	Inhibition	%	95.0	CHEMBL4439	Homo sapiens	INH	%	95.0
	3329182	CHEMBL1166741	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced SBE-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2nn(Cc3cccc(C#N)c3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1163955	=	Inhibition	%	38.0	CHEMBL4439	Homo sapiens	INH	%	38.0
	3329183	CHEMBL1166741	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced SBE-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3ncccc3n2)n1		CHEMBL1165041	=	Inhibition	%	74.0	CHEMBL4439	Homo sapiens	INH	%	74.0
	3329184	CHEMBL1166741	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced SBE-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3ncccc3c2)n1		CHEMBL1164957	=	Inhibition	%	22.0	CHEMBL4439	Homo sapiens	INH	%	22.0
	3329185	CHEMBL1166741	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced SBE-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2[nH]c(Cc3cccc(C#N)c3)nc2-c2ccc3ncccc3n2)n1		CHEMBL1164092	=	Inhibition	%	74.0	CHEMBL4439	Homo sapiens	INH	%	74.0
	3329186	CHEMBL1166741	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced SBE-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2[nH]c(Cc3cccc(C#N)c3)nc2-c2ccc3ncccc3c2)n1		CHEMBL1165374	=	Inhibition	%	16.0	CHEMBL4439	Homo sapiens	INH	%	16.0
	3329187	CHEMBL1166740	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced p3TP-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL492634	=	Inhibition	%	6.0	CHEMBL4439	Homo sapiens	INH	%	6.0
	3329188	CHEMBL1166740	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced p3TP-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3nccnc3c2)n1		CHEMBL401570	=	Inhibition	%	29.0	CHEMBL4439	Homo sapiens	INH	%	29.0
	3329189	CHEMBL1166740	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced p3TP-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Inhibition	%	26.0	CHEMBL4439	Homo sapiens	INH	%	26.0
	3329190	CHEMBL1166740	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced p3TP-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2cn(Cc3cccc(C(N)=O)c3)nc2-c2ccc3ncccc3c2)n1		CHEMBL1165063	=	Inhibition	%	87.0	CHEMBL4439	Homo sapiens	INH	%	87.0
	3329191	CHEMBL1166740	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced p3TP-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2cn(Cc3cccc(C#N)c3)nc2-c2ccc3ncccc3c2)n1		CHEMBL1164971	=	Inhibition	%	49.0	CHEMBL4439	Homo sapiens	INH	%	49.0
	3329192	CHEMBL1166740	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced p3TP-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2c(-c3ccc4ncccc4n3)cnn2Cc2cccc(C(N)=O)c2)n1		CHEMBL1164023	=	Inhibition	%	95.0	CHEMBL4439	Homo sapiens	INH	%	95.0
	3329193	CHEMBL1166740	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced p3TP-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2nn(Cc3cccc(C(N)=O)c3)cc2-c2ccc3ncccc3n2)n1		CHEMBL1164843	=	Inhibition	%	20.0	CHEMBL4439	Homo sapiens	INH	%	20.0
	3329194	CHEMBL1166740	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced p3TP-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2c(-c3ccc4ncccc4c3)cnn2Cc2cccc(C(N)=O)c2)n1		CHEMBL1165405	=	Inhibition	%	147.0	CHEMBL4439	Homo sapiens	INH	%	147.0
	3329195	CHEMBL1166740	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced p3TP-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2nn(Cc3cccc(C(N)=O)c3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1164022	=	Inhibition	%	9.0	CHEMBL4439	Homo sapiens	INH	%	9.0
	3329196	CHEMBL1166740	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced p3TP-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2c(-c3ccc4ncccc4n3)cnn2Cc2cccc(C#N)c2)n1		CHEMBL1165055	=	Inhibition	%	132.0	CHEMBL4439	Homo sapiens	INH	%	132.0
	3329197	CHEMBL1166740	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced p3TP-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2nn(Cc3cccc(C#N)c3)cc2-c2ccc3ncccc3n2)n1		CHEMBL1165694	=	Inhibition	%	21.0	CHEMBL4439	Homo sapiens	INH	%	21.0
	3329198	CHEMBL1166740	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced p3TP-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2c(-c3ccc4ncccc4c3)cnn2Cc2cccc(C#N)c2)n1		CHEMBL1163956	=	Inhibition	%	114.0	CHEMBL4439	Homo sapiens	INH	%	114.0
	3329199	CHEMBL1166740	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced p3TP-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2nn(Cc3cccc(C#N)c3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1163955	=	Inhibition	%	15.0	CHEMBL4439	Homo sapiens	INH	%	15.0
	3329200	CHEMBL1166740	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced p3TP-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3ncccc3n2)n1		CHEMBL1165041	=	Inhibition	%	74.0	CHEMBL4439	Homo sapiens	INH	%	74.0
	3329201	CHEMBL1166740	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced p3TP-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3ncccc3c2)n1		CHEMBL1164957	=	Inhibition	%	7.0	CHEMBL4439	Homo sapiens	INH	%	7.0
	3329202	CHEMBL1166740	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced p3TP-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2[nH]c(Cc3cccc(C#N)c3)nc2-c2ccc3ncccc3n2)n1		CHEMBL1164092	=	Inhibition	%	104.0	CHEMBL4439	Homo sapiens	INH	%	104.0
	3329203	CHEMBL1166740	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced p3TP-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2[nH]c(Cc3cccc(C#N)c3)nc2-c2ccc3ncccc3c2)n1		CHEMBL1165374	=	Inhibition	%	4.0	CHEMBL4439	Homo sapiens	INH	%	4.0
	3329204	CHEMBL1166316	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL492634	=	IC50	nM	36.0	CHEMBL4439	Homo sapiens	IC50	uM	0.036
	3329205	CHEMBL1166316	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3nccnc3c2)n1		CHEMBL401570	=	IC50	nM	162.0	CHEMBL4439	Homo sapiens	IC50	uM	0.162
	3329206	CHEMBL1166316	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	IC50	nM	169.0	CHEMBL4439	Homo sapiens	IC50	uM	0.169
	3329207	CHEMBL1166316	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells	B	Cc1cccc(-c2cn(Cc3cccc(C(N)=O)c3)nc2-c2ccc3ncccc3c2)n1		CHEMBL1165063	=	IC50	nM	61.0	CHEMBL4439	Homo sapiens	IC50	uM	0.061
	3329208	CHEMBL1166316	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells	B	Cc1cccc(-c2cn(Cc3cccc(C#N)c3)nc2-c2ccc3ncccc3c2)n1		CHEMBL1164971	=	IC50	nM	34.0	CHEMBL4439	Homo sapiens	IC50	uM	0.034
	3329209	CHEMBL1166316	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells	B	Cc1cccc(-c2c(-c3ccc4ncccc4n3)cnn2Cc2cccc(C(N)=O)c2)n1		CHEMBL1164023	>	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	IC50	uM	10.0
	3329210	CHEMBL1166316	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells	B	Cc1cccc(-c2nn(Cc3cccc(C(N)=O)c3)cc2-c2ccc3ncccc3n2)n1		CHEMBL1164843	=	IC50	nM	255.0	CHEMBL4439	Homo sapiens	IC50	uM	0.255
	3329211	CHEMBL1166316	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells	B	Cc1cccc(-c2c(-c3ccc4ncccc4c3)cnn2Cc2cccc(C(N)=O)c2)n1		CHEMBL1165405	>	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	IC50	uM	10.0
	3329212	CHEMBL1166316	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells	B	Cc1cccc(-c2nn(Cc3cccc(C(N)=O)c3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1164022	=	IC50	nM	131.0	CHEMBL4439	Homo sapiens	IC50	uM	0.131
	3329213	CHEMBL1166316	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells	B	Cc1cccc(-c2c(-c3ccc4ncccc4n3)cnn2Cc2cccc(C#N)c2)n1		CHEMBL1165055	>	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	IC50	uM	10.0
	3329214	CHEMBL1166316	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells	B	Cc1cccc(-c2nn(Cc3cccc(C#N)c3)cc2-c2ccc3ncccc3n2)n1		CHEMBL1165694	=	IC50	nM	318.0	CHEMBL4439	Homo sapiens	IC50	uM	0.318
	3329215	CHEMBL1166316	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells	B	Cc1cccc(-c2c(-c3ccc4ncccc4c3)cnn2Cc2cccc(C#N)c2)n1		CHEMBL1163956	>	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	IC50	uM	10.0
	3329216	CHEMBL1166316	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells	B	Cc1cccc(-c2nn(Cc3cccc(C#N)c3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1163955	=	IC50	nM	231.0	CHEMBL4439	Homo sapiens	IC50	uM	0.231
	3329217	CHEMBL1166316	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3ncccc3n2)n1		CHEMBL1165041	=	IC50	nM	2600.0	CHEMBL4439	Homo sapiens	IC50	uM	2.6
	3329218	CHEMBL1166316	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3ncccc3c2)n1		CHEMBL1164957	=	IC50	nM	34.0	CHEMBL4439	Homo sapiens	IC50	uM	0.034
	3329219	CHEMBL1166316	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells	B	Cc1cccc(-c2[nH]c(Cc3cccc(C#N)c3)nc2-c2ccc3ncccc3n2)n1		CHEMBL1164092	=	IC50	nM	2250.0	CHEMBL4439	Homo sapiens	IC50	uM	2.25
	3329220	CHEMBL1166316	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells	B	Cc1cccc(-c2[nH]c(Cc3cccc(C#N)c3)nc2-c2ccc3ncccc3c2)n1		CHEMBL1165374	=	IC50	nM	26.0	CHEMBL4439	Homo sapiens	IC50	uM	0.026
	3333187	CHEMBL1168126	Inhibition of TGFBR1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL4439	Homo sapiens	INH	%	50.0
	3333589	CHEMBL1168126	Inhibition of TGFBR1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL4439	Homo sapiens	INH	%	50.0
	3334994	CHEMBL1168126	Inhibition of TGFBR1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL4439	Homo sapiens	INH	%	50.0
	3336414	CHEMBL1168126	Inhibition of TGFBR1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL4439	Homo sapiens	INH	%	50.0
	3337659	CHEMBL1168126	Inhibition of TGFBR1 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL4439	Homo sapiens	INH	%	50.0
	3338990	CHEMBL1168126	Inhibition of TGFBR1 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL4439	Homo sapiens	INH	%	50.0
	3339246	CHEMBL1168126	Inhibition of TGFBR1 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL4439	Homo sapiens	INH	%	50.0
	3340551	CHEMBL1168126	Inhibition of TGFBR1 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL4439	Homo sapiens	INH	%	50.0
	3341956	CHEMBL1168126	Inhibition of TGFBR1 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL4439	Homo sapiens	INH	%	50.0
	3343403	CHEMBL1168126	Inhibition of TGFBR1 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL4439	Homo sapiens	INH	%	50.0
	3351780	CHEMBL1175094	Inhibition of TGFBR1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	100.0	CHEMBL4439	Homo sapiens	INH	%	100.0
Dose-dependent effect	3357568	CHEMBL1175512	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced p3TP-luciferase reporter activity after 18 to 24 hrs by luminescence assay	B	Cc1cccc(-c2nn(C(=S)Nc3cccc(C(N)=O)c3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1172545		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
	3357569	CHEMBL1175511	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced SBE-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3ccccc3)cc2-c2ccnc3ccccc23)n1		CHEMBL1170377	=	Inhibition	%	28.0	CHEMBL4439	Homo sapiens	INH	%	28.0
	3357570	CHEMBL1175511	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced SBE-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL492634	=	Inhibition	%	42.0	CHEMBL4439	Homo sapiens	INH	%	42.0
	3357571	CHEMBL1175511	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced SBE-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3nccnc3c2)n1		CHEMBL401570	=	Inhibition	%	54.0	CHEMBL4439	Homo sapiens	INH	%	54.0
	3357572	CHEMBL1175511	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced SBE-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Inhibition	%	56.0	CHEMBL4439	Homo sapiens	INH	%	56.0
	3357573	CHEMBL1175511	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced SBE-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3ccccc3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1171402	=	Inhibition	%	22.0	CHEMBL4439	Homo sapiens	INH	%	22.0
	3357574	CHEMBL1175511	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced SBE-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3ccc(C(N)=O)cc3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1171240	=	Inhibition	%	22.0	CHEMBL4439	Homo sapiens	INH	%	22.0
	3357575	CHEMBL1175511	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced SBE-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3cccc(C(N)=O)c3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1172545	=	Inhibition	%	20.0	CHEMBL4439	Homo sapiens	INH	%	20.0
	3357576	CHEMBL1175511	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced SBE-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3ccc(C#N)cc3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1172364	=	Inhibition	%	21.0	CHEMBL4439	Homo sapiens	INH	%	21.0
	3357577	CHEMBL1175511	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced SBE-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3cccc(C#N)c3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1172363	=	Inhibition	%	21.0	CHEMBL4439	Homo sapiens	INH	%	21.0
	3357578	CHEMBL1175511	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced SBE-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccnc3ccccc23)n1		CHEMBL1171212	=	Inhibition	%	90.0	CHEMBL4439	Homo sapiens	INH	%	90.0
	3357579	CHEMBL1175511	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced SBE-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2[nH]c(Cc3cccc(C#N)c3)nc2-c2ccnc3ccccc23)n1		CHEMBL1171943	=	Inhibition	%	95.0	CHEMBL4439	Homo sapiens	INH	%	95.0
	3357580	CHEMBL1175511	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced SBE-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2nn(Cc3cccc(C(N)=O)c3)cc2-c2ccnc3ccccc23)n1		CHEMBL1171942	=	Inhibition	%	86.0	CHEMBL4439	Homo sapiens	INH	%	86.0
	3357581	CHEMBL1175511	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced SBE-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2nn(Cc3cccc(C#N)c3)cc2-c2ccnc3ccccc23)n1		CHEMBL1171765	=	Inhibition	%	76.0	CHEMBL4439	Homo sapiens	INH	%	76.0
	3357582	CHEMBL1175511	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced SBE-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3ccc(C(N)=O)cc3)cc2-c2ccnc3ccccc23)n1		CHEMBL1170205	=	Inhibition	%	25.0	CHEMBL4439	Homo sapiens	INH	%	25.0
	3357583	CHEMBL1175511	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced SBE-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3cccc(C(N)=O)c3)cc2-c2ccnc3ccccc23)n1		CHEMBL1172162	=	Inhibition	%	23.0	CHEMBL4439	Homo sapiens	INH	%	23.0
	3357584	CHEMBL1175511	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced SBE-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3ccc(C#N)cc3)cc2-c2ccnc3ccccc23)n1		CHEMBL1172161	=	Inhibition	%	24.0	CHEMBL4439	Homo sapiens	INH	%	24.0
	3357585	CHEMBL1175511	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced SBE-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3cccc(C#N)c3)cc2-c2ccnc3ccccc23)n1		CHEMBL1172160	=	Inhibition	%	24.0	CHEMBL4439	Homo sapiens	INH	%	24.0
	3357586	CHEMBL1175510	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced ARE-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3ccccc3)cc2-c2ccnc3ccccc23)n1		CHEMBL1170377	=	Inhibition	%	40.0	CHEMBL4439	Homo sapiens	INH	%	40.0
	3357587	CHEMBL1175510	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced ARE-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL492634	=	Inhibition	%	43.0	CHEMBL4439	Homo sapiens	INH	%	43.0
	3357588	CHEMBL1175510	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced ARE-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3nccnc3c2)n1		CHEMBL401570	=	Inhibition	%	54.0	CHEMBL4439	Homo sapiens	INH	%	54.0
	3357589	CHEMBL1175510	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced ARE-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Inhibition	%	93.0	CHEMBL4439	Homo sapiens	INH	%	93.0
	3357590	CHEMBL1175510	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced ARE-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3ccccc3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1171402	=	Inhibition	%	12.0	CHEMBL4439	Homo sapiens	INH	%	12.0
	3357591	CHEMBL1175510	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced ARE-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3ccc(C(N)=O)cc3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1171240	=	Inhibition	%	12.0	CHEMBL4439	Homo sapiens	INH	%	12.0
	3357592	CHEMBL1175510	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced ARE-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3cccc(C(N)=O)c3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1172545	=	Inhibition	%	7.0	CHEMBL4439	Homo sapiens	INH	%	7.0
	3357593	CHEMBL1175510	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced ARE-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3ccc(C#N)cc3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1172364	=	Inhibition	%	12.0	CHEMBL4439	Homo sapiens	INH	%	12.0
	3357594	CHEMBL1175510	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced ARE-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3cccc(C#N)c3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1172363	=	Inhibition	%	14.0	CHEMBL4439	Homo sapiens	INH	%	14.0
	3357595	CHEMBL1175510	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced ARE-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccnc3ccccc23)n1		CHEMBL1171212	=	Inhibition	%	98.0	CHEMBL4439	Homo sapiens	INH	%	98.0
	3357596	CHEMBL1175510	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced ARE-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2[nH]c(Cc3cccc(C#N)c3)nc2-c2ccnc3ccccc23)n1		CHEMBL1171943	=	Inhibition	%	85.0	CHEMBL4439	Homo sapiens	INH	%	85.0
	3357597	CHEMBL1175510	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced ARE-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2nn(Cc3cccc(C(N)=O)c3)cc2-c2ccnc3ccccc23)n1		CHEMBL1171942	=	Inhibition	%	99.0	CHEMBL4439	Homo sapiens	INH	%	99.0
	3357598	CHEMBL1175510	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced ARE-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2nn(Cc3cccc(C#N)c3)cc2-c2ccnc3ccccc23)n1		CHEMBL1171765	=	Inhibition	%	89.0	CHEMBL4439	Homo sapiens	INH	%	89.0
	3357599	CHEMBL1175510	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced ARE-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3ccc(C(N)=O)cc3)cc2-c2ccnc3ccccc23)n1		CHEMBL1170205	=	Inhibition	%	42.0	CHEMBL4439	Homo sapiens	INH	%	42.0
	3357600	CHEMBL1175510	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced ARE-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3cccc(C(N)=O)c3)cc2-c2ccnc3ccccc23)n1		CHEMBL1172162	=	Inhibition	%	26.0	CHEMBL4439	Homo sapiens	INH	%	26.0
	3357601	CHEMBL1175510	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced ARE-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3ccc(C#N)cc3)cc2-c2ccnc3ccccc23)n1		CHEMBL1172161	=	Inhibition	%	39.0	CHEMBL4439	Homo sapiens	INH	%	39.0
	3357602	CHEMBL1175510	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced ARE-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3cccc(C#N)c3)cc2-c2ccnc3ccccc23)n1		CHEMBL1172160	=	Inhibition	%	36.0	CHEMBL4439	Homo sapiens	INH	%	36.0
	3357603	CHEMBL1175163	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced p3TP-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3ccccc3)cc2-c2ccnc3ccccc23)n1		CHEMBL1170377	=	Inhibition	%	13.0	CHEMBL4439	Homo sapiens	INH	%	13.0
	3357604	CHEMBL1175163	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced p3TP-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL492634	=	Inhibition	%	20.0	CHEMBL4439	Homo sapiens	INH	%	20.0
	3357605	CHEMBL1175163	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced p3TP-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3nccnc3c2)n1		CHEMBL401570	=	Inhibition	%	39.0	CHEMBL4439	Homo sapiens	INH	%	39.0
	3357606	CHEMBL1175163	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced p3TP-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Inhibition	%	35.0	CHEMBL4439	Homo sapiens	INH	%	35.0
	3357607	CHEMBL1175163	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced p3TP-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3ccccc3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1171402	=	Inhibition	%	12.0	CHEMBL4439	Homo sapiens	INH	%	12.0
	3357608	CHEMBL1175163	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced p3TP-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3ccc(C(N)=O)cc3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1171240	=	Inhibition	%	6.0	CHEMBL4439	Homo sapiens	INH	%	6.0
	3357609	CHEMBL1175163	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced p3TP-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3cccc(C(N)=O)c3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1172545	=	Inhibition	%	4.0	CHEMBL4439	Homo sapiens	INH	%	4.0
	3357610	CHEMBL1175163	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced p3TP-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3ccc(C#N)cc3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1172364	=	Inhibition	%	6.0	CHEMBL4439	Homo sapiens	INH	%	6.0
	3357611	CHEMBL1175163	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced p3TP-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3cccc(C#N)c3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1172363	=	Inhibition	%	5.0	CHEMBL4439	Homo sapiens	INH	%	5.0
	3357612	CHEMBL1175163	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced p3TP-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccnc3ccccc23)n1		CHEMBL1171212	=	Inhibition	%	98.0	CHEMBL4439	Homo sapiens	INH	%	98.0
	3357613	CHEMBL1175163	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced p3TP-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2[nH]c(Cc3cccc(C#N)c3)nc2-c2ccnc3ccccc23)n1		CHEMBL1171943	=	Inhibition	%	91.0	CHEMBL4439	Homo sapiens	INH	%	91.0
	3357614	CHEMBL1175163	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced p3TP-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2nn(Cc3cccc(C(N)=O)c3)cc2-c2ccnc3ccccc23)n1		CHEMBL1171942	=	Inhibition	%	57.0	CHEMBL4439	Homo sapiens	INH	%	57.0
	3357615	CHEMBL1175163	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced p3TP-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2nn(Cc3cccc(C#N)c3)cc2-c2ccnc3ccccc23)n1		CHEMBL1171765	=	Inhibition	%	52.0	CHEMBL4439	Homo sapiens	INH	%	52.0
	3357616	CHEMBL1175163	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced p3TP-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3ccc(C(N)=O)cc3)cc2-c2ccnc3ccccc23)n1		CHEMBL1170205	=	Inhibition	%	15.0	CHEMBL4439	Homo sapiens	INH	%	15.0
	3357617	CHEMBL1175163	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced p3TP-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3cccc(C(N)=O)c3)cc2-c2ccnc3ccccc23)n1		CHEMBL1172162	=	Inhibition	%	6.0	CHEMBL4439	Homo sapiens	INH	%	6.0
	3357618	CHEMBL1175163	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced p3TP-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3ccc(C#N)cc3)cc2-c2ccnc3ccccc23)n1		CHEMBL1172161	=	Inhibition	%	11.0	CHEMBL4439	Homo sapiens	INH	%	11.0
	3357619	CHEMBL1175163	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGF-beta-induced p3TP-luciferase reporter activity at 0.1 uM after 18 to 24 hrs by luminescence assay relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3cccc(C#N)c3)cc2-c2ccnc3ccccc23)n1		CHEMBL1172160	=	Inhibition	%	8.0	CHEMBL4439	Homo sapiens	INH	%	8.0
	3358832	CHEMBL1175094	Inhibition of TGFBR1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	100.0	CHEMBL4439	Homo sapiens	INH	%	100.0
	3448647	CHEMBL1245000	Binding affinity to TGFBR1	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	uM	10.0
	3448804	CHEMBL1245000	Binding affinity to TGFBR1	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	120.0	CHEMBL4439	Homo sapiens	Kd	nM	120.0
	3449873	CHEMBL1245000	Binding affinity to TGFBR1	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	uM	10.0
	3450258	CHEMBL1245000	Binding affinity to TGFBR1	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	uM	10.0
	3450420	CHEMBL1245000	Binding affinity to TGFBR1	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	uM	10.0
	3450877	CHEMBL1245000	Binding affinity to TGFBR1	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	uM	10.0
	3451165	CHEMBL1245000	Binding affinity to TGFBR1	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	uM	10.0
	3524660	CHEMBL1272395	Inhibition of TGFbeta receptor	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL496862	=	IC50	nM	34.0	CHEMBL4439	Homo sapiens	IC50	nM	34.0
	3524661	CHEMBL1272395	Inhibition of TGFbeta receptor	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL1271472	=	IC50	nM	24.0	CHEMBL4439	Homo sapiens	IC50	nM	24.0
	3524662	CHEMBL1272395	Inhibition of TGFbeta receptor	B	CNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL497724	=	IC50	nM	32.0	CHEMBL4439	Homo sapiens	IC50	nM	32.0
	3524663	CHEMBL1272395	Inhibition of TGFbeta receptor	B	CN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL496861	=	IC50	nM	35.0	CHEMBL4439	Homo sapiens	IC50	nM	35.0
	3524664	CHEMBL1272395	Inhibition of TGFbeta receptor	B	CCCCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL1271578	=	IC50	nM	91.0	CHEMBL4439	Homo sapiens	IC50	nM	91.0
	3524665	CHEMBL1272395	Inhibition of TGFbeta receptor	B	O=C1Nc2cc(C(=O)C3CCCN3)ccc2/C1=C(/Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL1271632	=	IC50	nM	245.0	CHEMBL4439	Homo sapiens	IC50	nM	245.0
	3524666	CHEMBL1272395	Inhibition of TGFbeta receptor	B	CC(C)NC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL524647	=	IC50	nM	318.0	CHEMBL4439	Homo sapiens	IC50	nM	318.0
	3524667	CHEMBL1272395	Inhibition of TGFbeta receptor	B	NC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL497949	=	IC50	nM	369.0	CHEMBL4439	Homo sapiens	IC50	nM	369.0
	3524668	CHEMBL1272395	Inhibition of TGFbeta receptor	B	O=C1Nc2cc(C(=O)NCCO)ccc2/C1=C(/Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL1271910	=	IC50	nM	430.0	CHEMBL4439	Homo sapiens	IC50	nM	430.0
	3524669	CHEMBL1272395	Inhibition of TGFbeta receptor	B	CCN(CC)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL1271966	=	IC50	nM	625.0	CHEMBL4439	Homo sapiens	IC50	nM	625.0
	3524670	CHEMBL1272395	Inhibition of TGFbeta receptor	B	O=C1Nc2cc(C(=O)NCc3ccccc3)ccc2/C1=C(/Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL1272022	=	IC50	nM	1532.0	CHEMBL4439	Homo sapiens	IC50	nM	1532.0
	3524671	CHEMBL1272395	Inhibition of TGFbeta receptor	B	O=C1Nc2ccccc2/C1=C(/Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL500435	=	IC50	nM	3462.0	CHEMBL4439	Homo sapiens	IC50	nM	3462.0
	3524672	CHEMBL1272395	Inhibition of TGFbeta receptor	B	CN(C)C(=O)c1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL1272078	=	IC50	nM	186.0	CHEMBL4439	Homo sapiens	IC50	nM	186.0
	3524673	CHEMBL1272395	Inhibition of TGFbeta receptor	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	IC50	nM	125.0	CHEMBL4439	Homo sapiens	IC50	nM	125.0
	3524674	CHEMBL1272395	Inhibition of TGFbeta receptor	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CCN(C)C)S(C)(=O)=O)cc1)c1ccccc1		CHEMBL1272128	=	IC50	nM	1.0	CHEMBL4439	Homo sapiens	IC50	nM	1.0
	3524675	CHEMBL1272395	Inhibition of TGFbeta receptor	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CCN(C)C)S(C)(=O)=O)cc1)c1ccccc1		CHEMBL1272182	=	IC50	nM	7.0	CHEMBL4439	Homo sapiens	IC50	nM	7.0
	3524676	CHEMBL1272395	Inhibition of TGFbeta receptor	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CCN(C)C)C(C)=O)cc1)c1ccccc1		CHEMBL1272238	=	IC50	nM	3.0	CHEMBL4439	Homo sapiens	IC50	nM	3.0
	3524677	CHEMBL1272395	Inhibition of TGFbeta receptor	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CCN(C)C)C(C)=O)cc1)c1ccccc1		CHEMBL1272291	=	IC50	nM	8.0	CHEMBL4439	Homo sapiens	IC50	nM	8.0
	3524678	CHEMBL1272395	Inhibition of TGFbeta receptor	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CCCN(C)C)C(C)=O)cc1)c1ccccc1		CHEMBL1271736	=	IC50	nM	3.0	CHEMBL4439	Homo sapiens	IC50	nM	3.0
	3524679	CHEMBL1272395	Inhibition of TGFbeta receptor	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CCCN(C)C)C(C)=O)cc1)c1ccccc1		CHEMBL1271796	=	IC50	nM	9.0	CHEMBL4439	Homo sapiens	IC50	nM	9.0
	3524680	CHEMBL1272395	Inhibition of TGFbeta receptor	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL1271853	=	IC50	nM	9.0	CHEMBL4439	Homo sapiens	IC50	nM	9.0
	3524681	CHEMBL1272395	Inhibition of TGFbeta receptor	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL1269806	=	IC50	nM	7.0	CHEMBL4439	Homo sapiens	IC50	nM	7.0
	3524682	CHEMBL1272395	Inhibition of TGFbeta receptor	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL1272289	=	IC50	nM	19.0	CHEMBL4439	Homo sapiens	IC50	nM	19.0
	3524683	CHEMBL1272395	Inhibition of TGFbeta receptor	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN(C)C)cc1)c1ccccc1		CHEMBL1272290	=	IC50	nM	35.0	CHEMBL4439	Homo sapiens	IC50	nM	35.0
	3524684	CHEMBL1272395	Inhibition of TGFbeta receptor	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN(C)C)cc1)c1ccccc1		CHEMBL1271470	=	IC50	nM	29.0	CHEMBL4439	Homo sapiens	IC50	nM	29.0
	3524685	CHEMBL1272395	Inhibition of TGFbeta receptor	B	CCNCc1ccc(N/C(=C2\C(=O)Nc3cc(C(=O)N(C)CC)ccc32)c2ccccc2)cc1		CHEMBL1271471	=	IC50	nM	32.0	CHEMBL4439	Homo sapiens	IC50	nM	32.0
	3524686	CHEMBL1272395	Inhibition of TGFbeta receptor	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(C(=O)NCCN(CC)CC)cc1)c1ccccc1		CHEMBL1271524	=	IC50	nM	33.0	CHEMBL4439	Homo sapiens	IC50	nM	33.0
	3524687	CHEMBL1272395	Inhibition of TGFbeta receptor	B	CCN(CC)CCNC(=O)c1ccc(N/C(=C2\C(=O)Nc3cc(C(=O)N(C)CC)ccc32)c2ccccc2)cc1		CHEMBL1271576	=	IC50	nM	64.0	CHEMBL4439	Homo sapiens	IC50	nM	64.0
	3524688	CHEMBL1272395	Inhibition of TGFbeta receptor	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CCN(C)C)cc1)c1ccccc1		CHEMBL1271577	=	IC50	nM	47.0	CHEMBL4439	Homo sapiens	IC50	nM	47.0
	3524689	CHEMBL1272395	Inhibition of TGFbeta receptor	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CCN(C)C)cc1)c1ccccc1		CHEMBL1271631	=	IC50	nM	64.0	CHEMBL4439	Homo sapiens	IC50	nM	64.0
	3524690	CHEMBL1272395	Inhibition of TGFbeta receptor	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CC(=O)N(C)C)S(C)(=O)=O)cc1)c1ccccc1		CHEMBL1271683	=	IC50	nM	86.0	CHEMBL4439	Homo sapiens	IC50	nM	86.0
	3524691	CHEMBL1272395	Inhibition of TGFbeta receptor	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)S(C)(=O)=O)cc1)c1ccccc1		CHEMBL1272127	=	IC50	nM	231.0	CHEMBL4439	Homo sapiens	IC50	nM	231.0
	3524692	CHEMBL1272395	Inhibition of TGFbeta receptor	B	CCN(CC)Cc1cccc(N/C(=C2\C(=O)Nc3cc(C(=O)N(C)CC)ccc32)c2ccccc2)c1		CHEMBL1272180	=	IC50	nM	616.0	CHEMBL4439	Homo sapiens	IC50	nM	616.0
	3524693	CHEMBL1272395	Inhibition of TGFbeta receptor	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(C(=O)O)cc1)c1ccccc1		CHEMBL1272181	=	IC50	nM	782.0	CHEMBL4439	Homo sapiens	IC50	nM	782.0
	3524694	CHEMBL1272395	Inhibition of TGFbeta receptor	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(C(=O)OC)cc1)c1ccccc1		CHEMBL1272236	=	IC50	nM	1970.0	CHEMBL4439	Homo sapiens	IC50	nM	1970.0
	3524695	CHEMBL1272395	Inhibition of TGFbeta receptor	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccccc1)c1ccccc1		CHEMBL1272237	=	IC50	nM	2586.0	CHEMBL4439	Homo sapiens	IC50	nM	2586.0
	3524696	CHEMBL1272395	Inhibition of TGFbeta receptor	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C\Nc1ccc(N(CCCN(C)C)C(C)=O)cc1		CHEMBL1271965	=	IC50	nM	17.0	CHEMBL4439	Homo sapiens	IC50	nM	17.0
	3524697	CHEMBL1272395	Inhibition of TGFbeta receptor	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1		CHEMBL1272020	=	IC50	nM	15.0	CHEMBL4439	Homo sapiens	IC50	nM	15.0
	3524698	CHEMBL1272395	Inhibition of TGFbeta receptor	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C\Nc1ccc(CN2CCCCC2)cc1		CHEMBL1272021	=	IC50	nM	69.0	CHEMBL4439	Homo sapiens	IC50	nM	69.0
	3524699	CHEMBL1272395	Inhibition of TGFbeta receptor	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C\Nc1ccc(N(C)C(=O)CN(C)C)cc1		CHEMBL1272076	=	IC50	nM	52.0	CHEMBL4439	Homo sapiens	IC50	nM	52.0
	3524700	CHEMBL1272395	Inhibition of TGFbeta receptor	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\NC1CCN(C)CC1)c1ccccc1		CHEMBL1272077	>	IC50	nM	50000.0	CHEMBL4439	Homo sapiens	IC50	nM	50000.0
	3524701	CHEMBL1272395	Inhibition of TGFbeta receptor	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\NC1CCCCC1)c1ccccc1		CHEMBL1272126	>	IC50	nM	50000.0	CHEMBL4439	Homo sapiens	IC50	nM	50000.0
	3524702	CHEMBL1272394	Inhibition of TGFbeta receptor in human HaCaT cells assessed as Smad phosphorylation by ELISA	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL496862	=	EC50	nM	105.0	CHEMBL4439	Homo sapiens	EC50	nM	105.0
	3524703	CHEMBL1272394	Inhibition of TGFbeta receptor in human HaCaT cells assessed as Smad phosphorylation by ELISA	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL1271472	=	EC50	nM	75.0	CHEMBL4439	Homo sapiens	EC50	nM	75.0
Not Determined	3524704	CHEMBL1272394	Inhibition of TGFbeta receptor in human HaCaT cells assessed as Smad phosphorylation by ELISA	B	CNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL497724		EC50			CHEMBL4439	Homo sapiens	EC50		
	3524705	CHEMBL1272394	Inhibition of TGFbeta receptor in human HaCaT cells assessed as Smad phosphorylation by ELISA	B	CN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL496861	=	EC50	nM	246.0	CHEMBL4439	Homo sapiens	EC50	nM	246.0
	3524706	CHEMBL1272394	Inhibition of TGFbeta receptor in human HaCaT cells assessed as Smad phosphorylation by ELISA	B	CCCCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL1271578	=	EC50	nM	1065.0	CHEMBL4439	Homo sapiens	EC50	nM	1065.0
	3524707	CHEMBL1272394	Inhibition of TGFbeta receptor in human HaCaT cells assessed as Smad phosphorylation by ELISA	B	O=C1Nc2cc(C(=O)C3CCCN3)ccc2/C1=C(/Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL1271632	=	EC50	nM	696.0	CHEMBL4439	Homo sapiens	EC50	nM	696.0
	3524708	CHEMBL1272394	Inhibition of TGFbeta receptor in human HaCaT cells assessed as Smad phosphorylation by ELISA	B	CC(C)NC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL524647	=	EC50	nM	708.0	CHEMBL4439	Homo sapiens	EC50	nM	708.0
	3524709	CHEMBL1272394	Inhibition of TGFbeta receptor in human HaCaT cells assessed as Smad phosphorylation by ELISA	B	NC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL497949	>	EC50	nM	50000.0	CHEMBL4439	Homo sapiens	EC50	nM	50000.0
	3524710	CHEMBL1272394	Inhibition of TGFbeta receptor in human HaCaT cells assessed as Smad phosphorylation by ELISA	B	O=C1Nc2cc(C(=O)NCCO)ccc2/C1=C(/Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL1271910	>	EC50	nM	50000.0	CHEMBL4439	Homo sapiens	EC50	nM	50000.0
Not Determined	3524711	CHEMBL1272394	Inhibition of TGFbeta receptor in human HaCaT cells assessed as Smad phosphorylation by ELISA	B	CCN(CC)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL1271966		EC50			CHEMBL4439	Homo sapiens	EC50		
Not Determined	3524712	CHEMBL1272394	Inhibition of TGFbeta receptor in human HaCaT cells assessed as Smad phosphorylation by ELISA	B	O=C1Nc2cc(C(=O)NCc3ccccc3)ccc2/C1=C(/Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL1272022		EC50			CHEMBL4439	Homo sapiens	EC50		
Not Determined	3524713	CHEMBL1272394	Inhibition of TGFbeta receptor in human HaCaT cells assessed as Smad phosphorylation by ELISA	B	O=C1Nc2ccccc2/C1=C(/Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL500435		EC50			CHEMBL4439	Homo sapiens	EC50		
	3524714	CHEMBL1272394	Inhibition of TGFbeta receptor in human HaCaT cells assessed as Smad phosphorylation by ELISA	B	CN(C)C(=O)c1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL1272078	=	EC50	nM	198.0	CHEMBL4439	Homo sapiens	EC50	nM	198.0
	3524715	CHEMBL1272394	Inhibition of TGFbeta receptor in human HaCaT cells assessed as Smad phosphorylation by ELISA	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	EC50	nM	172.0	CHEMBL4439	Homo sapiens	EC50	nM	172.0
	3524716	CHEMBL1272394	Inhibition of TGFbeta receptor in human HaCaT cells assessed as Smad phosphorylation by ELISA	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CCN(C)C)S(C)(=O)=O)cc1)c1ccccc1		CHEMBL1272128	=	EC50	nM	108.0	CHEMBL4439	Homo sapiens	EC50	nM	108.0
	3524717	CHEMBL1272394	Inhibition of TGFbeta receptor in human HaCaT cells assessed as Smad phosphorylation by ELISA	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CCN(C)C)S(C)(=O)=O)cc1)c1ccccc1		CHEMBL1272182	=	EC50	nM	209.0	CHEMBL4439	Homo sapiens	EC50	nM	209.0
	3524718	CHEMBL1272394	Inhibition of TGFbeta receptor in human HaCaT cells assessed as Smad phosphorylation by ELISA	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CCN(C)C)C(C)=O)cc1)c1ccccc1		CHEMBL1272238	=	EC50	nM	1066.0	CHEMBL4439	Homo sapiens	EC50	nM	1066.0
	3524719	CHEMBL1272394	Inhibition of TGFbeta receptor in human HaCaT cells assessed as Smad phosphorylation by ELISA	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CCN(C)C)C(C)=O)cc1)c1ccccc1		CHEMBL1272291	=	EC50	nM	102.0	CHEMBL4439	Homo sapiens	EC50	nM	102.0
	3524720	CHEMBL1272394	Inhibition of TGFbeta receptor in human HaCaT cells assessed as Smad phosphorylation by ELISA	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CCCN(C)C)C(C)=O)cc1)c1ccccc1		CHEMBL1271736	=	EC50	nM	1249.0	CHEMBL4439	Homo sapiens	EC50	nM	1249.0
	3524721	CHEMBL1272394	Inhibition of TGFbeta receptor in human HaCaT cells assessed as Smad phosphorylation by ELISA	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CCCN(C)C)C(C)=O)cc1)c1ccccc1		CHEMBL1271796	=	EC50	nM	411.0	CHEMBL4439	Homo sapiens	EC50	nM	411.0
	3524722	CHEMBL1272394	Inhibition of TGFbeta receptor in human HaCaT cells assessed as Smad phosphorylation by ELISA	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL1271853	=	EC50	nM	1370.0	CHEMBL4439	Homo sapiens	EC50	nM	1370.0
	3524723	CHEMBL1272394	Inhibition of TGFbeta receptor in human HaCaT cells assessed as Smad phosphorylation by ELISA	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL1269806	=	EC50	nM	833.0	CHEMBL4439	Homo sapiens	EC50	nM	833.0
	3524724	CHEMBL1272394	Inhibition of TGFbeta receptor in human HaCaT cells assessed as Smad phosphorylation by ELISA	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL1272289	=	EC50	nM	185.0	CHEMBL4439	Homo sapiens	EC50	nM	185.0
	3524725	CHEMBL1272394	Inhibition of TGFbeta receptor in human HaCaT cells assessed as Smad phosphorylation by ELISA	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN(C)C)cc1)c1ccccc1		CHEMBL1272290	=	EC50	nM	3383.0	CHEMBL4439	Homo sapiens	EC50	nM	3383.0
	3525099	CHEMBL1272394	Inhibition of TGFbeta receptor in human HaCaT cells assessed as Smad phosphorylation by ELISA	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN(C)C)cc1)c1ccccc1		CHEMBL1271470	=	EC50	nM	382.0	CHEMBL4439	Homo sapiens	EC50	nM	382.0
	3525100	CHEMBL1272394	Inhibition of TGFbeta receptor in human HaCaT cells assessed as Smad phosphorylation by ELISA	B	CCNCc1ccc(N/C(=C2\C(=O)Nc3cc(C(=O)N(C)CC)ccc32)c2ccccc2)cc1		CHEMBL1271471	=	EC50	nM	160.0	CHEMBL4439	Homo sapiens	EC50	nM	160.0
	3525101	CHEMBL1272394	Inhibition of TGFbeta receptor in human HaCaT cells assessed as Smad phosphorylation by ELISA	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(C(=O)NCCN(CC)CC)cc1)c1ccccc1		CHEMBL1271524	=	EC50	nM	505.0	CHEMBL4439	Homo sapiens	EC50	nM	505.0
	3525102	CHEMBL1272394	Inhibition of TGFbeta receptor in human HaCaT cells assessed as Smad phosphorylation by ELISA	B	CCN(CC)CCNC(=O)c1ccc(N/C(=C2\C(=O)Nc3cc(C(=O)N(C)CC)ccc32)c2ccccc2)cc1		CHEMBL1271576	=	EC50	nM	542.0	CHEMBL4439	Homo sapiens	EC50	nM	542.0
	3525103	CHEMBL1272394	Inhibition of TGFbeta receptor in human HaCaT cells assessed as Smad phosphorylation by ELISA	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CCN(C)C)cc1)c1ccccc1		CHEMBL1271577	=	EC50	nM	135.0	CHEMBL4439	Homo sapiens	EC50	nM	135.0
	3525104	CHEMBL1272394	Inhibition of TGFbeta receptor in human HaCaT cells assessed as Smad phosphorylation by ELISA	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CCN(C)C)cc1)c1ccccc1		CHEMBL1271631	=	EC50	nM	259.0	CHEMBL4439	Homo sapiens	EC50	nM	259.0
	3525105	CHEMBL1272394	Inhibition of TGFbeta receptor in human HaCaT cells assessed as Smad phosphorylation by ELISA	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CC(=O)N(C)C)S(C)(=O)=O)cc1)c1ccccc1		CHEMBL1271683	>	EC50	nM	3000.0	CHEMBL4439	Homo sapiens	EC50	nM	3000.0
	3525106	CHEMBL1272394	Inhibition of TGFbeta receptor in human HaCaT cells assessed as Smad phosphorylation by ELISA	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)S(C)(=O)=O)cc1)c1ccccc1		CHEMBL1272127	>	EC50	nM	10000.0	CHEMBL4439	Homo sapiens	EC50	nM	10000.0
Not Determined	3525107	CHEMBL1272394	Inhibition of TGFbeta receptor in human HaCaT cells assessed as Smad phosphorylation by ELISA	B	CCN(CC)Cc1cccc(N/C(=C2\C(=O)Nc3cc(C(=O)N(C)CC)ccc32)c2ccccc2)c1		CHEMBL1272180		EC50			CHEMBL4439	Homo sapiens	EC50		
Not Determined	3525108	CHEMBL1272394	Inhibition of TGFbeta receptor in human HaCaT cells assessed as Smad phosphorylation by ELISA	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(C(=O)O)cc1)c1ccccc1		CHEMBL1272181		EC50			CHEMBL4439	Homo sapiens	EC50		
Not Determined	3525109	CHEMBL1272394	Inhibition of TGFbeta receptor in human HaCaT cells assessed as Smad phosphorylation by ELISA	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(C(=O)OC)cc1)c1ccccc1		CHEMBL1272236		EC50			CHEMBL4439	Homo sapiens	EC50		
Not Determined	3525110	CHEMBL1272394	Inhibition of TGFbeta receptor in human HaCaT cells assessed as Smad phosphorylation by ELISA	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccccc1)c1ccccc1		CHEMBL1272237		EC50			CHEMBL4439	Homo sapiens	EC50		
	3525111	CHEMBL1272394	Inhibition of TGFbeta receptor in human HaCaT cells assessed as Smad phosphorylation by ELISA	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C\Nc1ccc(N(CCCN(C)C)C(C)=O)cc1		CHEMBL1271965	=	EC50	nM	597.0	CHEMBL4439	Homo sapiens	EC50	nM	597.0
	3525112	CHEMBL1272394	Inhibition of TGFbeta receptor in human HaCaT cells assessed as Smad phosphorylation by ELISA	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1		CHEMBL1272020	=	EC50	nM	2175.0	CHEMBL4439	Homo sapiens	EC50	nM	2175.0
	3525113	CHEMBL1272394	Inhibition of TGFbeta receptor in human HaCaT cells assessed as Smad phosphorylation by ELISA	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C\Nc1ccc(CN2CCCCC2)cc1		CHEMBL1272021	=	EC50	nM	376.0	CHEMBL4439	Homo sapiens	EC50	nM	376.0
	3525114	CHEMBL1272394	Inhibition of TGFbeta receptor in human HaCaT cells assessed as Smad phosphorylation by ELISA	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C\Nc1ccc(N(C)C(=O)CN(C)C)cc1		CHEMBL1272076	=	EC50	nM	4355.0	CHEMBL4439	Homo sapiens	EC50	nM	4355.0
	3525115	CHEMBL1272394	Inhibition of TGFbeta receptor in human HaCaT cells assessed as Smad phosphorylation by ELISA	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\NC1CCN(C)CC1)c1ccccc1		CHEMBL1272077	>	EC50	nM	10000.0	CHEMBL4439	Homo sapiens	EC50	nM	10000.0
	3525116	CHEMBL1272394	Inhibition of TGFbeta receptor in human HaCaT cells assessed as Smad phosphorylation by ELISA	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\NC1CCCCC1)c1ccccc1		CHEMBL1272126	>	EC50	nM	10000.0	CHEMBL4439	Homo sapiens	EC50	nM	10000.0
	6168233	CHEMBL1768523	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1766440	=	IC50	nM	207.0	CHEMBL4439	Homo sapiens	IC50	uM	0.207
	6168234	CHEMBL1768523	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(C#N)c3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1766441	=	IC50	nM	22.0	CHEMBL4439	Homo sapiens	IC50	uM	0.022
	6168235	CHEMBL1768523	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells	B	COc1ccnc2ccc(-c3cn(CC(=O)Nc4ccccc4)nc3-c3cccc(C)n3)cc12		CHEMBL1766442	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	6168236	CHEMBL1768523	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells	B	COc1ccnc2ccc(-c3cn(CC(=O)Nc4cccc(C#N)c4)nc3-c3cccc(C)n3)cc12		CHEMBL1766443	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	6168237	CHEMBL1768523	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(C(N)=O)c3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1766444	=	IC50	nM	75.0	CHEMBL4439	Homo sapiens	IC50	uM	0.075
	6168238	CHEMBL1768523	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells	B	Cc1cccc(-c2c(-c3ccc4ncccc4c3)cnn2CC(=O)Nc2ccccc2)n1		CHEMBL1766445	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	6168239	CHEMBL1768523	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells	B	Cc1cccc(-c2c(-c3ccc4ncccc4c3)cnn2CC(=O)Nc2cccc(C#N)c2)n1		CHEMBL1766446	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	6168240	CHEMBL1768523	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells	B	COc1ccnc2ccc(-c3cnn(CC(=O)Nc4ccccc4)c3-c3cccc(C)n3)cc12		CHEMBL1766447	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	6168241	CHEMBL1768523	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells	B	COc1ccnc2ccc(-c3cnn(CC(=O)Nc4cccc(C#N)c4)c3-c3cccc(C)n3)cc12		CHEMBL1766448	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	6168242	CHEMBL1768523	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells	B	Cc1cccc(-c2c(-c3ccc4ncccc4c3)cnn2CC(=O)Nc2cccc(C(N)=O)c2)n1		CHEMBL1766449	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	6168243	CHEMBL1768523	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells	B	Cc1cccc(-c2nn(CCC(=O)Nc3ccccc3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1766450	=	IC50	nM	25.0	CHEMBL4439	Homo sapiens	IC50	uM	0.025
	6168244	CHEMBL1768523	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells	B	Cc1cccc(-c2nn(CCC(=O)Nc3cccc(C#N)c3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1766451	=	IC50	nM	101.0	CHEMBL4439	Homo sapiens	IC50	uM	0.101
	6168245	CHEMBL1768523	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells	B	COc1ccnc2ccc(-c3cn(CCC(=O)Nc4cccc(C#N)c4)nc3-c3cccc(C)n3)cc12		CHEMBL1766452	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	6168246	CHEMBL1768523	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells	B	Cc1cccc(-c2nn(CC(=S)Nc3ccccc3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1766453	=	IC50	nM	94.0	CHEMBL4439	Homo sapiens	IC50	uM	0.094
	6168247	CHEMBL1768523	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(C#N)c3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1766454	=	IC50	nM	51.0	CHEMBL4439	Homo sapiens	IC50	uM	0.051
	6168248	CHEMBL1768523	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells	B	Cc1cccc(-c2nn(CCC(=S)Nc3ccccc3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1766455	=	IC50	nM	88.0	CHEMBL4439	Homo sapiens	IC50	uM	0.088
	6168431	CHEMBL1768781	Inhibition of ALK5	B	C[C@@H]1COCCN1c1cc(-c2ccc3c(N)[nH]nc3c2)nc(N)n1		CHEMBL1614773	<	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	pIC50		5.0
	6168432	CHEMBL1768781	Inhibition of ALK5	B	C[C@H]1COCCN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765727	<	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	pIC50		5.0
	6168433	CHEMBL1768781	Inhibition of ALK5	B	CC[C@@H]1COCCN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765728	<	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	pIC50		5.0
	6168434	CHEMBL1768781	Inhibition of ALK5	B	CC(C)[C@@H]1COCCN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765729	<	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	pIC50		5.0
	6168435	CHEMBL1768781	Inhibition of ALK5	B	C[C@@H]1CCCCN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765730	=	IC50	nM	7943.28	CHEMBL4439	Homo sapiens	pIC50		5.1
	6168436	CHEMBL1768781	Inhibition of ALK5	B	Nc1nc(-c2ccc3c(N)[nH]nc3c2)cc(N2CCO[C@H](C(=O)Nc3ccccc3)C2)n1		CHEMBL1614774	<	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	pIC50		5.0
	6168437	CHEMBL1768781	Inhibition of ALK5	B	Nc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2CCO[C@@H](C(=O)Nc3ccccc3)C2)n1		CHEMBL1765731	<	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	pIC50		5.0
	6168438	CHEMBL1768781	Inhibition of ALK5	B	Nc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2CCC[C@H](C(=O)Nc3ccccc3)C2)n1		CHEMBL1765732	<	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	pIC50		5.0
	6168439	CHEMBL1768781	Inhibition of ALK5	B	Nc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2CCC[C@@H](C(=O)Nc3ccccc3)C2)n1		CHEMBL1765733	<	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	pIC50		5.0
	6168440	CHEMBL1768781	Inhibition of ALK5	B	Nc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2CCC[C@H](C(=O)NC3CCCCC3)C2)n1		CHEMBL1765734	<	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	pIC50		5.0
	6168441	CHEMBL1768781	Inhibition of ALK5	B	Nc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2CCC[C@H](C(=O)NC3CCCC3)C2)n1		CHEMBL1765735	<	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	pIC50		5.0
	6168442	CHEMBL1768781	Inhibition of ALK5	B	C[C@@H]1CC[C@H](C(=O)Nc2ccccc2)CN1c1cc(-c2ccc3c(N)[nH]nc3c2)nc(N)n1		CHEMBL1614775	=	IC50	nM	6309.57	CHEMBL4439	Homo sapiens	pIC50		5.2
	6168443	CHEMBL1768781	Inhibition of ALK5	B	C[C@H]1CC[C@@H](C(=O)Nc2ccccc2)CN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765736	<	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	pIC50		5.0
	6168444	CHEMBL1768781	Inhibition of ALK5	B	C[C@@H]1CC[C@@H](C(=O)Nc2ccccc2)CN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765737	<	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	pIC50		5.0
	6168445	CHEMBL1768781	Inhibition of ALK5	B	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)Nc3ccccc3)CC[C@H]2C)n1		CHEMBL1765738	<	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	pIC50		5.0
	6168446	CHEMBL1768781	Inhibition of ALK5	B	C[C@@H]1CC[C@H](C(=O)NC2CCCCC2)CN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765739	<	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	pIC50		5.0
	6168447	CHEMBL1768781	Inhibition of ALK5	B	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)NC3CCCCC3)CC[C@H]2C)n1		CHEMBL1765740	<	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	pIC50		5.0
	6168448	CHEMBL1768781	Inhibition of ALK5	B	C[C@@H]1CO[C@H](C(=O)Nc2ccccc2)CN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765741	<	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	pIC50		5.0
	6168449	CHEMBL1768781	Inhibition of ALK5	B	CC[C@@H]1CO[C@H](C(=O)Nc2ccccc2)CN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(NC)n1		CHEMBL1765742	<	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	pIC50		5.0
	6168450	CHEMBL1768781	Inhibition of ALK5	B	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)NC3CCCCC3)OC[C@H]2C)n1		CHEMBL1765743	<	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	pIC50		5.0
	6168451	CHEMBL1768781	Inhibition of ALK5	B	CC[C@@H]1CO[C@H](C(=O)NC2CCCCC2)CN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(NC)n1		CHEMBL1765744	<	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	pIC50		5.0
	6168452	CHEMBL1768781	Inhibition of ALK5	B	Nc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2CCCC(NC(=O)c3ccccc3)C2)n1		CHEMBL1765745	<	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	pIC50		5.0
	6168453	CHEMBL1768781	Inhibition of ALK5	B	CC(C)(C)OC(=O)NC1CCCN(c2cc(-c3ccc4c(N)n[nH]c4c3)nc(N)n2)C1		CHEMBL1765746	<	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	pIC50		5.0
	6168454	CHEMBL1768781	Inhibition of ALK5	B	CC(C)(C)OC(=O)N[C@H]1CCCN(c2cc(-c3ccc4c(N)n[nH]c4c3)nc(N)n2)C1		CHEMBL1765747	<	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	pIC50		5.0
	6168455	CHEMBL1768781	Inhibition of ALK5	B	CC(C)(C)OC(=O)N[C@@H]1CCCN(c2cc(-c3ccc4c(N)n[nH]c4c3)nc(N)n2)C1		CHEMBL1765748	<	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	pIC50		5.0
	6168456	CHEMBL1768781	Inhibition of ALK5	B	C[C@H]1CC[C@@H](NC(=O)OC(C)(C)C)CN1c1cc(-c2ccc3c(N)[nH]nc3c2)nc(N)n1		CHEMBL1614776	<	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	pIC50		5.0
	6168457	CHEMBL1768781	Inhibition of ALK5	B	C[C@@H]1CC[C@H](NC(=O)OC(C)(C)C)CN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765749	<	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	pIC50		5.0
	6168458	CHEMBL1768781	Inhibition of ALK5	B	C[C@H]1CC[C@@H](NC(=O)OC(C)(C)C)CN1c1cc(-c2ccc3c(N)[nH]nc3c2)nc(N)n1		CHEMBL1614776	<	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	pIC50		5.0
	6168459	CHEMBL1768781	Inhibition of ALK5	B	C[C@@H]1C[C@@H](NC(=O)OC(C)(C)C)CN(c2cc(-c3ccc4c(N)[nH]nc4c3)nc(N)n2)C1		CHEMBL1614777	<	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	pIC50		5.0
	6168460	CHEMBL1768781	Inhibition of ALK5	B	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@H](C)C[C@@H](N(C)C(=O)OC(C)(C)C)C2)n1		CHEMBL1765750	<	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	pIC50		5.0
	6168461	CHEMBL1768781	Inhibition of ALK5	B	C[C@@H]1C[C@@H](N(C)C(=O)CC(C)(C)C)CN(c2cc(-c3ccc4c(N)n[nH]c4c3)nc(N)n2)C1		CHEMBL1765751	<	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	pIC50		5.0
	6168462	CHEMBL1768781	Inhibition of ALK5	B	Nc1nccc(-c2ccc3c(N)n[nH]c3c2)n1		CHEMBL1688215	=	IC50	nM	1584.89	CHEMBL4439	Homo sapiens	pIC50		5.8
	6168463	CHEMBL1768781	Inhibition of ALK5	B	Cc1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765756	=	IC50	nM	7943.28	CHEMBL4439	Homo sapiens	pIC50		5.1
	6168464	CHEMBL1768781	Inhibition of ALK5	B	CC(C)c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765757	=	IC50	nM	1995.26	CHEMBL4439	Homo sapiens	pIC50		5.7
	6168465	CHEMBL1768781	Inhibition of ALK5	B	Nc1nc(-c2ccccc2)cc(-c2ccc3c(N)n[nH]c3c2)n1		CHEMBL1765758	=	IC50	nM	3162.28	CHEMBL4439	Homo sapiens	pIC50		5.5
	6168466	CHEMBL1768781	Inhibition of ALK5	B	COc1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765759	=	IC50	nM	3162.28	CHEMBL4439	Homo sapiens	pIC50		5.5
	6168467	CHEMBL1768781	Inhibition of ALK5	B	CNc1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765760	=	IC50	nM	398.11	CHEMBL4439	Homo sapiens	pIC50		6.4
	6168468	CHEMBL1768781	Inhibition of ALK5	B	CCNc1cc(-c2ccc3c(N)[nH]nc3c2)nc(N)n1		CHEMBL1614771	=	IC50	nM	501.19	CHEMBL4439	Homo sapiens	pIC50		6.3
	6168469	CHEMBL1768781	Inhibition of ALK5	B	CC(C)Nc1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765761	=	IC50	nM	501.19	CHEMBL4439	Homo sapiens	pIC50		6.3
	6168470	CHEMBL1768781	Inhibition of ALK5	B	Nc1nc(NC2CCCC2)cc(-c2ccc3c(N)n[nH]c3c2)n1		CHEMBL1765762	=	IC50	nM	398.11	CHEMBL4439	Homo sapiens	pIC50		6.4
	6168471	CHEMBL1768781	Inhibition of ALK5	B	Nc1nc(Nc2ccccc2)cc(-c2ccc3c(N)n[nH]c3c2)n1		CHEMBL1765876	=	IC50	nM	25.12	CHEMBL4439	Homo sapiens	pIC50		7.6
	6168472	CHEMBL1768781	Inhibition of ALK5	B	CN(C)c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765877	=	IC50	nM	5011.87	CHEMBL4439	Homo sapiens	pIC50		5.3
	6168473	CHEMBL1768781	Inhibition of ALK5	B	Nc1nc(-c2ccc3c(N)[nH]nc3c2)cc(N2CCOCC2)n1		CHEMBL1614772	<	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	pIC50		5.0
	6168474	CHEMBL1768781	Inhibition of ALK5	B	Nc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2CCCC2)n1		CHEMBL1765878	<	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	pIC50		5.0
	6168475	CHEMBL1768781	Inhibition of ALK5	B	Nc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2CCCCC2)n1		CHEMBL1765879	<	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	pIC50		5.0
	6168873	CHEMBL1768523	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells	B	Cc1cccc(-c2nn(CCC(=S)Nc3cccc(C#N)c3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1766456	=	IC50	nM	232.0	CHEMBL4439	Homo sapiens	IC50	uM	0.232
	6168874	CHEMBL1768523	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	IC50	nM	54.0	CHEMBL4439	Homo sapiens	IC50	uM	0.054
	6168875	CHEMBL1768523	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL492634	=	IC50	nM	17.0	CHEMBL4439	Homo sapiens	IC50	uM	0.017
	6168906	CHEMBL1768526	Inhibition of human recombinant ALK5 activity in human HaCaT cells assessed as TGFbeta-induced p3TP-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1766440	=	Activity	%	51.0	CHEMBL4439	Homo sapiens	Activity	%	51.0
	6168907	CHEMBL1768526	Inhibition of human recombinant ALK5 activity in human HaCaT cells assessed as TGFbeta-induced p3TP-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(C#N)c3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1766441	=	Activity	%	16.0	CHEMBL4439	Homo sapiens	Activity	%	16.0
	6168908	CHEMBL1768526	Inhibition of human recombinant ALK5 activity in human HaCaT cells assessed as TGFbeta-induced p3TP-luciferase reporter activity at 0.1 uM relative to control	B	COc1ccnc2ccc(-c3cn(CC(=O)Nc4ccccc4)nc3-c3cccc(C)n3)cc12		CHEMBL1766442	=	Activity	%	108.0	CHEMBL4439	Homo sapiens	Activity	%	108.0
	6168909	CHEMBL1768526	Inhibition of human recombinant ALK5 activity in human HaCaT cells assessed as TGFbeta-induced p3TP-luciferase reporter activity at 0.1 uM relative to control	B	COc1ccnc2ccc(-c3cn(CC(=O)Nc4cccc(C#N)c4)nc3-c3cccc(C)n3)cc12		CHEMBL1766443	=	Activity	%	108.0	CHEMBL4439	Homo sapiens	Activity	%	108.0
	6168910	CHEMBL1768526	Inhibition of human recombinant ALK5 activity in human HaCaT cells assessed as TGFbeta-induced p3TP-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(C(N)=O)c3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1766444	=	Activity	%	58.0	CHEMBL4439	Homo sapiens	Activity	%	58.0
	6168911	CHEMBL1768526	Inhibition of human recombinant ALK5 activity in human HaCaT cells assessed as TGFbeta-induced p3TP-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2c(-c3ccc4ncccc4c3)cnn2CC(=O)Nc2ccccc2)n1		CHEMBL1766445	=	Activity	%	102.0	CHEMBL4439	Homo sapiens	Activity	%	102.0
	6168912	CHEMBL1768526	Inhibition of human recombinant ALK5 activity in human HaCaT cells assessed as TGFbeta-induced p3TP-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2c(-c3ccc4ncccc4c3)cnn2CC(=O)Nc2cccc(C#N)c2)n1		CHEMBL1766446	=	Activity	%	110.0	CHEMBL4439	Homo sapiens	Activity	%	110.0
	6168913	CHEMBL1768526	Inhibition of human recombinant ALK5 activity in human HaCaT cells assessed as TGFbeta-induced p3TP-luciferase reporter activity at 0.1 uM relative to control	B	COc1ccnc2ccc(-c3cnn(CC(=O)Nc4ccccc4)c3-c3cccc(C)n3)cc12		CHEMBL1766447	=	Activity	%	104.0	CHEMBL4439	Homo sapiens	Activity	%	104.0
	6168914	CHEMBL1768526	Inhibition of human recombinant ALK5 activity in human HaCaT cells assessed as TGFbeta-induced p3TP-luciferase reporter activity at 0.1 uM relative to control	B	COc1ccnc2ccc(-c3cnn(CC(=O)Nc4cccc(C#N)c4)c3-c3cccc(C)n3)cc12		CHEMBL1766448	=	Activity	%	107.0	CHEMBL4439	Homo sapiens	Activity	%	107.0
	6168915	CHEMBL1768526	Inhibition of human recombinant ALK5 activity in human HaCaT cells assessed as TGFbeta-induced p3TP-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2c(-c3ccc4ncccc4c3)cnn2CC(=O)Nc2cccc(C(N)=O)c2)n1		CHEMBL1766449	=	Activity	%	104.0	CHEMBL4439	Homo sapiens	Activity	%	104.0
	6168916	CHEMBL1768526	Inhibition of human recombinant ALK5 activity in human HaCaT cells assessed as TGFbeta-induced p3TP-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2nn(CCC(=O)Nc3ccccc3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1766450	=	Activity	%	34.0	CHEMBL4439	Homo sapiens	Activity	%	34.0
	6168917	CHEMBL1768526	Inhibition of human recombinant ALK5 activity in human HaCaT cells assessed as TGFbeta-induced p3TP-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2nn(CCC(=O)Nc3cccc(C#N)c3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1766451	=	Activity	%	61.0	CHEMBL4439	Homo sapiens	Activity	%	61.0
	6168918	CHEMBL1768526	Inhibition of human recombinant ALK5 activity in human HaCaT cells assessed as TGFbeta-induced p3TP-luciferase reporter activity at 0.1 uM relative to control	B	COc1ccnc2ccc(-c3cn(CCC(=O)Nc4cccc(C#N)c4)nc3-c3cccc(C)n3)cc12		CHEMBL1766452	=	Activity	%	119.0	CHEMBL4439	Homo sapiens	Activity	%	119.0
	6168919	CHEMBL1768526	Inhibition of human recombinant ALK5 activity in human HaCaT cells assessed as TGFbeta-induced p3TP-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2nn(CC(=S)Nc3ccccc3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1766453	=	Activity	%	44.0	CHEMBL4439	Homo sapiens	Activity	%	44.0
	6168920	CHEMBL1768526	Inhibition of human recombinant ALK5 activity in human HaCaT cells assessed as TGFbeta-induced p3TP-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(C#N)c3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1766454	=	Activity	%	31.0	CHEMBL4439	Homo sapiens	Activity	%	31.0
	6168921	CHEMBL1768526	Inhibition of human recombinant ALK5 activity in human HaCaT cells assessed as TGFbeta-induced p3TP-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2nn(CCC(=S)Nc3ccccc3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1766455	=	Activity	%	64.0	CHEMBL4439	Homo sapiens	Activity	%	64.0
	6168922	CHEMBL1768526	Inhibition of human recombinant ALK5 activity in human HaCaT cells assessed as TGFbeta-induced p3TP-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2nn(CCC(=S)Nc3cccc(C#N)c3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1766456	=	Activity	%	77.0	CHEMBL4439	Homo sapiens	Activity	%	77.0
	6168923	CHEMBL1768526	Inhibition of human recombinant ALK5 activity in human HaCaT cells assessed as TGFbeta-induced p3TP-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Activity	%	34.0	CHEMBL4439	Homo sapiens	Activity	%	34.0
	6168924	CHEMBL1768526	Inhibition of human recombinant ALK5 activity in human HaCaT cells assessed as TGFbeta-induced p3TP-luciferase reporter activity at 0.1 uM relative to control	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL492634	=	Activity	%	20.0	CHEMBL4439	Homo sapiens	Activity	%	20.0
Dose-dependent effect	6168925	CHEMBL1768527	Inhibition of human recombinant ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(C#N)c3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1766441		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
	6169241	CHEMBL1768781	Inhibition of ALK5	B	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)NC3CCCCC3)CC[C@H]2C)n1		CHEMBL1765740	>	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	IC50	nM	10000.0
Not Active	6230333	CHEMBL1785276	Inhibition of human ALK5	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
	6265579	CHEMBL1798288	Inhibition of TGFBR1 at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NS(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796254	<	Inhibition	%	65.0	CHEMBL4439	Homo sapiens	INH	%	65.0
	6265683	CHEMBL1798288	Inhibition of TGFBR1 at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4N(C)S(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796257	<	Inhibition	%	65.0	CHEMBL4439	Homo sapiens	INH	%	65.0
	6294801	CHEMBL1811526	Inhibition of ALK5	B	CC(C)c1nc(-c2ccc(F)c(NS(=O)(=O)c3c(F)cccc3F)c2)c(-c2ccnc(Nc3ccc(N4CCOCC4)nc3)n2)s1		CHEMBL1808264	=	IC50	nM	10.0	CHEMBL4439	Homo sapiens	IC50	nM	10.0
	6339980	CHEMBL1826917	Activity of TGFBR1 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	83.0	CHEMBL4439	Homo sapiens	Activity	%	83.0
	6352110	CHEMBL1827917	Inhibition of human recombinant GST-fused ALK5 expressed in insect Sf9 cells using casein as substrate by radiometric kinase assay	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3)cc2-c2ccc3nccnc3c2)n1		CHEMBL1824226	=	IC50	nM	38.0	CHEMBL4439	Homo sapiens	IC50	uM	0.038
	6352111	CHEMBL1827917	Inhibition of human recombinant GST-fused ALK5 expressed in insect Sf9 cells using casein as substrate by radiometric kinase assay	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3)cc2-c2ccc3nc(C)c(C)nc3c2)n1		CHEMBL1824227	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	6352112	CHEMBL1827917	Inhibition of human recombinant GST-fused ALK5 expressed in insect Sf9 cells using casein as substrate by radiometric kinase assay	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(C#N)c3)cc2-c2ccc3nccnc3c2)n1		CHEMBL1824432	=	IC50	nM	153.0	CHEMBL4439	Homo sapiens	IC50	uM	0.153
	6352113	CHEMBL1827917	Inhibition of human recombinant GST-fused ALK5 expressed in insect Sf9 cells using casein as substrate by radiometric kinase assay	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(C#N)c3)cc2-c2ccc3nc(C)c(C)nc3c2)n1		CHEMBL1824433	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	6352114	CHEMBL1827917	Inhibition of human recombinant GST-fused ALK5 expressed in insect Sf9 cells using casein as substrate by radiometric kinase assay	B	Cc1cccc(-c2c(-c3ccc4nccnc4c3)cnn2CC(=O)Nc2ccccc2)n1		CHEMBL1824434	=	IC50	nM	143.0	CHEMBL4439	Homo sapiens	IC50	uM	0.143
	6352115	CHEMBL1827917	Inhibition of human recombinant GST-fused ALK5 expressed in insect Sf9 cells using casein as substrate by radiometric kinase assay	B	Cc1cccc(-c2c(-c3ccc4nc(C)c(C)nc4c3)cnn2CC(=O)Nc2ccccc2)n1		CHEMBL1824435	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	6352116	CHEMBL1827917	Inhibition of human recombinant GST-fused ALK5 expressed in insect Sf9 cells using casein as substrate by radiometric kinase assay	B	Cc1cccc(-c2c(-c3ccc4nccnc4c3)cnn2CC(=O)Nc2cccc(C#N)c2)n1		CHEMBL1824436	=	IC50	nM	737.0	CHEMBL4439	Homo sapiens	IC50	uM	0.737
	6352117	CHEMBL1827917	Inhibition of human recombinant GST-fused ALK5 expressed in insect Sf9 cells using casein as substrate by radiometric kinase assay	B	Cc1cccc(-c2c(-c3ccc4nc(C)c(C)nc4c3)cnn2CC(=O)Nc2cccc(C#N)c2)n1		CHEMBL1824437	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	6352118	CHEMBL1827917	Inhibition of human recombinant GST-fused ALK5 expressed in insect Sf9 cells using casein as substrate by radiometric kinase assay	B	Cc1cccc(-c2nn(CCC(=O)Nc3ccccc3)cc2-c2ccc3nccnc3c2)n1		CHEMBL1824438	=	IC50	nM	82.0	CHEMBL4439	Homo sapiens	IC50	uM	0.082
	6352119	CHEMBL1827917	Inhibition of human recombinant GST-fused ALK5 expressed in insect Sf9 cells using casein as substrate by radiometric kinase assay	B	Cc1cccc(-c2nn(CCC(=O)Nc3cccc(C#N)c3)cc2-c2ccc3nc(C)c(C)nc3c2)n1		CHEMBL1824439	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	6352120	CHEMBL1827917	Inhibition of human recombinant GST-fused ALK5 expressed in insect Sf9 cells using casein as substrate by radiometric kinase assay	B	Cc1cccc(-c2nn(CC(=S)Nc3ccccc3)cc2-c2ccc3nccnc3c2)n1		CHEMBL1824440	=	IC50	nM	13.0	CHEMBL4439	Homo sapiens	IC50	uM	0.013
	6352121	CHEMBL1827917	Inhibition of human recombinant GST-fused ALK5 expressed in insect Sf9 cells using casein as substrate by radiometric kinase assay	B	Cc1cccc(-c2nn(CC(=S)Nc3ccccc3)cc2-c2ccc3nc(C)c(C)nc3c2)n1		CHEMBL1824441	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	6352122	CHEMBL1827917	Inhibition of human recombinant GST-fused ALK5 expressed in insect Sf9 cells using casein as substrate by radiometric kinase assay	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(C#N)c3)cc2-c2ccc3nccnc3c2)n1		CHEMBL1824442	=	IC50	nM	26.0	CHEMBL4439	Homo sapiens	IC50	uM	0.026
	6352123	CHEMBL1827917	Inhibition of human recombinant GST-fused ALK5 expressed in insect Sf9 cells using casein as substrate by radiometric kinase assay	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(C#N)c3)cc2-c2ccc3nc(C)c(C)nc3c2)n1		CHEMBL1824443	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	6352124	CHEMBL1827917	Inhibition of human recombinant GST-fused ALK5 expressed in insect Sf9 cells using casein as substrate by radiometric kinase assay	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(C(N)=O)c3)cc2-c2ccc3nccnc3c2)n1		CHEMBL1824444	=	IC50	nM	48.0	CHEMBL4439	Homo sapiens	IC50	uM	0.048
	6352125	CHEMBL1827917	Inhibition of human recombinant GST-fused ALK5 expressed in insect Sf9 cells using casein as substrate by radiometric kinase assay	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(C(N)=O)c3)cc2-c2ccc3nc(C)c(C)nc3c2)n1		CHEMBL1824445	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	uM	1.0
	6352126	CHEMBL1827917	Inhibition of human recombinant GST-fused ALK5 expressed in insect Sf9 cells using casein as substrate by radiometric kinase assay	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1.Cl		CHEMBL1824446	=	IC50	nM	54.0	CHEMBL4439	Homo sapiens	IC50	uM	0.054
	6352127	CHEMBL1827917	Inhibition of human recombinant GST-fused ALK5 expressed in insect Sf9 cells using casein as substrate by radiometric kinase assay	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL492634	=	IC50	nM	17.0	CHEMBL4439	Homo sapiens	IC50	uM	0.017
	6352156	CHEMBL1827920	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 0.1 uM after 24 hrs by luminescence assay	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3)cc2-c2ccc3nccnc3c2)n1		CHEMBL1824226	=	Inhibition	%	36.0	CHEMBL4439	Homo sapiens	INH	%	36.0
	6352157	CHEMBL1827920	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 0.1 uM after 24 hrs by luminescence assay	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3)cc2-c2ccc3nc(C)c(C)nc3c2)n1		CHEMBL1824227	=	Inhibition	%	99.0	CHEMBL4439	Homo sapiens	INH	%	99.0
	6352158	CHEMBL1827920	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 0.1 uM after 24 hrs by luminescence assay	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(C#N)c3)cc2-c2ccc3nccnc3c2)n1		CHEMBL1824432	=	Inhibition	%	36.0	CHEMBL4439	Homo sapiens	INH	%	36.0
	6352159	CHEMBL1827920	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 0.1 uM after 24 hrs by luminescence assay	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(C#N)c3)cc2-c2ccc3nc(C)c(C)nc3c2)n1		CHEMBL1824433	=	Inhibition	%	92.0	CHEMBL4439	Homo sapiens	INH	%	92.0
	6352160	CHEMBL1827920	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 0.1 uM after 24 hrs by luminescence assay	B	Cc1cccc(-c2c(-c3ccc4nccnc4c3)cnn2CC(=O)Nc2ccccc2)n1		CHEMBL1824434	=	Inhibition	%	80.0	CHEMBL4439	Homo sapiens	INH	%	80.0
	6352161	CHEMBL1827920	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 0.1 uM after 24 hrs by luminescence assay	B	Cc1cccc(-c2c(-c3ccc4nc(C)c(C)nc4c3)cnn2CC(=O)Nc2ccccc2)n1		CHEMBL1824435	=	Inhibition	%	112.0	CHEMBL4439	Homo sapiens	INH	%	112.0
	6352162	CHEMBL1827920	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 0.1 uM after 24 hrs by luminescence assay	B	Cc1cccc(-c2c(-c3ccc4nccnc4c3)cnn2CC(=O)Nc2cccc(C#N)c2)n1		CHEMBL1824436	=	Inhibition	%	90.0	CHEMBL4439	Homo sapiens	INH	%	90.0
	6352163	CHEMBL1827920	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 0.1 uM after 24 hrs by luminescence assay	B	Cc1cccc(-c2c(-c3ccc4nc(C)c(C)nc4c3)cnn2CC(=O)Nc2cccc(C#N)c2)n1		CHEMBL1824437	=	Inhibition	%	127.0	CHEMBL4439	Homo sapiens	INH	%	127.0
	6352164	CHEMBL1827920	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 0.1 uM after 24 hrs by luminescence assay	B	Cc1cccc(-c2nn(CCC(=O)Nc3ccccc3)cc2-c2ccc3nccnc3c2)n1		CHEMBL1824438	=	Inhibition	%	34.0	CHEMBL4439	Homo sapiens	INH	%	34.0
	6352165	CHEMBL1827920	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 0.1 uM after 24 hrs by luminescence assay	B	Cc1cccc(-c2nn(CCC(=O)Nc3cccc(C#N)c3)cc2-c2ccc3nc(C)c(C)nc3c2)n1		CHEMBL1824439	=	Inhibition	%	113.0	CHEMBL4439	Homo sapiens	INH	%	113.0
	6352166	CHEMBL1827920	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 0.1 uM after 24 hrs by luminescence assay	B	Cc1cccc(-c2nn(CC(=S)Nc3ccccc3)cc2-c2ccc3nccnc3c2)n1		CHEMBL1824440	=	Inhibition	%	20.0	CHEMBL4439	Homo sapiens	INH	%	20.0
	6352167	CHEMBL1827920	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 0.1 uM after 24 hrs by luminescence assay	B	Cc1cccc(-c2nn(CC(=S)Nc3ccccc3)cc2-c2ccc3nc(C)c(C)nc3c2)n1		CHEMBL1824441	=	Inhibition	%	97.0	CHEMBL4439	Homo sapiens	INH	%	97.0
	6352791	CHEMBL1827920	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 0.1 uM after 24 hrs by luminescence assay	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(C#N)c3)cc2-c2ccc3nccnc3c2)n1		CHEMBL1824442	=	Inhibition	%	24.0	CHEMBL4439	Homo sapiens	INH	%	24.0
	6352792	CHEMBL1827920	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 0.1 uM after 24 hrs by luminescence assay	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(C#N)c3)cc2-c2ccc3nc(C)c(C)nc3c2)n1		CHEMBL1824443	=	Inhibition	%	92.0	CHEMBL4439	Homo sapiens	INH	%	92.0
	6352793	CHEMBL1827920	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 0.1 uM after 24 hrs by luminescence assay	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(C(N)=O)c3)cc2-c2ccc3nccnc3c2)n1		CHEMBL1824444	=	Inhibition	%	46.0	CHEMBL4439	Homo sapiens	INH	%	46.0
	6352794	CHEMBL1827920	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 0.1 uM after 24 hrs by luminescence assay	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(C(N)=O)c3)cc2-c2ccc3nc(C)c(C)nc3c2)n1		CHEMBL1824445	=	Inhibition	%	97.0	CHEMBL4439	Homo sapiens	INH	%	97.0
	6352795	CHEMBL1827920	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 0.1 uM after 24 hrs by luminescence assay	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1.Cl		CHEMBL1824446	=	Inhibition	%	34.0	CHEMBL4439	Homo sapiens	INH	%	34.0
	6352796	CHEMBL1827920	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 0.1 uM after 24 hrs by luminescence assay	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL492634	=	Inhibition	%	20.0	CHEMBL4439	Homo sapiens	INH	%	20.0
Dose-dependent effect	6352797	CHEMBL1828084	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity after 24 hrs by luminescence assay	B	Cc1cccc(-c2nn(CC(=S)Nc3ccccc3)cc2-c2ccc3nccnc3c2)n1		CHEMBL1824440		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
Dose-dependent effect	6352798	CHEMBL1828084	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity after 24 hrs by luminescence assay	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1.Cl		CHEMBL1824446		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
Dose-dependent effect	6352799	CHEMBL1828084	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity after 24 hrs by luminescence assay	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL492634		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
	6366224	CHEMBL1831609	Inhibition of TGF-beta1 signaling expressed in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 1 uM after 16 hrs by luciferase reporter gene assay relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc(-n3ccnc3)c2)nc1		CHEMBL1829505	=	Inhibition	%	11.0	CHEMBL4439	Homo sapiens	INH	%	11.0
	6366225	CHEMBL1831609	Inhibition of TGF-beta1 signaling expressed in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 1 uM after 16 hrs by luciferase reporter gene assay relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3cccc4cccnc34)c2)nc1		CHEMBL1829516	=	Inhibition	%	46.0	CHEMBL4439	Homo sapiens	INH	%	46.0
	6366226	CHEMBL1831609	Inhibition of TGF-beta1 signaling expressed in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 1 uM after 16 hrs by luciferase reporter gene assay relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc(-n3cccn3)c2)nc1		CHEMBL1829504	=	Inhibition	%	1.0	CHEMBL4439	Homo sapiens	INH	%	1.0
	6366227	CHEMBL1831609	Inhibition of TGF-beta1 signaling expressed in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 1 uM after 16 hrs by luciferase reporter gene assay relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3cnc4ccccc4c3)c2)nc1		CHEMBL1829515	=	Inhibition	%	29.0	CHEMBL4439	Homo sapiens	INH	%	29.0
	6366228	CHEMBL1831609	Inhibition of TGF-beta1 signaling expressed in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 1 uM after 16 hrs by luciferase reporter gene assay relative to control	B	Cn1cc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cn1		CHEMBL1828640	=	Inhibition	%	1.0	CHEMBL4439	Homo sapiens	INH	%	1.0
	6366229	CHEMBL1831609	Inhibition of TGF-beta1 signaling expressed in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 1 uM after 16 hrs by luciferase reporter gene assay relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3cccnc3)c2)nc1		CHEMBL1829514	=	Inhibition	%	7.0	CHEMBL4439	Homo sapiens	INH	%	7.0
	6366230	CHEMBL1831609	Inhibition of TGF-beta1 signaling expressed in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 1 uM after 16 hrs by luciferase reporter gene assay relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3cncnc3)c2)nc1		CHEMBL1829602	=	Inhibition	%	58.0	CHEMBL4439	Homo sapiens	INH	%	58.0
	6366231	CHEMBL1831609	Inhibition of TGF-beta1 signaling expressed in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 1 uM after 16 hrs by luciferase reporter gene assay relative to control	B	c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)nc1		CHEMBL1829513	=	Inhibition	%	1.0	CHEMBL4439	Homo sapiens	INH	%	1.0
	6366232	CHEMBL1831609	Inhibition of TGF-beta1 signaling expressed in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 1 uM after 16 hrs by luciferase reporter gene assay relative to control	B	c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL205736	=	Inhibition	%	14.0	CHEMBL4439	Homo sapiens	INH	%	14.0
	6366234	CHEMBL1831609	Inhibition of TGF-beta1 signaling expressed in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 1 uM after 16 hrs by luciferase reporter gene assay relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc(-n3cnc4ccccc43)c2)nc1		CHEMBL1829506	=	Inhibition	%	34.0	CHEMBL4439	Homo sapiens	INH	%	34.0
	6366235	CHEMBL1831609	Inhibition of TGF-beta1 signaling expressed in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 1 uM after 16 hrs by luciferase reporter gene assay relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc(N3CCCCC3)c2)nc1		CHEMBL1829507	=	Inhibition	%	80.0	CHEMBL4439	Homo sapiens	INH	%	80.0
	6366236	CHEMBL1831609	Inhibition of TGF-beta1 signaling expressed in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 1 uM after 16 hrs by luciferase reporter gene assay relative to control	B	CN1CCN(c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)CC1		CHEMBL1829508	=	Inhibition	%	90.0	CHEMBL4439	Homo sapiens	INH	%	90.0
	6366237	CHEMBL1831609	Inhibition of TGF-beta1 signaling expressed in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 1 uM after 16 hrs by luciferase reporter gene assay relative to control	B	c1ccc(-c2n[nH]cc2-c2ccncc2)nc1		CHEMBL1829509	=	Inhibition	%	50.0	CHEMBL4439	Homo sapiens	INH	%	50.0
Not Active	6366238	CHEMBL1831609	Inhibition of TGF-beta1 signaling expressed in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 1 uM after 16 hrs by luciferase reporter gene assay relative to control	B	COc1cccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)c1		CHEMBL382799		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
	6366239	CHEMBL1831609	Inhibition of TGF-beta1 signaling expressed in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 1 uM after 16 hrs by luciferase reporter gene assay relative to control	B	COc1ccccc1-c1cc(-c2c[nH]nc2-c2ccccn2)ccn1		CHEMBL1829510	=	Inhibition	%	54.0	CHEMBL4439	Homo sapiens	INH	%	54.0
Not Active	6366240	CHEMBL1831610	Inhibition of TGF-beta1 signaling in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 100 nM after 16 hrs by luciferase reporter gene assay relative to control	B	c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL205736		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
	6366241	CHEMBL1831610	Inhibition of TGF-beta1 signaling in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 100 nM after 16 hrs by luciferase reporter gene assay relative to control	B	c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)nc1		CHEMBL1829513	=	Inhibition	%	63.0	CHEMBL4439	Homo sapiens	INH	%	63.0
	6366242	CHEMBL1831610	Inhibition of TGF-beta1 signaling in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 100 nM after 16 hrs by luciferase reporter gene assay relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3cccnc3)c2)nc1		CHEMBL1829514	=	Inhibition	%	72.0	CHEMBL4439	Homo sapiens	INH	%	72.0
	6366243	CHEMBL1831610	Inhibition of TGF-beta1 signaling in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 100 nM after 16 hrs by luciferase reporter gene assay relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3cnc4ccccc4c3)c2)nc1		CHEMBL1829515	=	Inhibition	%	69.0	CHEMBL4439	Homo sapiens	INH	%	69.0
Not Active	6366244	CHEMBL1831610	Inhibition of TGF-beta1 signaling in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 100 nM after 16 hrs by luciferase reporter gene assay relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3cccc4cccnc34)c2)nc1		CHEMBL1829516		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
Not Active	6366245	CHEMBL1831610	Inhibition of TGF-beta1 signaling in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 100 nM after 16 hrs by luciferase reporter gene assay relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3cncnc3)c2)nc1		CHEMBL1829602		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
	6366246	CHEMBL1831610	Inhibition of TGF-beta1 signaling in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 100 nM after 16 hrs by luciferase reporter gene assay relative to control	B	Cn1cc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cn1		CHEMBL1828640	=	Inhibition	%	3.0	CHEMBL4439	Homo sapiens	INH	%	3.0
	6366247	CHEMBL1831610	Inhibition of TGF-beta1 signaling in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 100 nM after 16 hrs by luciferase reporter gene assay relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc(-n3cccn3)c2)nc1		CHEMBL1829504	=	Inhibition	%	42.0	CHEMBL4439	Homo sapiens	INH	%	42.0
	6366248	CHEMBL1831610	Inhibition of TGF-beta1 signaling in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 100 nM after 16 hrs by luciferase reporter gene assay relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc(-n3ccnc3)c2)nc1		CHEMBL1829505	=	Inhibition	%	50.0	CHEMBL4439	Homo sapiens	INH	%	50.0
	6366249	CHEMBL1831610	Inhibition of TGF-beta1 signaling in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 100 nM after 16 hrs by luciferase reporter gene assay relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc(-n3cnc4ccccc43)c2)nc1		CHEMBL1829506	=	Inhibition	%	70.0	CHEMBL4439	Homo sapiens	INH	%	70.0
Not Active	6366250	CHEMBL1831610	Inhibition of TGF-beta1 signaling in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 100 nM after 16 hrs by luciferase reporter gene assay relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc(N3CCCCC3)c2)nc1		CHEMBL1829507		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
Not Active	6366251	CHEMBL1831610	Inhibition of TGF-beta1 signaling in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 100 nM after 16 hrs by luciferase reporter gene assay relative to control	B	CN1CCN(c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)CC1		CHEMBL1829508		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
	6366252	CHEMBL1831610	Inhibition of TGF-beta1 signaling in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 100 nM after 16 hrs by luciferase reporter gene assay relative to control	B	c1ccc(-c2n[nH]cc2-c2ccncc2)nc1		CHEMBL1829509	=	Inhibition	%	87.0	CHEMBL4439	Homo sapiens	INH	%	87.0
	6366253	CHEMBL1831610	Inhibition of TGF-beta1 signaling in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 100 nM after 16 hrs by luciferase reporter gene assay relative to control	B	CN(C)CCOc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL424676	=	Inhibition	%	1.0	CHEMBL4439	Homo sapiens	INH	%	1.0
	6366254	CHEMBL1831610	Inhibition of TGF-beta1 signaling in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 100 nM after 16 hrs by luciferase reporter gene assay relative to control	B	O=C(NC1CCOCC1)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202887	=	Inhibition	%	52.0	CHEMBL4439	Homo sapiens	INH	%	52.0
	6366255	CHEMBL1831610	Inhibition of TGF-beta1 signaling in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 100 nM after 16 hrs by luciferase reporter gene assay relative to control	B	CN(C)CCCOc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cn1		CHEMBL1829511	=	Inhibition	%	1.0	CHEMBL4439	Homo sapiens	INH	%	1.0
	6366256	CHEMBL1831610	Inhibition of TGF-beta1 signaling in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 100 nM after 16 hrs by luciferase reporter gene assay relative to control	B	CN1CCN(c2ccc(-c3cc(-c4c[nH]nc4-c4ccccn4)ccn3)cn2)CC1		CHEMBL1829512	=	Inhibition	%	1.0	CHEMBL4439	Homo sapiens	INH	%	1.0
	6366288	CHEMBL1831613	Inhibition of TGF-beta1 signaling in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX after 16 hrs by luciferase reporter gene assay	B	Cn1cc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cn1		CHEMBL1828640	=	IC50	nM	68.0	CHEMBL4439	Homo sapiens	IC50	nM	68.0
	6366289	CHEMBL1831613	Inhibition of TGF-beta1 signaling in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX after 16 hrs by luciferase reporter gene assay	B	c1ccc(-c2n[nH]cc2-c2ccnc(-n3cccn3)c2)nc1		CHEMBL1829504	=	IC50	nM	77.0	CHEMBL4439	Homo sapiens	IC50	nM	77.0
	6366290	CHEMBL1831613	Inhibition of TGF-beta1 signaling in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX after 16 hrs by luciferase reporter gene assay	B	c1ccc(-c2n[nH]cc2-c2ccnc(-n3ccnc3)c2)nc1		CHEMBL1829505	=	IC50	nM	88.0	CHEMBL4439	Homo sapiens	IC50	nM	88.0
	6366291	CHEMBL1831613	Inhibition of TGF-beta1 signaling in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX after 16 hrs by luciferase reporter gene assay	B	CN(C)CCOc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL424676	=	IC50	nM	19.0	CHEMBL4439	Homo sapiens	IC50	nM	19.0
	6366292	CHEMBL1831613	Inhibition of TGF-beta1 signaling in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX after 16 hrs by luciferase reporter gene assay	B	O=C(NC1CCOCC1)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202887	=	IC50	nM	446.0	CHEMBL4439	Homo sapiens	IC50	nM	446.0
	6366293	CHEMBL1831613	Inhibition of TGF-beta1 signaling in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX after 16 hrs by luciferase reporter gene assay	B	CN(C)CCCOc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cn1		CHEMBL1829511	=	IC50	nM	11.0	CHEMBL4439	Homo sapiens	IC50	nM	11.0
	6366294	CHEMBL1831613	Inhibition of TGF-beta1 signaling in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX after 16 hrs by luciferase reporter gene assay	B	CN1CCN(c2ccc(-c3cc(-c4c[nH]nc4-c4ccccn4)ccn3)cn2)CC1		CHEMBL1829512	=	IC50	nM	32.0	CHEMBL4439	Homo sapiens	IC50	nM	32.0
	6376830	CHEMBL1837693	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL492634	=	IC50	nM	480.0	CHEMBL4439	Homo sapiens	IC50	nM	480.0
	6376831	CHEMBL1837693	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1.Cl		CHEMBL1824446	=	IC50	nM	594.0	CHEMBL4439	Homo sapiens	IC50	nM	594.0
	6376832	CHEMBL1837693	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3cccc(C(N)=O)c3)cc2-c2ccc3nc(C)nn3c2)n1		CHEMBL1835713	=	IC50	nM	6580.0	CHEMBL4439	Homo sapiens	IC50	nM	6580.0
	6376833	CHEMBL1837693	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3cccc(C#N)c3)cc2-c2ccc3nc(C)nn3c2)n1		CHEMBL1835712	=	IC50	nM	3200.0	CHEMBL4439	Homo sapiens	IC50	nM	3200.0
	6376834	CHEMBL1837693	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3ccccc3)cc2-c2ccc3nc(C)nn3c2)n1		CHEMBL1835711	=	IC50	nM	7260.0	CHEMBL4439	Homo sapiens	IC50	nM	7260.0
	6376835	CHEMBL1837693	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)NC3CCN(Cc4ccccc4)CC3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835710	=	IC50	nM	598.0	CHEMBL4439	Homo sapiens	IC50	nM	598.0
	6376836	CHEMBL1837693	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)NC3CCN(C)CC3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835709	=	IC50	nM	496.0	CHEMBL4439	Homo sapiens	IC50	nM	496.0
	6376837	CHEMBL1837693	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	COc1cc(NC(=S)n2cc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)n2)cc(OC)c1		CHEMBL1835630	=	IC50	nM	2460.0	CHEMBL4439	Homo sapiens	IC50	nM	2460.0
	6376838	CHEMBL1837693	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	COc1ccc(NC(=S)n2cc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)n2)cc1OC		CHEMBL1835629	=	IC50	nM	3840.0	CHEMBL4439	Homo sapiens	IC50	nM	3840.0
	6376839	CHEMBL1837693	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3cc(C(F)(F)F)cc(C(F)(F)F)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835628	=	IC50	nM	5040.0	CHEMBL4439	Homo sapiens	IC50	nM	5040.0
	6376840	CHEMBL1837693	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cc(C)cc(NC(=S)n2cc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)n2)c1		CHEMBL1835627	=	IC50	nM	5390.0	CHEMBL4439	Homo sapiens	IC50	nM	5390.0
	6376841	CHEMBL1837693	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3ccc(C)c(C)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835626	=	IC50	nM	5810.0	CHEMBL4439	Homo sapiens	IC50	nM	5810.0
	6376842	CHEMBL1837693	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3cc(Cl)cc(Cl)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835625	=	IC50	nM	2850.0	CHEMBL4439	Homo sapiens	IC50	nM	2850.0
	6376843	CHEMBL1837693	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3ccc(Cl)c(Cl)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835624	=	IC50	nM	1690.0	CHEMBL4439	Homo sapiens	IC50	nM	1690.0
	6376844	CHEMBL1837693	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3cc(F)cc(F)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835623	=	IC50	nM	3810.0	CHEMBL4439	Homo sapiens	IC50	nM	3810.0
	6376845	CHEMBL1837693	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3ccc(F)c(F)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835622	=	IC50	nM	1450.0	CHEMBL4439	Homo sapiens	IC50	nM	1450.0
	6376846	CHEMBL1837693	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3ccccc3OC(F)(F)F)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835621	=	IC50	nM	3830.0	CHEMBL4439	Homo sapiens	IC50	nM	3830.0
	6376847	CHEMBL1837693	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	COc1ccccc1NC(=S)n1cc(-c2ccc3ncnn3c2)c(-c2cccc(C)n2)n1		CHEMBL1835620	=	IC50	nM	7560.0	CHEMBL4439	Homo sapiens	IC50	nM	7560.0
	6376848	CHEMBL1837693	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3ccccc3C)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835536	=	IC50	nM	3680.0	CHEMBL4439	Homo sapiens	IC50	nM	3680.0
	6376849	CHEMBL1837693	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3ccccc3Cl)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835535	=	IC50	nM	3220.0	CHEMBL4439	Homo sapiens	IC50	nM	3220.0
	6376850	CHEMBL1837693	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3ccccc3F)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835534	=	IC50	nM	3000.0	CHEMBL4439	Homo sapiens	IC50	nM	3000.0
	6376851	CHEMBL1837693	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3ccc(C(N)=O)cc3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835533	=	IC50	nM	4950.0	CHEMBL4439	Homo sapiens	IC50	nM	4950.0
	6376852	CHEMBL1837693	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3ccc(C#N)cc3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835532	=	IC50	nM	5230.0	CHEMBL4439	Homo sapiens	IC50	nM	5230.0
	6376853	CHEMBL1837693	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3ccc(OC(F)(F)F)cc3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835531	=	IC50	nM	5220.0	CHEMBL4439	Homo sapiens	IC50	nM	5220.0
	6376854	CHEMBL1837693	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	COc1ccc(NC(=S)n2cc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)n2)cc1		CHEMBL1835530	=	IC50	nM	6360.0	CHEMBL4439	Homo sapiens	IC50	nM	6360.0
	6376855	CHEMBL1837693	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3ccc(C(F)(F)F)cc3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835529	=	IC50	nM	4120.0	CHEMBL4439	Homo sapiens	IC50	nM	4120.0
	6376856	CHEMBL1837693	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1ccc(NC(=S)n2cc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)n2)cc1		CHEMBL1835528	=	IC50	nM	2960.0	CHEMBL4439	Homo sapiens	IC50	nM	2960.0
	6376857	CHEMBL1837693	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3ccc(Cl)cc3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835527	=	IC50	nM	5530.0	CHEMBL4439	Homo sapiens	IC50	nM	5530.0
	6376858	CHEMBL1837693	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3ccc(F)cc3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835526	=	IC50	nM	6670.0	CHEMBL4439	Homo sapiens	IC50	nM	6670.0
	6376859	CHEMBL1837693	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3cccc(C(N)=O)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835525	=	IC50	nM	4280.0	CHEMBL4439	Homo sapiens	IC50	nM	4280.0
	6376860	CHEMBL1837693	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3cccc(C#N)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835524	=	IC50	nM	6430.0	CHEMBL4439	Homo sapiens	IC50	nM	6430.0
	6376861	CHEMBL1837693	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3cccc(OC(F)(F)F)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835523	>	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	IC50	nM	10000.0
	6376862	CHEMBL1837693	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	COc1cccc(NC(=S)n2cc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)n2)c1		CHEMBL1835522	>	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	IC50	nM	10000.0
	6376863	CHEMBL1837693	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3cccc(C(F)(F)F)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835521	=	IC50	nM	1980.0	CHEMBL4439	Homo sapiens	IC50	nM	1980.0
	6376864	CHEMBL1837693	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(NC(=S)n2cc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)n2)c1		CHEMBL1835520	=	IC50	nM	3680.0	CHEMBL4439	Homo sapiens	IC50	nM	3680.0
	6376865	CHEMBL1837693	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3cccc(Cl)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835519	=	IC50	nM	5440.0	CHEMBL4439	Homo sapiens	IC50	nM	5440.0
	6376866	CHEMBL1837693	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3cccc(F)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835518	=	IC50	nM	5680.0	CHEMBL4439	Homo sapiens	IC50	nM	5680.0
	6376867	CHEMBL1837693	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3ccccc3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835112	=	IC50	nM	2800.0	CHEMBL4439	Homo sapiens	IC50	nM	2800.0
	6376868	CHEMBL1837692	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL492634	=	IC50	nM	17.2	CHEMBL4439	Homo sapiens	IC50	nM	17.2
	6376869	CHEMBL1837692	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1.Cl		CHEMBL1824446	=	IC50	nM	54.4	CHEMBL4439	Homo sapiens	IC50	nM	54.4
	6376870	CHEMBL1837692	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3cccc(C(N)=O)c3)cc2-c2ccc3nc(C)nn3c2)n1		CHEMBL1835713	=	IC50	nM	66.8	CHEMBL4439	Homo sapiens	IC50	nM	66.8
	6376871	CHEMBL1837692	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3cccc(C#N)c3)cc2-c2ccc3nc(C)nn3c2)n1		CHEMBL1835712	=	IC50	nM	85.3	CHEMBL4439	Homo sapiens	IC50	nM	85.3
	6376872	CHEMBL1837692	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3ccccc3)cc2-c2ccc3nc(C)nn3c2)n1		CHEMBL1835711	=	IC50	nM	102.0	CHEMBL4439	Homo sapiens	IC50	nM	102.0
	6376873	CHEMBL1837692	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)NC3CCN(Cc4ccccc4)CC3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835710	=	IC50	nM	95.7	CHEMBL4439	Homo sapiens	IC50	nM	95.7
	6376874	CHEMBL1837692	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)NC3CCN(C)CC3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835709	=	IC50	nM	39.47	CHEMBL4439	Homo sapiens	IC50	nM	39.47
	6376875	CHEMBL1837692	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	COc1cc(NC(=S)n2cc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)n2)cc(OC)c1		CHEMBL1835630	=	IC50	nM	2.49	CHEMBL4439	Homo sapiens	IC50	nM	2.49
	6376876	CHEMBL1837692	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	COc1ccc(NC(=S)n2cc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)n2)cc1OC		CHEMBL1835629	=	IC50	nM	4.37	CHEMBL4439	Homo sapiens	IC50	nM	4.37
	6376877	CHEMBL1837692	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3cc(C(F)(F)F)cc(C(F)(F)F)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835628	=	IC50	nM	4.12	CHEMBL4439	Homo sapiens	IC50	nM	4.12
	6376878	CHEMBL1837692	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cc(C)cc(NC(=S)n2cc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)n2)c1		CHEMBL1835627	=	IC50	nM	3.97	CHEMBL4439	Homo sapiens	IC50	nM	3.97
	6376879	CHEMBL1837692	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3ccc(C)c(C)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835626	=	IC50	nM	3.54	CHEMBL4439	Homo sapiens	IC50	nM	3.54
	6376880	CHEMBL1837692	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3cc(Cl)cc(Cl)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835625	=	IC50	nM	5.08	CHEMBL4439	Homo sapiens	IC50	nM	5.08
	6376881	CHEMBL1837692	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3ccc(Cl)c(Cl)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835624	=	IC50	nM	3.78	CHEMBL4439	Homo sapiens	IC50	nM	3.78
	6376882	CHEMBL1837692	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3cc(F)cc(F)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835623	=	IC50	nM	3.2	CHEMBL4439	Homo sapiens	IC50	nM	3.2
	6376883	CHEMBL1837692	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3ccc(F)c(F)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835622	=	IC50	nM	2.12	CHEMBL4439	Homo sapiens	IC50	nM	2.12
	6376884	CHEMBL1837692	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3ccccc3OC(F)(F)F)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835621	=	IC50	nM	3.98	CHEMBL4439	Homo sapiens	IC50	nM	3.98
	6376885	CHEMBL1837692	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	COc1ccccc1NC(=S)n1cc(-c2ccc3ncnn3c2)c(-c2cccc(C)n2)n1		CHEMBL1835620	=	IC50	nM	5.69	CHEMBL4439	Homo sapiens	IC50	nM	5.69
	6376886	CHEMBL1837692	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3ccccc3C)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835536	=	IC50	nM	4.0	CHEMBL4439	Homo sapiens	IC50	nM	4.0
	6376887	CHEMBL1837692	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3ccccc3Cl)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835535	=	IC50	nM	2.83	CHEMBL4439	Homo sapiens	IC50	nM	2.83
	6376888	CHEMBL1837692	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3ccccc3F)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835534	=	IC50	nM	5.39	CHEMBL4439	Homo sapiens	IC50	nM	5.39
	6376889	CHEMBL1837692	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3ccc(C(N)=O)cc3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835533	=	IC50	nM	15.6	CHEMBL4439	Homo sapiens	IC50	nM	15.6
	6376890	CHEMBL1837692	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3ccc(C#N)cc3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835532	=	IC50	nM	2.95	CHEMBL4439	Homo sapiens	IC50	nM	2.95
	6376891	CHEMBL1837692	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3ccc(OC(F)(F)F)cc3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835531	=	IC50	nM	3.3	CHEMBL4439	Homo sapiens	IC50	nM	3.3
	6376892	CHEMBL1837692	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	COc1ccc(NC(=S)n2cc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)n2)cc1		CHEMBL1835530	=	IC50	nM	0.57	CHEMBL4439	Homo sapiens	IC50	nM	0.57
	6376893	CHEMBL1837692	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3ccc(C(F)(F)F)cc3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835529	=	IC50	nM	3.04	CHEMBL4439	Homo sapiens	IC50	nM	3.04
	6376894	CHEMBL1837692	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1ccc(NC(=S)n2cc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)n2)cc1		CHEMBL1835528	=	IC50	nM	6.61	CHEMBL4439	Homo sapiens	IC50	nM	6.61
	6376895	CHEMBL1837692	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3ccc(Cl)cc3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835527	=	IC50	nM	3.87	CHEMBL4439	Homo sapiens	IC50	nM	3.87
	6376896	CHEMBL1837692	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3ccc(F)cc3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835526	=	IC50	nM	4.09	CHEMBL4439	Homo sapiens	IC50	nM	4.09
	6376897	CHEMBL1837692	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3cccc(C(N)=O)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835525	=	IC50	nM	3.45	CHEMBL4439	Homo sapiens	IC50	nM	3.45
	6376898	CHEMBL1837692	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3cccc(C#N)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835524	=	IC50	nM	4.5	CHEMBL4439	Homo sapiens	IC50	nM	4.5
	6376899	CHEMBL1837692	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3cccc(OC(F)(F)F)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835523	=	IC50	nM	10.0	CHEMBL4439	Homo sapiens	IC50	nM	10.0
	6376900	CHEMBL1837692	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	COc1cccc(NC(=S)n2cc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)n2)c1		CHEMBL1835522	=	IC50	nM	2.26	CHEMBL4439	Homo sapiens	IC50	nM	2.26
	6376901	CHEMBL1837692	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3cccc(C(F)(F)F)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835521	=	IC50	nM	3.01	CHEMBL4439	Homo sapiens	IC50	nM	3.01
	6376902	CHEMBL1837692	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(NC(=S)n2cc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)n2)c1		CHEMBL1835520	=	IC50	nM	3.98	CHEMBL4439	Homo sapiens	IC50	nM	3.98
	6376903	CHEMBL1837692	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3cccc(Cl)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835519	=	IC50	nM	2.37	CHEMBL4439	Homo sapiens	IC50	nM	2.37
	6376904	CHEMBL1837692	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3cccc(F)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835518	=	IC50	nM	4.43	CHEMBL4439	Homo sapiens	IC50	nM	4.43
	6376905	CHEMBL1837692	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(C(=S)Nc3ccccc3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835112	=	IC50	nM	2.82	CHEMBL4439	Homo sapiens	IC50	nM	2.82
	6376910	CHEMBL1837686	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 100 nM pretreated for 2 hrs measured after 18 to 24 hrs by luminometry	B	Cc1cccc(-c2nn(C(=S)Nc3cccc(C(N)=O)c3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1172545	=	Inhibition	%	90.0	CHEMBL4439	Homo sapiens	INH	%	90.0
	6376911	CHEMBL1837687	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 100 nM relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3ccccc3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835112	=	Inhibition	%	10.0	CHEMBL4439	Homo sapiens	INH	%	10.0
	6376912	CHEMBL1837687	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 100 nM relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3cccc(F)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835518	=	Inhibition	%	8.0	CHEMBL4439	Homo sapiens	INH	%	8.0
	6376913	CHEMBL1837687	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 100 nM relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3cccc(Cl)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835519	=	Inhibition	%	8.0	CHEMBL4439	Homo sapiens	INH	%	8.0
	6376914	CHEMBL1837687	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 100 nM relative to control	B	Cc1cccc(NC(=S)n2cc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)n2)c1		CHEMBL1835520	=	Inhibition	%	8.0	CHEMBL4439	Homo sapiens	INH	%	8.0
	6376915	CHEMBL1837687	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 100 nM relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3cccc(C(F)(F)F)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835521	=	Inhibition	%	5.0	CHEMBL4439	Homo sapiens	INH	%	5.0
	6376916	CHEMBL1837687	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 100 nM relative to control	B	COc1cccc(NC(=S)n2cc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)n2)c1		CHEMBL1835522	=	Inhibition	%	8.0	CHEMBL4439	Homo sapiens	INH	%	8.0
	6376917	CHEMBL1837687	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 100 nM relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3cccc(OC(F)(F)F)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835523	=	Inhibition	%	7.0	CHEMBL4439	Homo sapiens	INH	%	7.0
	6376918	CHEMBL1837687	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 100 nM relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3cccc(C#N)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835524	=	Inhibition	%	5.0	CHEMBL4439	Homo sapiens	INH	%	5.0
	6376919	CHEMBL1837687	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 100 nM relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3cccc(C(N)=O)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835525	=	Inhibition	%	8.0	CHEMBL4439	Homo sapiens	INH	%	8.0
	6376920	CHEMBL1837687	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 100 nM relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3ccc(F)cc3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835526	=	Inhibition	%	6.0	CHEMBL4439	Homo sapiens	INH	%	6.0
	6376921	CHEMBL1837687	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 100 nM relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3ccc(Cl)cc3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835527	=	Inhibition	%	7.0	CHEMBL4439	Homo sapiens	INH	%	7.0
	6376922	CHEMBL1837687	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 100 nM relative to control	B	Cc1ccc(NC(=S)n2cc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)n2)cc1		CHEMBL1835528	=	Inhibition	%	6.0	CHEMBL4439	Homo sapiens	INH	%	6.0
	6376923	CHEMBL1837687	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 100 nM relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3ccc(C(F)(F)F)cc3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835529	=	Inhibition	%	6.0	CHEMBL4439	Homo sapiens	INH	%	6.0
	6376924	CHEMBL1837687	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 100 nM relative to control	B	COc1ccc(NC(=S)n2cc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)n2)cc1		CHEMBL1835530	=	Inhibition	%	6.0	CHEMBL4439	Homo sapiens	INH	%	6.0
	6376925	CHEMBL1837687	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 100 nM relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3ccc(OC(F)(F)F)cc3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835531	=	Inhibition	%	7.0	CHEMBL4439	Homo sapiens	INH	%	7.0
	6376926	CHEMBL1837687	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 100 nM relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3ccc(C#N)cc3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835532	=	Inhibition	%	5.0	CHEMBL4439	Homo sapiens	INH	%	5.0
	6376927	CHEMBL1837687	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 100 nM relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3ccc(C(N)=O)cc3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835533	=	Inhibition	%	9.0	CHEMBL4439	Homo sapiens	INH	%	9.0
	6376928	CHEMBL1837687	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 100 nM relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3ccccc3F)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835534	=	Inhibition	%	4.0	CHEMBL4439	Homo sapiens	INH	%	4.0
	6376929	CHEMBL1837687	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 100 nM relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3ccccc3Cl)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835535	=	Inhibition	%	5.0	CHEMBL4439	Homo sapiens	INH	%	5.0
	6376930	CHEMBL1837687	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 100 nM relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3ccccc3C)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835536	=	Inhibition	%	21.0	CHEMBL4439	Homo sapiens	INH	%	21.0
	6376931	CHEMBL1837687	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 100 nM relative to control	B	COc1ccccc1NC(=S)n1cc(-c2ccc3ncnn3c2)c(-c2cccc(C)n2)n1		CHEMBL1835620	=	Inhibition	%	11.0	CHEMBL4439	Homo sapiens	INH	%	11.0
	6376932	CHEMBL1837687	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 100 nM relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3ccccc3OC(F)(F)F)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835621	=	Inhibition	%	5.0	CHEMBL4439	Homo sapiens	INH	%	5.0
	6376933	CHEMBL1837687	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 100 nM relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3ccc(F)c(F)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835622	=	Inhibition	%	7.0	CHEMBL4439	Homo sapiens	INH	%	7.0
	6376934	CHEMBL1837687	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 100 nM relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3cc(F)cc(F)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835623	=	Inhibition	%	6.0	CHEMBL4439	Homo sapiens	INH	%	6.0
	6376935	CHEMBL1837687	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 100 nM relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3ccc(Cl)c(Cl)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835624	=	Inhibition	%	6.0	CHEMBL4439	Homo sapiens	INH	%	6.0
	6376936	CHEMBL1837687	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 100 nM relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3cc(Cl)cc(Cl)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835625	=	Inhibition	%	7.0	CHEMBL4439	Homo sapiens	INH	%	7.0
	6376937	CHEMBL1837687	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 100 nM relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3ccc(C)c(C)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835626	=	Inhibition	%	7.0	CHEMBL4439	Homo sapiens	INH	%	7.0
	6376938	CHEMBL1837687	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 100 nM relative to control	B	Cc1cc(C)cc(NC(=S)n2cc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)n2)c1		CHEMBL1835627	=	Inhibition	%	9.0	CHEMBL4439	Homo sapiens	INH	%	9.0
	6376939	CHEMBL1837687	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 100 nM relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3cc(C(F)(F)F)cc(C(F)(F)F)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835628	=	Inhibition	%	8.0	CHEMBL4439	Homo sapiens	INH	%	8.0
	6376940	CHEMBL1837687	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 100 nM relative to control	B	COc1ccc(NC(=S)n2cc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)n2)cc1OC		CHEMBL1835629	=	Inhibition	%	10.0	CHEMBL4439	Homo sapiens	INH	%	10.0
	6376941	CHEMBL1837687	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 100 nM relative to control	B	COc1cc(NC(=S)n2cc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)n2)cc(OC)c1		CHEMBL1835630	=	Inhibition	%	8.0	CHEMBL4439	Homo sapiens	INH	%	8.0
	6376942	CHEMBL1837687	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 100 nM relative to control	B	Cc1cccc(-c2nn(C(=S)NC3CCN(C)CC3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835709	=	Inhibition	%	81.0	CHEMBL4439	Homo sapiens	INH	%	81.0
	6376943	CHEMBL1837687	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 100 nM relative to control	B	Cc1cccc(-c2nn(C(=S)NC3CCN(Cc4ccccc4)CC3)cc2-c2ccc3ncnn3c2)n1		CHEMBL1835710	=	Inhibition	%	90.0	CHEMBL4439	Homo sapiens	INH	%	90.0
	6376944	CHEMBL1837687	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 100 nM relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3ccccc3)cc2-c2ccc3nc(C)nn3c2)n1		CHEMBL1835711	=	Inhibition	%	64.0	CHEMBL4439	Homo sapiens	INH	%	64.0
	6376945	CHEMBL1837687	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 100 nM relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3cccc(C#N)c3)cc2-c2ccc3nc(C)nn3c2)n1		CHEMBL1835712	=	Inhibition	%	53.0	CHEMBL4439	Homo sapiens	INH	%	53.0
	6376946	CHEMBL1837687	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 100 nM relative to control	B	Cc1cccc(-c2nn(C(=S)Nc3cccc(C(N)=O)c3)cc2-c2ccc3nc(C)nn3c2)n1		CHEMBL1835713	=	Inhibition	%	63.0	CHEMBL4439	Homo sapiens	INH	%	63.0
	6376947	CHEMBL1837687	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 100 nM relative to control	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1.Cl		CHEMBL1824446	=	Inhibition	%	34.0	CHEMBL4439	Homo sapiens	INH	%	34.0
	6376948	CHEMBL1837687	Inhibition of human ALK5 activity in human HaCaT cells assessed as inhibition of TGFbeta-induced p3TP-luciferase reporter activity at 100 nM relative to control	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL492634	=	Inhibition	%	20.0	CHEMBL4439	Homo sapiens	INH	%	20.0
	7567359	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	1700.0	CHEMBL4439	Homo sapiens	Kd	nM	1700.0
	7567818	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7568315	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	1500.0	CHEMBL4439	Homo sapiens	Kd	nM	1500.0
	7568747	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7569332	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7569822	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7570285	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7570712	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7571323	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	1000.0	CHEMBL4439	Homo sapiens	Kd	nM	1000.0
	7571799	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7572262	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7572678	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	190.0	CHEMBL4439	Homo sapiens	Kd	nM	190.0
	7572847	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7573304	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	230.0	CHEMBL4439	Homo sapiens	Kd	nM	230.0
	7573780	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	1100.0	CHEMBL4439	Homo sapiens	Kd	nM	1100.0
	7574249	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7574657	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7574825	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	4200.0	CHEMBL4439	Homo sapiens	Kd	nM	4200.0
	7575286	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7575757	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7576222	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7576630	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7576799	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7577258	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7577736	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7578206	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	100.0	CHEMBL4439	Homo sapiens	Kd	nM	100.0
	7578807	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7579181	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7579631	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7580105	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7580535	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7581165	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7581550	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7581995	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	=	Kd	nM	4900.0	CHEMBL4439	Homo sapiens	Kd	nM	4900.0
	7582488	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7582888	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	8400.0	CHEMBL4439	Homo sapiens	Kd	nM	8400.0
	7583511	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7583908	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7584353	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7584382	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7584844	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	2600.0	CHEMBL4439	Homo sapiens	Kd	nM	2600.0
	7585248	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7585841	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7586249	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7586724	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7587178	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7588232	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7588703	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7589154	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	7100.0	CHEMBL4439	Homo sapiens	Kd	nM	7100.0
	7589325	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7589749	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	120.0	CHEMBL4439	Homo sapiens	Kd	nM	120.0
	7590216	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7590690	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7591141	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7591298	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7591720	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7592192	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7592665	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7593118	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7593265	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7593700	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7594172	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7594645	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7595233	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7595677	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	9600.0	CHEMBL4439	Homo sapiens	Kd	nM	9600.0
	7596151	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7596627	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7597205	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7597658	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7598131	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7598159	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL4439	Homo sapiens	Kd	nM	10000.0
	7598601	CHEMBL1908658	Binding constant for TGFBR1 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	2000.0	CHEMBL4439	Homo sapiens	Kd	nM	2000.0
	8046164	CHEMBL1960378	Inhibition of ALK5	B	COc1ccc(-c2ocnc2C(=O)NCc2ccncc2)cc1		CHEMBL1957085	>	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	IC50	uM	10.0
	8050040	CHEMBL1961066	Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISA	B	NC(=O)c1ccc(-c2nc(-c3nccs3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1957648	=	IC50	nM	1100.0	CHEMBL4439	Homo sapiens	IC50	nM	1100.0
	8050041	CHEMBL1961066	Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISA	B	Cc1csc(-c2nc(-c3ccc(C(N)=O)cc3)[nH]c2-c2ccc3c(c2)OCO3)n1		CHEMBL1957649	=	IC50	nM	54.0	CHEMBL4439	Homo sapiens	IC50	nM	54.0
	8050042	CHEMBL1961066	Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISA	B	CCc1csc(-c2nc(-c3ccc(C(N)=O)cc3)[nH]c2-c2ccc3c(c2)OCO3)n1		CHEMBL1957650	=	IC50	nM	340.0	CHEMBL4439	Homo sapiens	IC50	nM	340.0
	8050043	CHEMBL1961066	Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISA	B	NC(=O)c1ccc(-c2nc(-c3nc(Br)cs3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1957623	=	IC50	nM	270.0	CHEMBL4439	Homo sapiens	IC50	nM	270.0
	8050044	CHEMBL1961066	Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISA	B	Cc1nc(-c2nc(-c3ccc(C(N)=O)cc3)[nH]c2-c2ccc3c(c2)OCO3)cs1		CHEMBL1957651	=	IC50	nM	370.0	CHEMBL4439	Homo sapiens	IC50	nM	370.0
	8050045	CHEMBL1961066	Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISA	B	Cc1csc(-c2nc(CN)[nH]c2-c2ccc3c(c2)OCO3)n1		CHEMBL1957652	=	IC50	nM	790.0	CHEMBL4439	Homo sapiens	IC50	nM	790.0
	8050046	CHEMBL1961066	Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISA	B	Cc1csc(-c2nc(CCN)[nH]c2-c2ccc3c(c2)OCO3)n1		CHEMBL1957653	=	IC50	nM	2200.0	CHEMBL4439	Homo sapiens	IC50	nM	2200.0
	8050047	CHEMBL1961066	Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISA	B	Cc1csc(-c2nc(CCCN)[nH]c2-c2ccc3c(c2)OCO3)n1		CHEMBL1957654	=	IC50	nM	810.0	CHEMBL4439	Homo sapiens	IC50	nM	810.0
	8050048	CHEMBL1961066	Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISA	B	Cc1csc(-c2nc(CNC(=O)c3ccccc3)[nH]c2-c2ccc3c(c2)OCO3)n1		CHEMBL1957655	=	IC50	nM	150.0	CHEMBL4439	Homo sapiens	IC50	nM	150.0
	8050049	CHEMBL1961066	Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISA	B	CCCC(=O)NCc1nc(-c2nc(C)cs2)c(-c2ccc3c(c2)OCO3)[nH]1		CHEMBL1957656	=	IC50	nM	63.0	CHEMBL4439	Homo sapiens	IC50	nM	63.0
	8050050	CHEMBL1961066	Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISA	B	CCCC(=O)NCCc1nc(-c2nc(C)cs2)c(-c2ccc3c(c2)OCO3)[nH]1		CHEMBL1957657	=	IC50	nM	420.0	CHEMBL4439	Homo sapiens	IC50	nM	420.0
	8050051	CHEMBL1961066	Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISA	B	CCCC(=O)NCCCc1nc(-c2nc(C)cs2)c(-c2ccc3c(c2)OCO3)[nH]1		CHEMBL1957658	=	IC50	nM	600.0	CHEMBL4439	Homo sapiens	IC50	nM	600.0
	8050052	CHEMBL1961066	Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISA	B	Cc1csc(-c2nc(C(=O)O)[nH]c2-c2ccc3c(c2)OCO3)n1		CHEMBL1957659	=	IC50	nM	190.0	CHEMBL4439	Homo sapiens	IC50	nM	190.0
	8050053	CHEMBL1961066	Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISA	B	Cc1csc(-c2nc(CCC(=O)O)[nH]c2-c2ccc3c(c2)OCO3)n1		CHEMBL1957660	=	IC50	nM	530.0	CHEMBL4439	Homo sapiens	IC50	nM	530.0
	8050054	CHEMBL1961066	Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISA	B	Cc1csc(-c2nc(CCCC(=O)O)[nH]c2-c2ccc3c(c2)OCO3)n1		CHEMBL1957661	=	IC50	nM	130.0	CHEMBL4439	Homo sapiens	IC50	nM	130.0
	8050055	CHEMBL1961066	Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISA	B	Cc1csc(-c2nc(CCCCC(=O)O)[nH]c2-c2ccc3c(c2)OCO3)n1		CHEMBL1957662	=	IC50	nM	30.0	CHEMBL4439	Homo sapiens	IC50	nM	30.0
	8050056	CHEMBL1961066	Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISA	B	Cc1csc(-c2nc(C(=O)Nc3ccccc3)[nH]c2-c2ccc3c(c2)OCO3)n1		CHEMBL1957663	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	nM	1000.0
	8050057	CHEMBL1961066	Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISA	B	CCCNC(=O)c1nc(-c2nc(C)cs2)c(-c2ccc3c(c2)OCO3)[nH]1		CHEMBL1957664	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	nM	1000.0
	8050058	CHEMBL1961066	Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISA	B	CCCNC(=O)CCc1nc(-c2nc(C)cs2)c(-c2ccc3c(c2)OCO3)[nH]1		CHEMBL1957665	=	IC50	nM	380.0	CHEMBL4439	Homo sapiens	IC50	nM	380.0
	8050059	CHEMBL1961066	Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISA	B	CCCNC(=O)CCCc1nc(-c2nc(C)cs2)c(-c2ccc3c(c2)OCO3)[nH]1		CHEMBL1957666	=	IC50	nM	510.0	CHEMBL4439	Homo sapiens	IC50	nM	510.0
	8050060	CHEMBL1961066	Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISA	B	Cc1csc(-c2nc(CCCCC(=O)Nc3ccccc3)[nH]c2-c2ccc3c(c2)OCO3)n1		CHEMBL1955884	=	IC50	nM	170.0	CHEMBL4439	Homo sapiens	IC50	nM	170.0
	8050061	CHEMBL1961066	Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISA	B	CCCNC(=O)CCCCc1nc(-c2nc(C)cs2)c(-c2ccc3c(c2)OCO3)[nH]1		CHEMBL1957667	=	IC50	nM	130.0	CHEMBL4439	Homo sapiens	IC50	nM	130.0
	8050062	CHEMBL1961066	Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISA	B	Cc1csc(-c2nc(CCCCC(N)=O)[nH]c2-c2ccc3c(c2)OCO3)n1		CHEMBL1957668	=	IC50	nM	110.0	CHEMBL4439	Homo sapiens	IC50	nM	110.0
	8050063	CHEMBL1961066	Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISA	B	CC(=O)Nc1nc(-c2nc(C)cs2)c(-c2ccc3c(c2)OCO3)[nH]1		CHEMBL1957669	=	IC50	nM	1100.0	CHEMBL4439	Homo sapiens	IC50	nM	1100.0
	8050064	CHEMBL1961066	Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISA	B	Cc1csc(-c2nc(N)[nH]c2-c2ccc3c(c2)OCO3)n1		CHEMBL1957670	=	IC50	nM	90.0	CHEMBL4439	Homo sapiens	IC50	nM	90.0
	8050065	CHEMBL1961066	Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISA	B	Cc1csc(-c2nc(NC(=O)c3ccccc3)[nH]c2-c2ccc3c(c2)OCO3)n1		CHEMBL1957671	>	IC50	nM	4000.0	CHEMBL4439	Homo sapiens	IC50	nM	4000.0
	8050066	CHEMBL1961066	Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISA	B	CCCC(=O)Nc1nc(-c2nc(C)cs2)c(-c2ccc3c(c2)OCO3)[nH]1		CHEMBL1957672	>	IC50	nM	4000.0	CHEMBL4439	Homo sapiens	IC50	nM	4000.0
	8050067	CHEMBL1961066	Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISA	B	CCCC(=O)NCc1nc(-c2nc(C)cs2)c(-c2ccc(O)cc2)[nH]1		CHEMBL1957673	=	IC50	nM	130.0	CHEMBL4439	Homo sapiens	IC50	nM	130.0
	8050068	CHEMBL1961066	Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISA	B	CCCC(=O)NCc1nc(-c2nc(C)cs2)c(-c2ccc(F)cc2)[nH]1		CHEMBL1957674	=	IC50	nM	1800.0	CHEMBL4439	Homo sapiens	IC50	nM	1800.0
	8050069	CHEMBL1961066	Inhibition of human recombinant GST-fused ALK5 using TMB substrate after 30 mins by ELISA	B	CCCC(=O)NCc1nc(-c2nc(C)cs2)c(-c2ccc3ncsc3c2)[nH]1		CHEMBL1957675	=	IC50	nM	8.2	CHEMBL4439	Homo sapiens	IC50	nM	8.2
	8050070	CHEMBL1961074	Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence assay	B	NC(=O)c1ccc(-c2nc(-c3nccs3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1957648	=	IC50	nM	2700.0	CHEMBL4439	Homo sapiens	IC50	nM	2700.0
	8050071	CHEMBL1961074	Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence assay	B	Cc1csc(-c2nc(-c3ccc(C(N)=O)cc3)[nH]c2-c2ccc3c(c2)OCO3)n1		CHEMBL1957649	=	IC50	nM	170.0	CHEMBL4439	Homo sapiens	IC50	nM	170.0
	8050975	CHEMBL1961074	Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence assay	B	CCc1csc(-c2nc(-c3ccc(C(N)=O)cc3)[nH]c2-c2ccc3c(c2)OCO3)n1		CHEMBL1957650	=	IC50	nM	760.0	CHEMBL4439	Homo sapiens	IC50	nM	760.0
	8050976	CHEMBL1961074	Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence assay	B	NC(=O)c1ccc(-c2nc(-c3nc(Br)cs3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1957623	=	IC50	nM	390.0	CHEMBL4439	Homo sapiens	IC50	nM	390.0
	8050977	CHEMBL1961074	Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence assay	B	Cc1nc(-c2nc(-c3ccc(C(N)=O)cc3)[nH]c2-c2ccc3c(c2)OCO3)cs1		CHEMBL1957651	=	IC50	nM	680.0	CHEMBL4439	Homo sapiens	IC50	nM	680.0
	8050978	CHEMBL1961074	Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence assay	B	Cc1csc(-c2nc(CN)[nH]c2-c2ccc3c(c2)OCO3)n1		CHEMBL1957652	=	IC50	nM	3600.0	CHEMBL4439	Homo sapiens	IC50	nM	3600.0
	8050979	CHEMBL1961074	Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence assay	B	Cc1csc(-c2nc(CCN)[nH]c2-c2ccc3c(c2)OCO3)n1		CHEMBL1957653	=	IC50	nM	1900.0	CHEMBL4439	Homo sapiens	IC50	nM	1900.0
	8050980	CHEMBL1961074	Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence assay	B	Cc1csc(-c2nc(CCCN)[nH]c2-c2ccc3c(c2)OCO3)n1		CHEMBL1957654	=	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	nM	1000.0
	8050981	CHEMBL1961074	Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence assay	B	Cc1csc(-c2nc(CNC(=O)c3ccccc3)[nH]c2-c2ccc3c(c2)OCO3)n1		CHEMBL1957655	=	IC50	nM	680.0	CHEMBL4439	Homo sapiens	IC50	nM	680.0
	8050982	CHEMBL1961074	Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence assay	B	CCCC(=O)NCc1nc(-c2nc(C)cs2)c(-c2ccc3c(c2)OCO3)[nH]1		CHEMBL1957656	=	IC50	nM	350.0	CHEMBL4439	Homo sapiens	IC50	nM	350.0
	8050983	CHEMBL1961074	Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence assay	B	CCCC(=O)NCCc1nc(-c2nc(C)cs2)c(-c2ccc3c(c2)OCO3)[nH]1		CHEMBL1957657	=	IC50	nM	1600.0	CHEMBL4439	Homo sapiens	IC50	nM	1600.0
	8050984	CHEMBL1961074	Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence assay	B	CCCC(=O)NCCCc1nc(-c2nc(C)cs2)c(-c2ccc3c(c2)OCO3)[nH]1		CHEMBL1957658	=	IC50	nM	1400.0	CHEMBL4439	Homo sapiens	IC50	nM	1400.0
Not Determined	8050985	CHEMBL1961074	Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence assay	B	Cc1csc(-c2nc(C(=O)O)[nH]c2-c2ccc3c(c2)OCO3)n1		CHEMBL1957659		IC50			CHEMBL4439	Homo sapiens	IC50		
Not Determined	8050986	CHEMBL1961074	Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence assay	B	Cc1csc(-c2nc(CCC(=O)O)[nH]c2-c2ccc3c(c2)OCO3)n1		CHEMBL1957660		IC50			CHEMBL4439	Homo sapiens	IC50		
Not Determined	8050987	CHEMBL1961074	Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence assay	B	Cc1csc(-c2nc(CCCC(=O)O)[nH]c2-c2ccc3c(c2)OCO3)n1		CHEMBL1957661		IC50			CHEMBL4439	Homo sapiens	IC50		
Not Determined	8050988	CHEMBL1961074	Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence assay	B	Cc1csc(-c2nc(CCCCC(=O)O)[nH]c2-c2ccc3c(c2)OCO3)n1		CHEMBL1957662		IC50			CHEMBL4439	Homo sapiens	IC50		
	8050989	CHEMBL1961074	Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence assay	B	Cc1csc(-c2nc(C(=O)Nc3ccccc3)[nH]c2-c2ccc3c(c2)OCO3)n1		CHEMBL1957663	=	IC50	nM	1700.0	CHEMBL4439	Homo sapiens	IC50	nM	1700.0
	8050990	CHEMBL1961074	Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence assay	B	CCCNC(=O)c1nc(-c2nc(C)cs2)c(-c2ccc3c(c2)OCO3)[nH]1		CHEMBL1957664	=	IC50	nM	3900.0	CHEMBL4439	Homo sapiens	IC50	nM	3900.0
	8050991	CHEMBL1961074	Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence assay	B	CCCNC(=O)CCc1nc(-c2nc(C)cs2)c(-c2ccc3c(c2)OCO3)[nH]1		CHEMBL1957665	=	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	nM	1000.0
	8050992	CHEMBL1961074	Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence assay	B	CCCNC(=O)CCCc1nc(-c2nc(C)cs2)c(-c2ccc3c(c2)OCO3)[nH]1		CHEMBL1957666	=	IC50	nM	1700.0	CHEMBL4439	Homo sapiens	IC50	nM	1700.0
	8050993	CHEMBL1961074	Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence assay	B	Cc1csc(-c2nc(CCCCC(=O)Nc3ccccc3)[nH]c2-c2ccc3c(c2)OCO3)n1		CHEMBL1955884	=	IC50	nM	830.0	CHEMBL4439	Homo sapiens	IC50	nM	830.0
	8050994	CHEMBL1961074	Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence assay	B	CCCNC(=O)CCCCc1nc(-c2nc(C)cs2)c(-c2ccc3c(c2)OCO3)[nH]1		CHEMBL1957667	=	IC50	nM	750.0	CHEMBL4439	Homo sapiens	IC50	nM	750.0
	8050995	CHEMBL1961074	Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence assay	B	Cc1csc(-c2nc(CCCCC(N)=O)[nH]c2-c2ccc3c(c2)OCO3)n1		CHEMBL1957668	=	IC50	nM	730.0	CHEMBL4439	Homo sapiens	IC50	nM	730.0
	8050996	CHEMBL1961074	Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence assay	B	CC(=O)Nc1nc(-c2nc(C)cs2)c(-c2ccc3c(c2)OCO3)[nH]1		CHEMBL1957669	=	IC50	nM	1900.0	CHEMBL4439	Homo sapiens	IC50	nM	1900.0
	8050997	CHEMBL1961074	Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence assay	B	Cc1csc(-c2nc(N)[nH]c2-c2ccc3c(c2)OCO3)n1		CHEMBL1957670	=	IC50	nM	280.0	CHEMBL4439	Homo sapiens	IC50	nM	280.0
Not Determined	8050998	CHEMBL1961074	Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence assay	B	Cc1csc(-c2nc(NC(=O)c3ccccc3)[nH]c2-c2ccc3c(c2)OCO3)n1		CHEMBL1957671		IC50			CHEMBL4439	Homo sapiens	IC50		
	8050999	CHEMBL1961074	Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence assay	B	CCCC(=O)Nc1nc(-c2nc(C)cs2)c(-c2ccc3c(c2)OCO3)[nH]1		CHEMBL1957672	=	IC50	nM	2100.0	CHEMBL4439	Homo sapiens	IC50	nM	2100.0
	8051000	CHEMBL1961074	Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence assay	B	CCCC(=O)NCc1nc(-c2nc(C)cs2)c(-c2ccc(O)cc2)[nH]1		CHEMBL1957673	=	IC50	nM	1200.0	CHEMBL4439	Homo sapiens	IC50	nM	1200.0
	8051001	CHEMBL1961074	Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence assay	B	CCCC(=O)NCc1nc(-c2nc(C)cs2)c(-c2ccc(F)cc2)[nH]1		CHEMBL1957674	=	IC50	nM	6400.0	CHEMBL4439	Homo sapiens	IC50	nM	6400.0
	8051002	CHEMBL1961074	Inhibition of human recombinant ALK5 activity in human A549 cells assessed as TGFbeta-induced smad2/3 phosphorylation after 2 hrs by fluorescence assay	B	CCCC(=O)NCc1nc(-c2nc(C)cs2)c(-c2ccc3ncsc3c2)[nH]1		CHEMBL1957675	=	IC50	nM	32.0	CHEMBL4439	Homo sapiens	IC50	nM	32.0
	10868647	CHEMBL2026330	Inhibition of ALK5	B	Cc1cccc(-n2nccc2-c2ccc3ncn(C)c(=O)c3c2)n1		CHEMBL2024684	=	IC50	nM	13.0	CHEMBL4439	Homo sapiens	IC50	nM	13.0
	10868648	CHEMBL2026330	Inhibition of ALK5	B	C=Cn1cnc2ccc(-c3ccnn3-c3cccc(C)n3)cc2c1=O		CHEMBL2024685	=	IC50	nM	4.0	CHEMBL4439	Homo sapiens	IC50	nM	4.0
	10868649	CHEMBL2026330	Inhibition of ALK5	B	Cc1cccc(-n2ncc(C)c2-c2ccc3ncn(C)c(=O)c3c2)n1		CHEMBL2024686	=	IC50	nM	4.0	CHEMBL4439	Homo sapiens	IC50	nM	4.0
	10868650	CHEMBL2026330	Inhibition of ALK5	B	Cc1cccc(-n2nc(C)cc2-c2ccc3ncn(C)c(=O)c3c2)n1		CHEMBL2024687	=	IC50	nM	3.0	CHEMBL4439	Homo sapiens	IC50	nM	3.0
	10868651	CHEMBL2026330	Inhibition of ALK5	B	Cc1cccc(-n2ncc(C)c2-c2ccc3nc[nH]c(=O)c3c2)n1		CHEMBL2024688	=	IC50	nM	1.0	CHEMBL4439	Homo sapiens	IC50	nM	1.0
	10868652	CHEMBL2026330	Inhibition of ALK5	B	CCc1cc(-c2ccc3ncn(C)c(=O)c3c2)n(-c2cccc(C)n2)n1		CHEMBL2024689	=	IC50	nM	1.0	CHEMBL4439	Homo sapiens	IC50	nM	1.0
	10868653	CHEMBL2026330	Inhibition of ALK5	B	Cc1cccc(-n2nccc2-c2ccc3nc[nH]c(=O)c3c2)n1		CHEMBL2024690	=	IC50	nM	6.0	CHEMBL4439	Homo sapiens	IC50	nM	6.0
	10868654	CHEMBL2026330	Inhibition of ALK5	B	CCc1cnn(-c2cccc(C)n2)c1-c1ccc2nc[nH]c(=O)c2c1		CHEMBL2024691	=	IC50	nM	2.0	CHEMBL4439	Homo sapiens	IC50	nM	2.0
	10868655	CHEMBL2026330	Inhibition of ALK5	B	CCn1cnc2ccc(-c3ccnn3-c3cccc(C)n3)cc2c1=O		CHEMBL2024692	=	IC50	nM	69.0	CHEMBL4439	Homo sapiens	IC50	nM	69.0
	10868656	CHEMBL2026330	Inhibition of ALK5	B	Cc1cccc(-n2nc3c(c2-c2ccc4nc[nH]c(=O)c4c2)CCC3)n1		CHEMBL2024693	=	IC50	nM	5.0	CHEMBL4439	Homo sapiens	IC50	nM	5.0
Active	10990931	CHEMBL2071856	Binding affinity to human TGFBR1	B	CCNC(=O)Nc1ncc(-c2cc(-c3c(C)cc(OC)cc3C)nc(-c3cnccn3)n2)s1		CHEMBL2070615		Activity			CHEMBL4439	Homo sapiens	Activity		
	11023372	CHEMBL2091130	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL492634	=	IC50	nM	17.2	CHEMBL4439	Homo sapiens	IC50	nM	17.2
	11023373	CHEMBL2091130	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	IC50	nM	54.4	CHEMBL4439	Homo sapiens	IC50	nM	54.4
	11023374	CHEMBL2091130	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2sc(NCc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL2088224	=	IC50	nM	21.2	CHEMBL4439	Homo sapiens	IC50	nM	21.2
	11023375	CHEMBL2091130	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2sc(NCc3cccc(C(N)=O)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL2088223	=	IC50	nM	12.0	CHEMBL4439	Homo sapiens	IC50	nM	12.0
	11023376	CHEMBL2091130	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2sc(NCc3cccc(C#N)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL2088222	=	IC50	nM	25.1	CHEMBL4439	Homo sapiens	IC50	nM	25.1
	11023377	CHEMBL2091130	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2sc(NCc3ccccc3)nc2-c2ccc3ncnn3c2)n1		CHEMBL2088221	=	IC50	nM	24.5	CHEMBL4439	Homo sapiens	IC50	nM	24.5
	11023378	CHEMBL2091130	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nc(NCc3ccc(C(N)=O)cc3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2088220	=	IC50	nM	25.7	CHEMBL4439	Homo sapiens	IC50	nM	25.7
	11023379	CHEMBL2091130	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nc(NCc3cccc(C(N)=O)c3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2088219	=	IC50	nM	13.6	CHEMBL4439	Homo sapiens	IC50	nM	13.6
	11023380	CHEMBL2091130	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	COc1cc(CNc2nc(-c3cccc(C)n3)c(-c3ccc4ncnn4c3)s2)cc(OC)c1		CHEMBL2088218	=	IC50	nM	16.5	CHEMBL4439	Homo sapiens	IC50	nM	16.5
	11023381	CHEMBL2091130	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	COc1ccc(CNc2nc(-c3cccc(C)n3)c(-c3ccc4ncnn4c3)s2)cc1OC		CHEMBL2088217	=	IC50	nM	47.7	CHEMBL4439	Homo sapiens	IC50	nM	47.7
	11023382	CHEMBL2091130	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	COc1cccc(CNc2nc(-c3cccc(C)n3)c(-c3ccc4ncnn4c3)s2)c1OC		CHEMBL2088216	=	IC50	nM	43.5	CHEMBL4439	Homo sapiens	IC50	nM	43.5
	11023383	CHEMBL2091130	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cc(C)cc(CNc2nc(-c3cccc(C)n3)c(-c3ccc4ncnn4c3)s2)c1		CHEMBL2088215	=	IC50	nM	22.0	CHEMBL4439	Homo sapiens	IC50	nM	22.0
	11023384	CHEMBL2091130	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nc(NCc3cccc(C)c3C)sc2-c2ccc3ncnn3c2)n1		CHEMBL2088214	=	IC50	nM	22.1	CHEMBL4439	Homo sapiens	IC50	nM	22.1
	11023385	CHEMBL2091130	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nc(NCc3cc(Cl)cc(Cl)c3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2088213	=	IC50	nM	15.1	CHEMBL4439	Homo sapiens	IC50	nM	15.1
	11023386	CHEMBL2091130	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nc(NCc3ccc(Cl)c(Cl)c3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087986	=	IC50	nM	21.9	CHEMBL4439	Homo sapiens	IC50	nM	21.9
	11023387	CHEMBL2091130	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nc(NCc3cccc(Cl)c3Cl)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087985	=	IC50	nM	34.3	CHEMBL4439	Homo sapiens	IC50	nM	34.3
	11023388	CHEMBL2091130	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nc(NCc3cc(F)cc(F)c3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087984	=	IC50	nM	8.92	CHEMBL4439	Homo sapiens	IC50	nM	8.92
	11023389	CHEMBL2091130	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nc(NCc3ccc(F)c(F)c3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087983	=	IC50	nM	7.43	CHEMBL4439	Homo sapiens	IC50	nM	7.43
	11023390	CHEMBL2091130	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nc(NCc3cccc(F)c3F)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087982	=	IC50	nM	29.4	CHEMBL4439	Homo sapiens	IC50	nM	29.4
	11023391	CHEMBL2091130	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nc(NCc3ccccc3OC(F)(F)F)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087981	=	IC50	nM	35.9	CHEMBL4439	Homo sapiens	IC50	nM	35.9
	11023392	CHEMBL2091130	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nc(NCc3ccccc3C)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087980	=	IC50	nM	16.9	CHEMBL4439	Homo sapiens	IC50	nM	16.9
	11023393	CHEMBL2091130	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nc(NCc3ccccc3Cl)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087979	=	IC50	nM	15.5	CHEMBL4439	Homo sapiens	IC50	nM	15.5
	11023394	CHEMBL2091130	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nc(NCc3ccccc3F)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087978	=	IC50	nM	10.4	CHEMBL4439	Homo sapiens	IC50	nM	10.4
	11023395	CHEMBL2091130	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nc(NCc3ccc(C#N)cc3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087977	=	IC50	nM	30.8	CHEMBL4439	Homo sapiens	IC50	nM	30.8
	11023396	CHEMBL2091130	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nc(NCc3ccc(OC(F)(F)F)cc3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087976	=	IC50	nM	60.9	CHEMBL4439	Homo sapiens	IC50	nM	60.9
	11023397	CHEMBL2091130	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	COc1ccc(CNc2nc(-c3cccc(C)n3)c(-c3ccc4ncnn4c3)s2)cc1		CHEMBL2087975	=	IC50	nM	24.3	CHEMBL4439	Homo sapiens	IC50	nM	24.3
	11023398	CHEMBL2091130	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1ccc(CNc2nc(-c3cccc(C)n3)c(-c3ccc4ncnn4c3)s2)cc1		CHEMBL2087974	=	IC50	nM	8.75	CHEMBL4439	Homo sapiens	IC50	nM	8.75
	11023399	CHEMBL2091130	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nc(NCc3ccc(Cl)cc3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087973	=	IC50	nM	15.8	CHEMBL4439	Homo sapiens	IC50	nM	15.8
	11023400	CHEMBL2091130	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nc(NCc3ccc(F)cc3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087972	=	IC50	nM	8.61	CHEMBL4439	Homo sapiens	IC50	nM	8.61
	11023401	CHEMBL2091130	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nc(NCc3cccc(C#N)c3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087971	=	IC50	nM	9.26	CHEMBL4439	Homo sapiens	IC50	nM	9.26
	11023402	CHEMBL2091130	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nc(NCc3cccc(OC(F)(F)F)c3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087970	=	IC50	nM	19.3	CHEMBL4439	Homo sapiens	IC50	nM	19.3
	11023403	CHEMBL2091130	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	COc1cccc(CNc2nc(-c3cccc(C)n3)c(-c3ccc4ncnn4c3)s2)c1		CHEMBL2087969	=	IC50	nM	11.4	CHEMBL4439	Homo sapiens	IC50	nM	11.4
	11023404	CHEMBL2091130	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(CNc2nc(-c3cccc(C)n3)c(-c3ccc4ncnn4c3)s2)c1		CHEMBL2087968	=	IC50	nM	11.2	CHEMBL4439	Homo sapiens	IC50	nM	11.2
	11023405	CHEMBL2091130	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nc(NCc3cccc(Cl)c3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087967	=	IC50	nM	10.2	CHEMBL4439	Homo sapiens	IC50	nM	10.2
	11023406	CHEMBL2091130	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nc(NCc3cccc(F)c3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087966	=	IC50	nM	7.01	CHEMBL4439	Homo sapiens	IC50	nM	7.01
	11023407	CHEMBL2091130	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 cells using casein as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nc(NCc3ccccc3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087965	=	IC50	nM	11.3	CHEMBL4439	Homo sapiens	IC50	nM	11.3
	11023408	CHEMBL2091175	Inhibition of human ALK5 activity in human HaCaT cells expressing p3TP-luciferase reporter construct assessed as TGFbeta-induced p3TP-luciferase reporter activity at 30 nM relative to control	B	Cc1cccc(-c2nc(NCc3ccccc3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087965	=	Inhibition	%	42.0	CHEMBL4439	Homo sapiens	INH	%	42.0
	11023409	CHEMBL2091175	Inhibition of human ALK5 activity in human HaCaT cells expressing p3TP-luciferase reporter construct assessed as TGFbeta-induced p3TP-luciferase reporter activity at 30 nM relative to control	B	Cc1cccc(-c2nc(NCc3cccc(F)c3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087966	=	Inhibition	%	39.0	CHEMBL4439	Homo sapiens	INH	%	39.0
	11023410	CHEMBL2091175	Inhibition of human ALK5 activity in human HaCaT cells expressing p3TP-luciferase reporter construct assessed as TGFbeta-induced p3TP-luciferase reporter activity at 30 nM relative to control	B	Cc1cccc(-c2nc(NCc3cccc(Cl)c3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087967	=	Inhibition	%	42.0	CHEMBL4439	Homo sapiens	INH	%	42.0
	11023411	CHEMBL2091175	Inhibition of human ALK5 activity in human HaCaT cells expressing p3TP-luciferase reporter construct assessed as TGFbeta-induced p3TP-luciferase reporter activity at 30 nM relative to control	B	Cc1cccc(CNc2nc(-c3cccc(C)n3)c(-c3ccc4ncnn4c3)s2)c1		CHEMBL2087968	=	Inhibition	%	62.0	CHEMBL4439	Homo sapiens	INH	%	62.0
	11023412	CHEMBL2091175	Inhibition of human ALK5 activity in human HaCaT cells expressing p3TP-luciferase reporter construct assessed as TGFbeta-induced p3TP-luciferase reporter activity at 30 nM relative to control	B	COc1cccc(CNc2nc(-c3cccc(C)n3)c(-c3ccc4ncnn4c3)s2)c1		CHEMBL2087969	=	Inhibition	%	44.0	CHEMBL4439	Homo sapiens	INH	%	44.0
	11023413	CHEMBL2091175	Inhibition of human ALK5 activity in human HaCaT cells expressing p3TP-luciferase reporter construct assessed as TGFbeta-induced p3TP-luciferase reporter activity at 30 nM relative to control	B	Cc1cccc(-c2nc(NCc3cccc(OC(F)(F)F)c3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087970	=	Inhibition	%	81.0	CHEMBL4439	Homo sapiens	INH	%	81.0
	11023414	CHEMBL2091175	Inhibition of human ALK5 activity in human HaCaT cells expressing p3TP-luciferase reporter construct assessed as TGFbeta-induced p3TP-luciferase reporter activity at 30 nM relative to control	B	Cc1cccc(-c2nc(NCc3cccc(C#N)c3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087971	=	Inhibition	%	40.0	CHEMBL4439	Homo sapiens	INH	%	40.0
	11023415	CHEMBL2091175	Inhibition of human ALK5 activity in human HaCaT cells expressing p3TP-luciferase reporter construct assessed as TGFbeta-induced p3TP-luciferase reporter activity at 30 nM relative to control	B	Cc1cccc(-c2nc(NCc3ccc(F)cc3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087972	=	Inhibition	%	43.0	CHEMBL4439	Homo sapiens	INH	%	43.0
	11023416	CHEMBL2091175	Inhibition of human ALK5 activity in human HaCaT cells expressing p3TP-luciferase reporter construct assessed as TGFbeta-induced p3TP-luciferase reporter activity at 30 nM relative to control	B	Cc1cccc(-c2nc(NCc3ccc(Cl)cc3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087973	=	Inhibition	%	48.0	CHEMBL4439	Homo sapiens	INH	%	48.0
	11023417	CHEMBL2091175	Inhibition of human ALK5 activity in human HaCaT cells expressing p3TP-luciferase reporter construct assessed as TGFbeta-induced p3TP-luciferase reporter activity at 30 nM relative to control	B	Cc1ccc(CNc2nc(-c3cccc(C)n3)c(-c3ccc4ncnn4c3)s2)cc1		CHEMBL2087974	=	Inhibition	%	58.0	CHEMBL4439	Homo sapiens	INH	%	58.0
	11023418	CHEMBL2091175	Inhibition of human ALK5 activity in human HaCaT cells expressing p3TP-luciferase reporter construct assessed as TGFbeta-induced p3TP-luciferase reporter activity at 30 nM relative to control	B	COc1ccc(CNc2nc(-c3cccc(C)n3)c(-c3ccc4ncnn4c3)s2)cc1		CHEMBL2087975	=	Inhibition	%	56.0	CHEMBL4439	Homo sapiens	INH	%	56.0
	11023419	CHEMBL2091175	Inhibition of human ALK5 activity in human HaCaT cells expressing p3TP-luciferase reporter construct assessed as TGFbeta-induced p3TP-luciferase reporter activity at 30 nM relative to control	B	Cc1cccc(-c2nc(NCc3ccc(OC(F)(F)F)cc3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087976	=	Inhibition	%	90.0	CHEMBL4439	Homo sapiens	INH	%	90.0
	11023420	CHEMBL2091175	Inhibition of human ALK5 activity in human HaCaT cells expressing p3TP-luciferase reporter construct assessed as TGFbeta-induced p3TP-luciferase reporter activity at 30 nM relative to control	B	Cc1cccc(-c2nc(NCc3ccc(C#N)cc3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087977	=	Inhibition	%	59.0	CHEMBL4439	Homo sapiens	INH	%	59.0
	11023421	CHEMBL2091175	Inhibition of human ALK5 activity in human HaCaT cells expressing p3TP-luciferase reporter construct assessed as TGFbeta-induced p3TP-luciferase reporter activity at 30 nM relative to control	B	Cc1cccc(-c2nc(NCc3ccccc3F)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087978	=	Inhibition	%	51.0	CHEMBL4439	Homo sapiens	INH	%	51.0
	11023422	CHEMBL2091175	Inhibition of human ALK5 activity in human HaCaT cells expressing p3TP-luciferase reporter construct assessed as TGFbeta-induced p3TP-luciferase reporter activity at 30 nM relative to control	B	Cc1cccc(-c2nc(NCc3ccccc3Cl)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087979	=	Inhibition	%	49.0	CHEMBL4439	Homo sapiens	INH	%	49.0
	11023423	CHEMBL2091175	Inhibition of human ALK5 activity in human HaCaT cells expressing p3TP-luciferase reporter construct assessed as TGFbeta-induced p3TP-luciferase reporter activity at 30 nM relative to control	B	Cc1cccc(-c2nc(NCc3ccccc3C)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087980	=	Inhibition	%	56.0	CHEMBL4439	Homo sapiens	INH	%	56.0
	11023424	CHEMBL2091175	Inhibition of human ALK5 activity in human HaCaT cells expressing p3TP-luciferase reporter construct assessed as TGFbeta-induced p3TP-luciferase reporter activity at 30 nM relative to control	B	Cc1cccc(-c2nc(NCc3ccccc3OC(F)(F)F)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087981	=	Inhibition	%	80.0	CHEMBL4439	Homo sapiens	INH	%	80.0
	11023425	CHEMBL2091175	Inhibition of human ALK5 activity in human HaCaT cells expressing p3TP-luciferase reporter construct assessed as TGFbeta-induced p3TP-luciferase reporter activity at 30 nM relative to control	B	Cc1cccc(-c2nc(NCc3cccc(F)c3F)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087982	=	Inhibition	%	45.0	CHEMBL4439	Homo sapiens	INH	%	45.0
	11023426	CHEMBL2091175	Inhibition of human ALK5 activity in human HaCaT cells expressing p3TP-luciferase reporter construct assessed as TGFbeta-induced p3TP-luciferase reporter activity at 30 nM relative to control	B	Cc1cccc(-c2nc(NCc3ccc(F)c(F)c3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087983	=	Inhibition	%	49.0	CHEMBL4439	Homo sapiens	INH	%	49.0
	11023427	CHEMBL2091175	Inhibition of human ALK5 activity in human HaCaT cells expressing p3TP-luciferase reporter construct assessed as TGFbeta-induced p3TP-luciferase reporter activity at 30 nM relative to control	B	Cc1cccc(-c2nc(NCc3cc(F)cc(F)c3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087984	=	Inhibition	%	43.0	CHEMBL4439	Homo sapiens	INH	%	43.0
	11023428	CHEMBL2091175	Inhibition of human ALK5 activity in human HaCaT cells expressing p3TP-luciferase reporter construct assessed as TGFbeta-induced p3TP-luciferase reporter activity at 30 nM relative to control	B	Cc1cccc(-c2nc(NCc3cccc(Cl)c3Cl)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087985	=	Inhibition	%	66.0	CHEMBL4439	Homo sapiens	INH	%	66.0
	11023429	CHEMBL2091175	Inhibition of human ALK5 activity in human HaCaT cells expressing p3TP-luciferase reporter construct assessed as TGFbeta-induced p3TP-luciferase reporter activity at 30 nM relative to control	B	Cc1cccc(-c2nc(NCc3ccc(Cl)c(Cl)c3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087986	=	Inhibition	%	75.0	CHEMBL4439	Homo sapiens	INH	%	75.0
	11023430	CHEMBL2091175	Inhibition of human ALK5 activity in human HaCaT cells expressing p3TP-luciferase reporter construct assessed as TGFbeta-induced p3TP-luciferase reporter activity at 30 nM relative to control	B	Cc1cccc(-c2nc(NCc3cc(Cl)cc(Cl)c3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2088213	=	Inhibition	%	65.0	CHEMBL4439	Homo sapiens	INH	%	65.0
	11023431	CHEMBL2091175	Inhibition of human ALK5 activity in human HaCaT cells expressing p3TP-luciferase reporter construct assessed as TGFbeta-induced p3TP-luciferase reporter activity at 30 nM relative to control	B	Cc1cccc(-c2nc(NCc3cccc(C)c3C)sc2-c2ccc3ncnn3c2)n1		CHEMBL2088214	=	Inhibition	%	72.0	CHEMBL4439	Homo sapiens	INH	%	72.0
	11023432	CHEMBL2091175	Inhibition of human ALK5 activity in human HaCaT cells expressing p3TP-luciferase reporter construct assessed as TGFbeta-induced p3TP-luciferase reporter activity at 30 nM relative to control	B	Cc1cc(C)cc(CNc2nc(-c3cccc(C)n3)c(-c3ccc4ncnn4c3)s2)c1		CHEMBL2088215	=	Inhibition	%	69.0	CHEMBL4439	Homo sapiens	INH	%	69.0
	11023433	CHEMBL2091175	Inhibition of human ALK5 activity in human HaCaT cells expressing p3TP-luciferase reporter construct assessed as TGFbeta-induced p3TP-luciferase reporter activity at 30 nM relative to control	B	COc1cccc(CNc2nc(-c3cccc(C)n3)c(-c3ccc4ncnn4c3)s2)c1OC		CHEMBL2088216	=	Inhibition	%	64.0	CHEMBL4439	Homo sapiens	INH	%	64.0
	11023434	CHEMBL2091175	Inhibition of human ALK5 activity in human HaCaT cells expressing p3TP-luciferase reporter construct assessed as TGFbeta-induced p3TP-luciferase reporter activity at 30 nM relative to control	B	COc1ccc(CNc2nc(-c3cccc(C)n3)c(-c3ccc4ncnn4c3)s2)cc1OC		CHEMBL2088217	=	Inhibition	%	75.0	CHEMBL4439	Homo sapiens	INH	%	75.0
	11023435	CHEMBL2091175	Inhibition of human ALK5 activity in human HaCaT cells expressing p3TP-luciferase reporter construct assessed as TGFbeta-induced p3TP-luciferase reporter activity at 30 nM relative to control	B	COc1cc(CNc2nc(-c3cccc(C)n3)c(-c3ccc4ncnn4c3)s2)cc(OC)c1		CHEMBL2088218	=	Inhibition	%	59.0	CHEMBL4439	Homo sapiens	INH	%	59.0
	11023436	CHEMBL2091175	Inhibition of human ALK5 activity in human HaCaT cells expressing p3TP-luciferase reporter construct assessed as TGFbeta-induced p3TP-luciferase reporter activity at 30 nM relative to control	B	Cc1cccc(-c2nc(NCc3cccc(C(N)=O)c3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2088219	=	Inhibition	%	66.0	CHEMBL4439	Homo sapiens	INH	%	66.0
	11023437	CHEMBL2091175	Inhibition of human ALK5 activity in human HaCaT cells expressing p3TP-luciferase reporter construct assessed as TGFbeta-induced p3TP-luciferase reporter activity at 30 nM relative to control	B	Cc1cccc(-c2nc(NCc3ccc(C(N)=O)cc3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2088220	=	Inhibition	%	75.0	CHEMBL4439	Homo sapiens	INH	%	75.0
	11023438	CHEMBL2091175	Inhibition of human ALK5 activity in human HaCaT cells expressing p3TP-luciferase reporter construct assessed as TGFbeta-induced p3TP-luciferase reporter activity at 30 nM relative to control	B	Cc1cccc(-c2sc(NCc3ccccc3)nc2-c2ccc3ncnn3c2)n1		CHEMBL2088221	=	Inhibition	%	84.0	CHEMBL4439	Homo sapiens	INH	%	84.0
	11023439	CHEMBL2091175	Inhibition of human ALK5 activity in human HaCaT cells expressing p3TP-luciferase reporter construct assessed as TGFbeta-induced p3TP-luciferase reporter activity at 30 nM relative to control	B	Cc1cccc(-c2sc(NCc3cccc(C#N)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL2088222	=	Inhibition	%	86.0	CHEMBL4439	Homo sapiens	INH	%	86.0
	11023440	CHEMBL2091175	Inhibition of human ALK5 activity in human HaCaT cells expressing p3TP-luciferase reporter construct assessed as TGFbeta-induced p3TP-luciferase reporter activity at 30 nM relative to control	B	Cc1cccc(-c2sc(NCc3cccc(C(N)=O)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL2088223	=	Inhibition	%	46.0	CHEMBL4439	Homo sapiens	INH	%	46.0
	11023441	CHEMBL2091175	Inhibition of human ALK5 activity in human HaCaT cells expressing p3TP-luciferase reporter construct assessed as TGFbeta-induced p3TP-luciferase reporter activity at 30 nM relative to control	B	Cc1cccc(-c2sc(NCc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL2088224	=	Inhibition	%	82.0	CHEMBL4439	Homo sapiens	INH	%	82.0
	11023442	CHEMBL2091175	Inhibition of human ALK5 activity in human HaCaT cells expressing p3TP-luciferase reporter construct assessed as TGFbeta-induced p3TP-luciferase reporter activity at 30 nM relative to control	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Inhibition	%	56.0	CHEMBL4439	Homo sapiens	INH	%	56.0
	11023443	CHEMBL2091175	Inhibition of human ALK5 activity in human HaCaT cells expressing p3TP-luciferase reporter construct assessed as TGFbeta-induced p3TP-luciferase reporter activity at 30 nM relative to control	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL492634	=	Inhibition	%	49.0	CHEMBL4439	Homo sapiens	INH	%	49.0
	12081730	CHEMBL2166437	Inhibition of TGFB-R1 assessed as residual enzyme activity at 10 uM by radiometric protein kinase assay	B	Cc1c2c(cc[n+]1Cc1ccc(F)cc1)c1ccc(OCc3cccc(F)c3)cc1n2Cc1cccc(F)c1.[Br-]		CHEMBL2164692	=	Activity	%	6.0	CHEMBL4439	Homo sapiens	Activity	%	6.0
	12163057	CHEMBL2182418	Inhibition of TGFBR1 at 2.5 uM	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	Inhibition	%	99.0	CHEMBL4439	Homo sapiens	INH	%	99.0
	12163080	CHEMBL2182428	Inhibition of TGFBR1	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	IC50	nM	40.0	CHEMBL4439	Homo sapiens	IC50	nM	40.0
	12163081	CHEMBL2182428	Inhibition of TGFBR1	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	IC50	nM	66.0	CHEMBL4439	Homo sapiens	IC50	nM	66.0
	12172183	CHEMBL2209261	Inhibition of TGFBR1 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	94.0	CHEMBL4439	Homo sapiens	Activity	%	94.0
	12183800	CHEMBL2214461	Inhibition of TGFBR1	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	pIC50		5.0
	12202371	CHEMBL2211754	Inhibition of ALK5-mediated TNFalpha-induced Smad2/3 phosphorylation in human A549 cells preincubated for 2 hrs before addition of TNFalpha after 1 hr by fluorescence analysis	B	Cc1csc(-c2nc(CNC(=O)OCC(C)(C)C)[nH]c2-c2ccc3ncsc3c2)n1		CHEMBL2208238	=	IC50	nM	79.0	CHEMBL4439	Homo sapiens	IC50	nM	79.0
	12202372	CHEMBL2211754	Inhibition of ALK5-mediated TNFalpha-induced Smad2/3 phosphorylation in human A549 cells preincubated for 2 hrs before addition of TNFalpha after 1 hr by fluorescence analysis	B	Cc1csc(-c2nc(CNC(=O)OCC(C)C)[nH]c2-c2ccc3ncsc3c2)n1		CHEMBL2208237	=	IC50	nM	36.0	CHEMBL4439	Homo sapiens	IC50	nM	36.0
	12202373	CHEMBL2211754	Inhibition of ALK5-mediated TNFalpha-induced Smad2/3 phosphorylation in human A549 cells preincubated for 2 hrs before addition of TNFalpha after 1 hr by fluorescence analysis	B	Cc1csc(-c2nc(CNC(=O)OC(C)C)[nH]c2-c2ccc3ncsc3c2)n1		CHEMBL2208022	=	IC50	nM	41.0	CHEMBL4439	Homo sapiens	IC50	nM	41.0
	12202374	CHEMBL2211754	Inhibition of ALK5-mediated TNFalpha-induced Smad2/3 phosphorylation in human A549 cells preincubated for 2 hrs before addition of TNFalpha after 1 hr by fluorescence analysis	B	CCCCCOC(=O)NCc1nc(-c2nc(C)cs2)c(-c2ccc3ncsc3c2)[nH]1		CHEMBL2208021	=	IC50	nM	140.0	CHEMBL4439	Homo sapiens	IC50	nM	140.0
	12202375	CHEMBL2211754	Inhibition of ALK5-mediated TNFalpha-induced Smad2/3 phosphorylation in human A549 cells preincubated for 2 hrs before addition of TNFalpha after 1 hr by fluorescence analysis	B	CCCCOC(=O)NCc1nc(-c2nc(C)cs2)c(-c2ccc3ncsc3c2)[nH]1		CHEMBL2208020	=	IC50	nM	74.0	CHEMBL4439	Homo sapiens	IC50	nM	74.0
	12202376	CHEMBL2211754	Inhibition of ALK5-mediated TNFalpha-induced Smad2/3 phosphorylation in human A549 cells preincubated for 2 hrs before addition of TNFalpha after 1 hr by fluorescence analysis	B	CCCOC(=O)NCc1nc(-c2nc(C)cs2)c(-c2ccc3ncsc3c2)[nH]1		CHEMBL2208019	=	IC50	nM	36.0	CHEMBL4439	Homo sapiens	IC50	nM	36.0
	12202377	CHEMBL2211754	Inhibition of ALK5-mediated TNFalpha-induced Smad2/3 phosphorylation in human A549 cells preincubated for 2 hrs before addition of TNFalpha after 1 hr by fluorescence analysis	B	COC(=O)NCc1nc(-c2nc(C)cs2)c(-c2ccc3ncsc3c2)[nH]1		CHEMBL2208018	=	IC50	nM	38.0	CHEMBL4439	Homo sapiens	IC50	nM	38.0
	12202378	CHEMBL2211754	Inhibition of ALK5-mediated TNFalpha-induced Smad2/3 phosphorylation in human A549 cells preincubated for 2 hrs before addition of TNFalpha after 1 hr by fluorescence analysis	B	Cc1csc(-c2nc(CN3CCOC3=O)[nH]c2-c2ccc3ncsc3c2)n1		CHEMBL2208017	=	IC50	nM	92.0	CHEMBL4439	Homo sapiens	IC50	nM	92.0
	12202379	CHEMBL2211754	Inhibition of ALK5-mediated TNFalpha-induced Smad2/3 phosphorylation in human A549 cells preincubated for 2 hrs before addition of TNFalpha after 1 hr by fluorescence analysis	B	CCOC(=O)NCc1nc(-c2nc(C)cs2)c(-c2ccc3ncsc3c2)[nH]1		CHEMBL2208016	=	IC50	nM	35.0	CHEMBL4439	Homo sapiens	IC50	nM	35.0
	12202380	CHEMBL2211754	Inhibition of ALK5-mediated TNFalpha-induced Smad2/3 phosphorylation in human A549 cells preincubated for 2 hrs before addition of TNFalpha after 1 hr by fluorescence analysis	B	CCCS(=O)(=O)NCc1nc(-c2nc(C)cs2)c(-c2ccc3ncsc3c2)[nH]1		CHEMBL2208015	=	IC50	nM	150.0	CHEMBL4439	Homo sapiens	IC50	nM	150.0
	12202381	CHEMBL2211754	Inhibition of ALK5-mediated TNFalpha-induced Smad2/3 phosphorylation in human A549 cells preincubated for 2 hrs before addition of TNFalpha after 1 hr by fluorescence analysis	B	CCNC(=O)NCc1nc(-c2nc(C)cs2)c(-c2ccc3ncsc3c2)[nH]1		CHEMBL2208014	=	IC50	nM	130.0	CHEMBL4439	Homo sapiens	IC50	nM	130.0
	12202382	CHEMBL2211754	Inhibition of ALK5-mediated TNFalpha-induced Smad2/3 phosphorylation in human A549 cells preincubated for 2 hrs before addition of TNFalpha after 1 hr by fluorescence analysis	B	CC(=O)NCCCc1nc(-c2nc(C)cs2)c(-c2ccc3ncsc3c2)[nH]1		CHEMBL2208013	=	IC50	nM	150.0	CHEMBL4439	Homo sapiens	IC50	nM	150.0
	12202383	CHEMBL2211754	Inhibition of ALK5-mediated TNFalpha-induced Smad2/3 phosphorylation in human A549 cells preincubated for 2 hrs before addition of TNFalpha after 1 hr by fluorescence analysis	B	CCC(=O)NCCc1nc(-c2nc(C)cs2)c(-c2ccc3ncsc3c2)[nH]1		CHEMBL2208012	=	IC50	nM	130.0	CHEMBL4439	Homo sapiens	IC50	nM	130.0
	12202384	CHEMBL2211754	Inhibition of ALK5-mediated TNFalpha-induced Smad2/3 phosphorylation in human A549 cells preincubated for 2 hrs before addition of TNFalpha after 1 hr by fluorescence analysis	B	CCNC(=O)OCc1nc(-c2nc(C)cs2)c(-c2ccc3ncsc3c2)[nH]1		CHEMBL2208011	=	IC50	nM	93.0	CHEMBL4439	Homo sapiens	IC50	nM	93.0
	12202385	CHEMBL2211754	Inhibition of ALK5-mediated TNFalpha-induced Smad2/3 phosphorylation in human A549 cells preincubated for 2 hrs before addition of TNFalpha after 1 hr by fluorescence analysis	B	Cc1csc(-c2nc(CCCCC(N)=O)[nH]c2-c2ccc3ncsc3c2)n1		CHEMBL2208010	=	IC50	nM	190.0	CHEMBL4439	Homo sapiens	IC50	nM	190.0
	12202386	CHEMBL2211754	Inhibition of ALK5-mediated TNFalpha-induced Smad2/3 phosphorylation in human A549 cells preincubated for 2 hrs before addition of TNFalpha after 1 hr by fluorescence analysis	B	CNC(=O)CCCc1nc(-c2nc(C)cs2)c(-c2ccc3ncsc3c2)[nH]1		CHEMBL2208009	=	IC50	nM	230.0	CHEMBL4439	Homo sapiens	IC50	nM	230.0
	12202387	CHEMBL2211754	Inhibition of ALK5-mediated TNFalpha-induced Smad2/3 phosphorylation in human A549 cells preincubated for 2 hrs before addition of TNFalpha after 1 hr by fluorescence analysis	B	CCNC(=O)CCc1nc(-c2nc(C)cs2)c(-c2ccc3ncsc3c2)[nH]1		CHEMBL2208008	=	IC50	nM	71.0	CHEMBL4439	Homo sapiens	IC50	nM	71.0
	12202388	CHEMBL2211754	Inhibition of ALK5-mediated TNFalpha-induced Smad2/3 phosphorylation in human A549 cells preincubated for 2 hrs before addition of TNFalpha after 1 hr by fluorescence analysis	B	CCCCNC(=O)c1nc(-c2nc(C)cs2)c(-c2ccc3ncsc3c2)[nH]1		CHEMBL2208007	=	IC50	nM	420.0	CHEMBL4439	Homo sapiens	IC50	nM	420.0
	12202389	CHEMBL2211754	Inhibition of ALK5-mediated TNFalpha-induced Smad2/3 phosphorylation in human A549 cells preincubated for 2 hrs before addition of TNFalpha after 1 hr by fluorescence analysis	B	CCCC(=O)CCc1nc(-c2nc(C)cs2)c(-c2ccc3ncsc3c2)[nH]1		CHEMBL2208006	=	IC50	nM	42.0	CHEMBL4439	Homo sapiens	IC50	nM	42.0
	12202390	CHEMBL2211754	Inhibition of ALK5-mediated TNFalpha-induced Smad2/3 phosphorylation in human A549 cells preincubated for 2 hrs before addition of TNFalpha after 1 hr by fluorescence analysis	B	CCCCNCc1nc(-c2nc(C)cs2)c(-c2ccc3ncsc3c2)[nH]1		CHEMBL2208005	=	IC50	nM	72.0	CHEMBL4439	Homo sapiens	IC50	nM	72.0
	12202391	CHEMBL2211754	Inhibition of ALK5-mediated TNFalpha-induced Smad2/3 phosphorylation in human A549 cells preincubated for 2 hrs before addition of TNFalpha after 1 hr by fluorescence analysis	B	CCCC(=O)N(C)Cc1nc(-c2nc(C)cs2)c(-c2ccc3ncsc3c2)[nH]1		CHEMBL2208004	=	IC50	nM	110.0	CHEMBL4439	Homo sapiens	IC50	nM	110.0
	12202392	CHEMBL2211754	Inhibition of ALK5-mediated TNFalpha-induced Smad2/3 phosphorylation in human A549 cells preincubated for 2 hrs before addition of TNFalpha after 1 hr by fluorescence analysis	B	Cc1csc(-c2nc(CN3CCCC3=O)[nH]c2-c2ccc3ncsc3c2)n1		CHEMBL2208003	=	IC50	nM	130.0	CHEMBL4439	Homo sapiens	IC50	nM	130.0
Not Determined	12202393	CHEMBL2211754	Inhibition of ALK5-mediated TNFalpha-induced Smad2/3 phosphorylation in human A549 cells preincubated for 2 hrs before addition of TNFalpha after 1 hr by fluorescence analysis	B	Cc1csc(-c2nc(C3CCNCC3)[nH]c2-c2ccc3ncsc3c2)n1		CHEMBL2208002		IC50			CHEMBL4439	Homo sapiens	IC50		
	12202394	CHEMBL2211754	Inhibition of ALK5-mediated TNFalpha-induced Smad2/3 phosphorylation in human A549 cells preincubated for 2 hrs before addition of TNFalpha after 1 hr by fluorescence analysis	B	Cc1csc(-c2nc(C3CCOCC3)[nH]c2-c2ccc3ncsc3c2)n1		CHEMBL2208001	=	IC50	nM	99.0	CHEMBL4439	Homo sapiens	IC50	nM	99.0
	12202395	CHEMBL2211754	Inhibition of ALK5-mediated TNFalpha-induced Smad2/3 phosphorylation in human A549 cells preincubated for 2 hrs before addition of TNFalpha after 1 hr by fluorescence analysis	B	Cc1csc(-c2nc(C3CCC(=O)CC3)[nH]c2-c2ccc3ncsc3c2)n1		CHEMBL2208000	=	IC50	nM	89.0	CHEMBL4439	Homo sapiens	IC50	nM	89.0
	12202396	CHEMBL2211754	Inhibition of ALK5-mediated TNFalpha-induced Smad2/3 phosphorylation in human A549 cells preincubated for 2 hrs before addition of TNFalpha after 1 hr by fluorescence analysis	B	Cc1csc(-c2nc(C3CCCCC3)[nH]c2-c2ccc3ncsc3c2)n1		CHEMBL2207999	=	IC50	nM	75.0	CHEMBL4439	Homo sapiens	IC50	nM	75.0
	12202397	CHEMBL2211754	Inhibition of ALK5-mediated TNFalpha-induced Smad2/3 phosphorylation in human A549 cells preincubated for 2 hrs before addition of TNFalpha after 1 hr by fluorescence analysis	B	Cc1csc(-c2nc(C3CCCC3)[nH]c2-c2ccc3ncsc3c2)n1		CHEMBL2207998	=	IC50	nM	40.0	CHEMBL4439	Homo sapiens	IC50	nM	40.0
	12202398	CHEMBL2211754	Inhibition of ALK5-mediated TNFalpha-induced Smad2/3 phosphorylation in human A549 cells preincubated for 2 hrs before addition of TNFalpha after 1 hr by fluorescence analysis	B	Cc1csc(-c2nc(C3CC3)[nH]c2-c2ccc3ncsc3c2)n1		CHEMBL2207997	=	IC50	nM	45.0	CHEMBL4439	Homo sapiens	IC50	nM	45.0
	12202399	CHEMBL2211754	Inhibition of ALK5-mediated TNFalpha-induced Smad2/3 phosphorylation in human A549 cells preincubated for 2 hrs before addition of TNFalpha after 1 hr by fluorescence analysis	B	Cc1csc(-c2nc(C(F)(F)F)[nH]c2-c2ccc3ncsc3c2)n1		CHEMBL2207996	=	IC50	nM	49.0	CHEMBL4439	Homo sapiens	IC50	nM	49.0
	12202400	CHEMBL2211754	Inhibition of ALK5-mediated TNFalpha-induced Smad2/3 phosphorylation in human A549 cells preincubated for 2 hrs before addition of TNFalpha after 1 hr by fluorescence analysis	B	CCCCCCc1nc(-c2nc(C)cs2)c(-c2ccc3ncsc3c2)[nH]1		CHEMBL2207995	=	IC50	nM	120.0	CHEMBL4439	Homo sapiens	IC50	nM	120.0
	12202401	CHEMBL2211754	Inhibition of ALK5-mediated TNFalpha-induced Smad2/3 phosphorylation in human A549 cells preincubated for 2 hrs before addition of TNFalpha after 1 hr by fluorescence analysis	B	Cc1csc(-c2nc(C(C)(C)C)[nH]c2-c2ccc3ncsc3c2)n1		CHEMBL2207994	=	IC50	nM	68.0	CHEMBL4439	Homo sapiens	IC50	nM	68.0
	12202402	CHEMBL2211754	Inhibition of ALK5-mediated TNFalpha-induced Smad2/3 phosphorylation in human A549 cells preincubated for 2 hrs before addition of TNFalpha after 1 hr by fluorescence analysis	B	Cc1csc(-c2nc(CC(C)C)[nH]c2-c2ccc3ncsc3c2)n1		CHEMBL2207993	=	IC50	nM	43.0	CHEMBL4439	Homo sapiens	IC50	nM	43.0
	12202403	CHEMBL2211754	Inhibition of ALK5-mediated TNFalpha-induced Smad2/3 phosphorylation in human A549 cells preincubated for 2 hrs before addition of TNFalpha after 1 hr by fluorescence analysis	B	Cc1csc(-c2nc(C(C)C)[nH]c2-c2ccc3ncsc3c2)n1		CHEMBL2207992	=	IC50	nM	48.0	CHEMBL4439	Homo sapiens	IC50	nM	48.0
	12202404	CHEMBL2211754	Inhibition of ALK5-mediated TNFalpha-induced Smad2/3 phosphorylation in human A549 cells preincubated for 2 hrs before addition of TNFalpha after 1 hr by fluorescence analysis	B	CCCc1nc(-c2nc(C)cs2)c(-c2ccc3ncsc3c2)[nH]1		CHEMBL2207991	=	IC50	nM	33.0	CHEMBL4439	Homo sapiens	IC50	nM	33.0
	12202405	CHEMBL2211754	Inhibition of ALK5-mediated TNFalpha-induced Smad2/3 phosphorylation in human A549 cells preincubated for 2 hrs before addition of TNFalpha after 1 hr by fluorescence analysis	B	CCc1nc(-c2nc(C)cs2)c(-c2ccc3ncsc3c2)[nH]1		CHEMBL2207990	=	IC50	nM	35.0	CHEMBL4439	Homo sapiens	IC50	nM	35.0
	12202406	CHEMBL2211754	Inhibition of ALK5-mediated TNFalpha-induced Smad2/3 phosphorylation in human A549 cells preincubated for 2 hrs before addition of TNFalpha after 1 hr by fluorescence analysis	B	Cc1csc(-c2nc(C)[nH]c2-c2ccc3ncsc3c2)n1		CHEMBL2207989	=	IC50	nM	17.0	CHEMBL4439	Homo sapiens	IC50	nM	17.0
	12202407	CHEMBL2211754	Inhibition of ALK5-mediated TNFalpha-induced Smad2/3 phosphorylation in human A549 cells preincubated for 2 hrs before addition of TNFalpha after 1 hr by fluorescence analysis	B	Cc1csc(-c2nc[nH]c2-c2ccc3ncsc3c2)n1		CHEMBL2207988	=	IC50	nM	8.7	CHEMBL4439	Homo sapiens	IC50	nM	8.7
	12202408	CHEMBL2211755	Inhibition of human ALK5 using GST-tagged Smad3 as substrate assessed as substrate phosphorylation after 30 mins by ELISA	B	Cc1csc(-c2nc(CNC(=O)OCC(C)(C)C)[nH]c2-c2ccc3ncsc3c2)n1		CHEMBL2208238	=	IC50	nM	9.3	CHEMBL4439	Homo sapiens	IC50	nM	9.3
	12202409	CHEMBL2211755	Inhibition of human ALK5 using GST-tagged Smad3 as substrate assessed as substrate phosphorylation after 30 mins by ELISA	B	Cc1csc(-c2nc(CNC(=O)OCC(C)C)[nH]c2-c2ccc3ncsc3c2)n1		CHEMBL2208237	=	IC50	nM	5.5	CHEMBL4439	Homo sapiens	IC50	nM	5.5
	12202410	CHEMBL2211755	Inhibition of human ALK5 using GST-tagged Smad3 as substrate assessed as substrate phosphorylation after 30 mins by ELISA	B	Cc1csc(-c2nc(CNC(=O)OC(C)C)[nH]c2-c2ccc3ncsc3c2)n1		CHEMBL2208022	=	IC50	nM	8.6	CHEMBL4439	Homo sapiens	IC50	nM	8.6
	12202411	CHEMBL2211755	Inhibition of human ALK5 using GST-tagged Smad3 as substrate assessed as substrate phosphorylation after 30 mins by ELISA	B	CCCCCOC(=O)NCc1nc(-c2nc(C)cs2)c(-c2ccc3ncsc3c2)[nH]1		CHEMBL2208021	=	IC50	nM	11.0	CHEMBL4439	Homo sapiens	IC50	nM	11.0
	12202412	CHEMBL2211755	Inhibition of human ALK5 using GST-tagged Smad3 as substrate assessed as substrate phosphorylation after 30 mins by ELISA	B	CCCCOC(=O)NCc1nc(-c2nc(C)cs2)c(-c2ccc3ncsc3c2)[nH]1		CHEMBL2208020	=	IC50	nM	9.1	CHEMBL4439	Homo sapiens	IC50	nM	9.1
	12202413	CHEMBL2211755	Inhibition of human ALK5 using GST-tagged Smad3 as substrate assessed as substrate phosphorylation after 30 mins by ELISA	B	CCCOC(=O)NCc1nc(-c2nc(C)cs2)c(-c2ccc3ncsc3c2)[nH]1		CHEMBL2208019	=	IC50	nM	7.3	CHEMBL4439	Homo sapiens	IC50	nM	7.3
	12202414	CHEMBL2211755	Inhibition of human ALK5 using GST-tagged Smad3 as substrate assessed as substrate phosphorylation after 30 mins by ELISA	B	COC(=O)NCc1nc(-c2nc(C)cs2)c(-c2ccc3ncsc3c2)[nH]1		CHEMBL2208018	=	IC50	nM	7.7	CHEMBL4439	Homo sapiens	IC50	nM	7.7
	12202415	CHEMBL2211755	Inhibition of human ALK5 using GST-tagged Smad3 as substrate assessed as substrate phosphorylation after 30 mins by ELISA	B	Cc1csc(-c2nc(CN3CCOC3=O)[nH]c2-c2ccc3ncsc3c2)n1		CHEMBL2208017	=	IC50	nM	8.1	CHEMBL4439	Homo sapiens	IC50	nM	8.1
	12202416	CHEMBL2211755	Inhibition of human ALK5 using GST-tagged Smad3 as substrate assessed as substrate phosphorylation after 30 mins by ELISA	B	CCOC(=O)NCc1nc(-c2nc(C)cs2)c(-c2ccc3ncsc3c2)[nH]1		CHEMBL2208016	=	IC50	nM	4.5	CHEMBL4439	Homo sapiens	IC50	nM	4.5
	12202417	CHEMBL2211755	Inhibition of human ALK5 using GST-tagged Smad3 as substrate assessed as substrate phosphorylation after 30 mins by ELISA	B	CCCS(=O)(=O)NCc1nc(-c2nc(C)cs2)c(-c2ccc3ncsc3c2)[nH]1		CHEMBL2208015	=	IC50	nM	17.0	CHEMBL4439	Homo sapiens	IC50	nM	17.0
	12202418	CHEMBL2211755	Inhibition of human ALK5 using GST-tagged Smad3 as substrate assessed as substrate phosphorylation after 30 mins by ELISA	B	CCNC(=O)NCc1nc(-c2nc(C)cs2)c(-c2ccc3ncsc3c2)[nH]1		CHEMBL2208014	=	IC50	nM	11.0	CHEMBL4439	Homo sapiens	IC50	nM	11.0
	12202419	CHEMBL2211755	Inhibition of human ALK5 using GST-tagged Smad3 as substrate assessed as substrate phosphorylation after 30 mins by ELISA	B	CC(=O)NCCCc1nc(-c2nc(C)cs2)c(-c2ccc3ncsc3c2)[nH]1		CHEMBL2208013	=	IC50	nM	26.0	CHEMBL4439	Homo sapiens	IC50	nM	26.0
	12202420	CHEMBL2211755	Inhibition of human ALK5 using GST-tagged Smad3 as substrate assessed as substrate phosphorylation after 30 mins by ELISA	B	CCC(=O)NCCc1nc(-c2nc(C)cs2)c(-c2ccc3ncsc3c2)[nH]1		CHEMBL2208012	=	IC50	nM	25.0	CHEMBL4439	Homo sapiens	IC50	nM	25.0
	12202421	CHEMBL2211755	Inhibition of human ALK5 using GST-tagged Smad3 as substrate assessed as substrate phosphorylation after 30 mins by ELISA	B	CCNC(=O)OCc1nc(-c2nc(C)cs2)c(-c2ccc3ncsc3c2)[nH]1		CHEMBL2208011	=	IC50	nM	7.2	CHEMBL4439	Homo sapiens	IC50	nM	7.2
	12202422	CHEMBL2211755	Inhibition of human ALK5 using GST-tagged Smad3 as substrate assessed as substrate phosphorylation after 30 mins by ELISA	B	Cc1csc(-c2nc(CCCCC(N)=O)[nH]c2-c2ccc3ncsc3c2)n1		CHEMBL2208010	=	IC50	nM	8.3	CHEMBL4439	Homo sapiens	IC50	nM	8.3
	12202423	CHEMBL2211755	Inhibition of human ALK5 using GST-tagged Smad3 as substrate assessed as substrate phosphorylation after 30 mins by ELISA	B	CNC(=O)CCCc1nc(-c2nc(C)cs2)c(-c2ccc3ncsc3c2)[nH]1		CHEMBL2208009	=	IC50	nM	37.0	CHEMBL4439	Homo sapiens	IC50	nM	37.0
	12202424	CHEMBL2211755	Inhibition of human ALK5 using GST-tagged Smad3 as substrate assessed as substrate phosphorylation after 30 mins by ELISA	B	CCNC(=O)CCc1nc(-c2nc(C)cs2)c(-c2ccc3ncsc3c2)[nH]1		CHEMBL2208008	=	IC50	nM	12.0	CHEMBL4439	Homo sapiens	IC50	nM	12.0
	12202425	CHEMBL2211755	Inhibition of human ALK5 using GST-tagged Smad3 as substrate assessed as substrate phosphorylation after 30 mins by ELISA	B	CCCCNC(=O)c1nc(-c2nc(C)cs2)c(-c2ccc3ncsc3c2)[nH]1		CHEMBL2208007	=	IC50	nM	45.0	CHEMBL4439	Homo sapiens	IC50	nM	45.0
	12202426	CHEMBL2211755	Inhibition of human ALK5 using GST-tagged Smad3 as substrate assessed as substrate phosphorylation after 30 mins by ELISA	B	CCCC(=O)CCc1nc(-c2nc(C)cs2)c(-c2ccc3ncsc3c2)[nH]1		CHEMBL2208006	=	IC50	nM	9.0	CHEMBL4439	Homo sapiens	IC50	nM	9.0
	12202427	CHEMBL2211755	Inhibition of human ALK5 using GST-tagged Smad3 as substrate assessed as substrate phosphorylation after 30 mins by ELISA	B	CCCCNCc1nc(-c2nc(C)cs2)c(-c2ccc3ncsc3c2)[nH]1		CHEMBL2208005	=	IC50	nM	13.0	CHEMBL4439	Homo sapiens	IC50	nM	13.0
	12202428	CHEMBL2211755	Inhibition of human ALK5 using GST-tagged Smad3 as substrate assessed as substrate phosphorylation after 30 mins by ELISA	B	CCCC(=O)N(C)Cc1nc(-c2nc(C)cs2)c(-c2ccc3ncsc3c2)[nH]1		CHEMBL2208004	=	IC50	nM	28.0	CHEMBL4439	Homo sapiens	IC50	nM	28.0
	12202429	CHEMBL2211755	Inhibition of human ALK5 using GST-tagged Smad3 as substrate assessed as substrate phosphorylation after 30 mins by ELISA	B	Cc1csc(-c2nc(CN3CCCC3=O)[nH]c2-c2ccc3ncsc3c2)n1		CHEMBL2208003	=	IC50	nM	26.0	CHEMBL4439	Homo sapiens	IC50	nM	26.0
	12202430	CHEMBL2211755	Inhibition of human ALK5 using GST-tagged Smad3 as substrate assessed as substrate phosphorylation after 30 mins by ELISA	B	Cc1csc(-c2nc(C3CCNCC3)[nH]c2-c2ccc3ncsc3c2)n1		CHEMBL2208002	=	IC50	nM	240.0	CHEMBL4439	Homo sapiens	IC50	nM	240.0
	12202431	CHEMBL2211755	Inhibition of human ALK5 using GST-tagged Smad3 as substrate assessed as substrate phosphorylation after 30 mins by ELISA	B	Cc1csc(-c2nc(C3CCOCC3)[nH]c2-c2ccc3ncsc3c2)n1		CHEMBL2208001	=	IC50	nM	21.0	CHEMBL4439	Homo sapiens	IC50	nM	21.0
	12202432	CHEMBL2211755	Inhibition of human ALK5 using GST-tagged Smad3 as substrate assessed as substrate phosphorylation after 30 mins by ELISA	B	Cc1csc(-c2nc(C3CCC(=O)CC3)[nH]c2-c2ccc3ncsc3c2)n1		CHEMBL2208000	=	IC50	nM	23.0	CHEMBL4439	Homo sapiens	IC50	nM	23.0
	12202433	CHEMBL2211755	Inhibition of human ALK5 using GST-tagged Smad3 as substrate assessed as substrate phosphorylation after 30 mins by ELISA	B	Cc1csc(-c2nc(C3CCCCC3)[nH]c2-c2ccc3ncsc3c2)n1		CHEMBL2207999	=	IC50	nM	12.0	CHEMBL4439	Homo sapiens	IC50	nM	12.0
	12202434	CHEMBL2211755	Inhibition of human ALK5 using GST-tagged Smad3 as substrate assessed as substrate phosphorylation after 30 mins by ELISA	B	Cc1csc(-c2nc(C3CCCC3)[nH]c2-c2ccc3ncsc3c2)n1		CHEMBL2207998	=	IC50	nM	8.7	CHEMBL4439	Homo sapiens	IC50	nM	8.7
	12202435	CHEMBL2211755	Inhibition of human ALK5 using GST-tagged Smad3 as substrate assessed as substrate phosphorylation after 30 mins by ELISA	B	Cc1csc(-c2nc(C3CC3)[nH]c2-c2ccc3ncsc3c2)n1		CHEMBL2207997	=	IC50	nM	8.8	CHEMBL4439	Homo sapiens	IC50	nM	8.8
	12202436	CHEMBL2211755	Inhibition of human ALK5 using GST-tagged Smad3 as substrate assessed as substrate phosphorylation after 30 mins by ELISA	B	Cc1csc(-c2nc(C(F)(F)F)[nH]c2-c2ccc3ncsc3c2)n1		CHEMBL2207996	=	IC50	nM	5.8	CHEMBL4439	Homo sapiens	IC50	nM	5.8
	12202437	CHEMBL2211755	Inhibition of human ALK5 using GST-tagged Smad3 as substrate assessed as substrate phosphorylation after 30 mins by ELISA	B	CCCCCCc1nc(-c2nc(C)cs2)c(-c2ccc3ncsc3c2)[nH]1		CHEMBL2207995	=	IC50	nM	7.0	CHEMBL4439	Homo sapiens	IC50	nM	7.0
	12202438	CHEMBL2211755	Inhibition of human ALK5 using GST-tagged Smad3 as substrate assessed as substrate phosphorylation after 30 mins by ELISA	B	Cc1csc(-c2nc(C(C)(C)C)[nH]c2-c2ccc3ncsc3c2)n1		CHEMBL2207994	=	IC50	nM	14.0	CHEMBL4439	Homo sapiens	IC50	nM	14.0
	12202439	CHEMBL2211755	Inhibition of human ALK5 using GST-tagged Smad3 as substrate assessed as substrate phosphorylation after 30 mins by ELISA	B	Cc1csc(-c2nc(CC(C)C)[nH]c2-c2ccc3ncsc3c2)n1		CHEMBL2207993	=	IC50	nM	9.0	CHEMBL4439	Homo sapiens	IC50	nM	9.0
	12202440	CHEMBL2211755	Inhibition of human ALK5 using GST-tagged Smad3 as substrate assessed as substrate phosphorylation after 30 mins by ELISA	B	Cc1csc(-c2nc(C(C)C)[nH]c2-c2ccc3ncsc3c2)n1		CHEMBL2207992	=	IC50	nM	8.2	CHEMBL4439	Homo sapiens	IC50	nM	8.2
	12202441	CHEMBL2211755	Inhibition of human ALK5 using GST-tagged Smad3 as substrate assessed as substrate phosphorylation after 30 mins by ELISA	B	CCCc1nc(-c2nc(C)cs2)c(-c2ccc3ncsc3c2)[nH]1		CHEMBL2207991	=	IC50	nM	8.1	CHEMBL4439	Homo sapiens	IC50	nM	8.1
	12202442	CHEMBL2211755	Inhibition of human ALK5 using GST-tagged Smad3 as substrate assessed as substrate phosphorylation after 30 mins by ELISA	B	CCc1nc(-c2nc(C)cs2)c(-c2ccc3ncsc3c2)[nH]1		CHEMBL2207990	=	IC50	nM	9.0	CHEMBL4439	Homo sapiens	IC50	nM	9.0
	12202443	CHEMBL2211755	Inhibition of human ALK5 using GST-tagged Smad3 as substrate assessed as substrate phosphorylation after 30 mins by ELISA	B	Cc1csc(-c2nc(C)[nH]c2-c2ccc3ncsc3c2)n1		CHEMBL2207989	=	IC50	nM	5.8	CHEMBL4439	Homo sapiens	IC50	nM	5.8
	12202444	CHEMBL2211755	Inhibition of human ALK5 using GST-tagged Smad3 as substrate assessed as substrate phosphorylation after 30 mins by ELISA	B	Cc1csc(-c2nc[nH]c2-c2ccc3ncsc3c2)n1		CHEMBL2207988	=	IC50	nM	2.7	CHEMBL4439	Homo sapiens	IC50	nM	2.7
	12278485	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	97.0	CHEMBL4439	Homo sapiens	Residual Activity	%	97.0
	12278486	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	96.0	CHEMBL4439	Homo sapiens	Residual Activity	%	96.0
	12278487	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	89.0	CHEMBL4439	Homo sapiens	Residual Activity	%	89.0
	12278488	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	86.0	CHEMBL4439	Homo sapiens	Residual Activity	%	86.0
	12278489	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	87.0	CHEMBL4439	Homo sapiens	Residual Activity	%	87.0
	12278490	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	92.0	CHEMBL4439	Homo sapiens	Residual Activity	%	92.0
	12278491	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	100.0	CHEMBL4439	Homo sapiens	Residual Activity	%	100.0
	12278492	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	100.0	CHEMBL4439	Homo sapiens	Residual Activity	%	100.0
	12278493	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	98.0	CHEMBL4439	Homo sapiens	Residual Activity	%	98.0
	12278494	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	86.0	CHEMBL4439	Homo sapiens	Residual Activity	%	86.0
	12278495	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	74.0	CHEMBL4439	Homo sapiens	Residual Activity	%	74.0
	12278496	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	76.0	CHEMBL4439	Homo sapiens	Residual Activity	%	76.0
	12278497	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	75.0	CHEMBL4439	Homo sapiens	Residual Activity	%	75.0
	12278498	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	78.0	CHEMBL4439	Homo sapiens	Residual Activity	%	78.0
	12278499	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	91.0	CHEMBL4439	Homo sapiens	Residual Activity	%	91.0
	12278500	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	94.0	CHEMBL4439	Homo sapiens	Residual Activity	%	94.0
	12278501	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	80.0	CHEMBL4439	Homo sapiens	Residual Activity	%	80.0
	12278502	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	82.0	CHEMBL4439	Homo sapiens	Residual Activity	%	82.0
	12278503	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	71.0	CHEMBL4439	Homo sapiens	Residual Activity	%	71.0
	12278504	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	75.0	CHEMBL4439	Homo sapiens	Residual Activity	%	75.0
	12278505	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	79.0	CHEMBL4439	Homo sapiens	Residual Activity	%	79.0
	12278506	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	78.0	CHEMBL4439	Homo sapiens	Residual Activity	%	78.0
	12278507	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	90.0	CHEMBL4439	Homo sapiens	Residual Activity	%	90.0
	12278508	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	92.0	CHEMBL4439	Homo sapiens	Residual Activity	%	92.0
	12278509	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	97.0	CHEMBL4439	Homo sapiens	Residual Activity	%	97.0
	12278510	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	89.0	CHEMBL4439	Homo sapiens	Residual Activity	%	89.0
	12278511	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	79.0	CHEMBL4439	Homo sapiens	Residual Activity	%	79.0
	12278512	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	79.0	CHEMBL4439	Homo sapiens	Residual Activity	%	79.0
	12278513	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	80.0	CHEMBL4439	Homo sapiens	Residual Activity	%	80.0
	12278514	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	89.0	CHEMBL4439	Homo sapiens	Residual Activity	%	89.0
	12278515	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	6.0	CHEMBL4439	Homo sapiens	Residual Activity	%	6.0
	12278516	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	93.0	CHEMBL4439	Homo sapiens	Residual Activity	%	93.0
	12278517	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	91.0	CHEMBL4439	Homo sapiens	Residual Activity	%	91.0
	12278518	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	89.0	CHEMBL4439	Homo sapiens	Residual Activity	%	89.0
	12278519	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	79.0	CHEMBL4439	Homo sapiens	Residual Activity	%	79.0
	12278520	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	76.0	CHEMBL4439	Homo sapiens	Residual Activity	%	76.0
	12278521	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	78.0	CHEMBL4439	Homo sapiens	Residual Activity	%	78.0
	12278522	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	82.0	CHEMBL4439	Homo sapiens	Residual Activity	%	82.0
	12278523	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	10.0	CHEMBL4439	Homo sapiens	Residual Activity	%	10.0
	12278524	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	98.0	CHEMBL4439	Homo sapiens	Residual Activity	%	98.0
	12278525	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	84.0	CHEMBL4439	Homo sapiens	Residual Activity	%	84.0
	12278526	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	83.0	CHEMBL4439	Homo sapiens	Residual Activity	%	83.0
	12278527	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	69.0	CHEMBL4439	Homo sapiens	Residual Activity	%	69.0
	12278528	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	58.0	CHEMBL4439	Homo sapiens	Residual Activity	%	58.0
	12278529	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	78.0	CHEMBL4439	Homo sapiens	Residual Activity	%	78.0
	12278530	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	87.0	CHEMBL4439	Homo sapiens	Residual Activity	%	87.0
	12278531	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	90.0	CHEMBL4439	Homo sapiens	Residual Activity	%	90.0
	12278532	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	95.0	CHEMBL4439	Homo sapiens	Residual Activity	%	95.0
	12278533	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	91.0	CHEMBL4439	Homo sapiens	Residual Activity	%	91.0
	12278534	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	82.0	CHEMBL4439	Homo sapiens	Residual Activity	%	82.0
	12278535	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	69.0	CHEMBL4439	Homo sapiens	Residual Activity	%	69.0
	12278536	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	76.0	CHEMBL4439	Homo sapiens	Residual Activity	%	76.0
	12278537	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	68.0	CHEMBL4439	Homo sapiens	Residual Activity	%	68.0
	12278538	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	78.0	CHEMBL4439	Homo sapiens	Residual Activity	%	78.0
	12278539	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	81.0	CHEMBL4439	Homo sapiens	Residual Activity	%	81.0
	12278540	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	84.0	CHEMBL4439	Homo sapiens	Residual Activity	%	84.0
	12278541	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	98.0	CHEMBL4439	Homo sapiens	Residual Activity	%	98.0
	12278542	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	95.0	CHEMBL4439	Homo sapiens	Residual Activity	%	95.0
	12278543	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	82.0	CHEMBL4439	Homo sapiens	Residual Activity	%	82.0
	12278544	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	83.0	CHEMBL4439	Homo sapiens	Residual Activity	%	83.0
	12278545	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	79.0	CHEMBL4439	Homo sapiens	Residual Activity	%	79.0
	12278546	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	85.0	CHEMBL4439	Homo sapiens	Residual Activity	%	85.0
	12278547	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	91.0	CHEMBL4439	Homo sapiens	Residual Activity	%	91.0
	12278548	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	95.0	CHEMBL4439	Homo sapiens	Residual Activity	%	95.0
	12278549	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	106.0	CHEMBL4439	Homo sapiens	Residual Activity	%	106.0
	12278550	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	93.0	CHEMBL4439	Homo sapiens	Residual Activity	%	93.0
	12278551	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	99.0	CHEMBL4439	Homo sapiens	Residual Activity	%	99.0
	12278552	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	91.0	CHEMBL4439	Homo sapiens	Residual Activity	%	91.0
	12278553	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	92.0	CHEMBL4439	Homo sapiens	Residual Activity	%	92.0
	12278554	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	99.0	CHEMBL4439	Homo sapiens	Residual Activity	%	99.0
	12278555	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	100.0	CHEMBL4439	Homo sapiens	Residual Activity	%	100.0
	12278556	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	105.0	CHEMBL4439	Homo sapiens	Residual Activity	%	105.0
	12278557	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	91.0	CHEMBL4439	Homo sapiens	Residual Activity	%	91.0
	12278558	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	102.0	CHEMBL4439	Homo sapiens	Residual Activity	%	102.0
	12278559	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	92.0	CHEMBL4439	Homo sapiens	Residual Activity	%	92.0
	12278560	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	86.0	CHEMBL4439	Homo sapiens	Residual Activity	%	86.0
	12278561	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	95.0	CHEMBL4439	Homo sapiens	Residual Activity	%	95.0
	12278562	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	101.0	CHEMBL4439	Homo sapiens	Residual Activity	%	101.0
	12278563	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	105.0	CHEMBL4439	Homo sapiens	Residual Activity	%	105.0
	12278564	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	79.0	CHEMBL4439	Homo sapiens	Residual Activity	%	79.0
	12278565	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	110.0	CHEMBL4439	Homo sapiens	Residual Activity	%	110.0
	12278566	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	105.0	CHEMBL4439	Homo sapiens	Residual Activity	%	105.0
	12278567	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	100.0	CHEMBL4439	Homo sapiens	Residual Activity	%	100.0
	12278568	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	113.0	CHEMBL4439	Homo sapiens	Residual Activity	%	113.0
	12278569	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	88.0	CHEMBL4439	Homo sapiens	Residual Activity	%	88.0
	12278570	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	108.0	CHEMBL4439	Homo sapiens	Residual Activity	%	108.0
	12278571	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	114.0	CHEMBL4439	Homo sapiens	Residual Activity	%	114.0
	12278572	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	130.0	CHEMBL4439	Homo sapiens	Residual Activity	%	130.0
	12278573	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	114.0	CHEMBL4439	Homo sapiens	Residual Activity	%	114.0
	12278574	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	104.0	CHEMBL4439	Homo sapiens	Residual Activity	%	104.0
	12278575	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	101.0	CHEMBL4439	Homo sapiens	Residual Activity	%	101.0
	12278576	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	88.0	CHEMBL4439	Homo sapiens	Residual Activity	%	88.0
	12278577	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	96.0	CHEMBL4439	Homo sapiens	Residual Activity	%	96.0
	12278578	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	109.0	CHEMBL4439	Homo sapiens	Residual Activity	%	109.0
	12278579	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	91.0	CHEMBL4439	Homo sapiens	Residual Activity	%	91.0
	12278580	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	121.0	CHEMBL4439	Homo sapiens	Residual Activity	%	121.0
	12278581	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	98.0	CHEMBL4439	Homo sapiens	Residual Activity	%	98.0
	12278582	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	98.0	CHEMBL4439	Homo sapiens	Residual Activity	%	98.0
	12278583	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	90.0	CHEMBL4439	Homo sapiens	Residual Activity	%	90.0
	12278584	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	84.0	CHEMBL4439	Homo sapiens	Residual Activity	%	84.0
	12278585	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	91.0	CHEMBL4439	Homo sapiens	Residual Activity	%	91.0
	12278586	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	49.0	CHEMBL4439	Homo sapiens	Residual Activity	%	49.0
	12278587	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	104.0	CHEMBL4439	Homo sapiens	Residual Activity	%	104.0
	12278588	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	114.0	CHEMBL4439	Homo sapiens	Residual Activity	%	114.0
	12278589	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	89.0	CHEMBL4439	Homo sapiens	Residual Activity	%	89.0
	12278590	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	93.0	CHEMBL4439	Homo sapiens	Residual Activity	%	93.0
	12278591	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	74.0	CHEMBL4439	Homo sapiens	Residual Activity	%	74.0
	12278592	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	81.0	CHEMBL4439	Homo sapiens	Residual Activity	%	81.0
	12278593	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	79.0	CHEMBL4439	Homo sapiens	Residual Activity	%	79.0
	12278594	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	85.0	CHEMBL4439	Homo sapiens	Residual Activity	%	85.0
	12278595	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	61.0	CHEMBL4439	Homo sapiens	Residual Activity	%	61.0
	12278596	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	116.0	CHEMBL4439	Homo sapiens	Residual Activity	%	116.0
	12278597	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	73.0	CHEMBL4439	Homo sapiens	Residual Activity	%	73.0
	12278598	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	98.0	CHEMBL4439	Homo sapiens	Residual Activity	%	98.0
	12278599	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	84.0	CHEMBL4439	Homo sapiens	Residual Activity	%	84.0
	12278600	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	77.0	CHEMBL4439	Homo sapiens	Residual Activity	%	77.0
	12278601	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	75.0	CHEMBL4439	Homo sapiens	Residual Activity	%	75.0
	12278602	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	97.0	CHEMBL4439	Homo sapiens	Residual Activity	%	97.0
	12278603	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	81.0	CHEMBL4439	Homo sapiens	Residual Activity	%	81.0
	12278604	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	107.0	CHEMBL4439	Homo sapiens	Residual Activity	%	107.0
	12278605	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	91.0	CHEMBL4439	Homo sapiens	Residual Activity	%	91.0
	12278606	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	101.0	CHEMBL4439	Homo sapiens	Residual Activity	%	101.0
	12278607	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	79.0	CHEMBL4439	Homo sapiens	Residual Activity	%	79.0
	12278608	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	82.0	CHEMBL4439	Homo sapiens	Residual Activity	%	82.0
	12278609	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	77.0	CHEMBL4439	Homo sapiens	Residual Activity	%	77.0
	12278610	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	95.0	CHEMBL4439	Homo sapiens	Residual Activity	%	95.0
	12278611	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	95.0	CHEMBL4439	Homo sapiens	Residual Activity	%	95.0
	12278612	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	123.0	CHEMBL4439	Homo sapiens	Residual Activity	%	123.0
	12278613	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	84.0	CHEMBL4439	Homo sapiens	Residual Activity	%	84.0
	12280197	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	13.0	CHEMBL4439	Homo sapiens	Residual Activity	%	13.0
	12280198	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	88.0	CHEMBL4439	Homo sapiens	Residual Activity	%	88.0
	12280199	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	93.0	CHEMBL4439	Homo sapiens	Residual Activity	%	93.0
	12280200	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	88.0	CHEMBL4439	Homo sapiens	Residual Activity	%	88.0
	12280201	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	100.0	CHEMBL4439	Homo sapiens	Residual Activity	%	100.0
	12280202	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	101.0	CHEMBL4439	Homo sapiens	Residual Activity	%	101.0
	12280203	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	98.0	CHEMBL4439	Homo sapiens	Residual Activity	%	98.0
	12280204	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	91.0	CHEMBL4439	Homo sapiens	Residual Activity	%	91.0
	12280205	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	82.0	CHEMBL4439	Homo sapiens	Residual Activity	%	82.0
	12280206	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	88.0	CHEMBL4439	Homo sapiens	Residual Activity	%	88.0
	12280207	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	85.0	CHEMBL4439	Homo sapiens	Residual Activity	%	85.0
	12280208	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	101.0	CHEMBL4439	Homo sapiens	Residual Activity	%	101.0
	12280209	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	104.0	CHEMBL4439	Homo sapiens	Residual Activity	%	104.0
	12280210	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	111.0	CHEMBL4439	Homo sapiens	Residual Activity	%	111.0
	12280211	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	78.0	CHEMBL4439	Homo sapiens	Residual Activity	%	78.0
	12280212	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	38.0	CHEMBL4439	Homo sapiens	Residual Activity	%	38.0
	12280213	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	94.0	CHEMBL4439	Homo sapiens	Residual Activity	%	94.0
	12280214	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	91.0	CHEMBL4439	Homo sapiens	Residual Activity	%	91.0
	12280215	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	96.0	CHEMBL4439	Homo sapiens	Residual Activity	%	96.0
	12280216	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	107.0	CHEMBL4439	Homo sapiens	Residual Activity	%	107.0
	12280217	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	91.0	CHEMBL4439	Homo sapiens	Residual Activity	%	91.0
	12280218	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	111.0	CHEMBL4439	Homo sapiens	Residual Activity	%	111.0
	12280219	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	101.0	CHEMBL4439	Homo sapiens	Residual Activity	%	101.0
	12280220	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	98.0	CHEMBL4439	Homo sapiens	Residual Activity	%	98.0
	12280221	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	103.0	CHEMBL4439	Homo sapiens	Residual Activity	%	103.0
	12280222	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	102.0	CHEMBL4439	Homo sapiens	Residual Activity	%	102.0
	12280223	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	117.0	CHEMBL4439	Homo sapiens	Residual Activity	%	117.0
	12280224	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	100.0	CHEMBL4439	Homo sapiens	Residual Activity	%	100.0
	12280225	CHEMBL2219207	Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	126.0	CHEMBL4439	Homo sapiens	Residual Activity	%	126.0
	12280226	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	97.0	CHEMBL4439	Homo sapiens	Residual Activity	%	97.0
	12280227	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	81.0	CHEMBL4439	Homo sapiens	Residual Activity	%	81.0
	12280228	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	77.0	CHEMBL4439	Homo sapiens	Residual Activity	%	77.0
	12280229	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	94.0	CHEMBL4439	Homo sapiens	Residual Activity	%	94.0
	12280230	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	94.0	CHEMBL4439	Homo sapiens	Residual Activity	%	94.0
	12280231	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	103.0	CHEMBL4439	Homo sapiens	Residual Activity	%	103.0
	12280232	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	96.0	CHEMBL4439	Homo sapiens	Residual Activity	%	96.0
	12280233	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	103.0	CHEMBL4439	Homo sapiens	Residual Activity	%	103.0
	12280234	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	118.0	CHEMBL4439	Homo sapiens	Residual Activity	%	118.0
	12280235	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	85.0	CHEMBL4439	Homo sapiens	Residual Activity	%	85.0
	12280236	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	89.0	CHEMBL4439	Homo sapiens	Residual Activity	%	89.0
	12280237	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	92.0	CHEMBL4439	Homo sapiens	Residual Activity	%	92.0
	12280238	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	94.0	CHEMBL4439	Homo sapiens	Residual Activity	%	94.0
	12280239	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	57.0	CHEMBL4439	Homo sapiens	Residual Activity	%	57.0
	12280240	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	100.0	CHEMBL4439	Homo sapiens	Residual Activity	%	100.0
	12280241	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	101.0	CHEMBL4439	Homo sapiens	Residual Activity	%	101.0
	12280242	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	102.0	CHEMBL4439	Homo sapiens	Residual Activity	%	102.0
	12280243	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	89.0	CHEMBL4439	Homo sapiens	Residual Activity	%	89.0
	12280244	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	92.0	CHEMBL4439	Homo sapiens	Residual Activity	%	92.0
	12280245	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	77.0	CHEMBL4439	Homo sapiens	Residual Activity	%	77.0
	12280246	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	93.0	CHEMBL4439	Homo sapiens	Residual Activity	%	93.0
	12280247	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	76.0	CHEMBL4439	Homo sapiens	Residual Activity	%	76.0
	12280248	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	101.0	CHEMBL4439	Homo sapiens	Residual Activity	%	101.0
	12280249	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	106.0	CHEMBL4439	Homo sapiens	Residual Activity	%	106.0
	12280250	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	96.0	CHEMBL4439	Homo sapiens	Residual Activity	%	96.0
	12280251	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	81.0	CHEMBL4439	Homo sapiens	Residual Activity	%	81.0
	12280252	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	80.0	CHEMBL4439	Homo sapiens	Residual Activity	%	80.0
	12280253	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	71.0	CHEMBL4439	Homo sapiens	Residual Activity	%	71.0
	12280254	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	76.0	CHEMBL4439	Homo sapiens	Residual Activity	%	76.0
	12280255	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	83.0	CHEMBL4439	Homo sapiens	Residual Activity	%	83.0
	12280256	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	0.0	CHEMBL4439	Homo sapiens	Residual Activity	%	0.0
	12280257	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	74.0	CHEMBL4439	Homo sapiens	Residual Activity	%	74.0
	12280258	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	87.0	CHEMBL4439	Homo sapiens	Residual Activity	%	87.0
	12280259	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	88.0	CHEMBL4439	Homo sapiens	Residual Activity	%	88.0
	12280260	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	77.0	CHEMBL4439	Homo sapiens	Residual Activity	%	77.0
	12280261	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	74.0	CHEMBL4439	Homo sapiens	Residual Activity	%	74.0
	12280262	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	66.0	CHEMBL4439	Homo sapiens	Residual Activity	%	66.0
	12280263	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	78.0	CHEMBL4439	Homo sapiens	Residual Activity	%	78.0
	12280264	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	0.0	CHEMBL4439	Homo sapiens	Residual Activity	%	0.0
	12280265	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	94.0	CHEMBL4439	Homo sapiens	Residual Activity	%	94.0
	12280266	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	105.0	CHEMBL4439	Homo sapiens	Residual Activity	%	105.0
	12280267	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	90.0	CHEMBL4439	Homo sapiens	Residual Activity	%	90.0
	12280268	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	63.0	CHEMBL4439	Homo sapiens	Residual Activity	%	63.0
	12280269	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	19.0	CHEMBL4439	Homo sapiens	Residual Activity	%	19.0
	12280270	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	77.0	CHEMBL4439	Homo sapiens	Residual Activity	%	77.0
	12280271	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	88.0	CHEMBL4439	Homo sapiens	Residual Activity	%	88.0
	12280272	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	89.0	CHEMBL4439	Homo sapiens	Residual Activity	%	89.0
	12280273	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	96.0	CHEMBL4439	Homo sapiens	Residual Activity	%	96.0
	12280274	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	110.0	CHEMBL4439	Homo sapiens	Residual Activity	%	110.0
	12280275	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	91.0	CHEMBL4439	Homo sapiens	Residual Activity	%	91.0
	12280276	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	49.0	CHEMBL4439	Homo sapiens	Residual Activity	%	49.0
	12280277	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	72.0	CHEMBL4439	Homo sapiens	Residual Activity	%	72.0
	12280278	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	38.0	CHEMBL4439	Homo sapiens	Residual Activity	%	38.0
	12280279	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	86.0	CHEMBL4439	Homo sapiens	Residual Activity	%	86.0
	12280280	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	96.0	CHEMBL4439	Homo sapiens	Residual Activity	%	96.0
	12280281	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	105.0	CHEMBL4439	Homo sapiens	Residual Activity	%	105.0
	12280282	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	113.0	CHEMBL4439	Homo sapiens	Residual Activity	%	113.0
	12280283	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	80.0	CHEMBL4439	Homo sapiens	Residual Activity	%	80.0
	12280284	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	88.0	CHEMBL4439	Homo sapiens	Residual Activity	%	88.0
	12280285	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	83.0	CHEMBL4439	Homo sapiens	Residual Activity	%	83.0
	12280286	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	42.0	CHEMBL4439	Homo sapiens	Residual Activity	%	42.0
	12280287	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	81.0	CHEMBL4439	Homo sapiens	Residual Activity	%	81.0
	12280288	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	91.0	CHEMBL4439	Homo sapiens	Residual Activity	%	91.0
	12280289	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	99.0	CHEMBL4439	Homo sapiens	Residual Activity	%	99.0
	12280290	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	92.0	CHEMBL4439	Homo sapiens	Residual Activity	%	92.0
	12280291	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	98.0	CHEMBL4439	Homo sapiens	Residual Activity	%	98.0
	12280292	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	89.0	CHEMBL4439	Homo sapiens	Residual Activity	%	89.0
	12280293	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	85.0	CHEMBL4439	Homo sapiens	Residual Activity	%	85.0
	12280294	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	75.0	CHEMBL4439	Homo sapiens	Residual Activity	%	75.0
	12280295	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	98.0	CHEMBL4439	Homo sapiens	Residual Activity	%	98.0
	12280296	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	91.0	CHEMBL4439	Homo sapiens	Residual Activity	%	91.0
	12280297	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	72.0	CHEMBL4439	Homo sapiens	Residual Activity	%	72.0
	12280298	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	71.0	CHEMBL4439	Homo sapiens	Residual Activity	%	71.0
	12280299	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	100.0	CHEMBL4439	Homo sapiens	Residual Activity	%	100.0
	12280300	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	74.0	CHEMBL4439	Homo sapiens	Residual Activity	%	74.0
	12280301	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	78.0	CHEMBL4439	Homo sapiens	Residual Activity	%	78.0
	12280302	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	89.0	CHEMBL4439	Homo sapiens	Residual Activity	%	89.0
	12280303	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	83.0	CHEMBL4439	Homo sapiens	Residual Activity	%	83.0
	12280304	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	100.0	CHEMBL4439	Homo sapiens	Residual Activity	%	100.0
	12280305	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	30.0	CHEMBL4439	Homo sapiens	Residual Activity	%	30.0
	12280306	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	101.0	CHEMBL4439	Homo sapiens	Residual Activity	%	101.0
	12280307	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	62.0	CHEMBL4439	Homo sapiens	Residual Activity	%	62.0
	12280308	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	98.0	CHEMBL4439	Homo sapiens	Residual Activity	%	98.0
	12280309	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	105.0	CHEMBL4439	Homo sapiens	Residual Activity	%	105.0
	12280310	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	91.0	CHEMBL4439	Homo sapiens	Residual Activity	%	91.0
	12280311	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	112.0	CHEMBL4439	Homo sapiens	Residual Activity	%	112.0
	12280312	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	114.0	CHEMBL4439	Homo sapiens	Residual Activity	%	114.0
	12280313	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	77.0	CHEMBL4439	Homo sapiens	Residual Activity	%	77.0
	12280314	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	88.0	CHEMBL4439	Homo sapiens	Residual Activity	%	88.0
	12280315	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	73.0	CHEMBL4439	Homo sapiens	Residual Activity	%	73.0
	12280316	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	81.0	CHEMBL4439	Homo sapiens	Residual Activity	%	81.0
	12280317	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	83.0	CHEMBL4439	Homo sapiens	Residual Activity	%	83.0
	12280318	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	78.0	CHEMBL4439	Homo sapiens	Residual Activity	%	78.0
	12280319	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	96.0	CHEMBL4439	Homo sapiens	Residual Activity	%	96.0
	12280320	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	30.0	CHEMBL4439	Homo sapiens	Residual Activity	%	30.0
	12280321	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	112.0	CHEMBL4439	Homo sapiens	Residual Activity	%	112.0
	12280322	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	87.0	CHEMBL4439	Homo sapiens	Residual Activity	%	87.0
	12280323	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	81.0	CHEMBL4439	Homo sapiens	Residual Activity	%	81.0
	12280324	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	83.0	CHEMBL4439	Homo sapiens	Residual Activity	%	83.0
	12280325	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	74.0	CHEMBL4439	Homo sapiens	Residual Activity	%	74.0
	12280326	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	84.0	CHEMBL4439	Homo sapiens	Residual Activity	%	84.0
	12280327	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	8.0	CHEMBL4439	Homo sapiens	Residual Activity	%	8.0
	12280328	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	93.0	CHEMBL4439	Homo sapiens	Residual Activity	%	93.0
	12280329	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	107.0	CHEMBL4439	Homo sapiens	Residual Activity	%	107.0
	12280330	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	65.0	CHEMBL4439	Homo sapiens	Residual Activity	%	65.0
	12280331	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	81.0	CHEMBL4439	Homo sapiens	Residual Activity	%	81.0
	12280332	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	87.0	CHEMBL4439	Homo sapiens	Residual Activity	%	87.0
	12280333	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	78.0	CHEMBL4439	Homo sapiens	Residual Activity	%	78.0
	12280334	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	81.0	CHEMBL4439	Homo sapiens	Residual Activity	%	81.0
	12280335	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	64.0	CHEMBL4439	Homo sapiens	Residual Activity	%	64.0
	12280336	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	59.0	CHEMBL4439	Homo sapiens	Residual Activity	%	59.0
	12280337	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	100.0	CHEMBL4439	Homo sapiens	Residual Activity	%	100.0
	12280338	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	28.0	CHEMBL4439	Homo sapiens	Residual Activity	%	28.0
	12280339	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	74.0	CHEMBL4439	Homo sapiens	Residual Activity	%	74.0
	12280340	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	85.0	CHEMBL4439	Homo sapiens	Residual Activity	%	85.0
	12280341	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	72.0	CHEMBL4439	Homo sapiens	Residual Activity	%	72.0
	12280342	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	74.0	CHEMBL4439	Homo sapiens	Residual Activity	%	74.0
	12280343	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	92.0	CHEMBL4439	Homo sapiens	Residual Activity	%	92.0
	12280344	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	40.0	CHEMBL4439	Homo sapiens	Residual Activity	%	40.0
	12280345	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	64.0	CHEMBL4439	Homo sapiens	Residual Activity	%	64.0
	12280346	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	46.0	CHEMBL4439	Homo sapiens	Residual Activity	%	46.0
	12280347	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	79.0	CHEMBL4439	Homo sapiens	Residual Activity	%	79.0
	12280348	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	85.0	CHEMBL4439	Homo sapiens	Residual Activity	%	85.0
	12280349	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	79.0	CHEMBL4439	Homo sapiens	Residual Activity	%	79.0
	12280350	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	64.0	CHEMBL4439	Homo sapiens	Residual Activity	%	64.0
	12280351	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	79.0	CHEMBL4439	Homo sapiens	Residual Activity	%	79.0
	12280352	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	93.0	CHEMBL4439	Homo sapiens	Residual Activity	%	93.0
	12280353	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	100.0	CHEMBL4439	Homo sapiens	Residual Activity	%	100.0
	12280354	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	73.0	CHEMBL4439	Homo sapiens	Residual Activity	%	73.0
	12280355	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	2.0	CHEMBL4439	Homo sapiens	Residual Activity	%	2.0
	12280356	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	74.0	CHEMBL4439	Homo sapiens	Residual Activity	%	74.0
	12280357	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	75.0	CHEMBL4439	Homo sapiens	Residual Activity	%	75.0
	12280358	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	74.0	CHEMBL4439	Homo sapiens	Residual Activity	%	74.0
	12280359	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	90.0	CHEMBL4439	Homo sapiens	Residual Activity	%	90.0
	12280360	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	56.0	CHEMBL4439	Homo sapiens	Residual Activity	%	56.0
	12280361	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	91.0	CHEMBL4439	Homo sapiens	Residual Activity	%	91.0
	12280362	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	82.0	CHEMBL4439	Homo sapiens	Residual Activity	%	82.0
	12280363	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	50.0	CHEMBL4439	Homo sapiens	Residual Activity	%	50.0
	12280364	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	77.0	CHEMBL4439	Homo sapiens	Residual Activity	%	77.0
	12280365	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	76.0	CHEMBL4439	Homo sapiens	Residual Activity	%	76.0
	12280366	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	95.0	CHEMBL4439	Homo sapiens	Residual Activity	%	95.0
	12280367	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	94.0	CHEMBL4439	Homo sapiens	Residual Activity	%	94.0
	12280368	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	102.0	CHEMBL4439	Homo sapiens	Residual Activity	%	102.0
	12280369	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	30.0	CHEMBL4439	Homo sapiens	Residual Activity	%	30.0
	12280370	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	5.0	CHEMBL4439	Homo sapiens	Residual Activity	%	5.0
	12280371	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	86.0	CHEMBL4439	Homo sapiens	Residual Activity	%	86.0
	12280372	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	74.0	CHEMBL4439	Homo sapiens	Residual Activity	%	74.0
	12280373	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	69.0	CHEMBL4439	Homo sapiens	Residual Activity	%	69.0
	12280374	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	74.0	CHEMBL4439	Homo sapiens	Residual Activity	%	74.0
	12280375	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	106.0	CHEMBL4439	Homo sapiens	Residual Activity	%	106.0
	12280376	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	106.0	CHEMBL4439	Homo sapiens	Residual Activity	%	106.0
	12280377	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	97.0	CHEMBL4439	Homo sapiens	Residual Activity	%	97.0
	12280378	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	98.0	CHEMBL4439	Homo sapiens	Residual Activity	%	98.0
	12280379	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	91.0	CHEMBL4439	Homo sapiens	Residual Activity	%	91.0
	12280380	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	97.0	CHEMBL4439	Homo sapiens	Residual Activity	%	97.0
	12280381	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	112.0	CHEMBL4439	Homo sapiens	Residual Activity	%	112.0
	12280382	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	40.0	CHEMBL4439	Homo sapiens	Residual Activity	%	40.0
	12280383	CHEMBL2219208	Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	123.0	CHEMBL4439	Homo sapiens	Residual Activity	%	123.0
	12655812	CHEMBL2328424	Inhibition of human ALK5 in presence of 1 microM ATP	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	6870.0	CHEMBL4439	Homo sapiens	IC50	uM	6.87
	12657173	CHEMBL2328424	Inhibition of human ALK5 in presence of 1 microM ATP	B	Cc1cccc(-n2nnc(Cc3ccccc3)c2-c2ccc3nccnc3c2)n1		CHEMBL2325040	=	IC50	nM	4690.0	CHEMBL4439	Homo sapiens	IC50	uM	4.69
Not Determined	12657174	CHEMBL2328424	Inhibition of human ALK5 in presence of 1 microM ATP	B	Cc1ccc(-c2nnn(-c3cccc(C)n3)c2-c2ccc3nccnc3c2)cc1		CHEMBL2325039		IC50			CHEMBL4439	Homo sapiens	IC50		
Not Determined	12657175	CHEMBL2328424	Inhibition of human ALK5 in presence of 1 microM ATP	B	Cc1cccc(-n2nnc(-c3cc(F)cc(F)c3)c2-c2ccc3nccnc3c2)n1		CHEMBL2324835		IC50			CHEMBL4439	Homo sapiens	IC50		
Not Determined	12657176	CHEMBL2328424	Inhibition of human ALK5 in presence of 1 microM ATP	B	COc1ccc(-c2nnn(-c3cccc(C)n3)c2-c2ccc3nccnc3c2)cc1		CHEMBL2324834		IC50			CHEMBL4439	Homo sapiens	IC50		
	12657177	CHEMBL2328424	Inhibition of human ALK5 in presence of 1 microM ATP	B	COc1ccccc1-c1nnn(-c2cccc(C)n2)c1-c1ccc2nccnc2c1		CHEMBL2324833	=	IC50	nM	34500.0	CHEMBL4439	Homo sapiens	IC50	uM	34.5
Not Determined	12657178	CHEMBL2328424	Inhibition of human ALK5 in presence of 1 microM ATP	B	Cc1cccc(-n2nnc(-c3ccc(F)cc3)c2-c2ccc3nccnc3c2)n1		CHEMBL2324832		IC50			CHEMBL4439	Homo sapiens	IC50		
Not Determined	12657179	CHEMBL2328424	Inhibition of human ALK5 in presence of 1 microM ATP	B	Cc1cccc(-n2nnc(-c3ccccc3)c2-c2ccc3nccnc3c2)n1		CHEMBL2324831		IC50			CHEMBL4439	Homo sapiens	IC50		
Not Determined	12657180	CHEMBL2328424	Inhibition of human ALK5 in presence of 1 microM ATP	B	COc1cc(OC)cc(-c2nnn(-c3cccc(C)n3)c2-c2ccc3nccnc3c2)c1		CHEMBL2324830		IC50			CHEMBL4439	Homo sapiens	IC50		
	12657181	CHEMBL2328424	Inhibition of human ALK5 in presence of 1 microM ATP	B	Cc1cccc(-n2nnc(CCCCO)c2-c2ccc3nccnc3c2)n1		CHEMBL2324829	=	IC50	nM	50800.0	CHEMBL4439	Homo sapiens	IC50	uM	50.8
	12657182	CHEMBL2328424	Inhibition of human ALK5 in presence of 1 microM ATP	B	Cc1cccc(-n2nnc(CCC(C)C)c2-c2ccc3nccnc3c2)n1		CHEMBL2324828	=	IC50	nM	8600.0	CHEMBL4439	Homo sapiens	IC50	uM	8.6
	12657183	CHEMBL2328424	Inhibition of human ALK5 in presence of 1 microM ATP	B	CCCCc1nnn(-c2cccc(C)n2)c1-c1ccc2nccnc2c1		CHEMBL2321907	=	IC50	nM	7380.0	CHEMBL4439	Homo sapiens	IC50	uM	7.38
	12657196	CHEMBL2328426	Inhibition of human ALK5 at 10 uM in presence of 1 microM ATP relative to control	B	Cc1cccc(-n2nnc(Cc3ccccc3)c2-c2ccc3nccnc3c2)n1		CHEMBL2325040	=	Inhibition	%	80.8	CHEMBL4439	Homo sapiens	INH	%	80.8
	12657197	CHEMBL2328426	Inhibition of human ALK5 at 10 uM in presence of 1 microM ATP relative to control	B	Cc1ccc(-c2nnn(-c3cccc(C)n3)c2-c2ccc3nccnc3c2)cc1		CHEMBL2325039	=	Inhibition	%	20.7	CHEMBL4439	Homo sapiens	INH	%	20.7
	12657198	CHEMBL2328426	Inhibition of human ALK5 at 10 uM in presence of 1 microM ATP relative to control	B	Cc1cccc(-n2nnc(-c3cc(F)cc(F)c3)c2-c2ccc3nccnc3c2)n1		CHEMBL2324835	=	Inhibition	%	17.4	CHEMBL4439	Homo sapiens	INH	%	17.4
	12657199	CHEMBL2328426	Inhibition of human ALK5 at 10 uM in presence of 1 microM ATP relative to control	B	COc1ccc(-c2nnn(-c3cccc(C)n3)c2-c2ccc3nccnc3c2)cc1		CHEMBL2324834	=	Inhibition	%	0.26	CHEMBL4439	Homo sapiens	INH	%	0.26
	12657200	CHEMBL2328426	Inhibition of human ALK5 at 10 uM in presence of 1 microM ATP relative to control	B	COc1ccccc1-c1nnn(-c2cccc(C)n2)c1-c1ccc2nccnc2c1		CHEMBL2324833	=	Inhibition	%	34.9	CHEMBL4439	Homo sapiens	INH	%	34.9
	12657201	CHEMBL2328426	Inhibition of human ALK5 at 10 uM in presence of 1 microM ATP relative to control	B	Cc1cccc(-n2nnc(-c3ccc(F)cc3)c2-c2ccc3nccnc3c2)n1		CHEMBL2324832	=	Inhibition	%	8.19	CHEMBL4439	Homo sapiens	INH	%	8.19
	12657202	CHEMBL2328426	Inhibition of human ALK5 at 10 uM in presence of 1 microM ATP relative to control	B	Cc1cccc(-n2nnc(-c3ccccc3)c2-c2ccc3nccnc3c2)n1		CHEMBL2324831	=	Inhibition	%	-4.94	CHEMBL4439	Homo sapiens	INH	%	-4.94
	12657203	CHEMBL2328426	Inhibition of human ALK5 at 10 uM in presence of 1 microM ATP relative to control	B	COc1cc(OC)cc(-c2nnn(-c3cccc(C)n3)c2-c2ccc3nccnc3c2)c1		CHEMBL2324830	=	Inhibition	%	23.4	CHEMBL4439	Homo sapiens	INH	%	23.4
	12657204	CHEMBL2328426	Inhibition of human ALK5 at 10 uM in presence of 1 microM ATP relative to control	B	Cc1cccc(-n2nnc(CCCCO)c2-c2ccc3nccnc3c2)n1		CHEMBL2324829	=	Inhibition	%	20.4	CHEMBL4439	Homo sapiens	INH	%	20.4
	12657205	CHEMBL2328426	Inhibition of human ALK5 at 10 uM in presence of 1 microM ATP relative to control	B	Cc1cccc(-n2nnc(CCC(C)C)c2-c2ccc3nccnc3c2)n1		CHEMBL2324828	=	Inhibition	%	73.1	CHEMBL4439	Homo sapiens	INH	%	73.1
	12657206	CHEMBL2328426	Inhibition of human ALK5 at 10 uM in presence of 1 microM ATP relative to control	B	CCCCc1nnn(-c2cccc(C)n2)c1-c1ccc2nccnc2c1		CHEMBL2321907	=	Inhibition	%	70.0	CHEMBL4439	Homo sapiens	INH	%	70.0
	12691437	CHEMBL2340067	Inhibition of Alk5 in TGF-beta-stimulated human HepG2 cells assessed as decrease in Smad2 phosphorylation treated for 45 mins prior to TGF-beta stimulation measured after 60 mins by odyssey blot scanner analysis	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	=	IC50	nM	3700.0	CHEMBL4439	Homo sapiens	IC50	uM	3.7
	12730936	CHEMBL2350109	Inhibition of ALK5 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	89.0	CHEMBL4439	Homo sapiens	Activity	%	89.0
Not Active	13321763	CHEMBL2390521	Inhibition of ALK5 (unknown origin)	B	COc1ccc(-c2cnc3c(-c4cccc5ncccc45)cnn3c2)cc1		CHEMBL502351		IC50			CHEMBL4439	Homo sapiens	IC50		
Not Active	13321764	CHEMBL2390521	Inhibition of ALK5 (unknown origin)	B	COc1ccc(-c2cnc3c(-c4cn[nH]c4)cnn3c2)cc1		CHEMBL2385600		IC50			CHEMBL4439	Homo sapiens	IC50		
Not Active	13321765	CHEMBL2390521	Inhibition of ALK5 (unknown origin)	B	CC(C)Oc1ccc(-c2cnc3c(-c4ccnc5ccccc45)cnn3c2)cc1		CHEMBL2385597		IC50			CHEMBL4439	Homo sapiens	IC50		
	13321798	CHEMBL2390521	Inhibition of ALK5 (unknown origin)	B	COc1ccc(-c2cnc3c(-c4ccnc5ccccc45)cnn3c2)cc1		CHEMBL511563	=	IC50	nM	33300.0	CHEMBL4439	Homo sapiens	IC50	nM	33300.0
	13321801	CHEMBL2390521	Inhibition of ALK5 (unknown origin)	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	IC50	nM	17090.0	CHEMBL4439	Homo sapiens	IC50	nM	17090.0
	13321802	CHEMBL2390521	Inhibition of ALK5 (unknown origin)	B	c1cc(N2CCOCC2)ccc1-c1cnc2c(-c3cn[nH]c3)cnn2c1		CHEMBL2385579	=	IC50	nM	10900.0	CHEMBL4439	Homo sapiens	IC50	nM	10900.0
	13321813	CHEMBL2390521	Inhibition of ALK5 (unknown origin)	B	c1cc(-c2cnn3cc(-c4ccc(N5CCNCC5)cc4)cnc23)c2cccnc2c1		CHEMBL2385591	=	IC50	nM	3960.0	CHEMBL4439	Homo sapiens	IC50	nM	3960.0
	13321817	CHEMBL2390521	Inhibition of ALK5 (unknown origin)	B	c1cc(N2CCNCC2)ccc1-c1cnc2c(-c3cn[nH]c3)cnn2c1		CHEMBL2385586	=	IC50	nM	3320.0	CHEMBL4439	Homo sapiens	IC50	nM	3320.0
	13321830	CHEMBL2390521	Inhibition of ALK5 (unknown origin)	B	c1ccc2c(-c3cnn4cc(-c5ccc(N6CCNCC6)cc5)cnc34)ccnc2c1		CHEMBL513147	=	IC50	nM	565.0	CHEMBL4439	Homo sapiens	IC50	nM	565.0
	13321845	CHEMBL2390521	Inhibition of ALK5 (unknown origin)	B	c1ccc2c(-c3cnn4cc(-c5ccc(N6CCOCC6)cc5)cnc34)ccnc2c1		CHEMBL2385582	=	IC50	nM	178.0	CHEMBL4439	Homo sapiens	IC50	nM	178.0
	13322754	CHEMBL2390521	Inhibition of ALK5 (unknown origin)	B	CN1CCN(c2ccc(-c3cnc4c(-c5ccnc6ccccc56)cnn4c3)cc2)CC1		CHEMBL2385596	=	IC50	nM	75.0	CHEMBL4439	Homo sapiens	IC50	nM	75.0
	13374322	CHEMBL2405488	Inhibition of TGFBR1 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	9.0	CHEMBL4439	Homo sapiens	INH	%	9.0
	13439742	CHEMBL2428983	Competitive binding affinity to TGFBR1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL4439	Homo sapiens	INH	%	50.0
	13442605	CHEMBL2428983	Competitive binding affinity to TGFBR1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	<	Inhibition	%	50.0	CHEMBL4439	Homo sapiens	INH	%	50.0
	13445575	CHEMBL2428983	Competitive binding affinity to TGFBR1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL4439	Homo sapiens	INH	%	50.0
	13451562	CHEMBL2428983	Competitive binding affinity to TGFBR1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL4439	Homo sapiens	INH	%	50.0
	13483600	CHEMBL2437523	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 3 nM after 2 hrs by luciferase assay	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	Inhibition	%	8.17	CHEMBL4439	Homo sapiens	INH	%	8.17
	13483601	CHEMBL2437524	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 1 nM after 2 hrs by luciferase assay	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	Inhibition	%	8.51	CHEMBL4439	Homo sapiens	INH	%	8.51
	13483602	CHEMBL2437525	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 30 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNC(=O)NC(C)C)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435039	=	Inhibition	%	96.77	CHEMBL4439	Homo sapiens	INH	%	96.77
	13483603	CHEMBL2437525	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 30 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CN3C(=O)c4ccccc4C3=O)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435045	=	Inhibition	%	63.55	CHEMBL4439	Homo sapiens	INH	%	63.55
	13483604	CHEMBL2437525	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 30 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CO)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435044	=	Inhibition	%	88.28	CHEMBL4439	Homo sapiens	INH	%	88.28
	13483605	CHEMBL2437525	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 30 uM after 2 hrs by luciferase assay	B	CCOC(=O)c1cn(-c2ccc3c(c2)OCO3)c(-c2cccc(C)n2)n1		CHEMBL2435043	=	Inhibition	%	97.75	CHEMBL4439	Homo sapiens	INH	%	97.75
	13483606	CHEMBL2437526	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 10 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNc3ccc(C(N)=O)cc3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435036	=	Inhibition	%	103.3	CHEMBL4439	Homo sapiens	INH	%	103.3
	13483607	CHEMBL2437526	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 10 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNc3ccc(C#N)cc3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435035	=	Inhibition	%	106.19	CHEMBL4439	Homo sapiens	INH	%	106.19
	13483608	CHEMBL2437526	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 10 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNc3ccc(S(N)(=O)=O)cc3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435034	=	Inhibition	%	93.78	CHEMBL4439	Homo sapiens	INH	%	93.78
	13483609	CHEMBL2437526	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 10 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNC(=O)Nc3ccccc3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435041	=	Inhibition	%	107.4	CHEMBL4439	Homo sapiens	INH	%	107.4
	13483610	CHEMBL2437526	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 10 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNC(=O)N3CCOCC3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435040	=	Inhibition	%	80.71	CHEMBL4439	Homo sapiens	INH	%	80.71
	13483611	CHEMBL2437526	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 10 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNC(=O)NC(C)C)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435039	=	Inhibition	%	83.23	CHEMBL4439	Homo sapiens	INH	%	83.23
	13483612	CHEMBL2437526	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 10 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(C(N)=O)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435037	=	Inhibition	%	83.69	CHEMBL4439	Homo sapiens	INH	%	83.69
	13483613	CHEMBL2437526	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 10 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CN3C(=O)c4ccccc4C3=O)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435045	=	Inhibition	%	78.58	CHEMBL4439	Homo sapiens	INH	%	78.58
	13483614	CHEMBL2437526	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 10 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CO)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435044	=	Inhibition	%	90.3	CHEMBL4439	Homo sapiens	INH	%	90.3
	13483615	CHEMBL2437526	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 10 uM after 2 hrs by luciferase assay	B	CCOC(=O)c1cn(-c2ccc3c(c2)OCO3)c(-c2cccc(C)n2)n1		CHEMBL2435043	=	Inhibition	%	88.76	CHEMBL4439	Homo sapiens	INH	%	88.76
	13483616	CHEMBL2437527	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 3 uM after 2 hrs by luciferase assay	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	Inhibition	%	96.52	CHEMBL4439	Homo sapiens	INH	%	96.52
	13483617	CHEMBL2437527	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 3 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNc3ccc(C(N)=O)cc3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435036	=	Inhibition	%	74.2	CHEMBL4439	Homo sapiens	INH	%	74.2
	13483618	CHEMBL2437527	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 3 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNc3ccc(C#N)cc3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435035	=	Inhibition	%	92.08	CHEMBL4439	Homo sapiens	INH	%	92.08
	13483619	CHEMBL2437527	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 3 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNc3ccc(S(N)(=O)=O)cc3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435034	=	Inhibition	%	91.4	CHEMBL4439	Homo sapiens	INH	%	91.4
	13483620	CHEMBL2437527	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 3 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNC(=O)Nc3ccccc3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435041	=	Inhibition	%	77.67	CHEMBL4439	Homo sapiens	INH	%	77.67
	13483621	CHEMBL2437527	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 3 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNC(=O)N3CCOCC3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435040	=	Inhibition	%	64.55	CHEMBL4439	Homo sapiens	INH	%	64.55
	13483622	CHEMBL2437527	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 3 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNC(=O)NC(C)C)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435039	=	Inhibition	%	60.4	CHEMBL4439	Homo sapiens	INH	%	60.4
Not Active	13483623	CHEMBL2437527	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 3 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNC(N)=O)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435042		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
	13483624	CHEMBL2437527	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 3 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(C(N)=O)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435037	=	Inhibition	%	36.96	CHEMBL4439	Homo sapiens	INH	%	36.96
Not Active	13483625	CHEMBL2437527	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 3 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CN)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435038		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
	13483626	CHEMBL2437527	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 3 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CN3C(=O)c4ccccc4C3=O)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435045	=	Inhibition	%	60.0	CHEMBL4439	Homo sapiens	INH	%	60.0
	13483627	CHEMBL2437527	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 3 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CO)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435044	=	Inhibition	%	66.04	CHEMBL4439	Homo sapiens	INH	%	66.04
	13483628	CHEMBL2437527	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 3 uM after 2 hrs by luciferase assay	B	CCOC(=O)c1cn(-c2ccc3c(c2)OCO3)c(-c2cccc(C)n2)n1		CHEMBL2435043	=	Inhibition	%	55.62	CHEMBL4439	Homo sapiens	INH	%	55.62
	13483629	CHEMBL2437528	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 0.3 uM after 2 hrs by luciferase assay	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	Inhibition	%	39.82	CHEMBL4439	Homo sapiens	INH	%	39.82
	13483630	CHEMBL2437528	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 0.3 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNc3ccc(C(N)=O)cc3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435036	=	Inhibition	%	31.81	CHEMBL4439	Homo sapiens	INH	%	31.81
	13483631	CHEMBL2437528	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 0.3 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNc3ccc(C#N)cc3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435035	=	Inhibition	%	21.34	CHEMBL4439	Homo sapiens	INH	%	21.34
	13483632	CHEMBL2437528	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 0.3 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNc3ccc(S(N)(=O)=O)cc3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435034	=	Inhibition	%	50.98	CHEMBL4439	Homo sapiens	INH	%	50.98
	13483633	CHEMBL2437528	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 0.3 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNC(=O)Nc3ccccc3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435041	=	Inhibition	%	23.31	CHEMBL4439	Homo sapiens	INH	%	23.31
	13483634	CHEMBL2437528	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 0.3 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNC(=O)N3CCOCC3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435040	=	Inhibition	%	7.27	CHEMBL4439	Homo sapiens	INH	%	7.27
	13483635	CHEMBL2437528	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 0.3 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNC(=O)NC(C)C)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435039	=	Inhibition	%	7.68	CHEMBL4439	Homo sapiens	INH	%	7.68
	13483636	CHEMBL2437528	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 0.3 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(C(N)=O)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435037	=	Inhibition	%	4.86	CHEMBL4439	Homo sapiens	INH	%	4.86
	13483637	CHEMBL2437528	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 0.3 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CN3C(=O)c4ccccc4C3=O)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435045	=	Inhibition	%	2.96	CHEMBL4439	Homo sapiens	INH	%	2.96
	13483638	CHEMBL2437528	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 0.3 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CO)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435044	=	Inhibition	%	28.28	CHEMBL4439	Homo sapiens	INH	%	28.28
	13483639	CHEMBL2437528	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 0.3 uM after 2 hrs by luciferase assay	B	CCOC(=O)c1cn(-c2ccc3c(c2)OCO3)c(-c2cccc(C)n2)n1		CHEMBL2435043	=	Inhibition	%	11.72	CHEMBL4439	Homo sapiens	INH	%	11.72
	13483640	CHEMBL2437529	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 0.1 uM after 2 hrs by luciferase assay	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	Inhibition	%	14.58	CHEMBL4439	Homo sapiens	INH	%	14.58
	13483641	CHEMBL2437529	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 0.1 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNc3ccc(C(N)=O)cc3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435036	=	Inhibition	%	22.09	CHEMBL4439	Homo sapiens	INH	%	22.09
	13483642	CHEMBL2437529	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 0.1 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNc3ccc(C#N)cc3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435035	=	Inhibition	%	14.05	CHEMBL4439	Homo sapiens	INH	%	14.05
	13483643	CHEMBL2437529	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 0.1 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNc3ccc(S(N)(=O)=O)cc3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435034	=	Inhibition	%	31.24	CHEMBL4439	Homo sapiens	INH	%	31.24
	13483644	CHEMBL2437529	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 0.1 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNC(=O)Nc3ccccc3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435041	=	Inhibition	%	3.7	CHEMBL4439	Homo sapiens	INH	%	3.7
	13483645	CHEMBL2437529	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 0.1 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNC(=O)N3CCOCC3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435040	=	Inhibition	%	5.25	CHEMBL4439	Homo sapiens	INH	%	5.25
	13483646	CHEMBL2437529	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 0.1 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNC(=O)NC(C)C)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435039	=	Inhibition	%	2.93	CHEMBL4439	Homo sapiens	INH	%	2.93
Not Active	13483647	CHEMBL2437529	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 0.1 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNC(N)=O)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435042		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
	13483648	CHEMBL2437529	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 0.1 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(C(N)=O)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435037	=	Inhibition	%	6.65	CHEMBL4439	Homo sapiens	INH	%	6.65
Not Active	13483649	CHEMBL2437529	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 0.1 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CN)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435038		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
	13483650	CHEMBL2437529	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 0.1 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CN3C(=O)c4ccccc4C3=O)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435045	=	Inhibition	%	6.27	CHEMBL4439	Homo sapiens	INH	%	6.27
	13483651	CHEMBL2437529	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 0.1 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CO)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435044	=	Inhibition	%	21.42	CHEMBL4439	Homo sapiens	INH	%	21.42
	13483652	CHEMBL2437529	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 0.1 uM after 2 hrs by luciferase assay	B	CCOC(=O)c1cn(-c2ccc3c(c2)OCO3)c(-c2cccc(C)n2)n1		CHEMBL2435043	=	Inhibition	%	24.5	CHEMBL4439	Homo sapiens	INH	%	24.5
	13483653	CHEMBL2437533	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 0.03 uM after 2 hrs by luciferase assay	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	Inhibition	%	15.8	CHEMBL4439	Homo sapiens	INH	%	15.8
	13483654	CHEMBL2437533	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 0.03 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNc3ccc(C(N)=O)cc3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435036	=	Inhibition	%	9.37	CHEMBL4439	Homo sapiens	INH	%	9.37
	13483655	CHEMBL2437533	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 0.03 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNc3ccc(C#N)cc3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435035	=	Inhibition	%	16.71	CHEMBL4439	Homo sapiens	INH	%	16.71
	13483656	CHEMBL2437533	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 0.03 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNc3ccc(S(N)(=O)=O)cc3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435034	=	Inhibition	%	19.03	CHEMBL4439	Homo sapiens	INH	%	19.03
	13483657	CHEMBL2437533	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 0.03 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNC(=O)Nc3ccccc3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435041	=	Inhibition	%	3.82	CHEMBL4439	Homo sapiens	INH	%	3.82
	13483658	CHEMBL2437533	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 0.03 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNC(=O)N3CCOCC3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435040	=	Inhibition	%	-3.13	CHEMBL4439	Homo sapiens	INH	%	-3.13
	13483659	CHEMBL2437533	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 0.03 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNC(=O)NC(C)C)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435039	=	Inhibition	%	-3.64	CHEMBL4439	Homo sapiens	INH	%	-3.64
	13483660	CHEMBL2437533	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 0.03 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(C(N)=O)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435037	=	Inhibition	%	5.44	CHEMBL4439	Homo sapiens	INH	%	5.44
	13483661	CHEMBL2437533	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 0.03 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CN3C(=O)c4ccccc4C3=O)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435045	=	Inhibition	%	-1.89	CHEMBL4439	Homo sapiens	INH	%	-1.89
	13483662	CHEMBL2437533	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 0.03 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CO)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435044	=	Inhibition	%	17.75	CHEMBL4439	Homo sapiens	INH	%	17.75
	13483663	CHEMBL2437533	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 0.03 uM after 2 hrs by luciferase assay	B	CCOC(=O)c1cn(-c2ccc3c(c2)OCO3)c(-c2cccc(C)n2)n1		CHEMBL2435043	=	Inhibition	%	3.08	CHEMBL4439	Homo sapiens	INH	%	3.08
	13483664	CHEMBL2437530	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 0.01 uM after 2 hrs by luciferase assay	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	Inhibition	%	7.54	CHEMBL4439	Homo sapiens	INH	%	7.54
	13483665	CHEMBL2437530	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 0.01 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNc3ccc(C(N)=O)cc3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435036	=	Inhibition	%	11.39	CHEMBL4439	Homo sapiens	INH	%	11.39
	13483666	CHEMBL2437530	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 0.01 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNc3ccc(C#N)cc3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435035	=	Inhibition	%	11.97	CHEMBL4439	Homo sapiens	INH	%	11.97
	13483667	CHEMBL2437530	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 0.01 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNc3ccc(S(N)(=O)=O)cc3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435034	=	Inhibition	%	17.01	CHEMBL4439	Homo sapiens	INH	%	17.01
	13483668	CHEMBL2437530	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 0.01 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNC(=O)Nc3ccccc3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435041	=	Inhibition	%	9.54	CHEMBL4439	Homo sapiens	INH	%	9.54
	13483669	CHEMBL2437530	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 0.01 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNC(=O)N3CCOCC3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435040	=	Inhibition	%	0.61	CHEMBL4439	Homo sapiens	INH	%	0.61
	13483670	CHEMBL2437530	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 0.01 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(C(N)=O)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435037	=	Inhibition	%	1.68	CHEMBL4439	Homo sapiens	INH	%	1.68
	13483671	CHEMBL2437532	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 1 uM after 2 hrs by luciferase assay	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	Inhibition	%	84.75	CHEMBL4439	Homo sapiens	INH	%	84.75
	13483672	CHEMBL2437532	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 1 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNc3ccc(C(N)=O)cc3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435036	=	Inhibition	%	42.74	CHEMBL4439	Homo sapiens	INH	%	42.74
	13483673	CHEMBL2437532	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 1 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNc3ccc(C#N)cc3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435035	=	Inhibition	%	62.7	CHEMBL4439	Homo sapiens	INH	%	62.7
	13483674	CHEMBL2437532	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 1 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNc3ccc(S(N)(=O)=O)cc3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435034	=	Inhibition	%	75.04	CHEMBL4439	Homo sapiens	INH	%	75.04
	13483675	CHEMBL2437532	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 1 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNC(=O)Nc3ccccc3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435041	=	Inhibition	%	48.64	CHEMBL4439	Homo sapiens	INH	%	48.64
	13483676	CHEMBL2437532	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 1 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNC(=O)N3CCOCC3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435040	=	Inhibition	%	40.3	CHEMBL4439	Homo sapiens	INH	%	40.3
	13483677	CHEMBL2437532	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 1 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNC(=O)NC(C)C)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435039	=	Inhibition	%	32.53	CHEMBL4439	Homo sapiens	INH	%	32.53
Not Active	13483678	CHEMBL2437531	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CN)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435038		IC50			CHEMBL4439	Homo sapiens	IC50		
	13483679	CHEMBL2437531	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(C(N)=O)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435037	=	IC50	nM	3820.0	CHEMBL4439	Homo sapiens	IC50	uM	3.82
Not Active	13483680	CHEMBL2437531	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNC(N)=O)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435042		IC50			CHEMBL4439	Homo sapiens	IC50		
	13483681	CHEMBL2437532	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 1 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNC(N)=O)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435042	=	Inhibition	%	5.15	CHEMBL4439	Homo sapiens	INH	%	5.15
	13483682	CHEMBL2437532	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 1 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(C(N)=O)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435037	=	Inhibition	%	16.19	CHEMBL4439	Homo sapiens	INH	%	16.19
	13483683	CHEMBL2437532	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 1 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CN)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435038	=	Inhibition	%	-5.28	CHEMBL4439	Homo sapiens	INH	%	-5.28
	13483684	CHEMBL2437532	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 1 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CN3C(=O)c4ccccc4C3=O)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435045	=	Inhibition	%	24.02	CHEMBL4439	Homo sapiens	INH	%	24.02
	13483685	CHEMBL2437532	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 1 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CO)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435044	=	Inhibition	%	44.97	CHEMBL4439	Homo sapiens	INH	%	44.97
	13483686	CHEMBL2437532	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 1 uM after 2 hrs by luciferase assay	B	CCOC(=O)c1cn(-c2ccc3c(c2)OCO3)c(-c2cccc(C)n2)n1		CHEMBL2435043	=	Inhibition	%	19.05	CHEMBL4439	Homo sapiens	INH	%	19.05
	13483687	CHEMBL2437532	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 1 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(-c3ccc(C#N)cc3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL560207	=	Inhibition	%	41.0	CHEMBL4439	Homo sapiens	INH	%	41.0
	13483688	CHEMBL2437532	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 at 1 uM after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(-c3ccc(C(N)=O)cc3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL551623	=	Inhibition	%	69.0	CHEMBL4439	Homo sapiens	INH	%	69.0
	13483689	CHEMBL2437531	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 after 2 hrs by luciferase assay	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	IC50	nM	350.0	CHEMBL4439	Homo sapiens	IC50	uM	0.35
	13483690	CHEMBL2437531	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNc3ccc(C(N)=O)cc3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435036	=	IC50	nM	800.0	CHEMBL4439	Homo sapiens	IC50	uM	0.8
	13483691	CHEMBL2437531	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNc3ccc(C#N)cc3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435035	=	IC50	nM	650.0	CHEMBL4439	Homo sapiens	IC50	uM	0.65
	13483692	CHEMBL2437531	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNc3ccc(S(N)(=O)=O)cc3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435034	=	IC50	nM	240.0	CHEMBL4439	Homo sapiens	IC50	uM	0.24
	13483693	CHEMBL2437531	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNC(=O)Nc3ccccc3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435041	=	IC50	nM	950.0	CHEMBL4439	Homo sapiens	IC50	uM	0.95
	13484520	CHEMBL2437531	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNC(=O)N3CCOCC3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435040	=	IC50	nM	1780.0	CHEMBL4439	Homo sapiens	IC50	uM	1.78
	13484521	CHEMBL2437531	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CNC(=O)NC(C)C)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435039	=	IC50	nM	2080.0	CHEMBL4439	Homo sapiens	IC50	uM	2.08
	13484522	CHEMBL2437531	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CN3C(=O)c4ccccc4C3=O)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435045	=	IC50	nM	3360.0	CHEMBL4439	Homo sapiens	IC50	uM	3.36
	13484523	CHEMBL2437531	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 after 2 hrs by luciferase assay	B	Cc1cccc(-c2nc(CO)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL2435044	=	IC50	nM	990.0	CHEMBL4439	Homo sapiens	IC50	uM	0.99
	13484524	CHEMBL2437531	Inhibition of TGFbeta-induced downstream transcriptional activation of ALK5 (unknown origin) expressed in CHO-HIR cells assessed as intracellular translocation of EGFP-Smad2 after 2 hrs by luciferase assay	B	CCOC(=O)c1cn(-c2ccc3c(c2)OCO3)c(-c2cccc(C)n2)n1		CHEMBL2435043	=	IC50	nM	2430.0	CHEMBL4439	Homo sapiens	IC50	uM	2.43
	13953223	CHEMBL3132636	Inhibition of human TGFBR1 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125726	=	Activity	%	111.0	CHEMBL4439	Homo sapiens	Activity	%	111.0
	13953245	CHEMBL3132636	Inhibition of human TGFBR1 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125727	=	Activity	%	104.0	CHEMBL4439	Homo sapiens	Activity	%	104.0
	13954710	CHEMBL3132636	Inhibition of human TGFBR1 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125728	=	Activity	%	85.0	CHEMBL4439	Homo sapiens	Activity	%	85.0
	14657754	CHEMBL3269341	Inhibition of GST-fused recombinant human ALK5 expressed in baculovirus-infected insect Sf9 cells using casein as substrate by radioisotope-based assay	B	Cc1cccc(-c2[nH]c(CNC(=O)c3cccc(C(N)=O)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3261086	=	IC50	nM	106.0	CHEMBL4439	Homo sapiens	IC50	uM	0.106
	14657755	CHEMBL3269341	Inhibition of GST-fused recombinant human ALK5 expressed in baculovirus-infected insect Sf9 cells using casein as substrate by radioisotope-based assay	B	Cc1cccc(-c2[nH]c(CNC(=O)c3cccc(C#N)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3261085	=	IC50	nM	90.0	CHEMBL4439	Homo sapiens	IC50	uM	0.09
	14657756	CHEMBL3269341	Inhibition of GST-fused recombinant human ALK5 expressed in baculovirus-infected insect Sf9 cells using casein as substrate by radioisotope-based assay	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3F)cc2-c2ccc3ncnn3c2)n1		CHEMBL3261092	=	IC50	nM	85.0	CHEMBL4439	Homo sapiens	IC50	uM	0.085
	14657757	CHEMBL3269341	Inhibition of GST-fused recombinant human ALK5 expressed in baculovirus-infected insect Sf9 cells using casein as substrate by radioisotope-based assay	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3)cc2-c2ccc3ncnn3c2)n1		CHEMBL3261091	=	IC50	nM	78.0	CHEMBL4439	Homo sapiens	IC50	uM	0.078
	14657758	CHEMBL3269341	Inhibition of GST-fused recombinant human ALK5 expressed in baculovirus-infected insect Sf9 cells using casein as substrate by radioisotope-based assay	B	Cc1cccc(-c2[nH]c(CNC(=O)c3ccccc3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3261083	=	IC50	nM	57.0	CHEMBL4439	Homo sapiens	IC50	uM	0.057
	14657759	CHEMBL3269341	Inhibition of GST-fused recombinant human ALK5 expressed in baculovirus-infected insect Sf9 cells using casein as substrate by radioisotope-based assay	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	IC50	nM	54.0	CHEMBL4439	Homo sapiens	IC50	uM	0.054
	14657760	CHEMBL3269341	Inhibition of GST-fused recombinant human ALK5 expressed in baculovirus-infected insect Sf9 cells using casein as substrate by radioisotope-based assay	B	Cc1cccc(-c2[nH]c(CNC(=S)c3ccccc3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3261087	=	IC50	nM	48.0	CHEMBL4439	Homo sapiens	IC50	uM	0.048
	14657761	CHEMBL3269341	Inhibition of GST-fused recombinant human ALK5 expressed in baculovirus-infected insect Sf9 cells using casein as substrate by radioisotope-based assay	B	Cc1cccc(-c2[nH]c(CNC(=O)c3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3261084	=	IC50	nM	37.0	CHEMBL4439	Homo sapiens	IC50	uM	0.037
	14657762	CHEMBL3269341	Inhibition of GST-fused recombinant human ALK5 expressed in baculovirus-infected insect Sf9 cells using casein as substrate by radioisotope-based assay	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(C(N)=O)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL3261094	=	IC50	nM	36.0	CHEMBL4439	Homo sapiens	IC50	uM	0.036
	14657763	CHEMBL3269341	Inhibition of GST-fused recombinant human ALK5 expressed in baculovirus-infected insect Sf9 cells using casein as substrate by radioisotope-based assay	B	Cc1cccc(-c2[nH]c(CNC(=S)c3cccc(C#N)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3261089	=	IC50	nM	36.0	CHEMBL4439	Homo sapiens	IC50	uM	0.036
	14657764	CHEMBL3269341	Inhibition of GST-fused recombinant human ALK5 expressed in baculovirus-infected insect Sf9 cells using casein as substrate by radioisotope-based assay	B	Cc1cccc(-c2nn(CC(=S)Nc3ccccc3F)cc2-c2ccc3ncnn3c2)n1		CHEMBL3261095	=	IC50	nM	29.0	CHEMBL4439	Homo sapiens	IC50	uM	0.029
	14657765	CHEMBL3269341	Inhibition of GST-fused recombinant human ALK5 expressed in baculovirus-infected insect Sf9 cells using casein as substrate by radioisotope-based assay	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(C#N)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL3261093	=	IC50	nM	27.0	CHEMBL4439	Homo sapiens	IC50	uM	0.027
	14657766	CHEMBL3269341	Inhibition of GST-fused recombinant human ALK5 expressed in baculovirus-infected insect Sf9 cells using casein as substrate by radioisotope-based assay	B	Cc1cccc(-c2[nH]c(CNC(=S)c3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3261088	=	IC50	nM	27.0	CHEMBL4439	Homo sapiens	IC50	uM	0.027
	14657767	CHEMBL3269341	Inhibition of GST-fused recombinant human ALK5 expressed in baculovirus-infected insect Sf9 cells using casein as substrate by radioisotope-based assay	B	Cc1cccc(-c2[nH]c(CNC(=S)c3cccc(C(N)=O)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3261090	=	IC50	nM	22.0	CHEMBL4439	Homo sapiens	IC50	uM	0.022
	14657768	CHEMBL3269341	Inhibition of GST-fused recombinant human ALK5 expressed in baculovirus-infected insect Sf9 cells using casein as substrate by radioisotope-based assay	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(C#N)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL3261096	=	IC50	nM	18.0	CHEMBL4439	Homo sapiens	IC50	uM	0.018
	14657769	CHEMBL3269341	Inhibition of GST-fused recombinant human ALK5 expressed in baculovirus-infected insect Sf9 cells using casein as substrate by radioisotope-based assay	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL492634	=	IC50	nM	17.0	CHEMBL4439	Homo sapiens	IC50	uM	0.017
	14657770	CHEMBL3269344	Inhibition of ALK5 in human HaCaT cells assessed as remaining TGF-beta1-induced p3TP-luciferase reporter gene expression at 0.03 uM after 24 hrs by luminometric analysis relative to control	B	Cc1cccc(-c2[nH]c(CNC(=S)c3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3261088	=	Activity	%	110.0	CHEMBL4439	Homo sapiens	Activity	%	110.0
	14657771	CHEMBL3269344	Inhibition of ALK5 in human HaCaT cells assessed as remaining TGF-beta1-induced p3TP-luciferase reporter gene expression at 0.03 uM after 24 hrs by luminometric analysis relative to control	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(C(N)=O)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL3261094	=	Activity	%	90.0	CHEMBL4439	Homo sapiens	Activity	%	90.0
	14657772	CHEMBL3269344	Inhibition of ALK5 in human HaCaT cells assessed as remaining TGF-beta1-induced p3TP-luciferase reporter gene expression at 0.03 uM after 24 hrs by luminometric analysis relative to control	B	Cc1cccc(-c2[nH]c(CNC(=O)c3cccc(C(N)=O)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3261086	=	Activity	%	82.0	CHEMBL4439	Homo sapiens	Activity	%	82.0
	14657773	CHEMBL3269344	Inhibition of ALK5 in human HaCaT cells assessed as remaining TGF-beta1-induced p3TP-luciferase reporter gene expression at 0.03 uM after 24 hrs by luminometric analysis relative to control	B	Cc1cccc(-c2[nH]c(CNC(=S)c3cccc(C(N)=O)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3261090	=	Activity	%	80.0	CHEMBL4439	Homo sapiens	Activity	%	80.0
	14657774	CHEMBL3269344	Inhibition of ALK5 in human HaCaT cells assessed as remaining TGF-beta1-induced p3TP-luciferase reporter gene expression at 0.03 uM after 24 hrs by luminometric analysis relative to control	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Activity	%	78.0	CHEMBL4439	Homo sapiens	Activity	%	78.0
	14657775	CHEMBL3269344	Inhibition of ALK5 in human HaCaT cells assessed as remaining TGF-beta1-induced p3TP-luciferase reporter gene expression at 0.03 uM after 24 hrs by luminometric analysis relative to control	B	Cc1cccc(-c2[nH]c(CNC(=S)c3ccccc3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3261087	=	Activity	%	78.0	CHEMBL4439	Homo sapiens	Activity	%	78.0
	14657776	CHEMBL3269344	Inhibition of ALK5 in human HaCaT cells assessed as remaining TGF-beta1-induced p3TP-luciferase reporter gene expression at 0.03 uM after 24 hrs by luminometric analysis relative to control	B	Cc1cccc(-c2nn(CC(=S)Nc3ccccc3F)cc2-c2ccc3ncnn3c2)n1		CHEMBL3261095	=	Activity	%	77.0	CHEMBL4439	Homo sapiens	Activity	%	77.0
	14657777	CHEMBL3269344	Inhibition of ALK5 in human HaCaT cells assessed as remaining TGF-beta1-induced p3TP-luciferase reporter gene expression at 0.03 uM after 24 hrs by luminometric analysis relative to control	B	Cc1cccc(-c2[nH]c(CNC(=O)c3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3261084	=	Activity	%	43.0	CHEMBL4439	Homo sapiens	Activity	%	43.0
	14657778	CHEMBL3269344	Inhibition of ALK5 in human HaCaT cells assessed as remaining TGF-beta1-induced p3TP-luciferase reporter gene expression at 0.03 uM after 24 hrs by luminometric analysis relative to control	B	Cc1cccc(-c2[nH]c(CNC(=O)c3cccc(C#N)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3261085	=	Activity	%	35.0	CHEMBL4439	Homo sapiens	Activity	%	35.0
	14657779	CHEMBL3269344	Inhibition of ALK5 in human HaCaT cells assessed as remaining TGF-beta1-induced p3TP-luciferase reporter gene expression at 0.03 uM after 24 hrs by luminometric analysis relative to control	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3F)cc2-c2ccc3ncnn3c2)n1		CHEMBL3261092	=	Activity	%	32.0	CHEMBL4439	Homo sapiens	Activity	%	32.0
	14657780	CHEMBL3269344	Inhibition of ALK5 in human HaCaT cells assessed as remaining TGF-beta1-induced p3TP-luciferase reporter gene expression at 0.03 uM after 24 hrs by luminometric analysis relative to control	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3)cc2-c2ccc3ncnn3c2)n1		CHEMBL3261091	=	Activity	%	26.0	CHEMBL4439	Homo sapiens	Activity	%	26.0
	14657781	CHEMBL3269344	Inhibition of ALK5 in human HaCaT cells assessed as remaining TGF-beta1-induced p3TP-luciferase reporter gene expression at 0.03 uM after 24 hrs by luminometric analysis relative to control	B	Cc1cccc(-c2[nH]c(CNC(=S)c3cccc(C#N)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3261089	=	Activity	%	23.0	CHEMBL4439	Homo sapiens	Activity	%	23.0
	14657782	CHEMBL3269344	Inhibition of ALK5 in human HaCaT cells assessed as remaining TGF-beta1-induced p3TP-luciferase reporter gene expression at 0.03 uM after 24 hrs by luminometric analysis relative to control	B	Cc1cccc(-c2[nH]c(CNC(=O)c3ccccc3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3261083	=	Activity	%	22.0	CHEMBL4439	Homo sapiens	Activity	%	22.0
	14657783	CHEMBL3269344	Inhibition of ALK5 in human HaCaT cells assessed as remaining TGF-beta1-induced p3TP-luciferase reporter gene expression at 0.03 uM after 24 hrs by luminometric analysis relative to control	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(C#N)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL3261093	=	Activity	%	14.0	CHEMBL4439	Homo sapiens	Activity	%	14.0
	14657784	CHEMBL3269344	Inhibition of ALK5 in human HaCaT cells assessed as remaining TGF-beta1-induced p3TP-luciferase reporter gene expression at 0.03 uM after 24 hrs by luminometric analysis relative to control	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL492634	=	Activity	%	5.0	CHEMBL4439	Homo sapiens	Activity	%	5.0
	14657785	CHEMBL3269344	Inhibition of ALK5 in human HaCaT cells assessed as remaining TGF-beta1-induced p3TP-luciferase reporter gene expression at 0.03 uM after 24 hrs by luminometric analysis relative to control	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(C#N)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL3261096	=	Activity	%	5.0	CHEMBL4439	Homo sapiens	Activity	%	5.0
	14657794	CHEMBL3269345	Potency index, ratio of SB-505124 IC50 to compound IC50 for GST-fused recombinant human ALK5 expressed in baculovirus-infected insect Sf9 cells	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(C#N)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL3261096	=	Ratio IC50		3.0	CHEMBL4439	Homo sapiens	Ratio IC50		3.0
	14659460	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	COc1cccc(NCc2nc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)[nH]2)c1OC		CHEMBL3260617	=	IC50	nM	58.0	CHEMBL4439	Homo sapiens	IC50	uM	0.058
	14659461	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cccc(C#N)c3C#N)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260618	=	IC50	nM	21.0	CHEMBL4439	Homo sapiens	IC50	uM	0.021
	14659462	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccc(F)c(F)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260619	=	IC50	nM	10.0	CHEMBL4439	Homo sapiens	IC50	uM	0.01
	14659463	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccc(Cl)c(Cl)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260620	=	IC50	nM	8.0	CHEMBL4439	Homo sapiens	IC50	uM	0.008
	14659464	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccc(C)c(C)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260621	=	IC50	nM	17.0	CHEMBL4439	Homo sapiens	IC50	uM	0.017
	14659465	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	COc1ccc(NCc2nc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)[nH]2)cc1OC		CHEMBL3260622	=	IC50	nM	44.0	CHEMBL4439	Homo sapiens	IC50	uM	0.044
	14659466	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cc(F)cc(F)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260623	=	IC50	nM	6.0	CHEMBL4439	Homo sapiens	IC50	uM	0.006
	14659467	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cc(Cl)cc(Cl)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260624	=	IC50	nM	15.0	CHEMBL4439	Homo sapiens	IC50	uM	0.015
	14659468	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cc(C)cc(NCc2nc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)[nH]2)c1		CHEMBL3260625	=	IC50	nM	14.0	CHEMBL4439	Homo sapiens	IC50	uM	0.014
	14659469	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	COc1cc(NCc2nc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)[nH]2)cc(OC)c1		CHEMBL3260626	=	IC50	nM	14.0	CHEMBL4439	Homo sapiens	IC50	uM	0.014
	14659470	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	IC50	nM	54.0	CHEMBL4439	Homo sapiens	IC50	uM	0.054
	14659471	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL492634	=	IC50	nM	17.0	CHEMBL4439	Homo sapiens	IC50	uM	0.017
	14659472	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cc(N(C)C)ccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260627	=	IC50	nM	2.9	CHEMBL4439	Homo sapiens	IC50	uM	0.0029
	14659473	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cc(CN(C)C)ccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260628	=	IC50	nM	15.3	CHEMBL4439	Homo sapiens	IC50	uM	0.0153
	14659474	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cccc(CN(C)C)c3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260629	=	IC50	nM	11.0	CHEMBL4439	Homo sapiens	IC50	uM	0.011
	14659475	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cccc(CN4CCCC4)c3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260630	=	IC50	nM	22.1	CHEMBL4439	Homo sapiens	IC50	uM	0.0221
	14659476	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cccc(CN4CCOCC4)c3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260631	=	IC50	nM	6.8	CHEMBL4439	Homo sapiens	IC50	uM	0.0068
	14659477	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cccc(C#N)c3CN(C)C)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260897	=	IC50	nM	2.4	CHEMBL4439	Homo sapiens	IC50	uM	0.0024
	14659478	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cccc(C#N)c3CN3CCCC3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260898	=	IC50	nM	5.6	CHEMBL4439	Homo sapiens	IC50	uM	0.0056
	14659479	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cccc(C#N)c3CN3CCOCC3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260899	=	IC50	nM	8.1	CHEMBL4439	Homo sapiens	IC50	uM	0.0081
	14659480	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cc(C#N)cc(N(C)C)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260900	=	IC50	nM	2.6	CHEMBL4439	Homo sapiens	IC50	uM	0.0026
	14659481	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cc(C#N)cc(CN(C)C)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260901	=	IC50	nM	4.9	CHEMBL4439	Homo sapiens	IC50	uM	0.0049
	14659482	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cc(C#N)cc(CN4CCCC4)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260902	=	IC50	nM	17.8	CHEMBL4439	Homo sapiens	IC50	uM	0.0178
	14659483	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cc(C#N)cc(CN4CCOCC4)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260903	=	IC50	nM	3.3	CHEMBL4439	Homo sapiens	IC50	uM	0.0033
	14659484	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cc(C#N)ccc3N(C)C)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260904	=	IC50	nM	1.3	CHEMBL4439	Homo sapiens	IC50	uM	0.0013
	14659485	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cc(C#N)ccc3CN(C)C)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260905	=	IC50	nM	3.1	CHEMBL4439	Homo sapiens	IC50	uM	0.0031
	14659486	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cc(C#N)ccc3CN3CCCC3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260906	=	IC50	nM	6.8	CHEMBL4439	Homo sapiens	IC50	uM	0.0068
	14659487	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cc(C#N)ccc3CN3CCOCC3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260907	=	IC50	nM	4.8	CHEMBL4439	Homo sapiens	IC50	uM	0.0048
	14659655	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	>	IC50	nM	18500.0	CHEMBL4439	Homo sapiens	IC50	uM	18.5
	14659692	CHEMBL3269165	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate assessed as residual activity at 0.01 uM by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	Activity	%	35.0	CHEMBL4439	Homo sapiens	Activity	%	35.0
	14659693	CHEMBL3269166	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate assessed as residual activity at 0.1 uM by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	Activity	%	4.0	CHEMBL4439	Homo sapiens	Activity	%	4.0
	14659694	CHEMBL3269167	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate assessed as residual activity at 1 uM by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	Activity	%	1.0	CHEMBL4439	Homo sapiens	Activity	%	1.0
	14659695	CHEMBL3269168	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate assessed as residual activity at 10 uM by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	Activity	%	0.0	CHEMBL4439	Homo sapiens	Activity	%	0.0
	14659756	CHEMBL3270798	Inhibition of ALK5 in human HaCaT cells assessed as inhibition of TGFbeta1-induced luciferase activity after 24 hrs by luciferase reporter gene assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	IC50	nM	16.5	CHEMBL4439	Homo sapiens	IC50	uM	0.0165
	14659757	CHEMBL3270798	Inhibition of ALK5 in human HaCaT cells assessed as inhibition of TGFbeta1-induced luciferase activity after 24 hrs by luciferase reporter gene assay	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	IC50	nM	43.8	CHEMBL4439	Homo sapiens	IC50	uM	0.0438
	14660352	CHEMBL3270798	Inhibition of ALK5 in human HaCaT cells assessed as inhibition of TGFbeta1-induced luciferase activity after 24 hrs by luciferase reporter gene assay	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL492634	=	IC50	nM	19.6	CHEMBL4439	Homo sapiens	IC50	uM	0.0196
	14660353	CHEMBL3270798	Inhibition of ALK5 in human HaCaT cells assessed as inhibition of TGFbeta1-induced luciferase activity after 24 hrs by luciferase reporter gene assay	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	IC50	nM	100.0	CHEMBL4439	Homo sapiens	IC50	uM	0.1
	14660358	CHEMBL3270801	Competitive inhibition of ALK5 (unknown origin) by Michaelis-Menten plot analysis in presence of ATP	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	Ki	nM	20.59	CHEMBL4439	Homo sapiens	Ki	nM	20.5937
	14660359	CHEMBL3270802	Competitive inhibition of ALK5 (unknown origin) assessed as enzyme/ATP complex by Michaelis-Menten plot analysis in presence of ATP	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	Ki	nM	6.296	CHEMBL4439	Homo sapiens	Ki	nM	6.296
	14660442	CHEMBL3268791	Inhibition of ALK5 in human HaCaT cells assessed as residual activity at 0.03 uM after 24 hrs by luciferase reporter gene assay relative to control	B	Cc1cccc(-c2[nH]c(COc3ccccc3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260564	=	Activity	%	89.0	CHEMBL4439	Homo sapiens	Activity	%	89.0
	14660443	CHEMBL3268791	Inhibition of ALK5 in human HaCaT cells assessed as residual activity at 0.03 uM after 24 hrs by luciferase reporter gene assay relative to control	B	Cc1cccc(-c2[nH]c(CSc3ccccc3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260565	=	Activity	%	92.0	CHEMBL4439	Homo sapiens	Activity	%	92.0
	14660444	CHEMBL3268791	Inhibition of ALK5 in human HaCaT cells assessed as residual activity at 0.03 uM after 24 hrs by luciferase reporter gene assay relative to control	B	Cc1cccc(-c2[nH]c(CNc3ccccc3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260566	=	Activity	%	48.0	CHEMBL4439	Homo sapiens	Activity	%	48.0
	14660445	CHEMBL3268791	Inhibition of ALK5 in human HaCaT cells assessed as residual activity at 0.03 uM after 24 hrs by luciferase reporter gene assay relative to control	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	Activity	%	41.0	CHEMBL4439	Homo sapiens	Activity	%	41.0
	14660446	CHEMBL3268791	Inhibition of ALK5 in human HaCaT cells assessed as residual activity at 0.03 uM after 24 hrs by luciferase reporter gene assay relative to control	B	Cc1cccc(-c2[nH]c(CNc3ccccc3Cl)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260568	=	Activity	%	54.0	CHEMBL4439	Homo sapiens	Activity	%	54.0
	14660447	CHEMBL3268791	Inhibition of ALK5 in human HaCaT cells assessed as residual activity at 0.03 uM after 24 hrs by luciferase reporter gene assay relative to control	B	Cc1cccc(-c2[nH]c(CNc3ccccc3Br)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260569	=	Activity	%	47.0	CHEMBL4439	Homo sapiens	Activity	%	47.0
	14660448	CHEMBL3268791	Inhibition of ALK5 in human HaCaT cells assessed as residual activity at 0.03 uM after 24 hrs by luciferase reporter gene assay relative to control	B	Cc1cccc(-c2[nH]c(CNc3cccc(F)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260581	=	Activity	%	38.0	CHEMBL4439	Homo sapiens	Activity	%	38.0
	14660449	CHEMBL3268791	Inhibition of ALK5 in human HaCaT cells assessed as residual activity at 0.03 uM after 24 hrs by luciferase reporter gene assay relative to control	B	Cc1cccc(-c2[nH]c(CNc3cccc(Cl)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260582	=	Activity	%	34.0	CHEMBL4439	Homo sapiens	Activity	%	34.0
	14660450	CHEMBL3268791	Inhibition of ALK5 in human HaCaT cells assessed as residual activity at 0.03 uM after 24 hrs by luciferase reporter gene assay relative to control	B	Cc1cccc(-c2[nH]c(CNc3cccc(Br)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260583	=	Activity	%	29.0	CHEMBL4439	Homo sapiens	Activity	%	29.0
	14660451	CHEMBL3268791	Inhibition of ALK5 in human HaCaT cells assessed as residual activity at 0.03 uM after 24 hrs by luciferase reporter gene assay relative to control	B	Cc1cccc(NCc2nc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)[nH]2)c1		CHEMBL3260584	=	Activity	%	46.0	CHEMBL4439	Homo sapiens	Activity	%	46.0
	14660452	CHEMBL3268791	Inhibition of ALK5 in human HaCaT cells assessed as residual activity at 0.03 uM after 24 hrs by luciferase reporter gene assay relative to control	B	CSc1cccc(NCc2nc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)[nH]2)c1		CHEMBL3260589	=	Activity	%	40.0	CHEMBL4439	Homo sapiens	Activity	%	40.0
	14660453	CHEMBL3268791	Inhibition of ALK5 in human HaCaT cells assessed as residual activity at 0.03 uM after 24 hrs by luciferase reporter gene assay relative to control	B	Cc1cccc(-c2[nH]c(CNc3cccc(C#N)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260591	=	Activity	%	48.0	CHEMBL4439	Homo sapiens	Activity	%	48.0
	14660454	CHEMBL3268791	Inhibition of ALK5 in human HaCaT cells assessed as residual activity at 0.03 uM after 24 hrs by luciferase reporter gene assay relative to control	B	Cc1cccc(-c2[nH]c(CNc3cccc(C(N)=O)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260592	=	Activity	%	98.0	CHEMBL4439	Homo sapiens	Activity	%	98.0
	14660455	CHEMBL3268791	Inhibition of ALK5 in human HaCaT cells assessed as residual activity at 0.03 uM after 24 hrs by luciferase reporter gene assay relative to control	B	Cc1cccc(-c2[nH]c(CNc3ccc(Br)cc3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260600	=	Activity	%	52.0	CHEMBL4439	Homo sapiens	Activity	%	52.0
	14660456	CHEMBL3268791	Inhibition of ALK5 in human HaCaT cells assessed as residual activity at 0.03 uM after 24 hrs by luciferase reporter gene assay relative to control	B	Cc1cccc(-c2[nH]c(CNc3cccc(F)c3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260614	=	Activity	%	58.0	CHEMBL4439	Homo sapiens	Activity	%	58.0
	14660457	CHEMBL3268791	Inhibition of ALK5 in human HaCaT cells assessed as residual activity at 0.03 uM after 24 hrs by luciferase reporter gene assay relative to control	B	Cc1cccc(-c2[nH]c(CNc3cc(F)cc(F)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260623	=	Activity	%	36.0	CHEMBL4439	Homo sapiens	Activity	%	36.0
	14660458	CHEMBL3268791	Inhibition of ALK5 in human HaCaT cells assessed as residual activity at 0.03 uM after 24 hrs by luciferase reporter gene assay relative to control	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Activity	%	74.0	CHEMBL4439	Homo sapiens	Activity	%	74.0
	14660497	CHEMBL3268791	Inhibition of ALK5 in human HaCaT cells assessed as residual activity at 0.03 uM after 24 hrs by luciferase reporter gene assay relative to control	B	Cc1ccc(NCc2nc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)[nH]2)cc1		CHEMBL3260601	=	Activity	%	63.0	CHEMBL4439	Homo sapiens	Activity	%	63.0
Active	14660500	CHEMBL3270800	Competitive inhibition of ALK5 (unknown origin) assessed as increase in apparent Km for ATP at 1 to 370 nM by Michaelis-Menten plot analysis	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
	14664341	CHEMBL3271273	Inhibition of TGFBR1 (unknown origin) at 1 uM relative to control	B	CCOC(=O)c1sc(-c2ccncc2)nc1O		CHEMBL3261228	=	Inhibition	%	100.0	CHEMBL4439	Homo sapiens	INH	%	100.0
	14664342	CHEMBL3271273	Inhibition of TGFBR1 (unknown origin) at 1 uM relative to control	B	NC(=O)c1sc(-c2ccnc(N)n2)nc1-c1ccc(Cl)cc1Cl		CHEMBL3261514	=	Inhibition	%	91.0	CHEMBL4439	Homo sapiens	INH	%	91.0
	14664343	CHEMBL3271273	Inhibition of TGFBR1 (unknown origin) at 1 uM relative to control	B	COc1ccc(-c2nc(-c3ccnc(N)n3)sc2C(N)=O)c(Cl)c1		CHEMBL3261517	=	Inhibition	%	72.0	CHEMBL4439	Homo sapiens	INH	%	72.0
	14674732	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(COc3ccccc3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260564	=	IC50	nM	13.0	CHEMBL4439	Homo sapiens	IC50	uM	0.013
	14674733	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CSc3ccccc3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260565	=	IC50	nM	21.0	CHEMBL4439	Homo sapiens	IC50	uM	0.021
	14674734	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260566	=	IC50	nM	13.0	CHEMBL4439	Homo sapiens	IC50	uM	0.013
	14674735	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	IC50	nM	7.0	CHEMBL4439	Homo sapiens	IC50	uM	0.007
	14674736	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3Cl)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260568	=	IC50	nM	9.0	CHEMBL4439	Homo sapiens	IC50	uM	0.009
	14674737	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3Br)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260569	=	IC50	nM	7.0	CHEMBL4439	Homo sapiens	IC50	uM	0.007
	14674738	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3C)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260570	=	IC50	nM	14.0	CHEMBL4439	Homo sapiens	IC50	uM	0.014
	14674739	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	CCc1ccccc1NCc1nc(-c2ccc3ncnn3c2)c(-c2cccc(C)n2)[nH]1		CHEMBL3260571	=	IC50	nM	11.0	CHEMBL4439	Homo sapiens	IC50	uM	0.011
	14674740	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3C(C)C)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260572	=	IC50	nM	14.0	CHEMBL4439	Homo sapiens	IC50	uM	0.014
	14674741	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	COc1ccccc1NCc1nc(-c2ccc3ncnn3c2)c(-c2cccc(C)n2)[nH]1		CHEMBL3260573	=	IC50	nM	14.0	CHEMBL4439	Homo sapiens	IC50	uM	0.014
	14674742	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3OC(F)(F)F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260574	=	IC50	nM	12.0	CHEMBL4439	Homo sapiens	IC50	uM	0.012
	14674743	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	CSc1ccccc1NCc1nc(-c2ccc3ncnn3c2)c(-c2cccc(C)n2)[nH]1		CHEMBL3260575	=	IC50	nM	10.0	CHEMBL4439	Homo sapiens	IC50	uM	0.01
	14674744	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	C=Cc1ccccc1NCc1nc(-c2ccc3ncnn3c2)c(-c2cccc(C)n2)[nH]1		CHEMBL3260576	=	IC50	nM	14.0	CHEMBL4439	Homo sapiens	IC50	uM	0.014
	14674745	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3C#N)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260577	=	IC50	nM	20.0	CHEMBL4439	Homo sapiens	IC50	uM	0.02
	14674746	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3C(N)=O)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260578	=	IC50	nM	30.0	CHEMBL4439	Homo sapiens	IC50	uM	0.03
	14674747	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3NS(C)(=O)=O)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260579	=	IC50	nM	15.0	CHEMBL4439	Homo sapiens	IC50	uM	0.015
	14674748	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	CC(=O)Nc1ccccc1NCc1nc(-c2ccc3ncnn3c2)c(-c2cccc(C)n2)[nH]1		CHEMBL3260580	=	IC50	nM	40.0	CHEMBL4439	Homo sapiens	IC50	uM	0.04
	14674749	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cccc(F)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260581	=	IC50	nM	9.0	CHEMBL4439	Homo sapiens	IC50	uM	0.009
	14674750	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cccc(Cl)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260582	=	IC50	nM	6.0	CHEMBL4439	Homo sapiens	IC50	uM	0.006
	14674751	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cccc(Br)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260583	=	IC50	nM	5.0	CHEMBL4439	Homo sapiens	IC50	uM	0.005
	14674752	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(NCc2nc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)[nH]2)c1		CHEMBL3260584	=	IC50	nM	9.0	CHEMBL4439	Homo sapiens	IC50	uM	0.009
	14674753	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	CCc1cccc(NCc2nc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)[nH]2)c1		CHEMBL3260585	=	IC50	nM	8.0	CHEMBL4439	Homo sapiens	IC50	uM	0.008
	14674754	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cccc(C(C)C)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260586	=	IC50	nM	16.0	CHEMBL4439	Homo sapiens	IC50	uM	0.016
	14674755	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	COc1cccc(NCc2nc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)[nH]2)c1		CHEMBL3260587	=	IC50	nM	14.0	CHEMBL4439	Homo sapiens	IC50	uM	0.014
	14674756	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cccc(OC(F)(F)F)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260588	=	IC50	nM	23.0	CHEMBL4439	Homo sapiens	IC50	uM	0.023
	14674757	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	CSc1cccc(NCc2nc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)[nH]2)c1		CHEMBL3260589	=	IC50	nM	7.0	CHEMBL4439	Homo sapiens	IC50	uM	0.007
	14674758	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	C=Cc1cccc(NCc2nc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)[nH]2)c1		CHEMBL3260590	=	IC50	nM	12.0	CHEMBL4439	Homo sapiens	IC50	uM	0.012
	14674759	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cccc(C#N)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260591	=	IC50	nM	5.0	CHEMBL4439	Homo sapiens	IC50	uM	0.005
	14674760	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cccc(C(N)=O)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260592	=	IC50	nM	9.0	CHEMBL4439	Homo sapiens	IC50	uM	0.009
	14674761	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cccc(CC#N)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260593	=	IC50	nM	11.0	CHEMBL4439	Homo sapiens	IC50	uM	0.011
	14674762	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	CC(=O)c1cccc(NCc2nc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)[nH]2)c1		CHEMBL3260594	=	IC50	nM	13.0	CHEMBL4439	Homo sapiens	IC50	uM	0.013
	14674763	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	COC(=O)c1cccc(NCc2nc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)[nH]2)c1		CHEMBL3260595	=	IC50	nM	17.0	CHEMBL4439	Homo sapiens	IC50	uM	0.017
	14674764	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cccc(NS(C)(=O)=O)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260596	=	IC50	nM	15.0	CHEMBL4439	Homo sapiens	IC50	uM	0.015
	14674765	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	CC(=O)Nc1cccc(NCc2nc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)[nH]2)c1		CHEMBL3260597	=	IC50	nM	15.0	CHEMBL4439	Homo sapiens	IC50	uM	0.015
	14674766	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccc(F)cc3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260598	=	IC50	nM	17.0	CHEMBL4439	Homo sapiens	IC50	uM	0.017
	14674767	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccc(Cl)cc3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260599	=	IC50	nM	11.0	CHEMBL4439	Homo sapiens	IC50	uM	0.011
	14674768	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccc(Br)cc3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260600	=	IC50	nM	17.0	CHEMBL4439	Homo sapiens	IC50	uM	0.017
	14674769	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1ccc(NCc2nc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)[nH]2)cc1		CHEMBL3260601	=	IC50	nM	16.0	CHEMBL4439	Homo sapiens	IC50	uM	0.016
	14674770	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccc(C(C)C)cc3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260602	=	IC50	nM	46.0	CHEMBL4439	Homo sapiens	IC50	uM	0.046
	14674771	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	COc1ccc(NCc2nc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)[nH]2)cc1		CHEMBL3260603	=	IC50	nM	48.0	CHEMBL4439	Homo sapiens	IC50	uM	0.048
	14674772	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccc(OC(F)(F)F)cc3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260604	=	IC50	nM	60.0	CHEMBL4439	Homo sapiens	IC50	uM	0.06
	14674773	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	CSc1ccc(NCc2nc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)[nH]2)cc1		CHEMBL3260605	=	IC50	nM	40.0	CHEMBL4439	Homo sapiens	IC50	uM	0.04
	14674774	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	C=Cc1ccc(NCc2nc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)[nH]2)cc1		CHEMBL3260606	=	IC50	nM	30.0	CHEMBL4439	Homo sapiens	IC50	uM	0.03
	14674775	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccc(C#N)cc3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260607	=	IC50	nM	32.0	CHEMBL4439	Homo sapiens	IC50	uM	0.032
	14674776	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccc(C(N)=O)cc3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260608	=	IC50	nM	55.0	CHEMBL4439	Homo sapiens	IC50	uM	0.055
	14674777	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccc(CC#N)cc3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260609	=	IC50	nM	25.0	CHEMBL4439	Homo sapiens	IC50	uM	0.025
	14674778	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	CC(=O)c1ccc(NCc2nc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)[nH]2)cc1		CHEMBL3260610	=	IC50	nM	59.0	CHEMBL4439	Homo sapiens	IC50	uM	0.059
	14674779	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	COC(=O)c1ccc(NCc2nc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)[nH]2)cc1		CHEMBL3260611	=	IC50	nM	78.0	CHEMBL4439	Homo sapiens	IC50	uM	0.078
	14674780	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccc(NS(C)(=O)=O)cc3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260612	=	IC50	nM	47.0	CHEMBL4439	Homo sapiens	IC50	uM	0.047
	14674781	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	CC(=O)Nc1ccc(NCc2nc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)[nH]2)cc1		CHEMBL3260613	=	IC50	nM	39.0	CHEMBL4439	Homo sapiens	IC50	uM	0.039
	14674782	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cccc(F)c3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260614	=	IC50	nM	9.0	CHEMBL4439	Homo sapiens	IC50	uM	0.009
	14674783	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cccc(Cl)c3Cl)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260615	=	IC50	nM	12.0	CHEMBL4439	Homo sapiens	IC50	uM	0.012
	14674784	CHEMBL3268788	Inhibition of human recombinant ALK5 expressed in insect Sf9 cells using casein as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cccc(C)c3C)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260616	=	IC50	nM	18.0	CHEMBL4439	Homo sapiens	IC50	uM	0.018
	15060726	CHEMBL3365508	Inhibition of purified ALK5 kinase (unknown origin) by RT-PCR analysis	B	COc1cc(-c2cc(-c3cccc(O)c3)cnc2N)cc(OC)c1OC		CHEMBL1230714	=	Delta Tm	degrees C	11.2	CHEMBL4439	Homo sapiens	deltaTm	degrees C	11.2
	15060727	CHEMBL3365508	Inhibition of purified ALK5 kinase (unknown origin) by RT-PCR analysis	B	COc1cc(-c2cc(-c3ccc(O)cc3)cnc2N)cc(OC)c1OC		CHEMBL3341941	=	Delta Tm	degrees C	12.0	CHEMBL4439	Homo sapiens	deltaTm	degrees C	12.0
	15060728	CHEMBL3365508	Inhibition of purified ALK5 kinase (unknown origin) by RT-PCR analysis	B	COc1cc(-c2cnc(N)c(-c3cc(OC)c(OC)c(OC)c3)c2)ccc1O		CHEMBL3341942	=	Delta Tm	degrees C	12.2	CHEMBL4439	Homo sapiens	deltaTm	degrees C	12.2
	15060729	CHEMBL3365508	Inhibition of purified ALK5 kinase (unknown origin) by RT-PCR analysis	B	COc1cc(-c2cc(-c3cccc(NS(C)(=O)=O)c3)cnc2N)cc(OC)c1OC		CHEMBL3341943	=	Delta Tm	degrees C	13.4	CHEMBL4439	Homo sapiens	deltaTm	degrees C	13.4
	15060730	CHEMBL3365508	Inhibition of purified ALK5 kinase (unknown origin) by RT-PCR analysis	B	COc1cc(-c2cc(-c3cccc(N4CCNCC4)c3)cnc2N)cc(OC)c1OC		CHEMBL3341944	=	Delta Tm	degrees C	13.7	CHEMBL4439	Homo sapiens	deltaTm	degrees C	13.7
	15060731	CHEMBL3365508	Inhibition of purified ALK5 kinase (unknown origin) by RT-PCR analysis	B	COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)cc(OC)c1OC		CHEMBL3341945	=	Delta Tm	degrees C	13.9	CHEMBL4439	Homo sapiens	deltaTm	degrees C	13.9
	15060732	CHEMBL3365508	Inhibition of purified ALK5 kinase (unknown origin) by RT-PCR analysis	B	COc1ccc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)cc1OC		CHEMBL3341946	=	Delta Tm	degrees C	7.2	CHEMBL4439	Homo sapiens	deltaTm	degrees C	7.2
	15060733	CHEMBL3365508	Inhibition of purified ALK5 kinase (unknown origin) by RT-PCR analysis	B	COc1cc(OC)cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)c1		CHEMBL3341947	=	Delta Tm	degrees C	10.4	CHEMBL4439	Homo sapiens	deltaTm	degrees C	10.4
	15060734	CHEMBL3365508	Inhibition of purified ALK5 kinase (unknown origin) by RT-PCR analysis	B	COc1cccc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)c1		CHEMBL3341948	=	Delta Tm	degrees C	8.3	CHEMBL4439	Homo sapiens	deltaTm	degrees C	8.3
	15060735	CHEMBL3365508	Inhibition of purified ALK5 kinase (unknown origin) by RT-PCR analysis	B	Nc1ncc(-c2ccc(N3CCNCC3)cc2)cc1-c1ccc2c(c1)OCCO2		CHEMBL3341949	=	Delta Tm	degrees C	5.5	CHEMBL4439	Homo sapiens	deltaTm	degrees C	5.5
	15060736	CHEMBL3365508	Inhibition of purified ALK5 kinase (unknown origin) by RT-PCR analysis	B	COc1ccc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)cc1		CHEMBL3341950	=	Delta Tm	degrees C	4.2	CHEMBL4439	Homo sapiens	deltaTm	degrees C	4.2
	15060737	CHEMBL3365508	Inhibition of purified ALK5 kinase (unknown origin) by RT-PCR analysis	B	CC(C)Oc1cccc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)c1		CHEMBL3341951	=	Delta Tm	degrees C	7.6	CHEMBL4439	Homo sapiens	deltaTm	degrees C	7.6
	15060738	CHEMBL3365508	Inhibition of purified ALK5 kinase (unknown origin) by RT-PCR analysis	B	COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)ccc1Cl		CHEMBL3341952	=	Delta Tm	degrees C	9.2	CHEMBL4439	Homo sapiens	deltaTm	degrees C	9.2
	15060739	CHEMBL3365508	Inhibition of purified ALK5 kinase (unknown origin) by RT-PCR analysis	B	COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)ccc1C		CHEMBL3341953	=	Delta Tm	degrees C	7.3	CHEMBL4439	Homo sapiens	deltaTm	degrees C	7.3
	15060740	CHEMBL3365508	Inhibition of purified ALK5 kinase (unknown origin) by RT-PCR analysis	B	CNc1ncc(-c2ccc(N3CCNCC3)cc2)cc1-c1cc(OC)c(OC)c(OC)c1		CHEMBL3341954	=	Delta Tm	degrees C	0.9	CHEMBL4439	Homo sapiens	deltaTm	degrees C	0.9
	15060741	CHEMBL3365508	Inhibition of purified ALK5 kinase (unknown origin) by RT-PCR analysis	B	COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N(C)C)cc(OC)c1OC		CHEMBL3341955	=	Delta Tm	degrees C	0.5	CHEMBL4439	Homo sapiens	deltaTm	degrees C	0.5
	15060742	CHEMBL3365508	Inhibition of purified ALK5 kinase (unknown origin) by RT-PCR analysis	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2)cc(OC)c1OC		CHEMBL3341787	=	Delta Tm	degrees C	10.4	CHEMBL4439	Homo sapiens	deltaTm	degrees C	10.4
	15060743	CHEMBL3365508	Inhibition of purified ALK5 kinase (unknown origin) by RT-PCR analysis	B	COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2Cl)cc(OC)c1OC		CHEMBL3341788	=	Delta Tm	degrees C	9.0	CHEMBL4439	Homo sapiens	deltaTm	degrees C	9.0
	15060744	CHEMBL3365508	Inhibition of purified ALK5 kinase (unknown origin) by RT-PCR analysis	B	COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2C)cc(OC)c1OC		CHEMBL3341789	=	Delta Tm	degrees C	9.7	CHEMBL4439	Homo sapiens	deltaTm	degrees C	9.7
	15060745	CHEMBL3365508	Inhibition of purified ALK5 kinase (unknown origin) by RT-PCR analysis	B	COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2OC)cc(OC)c1OC		CHEMBL3341790	=	Delta Tm	degrees C	1.2	CHEMBL4439	Homo sapiens	deltaTm	degrees C	1.2
	15060746	CHEMBL3365508	Inhibition of purified ALK5 kinase (unknown origin) by RT-PCR analysis	B	Nc1ncc(-c2ccc(N3CCNCC3)cc2)cc1-c1ccnc2ccccc12		CHEMBL3341791	=	Delta Tm	degrees C	6.9	CHEMBL4439	Homo sapiens	deltaTm	degrees C	6.9
	15060747	CHEMBL3365508	Inhibition of purified ALK5 kinase (unknown origin) by RT-PCR analysis	B	Nc1ncc(-c2cccc(N3CCNCC3)c2)cc1-c1ccnc2ccccc12		CHEMBL3341792	=	Delta Tm	degrees C	7.4	CHEMBL4439	Homo sapiens	deltaTm	degrees C	7.4
	15060748	CHEMBL3365508	Inhibition of purified ALK5 kinase (unknown origin) by RT-PCR analysis	B	Nc1ncc(-c2ccc(N3CCNCC3)cc2)cc1-c1cccc2ncccc12		CHEMBL3341793	=	Delta Tm	degrees C	5.3	CHEMBL4439	Homo sapiens	deltaTm	degrees C	5.3
	15060749	CHEMBL3365508	Inhibition of purified ALK5 kinase (unknown origin) by RT-PCR analysis	B	COc1cc(-c2cnn3cc(-c4ccc(N5CCNCC5)cc4)cnc23)cc(OC)c1OC		CHEMBL3341794	=	Delta Tm	degrees C	11.6	CHEMBL4439	Homo sapiens	deltaTm	degrees C	11.6
	15060750	CHEMBL3365508	Inhibition of purified ALK5 kinase (unknown origin) by RT-PCR analysis	B	COc1cc(OC)cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2)c1		CHEMBL3341795	=	Delta Tm	degrees C	8.1	CHEMBL4439	Homo sapiens	deltaTm	degrees C	8.1
	15060776	CHEMBL3365509	Inhibition of purified human ALK5 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	COc1cc(-c2cc(-c3cccc(O)c3)cnc2N)cc(OC)c1OC		CHEMBL1230714	=	IC50	nM	280.0	CHEMBL4439	Homo sapiens	IC50	nM	280.0
Not Determined	15060777	CHEMBL3365509	Inhibition of purified human ALK5 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	COc1cc(-c2cc(-c3ccc(O)cc3)cnc2N)cc(OC)c1OC		CHEMBL3341941		IC50			CHEMBL4439	Homo sapiens	IC50		
Not Determined	15060778	CHEMBL3365509	Inhibition of purified human ALK5 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	COc1cc(-c2cnc(N)c(-c3cc(OC)c(OC)c(OC)c3)c2)ccc1O		CHEMBL3341942		IC50			CHEMBL4439	Homo sapiens	IC50		
	15060779	CHEMBL3365509	Inhibition of purified human ALK5 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	COc1cc(-c2cc(-c3cccc(NS(C)(=O)=O)c3)cnc2N)cc(OC)c1OC		CHEMBL3341943	=	IC50	nM	180.0	CHEMBL4439	Homo sapiens	IC50	nM	180.0
	15060780	CHEMBL3365509	Inhibition of purified human ALK5 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	COc1cc(-c2cc(-c3cccc(N4CCNCC4)c3)cnc2N)cc(OC)c1OC		CHEMBL3341944	=	IC50	nM	49.0	CHEMBL4439	Homo sapiens	IC50	nM	49.0
	15060781	CHEMBL3365509	Inhibition of purified human ALK5 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)cc(OC)c1OC		CHEMBL3341945	=	IC50	nM	186.0	CHEMBL4439	Homo sapiens	IC50	nM	186.0
	15060782	CHEMBL3365509	Inhibition of purified human ALK5 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	COc1ccc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)cc1OC		CHEMBL3341946	=	IC50	nM	6900.0	CHEMBL4439	Homo sapiens	IC50	nM	6900.0
	15060783	CHEMBL3365509	Inhibition of purified human ALK5 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	COc1cc(OC)cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)c1		CHEMBL3341947	=	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	nM	1000.0
	15060784	CHEMBL3365509	Inhibition of purified human ALK5 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	COc1cccc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)c1		CHEMBL3341948	=	IC50	nM	12300.0	CHEMBL4439	Homo sapiens	IC50	nM	12300.0
	15060785	CHEMBL3365509	Inhibition of purified human ALK5 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	Nc1ncc(-c2ccc(N3CCNCC3)cc2)cc1-c1ccc2c(c1)OCCO2		CHEMBL3341949	=	IC50	nM	15000.0	CHEMBL4439	Homo sapiens	IC50	nM	15000.0
Not Determined	15060786	CHEMBL3365509	Inhibition of purified human ALK5 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	COc1ccc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)cc1		CHEMBL3341950		IC50			CHEMBL4439	Homo sapiens	IC50		
	15060787	CHEMBL3365509	Inhibition of purified human ALK5 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	CC(C)Oc1cccc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)c1		CHEMBL3341951	=	IC50	nM	1400.0	CHEMBL4439	Homo sapiens	IC50	nM	1400.0
	15060788	CHEMBL3365509	Inhibition of purified human ALK5 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)ccc1Cl		CHEMBL3341952	=	IC50	nM	1910.0	CHEMBL4439	Homo sapiens	IC50	nM	1910.0
	15060789	CHEMBL3365509	Inhibition of purified human ALK5 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)ccc1C		CHEMBL3341953	=	IC50	nM	21000.0	CHEMBL4439	Homo sapiens	IC50	nM	21000.0
Not Determined	15060790	CHEMBL3365509	Inhibition of purified human ALK5 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	CNc1ncc(-c2ccc(N3CCNCC3)cc2)cc1-c1cc(OC)c(OC)c(OC)c1		CHEMBL3341954		IC50			CHEMBL4439	Homo sapiens	IC50		
Not Determined	15060791	CHEMBL3365509	Inhibition of purified human ALK5 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N(C)C)cc(OC)c1OC		CHEMBL3341955		IC50			CHEMBL4439	Homo sapiens	IC50		
	15060792	CHEMBL3365509	Inhibition of purified human ALK5 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2)cc(OC)c1OC		CHEMBL3341787	=	IC50	nM	240.0	CHEMBL4439	Homo sapiens	IC50	nM	240.0
Not Determined	15060793	CHEMBL3365509	Inhibition of purified human ALK5 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2Cl)cc(OC)c1OC		CHEMBL3341788		IC50			CHEMBL4439	Homo sapiens	IC50		
	15060794	CHEMBL3365509	Inhibition of purified human ALK5 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2C)cc(OC)c1OC		CHEMBL3341789	=	IC50	nM	3000.0	CHEMBL4439	Homo sapiens	IC50	nM	3000.0
Not Determined	15060795	CHEMBL3365509	Inhibition of purified human ALK5 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2OC)cc(OC)c1OC		CHEMBL3341790		IC50			CHEMBL4439	Homo sapiens	IC50		
	15060796	CHEMBL3365509	Inhibition of purified human ALK5 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	Nc1ncc(-c2ccc(N3CCNCC3)cc2)cc1-c1ccnc2ccccc12		CHEMBL3341791	=	IC50	nM	21000.0	CHEMBL4439	Homo sapiens	IC50	nM	21000.0
	15060797	CHEMBL3365509	Inhibition of purified human ALK5 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	Nc1ncc(-c2cccc(N3CCNCC3)c2)cc1-c1ccnc2ccccc12		CHEMBL3341792	=	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	15060798	CHEMBL3365509	Inhibition of purified human ALK5 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	Nc1ncc(-c2ccc(N3CCNCC3)cc2)cc1-c1cccc2ncccc12		CHEMBL3341793	=	IC50	nM	99000.0	CHEMBL4439	Homo sapiens	IC50	nM	99000.0
	15060799	CHEMBL3365509	Inhibition of purified human ALK5 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	COc1cc(-c2cnn3cc(-c4ccc(N5CCNCC5)cc4)cnc23)cc(OC)c1OC		CHEMBL3341794	=	IC50	nM	30.0	CHEMBL4439	Homo sapiens	IC50	nM	30.0
Not Determined	15060800	CHEMBL3365509	Inhibition of purified human ALK5 kinase after 45 mins by liquid scintillation counting in presence of ATP [gamma-32P]	B	COc1cc(OC)cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2)c1		CHEMBL3341795		IC50			CHEMBL4439	Homo sapiens	IC50		
	15060826	CHEMBL3365512	Inhibition of TGFbeta1-induced TGFbeta type 1 ALK5 in HEK293T cells after 30 mins by luciferase reporter gene assay	B	COc1cc(-c2cc(-c3cccc(O)c3)cnc2N)cc(OC)c1OC		CHEMBL1230714	=	IC50	nM	3400.0	CHEMBL4439	Homo sapiens	IC50	nM	3400.0
	15060827	CHEMBL3365512	Inhibition of TGFbeta1-induced TGFbeta type 1 ALK5 in HEK293T cells after 30 mins by luciferase reporter gene assay	B	COc1cc(-c2cc(-c3ccc(O)cc3)cnc2N)cc(OC)c1OC		CHEMBL3341941	=	IC50	nM	580.0	CHEMBL4439	Homo sapiens	IC50	nM	580.0
	15060828	CHEMBL3365512	Inhibition of TGFbeta1-induced TGFbeta type 1 ALK5 in HEK293T cells after 30 mins by luciferase reporter gene assay	B	COc1cc(-c2cnc(N)c(-c3cc(OC)c(OC)c(OC)c3)c2)ccc1O		CHEMBL3341942	=	IC50	nM	2300.0	CHEMBL4439	Homo sapiens	IC50	nM	2300.0
	15060829	CHEMBL3365512	Inhibition of TGFbeta1-induced TGFbeta type 1 ALK5 in HEK293T cells after 30 mins by luciferase reporter gene assay	B	COc1cc(-c2cc(-c3cccc(NS(C)(=O)=O)c3)cnc2N)cc(OC)c1OC		CHEMBL3341943	=	IC50	nM	260.0	CHEMBL4439	Homo sapiens	IC50	nM	260.0
	15060830	CHEMBL3365512	Inhibition of TGFbeta1-induced TGFbeta type 1 ALK5 in HEK293T cells after 30 mins by luciferase reporter gene assay	B	COc1cc(-c2cc(-c3cccc(N4CCNCC4)c3)cnc2N)cc(OC)c1OC		CHEMBL3341944	=	IC50	nM	110.0	CHEMBL4439	Homo sapiens	IC50	nM	110.0
	15060831	CHEMBL3365512	Inhibition of TGFbeta1-induced TGFbeta type 1 ALK5 in HEK293T cells after 30 mins by luciferase reporter gene assay	B	COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)cc(OC)c1OC		CHEMBL3341945	=	IC50	nM	100.0	CHEMBL4439	Homo sapiens	IC50	nM	100.0
	15060832	CHEMBL3365512	Inhibition of TGFbeta1-induced TGFbeta type 1 ALK5 in HEK293T cells after 30 mins by luciferase reporter gene assay	B	COc1ccc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)cc1OC		CHEMBL3341946	=	IC50	nM	13100.0	CHEMBL4439	Homo sapiens	IC50	nM	13100.0
	15060833	CHEMBL3365512	Inhibition of TGFbeta1-induced TGFbeta type 1 ALK5 in HEK293T cells after 30 mins by luciferase reporter gene assay	B	COc1cc(OC)cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)c1		CHEMBL3341947	=	IC50	nM	650.0	CHEMBL4439	Homo sapiens	IC50	nM	650.0
	15060834	CHEMBL3365512	Inhibition of TGFbeta1-induced TGFbeta type 1 ALK5 in HEK293T cells after 30 mins by luciferase reporter gene assay	B	COc1cccc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)c1		CHEMBL3341948	=	IC50	nM	3800.0	CHEMBL4439	Homo sapiens	IC50	nM	3800.0
	15060835	CHEMBL3365512	Inhibition of TGFbeta1-induced TGFbeta type 1 ALK5 in HEK293T cells after 30 mins by luciferase reporter gene assay	B	Nc1ncc(-c2ccc(N3CCNCC3)cc2)cc1-c1ccc2c(c1)OCCO2		CHEMBL3341949	=	IC50	nM	38000.0	CHEMBL4439	Homo sapiens	IC50	nM	38000.0
	15060836	CHEMBL3365512	Inhibition of TGFbeta1-induced TGFbeta type 1 ALK5 in HEK293T cells after 30 mins by luciferase reporter gene assay	B	COc1ccc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)cc1		CHEMBL3341950	=	IC50	nM	95000.0	CHEMBL4439	Homo sapiens	IC50	nM	95000.0
	15060837	CHEMBL3365512	Inhibition of TGFbeta1-induced TGFbeta type 1 ALK5 in HEK293T cells after 30 mins by luciferase reporter gene assay	B	CC(C)Oc1cccc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)c1		CHEMBL3341951	=	IC50	nM	2600.0	CHEMBL4439	Homo sapiens	IC50	nM	2600.0
	15060838	CHEMBL3365512	Inhibition of TGFbeta1-induced TGFbeta type 1 ALK5 in HEK293T cells after 30 mins by luciferase reporter gene assay	B	COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)ccc1Cl		CHEMBL3341952	=	IC50	nM	5800.0	CHEMBL4439	Homo sapiens	IC50	nM	5800.0
	15060839	CHEMBL3365512	Inhibition of TGFbeta1-induced TGFbeta type 1 ALK5 in HEK293T cells after 30 mins by luciferase reporter gene assay	B	COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)ccc1C		CHEMBL3341953	=	IC50	nM	35500.0	CHEMBL4439	Homo sapiens	IC50	nM	35500.0
	15060840	CHEMBL3365512	Inhibition of TGFbeta1-induced TGFbeta type 1 ALK5 in HEK293T cells after 30 mins by luciferase reporter gene assay	B	CNc1ncc(-c2ccc(N3CCNCC3)cc2)cc1-c1cc(OC)c(OC)c(OC)c1		CHEMBL3341954	=	IC50	nM	28000.0	CHEMBL4439	Homo sapiens	IC50	nM	28000.0
	15060841	CHEMBL3365512	Inhibition of TGFbeta1-induced TGFbeta type 1 ALK5 in HEK293T cells after 30 mins by luciferase reporter gene assay	B	COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N(C)C)cc(OC)c1OC	Outside typical range	CHEMBL3341955	=	IC50	nM	115000.0	CHEMBL4439	Homo sapiens	IC50	nM	115000.0
	15060842	CHEMBL3365512	Inhibition of TGFbeta1-induced TGFbeta type 1 ALK5 in HEK293T cells after 30 mins by luciferase reporter gene assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2)cc(OC)c1OC		CHEMBL3341787	=	IC50	nM	1300.0	CHEMBL4439	Homo sapiens	IC50	nM	1300.0
	15060843	CHEMBL3365512	Inhibition of TGFbeta1-induced TGFbeta type 1 ALK5 in HEK293T cells after 30 mins by luciferase reporter gene assay	B	COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2Cl)cc(OC)c1OC		CHEMBL3341788	=	IC50	nM	99000.0	CHEMBL4439	Homo sapiens	IC50	nM	99000.0
	15060844	CHEMBL3365512	Inhibition of TGFbeta1-induced TGFbeta type 1 ALK5 in HEK293T cells after 30 mins by luciferase reporter gene assay	B	COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2C)cc(OC)c1OC		CHEMBL3341789	=	IC50	nM	16000.0	CHEMBL4439	Homo sapiens	IC50	nM	16000.0
	15060845	CHEMBL3365512	Inhibition of TGFbeta1-induced TGFbeta type 1 ALK5 in HEK293T cells after 30 mins by luciferase reporter gene assay	B	COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2OC)cc(OC)c1OC		CHEMBL3341790	=	IC50	nM	82000.0	CHEMBL4439	Homo sapiens	IC50	nM	82000.0
	15060846	CHEMBL3365512	Inhibition of TGFbeta1-induced TGFbeta type 1 ALK5 in HEK293T cells after 30 mins by luciferase reporter gene assay	B	Nc1ncc(-c2ccc(N3CCNCC3)cc2)cc1-c1ccnc2ccccc12		CHEMBL3341791	=	IC50	nM	4300.0	CHEMBL4439	Homo sapiens	IC50	nM	4300.0
	15060847	CHEMBL3365512	Inhibition of TGFbeta1-induced TGFbeta type 1 ALK5 in HEK293T cells after 30 mins by luciferase reporter gene assay	B	Nc1ncc(-c2cccc(N3CCNCC3)c2)cc1-c1ccnc2ccccc12		CHEMBL3341792	=	IC50	nM	2800.0	CHEMBL4439	Homo sapiens	IC50	nM	2800.0
	15060848	CHEMBL3365512	Inhibition of TGFbeta1-induced TGFbeta type 1 ALK5 in HEK293T cells after 30 mins by luciferase reporter gene assay	B	Nc1ncc(-c2ccc(N3CCNCC3)cc2)cc1-c1cccc2ncccc12		CHEMBL3341793	=	IC50	nM	34800.0	CHEMBL4439	Homo sapiens	IC50	nM	34800.0
	15060849	CHEMBL3365512	Inhibition of TGFbeta1-induced TGFbeta type 1 ALK5 in HEK293T cells after 30 mins by luciferase reporter gene assay	B	COc1cc(-c2cnn3cc(-c4ccc(N5CCNCC5)cc4)cnc23)cc(OC)c1OC		CHEMBL3341794	=	IC50	nM	760.0	CHEMBL4439	Homo sapiens	IC50	nM	760.0
	15060850	CHEMBL3365512	Inhibition of TGFbeta1-induced TGFbeta type 1 ALK5 in HEK293T cells after 30 mins by luciferase reporter gene assay	B	COc1cc(OC)cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2)c1		CHEMBL3341795	=	IC50	nM	26000.0	CHEMBL4439	Homo sapiens	IC50	nM	26000.0
	15072588	CHEMBL3388696	Inhibition of TGFBR1 (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	108.0	CHEMBL4439	Homo sapiens	Activity	%	108.0
	15088857	CHEMBL3373459	Inhibition of TGFBR1 (unknown origin) assessed as reduction in enzyme activity at 100 uM using GST-ALK5, GST-SMAD2 and ATP incubated for 45 mins by top count method	B	O=c1cc[nH]c2ncnc(Nc3ccncc3)c12		CHEMBL3353019	=	Inhibition	%	41.0	CHEMBL4439	Homo sapiens	INH	%	41.0
	15088858	CHEMBL3373459	Inhibition of TGFBR1 (unknown origin) assessed as reduction in enzyme activity at 100 uM using GST-ALK5, GST-SMAD2 and ATP incubated for 45 mins by top count method	B	Nc1cccc(Nc2ncnc3[nH]ccc(=O)c23)c1		CHEMBL3353018	=	Inhibition	%	8.0	CHEMBL4439	Homo sapiens	INH	%	8.0
	15088859	CHEMBL3373459	Inhibition of TGFBR1 (unknown origin) assessed as reduction in enzyme activity at 100 uM using GST-ALK5, GST-SMAD2 and ATP incubated for 45 mins by top count method	B	Nc1ccc(Nc2ncnc3[nH]ccc(=O)c23)cc1		CHEMBL3353017	=	Inhibition	%	31.0	CHEMBL4439	Homo sapiens	INH	%	31.0
	15088860	CHEMBL3373459	Inhibition of TGFBR1 (unknown origin) assessed as reduction in enzyme activity at 100 uM using GST-ALK5, GST-SMAD2 and ATP incubated for 45 mins by top count method	B	Nc1ccc(-n2ccc(=O)c3c(N)ncnc32)cc1		CHEMBL3353016	=	Inhibition	%	14.0	CHEMBL4439	Homo sapiens	INH	%	14.0
	15088861	CHEMBL3373459	Inhibition of TGFBR1 (unknown origin) assessed as reduction in enzyme activity at 100 uM using GST-ALK5, GST-SMAD2 and ATP incubated for 45 mins by top count method	B	Nc1ncnc2nccc(O)c12		CHEMBL122927	=	Inhibition	%	6.0	CHEMBL4439	Homo sapiens	INH	%	6.0
	15755934	CHEMBL3631585	Inhibition of TGFBR1 (unknown origin) assessed as remaining activity at 10 uM by high-throughput assay relative to control	B	O=C1c2ccccc2-c2c1oc1ccccc1c2=O		CHEMBL3629616	=	Activity	%	81.0	CHEMBL4439	Homo sapiens	Activity	%	81.0
	15756111	CHEMBL3631723	Inhibition of ALK5 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	69.57	CHEMBL4439	Homo sapiens	INH	%	69.57
	15757706	CHEMBL3631723	Inhibition of ALK5 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	-8.74	CHEMBL4439	Homo sapiens	INH	%	-8.74
	15757988	CHEMBL3631723	Inhibition of ALK5 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	-7.32	CHEMBL4439	Homo sapiens	INH	%	-7.32
	15766650	CHEMBL3635884	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 insect cells using casein as substrate by proprietary radioisotopic protein kinase assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	IC50	nM	9.67	CHEMBL4439	Homo sapiens	IC50	nM	9.67
	15766651	CHEMBL3635884	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 insect cells using casein as substrate by proprietary radioisotopic protein kinase assay	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	=	IC50	nM	69.4	CHEMBL4439	Homo sapiens	IC50	nM	69.4
	15766652	CHEMBL3635884	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 insect cells using casein as substrate by proprietary radioisotopic protein kinase assay	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	IC50	nM	34.9	CHEMBL4439	Homo sapiens	IC50	nM	34.9
	15766653	CHEMBL3635884	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 insect cells using casein as substrate by proprietary radioisotopic protein kinase assay	B	C=Cc1cccc(NCc2nc(-c3ccc4ncnn4c3)c(-c3ccc(F)c(C)n3)[nH]2)c1		CHEMBL3634801	=	IC50	nM	13.7	CHEMBL4439	Homo sapiens	IC50	nM	13.7
	15766654	CHEMBL3635884	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 insect cells using casein as substrate by proprietary radioisotopic protein kinase assay	B	Cc1nc(-c2[nH]c(CNc3cccc(C(N)=O)c3)nc2-c2ccc3ncnn3c2)ccc1F		CHEMBL3634800	=	IC50	nM	10.8	CHEMBL4439	Homo sapiens	IC50	nM	10.8
	15766655	CHEMBL3635884	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 insect cells using casein as substrate by proprietary radioisotopic protein kinase assay	B	Cc1nc(-c2[nH]c(CNc3cccc(C#N)c3)nc2-c2ccc3ncnn3c2)ccc1F		CHEMBL3634799	=	IC50	nM	7.68	CHEMBL4439	Homo sapiens	IC50	nM	7.68
	15766656	CHEMBL3635884	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 insect cells using casein as substrate by proprietary radioisotopic protein kinase assay	B	Cc1nc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)ccc1F		CHEMBL3634712	=	IC50	nM	12.5	CHEMBL4439	Homo sapiens	IC50	nM	12.5
	15766657	CHEMBL3635884	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 insect cells using casein as substrate by proprietary radioisotopic protein kinase assay	B	Cc1nc(-c2[nH]c(CNc3ccccc3)nc2-c2ccc3ncnn3c2)ccc1F		CHEMBL3634711	=	IC50	nM	9.23	CHEMBL4439	Homo sapiens	IC50	nM	9.23
	15766658	CHEMBL3635884	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 insect cells using casein as substrate by proprietary radioisotopic protein kinase assay	B	Cc1cc(F)cc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3634710	=	IC50	nM	41.9	CHEMBL4439	Homo sapiens	IC50	nM	41.9
	15766659	CHEMBL3635884	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 insect cells using casein as substrate by proprietary radioisotopic protein kinase assay	B	Cc1cc(F)cc(-c2[nH]c(CNc3ccccc3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3634709	=	IC50	nM	72.5	CHEMBL4439	Homo sapiens	IC50	nM	72.5
	15766660	CHEMBL3635884	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 insect cells using casein as substrate by proprietary radioisotopic protein kinase assay	B	C=Cc1cccc(NCc2nc(-c3ccc4ncnn4c3)c(-c3nc(C)ccc3F)[nH]2)c1		CHEMBL3634708	=	IC50	nM	9.81	CHEMBL4439	Homo sapiens	IC50	nM	9.81
	15766661	CHEMBL3635884	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 insect cells using casein as substrate by proprietary radioisotopic protein kinase assay	B	Cc1ccc(F)c(-c2[nH]c(CNc3cccc(C(N)=O)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3634707	=	IC50	nM	11.0	CHEMBL4439	Homo sapiens	IC50	nM	11.0
	15766662	CHEMBL3635884	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 insect cells using casein as substrate by proprietary radioisotopic protein kinase assay	B	Cc1ccc(F)c(-c2[nH]c(CNc3cccc(C#N)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3634706	=	IC50	nM	9.23	CHEMBL4439	Homo sapiens	IC50	nM	9.23
	15766663	CHEMBL3635884	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 insect cells using casein as substrate by proprietary radioisotopic protein kinase assay	B	Cc1ccc(F)c(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3634705	=	IC50	nM	12.1	CHEMBL4439	Homo sapiens	IC50	nM	12.1
	15766664	CHEMBL3635884	Inhibition of human recombinant GST-fused ALK5 expressed in Sf9 insect cells using casein as substrate by proprietary radioisotopic protein kinase assay	B	Cc1ccc(F)c(-c2[nH]c(CNc3ccccc3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3634704	=	IC50	nM	9.76	CHEMBL4439	Homo sapiens	IC50	nM	9.76
	15766692	CHEMBL3635887	Inhibition of ALK5 in human HaCaT cells assessed as residual enzyme activity at 100 nM by p3TP-luciferase assay relative to control	B	Cc1nc(-c2[nH]c(CNc3cccc(C#N)c3)nc2-c2ccc3ncnn3c2)ccc1F		CHEMBL3634799	=	Activity	%	18.0	CHEMBL4439	Homo sapiens	Activity	%	18.0
	15766693	CHEMBL3635887	Inhibition of ALK5 in human HaCaT cells assessed as residual enzyme activity at 100 nM by p3TP-luciferase assay relative to control	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Activity	%	45.0	CHEMBL4439	Homo sapiens	Activity	%	45.0
	15766694	CHEMBL3635887	Inhibition of ALK5 in human HaCaT cells assessed as residual enzyme activity at 100 nM by p3TP-luciferase assay relative to control	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	=	Activity	%	140.0	CHEMBL4439	Homo sapiens	Activity	%	140.0
	15766695	CHEMBL3635887	Inhibition of ALK5 in human HaCaT cells assessed as residual enzyme activity at 100 nM by p3TP-luciferase assay relative to control	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	Activity	%	35.0	CHEMBL4439	Homo sapiens	Activity	%	35.0
303517	16260633	CHEMBL3707741	Kinase Assay: Kinase assays were performed using the assay kit by Reaction Biology Corp (Malvern, Pa.). The compounds were tested at 10 concentrations by 3-fold serial dilutions starting at 30 μM. Staurosporin was used as a control nonspecific kinase inhibitor. In vitro kinase reactions using purified kinases were carried out in the presence of 10 μM ATP and test compounds.	B	CN(C)CCCOc1ccc(-c2cnc3c(-c4ccnc5ccccc45)cnn3c2)cc1		CHEMBL3668019	=	IC50	nM	998.99	CHEMBL4439	Homo sapiens	IC50	nM	998.99
303518	16277714	CHEMBL3707741	Kinase Assay: Kinase assays were performed using the assay kit by Reaction Biology Corp (Malvern, Pa.). The compounds were tested at 10 concentrations by 3-fold serial dilutions starting at 30 μM. Staurosporin was used as a control nonspecific kinase inhibitor. In vitro kinase reactions using purified kinases were carried out in the presence of 10 μM ATP and test compounds.	B	c1ccc(-c2cnn3cc(-c4ccc(N5CCNCC5)cc4)cnc23)cc1		CHEMBL2385590	=	IC50	nM	565.0	CHEMBL4439	Homo sapiens	IC50	nM	565.0
303516	16337880	CHEMBL3707741	Kinase Assay: Kinase assays were performed using the assay kit by Reaction Biology Corp (Malvern, Pa.). The compounds were tested at 10 concentrations by 3-fold serial dilutions starting at 30 μM. Staurosporin was used as a control nonspecific kinase inhibitor. In vitro kinase reactions using purified kinases were carried out in the presence of 10 μM ATP and test compounds.	B	c1ccc2c(-c3cnn4cc(-c5ccc(OCCN6CCOCC6)cc5)cnc34)ccnc2c1		CHEMBL3668018	=	IC50	nM	1578.0	CHEMBL4439	Homo sapiens	IC50	nM	1578.003
303519	16345712	CHEMBL3707741	Kinase Assay: Kinase assays were performed using the assay kit by Reaction Biology Corp (Malvern, Pa.). The compounds were tested at 10 concentrations by 3-fold serial dilutions starting at 30 μM. Staurosporin was used as a control nonspecific kinase inhibitor. In vitro kinase reactions using purified kinases were carried out in the presence of 10 μM ATP and test compounds.	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	IC50	nM	10760.0	CHEMBL4439	Homo sapiens	IC50	nM	10760.0
	16419334	CHEMBL3748099	Inhibition of human ALK5 in presence of (33P)gamma ATP	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	IC50	uM	10.0
	16419335	CHEMBL3748099	Inhibition of human ALK5 in presence of (33P)gamma ATP	B	c1ccc2c(-c3cnn4cc(-c5ccc(N6CCNCC6)cc5)cnc34)ccnc2c1		CHEMBL513147	=	IC50	nM	500.0	CHEMBL4439	Homo sapiens	IC50	uM	0.5
	16426136	CHEMBL3750463	Inhibition of TGFBR1 (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1	Outside typical range	CHEMBL3746293	=	Inhibition	%	-15.1	CHEMBL4439	Homo sapiens	INH	%	-15.1
	16431729	CHEMBL3748985	Inhibition of human ALK5 using casein as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	IC50	uM	10.0
	16451627	CHEMBL3761208	Inhibition of TGFBR1 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	97.9	CHEMBL4439	Homo sapiens	INH	%	97.9
	16486393	CHEMBL3772127	Inhibition of human recombinant TGFBR1 assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control	B	Cc1c(Cl)cccc1NC(=O)c1sc2nc3c(cc2c1N)C(=O)CC3		CHEMBL3771285	=	Activity	%	100.0	CHEMBL4439	Homo sapiens	Activity	%	100.0
	16495242	CHEMBL3778885	Inhibition of N-terminal His6-tagged recombinant human TGFBR1 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-13.0	CHEMBL4439	Homo sapiens	Activity	%	-13.0
	16496161	CHEMBL3778885	Inhibition of N-terminal His6-tagged recombinant human TGFBR1 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	2.0	CHEMBL4439	Homo sapiens	Activity	%	2.0
	16508951	CHEMBL3778885	Inhibition of N-terminal His6-tagged recombinant human TGFBR1 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	-33.0	CHEMBL4439	Homo sapiens	Activity	%	-33.0
Not Active	16515658	CHEMBL3782399	Inhibition of partial length human TGFBR1 expressed in bacterial system at 1 uM	B	Cc1cnc(N)nc1OCC(C)(C)CO		CHEMBL3780032		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
	16578326	CHEMBL3804380	Inhibition of partial length wild type human TGFBR1 expressed in bacterial system assessed as enzyme activity at 1 uM relative to control	B	CN(C)S(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F		CHEMBL3798256	=	Activity	%	65.0	CHEMBL4439	Homo sapiens	Activity	%	65.0
	16594836	CHEMBL3812901	Inhibition of human TGFBR1 (179 to 503 amino acid residues) expressed in bacterial system assessed as enzyme activity at 10 uM by KINOMEScan assay	B	O=C1C2=C(C(=O)c3c(O)ccc(O)c31)[C@@H](O)[C@@H](O)[C@@H](O)C2		CHEMBL1987813	=	Activity	%	100.0	CHEMBL4439	Homo sapiens	Activity	%	100.0
	16613768	CHEMBL3816561	Inhibition of human ALK5 at 1 uM using casein as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	5.0	CHEMBL4439	Homo sapiens	INH	%	5.0
	16628459	CHEMBL3820162	Inhibition of ALK5 in recombinant human MDA-MB-468 cells assessed as translocation of GFP-smad2	B	O=C(Nc1cc(Nc2c(Cl)cnc3c2OCO3)ccn1)C1CC1	Non standard unit for type	CHEMBL3818173	=	INH	uM	0.12	CHEMBL4439	Homo sapiens	INH	uM	0.12
	16628464	CHEMBL3820167	Inhibition of full length human N-terminal GST-tagged ALK5 expressed in baculovirus by FRET assay	B	O=C(Nc1cc(Nc2c(Cl)cnc3c2OCO3)ccn1)C1CC1		CHEMBL3818173	=	IC50	nM	1.9	CHEMBL4439	Homo sapiens	IC50	nM	1.9
	16633215	CHEMBL3826650	Inhibition of TGFBR1 (unknown origin)	B	COc1cc(-c2cn(C)c(=O)c3cnccc23)cc(OC)c1CN(C)C		CHEMBL3823478	=	IC50	nM	3850.0	CHEMBL4439	Homo sapiens	IC50	nM	3850.0
	16633216	CHEMBL3826650	Inhibition of TGFBR1 (unknown origin)	B	COc1cc(-c2cn(C)c(=O)c3cnccc23)c(OC)cc1CN(C)C		CHEMBL3823101	=	IC50	nM	5140.0	CHEMBL4439	Homo sapiens	IC50	nM	5140.0
	16633277	CHEMBL3826500	Inhibition of TGFBR1 (unknown origin) assessed as remaining activity at 10 uM	B	COc1cc(-c2cn(C)c(=O)c3cnccc23)c(OC)cc1CN(C)C		CHEMBL3823101	=	Activity	%	74.0	CHEMBL4439	Homo sapiens	Activity	%	74.0
255866	17638634	CHEMBL3705801	Signal Transduction Inhibitory Assay: The biological activity of a compound was determined by measuring the activation of Smad3/Smad4 complex which is a transcription factor showing activation induced by TGF-beta stimulation. That is, a reporter plasmid having a DNA sequence (CAGA sequence), which is activated by binding to Smad3/Smad4 complex, is linked to the upstream of the luciferase gene (luminescence enzyme) was prepared. Mink lung epithelial cells CCL64 (named as x9CAGA/CCL64 cells) stably incorporating this reporter plasmid were established. The x9CAGA/CCL64 cells were cultured in DMEM medium containing 10% FBS, penicillin (100 U/ml), streptomycin (100 g/ml), and blasticidin S (1 ug/ml). The x9CAGA/CCL64 cells were seeded in a 96 well plate at a concentration of 10000 cells/well, and cultured in a 5% CO2 incubator at 37C. The next day, the medium was changed to DMEM medium containing 0.2% FBS, and the test compound was added.	B	CC(C)(C)OC(=O)N1CCC(CNS(=O)(=O)c2cccc(S(=O)(=O)Nc3ccccc3)c2)CC1		CHEMBL3701790	=	IC50	nM	27000.0	CHEMBL4439	Homo sapiens	IC50	nM	27000.0
255867	17638635	CHEMBL3705801	Signal Transduction Inhibitory Assay: The biological activity of a compound was determined by measuring the activation of Smad3/Smad4 complex which is a transcription factor showing activation induced by TGF-beta stimulation. That is, a reporter plasmid having a DNA sequence (CAGA sequence), which is activated by binding to Smad3/Smad4 complex, is linked to the upstream of the luciferase gene (luminescence enzyme) was prepared. Mink lung epithelial cells CCL64 (named as x9CAGA/CCL64 cells) stably incorporating this reporter plasmid were established. The x9CAGA/CCL64 cells were cultured in DMEM medium containing 10% FBS, penicillin (100 U/ml), streptomycin (100 g/ml), and blasticidin S (1 ug/ml). The x9CAGA/CCL64 cells were seeded in a 96 well plate at a concentration of 10000 cells/well, and cultured in a 5% CO2 incubator at 37C. The next day, the medium was changed to DMEM medium containing 0.2% FBS, and the test compound was added.	B	COc1ccc(NS(=O)(=O)c2cccc(S(=O)(=O)NCC3CCN(C(=O)OC(C)(C)C)CC3)c2)cc1		CHEMBL3701791	=	IC50	nM	17000.0	CHEMBL4439	Homo sapiens	IC50	nM	17000.0
255868	17638636	CHEMBL3705801	Signal Transduction Inhibitory Assay: The biological activity of a compound was determined by measuring the activation of Smad3/Smad4 complex which is a transcription factor showing activation induced by TGF-beta stimulation. That is, a reporter plasmid having a DNA sequence (CAGA sequence), which is activated by binding to Smad3/Smad4 complex, is linked to the upstream of the luciferase gene (luminescence enzyme) was prepared. Mink lung epithelial cells CCL64 (named as x9CAGA/CCL64 cells) stably incorporating this reporter plasmid were established. The x9CAGA/CCL64 cells were cultured in DMEM medium containing 10% FBS, penicillin (100 U/ml), streptomycin (100 g/ml), and blasticidin S (1 ug/ml). The x9CAGA/CCL64 cells were seeded in a 96 well plate at a concentration of 10000 cells/well, and cultured in a 5% CO2 incubator at 37C. The next day, the medium was changed to DMEM medium containing 0.2% FBS, and the test compound was added.	B	COc1cccc(NS(=O)(=O)c2cccc(S(=O)(=O)NCC3CCN(C(=O)OC(C)(C)C)CC3)c2)c1		CHEMBL3701792	=	IC50	nM	22000.0	CHEMBL4439	Homo sapiens	IC50	nM	22000.0
255869	17638637	CHEMBL3705801	Signal Transduction Inhibitory Assay: The biological activity of a compound was determined by measuring the activation of Smad3/Smad4 complex which is a transcription factor showing activation induced by TGF-beta stimulation. That is, a reporter plasmid having a DNA sequence (CAGA sequence), which is activated by binding to Smad3/Smad4 complex, is linked to the upstream of the luciferase gene (luminescence enzyme) was prepared. Mink lung epithelial cells CCL64 (named as x9CAGA/CCL64 cells) stably incorporating this reporter plasmid were established. The x9CAGA/CCL64 cells were cultured in DMEM medium containing 10% FBS, penicillin (100 U/ml), streptomycin (100 g/ml), and blasticidin S (1 ug/ml). The x9CAGA/CCL64 cells were seeded in a 96 well plate at a concentration of 10000 cells/well, and cultured in a 5% CO2 incubator at 37C. The next day, the medium was changed to DMEM medium containing 0.2% FBS, and the test compound was added.	B	COc1ccccc1NS(=O)(=O)c1cccc(S(=O)(=O)NCC2CCN(C(=O)OC(C)(C)C)CC2)c1		CHEMBL3701793	=	IC50	nM	30000.0	CHEMBL4439	Homo sapiens	IC50	nM	30000.0
255870	17638638	CHEMBL3705801	Signal Transduction Inhibitory Assay: The biological activity of a compound was determined by measuring the activation of Smad3/Smad4 complex which is a transcription factor showing activation induced by TGF-beta stimulation. That is, a reporter plasmid having a DNA sequence (CAGA sequence), which is activated by binding to Smad3/Smad4 complex, is linked to the upstream of the luciferase gene (luminescence enzyme) was prepared. Mink lung epithelial cells CCL64 (named as x9CAGA/CCL64 cells) stably incorporating this reporter plasmid were established. The x9CAGA/CCL64 cells were cultured in DMEM medium containing 10% FBS, penicillin (100 U/ml), streptomycin (100 g/ml), and blasticidin S (1 ug/ml). The x9CAGA/CCL64 cells were seeded in a 96 well plate at a concentration of 10000 cells/well, and cultured in a 5% CO2 incubator at 37C. The next day, the medium was changed to DMEM medium containing 0.2% FBS, and the test compound was added.	B	CC(C)(C)OC(=O)N1CCC(CNS(=O)(=O)c2cccc(S(=O)(=O)Nc3ccc(C(F)(F)F)cc3)c2)CC1		CHEMBL3701794	=	IC50	nM	8000.0	CHEMBL4439	Homo sapiens	IC50	nM	8000.0
255871	17638639	CHEMBL3705801	Signal Transduction Inhibitory Assay: The biological activity of a compound was determined by measuring the activation of Smad3/Smad4 complex which is a transcription factor showing activation induced by TGF-beta stimulation. That is, a reporter plasmid having a DNA sequence (CAGA sequence), which is activated by binding to Smad3/Smad4 complex, is linked to the upstream of the luciferase gene (luminescence enzyme) was prepared. Mink lung epithelial cells CCL64 (named as x9CAGA/CCL64 cells) stably incorporating this reporter plasmid were established. The x9CAGA/CCL64 cells were cultured in DMEM medium containing 10% FBS, penicillin (100 U/ml), streptomycin (100 g/ml), and blasticidin S (1 ug/ml). The x9CAGA/CCL64 cells were seeded in a 96 well plate at a concentration of 10000 cells/well, and cultured in a 5% CO2 incubator at 37C. The next day, the medium was changed to DMEM medium containing 0.2% FBS, and the test compound was added.	B	CC(=O)Nc1ccccc1NS(=O)(=O)c1cccc(S(=O)(=O)NCC2CCN(C(=O)OC(C)(C)C)CC2)c1		CHEMBL3701795	=	IC50	nM	18000.0	CHEMBL4439	Homo sapiens	IC50	nM	18000.0
255872	17638640	CHEMBL3705801	Signal Transduction Inhibitory Assay: The biological activity of a compound was determined by measuring the activation of Smad3/Smad4 complex which is a transcription factor showing activation induced by TGF-beta stimulation. That is, a reporter plasmid having a DNA sequence (CAGA sequence), which is activated by binding to Smad3/Smad4 complex, is linked to the upstream of the luciferase gene (luminescence enzyme) was prepared. Mink lung epithelial cells CCL64 (named as x9CAGA/CCL64 cells) stably incorporating this reporter plasmid were established. The x9CAGA/CCL64 cells were cultured in DMEM medium containing 10% FBS, penicillin (100 U/ml), streptomycin (100 g/ml), and blasticidin S (1 ug/ml). The x9CAGA/CCL64 cells were seeded in a 96 well plate at a concentration of 10000 cells/well, and cultured in a 5% CO2 incubator at 37C. The next day, the medium was changed to DMEM medium containing 0.2% FBS, and the test compound was added.	B	Cc1ccccc1NS(=O)(=O)c1cccc(S(=O)(=O)NCC2CCN(C(=O)OC(C)(C)C)CC2)c1		CHEMBL3701796	=	IC50	nM	14000.0	CHEMBL4439	Homo sapiens	IC50	nM	14000.0
255873	17638641	CHEMBL3705801	Signal Transduction Inhibitory Assay: The biological activity of a compound was determined by measuring the activation of Smad3/Smad4 complex which is a transcription factor showing activation induced by TGF-beta stimulation. That is, a reporter plasmid having a DNA sequence (CAGA sequence), which is activated by binding to Smad3/Smad4 complex, is linked to the upstream of the luciferase gene (luminescence enzyme) was prepared. Mink lung epithelial cells CCL64 (named as x9CAGA/CCL64 cells) stably incorporating this reporter plasmid were established. The x9CAGA/CCL64 cells were cultured in DMEM medium containing 10% FBS, penicillin (100 U/ml), streptomycin (100 g/ml), and blasticidin S (1 ug/ml). The x9CAGA/CCL64 cells were seeded in a 96 well plate at a concentration of 10000 cells/well, and cultured in a 5% CO2 incubator at 37C. The next day, the medium was changed to DMEM medium containing 0.2% FBS, and the test compound was added.	B	CC(C)(C)OC(=O)N1CCC(CNS(=O)(=O)c2cccc(S(=O)(=O)Nc3ccc(C(C)(C)C)cc3)c2)CC1		CHEMBL3701797	=	IC50	nM	2000.0	CHEMBL4439	Homo sapiens	IC50	nM	2000.0
255874	17638642	CHEMBL3705801	Signal Transduction Inhibitory Assay: The biological activity of a compound was determined by measuring the activation of Smad3/Smad4 complex which is a transcription factor showing activation induced by TGF-beta stimulation. That is, a reporter plasmid having a DNA sequence (CAGA sequence), which is activated by binding to Smad3/Smad4 complex, is linked to the upstream of the luciferase gene (luminescence enzyme) was prepared. Mink lung epithelial cells CCL64 (named as x9CAGA/CCL64 cells) stably incorporating this reporter plasmid were established. The x9CAGA/CCL64 cells were cultured in DMEM medium containing 10% FBS, penicillin (100 U/ml), streptomycin (100 g/ml), and blasticidin S (1 ug/ml). The x9CAGA/CCL64 cells were seeded in a 96 well plate at a concentration of 10000 cells/well, and cultured in a 5% CO2 incubator at 37C. The next day, the medium was changed to DMEM medium containing 0.2% FBS, and the test compound was added.	B	CC(C)(C)OC(=O)N1CCC(CNS(=O)(=O)c2cccc(S(=O)(=O)Nc3ccc(N4CCCCC4)cc3)c2)CC1		CHEMBL3701798	=	IC50	nM	2400.0	CHEMBL4439	Homo sapiens	IC50	nM	2400.0
255875	17638643	CHEMBL3705801	Signal Transduction Inhibitory Assay: The biological activity of a compound was determined by measuring the activation of Smad3/Smad4 complex which is a transcription factor showing activation induced by TGF-beta stimulation. That is, a reporter plasmid having a DNA sequence (CAGA sequence), which is activated by binding to Smad3/Smad4 complex, is linked to the upstream of the luciferase gene (luminescence enzyme) was prepared. Mink lung epithelial cells CCL64 (named as x9CAGA/CCL64 cells) stably incorporating this reporter plasmid were established. The x9CAGA/CCL64 cells were cultured in DMEM medium containing 10% FBS, penicillin (100 U/ml), streptomycin (100 g/ml), and blasticidin S (1 ug/ml). The x9CAGA/CCL64 cells were seeded in a 96 well plate at a concentration of 10000 cells/well, and cultured in a 5% CO2 incubator at 37C. The next day, the medium was changed to DMEM medium containing 0.2% FBS, and the test compound was added.	B	CCN(CC)c1ccc(NS(=O)(=O)c2cccc(S(=O)(=O)NCC3CCN(C(=O)OC(C)(C)C)CC3)c2)cc1		CHEMBL3701799	=	IC50	nM	3600.0	CHEMBL4439	Homo sapiens	IC50	nM	3600.0
255876	17638644	CHEMBL3705801	Signal Transduction Inhibitory Assay: The biological activity of a compound was determined by measuring the activation of Smad3/Smad4 complex which is a transcription factor showing activation induced by TGF-beta stimulation. That is, a reporter plasmid having a DNA sequence (CAGA sequence), which is activated by binding to Smad3/Smad4 complex, is linked to the upstream of the luciferase gene (luminescence enzyme) was prepared. Mink lung epithelial cells CCL64 (named as x9CAGA/CCL64 cells) stably incorporating this reporter plasmid were established. The x9CAGA/CCL64 cells were cultured in DMEM medium containing 10% FBS, penicillin (100 U/ml), streptomycin (100 g/ml), and blasticidin S (1 ug/ml). The x9CAGA/CCL64 cells were seeded in a 96 well plate at a concentration of 10000 cells/well, and cultured in a 5% CO2 incubator at 37C. The next day, the medium was changed to DMEM medium containing 0.2% FBS, and the test compound was added.	B	CN(C)c1ccc(NS(=O)(=O)c2cccc(S(=O)(=O)NCC3CCN(C(=O)OC(C)(C)C)CC3)c2)cc1		CHEMBL3701800	=	IC50	nM	15000.0	CHEMBL4439	Homo sapiens	IC50	nM	15000.0
255877	17638645	CHEMBL3705801	Signal Transduction Inhibitory Assay: The biological activity of a compound was determined by measuring the activation of Smad3/Smad4 complex which is a transcription factor showing activation induced by TGF-beta stimulation. That is, a reporter plasmid having a DNA sequence (CAGA sequence), which is activated by binding to Smad3/Smad4 complex, is linked to the upstream of the luciferase gene (luminescence enzyme) was prepared. Mink lung epithelial cells CCL64 (named as x9CAGA/CCL64 cells) stably incorporating this reporter plasmid were established. The x9CAGA/CCL64 cells were cultured in DMEM medium containing 10% FBS, penicillin (100 U/ml), streptomycin (100 g/ml), and blasticidin S (1 ug/ml). The x9CAGA/CCL64 cells were seeded in a 96 well plate at a concentration of 10000 cells/well, and cultured in a 5% CO2 incubator at 37C. The next day, the medium was changed to DMEM medium containing 0.2% FBS, and the test compound was added.	B	CC(C)(C)OC(=O)N1CCC(CNS(=O)(=O)c2cccc(S(=O)(=O)Nc3ccc(N4CCOCC4)cc3)c2)CC1		CHEMBL3701801	=	IC50	nM	24000.0	CHEMBL4439	Homo sapiens	IC50	nM	24000.0
255878	17638646	CHEMBL3705801	Signal Transduction Inhibitory Assay: The biological activity of a compound was determined by measuring the activation of Smad3/Smad4 complex which is a transcription factor showing activation induced by TGF-beta stimulation. That is, a reporter plasmid having a DNA sequence (CAGA sequence), which is activated by binding to Smad3/Smad4 complex, is linked to the upstream of the luciferase gene (luminescence enzyme) was prepared. Mink lung epithelial cells CCL64 (named as x9CAGA/CCL64 cells) stably incorporating this reporter plasmid were established. The x9CAGA/CCL64 cells were cultured in DMEM medium containing 10% FBS, penicillin (100 U/ml), streptomycin (100 g/ml), and blasticidin S (1 ug/ml). The x9CAGA/CCL64 cells were seeded in a 96 well plate at a concentration of 10000 cells/well, and cultured in a 5% CO2 incubator at 37C. The next day, the medium was changed to DMEM medium containing 0.2% FBS, and the test compound was added.	B	CC(C)(C)OC(=O)N1CCC(CNS(=O)(=O)c2cccc(S(=O)(=O)Nc3ccc(O)cc3)c2)CC1		CHEMBL3701802	=	IC50	nM	16000.0	CHEMBL4439	Homo sapiens	IC50	nM	16000.0
255879	17638647	CHEMBL3705801	Signal Transduction Inhibitory Assay: The biological activity of a compound was determined by measuring the activation of Smad3/Smad4 complex which is a transcription factor showing activation induced by TGF-beta stimulation. That is, a reporter plasmid having a DNA sequence (CAGA sequence), which is activated by binding to Smad3/Smad4 complex, is linked to the upstream of the luciferase gene (luminescence enzyme) was prepared. Mink lung epithelial cells CCL64 (named as x9CAGA/CCL64 cells) stably incorporating this reporter plasmid were established. The x9CAGA/CCL64 cells were cultured in DMEM medium containing 10% FBS, penicillin (100 U/ml), streptomycin (100 g/ml), and blasticidin S (1 ug/ml). The x9CAGA/CCL64 cells were seeded in a 96 well plate at a concentration of 10000 cells/well, and cultured in a 5% CO2 incubator at 37C. The next day, the medium was changed to DMEM medium containing 0.2% FBS, and the test compound was added.	B	CC(C)(C)OC(=O)N1CCC(CNS(=O)(=O)c2cccc(S(=O)(=O)Nc3ccc(N=[N+]=[N-])cc3)c2)CC1		CHEMBL3701803	=	IC50	nM	700.0	CHEMBL4439	Homo sapiens	IC50	nM	700.0
255880	17638648	CHEMBL3705801	Signal Transduction Inhibitory Assay: The biological activity of a compound was determined by measuring the activation of Smad3/Smad4 complex which is a transcription factor showing activation induced by TGF-beta stimulation. That is, a reporter plasmid having a DNA sequence (CAGA sequence), which is activated by binding to Smad3/Smad4 complex, is linked to the upstream of the luciferase gene (luminescence enzyme) was prepared. Mink lung epithelial cells CCL64 (named as x9CAGA/CCL64 cells) stably incorporating this reporter plasmid were established. The x9CAGA/CCL64 cells were cultured in DMEM medium containing 10% FBS, penicillin (100 U/ml), streptomycin (100 g/ml), and blasticidin S (1 ug/ml). The x9CAGA/CCL64 cells were seeded in a 96 well plate at a concentration of 10000 cells/well, and cultured in a 5% CO2 incubator at 37C. The next day, the medium was changed to DMEM medium containing 0.2% FBS, and the test compound was added.	B	CC(C)(C)OC(=O)N1CCC(CNS(=O)(=O)c2cccc(S(=O)(=O)Nc3ccc(N4CCN(C(=O)OC(C)(C)C)CC4)cc3)c2)CC1		CHEMBL3701804	=	IC50	nM	1500.0	CHEMBL4439	Homo sapiens	IC50	nM	1500.0
255881	17638649	CHEMBL3705801	Signal Transduction Inhibitory Assay: The biological activity of a compound was determined by measuring the activation of Smad3/Smad4 complex which is a transcription factor showing activation induced by TGF-beta stimulation. That is, a reporter plasmid having a DNA sequence (CAGA sequence), which is activated by binding to Smad3/Smad4 complex, is linked to the upstream of the luciferase gene (luminescence enzyme) was prepared. Mink lung epithelial cells CCL64 (named as x9CAGA/CCL64 cells) stably incorporating this reporter plasmid were established. The x9CAGA/CCL64 cells were cultured in DMEM medium containing 10% FBS, penicillin (100 U/ml), streptomycin (100 g/ml), and blasticidin S (1 ug/ml). The x9CAGA/CCL64 cells were seeded in a 96 well plate at a concentration of 10000 cells/well, and cultured in a 5% CO2 incubator at 37C. The next day, the medium was changed to DMEM medium containing 0.2% FBS, and the test compound was added.	B	CC(C)(C)OC(=O)N1CCC(CNS(=O)(=O)c2cccc(S(=O)(=O)Nc3ccc(N4CCN(C(=O)c5ccccc5)CC4)cc3)c2)CC1		CHEMBL3701805	=	IC50	nM	7300.0	CHEMBL4439	Homo sapiens	IC50	nM	7300.0
255882	17638650	CHEMBL3705801	Signal Transduction Inhibitory Assay: The biological activity of a compound was determined by measuring the activation of Smad3/Smad4 complex which is a transcription factor showing activation induced by TGF-beta stimulation. That is, a reporter plasmid having a DNA sequence (CAGA sequence), which is activated by binding to Smad3/Smad4 complex, is linked to the upstream of the luciferase gene (luminescence enzyme) was prepared. Mink lung epithelial cells CCL64 (named as x9CAGA/CCL64 cells) stably incorporating this reporter plasmid were established. The x9CAGA/CCL64 cells were cultured in DMEM medium containing 10% FBS, penicillin (100 U/ml), streptomycin (100 g/ml), and blasticidin S (1 ug/ml). The x9CAGA/CCL64 cells were seeded in a 96 well plate at a concentration of 10000 cells/well, and cultured in a 5% CO2 incubator at 37C. The next day, the medium was changed to DMEM medium containing 0.2% FBS, and the test compound was added.	B	CN(C)c1ccc(NS(=O)(=O)c2cccc(S(=O)(=O)NCC3CCN(C(=O)OC(C)(C)C)CC3)c2)cc1-c1ccco1		CHEMBL3701806	=	IC50	nM	600.0	CHEMBL4439	Homo sapiens	IC50	nM	600.0
255883	17638651	CHEMBL3705801	Signal Transduction Inhibitory Assay: The biological activity of a compound was determined by measuring the activation of Smad3/Smad4 complex which is a transcription factor showing activation induced by TGF-beta stimulation. That is, a reporter plasmid having a DNA sequence (CAGA sequence), which is activated by binding to Smad3/Smad4 complex, is linked to the upstream of the luciferase gene (luminescence enzyme) was prepared. Mink lung epithelial cells CCL64 (named as x9CAGA/CCL64 cells) stably incorporating this reporter plasmid were established. The x9CAGA/CCL64 cells were cultured in DMEM medium containing 10% FBS, penicillin (100 U/ml), streptomycin (100 g/ml), and blasticidin S (1 ug/ml). The x9CAGA/CCL64 cells were seeded in a 96 well plate at a concentration of 10000 cells/well, and cultured in a 5% CO2 incubator at 37C. The next day, the medium was changed to DMEM medium containing 0.2% FBS, and the test compound was added.	B	CC(C)(C)OC(=O)N1CCC(CNS(=O)(=O)c2cccc(S(=O)(=O)Nc3ccc(N4CCCCC4)c(-c4ccco4)c3)c2)CC1		CHEMBL3701807	=	IC50	nM	2500.0	CHEMBL4439	Homo sapiens	IC50	nM	2500.0
255884	17638652	CHEMBL3705801	Signal Transduction Inhibitory Assay: The biological activity of a compound was determined by measuring the activation of Smad3/Smad4 complex which is a transcription factor showing activation induced by TGF-beta stimulation. That is, a reporter plasmid having a DNA sequence (CAGA sequence), which is activated by binding to Smad3/Smad4 complex, is linked to the upstream of the luciferase gene (luminescence enzyme) was prepared. Mink lung epithelial cells CCL64 (named as x9CAGA/CCL64 cells) stably incorporating this reporter plasmid were established. The x9CAGA/CCL64 cells were cultured in DMEM medium containing 10% FBS, penicillin (100 U/ml), streptomycin (100 g/ml), and blasticidin S (1 ug/ml). The x9CAGA/CCL64 cells were seeded in a 96 well plate at a concentration of 10000 cells/well, and cultured in a 5% CO2 incubator at 37C. The next day, the medium was changed to DMEM medium containing 0.2% FBS, and the test compound was added.	B	CC(C)(C)OC(=O)N1CCC(CNS(=O)(=O)c2cccc(S(=O)(=O)Nc3cccc(-c4ccco4)c3)c2)CC1		CHEMBL3701808	=	IC50	nM	6700.0	CHEMBL4439	Homo sapiens	IC50	nM	6700.0
255885	17638653	CHEMBL3705801	Signal Transduction Inhibitory Assay: The biological activity of a compound was determined by measuring the activation of Smad3/Smad4 complex which is a transcription factor showing activation induced by TGF-beta stimulation. That is, a reporter plasmid having a DNA sequence (CAGA sequence), which is activated by binding to Smad3/Smad4 complex, is linked to the upstream of the luciferase gene (luminescence enzyme) was prepared. Mink lung epithelial cells CCL64 (named as x9CAGA/CCL64 cells) stably incorporating this reporter plasmid were established. The x9CAGA/CCL64 cells were cultured in DMEM medium containing 10% FBS, penicillin (100 U/ml), streptomycin (100 g/ml), and blasticidin S (1 ug/ml). The x9CAGA/CCL64 cells were seeded in a 96 well plate at a concentration of 10000 cells/well, and cultured in a 5% CO2 incubator at 37C. The next day, the medium was changed to DMEM medium containing 0.2% FBS, and the test compound was added.	B	CC(C)(C)OC(=O)N1CCC(CNS(=O)(=O)c2cccc(S(=O)(=O)Nc3cccc(-c4cccs4)c3)c2)CC1		CHEMBL3641467	=	IC50	nM	4600.0	CHEMBL4439	Homo sapiens	IC50	nM	4600.0
317521	17697649	CHEMBL3705778	Kinase Assay: Pharmacol 2002, 62 58-62) The compounds named in the specified Examples were tested as follows for inhibition of ALK-5 autophosphorylation activity and of the ALK-5 phosphorylation of α-Casem Materials. Buffer 50 mM HEPES, pH 76, with 10 mM NaCI, 10 mM MgCI2, and 1 mM DTT GST-ALK-5 protein - 0 44 mg/ml (roughly 7 μM stock) A 1 350 dilution gives a 20 nM stock, which translates to 2 nM final in assay Human ALK-5 was expressed in Sf9 insect cells infected with Bacul ovirus expressing a ALK-5 truncation sequence (amino acids H149 -M503), fused at the N-terminus to Glutathione S-transferase GST, in a pFastBac vector (Invitrogen) The cells were disrupted by sonication at 4 0C The lysate was centrifuged at 40,000 x g for 45 minutes, and the supernantant applied to a 10 ml column of Glutathione Sepharose 4 Fast Flow (AmershamBioscienses) equilibrated with 100 mM Tπs-HCI pH 76 buffer containing 300 mM NaCI, 10% glycerol, 1 % NP40, 2 mM dithiothreitol (DTT) and one Protease...	B	Cc1cccc(-n2nccc2-c2cc3cnccc3s2)n1		CHEMBL3704648	=	IC50	nM	23.4	CHEMBL4439	Homo sapiens	IC50	nM	23.4
317522	17697650	CHEMBL3705778	Kinase Assay: Pharmacol 2002, 62 58-62) The compounds named in the specified Examples were tested as follows for inhibition of ALK-5 autophosphorylation activity and of the ALK-5 phosphorylation of α-Casem Materials. Buffer 50 mM HEPES, pH 76, with 10 mM NaCI, 10 mM MgCI2, and 1 mM DTT GST-ALK-5 protein - 0 44 mg/ml (roughly 7 μM stock) A 1 350 dilution gives a 20 nM stock, which translates to 2 nM final in assay Human ALK-5 was expressed in Sf9 insect cells infected with Bacul ovirus expressing a ALK-5 truncation sequence (amino acids H149 -M503), fused at the N-terminus to Glutathione S-transferase GST, in a pFastBac vector (Invitrogen) The cells were disrupted by sonication at 4 0C The lysate was centrifuged at 40,000 x g for 45 minutes, and the supernantant applied to a 10 ml column of Glutathione Sepharose 4 Fast Flow (AmershamBioscienses) equilibrated with 100 mM Tπs-HCI pH 76 buffer containing 300 mM NaCI, 10% glycerol, 1 % NP40, 2 mM dithiothreitol (DTT) and one Protease...	B	Cc1cccc(-n2nc(C)cc2-c2cc3cnccc3s2)n1		CHEMBL3704649	=	IC50	nM	94.1	CHEMBL4439	Homo sapiens	IC50	nM	94.1
317523	17697651	CHEMBL3705778	Kinase Assay: Pharmacol 2002, 62 58-62) The compounds named in the specified Examples were tested as follows for inhibition of ALK-5 autophosphorylation activity and of the ALK-5 phosphorylation of α-Casem Materials. Buffer 50 mM HEPES, pH 76, with 10 mM NaCI, 10 mM MgCI2, and 1 mM DTT GST-ALK-5 protein - 0 44 mg/ml (roughly 7 μM stock) A 1 350 dilution gives a 20 nM stock, which translates to 2 nM final in assay Human ALK-5 was expressed in Sf9 insect cells infected with Bacul ovirus expressing a ALK-5 truncation sequence (amino acids H149 -M503), fused at the N-terminus to Glutathione S-transferase GST, in a pFastBac vector (Invitrogen) The cells were disrupted by sonication at 4 0C The lysate was centrifuged at 40,000 x g for 45 minutes, and the supernantant applied to a 10 ml column of Glutathione Sepharose 4 Fast Flow (AmershamBioscienses) equilibrated with 100 mM Tπs-HCI pH 76 buffer containing 300 mM NaCI, 10% glycerol, 1 % NP40, 2 mM dithiothreitol (DTT) and one Protease...	B	CCc1cc(-c2cc3cnccc3s2)n(-c2cccc(C)n2)n1		CHEMBL3704650	=	IC50	nM	108.0	CHEMBL4439	Homo sapiens	IC50	nM	108.0
317524	17697652	CHEMBL3705778	Kinase Assay: Pharmacol 2002, 62 58-62) The compounds named in the specified Examples were tested as follows for inhibition of ALK-5 autophosphorylation activity and of the ALK-5 phosphorylation of α-Casem Materials. Buffer 50 mM HEPES, pH 76, with 10 mM NaCI, 10 mM MgCI2, and 1 mM DTT GST-ALK-5 protein - 0 44 mg/ml (roughly 7 μM stock) A 1 350 dilution gives a 20 nM stock, which translates to 2 nM final in assay Human ALK-5 was expressed in Sf9 insect cells infected with Bacul ovirus expressing a ALK-5 truncation sequence (amino acids H149 -M503), fused at the N-terminus to Glutathione S-transferase GST, in a pFastBac vector (Invitrogen) The cells were disrupted by sonication at 4 0C The lysate was centrifuged at 40,000 x g for 45 minutes, and the supernantant applied to a 10 ml column of Glutathione Sepharose 4 Fast Flow (AmershamBioscienses) equilibrated with 100 mM Tπs-HCI pH 76 buffer containing 300 mM NaCI, 10% glycerol, 1 % NP40, 2 mM dithiothreitol (DTT) and one Protease...	B	CCc1cnn(-c2cccc(C)n2)c1-c1cc2cnccc2s1		CHEMBL3704651	=	IC50	nM	4.33	CHEMBL4439	Homo sapiens	IC50	nM	4.33
317525	17697653	CHEMBL3705778	Kinase Assay: Pharmacol 2002, 62 58-62) The compounds named in the specified Examples were tested as follows for inhibition of ALK-5 autophosphorylation activity and of the ALK-5 phosphorylation of α-Casem Materials. Buffer 50 mM HEPES, pH 76, with 10 mM NaCI, 10 mM MgCI2, and 1 mM DTT GST-ALK-5 protein - 0 44 mg/ml (roughly 7 μM stock) A 1 350 dilution gives a 20 nM stock, which translates to 2 nM final in assay Human ALK-5 was expressed in Sf9 insect cells infected with Bacul ovirus expressing a ALK-5 truncation sequence (amino acids H149 -M503), fused at the N-terminus to Glutathione S-transferase GST, in a pFastBac vector (Invitrogen) The cells were disrupted by sonication at 4 0C The lysate was centrifuged at 40,000 x g for 45 minutes, and the supernantant applied to a 10 ml column of Glutathione Sepharose 4 Fast Flow (AmershamBioscienses) equilibrated with 100 mM Tπs-HCI pH 76 buffer containing 300 mM NaCI, 10% glycerol, 1 % NP40, 2 mM dithiothreitol (DTT) and one Protease...	B	Cc1cccc(-n2nc3c(c2-c2cc4cnccc4s2)CCC3)n1		CHEMBL3704652	=	IC50	nM	12.9	CHEMBL4439	Homo sapiens	IC50	nM	12.9
317526	17697654	CHEMBL3705778	Kinase Assay: Pharmacol 2002, 62 58-62) The compounds named in the specified Examples were tested as follows for inhibition of ALK-5 autophosphorylation activity and of the ALK-5 phosphorylation of α-Casem Materials. Buffer 50 mM HEPES, pH 76, with 10 mM NaCI, 10 mM MgCI2, and 1 mM DTT GST-ALK-5 protein - 0 44 mg/ml (roughly 7 μM stock) A 1 350 dilution gives a 20 nM stock, which translates to 2 nM final in assay Human ALK-5 was expressed in Sf9 insect cells infected with Bacul ovirus expressing a ALK-5 truncation sequence (amino acids H149 -M503), fused at the N-terminus to Glutathione S-transferase GST, in a pFastBac vector (Invitrogen) The cells were disrupted by sonication at 4 0C The lysate was centrifuged at 40,000 x g for 45 minutes, and the supernantant applied to a 10 ml column of Glutathione Sepharose 4 Fast Flow (AmershamBioscienses) equilibrated with 100 mM Tπs-HCI pH 76 buffer containing 300 mM NaCI, 10% glycerol, 1 % NP40, 2 mM dithiothreitol (DTT) and one Protease...	B	Cc1cccc(-n2nc(C)c(C)c2-c2cc3cnccc3s2)n1		CHEMBL3704653	=	IC50	nM	35.2	CHEMBL4439	Homo sapiens	IC50	nM	35.2
317527	17697655	CHEMBL3705778	Kinase Assay: Pharmacol 2002, 62 58-62) The compounds named in the specified Examples were tested as follows for inhibition of ALK-5 autophosphorylation activity and of the ALK-5 phosphorylation of α-Casem Materials. Buffer 50 mM HEPES, pH 76, with 10 mM NaCI, 10 mM MgCI2, and 1 mM DTT GST-ALK-5 protein - 0 44 mg/ml (roughly 7 μM stock) A 1 350 dilution gives a 20 nM stock, which translates to 2 nM final in assay Human ALK-5 was expressed in Sf9 insect cells infected with Bacul ovirus expressing a ALK-5 truncation sequence (amino acids H149 -M503), fused at the N-terminus to Glutathione S-transferase GST, in a pFastBac vector (Invitrogen) The cells were disrupted by sonication at 4 0C The lysate was centrifuged at 40,000 x g for 45 minutes, and the supernantant applied to a 10 ml column of Glutathione Sepharose 4 Fast Flow (AmershamBioscienses) equilibrated with 100 mM Tπs-HCI pH 76 buffer containing 300 mM NaCI, 10% glycerol, 1 % NP40, 2 mM dithiothreitol (DTT) and one Protease...	B	Cc1cccc(-n2ncc(C)c2-c2cc3cnccc3s2)n1		CHEMBL3640035	=	IC50	nM	6.65	CHEMBL4439	Homo sapiens	IC50	nM	6.65
317528	17697656	CHEMBL3705778	Kinase Assay: Pharmacol 2002, 62 58-62) The compounds named in the specified Examples were tested as follows for inhibition of ALK-5 autophosphorylation activity and of the ALK-5 phosphorylation of α-Casem Materials. Buffer 50 mM HEPES, pH 76, with 10 mM NaCI, 10 mM MgCI2, and 1 mM DTT GST-ALK-5 protein - 0 44 mg/ml (roughly 7 μM stock) A 1 350 dilution gives a 20 nM stock, which translates to 2 nM final in assay Human ALK-5 was expressed in Sf9 insect cells infected with Bacul ovirus expressing a ALK-5 truncation sequence (amino acids H149 -M503), fused at the N-terminus to Glutathione S-transferase GST, in a pFastBac vector (Invitrogen) The cells were disrupted by sonication at 4 0C The lysate was centrifuged at 40,000 x g for 45 minutes, and the supernantant applied to a 10 ml column of Glutathione Sepharose 4 Fast Flow (AmershamBioscienses) equilibrated with 100 mM Tπs-HCI pH 76 buffer containing 300 mM NaCI, 10% glycerol, 1 % NP40, 2 mM dithiothreitol (DTT) and one Protease...	B	Cc1cccc(-n2ncc(C)c2-c2cc3ccncc3s2)n1		CHEMBL3704654	=	IC50	nM	7.94	CHEMBL4439	Homo sapiens	IC50	nM	7.94
317529	17697657	CHEMBL3705778	Kinase Assay: Pharmacol 2002, 62 58-62) The compounds named in the specified Examples were tested as follows for inhibition of ALK-5 autophosphorylation activity and of the ALK-5 phosphorylation of α-Casem Materials. Buffer 50 mM HEPES, pH 76, with 10 mM NaCI, 10 mM MgCI2, and 1 mM DTT GST-ALK-5 protein - 0 44 mg/ml (roughly 7 μM stock) A 1 350 dilution gives a 20 nM stock, which translates to 2 nM final in assay Human ALK-5 was expressed in Sf9 insect cells infected with Bacul ovirus expressing a ALK-5 truncation sequence (amino acids H149 -M503), fused at the N-terminus to Glutathione S-transferase GST, in a pFastBac vector (Invitrogen) The cells were disrupted by sonication at 4 0C The lysate was centrifuged at 40,000 x g for 45 minutes, and the supernantant applied to a 10 ml column of Glutathione Sepharose 4 Fast Flow (AmershamBioscienses) equilibrated with 100 mM Tπs-HCI pH 76 buffer containing 300 mM NaCI, 10% glycerol, 1 % NP40, 2 mM dithiothreitol (DTT) and one Protease...	B	Cc1cccc(-n2nc3c(c2-c2cc4ccncc4s2)CCC3)n1		CHEMBL3704655	=	IC50	nM	18.9	CHEMBL4439	Homo sapiens	IC50	nM	18.9
366772	17741813	CHEMBL3887993	ALK-5 Kinase Assay: In a 96 well filter-bottom plate (Millipore, #MSDV N6B 50), 58 ul Assay Buffer (50 mM HEPES, pH 7.6, with 10 mM NaCl, 10 mM MgCl2, and 1 mM DTT ) is added to reach well. Add 10 ul of Cold ATP mix in Assay Buffer, then 10 ul of a 1:10 dilution of alpha-Casein stock. Then add 2 ul of compound being tested (DMSO) at a 50x final concentration. Hot ATP mix (10 ul) is added, and the reaction is started with the addition of 10 ul of a 1:350 dilution of the ALK-5 protein (2 nM final) in Assay Buffer with 0.05% BSA (Bovine Serum Albumin). The reaction is mixed for 5 minutes at room temperature, and then continued for 145 minutes at room temperature. The reaction is then stopped with the addition of 100 ul of ice-cold 20% TCA (trichloroacetic acid). The assay is then incubated for at least 1 hour at 4° C., and then the contents of each well are filtered by suction through the filter. The wells are washed three times with 200 ul ice-cold 10% TCA. The plate bottom is blotted before and after removing plastic sub-base, and dried overnight at room temperature. Add 30 ul of scintillation fluid, and count 1 minute per well on a Wallac Tri-Lux scintillation counter.	B	Cc1cccc(-n2nccc2-c2cc3cnccc3s2)n1		CHEMBL3704648	=	IC50	nM	23.4	CHEMBL4439	Homo sapiens	IC50	nM	23.4
366773	17741814	CHEMBL3887993	ALK-5 Kinase Assay: In a 96 well filter-bottom plate (Millipore, #MSDV N6B 50), 58 ul Assay Buffer (50 mM HEPES, pH 7.6, with 10 mM NaCl, 10 mM MgCl2, and 1 mM DTT ) is added to reach well. Add 10 ul of Cold ATP mix in Assay Buffer, then 10 ul of a 1:10 dilution of alpha-Casein stock. Then add 2 ul of compound being tested (DMSO) at a 50x final concentration. Hot ATP mix (10 ul) is added, and the reaction is started with the addition of 10 ul of a 1:350 dilution of the ALK-5 protein (2 nM final) in Assay Buffer with 0.05% BSA (Bovine Serum Albumin). The reaction is mixed for 5 minutes at room temperature, and then continued for 145 minutes at room temperature. The reaction is then stopped with the addition of 100 ul of ice-cold 20% TCA (trichloroacetic acid). The assay is then incubated for at least 1 hour at 4° C., and then the contents of each well are filtered by suction through the filter. The wells are washed three times with 200 ul ice-cold 10% TCA. The plate bottom is blotted before and after removing plastic sub-base, and dried overnight at room temperature. Add 30 ul of scintillation fluid, and count 1 minute per well on a Wallac Tri-Lux scintillation counter.	B	Cc1cccc(-n2nc(C)cc2-c2cc3cnccc3s2)n1		CHEMBL3704649	=	IC50	nM	94.1	CHEMBL4439	Homo sapiens	IC50	nM	94.1
366774	17741815	CHEMBL3887993	ALK-5 Kinase Assay: In a 96 well filter-bottom plate (Millipore, #MSDV N6B 50), 58 ul Assay Buffer (50 mM HEPES, pH 7.6, with 10 mM NaCl, 10 mM MgCl2, and 1 mM DTT ) is added to reach well. Add 10 ul of Cold ATP mix in Assay Buffer, then 10 ul of a 1:10 dilution of alpha-Casein stock. Then add 2 ul of compound being tested (DMSO) at a 50x final concentration. Hot ATP mix (10 ul) is added, and the reaction is started with the addition of 10 ul of a 1:350 dilution of the ALK-5 protein (2 nM final) in Assay Buffer with 0.05% BSA (Bovine Serum Albumin). The reaction is mixed for 5 minutes at room temperature, and then continued for 145 minutes at room temperature. The reaction is then stopped with the addition of 100 ul of ice-cold 20% TCA (trichloroacetic acid). The assay is then incubated for at least 1 hour at 4° C., and then the contents of each well are filtered by suction through the filter. The wells are washed three times with 200 ul ice-cold 10% TCA. The plate bottom is blotted before and after removing plastic sub-base, and dried overnight at room temperature. Add 30 ul of scintillation fluid, and count 1 minute per well on a Wallac Tri-Lux scintillation counter.	B	CCc1cc(-c2cc3cnccc3s2)n(-c2cccc(C)n2)n1		CHEMBL3704650	=	IC50	nM	108.0	CHEMBL4439	Homo sapiens	IC50	nM	108.0
366775	17741816	CHEMBL3887993	ALK-5 Kinase Assay: In a 96 well filter-bottom plate (Millipore, #MSDV N6B 50), 58 ul Assay Buffer (50 mM HEPES, pH 7.6, with 10 mM NaCl, 10 mM MgCl2, and 1 mM DTT ) is added to reach well. Add 10 ul of Cold ATP mix in Assay Buffer, then 10 ul of a 1:10 dilution of alpha-Casein stock. Then add 2 ul of compound being tested (DMSO) at a 50x final concentration. Hot ATP mix (10 ul) is added, and the reaction is started with the addition of 10 ul of a 1:350 dilution of the ALK-5 protein (2 nM final) in Assay Buffer with 0.05% BSA (Bovine Serum Albumin). The reaction is mixed for 5 minutes at room temperature, and then continued for 145 minutes at room temperature. The reaction is then stopped with the addition of 100 ul of ice-cold 20% TCA (trichloroacetic acid). The assay is then incubated for at least 1 hour at 4° C., and then the contents of each well are filtered by suction through the filter. The wells are washed three times with 200 ul ice-cold 10% TCA. The plate bottom is blotted before and after removing plastic sub-base, and dried overnight at room temperature. Add 30 ul of scintillation fluid, and count 1 minute per well on a Wallac Tri-Lux scintillation counter.	B	CCc1cnn(-c2cccc(C)n2)c1-c1cc2cnccc2s1		CHEMBL3704651	=	IC50	nM	4.33	CHEMBL4439	Homo sapiens	IC50	nM	4.33
366776	17741817	CHEMBL3887993	ALK-5 Kinase Assay: In a 96 well filter-bottom plate (Millipore, #MSDV N6B 50), 58 ul Assay Buffer (50 mM HEPES, pH 7.6, with 10 mM NaCl, 10 mM MgCl2, and 1 mM DTT ) is added to reach well. Add 10 ul of Cold ATP mix in Assay Buffer, then 10 ul of a 1:10 dilution of alpha-Casein stock. Then add 2 ul of compound being tested (DMSO) at a 50x final concentration. Hot ATP mix (10 ul) is added, and the reaction is started with the addition of 10 ul of a 1:350 dilution of the ALK-5 protein (2 nM final) in Assay Buffer with 0.05% BSA (Bovine Serum Albumin). The reaction is mixed for 5 minutes at room temperature, and then continued for 145 minutes at room temperature. The reaction is then stopped with the addition of 100 ul of ice-cold 20% TCA (trichloroacetic acid). The assay is then incubated for at least 1 hour at 4° C., and then the contents of each well are filtered by suction through the filter. The wells are washed three times with 200 ul ice-cold 10% TCA. The plate bottom is blotted before and after removing plastic sub-base, and dried overnight at room temperature. Add 30 ul of scintillation fluid, and count 1 minute per well on a Wallac Tri-Lux scintillation counter.	B	Cc1cccc(-n2nc3c(c2-c2cc4cnccc4s2)CCC3)n1		CHEMBL3704652	=	IC50	nM	12.9	CHEMBL4439	Homo sapiens	IC50	nM	12.9
366777	17741818	CHEMBL3887993	ALK-5 Kinase Assay: In a 96 well filter-bottom plate (Millipore, #MSDV N6B 50), 58 ul Assay Buffer (50 mM HEPES, pH 7.6, with 10 mM NaCl, 10 mM MgCl2, and 1 mM DTT ) is added to reach well. Add 10 ul of Cold ATP mix in Assay Buffer, then 10 ul of a 1:10 dilution of alpha-Casein stock. Then add 2 ul of compound being tested (DMSO) at a 50x final concentration. Hot ATP mix (10 ul) is added, and the reaction is started with the addition of 10 ul of a 1:350 dilution of the ALK-5 protein (2 nM final) in Assay Buffer with 0.05% BSA (Bovine Serum Albumin). The reaction is mixed for 5 minutes at room temperature, and then continued for 145 minutes at room temperature. The reaction is then stopped with the addition of 100 ul of ice-cold 20% TCA (trichloroacetic acid). The assay is then incubated for at least 1 hour at 4° C., and then the contents of each well are filtered by suction through the filter. The wells are washed three times with 200 ul ice-cold 10% TCA. The plate bottom is blotted before and after removing plastic sub-base, and dried overnight at room temperature. Add 30 ul of scintillation fluid, and count 1 minute per well on a Wallac Tri-Lux scintillation counter.	B	Cc1cccc(-n2nc(C)c(C)c2-c2cc3cnccc3s2)n1		CHEMBL3704653	=	IC50	nM	35.2	CHEMBL4439	Homo sapiens	IC50	nM	35.2
366778	17741819	CHEMBL3887993	ALK-5 Kinase Assay: In a 96 well filter-bottom plate (Millipore, #MSDV N6B 50), 58 ul Assay Buffer (50 mM HEPES, pH 7.6, with 10 mM NaCl, 10 mM MgCl2, and 1 mM DTT ) is added to reach well. Add 10 ul of Cold ATP mix in Assay Buffer, then 10 ul of a 1:10 dilution of alpha-Casein stock. Then add 2 ul of compound being tested (DMSO) at a 50x final concentration. Hot ATP mix (10 ul) is added, and the reaction is started with the addition of 10 ul of a 1:350 dilution of the ALK-5 protein (2 nM final) in Assay Buffer with 0.05% BSA (Bovine Serum Albumin). The reaction is mixed for 5 minutes at room temperature, and then continued for 145 minutes at room temperature. The reaction is then stopped with the addition of 100 ul of ice-cold 20% TCA (trichloroacetic acid). The assay is then incubated for at least 1 hour at 4° C., and then the contents of each well are filtered by suction through the filter. The wells are washed three times with 200 ul ice-cold 10% TCA. The plate bottom is blotted before and after removing plastic sub-base, and dried overnight at room temperature. Add 30 ul of scintillation fluid, and count 1 minute per well on a Wallac Tri-Lux scintillation counter.	B	Cc1cccc(-n2ncc(C)c2-c2cc3cnccc3s2)n1		CHEMBL3640035	=	IC50	nM	6.65	CHEMBL4439	Homo sapiens	IC50	nM	6.65
366779	17741820	CHEMBL3887993	ALK-5 Kinase Assay: In a 96 well filter-bottom plate (Millipore, #MSDV N6B 50), 58 ul Assay Buffer (50 mM HEPES, pH 7.6, with 10 mM NaCl, 10 mM MgCl2, and 1 mM DTT ) is added to reach well. Add 10 ul of Cold ATP mix in Assay Buffer, then 10 ul of a 1:10 dilution of alpha-Casein stock. Then add 2 ul of compound being tested (DMSO) at a 50x final concentration. Hot ATP mix (10 ul) is added, and the reaction is started with the addition of 10 ul of a 1:350 dilution of the ALK-5 protein (2 nM final) in Assay Buffer with 0.05% BSA (Bovine Serum Albumin). The reaction is mixed for 5 minutes at room temperature, and then continued for 145 minutes at room temperature. The reaction is then stopped with the addition of 100 ul of ice-cold 20% TCA (trichloroacetic acid). The assay is then incubated for at least 1 hour at 4° C., and then the contents of each well are filtered by suction through the filter. The wells are washed three times with 200 ul ice-cold 10% TCA. The plate bottom is blotted before and after removing plastic sub-base, and dried overnight at room temperature. Add 30 ul of scintillation fluid, and count 1 minute per well on a Wallac Tri-Lux scintillation counter.	B	Cc1cccc(-n2ncc(C)c2-c2cc3ccncc3s2)n1		CHEMBL3704654	=	IC50	nM	7.94	CHEMBL4439	Homo sapiens	IC50	nM	7.94
366780	17741821	CHEMBL3887993	ALK-5 Kinase Assay: In a 96 well filter-bottom plate (Millipore, #MSDV N6B 50), 58 ul Assay Buffer (50 mM HEPES, pH 7.6, with 10 mM NaCl, 10 mM MgCl2, and 1 mM DTT ) is added to reach well. Add 10 ul of Cold ATP mix in Assay Buffer, then 10 ul of a 1:10 dilution of alpha-Casein stock. Then add 2 ul of compound being tested (DMSO) at a 50x final concentration. Hot ATP mix (10 ul) is added, and the reaction is started with the addition of 10 ul of a 1:350 dilution of the ALK-5 protein (2 nM final) in Assay Buffer with 0.05% BSA (Bovine Serum Albumin). The reaction is mixed for 5 minutes at room temperature, and then continued for 145 minutes at room temperature. The reaction is then stopped with the addition of 100 ul of ice-cold 20% TCA (trichloroacetic acid). The assay is then incubated for at least 1 hour at 4° C., and then the contents of each well are filtered by suction through the filter. The wells are washed three times with 200 ul ice-cold 10% TCA. The plate bottom is blotted before and after removing plastic sub-base, and dried overnight at room temperature. Add 30 ul of scintillation fluid, and count 1 minute per well on a Wallac Tri-Lux scintillation counter.	B	Cc1cccc(-n2nc3c(c2-c2cc4ccncc4s2)CCC3)n1		CHEMBL3704655	=	IC50	nM	18.9	CHEMBL4439	Homo sapiens	IC50	nM	18.9
366781	17741822	CHEMBL3887994	ALK-5 Gene : ALK-5 gene reporter assay methods have been described in the art (see e.g., Maliekal et al. (2004) J Biol Chem 279(35):36287-36292). The compounds named in the specified Examples were tested as follows for inhibition of Smad binding element (SBE) luciferase reporter activity in TGFbeta1 stimulated NIH-3T3 cells. The following luciferase assay employs NIH/3T3 (murine fibroblast) cells, which are transiently transfected with a Smad binding element (SBE) luciferase reporter construct. This expressed construct is responsive to agents that stimulate the Smad signaling pathway.	B	Cc1cccc(-n2nccc2-c2cc3cnccc3s2)n1		CHEMBL3704648	=	IC50	nM	149.0	CHEMBL4439	Homo sapiens	IC50	nM	149.0
366782	17741823	CHEMBL3887994	ALK-5 Gene : ALK-5 gene reporter assay methods have been described in the art (see e.g., Maliekal et al. (2004) J Biol Chem 279(35):36287-36292). The compounds named in the specified Examples were tested as follows for inhibition of Smad binding element (SBE) luciferase reporter activity in TGFbeta1 stimulated NIH-3T3 cells. The following luciferase assay employs NIH/3T3 (murine fibroblast) cells, which are transiently transfected with a Smad binding element (SBE) luciferase reporter construct. This expressed construct is responsive to agents that stimulate the Smad signaling pathway.	B	Cc1cccc(-n2nc(C)cc2-c2cc3cnccc3s2)n1		CHEMBL3704649	=	IC50	nM	440.0	CHEMBL4439	Homo sapiens	IC50	nM	440.0
366783	17741824	CHEMBL3887994	ALK-5 Gene : ALK-5 gene reporter assay methods have been described in the art (see e.g., Maliekal et al. (2004) J Biol Chem 279(35):36287-36292). The compounds named in the specified Examples were tested as follows for inhibition of Smad binding element (SBE) luciferase reporter activity in TGFbeta1 stimulated NIH-3T3 cells. The following luciferase assay employs NIH/3T3 (murine fibroblast) cells, which are transiently transfected with a Smad binding element (SBE) luciferase reporter construct. This expressed construct is responsive to agents that stimulate the Smad signaling pathway.	B	CCc1cc(-c2cc3cnccc3s2)n(-c2cccc(C)n2)n1		CHEMBL3704650	=	IC50	nM	403.0	CHEMBL4439	Homo sapiens	IC50	nM	403.0
366784	17741825	CHEMBL3887994	ALK-5 Gene : ALK-5 gene reporter assay methods have been described in the art (see e.g., Maliekal et al. (2004) J Biol Chem 279(35):36287-36292). The compounds named in the specified Examples were tested as follows for inhibition of Smad binding element (SBE) luciferase reporter activity in TGFbeta1 stimulated NIH-3T3 cells. The following luciferase assay employs NIH/3T3 (murine fibroblast) cells, which are transiently transfected with a Smad binding element (SBE) luciferase reporter construct. This expressed construct is responsive to agents that stimulate the Smad signaling pathway.	B	CCc1cnn(-c2cccc(C)n2)c1-c1cc2cnccc2s1		CHEMBL3704651	=	IC50	nM	21.5	CHEMBL4439	Homo sapiens	IC50	nM	21.5
366785	17741826	CHEMBL3887994	ALK-5 Gene : ALK-5 gene reporter assay methods have been described in the art (see e.g., Maliekal et al. (2004) J Biol Chem 279(35):36287-36292). The compounds named in the specified Examples were tested as follows for inhibition of Smad binding element (SBE) luciferase reporter activity in TGFbeta1 stimulated NIH-3T3 cells. The following luciferase assay employs NIH/3T3 (murine fibroblast) cells, which are transiently transfected with a Smad binding element (SBE) luciferase reporter construct. This expressed construct is responsive to agents that stimulate the Smad signaling pathway.	B	Cc1cccc(-n2nc3c(c2-c2cc4cnccc4s2)CCC3)n1		CHEMBL3704652	=	IC50	nM	30.8	CHEMBL4439	Homo sapiens	IC50	nM	30.8
366786	17741827	CHEMBL3887994	ALK-5 Gene : ALK-5 gene reporter assay methods have been described in the art (see e.g., Maliekal et al. (2004) J Biol Chem 279(35):36287-36292). The compounds named in the specified Examples were tested as follows for inhibition of Smad binding element (SBE) luciferase reporter activity in TGFbeta1 stimulated NIH-3T3 cells. The following luciferase assay employs NIH/3T3 (murine fibroblast) cells, which are transiently transfected with a Smad binding element (SBE) luciferase reporter construct. This expressed construct is responsive to agents that stimulate the Smad signaling pathway.	B	Cc1cccc(-n2nc(C)c(C)c2-c2cc3cnccc3s2)n1		CHEMBL3704653	=	IC50	nM	244.0	CHEMBL4439	Homo sapiens	IC50	nM	244.0
366787	17741828	CHEMBL3887994	ALK-5 Gene : ALK-5 gene reporter assay methods have been described in the art (see e.g., Maliekal et al. (2004) J Biol Chem 279(35):36287-36292). The compounds named in the specified Examples were tested as follows for inhibition of Smad binding element (SBE) luciferase reporter activity in TGFbeta1 stimulated NIH-3T3 cells. The following luciferase assay employs NIH/3T3 (murine fibroblast) cells, which are transiently transfected with a Smad binding element (SBE) luciferase reporter construct. This expressed construct is responsive to agents that stimulate the Smad signaling pathway.	B	Cc1cccc(-n2ncc(C)c2-c2cc3cnccc3s2)n1		CHEMBL3640035	=	IC50	nM	35.9	CHEMBL4439	Homo sapiens	IC50	nM	35.9
366788	17741829	CHEMBL3887994	ALK-5 Gene : ALK-5 gene reporter assay methods have been described in the art (see e.g., Maliekal et al. (2004) J Biol Chem 279(35):36287-36292). The compounds named in the specified Examples were tested as follows for inhibition of Smad binding element (SBE) luciferase reporter activity in TGFbeta1 stimulated NIH-3T3 cells. The following luciferase assay employs NIH/3T3 (murine fibroblast) cells, which are transiently transfected with a Smad binding element (SBE) luciferase reporter construct. This expressed construct is responsive to agents that stimulate the Smad signaling pathway.	B	Cc1cccc(-n2ncc(C)c2-c2cc3ccncc3s2)n1		CHEMBL3704654	=	IC50	nM	42.5	CHEMBL4439	Homo sapiens	IC50	nM	42.5
366789	17741830	CHEMBL3887994	ALK-5 Gene : ALK-5 gene reporter assay methods have been described in the art (see e.g., Maliekal et al. (2004) J Biol Chem 279(35):36287-36292). The compounds named in the specified Examples were tested as follows for inhibition of Smad binding element (SBE) luciferase reporter activity in TGFbeta1 stimulated NIH-3T3 cells. The following luciferase assay employs NIH/3T3 (murine fibroblast) cells, which are transiently transfected with a Smad binding element (SBE) luciferase reporter construct. This expressed construct is responsive to agents that stimulate the Smad signaling pathway.	B	Cc1cccc(-n2nc3c(c2-c2cc4ccncc4s2)CCC3)n1		CHEMBL3704655	=	IC50	nM	57.5	CHEMBL4439	Homo sapiens	IC50	nM	57.5
436745	17796709	CHEMBL3889146	Biochemical Binding Assay: Biochemical binding assays (DiscoveRx) and in vitro enzyme inhibition assays (LanthaScreen, Life Technologies) were conducted to determine the binding affinity and inhibition activities of CYT-0387 to Type-I BMPR-kinases (ALK2, ALK3, and ALK6) were conducted. Transforming growth factor beta receptor 1 (TGFBR1, ALK5) was used as a control to determine the selectivity to Type-I BMPR-kinases.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	=	IC50	nM	205.0	CHEMBL4439	Homo sapiens	IC50	nM	205.0
436745	17796710	CHEMBL3889146	Biochemical Binding Assay: Biochemical binding assays (DiscoveRx) and in vitro enzyme inhibition assays (LanthaScreen, Life Technologies) were conducted to determine the binding affinity and inhibition activities of CYT-0387 to Type-I BMPR-kinases (ALK2, ALK3, and ALK6) were conducted. Transforming growth factor beta receptor 1 (TGFBR1, ALK5) was used as a control to determine the selectivity to Type-I BMPR-kinases.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	=	Kd	nM	670.0	CHEMBL4439	Homo sapiens	Kd	nM	670.0
Inactive	17944544	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944545	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944546	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944547	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944548	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Active	17944549	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	77.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	77.0
Active	17944550	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	=	Kd	nM	1229.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	1229.0
Inactive	17944551	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Active	17944552	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	Kd	nM	5.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	5.0
Inactive	17944553	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944554	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944555	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944556	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944557	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Active	17944558	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	=	Kd	nM	79.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	79.0
Inactive	17944559	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944560	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944561	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944562	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944563	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944564	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944565	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944566	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944567	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944568	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944569	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944570	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944571	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944572	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944573	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944574	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944575	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944576	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Active	17944577	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	=	Kd	nM	3316.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	3316.0
Inactive	17944578	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944579	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944580	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944581	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944582	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944583	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944584	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944585	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944586	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944587	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944588	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944589	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944590	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944591	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944592	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944593	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944594	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944595	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944596	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944597	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944598	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Active	17944599	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	149.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	149.0
Inactive	17944600	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944601	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944602	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944603	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944604	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944605	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944606	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944607	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944608	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944609	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Active	17944610	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	=	Kd	nM	197.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	197.0
Inactive	17944611	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944612	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944613	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944614	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944615	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944616	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944617	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944618	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944619	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944620	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944621	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944622	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944623	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944624	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944625	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944626	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944627	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944628	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944629	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944630	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944631	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944632	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944633	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944634	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944635	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944636	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944637	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944638	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944639	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944640	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944641	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944642	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944643	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944644	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Active	17944645	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	1723.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	1723.0
Active	17944646	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	966.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	966.0
Inactive	17944647	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Active	17944648	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	=	Kd	nM	2384.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	2384.0
Inactive	17944649	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Active	17944650	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Kd	nM	1957.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	1957.0
Inactive	17944651	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944652	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Active	17944653	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	=	Kd	nM	197.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	197.0
Inactive	17944654	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944655	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944656	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944657	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944658	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944659	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944660	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944661	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944662	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944663	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Active	17944664	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Kd	nM	2179.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	2179.0
Inactive	17944665	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944666	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944667	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944668	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944669	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944670	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944671	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944672	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944673	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944674	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944675	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944676	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944677	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944678	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944679	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944680	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944681	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944682	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944683	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944684	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944685	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Active	17944686	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	=	Kd	nM	231.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	231.0
Inactive	17944687	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944688	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944689	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944690	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944691	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944692	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944693	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944694	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944695	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944696	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944697	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944698	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Active	17944699	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	=	Kd	nM	1702.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	1702.0
Inactive	17944700	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944701	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944702	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944703	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944704	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944705	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944706	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944707	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944708	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944709	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944710	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944711	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944712	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944713	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944714	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944715	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944716	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944717	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944718	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944719	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Active	17944720	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	3492.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	3492.0
Inactive	17944721	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944722	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944723	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944724	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944725	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944726	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944727	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944728	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944729	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944730	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Active	17944731	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	Kd	nM	1940.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	1940.0
Inactive	17944732	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Active	17944733	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	1866.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	1866.0
Inactive	17944734	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944735	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944736	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944737	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944738	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944739	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944740	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944741	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944742	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944743	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944744	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944745	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944746	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944747	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944748	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944749	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Active	17944750	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	2052.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	2052.0
Inactive	17944751	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944752	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944753	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Active	17944754	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	=	Kd	nM	2.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	2.0
Inactive	17944755	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944756	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944757	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944758	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944759	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944760	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944761	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944762	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944763	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944764	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944765	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944766	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944767	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944768	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Active	17944769	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	=	Kd	nM	2473.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	2473.0
Active	17944770	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	=	Kd	nM	780.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	780.0
Inactive	17944771	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944772	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944773	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944774	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944775	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944776	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944777	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944778	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944779	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944780	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Active	17944781	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Kd	nM	4262.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	4262.0
Inactive	17944782	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944783	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944784	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944785	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944786	CHEMBL3991909	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL4439	Homo sapiens	Kd apparent	nM	30000.0
	17964955	CHEMBL3995063	Inhibition of human TGFBR1 (D179 to M503 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by KINOMEscan assay relative to control	B	CNc1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)on3)c(C)c2)ncn1		CHEMBL4060295	=	Activity	%	60.0	CHEMBL4439	Homo sapiens	Activity	%	60.0
	17982213	CHEMBL3998849	Inhibition of human ALK5 using casein as substrate in presence of 10 uM ATP by radiometric kinase assay	A	COc1cc(O)c2c(c1)CCC[C@H](O)[C@H](O)C(=O)CCC[C@H](C)OC2=O		CHEMBL4099337	=	IC50	nM	7213.0	CHEMBL4439	Homo sapiens	IC50	nM	7213.0
	17982214	CHEMBL3998849	Inhibition of human ALK5 using casein as substrate in presence of 10 uM ATP by radiometric kinase assay	A	c1ccc2c(-c3cnn4cc(-c5ccc(N6CCNCC6)cc5)cnc34)ccnc2c1		CHEMBL513147	=	IC50	nM	27.15	CHEMBL4439	Homo sapiens	IC50	nM	27.15
	17982221	CHEMBL3998855	Inhibition of human ALK5 at 10 uM using casein as substrate in presence of 200 uM ATP by radiometric kinase assay relative to control	A	COc1cc(O)c2c(c1)CCC[C@H](O)[C@H](O)C(=O)CCC[C@H](C)OC2=O		CHEMBL4099337	<	Inhibition	%	40.0	CHEMBL4439	Homo sapiens	INH	%	40.0
	18056901	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	COc1cccc2nccc(Nc3ccnc(-c4ccccc4)c3)c12		CHEMBL4086498	=	IC50	nM	630.96	CHEMBL4439	Homo sapiens	pIC50		6.2
	18056902	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	COc1cccc2nccc(Nc3ccnc(-c4cccc(Cl)c4)c3)c12		CHEMBL4096668	=	IC50	nM	316.23	CHEMBL4439	Homo sapiens	pIC50		6.5
	18056903	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	COc1cccc2nccc(Nc3cc(-c4cccc(Cl)c4)ncc3C)c12		CHEMBL4078651	=	IC50	nM	31.62	CHEMBL4439	Homo sapiens	pIC50		7.5
	18056904	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	COc1cccc2nccc(Nc3ccnc(-c4cc(Cl)ccc4F)c3)c12		CHEMBL4077722	=	IC50	nM	19.95	CHEMBL4439	Homo sapiens	pIC50		7.7
	18056905	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	COc1cccc2nccc(Nc3cc(-c4cc(Cl)ccc4F)ncc3C)c12		CHEMBL4101991	=	IC50	nM	12.59	CHEMBL4439	Homo sapiens	pIC50		7.9
	18056906	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	CCc1cnc(-c2cc(Cl)ccc2F)cc1Nc1ccnc2cccc(OC)c12		CHEMBL4066735	=	IC50	nM	25.12	CHEMBL4439	Homo sapiens	pIC50		7.6
	18056907	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	COc1cccc2nccc(Nc3cc(-c4cc(Cl)ccc4F)ncc3C3CC3)c12		CHEMBL4094260	=	IC50	nM	50.12	CHEMBL4439	Homo sapiens	pIC50		7.3
	18056908	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	COc1cccc2nccc(Nc3ccnc(-c4cc(C)ccc4F)c3)c12		CHEMBL4070456	=	IC50	nM	25.12	CHEMBL4439	Homo sapiens	pIC50		7.6
	18056909	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	COc1cccc2nccc(Nc3cc(-c4cc(C)ccc4F)ncc3C)c12		CHEMBL4097629	=	IC50	nM	12.59	CHEMBL4439	Homo sapiens	pIC50		7.9
	18056910	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	COc1cccc2nccc(Nc3ccnc(-c4nc(C)ccc4F)c3)c12		CHEMBL4100266	=	IC50	nM	39.81	CHEMBL4439	Homo sapiens	pIC50		7.4
	18056911	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	Fc1ccc(Cl)cc1-c1cc(Nc2ccnc3cn[nH]c23)ccn1		CHEMBL4073422	=	IC50	nM	6.31	CHEMBL4439	Homo sapiens	pIC50		8.2
	18056912	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	Cc1ccc(F)c(-c2cc(Nc3ccnc4cn[nH]c34)ccn2)c1		CHEMBL4092523	=	IC50	nM	15.85	CHEMBL4439	Homo sapiens	pIC50		7.8
	18056913	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	Fc1ccc(F)c(-c2cc(Nc3ccnc4cn[nH]c34)ccn2)c1		CHEMBL4064820	=	IC50	nM	7.943	CHEMBL4439	Homo sapiens	pIC50		8.1
	18056914	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	Cc1cnc(-c2cc(Cl)ccc2F)cc1Nc1ccnc2cn[nH]c12		CHEMBL4084771	=	IC50	nM	15.85	CHEMBL4439	Homo sapiens	pIC50		7.8
	18056915	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	Cc1cnc(-c2cc(F)ccc2F)cc1Nc1ccnc2cn[nH]c12		CHEMBL4102696	=	IC50	nM	1.0	CHEMBL4439	Homo sapiens	pIC50		9.0
	18056916	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	COc1cccc2nccc(Nc3cc(-c4cccc(C)n4)ncc3C)c12		CHEMBL4074485	=	IC50	nM	5.012	CHEMBL4439	Homo sapiens	pIC50		8.3
	18056917	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	COc1cccc2nccc(Nc3cc(-c4nc(C)ccc4F)ncc3C)c12		CHEMBL4094958	=	IC50	nM	2.512	CHEMBL4439	Homo sapiens	pIC50		8.6
	18056918	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	NC(=O)Cn1ncc2nccc(Nc3ccnc(-c4cc(F)ccc4F)c3)c21		CHEMBL4089166	=	IC50	nM	50.12	CHEMBL4439	Homo sapiens	pIC50		7.3
	18056919	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	CNC(=O)n1ncc2nccc(Nc3ccnc(-c4cc(F)ccc4F)c3)c21		CHEMBL4060987	=	IC50	nM	2.512	CHEMBL4439	Homo sapiens	pIC50		8.6
	18056920	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	CCNC(=O)n1ncc2nccc(Nc3ccnc(-c4cc(F)ccc4F)c3)c21		CHEMBL4075081	=	IC50	nM	5.012	CHEMBL4439	Homo sapiens	pIC50		8.3
	18056921	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	CNC(=O)n1ncc2nccc(Nc3cc(-c4cc(F)ccc4F)ncc3C)c21		CHEMBL4101751	=	IC50	nM	1.0	CHEMBL4439	Homo sapiens	pIC50		9.0
	18056922	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	Cc1cnc(-c2cc(F)ccc2F)cc1Nc1ccnc2cnn(CC(C)O)c12		CHEMBL4085333	=	IC50	nM	3.162	CHEMBL4439	Homo sapiens	pIC50		8.5
	18056923	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	CNC(=O)n1ncc2nccc(Nc3ccnc(-c4cc(Cl)ccc4F)c3)c21		CHEMBL4063730	=	IC50	nM	3.162	CHEMBL4439	Homo sapiens	pIC50		8.5
	18056924	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	CNC(=O)n1ncc2nccc(Nc3cc(-c4cc(Cl)ccc4F)ncc3C)c21		CHEMBL4093090	=	IC50	nM	15.85	CHEMBL4439	Homo sapiens	pIC50		7.8
	18056925	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	Cc1cnc(-c2cc(Cl)ccc2F)cc1Nc1ccnc2cnn(CC(N)=O)c12		CHEMBL4072325	=	IC50	nM	12.59	CHEMBL4439	Homo sapiens	pIC50		7.9
	18056926	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	Fc1ccc(Cl)cc1-c1cc(Nc2ccnc3cnn(CC4CCNCC4)c23)ccn1		CHEMBL4100799	=	IC50	nM	2511.89	CHEMBL4439	Homo sapiens	pIC50		5.6
	18056927	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	NC(=O)Cn1cc2nccc(Nc3ccnc(-c4cc(F)ccc4F)c3)c2n1		CHEMBL4082821	=	IC50	nM	25.12	CHEMBL4439	Homo sapiens	pIC50		7.6
	18056928	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	Cc1cnc(-c2cc(F)ccc2F)cc1Nc1ccnc2cn(CC(C)O)nc12		CHEMBL4088735	=	IC50	nM	19.95	CHEMBL4439	Homo sapiens	pIC50		7.7
	18056929	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	NC(=O)Cn1cc2nccc(Nc3ccnc(-c4cc(Cl)ccc4F)c3)c2n1		CHEMBL4067488	=	IC50	nM	12.59	CHEMBL4439	Homo sapiens	pIC50		7.9
	18056930	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	Cc1cnc(-c2cc(Cl)ccc2F)cc1Nc1ccnc2cn(CC(N)=O)nc12		CHEMBL4069101	=	IC50	nM	15.85	CHEMBL4439	Homo sapiens	pIC50		7.8
	18056931	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	Fc1ccc(Cl)cc1-c1cc(Nc2ccnc3cn(CC4CCNCC4)nc23)ccn1		CHEMBL4096361	=	IC50	nM	100.0	CHEMBL4439	Homo sapiens	pIC50		7.0
	18056932	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	Cc1ccc(F)c(-c2cc(Nc3ccnc4cnn(C)c34)c(C)cn2)c1		CHEMBL4079857	=	IC50	nM	3.981	CHEMBL4439	Homo sapiens	pIC50		8.4
	18056933	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	CCn1ncc2nccc(Nc3cc(-c4cc(C)ccc4F)ncc3C)c21		CHEMBL4104104	=	IC50	nM	1.995	CHEMBL4439	Homo sapiens	pIC50		8.7
	18056934	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	Cc1ccc(F)c(-c2cc(Nc3ccnc4cnn(CCO)c34)c(C)cn2)c1		CHEMBL4087735	=	IC50	nM	12.59	CHEMBL4439	Homo sapiens	pIC50		7.9
	18056935	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	Cc1ccc(F)c(-c2cc(Nc3ccnc4cnn(C[C@@H](C)O)c34)c(C)cn2)c1		CHEMBL4066402	=	IC50	nM	7.943	CHEMBL4439	Homo sapiens	pIC50		8.1
	18056936	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	Cc1ccc(F)c(-c2cc(Nc3ccnc4cnn(C[C@H](C)O)c34)c(C)cn2)c1		CHEMBL4095435	=	IC50	nM	7.943	CHEMBL4439	Homo sapiens	pIC50		8.1
	18056937	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	Cc1ccc(F)c(-c2cc(Nc3ccnc4cnn(CC(N)=O)c34)c(C)cn2)c1		CHEMBL4075003	=	IC50	nM	3.162	CHEMBL4439	Homo sapiens	pIC50		8.5
	18056938	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	CNC(=O)Cn1ncc2nccc(Nc3cc(-c4cc(C)ccc4F)ncc3C)c21		CHEMBL4103188	=	IC50	nM	15.85	CHEMBL4439	Homo sapiens	pIC50		7.8
	18056939	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	Cc1ccc(F)c(-c2cc(Nc3ccnc4cn(C)nc34)c(C)cn2)c1		CHEMBL4085263	=	IC50	nM	3.981	CHEMBL4439	Homo sapiens	pIC50		8.4
	18056940	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	CCn1cc2nccc(Nc3cc(-c4cc(C)ccc4F)ncc3C)c2n1		CHEMBL4082868	=	IC50	nM	10.0	CHEMBL4439	Homo sapiens	pIC50		8.0
	18056941	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	Cc1ccc(F)c(-c2cc(Nc3ccnc4cn(CCO)nc34)c(C)cn2)c1		CHEMBL4074026	=	IC50	nM	7.943	CHEMBL4439	Homo sapiens	pIC50		8.1
	18056942	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	Cc1ccc(F)c(-c2cc(Nc3ccnc4cn(C[C@@H](C)O)nc34)c(C)cn2)c1		CHEMBL4077146	=	IC50	nM	7.943	CHEMBL4439	Homo sapiens	pIC50		8.1
	18056943	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	Cc1ccc(F)c(-c2cc(Nc3ccnc4cn(C[C@H](C)O)nc34)c(C)cn2)c1		CHEMBL4093131	=	IC50	nM	7.943	CHEMBL4439	Homo sapiens	pIC50		8.1
	18056944	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	Cc1ccc(F)c(-c2cc(Nc3ccnc4cn(CC(N)=O)nc34)c(C)cn2)c1		CHEMBL4075798	=	IC50	nM	10.0	CHEMBL4439	Homo sapiens	pIC50		8.0
	18056945	CHEMBL4012444	Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSIRCSS[PO4]VS peptide as substrate after 90 mins by LanthaScreen TR-FRET assay	A	CNC(=O)Cn1cc2nccc(Nc3cc(-c4cc(C)ccc4F)ncc3C)c2n1		CHEMBL4064329	=	IC50	nM	31.62	CHEMBL4439	Homo sapiens	pIC50		7.5
	18056946	CHEMBL4012445	Inhibition of ALK5 (unknown origin) expressed in SBE-bla HEK293T cells assessed as decrease in TGFbeta1-induced Smad2/3 phosphorylation by beta lactamase reporter gene assay	A	Fc1ccc(Cl)cc1-c1cc(Nc2ccnc3cn[nH]c23)ccn1		CHEMBL4073422	=	EC50	nM	50.12	CHEMBL4439	Homo sapiens	pEC50		7.3
	18056947	CHEMBL4012445	Inhibition of ALK5 (unknown origin) expressed in SBE-bla HEK293T cells assessed as decrease in TGFbeta1-induced Smad2/3 phosphorylation by beta lactamase reporter gene assay	A	Fc1ccc(F)c(-c2cc(Nc3ccnc4cn[nH]c34)ccn2)c1		CHEMBL4064820	=	EC50	nM	39.81	CHEMBL4439	Homo sapiens	pEC50		7.4
	18056948	CHEMBL4012445	Inhibition of ALK5 (unknown origin) expressed in SBE-bla HEK293T cells assessed as decrease in TGFbeta1-induced Smad2/3 phosphorylation by beta lactamase reporter gene assay	A	Cc1cnc(-c2cc(Cl)ccc2F)cc1Nc1ccnc2cn[nH]c12		CHEMBL4084771	=	EC50	nM	31.62	CHEMBL4439	Homo sapiens	pEC50		7.5
	18056949	CHEMBL4012445	Inhibition of ALK5 (unknown origin) expressed in SBE-bla HEK293T cells assessed as decrease in TGFbeta1-induced Smad2/3 phosphorylation by beta lactamase reporter gene assay	A	Cc1cnc(-c2cc(F)ccc2F)cc1Nc1ccnc2cn[nH]c12		CHEMBL4102696	=	EC50	nM	7.943	CHEMBL4439	Homo sapiens	pEC50		8.1
	18056950	CHEMBL4012445	Inhibition of ALK5 (unknown origin) expressed in SBE-bla HEK293T cells assessed as decrease in TGFbeta1-induced Smad2/3 phosphorylation by beta lactamase reporter gene assay	A	COc1cccc2nccc(Nc3cc(-c4cccc(C)n4)ncc3C)c12		CHEMBL4074485	=	EC50	nM	31.62	CHEMBL4439	Homo sapiens	pEC50		7.5
	18056951	CHEMBL4012445	Inhibition of ALK5 (unknown origin) expressed in SBE-bla HEK293T cells assessed as decrease in TGFbeta1-induced Smad2/3 phosphorylation by beta lactamase reporter gene assay	A	NC(=O)Cn1ncc2nccc(Nc3ccnc(-c4cc(F)ccc4F)c3)c21		CHEMBL4089166	=	EC50	nM	199.53	CHEMBL4439	Homo sapiens	pEC50		6.7
	18056952	CHEMBL4012445	Inhibition of ALK5 (unknown origin) expressed in SBE-bla HEK293T cells assessed as decrease in TGFbeta1-induced Smad2/3 phosphorylation by beta lactamase reporter gene assay	A	CNC(=O)n1ncc2nccc(Nc3ccnc(-c4cc(F)ccc4F)c3)c21		CHEMBL4060987	=	EC50	nM	19.95	CHEMBL4439	Homo sapiens	pEC50		7.7
	18056953	CHEMBL4012445	Inhibition of ALK5 (unknown origin) expressed in SBE-bla HEK293T cells assessed as decrease in TGFbeta1-induced Smad2/3 phosphorylation by beta lactamase reporter gene assay	A	CCNC(=O)n1ncc2nccc(Nc3ccnc(-c4cc(F)ccc4F)c3)c21		CHEMBL4075081	=	EC50	nM	31.62	CHEMBL4439	Homo sapiens	pEC50		7.5
	18056954	CHEMBL4012445	Inhibition of ALK5 (unknown origin) expressed in SBE-bla HEK293T cells assessed as decrease in TGFbeta1-induced Smad2/3 phosphorylation by beta lactamase reporter gene assay	A	CNC(=O)n1ncc2nccc(Nc3cc(-c4cc(F)ccc4F)ncc3C)c21		CHEMBL4101751	=	EC50	nM	25.12	CHEMBL4439	Homo sapiens	pEC50		7.6
	18056955	CHEMBL4012445	Inhibition of ALK5 (unknown origin) expressed in SBE-bla HEK293T cells assessed as decrease in TGFbeta1-induced Smad2/3 phosphorylation by beta lactamase reporter gene assay	A	Cc1cnc(-c2cc(F)ccc2F)cc1Nc1ccnc2cnn(CC(C)O)c12		CHEMBL4085333	=	EC50	nM	7.943	CHEMBL4439	Homo sapiens	pEC50		8.1
	18056956	CHEMBL4012445	Inhibition of ALK5 (unknown origin) expressed in SBE-bla HEK293T cells assessed as decrease in TGFbeta1-induced Smad2/3 phosphorylation by beta lactamase reporter gene assay	A	CNC(=O)n1ncc2nccc(Nc3ccnc(-c4cc(Cl)ccc4F)c3)c21		CHEMBL4063730	=	EC50	nM	25.12	CHEMBL4439	Homo sapiens	pEC50		7.6
	18056957	CHEMBL4012445	Inhibition of ALK5 (unknown origin) expressed in SBE-bla HEK293T cells assessed as decrease in TGFbeta1-induced Smad2/3 phosphorylation by beta lactamase reporter gene assay	A	CNC(=O)n1ncc2nccc(Nc3cc(-c4cc(Cl)ccc4F)ncc3C)c21		CHEMBL4093090	=	EC50	nM	31.62	CHEMBL4439	Homo sapiens	pEC50		7.5
	18056958	CHEMBL4012445	Inhibition of ALK5 (unknown origin) expressed in SBE-bla HEK293T cells assessed as decrease in TGFbeta1-induced Smad2/3 phosphorylation by beta lactamase reporter gene assay	A	Cc1cnc(-c2cc(Cl)ccc2F)cc1Nc1ccnc2cnn(CC(N)=O)c12		CHEMBL4072325	=	EC50	nM	19.95	CHEMBL4439	Homo sapiens	pEC50		7.7
	18056959	CHEMBL4012445	Inhibition of ALK5 (unknown origin) expressed in SBE-bla HEK293T cells assessed as decrease in TGFbeta1-induced Smad2/3 phosphorylation by beta lactamase reporter gene assay	A	NC(=O)Cn1cc2nccc(Nc3ccnc(-c4cc(F)ccc4F)c3)c2n1		CHEMBL4082821	=	EC50	nM	251.19	CHEMBL4439	Homo sapiens	pEC50		6.6
	18056960	CHEMBL4012445	Inhibition of ALK5 (unknown origin) expressed in SBE-bla HEK293T cells assessed as decrease in TGFbeta1-induced Smad2/3 phosphorylation by beta lactamase reporter gene assay	A	Cc1cnc(-c2cc(F)ccc2F)cc1Nc1ccnc2cn(CC(C)O)nc12		CHEMBL4088735	=	EC50	nM	125.89	CHEMBL4439	Homo sapiens	pEC50		6.9
	18056961	CHEMBL4012445	Inhibition of ALK5 (unknown origin) expressed in SBE-bla HEK293T cells assessed as decrease in TGFbeta1-induced Smad2/3 phosphorylation by beta lactamase reporter gene assay	A	NC(=O)Cn1cc2nccc(Nc3ccnc(-c4cc(Cl)ccc4F)c3)c2n1		CHEMBL4067488	=	EC50	nM	100.0	CHEMBL4439	Homo sapiens	pEC50		7.0
	18056962	CHEMBL4012445	Inhibition of ALK5 (unknown origin) expressed in SBE-bla HEK293T cells assessed as decrease in TGFbeta1-induced Smad2/3 phosphorylation by beta lactamase reporter gene assay	A	Cc1cnc(-c2cc(Cl)ccc2F)cc1Nc1ccnc2cn(CC(N)=O)nc12		CHEMBL4069101	=	EC50	nM	12.59	CHEMBL4439	Homo sapiens	pEC50		7.9
	18056963	CHEMBL4012445	Inhibition of ALK5 (unknown origin) expressed in SBE-bla HEK293T cells assessed as decrease in TGFbeta1-induced Smad2/3 phosphorylation by beta lactamase reporter gene assay	A	Fc1ccc(Cl)cc1-c1cc(Nc2ccnc3cn(CC4CCNCC4)nc23)ccn1		CHEMBL4096361	=	EC50	nM	1000.0	CHEMBL4439	Homo sapiens	pEC50		6.0
	18056964	CHEMBL4012445	Inhibition of ALK5 (unknown origin) expressed in SBE-bla HEK293T cells assessed as decrease in TGFbeta1-induced Smad2/3 phosphorylation by beta lactamase reporter gene assay	A	Cc1ccc(F)c(-c2cc(Nc3ccnc4cnn(C)c34)c(C)cn2)c1		CHEMBL4079857	=	EC50	nM	6.31	CHEMBL4439	Homo sapiens	pEC50		8.2
	18056965	CHEMBL4012445	Inhibition of ALK5 (unknown origin) expressed in SBE-bla HEK293T cells assessed as decrease in TGFbeta1-induced Smad2/3 phosphorylation by beta lactamase reporter gene assay	A	CCn1ncc2nccc(Nc3cc(-c4cc(C)ccc4F)ncc3C)c21		CHEMBL4104104	=	EC50	nM	7.943	CHEMBL4439	Homo sapiens	pEC50		8.1
	18056966	CHEMBL4012445	Inhibition of ALK5 (unknown origin) expressed in SBE-bla HEK293T cells assessed as decrease in TGFbeta1-induced Smad2/3 phosphorylation by beta lactamase reporter gene assay	A	Cc1ccc(F)c(-c2cc(Nc3ccnc4cnn(CCO)c34)c(C)cn2)c1		CHEMBL4087735	=	EC50	nM	19.95	CHEMBL4439	Homo sapiens	pEC50		7.7
	18056967	CHEMBL4012445	Inhibition of ALK5 (unknown origin) expressed in SBE-bla HEK293T cells assessed as decrease in TGFbeta1-induced Smad2/3 phosphorylation by beta lactamase reporter gene assay	A	Cc1ccc(F)c(-c2cc(Nc3ccnc4cnn(C[C@@H](C)O)c34)c(C)cn2)c1		CHEMBL4066402	=	EC50	nM	100.0	CHEMBL4439	Homo sapiens	pEC50		7.0
	18056968	CHEMBL4012445	Inhibition of ALK5 (unknown origin) expressed in SBE-bla HEK293T cells assessed as decrease in TGFbeta1-induced Smad2/3 phosphorylation by beta lactamase reporter gene assay	A	Cc1ccc(F)c(-c2cc(Nc3ccnc4cnn(C[C@H](C)O)c34)c(C)cn2)c1		CHEMBL4095435	=	EC50	nM	63.1	CHEMBL4439	Homo sapiens	pEC50		7.2
	18056969	CHEMBL4012445	Inhibition of ALK5 (unknown origin) expressed in SBE-bla HEK293T cells assessed as decrease in TGFbeta1-induced Smad2/3 phosphorylation by beta lactamase reporter gene assay	A	CNC(=O)Cn1ncc2nccc(Nc3cc(-c4cc(C)ccc4F)ncc3C)c21		CHEMBL4103188	=	EC50	nM	125.89	CHEMBL4439	Homo sapiens	pEC50		6.9
	18056970	CHEMBL4012445	Inhibition of ALK5 (unknown origin) expressed in SBE-bla HEK293T cells assessed as decrease in TGFbeta1-induced Smad2/3 phosphorylation by beta lactamase reporter gene assay	A	Cc1ccc(F)c(-c2cc(Nc3ccnc4cn(C)nc34)c(C)cn2)c1		CHEMBL4085263	=	EC50	nM	79.43	CHEMBL4439	Homo sapiens	pEC50		7.1
	18056971	CHEMBL4012445	Inhibition of ALK5 (unknown origin) expressed in SBE-bla HEK293T cells assessed as decrease in TGFbeta1-induced Smad2/3 phosphorylation by beta lactamase reporter gene assay	A	CCn1cc2nccc(Nc3cc(-c4cc(C)ccc4F)ncc3C)c2n1		CHEMBL4082868	=	EC50	nM	15.85	CHEMBL4439	Homo sapiens	pEC50		7.8
	18056972	CHEMBL4012445	Inhibition of ALK5 (unknown origin) expressed in SBE-bla HEK293T cells assessed as decrease in TGFbeta1-induced Smad2/3 phosphorylation by beta lactamase reporter gene assay	A	Cc1ccc(F)c(-c2cc(Nc3ccnc4cn(CCO)nc34)c(C)cn2)c1		CHEMBL4074026	=	EC50	nM	251.19	CHEMBL4439	Homo sapiens	pEC50		6.6
	18056973	CHEMBL4012445	Inhibition of ALK5 (unknown origin) expressed in SBE-bla HEK293T cells assessed as decrease in TGFbeta1-induced Smad2/3 phosphorylation by beta lactamase reporter gene assay	A	Cc1ccc(F)c(-c2cc(Nc3ccnc4cn(C[C@@H](C)O)nc34)c(C)cn2)c1		CHEMBL4077146	=	EC50	nM	158.49	CHEMBL4439	Homo sapiens	pEC50		6.8
	18056974	CHEMBL4012445	Inhibition of ALK5 (unknown origin) expressed in SBE-bla HEK293T cells assessed as decrease in TGFbeta1-induced Smad2/3 phosphorylation by beta lactamase reporter gene assay	A	Cc1ccc(F)c(-c2cc(Nc3ccnc4cn(C[C@H](C)O)nc34)c(C)cn2)c1		CHEMBL4093131	=	EC50	nM	79.43	CHEMBL4439	Homo sapiens	pEC50		7.1
	18056975	CHEMBL4012445	Inhibition of ALK5 (unknown origin) expressed in SBE-bla HEK293T cells assessed as decrease in TGFbeta1-induced Smad2/3 phosphorylation by beta lactamase reporter gene assay	A	CNC(=O)Cn1cc2nccc(Nc3cc(-c4cc(C)ccc4F)ncc3C)c2n1		CHEMBL4064329	=	EC50	nM	125.89	CHEMBL4439	Homo sapiens	pEC50		6.9
	18056976	CHEMBL4012446	Inhibition of ALK5 in human Calu6 cells assessed as reduction in Smad2/3 phosphorylation	A	Fc1ccc(F)c(-c2cc(Nc3ccnc4cn[nH]c34)ccn2)c1		CHEMBL4064820	=	EC50	nM	199.53	CHEMBL4439	Homo sapiens	pEC50		6.7
	18056977	CHEMBL4012446	Inhibition of ALK5 in human Calu6 cells assessed as reduction in Smad2/3 phosphorylation	A	Cc1cnc(-c2cc(F)ccc2F)cc1Nc1ccnc2cn[nH]c12		CHEMBL4102696	=	EC50	nM	31.62	CHEMBL4439	Homo sapiens	pEC50		7.5
	18056978	CHEMBL4012446	Inhibition of ALK5 in human Calu6 cells assessed as reduction in Smad2/3 phosphorylation	A	COc1cccc2nccc(Nc3cc(-c4cccc(C)n4)ncc3C)c12		CHEMBL4074485	=	EC50	nM	199.53	CHEMBL4439	Homo sapiens	pEC50		6.7
	18056979	CHEMBL4012446	Inhibition of ALK5 in human Calu6 cells assessed as reduction in Smad2/3 phosphorylation	A	COc1cccc2nccc(Nc3cc(-c4nc(C)ccc4F)ncc3C)c12		CHEMBL4094958	=	EC50	nM	31.62	CHEMBL4439	Homo sapiens	pEC50		7.5
	18056980	CHEMBL4012446	Inhibition of ALK5 in human Calu6 cells assessed as reduction in Smad2/3 phosphorylation	A	NC(=O)Cn1ncc2nccc(Nc3ccnc(-c4cc(F)ccc4F)c3)c21		CHEMBL4089166	=	EC50	nM	1258.93	CHEMBL4439	Homo sapiens	pEC50		5.9
	18056981	CHEMBL4012446	Inhibition of ALK5 in human Calu6 cells assessed as reduction in Smad2/3 phosphorylation	A	CNC(=O)n1ncc2nccc(Nc3ccnc(-c4cc(F)ccc4F)c3)c21		CHEMBL4060987	=	EC50	nM	125.89	CHEMBL4439	Homo sapiens	pEC50		6.9
	18056982	CHEMBL4012446	Inhibition of ALK5 in human Calu6 cells assessed as reduction in Smad2/3 phosphorylation	A	CCNC(=O)n1ncc2nccc(Nc3ccnc(-c4cc(F)ccc4F)c3)c21		CHEMBL4075081	=	EC50	nM	158.49	CHEMBL4439	Homo sapiens	pEC50		6.8
	18056983	CHEMBL4012446	Inhibition of ALK5 in human Calu6 cells assessed as reduction in Smad2/3 phosphorylation	A	CNC(=O)n1ncc2nccc(Nc3cc(-c4cc(F)ccc4F)ncc3C)c21		CHEMBL4101751	=	EC50	nM	19.95	CHEMBL4439	Homo sapiens	pEC50		7.7
	18056984	CHEMBL4012446	Inhibition of ALK5 in human Calu6 cells assessed as reduction in Smad2/3 phosphorylation	A	Cc1cnc(-c2cc(F)ccc2F)cc1Nc1ccnc2cnn(CC(C)O)c12		CHEMBL4085333	=	EC50	nM	19.95	CHEMBL4439	Homo sapiens	pEC50		7.7
	18056985	CHEMBL4012446	Inhibition of ALK5 in human Calu6 cells assessed as reduction in Smad2/3 phosphorylation	A	CNC(=O)n1ncc2nccc(Nc3ccnc(-c4cc(Cl)ccc4F)c3)c21		CHEMBL4063730	=	EC50	nM	63.1	CHEMBL4439	Homo sapiens	pEC50		7.2
	18056986	CHEMBL4012446	Inhibition of ALK5 in human Calu6 cells assessed as reduction in Smad2/3 phosphorylation	A	Cc1cnc(-c2cc(Cl)ccc2F)cc1Nc1ccnc2cnn(CC(N)=O)c12		CHEMBL4072325	=	EC50	nM	31.62	CHEMBL4439	Homo sapiens	pEC50		7.5
	18056987	CHEMBL4012446	Inhibition of ALK5 in human Calu6 cells assessed as reduction in Smad2/3 phosphorylation	A	NC(=O)Cn1cc2nccc(Nc3ccnc(-c4cc(F)ccc4F)c3)c2n1		CHEMBL4082821	=	EC50	nM	1584.89	CHEMBL4439	Homo sapiens	pEC50		5.8
	18056988	CHEMBL4012446	Inhibition of ALK5 in human Calu6 cells assessed as reduction in Smad2/3 phosphorylation	A	Cc1cnc(-c2cc(F)ccc2F)cc1Nc1ccnc2cn(CC(C)O)nc12		CHEMBL4088735	=	EC50	nM	158.49	CHEMBL4439	Homo sapiens	pEC50		6.8
	18056989	CHEMBL4012446	Inhibition of ALK5 in human Calu6 cells assessed as reduction in Smad2/3 phosphorylation	A	Cc1cnc(-c2cc(Cl)ccc2F)cc1Nc1ccnc2cn(CC(N)=O)nc12		CHEMBL4069101	=	EC50	nM	31.62	CHEMBL4439	Homo sapiens	pEC50		7.5
	18056990	CHEMBL4012446	Inhibition of ALK5 in human Calu6 cells assessed as reduction in Smad2/3 phosphorylation	A	Cc1ccc(F)c(-c2cc(Nc3ccnc4cnn(C)c34)c(C)cn2)c1		CHEMBL4079857	=	EC50	nM	39.81	CHEMBL4439	Homo sapiens	pEC50		7.4
	18056991	CHEMBL4012446	Inhibition of ALK5 in human Calu6 cells assessed as reduction in Smad2/3 phosphorylation	A	Cc1ccc(F)c(-c2cc(Nc3ccnc4cnn(C[C@@H](C)O)c34)c(C)cn2)c1		CHEMBL4066402	=	EC50	nM	501.19	CHEMBL4439	Homo sapiens	pEC50		6.3
	18056992	CHEMBL4012446	Inhibition of ALK5 in human Calu6 cells assessed as reduction in Smad2/3 phosphorylation	A	Cc1ccc(F)c(-c2cc(Nc3ccnc4cnn(C[C@H](C)O)c34)c(C)cn2)c1		CHEMBL4095435	=	EC50	nM	398.11	CHEMBL4439	Homo sapiens	pEC50		6.4
	18056993	CHEMBL4012446	Inhibition of ALK5 in human Calu6 cells assessed as reduction in Smad2/3 phosphorylation	A	Cc1ccc(F)c(-c2cc(Nc3ccnc4cnn(CC(N)=O)c34)c(C)cn2)c1		CHEMBL4075003	=	EC50	nM	501.19	CHEMBL4439	Homo sapiens	pEC50		6.3
	18056994	CHEMBL4012446	Inhibition of ALK5 in human Calu6 cells assessed as reduction in Smad2/3 phosphorylation	A	CNC(=O)Cn1ncc2nccc(Nc3cc(-c4cc(C)ccc4F)ncc3C)c21		CHEMBL4103188	=	EC50	nM	1584.89	CHEMBL4439	Homo sapiens	pEC50		5.8
	18056995	CHEMBL4012446	Inhibition of ALK5 in human Calu6 cells assessed as reduction in Smad2/3 phosphorylation	A	Cc1ccc(F)c(-c2cc(Nc3ccnc4cn(C)nc34)c(C)cn2)c1		CHEMBL4085263	=	EC50	nM	316.23	CHEMBL4439	Homo sapiens	pEC50		6.5
	18056996	CHEMBL4012446	Inhibition of ALK5 in human Calu6 cells assessed as reduction in Smad2/3 phosphorylation	A	CCn1cc2nccc(Nc3cc(-c4cc(C)ccc4F)ncc3C)c2n1		CHEMBL4082868	=	EC50	nM	158.49	CHEMBL4439	Homo sapiens	pEC50		6.8
	18056997	CHEMBL4012446	Inhibition of ALK5 in human Calu6 cells assessed as reduction in Smad2/3 phosphorylation	A	Cc1ccc(F)c(-c2cc(Nc3ccnc4cn(C[C@@H](C)O)nc34)c(C)cn2)c1		CHEMBL4077146	=	EC50	nM	501.19	CHEMBL4439	Homo sapiens	pEC50		6.3
	18056998	CHEMBL4012446	Inhibition of ALK5 in human Calu6 cells assessed as reduction in Smad2/3 phosphorylation	A	Cc1ccc(F)c(-c2cc(Nc3ccnc4cn(C[C@H](C)O)nc34)c(C)cn2)c1		CHEMBL4093131	=	EC50	nM	316.23	CHEMBL4439	Homo sapiens	pEC50		6.5
	18056999	CHEMBL4012446	Inhibition of ALK5 in human Calu6 cells assessed as reduction in Smad2/3 phosphorylation	A	Cc1ccc(F)c(-c2cc(Nc3ccnc4cn(CC(N)=O)nc34)c(C)cn2)c1		CHEMBL4075798	=	EC50	nM	251.19	CHEMBL4439	Homo sapiens	pEC50		6.6
	18057000	CHEMBL4012446	Inhibition of ALK5 in human Calu6 cells assessed as reduction in Smad2/3 phosphorylation	A	CNC(=O)Cn1cc2nccc(Nc3cc(-c4cc(C)ccc4F)ncc3C)c2n1		CHEMBL4064329	=	EC50	nM	501.19	CHEMBL4439	Homo sapiens	pEC50		6.3
	18057073	CHEMBL4012446	Inhibition of ALK5 in human Calu6 cells assessed as reduction in Smad2/3 phosphorylation	A	CCn1ncc2nccc(Nc3cc(-c4cc(C)ccc4F)ncc3C)c21		CHEMBL4104104	=	EC50	nM	50.12	CHEMBL4439	Homo sapiens	pEC50		7.3
	18114879	CHEMBL4025409	Inhibition of wild-type human partial length TGFBR1 (D179 to M503 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	93.0	CHEMBL4439	Homo sapiens	Activity	%	93.0
	18203933	CHEMBL4044220	Inhibition of wild-type human partial length TGFBR1 (D179 to M503 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	95.0	CHEMBL4439	Homo sapiens	Activity	%	95.0
	18232156	CHEMBL4050350	Inhibition of human TGFBR1 assessed as residual activity at 1 uM in presence of [33P]ATP by filter binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	85.0	CHEMBL4439	Homo sapiens	Activity	%	85.0
	18253961	CHEMBL4055265	Inhibition of wild-type human partial length TGFBR1 (D179 to M503 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	100.0	CHEMBL4439	Homo sapiens	Activity	%	100.0
	18253962	CHEMBL4055265	Inhibition of wild-type human partial length TGFBR1 (D179 to M503 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	95.0	CHEMBL4439	Homo sapiens	Activity	%	95.0
	18282182	CHEMBL4120137	Inhibition of recombinant full length N-terminal GST-tagged human TGFBR1 (200 to 503 residues) expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	1.6	CHEMBL4439	Homo sapiens	INH	%	1.6
	18282501	CHEMBL4120137	Inhibition of recombinant full length N-terminal GST-tagged human TGFBR1 (200 to 503 residues) expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	11.7	CHEMBL4439	Homo sapiens	INH	%	11.7
	18440475	CHEMBL4157299	Binding affinity to wild-type human partial length TGFBR1 (D179 to M503 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	86.0	CHEMBL4439	Homo sapiens	Activity	%	86.0
	18449745	CHEMBL4178039	Inhibition of TGFbeta-induced ALK5 in human HepG2 cells pretreated for 30 mins followed by TGFbeta stimulation measured after overnight incubation by luciferase reporter gene assay	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	IC50	nM	10.0	CHEMBL4439	Homo sapiens	IC50	nM	10.0
	18449940	CHEMBL4178174	Inhibition of human TGFbetaR1 T204D mutant (200 to 501 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	14.0	CHEMBL4439	Homo sapiens	Activity	%	14.0
	18449945	CHEMBL4178179	Inhibition of human TGFbetaR1 T204D mutant (200 to 501 residues) at 100 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Inhibition	%	86.0	CHEMBL4439	Homo sapiens	INH	%	86.0
	18484431	CHEMBL4186078	Binding affinity to wild-type human partial length TGFBR1 (D179 to M503 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	89.0	CHEMBL4439	Homo sapiens	Activity	%	89.0
	18484915	CHEMBL4186078	Binding affinity to wild-type human partial length TGFBR1 (D179 to M503 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	97.0	CHEMBL4439	Homo sapiens	Activity	%	97.0
	18489567	CHEMBL4187308	Inhibition of wild-type human partial length TGFBR1 (D179 to M503 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	Fc1cc(F)cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)c1		CHEMBL4207079	=	Activity	%	100.0	CHEMBL4439	Homo sapiens	Activity	%	100.0
	18496475	CHEMBL4188411	Inhibition of human His-tagged TGFbetaR1 T204D mutant expressed in Sf9 insect cells after 1 hr by HTRF assay	B	Cc1cccc(-c2nc(Nc3ccncc3F)c3nc[nH]c3n2)n1		CHEMBL4209835	=	Ki	nM	0.14	CHEMBL4439	Homo sapiens	Ki(app)	nM	0.14
	18496476	CHEMBL4188411	Inhibition of human His-tagged TGFbetaR1 T204D mutant expressed in Sf9 insect cells after 1 hr by HTRF assay	B	Cc1cccc(-c2nc(Nc3ccncc3F)c3cc[nH]c3n2)n1		CHEMBL4210246	=	Ki	nM	0.14	CHEMBL4439	Homo sapiens	Ki(app)	nM	0.14
Not Determined	18496477	CHEMBL4188411	Inhibition of human His-tagged TGFbetaR1 T204D mutant expressed in Sf9 insect cells after 1 hr by HTRF assay	B	CC(=O)Nc1cc(Nc2nc(-c3cccc(C(F)(F)F)n3)nc3[nH]cnc23)ccn1		CHEMBL4205456		Ki(app)			CHEMBL4439	Homo sapiens	Ki(app)		
	18496478	CHEMBL4188411	Inhibition of human His-tagged TGFbetaR1 T204D mutant expressed in Sf9 insect cells after 1 hr by HTRF assay	B	CC(=O)Nc1cc(Nc2nc(-c3cccc(C(F)(F)F)n3)nc3[nH]ccc23)ccn1		CHEMBL4209583	=	Ki	nM	0.15	CHEMBL4439	Homo sapiens	Ki(app)	nM	0.15
	18496479	CHEMBL4188411	Inhibition of human His-tagged TGFbetaR1 T204D mutant expressed in Sf9 insect cells after 1 hr by HTRF assay	B	Fc1cnccc1Nc1nc(-c2cccc(C(F)(F)F)n2)nc2[nH]ccc12		CHEMBL4217699	=	Ki	nM	0.22	CHEMBL4439	Homo sapiens	Ki(app)	nM	0.22
Not Determined	18496483	CHEMBL4188417	Inhibition of TGFbetaR1 in human primary T-cells assessed as TGFbeta-stimulated PSMAD phosphorylation preincubated for 1 hr followed by TGFbeta addition measured after 90 mins by Alpha screen assay	B	Fc1cnccc1Nc1nc(-c2cccc(C(F)(F)F)n2)nc2[nH]ccc12		CHEMBL4217699		IC50			CHEMBL4439	Homo sapiens	IC50		
	18496484	CHEMBL4188417	Inhibition of TGFbetaR1 in human primary T-cells assessed as TGFbeta-stimulated PSMAD phosphorylation preincubated for 1 hr followed by TGFbeta addition measured after 90 mins by Alpha screen assay	B	CC(=O)Nc1cc(Nc2nc(-c3cccc(C(F)(F)F)n3)nc3[nH]ccc23)ccn1		CHEMBL4209583	=	IC50	nM	12.0	CHEMBL4439	Homo sapiens	IC50	uM	0.012
	18496485	CHEMBL4188417	Inhibition of TGFbetaR1 in human primary T-cells assessed as TGFbeta-stimulated PSMAD phosphorylation preincubated for 1 hr followed by TGFbeta addition measured after 90 mins by Alpha screen assay	B	CC(=O)Nc1cc(Nc2nc(-c3cccc(C(F)(F)F)n3)nc3[nH]cnc23)ccn1		CHEMBL4205456	=	IC50	nM	50.0	CHEMBL4439	Homo sapiens	IC50	uM	0.05
	18496486	CHEMBL4188417	Inhibition of TGFbetaR1 in human primary T-cells assessed as TGFbeta-stimulated PSMAD phosphorylation preincubated for 1 hr followed by TGFbeta addition measured after 90 mins by Alpha screen assay	B	Cc1cccc(-c2nc(Nc3ccncc3F)c3cc[nH]c3n2)n1		CHEMBL4210246	=	IC50	nM	5.1	CHEMBL4439	Homo sapiens	IC50	uM	0.0051
	18496487	CHEMBL4188417	Inhibition of TGFbetaR1 in human primary T-cells assessed as TGFbeta-stimulated PSMAD phosphorylation preincubated for 1 hr followed by TGFbeta addition measured after 90 mins by Alpha screen assay	B	Cc1cccc(-c2nc(Nc3ccncc3F)c3nc[nH]c3n2)n1		CHEMBL4209835	=	IC50	nM	26.0	CHEMBL4439	Homo sapiens	IC50	uM	0.026
	18496488	CHEMBL4188417	Inhibition of TGFbetaR1 in human primary T-cells assessed as TGFbeta-stimulated PSMAD phosphorylation preincubated for 1 hr followed by TGFbeta addition measured after 90 mins by Alpha screen assay	B	c1ccc(-c2nn3c(c2-c2ccnc4cc(OCCN5CCOCC5)ccc24)CCC3)nc1		CHEMBL260015	=	IC50	nM	370.0	CHEMBL4439	Homo sapiens	IC50	uM	0.37
	18496489	CHEMBL4188417	Inhibition of TGFbetaR1 in human primary T-cells assessed as TGFbeta-stimulated PSMAD phosphorylation preincubated for 1 hr followed by TGFbeta addition measured after 90 mins by Alpha screen assay	B	CC(=O)Nc1cc(Nc2nc(-c3cccc(C(F)(F)F)n3)nn3cccc23)ccn1		CHEMBL4216706	=	IC50	nM	120.0	CHEMBL4439	Homo sapiens	IC50	uM	0.12
	18496590	CHEMBL4188411	Inhibition of human His-tagged TGFbetaR1 T204D mutant expressed in Sf9 insect cells after 1 hr by HTRF assay	B	Fc1cnccc1Nc1nc(-c2cccc(C(F)(F)F)n2)nc2[nH]ccc12		CHEMBL4217699	=	IC50	nM	0.55	CHEMBL4439	Homo sapiens	IC50	uM	0.00055
	18496591	CHEMBL4188411	Inhibition of human His-tagged TGFbetaR1 T204D mutant expressed in Sf9 insect cells after 1 hr by HTRF assay	B	CC(=O)Nc1cc(Nc2nc(-c3cccc(C(F)(F)F)n3)nc3[nH]ccc23)ccn1		CHEMBL4209583	=	IC50	nM	1.0	CHEMBL4439	Homo sapiens	IC50	uM	0.001
	18496592	CHEMBL4188411	Inhibition of human His-tagged TGFbetaR1 T204D mutant expressed in Sf9 insect cells after 1 hr by HTRF assay	B	CC(=O)Nc1cc(Nc2nc(-c3cccc(C(F)(F)F)n3)nc3[nH]cnc23)ccn1		CHEMBL4205456	=	IC50	nM	1.1	CHEMBL4439	Homo sapiens	IC50	uM	0.0011
	18496593	CHEMBL4188411	Inhibition of human His-tagged TGFbetaR1 T204D mutant expressed in Sf9 insect cells after 1 hr by HTRF assay	B	Cc1cccc(-c2nc(Nc3ccncc3F)c3cc[nH]c3n2)n1		CHEMBL4210246	=	IC50	nM	7.0	CHEMBL4439	Homo sapiens	IC50	uM	0.007
	18496594	CHEMBL4188411	Inhibition of human His-tagged TGFbetaR1 T204D mutant expressed in Sf9 insect cells after 1 hr by HTRF assay	B	Cc1cccc(-c2nc(Nc3ccncc3F)c3nc[nH]c3n2)n1		CHEMBL4209835	=	IC50	nM	5.2	CHEMBL4439	Homo sapiens	IC50	uM	0.0052
	18496595	CHEMBL4188411	Inhibition of human His-tagged TGFbetaR1 T204D mutant expressed in Sf9 insect cells after 1 hr by HTRF assay	B	c1ccc(-c2nn3c(c2-c2ccnc4cc(OCCN5CCOCC5)ccc24)CCC3)nc1		CHEMBL260015	=	IC50	nM	3.7	CHEMBL4439	Homo sapiens	IC50	uM	0.0037
	18496596	CHEMBL4188411	Inhibition of human His-tagged TGFbetaR1 T204D mutant expressed in Sf9 insect cells after 1 hr by HTRF assay	B	O=C(CN1CCN(CCO)CC1)Nc1cc(Nc2nc(-c3cccc(C(F)(F)F)n3)nn3cccc23)ccn1		CHEMBL4214237	=	IC50	nM	2.1	CHEMBL4439	Homo sapiens	IC50	uM	0.0021
	18496597	CHEMBL4188411	Inhibition of human His-tagged TGFbetaR1 T204D mutant expressed in Sf9 insect cells after 1 hr by HTRF assay	B	CC(=O)Nc1cc(Nc2nc(-c3cccc(C(F)(F)F)n3)nn3cccc23)c(F)cn1		CHEMBL4206910	=	IC50	nM	25.0	CHEMBL4439	Homo sapiens	IC50	uM	0.025
	18496598	CHEMBL4188411	Inhibition of human His-tagged TGFbetaR1 T204D mutant expressed in Sf9 insect cells after 1 hr by HTRF assay	B	CC(=O)Nc1cc(Nc2nc(-c3cccc(C(F)(F)F)n3)nn3cccc23)ccn1		CHEMBL4216706	=	IC50	nM	1.4	CHEMBL4439	Homo sapiens	IC50	uM	0.0014
	18496599	CHEMBL4188411	Inhibition of human His-tagged TGFbetaR1 T204D mutant expressed in Sf9 insect cells after 1 hr by HTRF assay	B	N[C@@H]1CCN(Cc2ccn3nc(-c4ccccn4)nc(Nc4ccncc4F)c23)C[C@H]1O		CHEMBL4217935	=	IC50	nM	4.4	CHEMBL4439	Homo sapiens	IC50	uM	0.0044
	18496600	CHEMBL4188411	Inhibition of human His-tagged TGFbetaR1 T204D mutant expressed in Sf9 insect cells after 1 hr by HTRF assay	B	N[C@H]1CCN(Cc2ccn3nc(-c4ccccn4)nc(Nc4ccncc4F)c23)C[C@@H]1O		CHEMBL4206220	=	IC50	nM	3.9	CHEMBL4439	Homo sapiens	IC50	uM	0.0039
	18496601	CHEMBL4188411	Inhibition of human His-tagged TGFbetaR1 T204D mutant expressed in Sf9 insect cells after 1 hr by HTRF assay	B	N[C@H]1CC[C@@H](NCc2ccn3nc(-c4ccccn4)nc(Nc4ccncc4F)c23)CC1		CHEMBL4214470	=	IC50	nM	4.3	CHEMBL4439	Homo sapiens	IC50	uM	0.0043
	18496602	CHEMBL4188411	Inhibition of human His-tagged TGFbetaR1 T204D mutant expressed in Sf9 insect cells after 1 hr by HTRF assay	B	Fc1cnccc1Nc1nc(-c2ccccn2)nn2cccc12		CHEMBL4204772	=	IC50	nM	1.7	CHEMBL4439	Homo sapiens	IC50	uM	0.0017
	18496603	CHEMBL4188411	Inhibition of human His-tagged TGFbetaR1 T204D mutant expressed in Sf9 insect cells after 1 hr by HTRF assay	B	Cc1cccc(-c2nc(Nc3ccncc3C(=O)NC(C)C)c3cccn3n2)n1		CHEMBL4210079	=	IC50	nM	62.0	CHEMBL4439	Homo sapiens	IC50	uM	0.062
	18496604	CHEMBL4188411	Inhibition of human His-tagged TGFbetaR1 T204D mutant expressed in Sf9 insect cells after 1 hr by HTRF assay	B	Cc1cccc(-c2nc(Nc3c(F)cncc3F)c3cccn3n2)n1		CHEMBL4211574	=	IC50	nM	3.4	CHEMBL4439	Homo sapiens	IC50	uM	0.0034
	18496605	CHEMBL4188411	Inhibition of human His-tagged TGFbetaR1 T204D mutant expressed in Sf9 insect cells after 1 hr by HTRF assay	B	Cc1cccc(-c2nc(Nc3ccncc3F)c3cccn3n2)n1		CHEMBL4205457	=	IC50	nM	0.96	CHEMBL4439	Homo sapiens	IC50	uM	0.00096
	18496606	CHEMBL4188411	Inhibition of human His-tagged TGFbetaR1 T204D mutant expressed in Sf9 insect cells after 1 hr by HTRF assay	B	FC(F)(F)c1cccc(-c2nc(Nc3ccncc3)c3cccn3n2)n1		CHEMBL4202469	=	IC50	nM	6.8	CHEMBL4439	Homo sapiens	IC50	uM	0.0068
	18496607	CHEMBL4188411	Inhibition of human His-tagged TGFbetaR1 T204D mutant expressed in Sf9 insect cells after 1 hr by HTRF assay	B	COc1cccc(-c2nc(Nc3ccncc3)c3cccn3n2)n1		CHEMBL4218893	=	IC50	nM	19.0	CHEMBL4439	Homo sapiens	IC50	uM	0.019
	18496608	CHEMBL4188411	Inhibition of human His-tagged TGFbetaR1 T204D mutant expressed in Sf9 insect cells after 1 hr by HTRF assay	B	c1ccc(-c2nc(Nc3ccncc3)c3cccn3n2)nc1		CHEMBL4205311	=	IC50	nM	2.5	CHEMBL4439	Homo sapiens	IC50	uM	0.0025
	18496609	CHEMBL4188411	Inhibition of human His-tagged TGFbetaR1 T204D mutant expressed in Sf9 insect cells after 1 hr by HTRF assay	B	Cc1cccc(-c2nc(Nc3ccncc3)c3cccn3n2)n1		CHEMBL4206793	=	IC50	nM	1.3	CHEMBL4439	Homo sapiens	IC50	uM	0.0013
	18496611	CHEMBL4188411	Inhibition of human His-tagged TGFbetaR1 T204D mutant expressed in Sf9 insect cells after 1 hr by HTRF assay	B	Cc1cccc(-c2nc(Nc3ccnc4ccccc34)c3cccn3n2)n1		CHEMBL4205979	=	IC50	nM	1.6	CHEMBL4439	Homo sapiens	IC50	uM	0.0016
	18496613	CHEMBL4188411	Inhibition of human His-tagged TGFbetaR1 T204D mutant expressed in Sf9 insect cells after 1 hr by HTRF assay	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	=	IC50	nM	4.1	CHEMBL4439	Homo sapiens	IC50	uM	0.0041
	18507582	CHEMBL4191209	Inhibition of recombinant activated human TGFBR1 (200 to end residues) at 1 uM using casein as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	76.0	CHEMBL4439	Homo sapiens	INH	%	76.0
	18655257	CHEMBL4230978	Binding affinity to wild-type human partial length TGFBR1 (D179 to M503 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	100.0	CHEMBL4439	Homo sapiens	Activity	%	100.0
	18663963	CHEMBL4232947	Inhibition of human TGFBR1 (D179 to M503 residues) expressed in bacterial expression system assessed as residual activity at 5 uM by KINOMEscan assay relative to control	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	=	Activity	%	100.0	CHEMBL4439	Homo sapiens	Activity	%	100.0
	18664060	CHEMBL4233044	Binding affinity to human TGFBR1 (D179 to M503 residues) expressed in bacterial expression system by KINOMEscan assay	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	>=	Kd	nM	5000.0	CHEMBL4439	Homo sapiens	Kd	uM	5.0
	18674986	CHEMBL4235476	Binding affinity to human ALK5 by KdELECT assay	B	Cc1nc2ccc(-c3ccnc4ccccc34)c(C)c2c(=O)[nH]1		CHEMBL4247751	=	Kd	nM	1000.0	CHEMBL4439	Homo sapiens	Kd	nM	1000.0
	18674987	CHEMBL4235476	Binding affinity to human ALK5 by KdELECT assay	B	O=c1c2cc(-c3ccnc4ccccc34)ccc2ncn1-c1ccc(N2CCOCC2)cc1		CHEMBL4244382	=	Kd	nM	19000.0	CHEMBL4439	Homo sapiens	Kd	nM	19000.0
Active	18674996	CHEMBL4235471	Inhibition of human ALK5 at 1 uM by scanEDGE assay	B	Cc1nc2ccc(-c3ccnc4ccccc34)c(C)c2c(=O)[nH]1		CHEMBL4247751		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
	18697689	CHEMBL4254362	Inhibition of wild-type human partial length TGFBR1 (D179 to M503 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCNc1cc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2C(F)(F)F)ccn1		CHEMBL4281348	=	Activity	%	86.0	CHEMBL4439	Homo sapiens	Activity	%	86.0
	18751368	CHEMBL4263985	Inhibition of ALK5 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr by TR-FRET analysis	B	CC(c1ccc(-c2cnc3c(-c4ccc(S(N)(=O)=O)c5ccccc45)cnn3c2)cc1)N1CCCC1		CHEMBL4283638	=	IC50	nM	18650.0	CHEMBL4439	Homo sapiens	IC50	nM	18650.0
	18752230	CHEMBL4264567	Binding affinity to wild-type human partial length TGFBR1 (D179 to M503 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	98.0	CHEMBL4439	Homo sapiens	Activity	%	98.0
	18761587	CHEMBL4266638	Inhibition of recombinant human N-terminal His6-tagged TGFBR1 (200 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1	Outside typical range	CHEMBL4279192	=	Inhibition	%	-11.0	CHEMBL4439	Homo sapiens	INH	%	-11.0
	18761858	CHEMBL4266638	Inhibition of recombinant human N-terminal His6-tagged TGFBR1 (200 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	=	Inhibition	%	12.0	CHEMBL4439	Homo sapiens	INH	%	12.0
	18762021	CHEMBL4266638	Inhibition of recombinant human N-terminal His6-tagged TGFBR1 (200 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1		CHEMBL4290222	=	Inhibition	%	-5.0	CHEMBL4439	Homo sapiens	INH	%	-5.0
	18782471	CHEMBL4270420	Inhibition of TGFbetaR1 in human Treg cells assessed as reduction in TGFbeta-stimulated induction of Treg cells by measuring FOXP3/CD25 expression level after 5 days by FACS analysis	B	CC(=O)Nc1cc(-c2[nH]c3cccnc3c2-c2cccc(C(F)F)n2)ccn1		CHEMBL4284170	=	IC50	nM	50.0	CHEMBL4439	Homo sapiens	IC50	uM	0.05
	18782472	CHEMBL4270420	Inhibition of TGFbetaR1 in human Treg cells assessed as reduction in TGFbeta-stimulated induction of Treg cells by measuring FOXP3/CD25 expression level after 5 days by FACS analysis	B	[2H]C([2H])([2H])Oc1ccc(-c2c(-c3ccnc(NC(C)=O)c3)[nH]c3cccnc23)nc1		CHEMBL4280731	=	IC50	nM	110.0	CHEMBL4439	Homo sapiens	IC50	uM	0.11
	18782473	CHEMBL4270419	Inhibition of TGFbetaR1 in human T cells assessed as reduction in TGFbeta-stimulated PSMAD3 phosphorylation preincubated for 1 hr followed by TGFbeta addition measured after 90 mins by AlphaLisa assay	B	CC(=O)Nc1cc(-c2[nH]c3cccnc3c2-c2cccc(C(F)F)n2)ccn1		CHEMBL4284170	=	IC50	nM	94.0	CHEMBL4439	Homo sapiens	IC50	uM	0.094
	18782498	CHEMBL4270418	Inhibition of TGFbetaR1 in NHLF assessed as reduction in TGFbeta-stimulated TSMAD phosphorylation preincubated for 1 hr followed by TGFbeta addition measured after 15 mins	B	[2H]C([2H])([2H])Oc1ccc(-c2c(-c3ccnc(NC(C)=O)c3)[nH]c3cccnc23)nc1		CHEMBL4280731	=	IC50	nM	450.0	CHEMBL4439	Homo sapiens	IC50	uM	0.45
	18782499	CHEMBL4270418	Inhibition of TGFbetaR1 in NHLF assessed as reduction in TGFbeta-stimulated TSMAD phosphorylation preincubated for 1 hr followed by TGFbeta addition measured after 15 mins	B	CC(=O)Nc1cc(-c2[nH]c3cccnc3c2-c2cccc(C(F)F)n2)ccn1		CHEMBL4284170	=	IC50	nM	68.0	CHEMBL4439	Homo sapiens	IC50	uM	0.068
	18782500	CHEMBL4270419	Inhibition of TGFbetaR1 in human T cells assessed as reduction in TGFbeta-stimulated PSMAD3 phosphorylation preincubated for 1 hr followed by TGFbeta addition measured after 90 mins by AlphaLisa assay	B	[2H]C([2H])([2H])Oc1ccc(-c2c(-c3ccnc(NC(C)=O)c3)[nH]c3cccnc23)nc1		CHEMBL4280731	=	IC50	nM	17.0	CHEMBL4439	Homo sapiens	IC50	uM	0.017
	18782508	CHEMBL4270414	Inhibition of TGFbetaR1 T204D mutant (unknown origin) kinase domain after 1 hr by HTRF assay	B	CC(=O)Nc1cc(-c2[nH]c3cccnc3c2-c2cccc(C(F)(F)F)n2)ccn1		CHEMBL4276907	=	IC50	nM	2.0	CHEMBL4439	Homo sapiens	IC50	uM	0.002
	18782509	CHEMBL4270414	Inhibition of TGFbetaR1 T204D mutant (unknown origin) kinase domain after 1 hr by HTRF assay	B	CC(=O)Nc1cc(-c2[nH]c3cccnc3c2-c2cccc(C(F)F)n2)ccn1		CHEMBL4284170	=	IC50	nM	1.0	CHEMBL4439	Homo sapiens	IC50	uM	0.001
	18782510	CHEMBL4270414	Inhibition of TGFbetaR1 T204D mutant (unknown origin) kinase domain after 1 hr by HTRF assay	B	CC(=O)Nc1cc(-c2[nH]c3cccnc3c2-c2cccc(C)n2)ccn1		CHEMBL4292047	=	IC50	nM	2.0	CHEMBL4439	Homo sapiens	IC50	uM	0.002
	18782511	CHEMBL4270414	Inhibition of TGFbetaR1 T204D mutant (unknown origin) kinase domain after 1 hr by HTRF assay	B	[2H]C([2H])([2H])Oc1ccc(-c2c(-c3ccnc(NC(C)=O)c3)[nH]c3cccnc23)nc1		CHEMBL4280731	=	IC50	nM	2.0	CHEMBL4439	Homo sapiens	IC50	uM	0.002
	18782512	CHEMBL4270414	Inhibition of TGFbetaR1 T204D mutant (unknown origin) kinase domain after 1 hr by HTRF assay	B	COc1ccc(-c2c(-c3ccnc(NC(C)=O)c3)[nH]c3cccnc23)nc1		CHEMBL4288634	=	IC50	nM	6.0	CHEMBL4439	Homo sapiens	IC50	uM	0.006
	18782513	CHEMBL4270414	Inhibition of TGFbetaR1 T204D mutant (unknown origin) kinase domain after 1 hr by HTRF assay	B	CC(=O)Nc1cc(-c2[nH]c3cccnc3c2-c2ccc(OC(F)F)cn2)ccn1		CHEMBL4277338	=	IC50	nM	11.0	CHEMBL4439	Homo sapiens	IC50	uM	0.011
	18782514	CHEMBL4270414	Inhibition of TGFbetaR1 T204D mutant (unknown origin) kinase domain after 1 hr by HTRF assay	B	CC(=O)Nc1cc(-c2[nH]c3cccnc3c2-c2ccc(C)cn2)ccn1		CHEMBL4285292	=	IC50	nM	5.0	CHEMBL4439	Homo sapiens	IC50	uM	0.005
	18782515	CHEMBL4270414	Inhibition of TGFbetaR1 T204D mutant (unknown origin) kinase domain after 1 hr by HTRF assay	B	CC(=O)Nc1cc(-c2[nH]c3cccnc3c2-c2ccc(Cl)cn2)ccn1		CHEMBL4280660	=	IC50	nM	2.0	CHEMBL4439	Homo sapiens	IC50	uM	0.002
	18782516	CHEMBL4270414	Inhibition of TGFbetaR1 T204D mutant (unknown origin) kinase domain after 1 hr by HTRF assay	B	CC(=O)Nc1cc(-c2[nH]c3cccnc3c2-c2ccc(F)cn2)ccn1		CHEMBL4291307	=	IC50	nM	3.0	CHEMBL4439	Homo sapiens	IC50	uM	0.003
	18782517	CHEMBL4270414	Inhibition of TGFbetaR1 T204D mutant (unknown origin) kinase domain after 1 hr by HTRF assay	B	COc1ccc(-c2c(-c3ccnc(NC(C)=O)c3)[nH]c3cccnc23)cn1		CHEMBL4279160	=	IC50	nM	3.0	CHEMBL4439	Homo sapiens	IC50	uM	0.003
	18782518	CHEMBL4270414	Inhibition of TGFbetaR1 T204D mutant (unknown origin) kinase domain after 1 hr by HTRF assay	B	CC(=O)Nc1cc(-c2[nH]c3cccnc3c2-c2ccc(F)nc2)ccn1		CHEMBL4289841	=	IC50	nM	22.0	CHEMBL4439	Homo sapiens	IC50	uM	0.022
	18782657	CHEMBL4270674	Inhibition of human ALK5 expressed in Sf9 insect cells using casein as substrate in presence of [gamma-33P]ATP	B	Cc1cccc(-c2nn3c(c2-c2ccncc2)C(C)C(C)(C)C3)n1		CHEMBL4279935	=	IC50	nM	181.0	CHEMBL4439	Homo sapiens	IC50	uM	0.181
	18782658	CHEMBL4270674	Inhibition of human ALK5 expressed in Sf9 insect cells using casein as substrate in presence of [gamma-33P]ATP	B	Cc1cc(-c2c(-c3cccc(C)n3)nn3c2C(C)C(C)(C)C3)ccn1		CHEMBL4287843	=	IC50	nM	548.0	CHEMBL4439	Homo sapiens	IC50	uM	0.548
	18782659	CHEMBL4270674	Inhibition of human ALK5 expressed in Sf9 insect cells using casein as substrate in presence of [gamma-33P]ATP	B	CCOC(=O)c1ccc(-c2c(-c3cccc(C)n3)nn3c2C(C)C(C)(C)C3)cc1		CHEMBL4294411	=	IC50	nM	2008.0	CHEMBL4439	Homo sapiens	IC50	uM	2.008
	18782660	CHEMBL4270674	Inhibition of human ALK5 expressed in Sf9 insect cells using casein as substrate in presence of [gamma-33P]ATP	B	Cc1cccc(-c2nn3c(c2-c2ccnc(Cl)c2)C(C)C(C)(C)C3)n1		CHEMBL4284434	=	IC50	nM	517.0	CHEMBL4439	Homo sapiens	IC50	uM	0.517
	18782661	CHEMBL4270674	Inhibition of human ALK5 expressed in Sf9 insect cells using casein as substrate in presence of [gamma-33P]ATP	B	Cc1cccc(-c2nn3c(c2-c2ccnc(Nc4ccc(S(N)(=O)=O)cc4)c2)C(C)C(C)(C)C3)n1		CHEMBL4291675	=	IC50	nM	154.0	CHEMBL4439	Homo sapiens	IC50	uM	0.154
	18782662	CHEMBL4270674	Inhibition of human ALK5 expressed in Sf9 insect cells using casein as substrate in presence of [gamma-33P]ATP	B	CCc1cccc(-c2nn3c(c2-c2ccncc2)C(C)C(C)(C)C3)n1		CHEMBL4281030	=	IC50	nM	183.0	CHEMBL4439	Homo sapiens	IC50	uM	0.183
	18782663	CHEMBL4270674	Inhibition of human ALK5 expressed in Sf9 insect cells using casein as substrate in presence of [gamma-33P]ATP	B	CCc1cccc(-c2nn3c(c2-c2ccnc(Cl)c2)C(C)C(C)(C)C3)n1		CHEMBL4287412	=	IC50	nM	2745.0	CHEMBL4439	Homo sapiens	IC50	uM	2.745
	18782664	CHEMBL4270674	Inhibition of human ALK5 expressed in Sf9 insect cells using casein as substrate in presence of [gamma-33P]ATP	B	CCc1cccc(-c2nn3c(c2-c2ccnc(Nc4ccc(S(N)(=O)=O)cc4)c2)C(C)C(C)(C)C3)n1		CHEMBL4279172	=	IC50	nM	229.0	CHEMBL4439	Homo sapiens	IC50	uM	0.229
	18782665	CHEMBL4270674	Inhibition of human ALK5 expressed in Sf9 insect cells using casein as substrate in presence of [gamma-33P]ATP	B	COc1ccc(-c2c(-c3cccc(C)n3)nn3c2C(C)C(C)(C)C3)cc1		CHEMBL4292170	=	IC50	nM	612.0	CHEMBL4439	Homo sapiens	IC50	uM	0.612
	18782666	CHEMBL4270674	Inhibition of human ALK5 expressed in Sf9 insect cells using casein as substrate in presence of [gamma-33P]ATP	B	CCc1cccc(-c2nn3c(c2-c2ccc(OC)cc2)C(C)C(C)(C)C3)n1		CHEMBL4284266	=	IC50	nM	805.0	CHEMBL4439	Homo sapiens	IC50	uM	0.805
	18782667	CHEMBL4270674	Inhibition of human ALK5 expressed in Sf9 insect cells using casein as substrate in presence of [gamma-33P]ATP	B	Cc1cccc(-c2nn3c(c2-c2ccc(O)cc2)C(C)C(C)(C)C3)n1		CHEMBL4277021	=	IC50	nM	80.0	CHEMBL4439	Homo sapiens	IC50	uM	0.08
	18782668	CHEMBL4270674	Inhibition of human ALK5 expressed in Sf9 insect cells using casein as substrate in presence of [gamma-33P]ATP	B	CCc1cccc(-c2nn3c(c2-c2ccc(O)cc2)C(C)C(C)(C)C3)n1		CHEMBL4287654	=	IC50	nM	98.0	CHEMBL4439	Homo sapiens	IC50	uM	0.098
	18782669	CHEMBL4270674	Inhibition of human ALK5 expressed in Sf9 insect cells using casein as substrate in presence of [gamma-33P]ATP	B	Cc1cccc(-c2nn3c(c2-c2ccc(O)cc2)[C@H](C)C(C)(C)C3)n1		CHEMBL4285400	=	IC50	nM	97.0	CHEMBL4439	Homo sapiens	IC50	uM	0.097
	18782670	CHEMBL4270674	Inhibition of human ALK5 expressed in Sf9 insect cells using casein as substrate in presence of [gamma-33P]ATP	B	Cc1cccc(-c2nn3c(c2-c2ccc(O)cc2)[C@@H](C)C(C)(C)C3)n1		CHEMBL4277446	=	IC50	nM	197.0	CHEMBL4439	Homo sapiens	IC50	uM	0.197
	18782671	CHEMBL4270674	Inhibition of human ALK5 expressed in Sf9 insect cells using casein as substrate in presence of [gamma-33P]ATP	B	CCc1cccc(-c2nn3c(c2-c2ccc(O)cc2)[C@H](C)C(C)(C)C3)n1		CHEMBL4288745	=	IC50	nM	137.0	CHEMBL4439	Homo sapiens	IC50	uM	0.137
	18782672	CHEMBL4270674	Inhibition of human ALK5 expressed in Sf9 insect cells using casein as substrate in presence of [gamma-33P]ATP	B	CCc1cccc(-c2nn3c(c2-c2ccc(O)cc2)[C@@H](C)C(C)(C)C3)n1		CHEMBL4283308	=	IC50	nM	261.0	CHEMBL4439	Homo sapiens	IC50	uM	0.261
	18782673	CHEMBL4270674	Inhibition of human ALK5 expressed in Sf9 insect cells using casein as substrate in presence of [gamma-33P]ATP	B	CC1c2c(-c3ccncc3)c(-c3ccccc3C#N)nn2CC1(C)C		CHEMBL4287261	=	IC50	nM	1288.0	CHEMBL4439	Homo sapiens	IC50	uM	1.288
	18782674	CHEMBL4270674	Inhibition of human ALK5 expressed in Sf9 insect cells using casein as substrate in presence of [gamma-33P]ATP	B	CC1c2c(-c3ccc(O)cc3)c(-c3ccccc3C#N)nn2CC1(C)C		CHEMBL4279331	=	IC50	nM	5194.0	CHEMBL4439	Homo sapiens	IC50	uM	5.194
	18782675	CHEMBL4270674	Inhibition of human ALK5 expressed in Sf9 insect cells using casein as substrate in presence of [gamma-33P]ATP	B	Cc1cccc(-c2nn3c(c2-c2ccncc2)C(C)C(C)(C)C3)c1C#N		CHEMBL4289487	=	IC50	nM	162.0	CHEMBL4439	Homo sapiens	IC50	uM	0.162
	18782676	CHEMBL4270674	Inhibition of human ALK5 expressed in Sf9 insect cells using casein as substrate in presence of [gamma-33P]ATP	B	Cc1cccc(-c2nn3c(c2-c2ccc(O)cc2)C(C)C(C)(C)C3)c1C#N		CHEMBL4278812	=	IC50	nM	341.0	CHEMBL4439	Homo sapiens	IC50	uM	0.341
	18782677	CHEMBL4270674	Inhibition of human ALK5 expressed in Sf9 insect cells using casein as substrate in presence of [gamma-33P]ATP	B	COCC1c2c(-c3ccncc3)c(-c3cccc(C)n3)nn2CC1(C)C		CHEMBL4292878	=	IC50	nM	743.0	CHEMBL4439	Homo sapiens	IC50	uM	0.743
	18782678	CHEMBL4270674	Inhibition of human ALK5 expressed in Sf9 insect cells using casein as substrate in presence of [gamma-33P]ATP	B	Cc1cccc(-c2nn3c(c2-c2ccncc2)C(CO)C(C)(C)C3)n1		CHEMBL4282287	=	IC50	nM	1413.0	CHEMBL4439	Homo sapiens	IC50	uM	1.413
	18782679	CHEMBL4270674	Inhibition of human ALK5 expressed in Sf9 insect cells using casein as substrate in presence of [gamma-33P]ATP	B	CC1(C)Cc2c(-c3ccncc3)c(-c3ccccc3C#N)nn2C1		CHEMBL4277755	=	IC50	nM	2518.0	CHEMBL4439	Homo sapiens	IC50	uM	2.518
	18782680	CHEMBL4270674	Inhibition of human ALK5 expressed in Sf9 insect cells using casein as substrate in presence of [gamma-33P]ATP	B	CC1(C)Cc2c(-c3ccncc3)c(-c3ccccn3)nn2C1		CHEMBL4285692	=	IC50	nM	1940.0	CHEMBL4439	Homo sapiens	IC50	uM	1.94
	18782681	CHEMBL4270674	Inhibition of human ALK5 expressed in Sf9 insect cells using casein as substrate in presence of [gamma-33P]ATP	B	CC1(C)Cc2c(-c3ccc(O)cc3)c(-c3ccccn3)nn2C1		CHEMBL4281195	=	IC50	nM	1985.0	CHEMBL4439	Homo sapiens	IC50	uM	1.985
	18782682	CHEMBL4270674	Inhibition of human ALK5 expressed in Sf9 insect cells using casein as substrate in presence of [gamma-33P]ATP	B	Cc1cccc(-c2nn3c(c2-c2ccncc2)CC(C)(C)C3)n1		CHEMBL4276896	=	IC50	nM	406.0	CHEMBL4439	Homo sapiens	IC50	uM	0.406
	18782683	CHEMBL4270674	Inhibition of human ALK5 expressed in Sf9 insect cells using casein as substrate in presence of [gamma-33P]ATP	B	Cc1cccc(-c2nn3c(c2-c2ccnc(Cl)c2)CC(C)(C)C3)n1		CHEMBL4284609	=	IC50	nM	1228.0	CHEMBL4439	Homo sapiens	IC50	uM	1.228
	18782684	CHEMBL4270674	Inhibition of human ALK5 expressed in Sf9 insect cells using casein as substrate in presence of [gamma-33P]ATP	B	Cc1cccc(-c2nn3c(c2-c2ccnc(Nc4ccc(S(N)(=O)=O)cc4)c2)CC(C)(C)C3)n1		CHEMBL4292491	=	IC50	nM	147.0	CHEMBL4439	Homo sapiens	IC50	uM	0.147
	18782685	CHEMBL4270674	Inhibition of human ALK5 expressed in Sf9 insect cells using casein as substrate in presence of [gamma-33P]ATP	B	Cc1cccc(-c2nn3c(c2-c2ccc(O)cc2)CC(C)(C)C3)n1		CHEMBL4291439	=	IC50	nM	229.0	CHEMBL4439	Homo sapiens	IC50	uM	0.229
	18782686	CHEMBL4270674	Inhibition of human ALK5 expressed in Sf9 insect cells using casein as substrate in presence of [gamma-33P]ATP	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	IC50	nM	181.0	CHEMBL4439	Homo sapiens	IC50	uM	0.181
	18782687	CHEMBL4270674	Inhibition of human ALK5 expressed in Sf9 insect cells using casein as substrate in presence of [gamma-33P]ATP	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	=	IC50	nM	51.0	CHEMBL4439	Homo sapiens	IC50	uM	0.051
Dose-dependent effect	18782814	CHEMBL4270681	Inhibition of ALK5 in serum starved human HeLa cells assessed as reduction in TGF-beta-induced SMAD2 S465/467 phosphorylation pre-incubated for 30 mins before TGF-beta stimulation for 30 mins by immunoblotting analysis	B	Cc1cccc(-c2nn3c(c2-c2ccc(O)cc2)C(C)C(C)(C)C3)n1		CHEMBL4277021		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
Active	18782815	CHEMBL4270682	Inhibition of ALK5 in serum starved human HeLa cells assessed as reduction in TGF-beta-induced SMAD2/3 nuclear transaction at 1 uM pre-incubated for 30 mins before TGF-beta stimulation for 30 mins by immunofluorescence analysis	B	Cc1cccc(-c2nn3c(c2-c2ccc(O)cc2)C(C)C(C)(C)C3)n1		CHEMBL4277021		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
Active	18782816	CHEMBL4270682	Inhibition of ALK5 in serum starved human HeLa cells assessed as reduction in TGF-beta-induced SMAD2/3 nuclear transaction at 1 uM pre-incubated for 30 mins before TGF-beta stimulation for 30 mins by immunofluorescence analysis	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
	18782817	CHEMBL4270683	Inhibition of ALK5 in serum starved human HeLa cells assessed as reduction in TGF-beta-induced SMAD2/3 nuclear transaction at 10 uM pre-incubated for 30 mins before TGF-beta stimulation for 30 mins by immunofluorescence analysis	B	Cc1cccc(-c2nn3c(c2-c2ccc(O)cc2)C(C)C(C)(C)C3)n1		CHEMBL4277021	=	Inhibition	%	100.0	CHEMBL4439	Homo sapiens	INH	%	100.0
	18782818	CHEMBL4270684	Inhibition of human ALK5 expressed in Sf9 insect cells assessed as residual enzyme activity at 1 uM using casein as substrate in presence of [gamma-33P]ATP relative to untreated control	B	Cc1cccc(-c2nn3c(c2-c2ccc(O)cc2)C(C)C(C)(C)C3)n1		CHEMBL4277021	=	Activity	%	6.0	CHEMBL4439	Homo sapiens	Activity	%	6.0
Not Active	18847264	CHEMBL4304956	Inhibition of wild-type human partial length TGFBR1 (D179 to M503 residues) expressed in bacterial expression system at 1 uM by Kinomescan method	B	O=C(Nc1ccc2[nH]nc(-c3ccc4[nH]ccc4c3)c2c1)c1c(Cl)cccc1Cl		CHEMBL4517719		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
	18858230	CHEMBL4308076	Binding affinity to wild-type human partial length TGFBR1 (D179 to M503 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	100.0	CHEMBL4439	Homo sapiens	Activity	%	100.0
	18892723	CHEMBL4314527	Inhibition of human TGFBR1 T204D mutant (200 to end residues) using casein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	98.0	CHEMBL4439	Homo sapiens	Activity	%	98.0
	18902115	CHEMBL4316522	Inhibition of full length GST-tagged ALK5 (unknown origin) expressed in baculovirus expression system incubated for 2 mins by fluorescent polarization assay	B	CC(C)(C)n1nc(-c2ccc3scnc3c2)c(C(N)=O)c1N		CHEMBL4437124	=	IC50	nM	320.0	CHEMBL4439	Homo sapiens	IC50	uM	0.32
	18902116	CHEMBL4316522	Inhibition of full length GST-tagged ALK5 (unknown origin) expressed in baculovirus expression system incubated for 2 mins by fluorescent polarization assay	B	CC(C)(C)S(=O)(=O)c1ccc2nccc(Nc3n[nH]c4ccc(F)cc34)c2c1		CHEMBL3823499	=	IC50	nM	3160.0	CHEMBL4439	Homo sapiens	IC50	uM	3.16
	18902117	CHEMBL4316522	Inhibition of full length GST-tagged ALK5 (unknown origin) expressed in baculovirus expression system incubated for 2 mins by fluorescent polarization assay	B	CCn1nc(-c2ccc3scnc3c2)c(C(N)=O)c1N		CHEMBL4561931	=	IC50	nM	320.0	CHEMBL4439	Homo sapiens	IC50	uM	0.32
	18902118	CHEMBL4316522	Inhibition of full length GST-tagged ALK5 (unknown origin) expressed in baculovirus expression system incubated for 2 mins by fluorescent polarization assay	B	CCn1nc(-c2ccc3scnc3c2)c(C(N)=O)c1NC		CHEMBL4475515	=	IC50	nM	790.0	CHEMBL4439	Homo sapiens	IC50	uM	0.79
	18902119	CHEMBL4316522	Inhibition of full length GST-tagged ALK5 (unknown origin) expressed in baculovirus expression system incubated for 2 mins by fluorescent polarization assay	B	NC(=O)c1c(-c2ccc3scnc3c2)nn2c1NCCC2		CHEMBL4558980	=	IC50	nM	3160.0	CHEMBL4439	Homo sapiens	IC50	uM	3.16
	18902120	CHEMBL4316522	Inhibition of full length GST-tagged ALK5 (unknown origin) expressed in baculovirus expression system incubated for 2 mins by fluorescent polarization assay	B	NC(=O)c1c(-c2ccc3scnc3c2)nn2c1NCCCC2		CHEMBL4535795	=	IC50	nM	3980.0	CHEMBL4439	Homo sapiens	IC50	uM	3.98
	18902121	CHEMBL4316522	Inhibition of full length GST-tagged ALK5 (unknown origin) expressed in baculovirus expression system incubated for 2 mins by fluorescent polarization assay	B	NC(=O)c1c(-c2ccc3scnc3c2)nn2c1NCCCCC2		CHEMBL4475766	=	IC50	nM	1260.0	CHEMBL4439	Homo sapiens	IC50	uM	1.26
	18902122	CHEMBL4316522	Inhibition of full length GST-tagged ALK5 (unknown origin) expressed in baculovirus expression system incubated for 2 mins by fluorescent polarization assay	B	NC(=O)c1c(-c2ccc3scnc3c2)nn2c1N[C@@H]1CC[C@@H](C1)C2		CHEMBL4551566	>	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	IC50	uM	10.0
	18902123	CHEMBL4316522	Inhibition of full length GST-tagged ALK5 (unknown origin) expressed in baculovirus expression system incubated for 2 mins by fluorescent polarization assay	B	NC(=O)c1c(-c2ccc3scnc3c2)nn2c1N[C@@H]1C[C@@H](C[C@H]1O)C2		CHEMBL4453606	>	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	IC50	uM	10.0
	18902124	CHEMBL4316522	Inhibition of full length GST-tagged ALK5 (unknown origin) expressed in baculovirus expression system incubated for 2 mins by fluorescent polarization assay	B	NC(=O)c1c(-c2ccc3scnc3c2)nn2c1N[C@H]1C[C@H](C[C@@H]1O)C2		CHEMBL4527824	>	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	IC50	uM	10.0
	18902125	CHEMBL4316522	Inhibition of full length GST-tagged ALK5 (unknown origin) expressed in baculovirus expression system incubated for 2 mins by fluorescent polarization assay	B	NC(=O)c1c(-c2ccc3scnc3c2)nn2c1N[C@H]1C[C@H](O)[C@H](C1)C2		CHEMBL4583311	>	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	IC50	uM	10.0
	18902126	CHEMBL4316522	Inhibition of full length GST-tagged ALK5 (unknown origin) expressed in baculovirus expression system incubated for 2 mins by fluorescent polarization assay	B	NC(=O)c1c(-c2ccc3scnc3c2)nn2c1N[C@H]1C[C@@H](C2)[C@H](O)C1		CHEMBL4562422	>	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	IC50	uM	10.0
	18937707	CHEMBL4327583	Inhibition of human ALK5 assessed as residual activity at 1 uM using casein as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	102.2	CHEMBL4439	Homo sapiens	Activity	%	102.2
	18937708	CHEMBL4327583	Inhibition of human ALK5 assessed as residual activity at 1 uM using casein as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	102.15	CHEMBL4439	Homo sapiens	Activity	%	102.15
	18938424	CHEMBL4327944	Inhibition of human ALK5 assessed as residual activity at 100 uM using casein as substrate by [gamma-33P]-ATP assay relative to control	B	c1ccc2c(-c3cnn4cc(-c5ccc(N6CCNCC6)cc5)cnc34)ccnc2c1		CHEMBL513147	<	Activity	%	65.0	CHEMBL4439	Homo sapiens	Activity	%	65.0
Not Determined	18938793	CHEMBL4328308	Inhibition of human ALK5 using casein as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978		IC50			CHEMBL4439	Homo sapiens	IC50		
	18938794	CHEMBL4328308	Inhibition of human ALK5 using casein as substrate by [gamma-33P]-ATP assay	B	c1ccc2c(-c3cnn4cc(-c5ccc(N6CCNCC6)cc5)cnc34)ccnc2c1		CHEMBL513147	=	IC50	nM	339.0	CHEMBL4439	Homo sapiens	IC50	10'-7M	3.39
	18952511	CHEMBL4331755	Inhibition of TGFBR1 (unknown origin)	B	Fc1ccc(Cl)cc1-c1nc(Nc2ccncc2)c2nccnc2n1		CHEMBL238125	=	IC50	nM	35.0	CHEMBL4439	Homo sapiens	IC50	nM	35.0
	18952512	CHEMBL4331755	Inhibition of TGFBR1 (unknown origin)	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL492634	=	IC50	nM	13.0	CHEMBL4439	Homo sapiens	IC50	nM	13.0
	18952513	CHEMBL4331755	Inhibition of TGFBR1 (unknown origin)	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	IC50	nM	70.0	CHEMBL4439	Homo sapiens	IC50	nM	70.0
	18952514	CHEMBL4331755	Inhibition of TGFBR1 (unknown origin)	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	IC50	nM	13.0	CHEMBL4439	Homo sapiens	IC50	nM	13.0
	18952515	CHEMBL4331755	Inhibition of TGFBR1 (unknown origin)	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	=	IC50	nM	56.0	CHEMBL4439	Homo sapiens	IC50	nM	56.0
	18959002	CHEMBL4333658	Binding affinity to wild-type human partial length TGFBR1 (D179 to M503 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	100.0	CHEMBL4439	Homo sapiens	Activity	%	100.0
	18964743	CHEMBL4335313	Inhibition of human TGFBR1 T204D mutant (200 to end residues) assessed as residual activity at 1 uM using casein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	111.0	CHEMBL4439	Homo sapiens	Activity	%	111.0
	18964744	CHEMBL4335313	Inhibition of human TGFBR1 T204D mutant (200 to end residues) assessed as residual activity at 1 uM using casein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	92.0	CHEMBL4439	Homo sapiens	Activity	%	92.0
	18972127	CHEMBL4337137	Inhibition of recombinant human TGFBR1 T204D mutant (200 to end residues) assessed as residual activity at 10 uM using casein as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	97.0	CHEMBL4439	Homo sapiens	Activity	%	97.0
	18980203	CHEMBL4339037	Inhibition of His-tagged TGFBR1 kinase domain T204D mutant (unknown origin) incubated for 1 hr by HTRF analysis	B	Cc1cccc(-c2ncn(C)c2-c2ccc3nccn3c2)c1		CHEMBL4534989	=	IC50	nM	17.0	CHEMBL4439	Homo sapiens	IC50	uM	0.017
	18980204	CHEMBL4339037	Inhibition of His-tagged TGFBR1 kinase domain T204D mutant (unknown origin) incubated for 1 hr by HTRF analysis	B	Cc1cccc(-c2ncn(CC(F)F)c2-c2ccc3nccn3c2)n1		CHEMBL4458215	=	IC50	nM	1.0	CHEMBL4439	Homo sapiens	IC50	uM	0.001
	18980205	CHEMBL4339037	Inhibition of His-tagged TGFBR1 kinase domain T204D mutant (unknown origin) incubated for 1 hr by HTRF analysis	B	Cc1cccc(-c2ncn(CC(F)F)c2-c2ccc3ncc(C(N)=O)n3c2)n1		CHEMBL4455462	=	IC50	nM	0.7	CHEMBL4439	Homo sapiens	IC50	uM	0.0007
	18980206	CHEMBL4339037	Inhibition of His-tagged TGFBR1 kinase domain T204D mutant (unknown origin) incubated for 1 hr by HTRF analysis	B	NC(=O)c1cnc2ccc(-c3c(-c4ccc(F)cc4)ncn3CC(F)F)nn12		CHEMBL4440988	=	IC50	nM	0.9	CHEMBL4439	Homo sapiens	IC50	uM	0.0009
	18980207	CHEMBL4339037	Inhibition of His-tagged TGFBR1 kinase domain T204D mutant (unknown origin) incubated for 1 hr by HTRF analysis	B	N#Cc1cnc2ccc(-c3c(-c4ccc(F)cc4)ncn3CC(F)F)nn12		CHEMBL4584495	=	IC50	nM	1.6	CHEMBL4439	Homo sapiens	IC50	uM	0.0016
	18980208	CHEMBL4339037	Inhibition of His-tagged TGFBR1 kinase domain T204D mutant (unknown origin) incubated for 1 hr by HTRF analysis	B	N#Cc1cnc2ccc(-c3c(-c4ccc(F)cc4)ncn3CCO)nn12		CHEMBL4452178	=	IC50	nM	6.7	CHEMBL4439	Homo sapiens	IC50	uM	0.0067
	18980209	CHEMBL4339037	Inhibition of His-tagged TGFBR1 kinase domain T204D mutant (unknown origin) incubated for 1 hr by HTRF analysis	B	N#Cc1cnc2ccc(-c3c(-c4ccc(F)c(Cl)c4)ncn3CCO)nn12		CHEMBL4514379	=	IC50	nM	1.6	CHEMBL4439	Homo sapiens	IC50	uM	0.0016
	18980217	CHEMBL4339035	Inhibition of TGFbetaR1 in TGFbeta-stimulated mink Mv1Lu cells assessed as reduction in SMAD nuclear translocation preincubated for 1 hr followed by TGFbeta-stimulation for 15 mins by array scan based method	B	Cc1cccc(-c2ncn(CC(F)F)c2-c2ccc3nccn3c2)n1		CHEMBL4458215	=	IC50	nM	420.0	CHEMBL4439	Homo sapiens	IC50	uM	0.42
	18980218	CHEMBL4339035	Inhibition of TGFbetaR1 in TGFbeta-stimulated mink Mv1Lu cells assessed as reduction in SMAD nuclear translocation preincubated for 1 hr followed by TGFbeta-stimulation for 15 mins by array scan based method	B	Cc1cccc(-c2ncn(CC(F)F)c2-c2ccc3ncc(C(N)=O)n3c2)n1		CHEMBL4455462	=	IC50	nM	560.0	CHEMBL4439	Homo sapiens	IC50	uM	0.56
	18980219	CHEMBL4339035	Inhibition of TGFbetaR1 in TGFbeta-stimulated mink Mv1Lu cells assessed as reduction in SMAD nuclear translocation preincubated for 1 hr followed by TGFbeta-stimulation for 15 mins by array scan based method	B	NC(=O)c1cnc2ccc(-c3c(-c4ccc(F)cc4)ncn3CC(F)F)nn12		CHEMBL4440988	=	IC50	nM	660.0	CHEMBL4439	Homo sapiens	IC50	uM	0.66
	18980220	CHEMBL4339035	Inhibition of TGFbetaR1 in TGFbeta-stimulated mink Mv1Lu cells assessed as reduction in SMAD nuclear translocation preincubated for 1 hr followed by TGFbeta-stimulation for 15 mins by array scan based method	B	N#Cc1cnc2ccc(-c3c(-c4ccc(F)cc4)ncn3CC(F)F)nn12		CHEMBL4584495	=	IC50	nM	200.0	CHEMBL4439	Homo sapiens	IC50	uM	0.2
	18980221	CHEMBL4339035	Inhibition of TGFbetaR1 in TGFbeta-stimulated mink Mv1Lu cells assessed as reduction in SMAD nuclear translocation preincubated for 1 hr followed by TGFbeta-stimulation for 15 mins by array scan based method	B	N#Cc1cnc2ccc(-c3c(-c4ccc(F)cc4)ncn3CCO)nn12		CHEMBL4452178	=	IC50	nM	800.0	CHEMBL4439	Homo sapiens	IC50	uM	0.8
	18980222	CHEMBL4339035	Inhibition of TGFbetaR1 in TGFbeta-stimulated mink Mv1Lu cells assessed as reduction in SMAD nuclear translocation preincubated for 1 hr followed by TGFbeta-stimulation for 15 mins by array scan based method	B	N#Cc1cnc2ccc(-c3c(-c4ccc(F)c(Cl)c4)ncn3CCO)nn12		CHEMBL4514379	=	IC50	nM	350.0	CHEMBL4439	Homo sapiens	IC50	uM	0.35
	18980223	CHEMBL4339034	Inhibition of TGFBR1 in TGFbeta-stimulated human NHLF cells assessed as reduction in SMAD2 nuclear translocation	B	Cc1cccc(-c2ncn(CC(F)F)c2-c2ccc3nccn3c2)n1		CHEMBL4458215	=	IC50	nM	90.0	CHEMBL4439	Homo sapiens	IC50	uM	0.09
	18980224	CHEMBL4339034	Inhibition of TGFBR1 in TGFbeta-stimulated human NHLF cells assessed as reduction in SMAD2 nuclear translocation	B	Cc1cccc(-c2ncn(CC(F)F)c2-c2ccc3ncc(C(N)=O)n3c2)n1		CHEMBL4455462	=	IC50	nM	130.0	CHEMBL4439	Homo sapiens	IC50	uM	0.13
	18980225	CHEMBL4339034	Inhibition of TGFBR1 in TGFbeta-stimulated human NHLF cells assessed as reduction in SMAD2 nuclear translocation	B	NC(=O)c1cnc2ccc(-c3c(-c4ccc(F)cc4)ncn3CC(F)F)nn12		CHEMBL4440988	=	IC50	nM	420.0	CHEMBL4439	Homo sapiens	IC50	uM	0.42
	18980226	CHEMBL4339034	Inhibition of TGFBR1 in TGFbeta-stimulated human NHLF cells assessed as reduction in SMAD2 nuclear translocation	B	N#Cc1cnc2ccc(-c3c(-c4ccc(F)cc4)ncn3CC(F)F)nn12		CHEMBL4584495	=	IC50	nM	80.0	CHEMBL4439	Homo sapiens	IC50	uM	0.08
	18980227	CHEMBL4339034	Inhibition of TGFBR1 in TGFbeta-stimulated human NHLF cells assessed as reduction in SMAD2 nuclear translocation	B	N#Cc1cnc2ccc(-c3c(-c4ccc(F)cc4)ncn3CCO)nn12		CHEMBL4452178	=	IC50	nM	350.0	CHEMBL4439	Homo sapiens	IC50	uM	0.35
	18980228	CHEMBL4339034	Inhibition of TGFBR1 in TGFbeta-stimulated human NHLF cells assessed as reduction in SMAD2 nuclear translocation	B	N#Cc1cnc2ccc(-c3c(-c4ccc(F)c(Cl)c4)ncn3CCO)nn12		CHEMBL4514379	=	IC50	nM	190.0	CHEMBL4439	Homo sapiens	IC50	uM	0.19
	18980247	CHEMBL4339042	Inhibition of TGFbetaR1 in TGFbeta-stimulated human T cells assessed as reduction in SMAD3 phosphorylation preincubated for 1 hr followed by TGFbeta-stimulation for 90 mins by Alphalisa assay	B	N#Cc1cnc2ccc(-c3c(-c4ccc(F)c(Cl)c4)ncn3CCO)nn12		CHEMBL4514379	=	IC50	nM	150.0	CHEMBL4439	Homo sapiens	IC50	uM	0.15
	18980249	CHEMBL4339044	Inhibition of TGFbetaR1 in anti-CD3/anti-CD28/IL-2/TGFbeta -stimulated human Treg cells assessed as downregulation of FOXP3 expression incubated for 5 days by flow cytometry analysis	B	N#Cc1cnc2ccc(-c3c(-c4ccc(F)c(Cl)c4)ncn3CCO)nn12		CHEMBL4514379	=	IC50	nM	230.0	CHEMBL4439	Homo sapiens	IC50	uM	0.23
	18980309	CHEMBL4339088	Inhibition of TGFBR1 in human whole blood assessed as apparent inhibition constant by measuring reduction in TGFbeta-induced SMAD phosphorylation	B	N#Cc1cnc2ccc(-c3c(-c4ccc(F)c(Cl)c4)ncn3CCO)nn12		CHEMBL4514379	=	Ki	nM	0.8	CHEMBL4439	Homo sapiens	Ki(app)	nM	0.8
Not Active	19040185	CHEMBL4352086	Inhibition of human TGFBR1 T204D mutant (200 to end residues) using casein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
Active	19041009	CHEMBL4352270	Inhibition of human ALK5 at 10 uM using casein as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
	19059855	CHEMBL4358156	Binding affinity to wild-type human partial length TGFBR1 (D179 to M503 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL4439	Homo sapiens	Activity	%	100.0
	19070710	CHEMBL4361668	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells at 10 uM using casein as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay relative to control	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3)cc2-c2ccc3nsnc3c2)n1		CHEMBL4569982	=	Inhibition	%	98.0	CHEMBL4439	Homo sapiens	INH	%	98.0
	19070711	CHEMBL4361668	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells at 10 uM using casein as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay relative to control	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3F)cc2-c2ccc3nsnc3c2)n1		CHEMBL4530888	=	Inhibition	%	98.0	CHEMBL4439	Homo sapiens	INH	%	98.0
	19070712	CHEMBL4361668	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells at 10 uM using casein as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay relative to control	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(F)c3)cc2-c2ccc3nsnc3c2)n1		CHEMBL4471215	=	Inhibition	%	98.0	CHEMBL4439	Homo sapiens	INH	%	98.0
	19070713	CHEMBL4361668	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells at 10 uM using casein as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay relative to control	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(C#N)c3)cc2-c2ccc3nsnc3c2)n1		CHEMBL4474331	=	Inhibition	%	98.0	CHEMBL4439	Homo sapiens	INH	%	98.0
	19070714	CHEMBL4361668	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells at 10 uM using casein as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay relative to control	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3)cc2-c2cc3cnccc3s2)n1		CHEMBL4576703	=	Inhibition	%	98.0	CHEMBL4439	Homo sapiens	INH	%	98.0
	19070715	CHEMBL4361668	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells at 10 uM using casein as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay relative to control	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3F)cc2-c2cc3cnccc3s2)n1		CHEMBL4460586	=	Inhibition	%	98.0	CHEMBL4439	Homo sapiens	INH	%	98.0
	19070716	CHEMBL4361668	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells at 10 uM using casein as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay relative to control	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(F)c3)cc2-c2cc3cnccc3s2)n1		CHEMBL4520187	=	Inhibition	%	98.0	CHEMBL4439	Homo sapiens	INH	%	98.0
	19070717	CHEMBL4361668	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells at 10 uM using casein as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay relative to control	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(C#N)c3)cc2-c2cc3cnccc3s2)n1		CHEMBL4531718	=	Inhibition	%	98.0	CHEMBL4439	Homo sapiens	INH	%	98.0
	19070718	CHEMBL4361668	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells at 10 uM using casein as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay relative to control	B	Cc1cccc(-c2c(-c3ccc4nsnc4c3)cnn2CC(=O)Nc2ccccc2)n1		CHEMBL4518531	=	Inhibition	%	52.0	CHEMBL4439	Homo sapiens	INH	%	52.0
	19070719	CHEMBL4361668	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells at 10 uM using casein as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay relative to control	B	Cc1cccc(-c2c(-c3ccc4nsnc4c3)cnn2CC(=O)Nc2ccccc2F)n1		CHEMBL4546065	=	Inhibition	%	52.0	CHEMBL4439	Homo sapiens	INH	%	52.0
	19070720	CHEMBL4361668	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells at 10 uM using casein as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay relative to control	B	Cc1cccc(-c2c(-c3ccc4nsnc4c3)cnn2CC(=O)Nc2cccc(F)c2)n1		CHEMBL4453089	=	Inhibition	%	52.0	CHEMBL4439	Homo sapiens	INH	%	52.0
	19070721	CHEMBL4361668	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells at 10 uM using casein as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay relative to control	B	Cc1cccc(-c2c(-c3ccc4nsnc4c3)cnn2CC(=O)Nc2cccc(C#N)c2)n1		CHEMBL4522374	=	Inhibition	%	52.0	CHEMBL4439	Homo sapiens	INH	%	52.0
	19070722	CHEMBL4361668	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells at 10 uM using casein as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay relative to control	B	Cc1cccc(-c2c(-c3cc4cnccc4s3)cnn2CC(=O)Nc2ccccc2)n1		CHEMBL4556543	=	Inhibition	%	46.0	CHEMBL4439	Homo sapiens	INH	%	46.0
	19070723	CHEMBL4361668	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells at 10 uM using casein as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay relative to control	B	Cc1cccc(-c2c(-c3cc4cnccc4s3)cnn2CC(=O)Nc2ccccc2F)n1		CHEMBL4447273	=	Inhibition	%	46.0	CHEMBL4439	Homo sapiens	INH	%	46.0
	19070724	CHEMBL4361668	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells at 10 uM using casein as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay relative to control	B	Cc1cccc(-c2c(-c3cc4cnccc4s3)cnn2CC(=O)Nc2cccc(F)c2)n1		CHEMBL4450974	=	Inhibition	%	46.0	CHEMBL4439	Homo sapiens	INH	%	46.0
	19070725	CHEMBL4361668	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells at 10 uM using casein as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay relative to control	B	Cc1cccc(-c2c(-c3cc4cnccc4s3)cnn2CC(=O)Nc2cccc(C#N)c2)n1		CHEMBL4592042	=	Inhibition	%	46.0	CHEMBL4439	Homo sapiens	INH	%	46.0
	19070748	CHEMBL4361670	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells using casein as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3)cc2-c2ccc3nsnc3c2)n1		CHEMBL4569982	=	IC50	nM	30.0	CHEMBL4439	Homo sapiens	IC50	uM	0.03
	19070749	CHEMBL4361670	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells using casein as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3F)cc2-c2ccc3nsnc3c2)n1		CHEMBL4530888	=	IC50	nM	168.0	CHEMBL4439	Homo sapiens	IC50	uM	0.168
	19070750	CHEMBL4361670	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells using casein as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(F)c3)cc2-c2ccc3nsnc3c2)n1		CHEMBL4471215	=	IC50	nM	87.0	CHEMBL4439	Homo sapiens	IC50	uM	0.087
	19070751	CHEMBL4361670	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells using casein as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(C#N)c3)cc2-c2ccc3nsnc3c2)n1		CHEMBL4474331	=	IC50	nM	165.0	CHEMBL4439	Homo sapiens	IC50	uM	0.165
	19070752	CHEMBL4361670	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells using casein as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay	B	Cc1cccc(-c2nn(CC(=S)Nc3ccccc3)cc2-c2ccc3nsnc3c2)n1		CHEMBL4594036	=	IC50	nM	42.0	CHEMBL4439	Homo sapiens	IC50	uM	0.042
	19070753	CHEMBL4361670	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells using casein as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay	B	Cc1cccc(-c2nn(CC(=S)Nc3ccccc3F)cc2-c2ccc3nsnc3c2)n1		CHEMBL4461256	=	IC50	nM	55.0	CHEMBL4439	Homo sapiens	IC50	uM	0.055
	19070754	CHEMBL4361670	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells using casein as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(F)c3)cc2-c2ccc3nsnc3c2)n1		CHEMBL4527908	=	IC50	nM	30.0	CHEMBL4439	Homo sapiens	IC50	uM	0.03
	19070755	CHEMBL4361670	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells using casein as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(C#N)c3)cc2-c2ccc3nsnc3c2)n1		CHEMBL4455044	=	IC50	nM	116.0	CHEMBL4439	Homo sapiens	IC50	uM	0.116
	19070756	CHEMBL4361670	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells using casein as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3)cc2-c2cc3cnccc3s2)n1		CHEMBL4576703	=	IC50	nM	39.0	CHEMBL4439	Homo sapiens	IC50	uM	0.039
	19070757	CHEMBL4361670	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells using casein as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3F)cc2-c2cc3cnccc3s2)n1		CHEMBL4460586	=	IC50	nM	312.0	CHEMBL4439	Homo sapiens	IC50	uM	0.312
	19070758	CHEMBL4361670	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells using casein as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(F)c3)cc2-c2cc3cnccc3s2)n1		CHEMBL4520187	=	IC50	nM	119.0	CHEMBL4439	Homo sapiens	IC50	uM	0.119
	19070759	CHEMBL4361670	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells using casein as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(C#N)c3)cc2-c2cc3cnccc3s2)n1		CHEMBL4531718	=	IC50	nM	230.0	CHEMBL4439	Homo sapiens	IC50	uM	0.23
	19070760	CHEMBL4361670	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells using casein as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(F)c3)cc2-c2cc3cnccc3s2)n1		CHEMBL4570292	=	IC50	nM	125.0	CHEMBL4439	Homo sapiens	IC50	uM	0.125
	19070761	CHEMBL4361670	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells using casein as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(C#N)c3)cc2-c2cc3cnccc3s2)n1		CHEMBL4513885	=	IC50	nM	78.0	CHEMBL4439	Homo sapiens	IC50	uM	0.078
	19070762	CHEMBL4361670	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells using casein as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	=	IC50	nM	119.0	CHEMBL4439	Homo sapiens	IC50	uM	0.119
	19070763	CHEMBL4361670	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells using casein as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	IC50	nM	10.0	CHEMBL4439	Homo sapiens	IC50	uM	0.01
Dose-dependent effect	19070798	CHEMBL4361674	Inhibition of ALK5 in human LX2 cells assessed as reduction in TGFbeta-induced collagen 1 production pretreated for 1 hr followed by TGFbeta addition and measured after 12 hrs by DAPI staining based immunocytochemistry analysis by confocal laser scanning microscopic method	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(F)c3)cc2-c2ccc3nsnc3c2)n1		CHEMBL4527908		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
Dose-dependent effect	19070799	CHEMBL4361674	Inhibition of ALK5 in human LX2 cells assessed as reduction in TGFbeta-induced collagen 1 production pretreated for 1 hr followed by TGFbeta addition and measured after 12 hrs by DAPI staining based immunocytochemistry analysis by confocal laser scanning microscopic method	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3)cc2-c2cc3cnccc3s2)n1		CHEMBL4576703		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
Dose-dependent effect	19070800	CHEMBL4361675	Inhibition of ALK5 in human LX2 cells assessed as reduction in TGFbeta-induced alphaSMA production pretreated for 1 hr followed by TGFbeta addition and measured after 12 hrs by DAPI staining based immunocytochemistry analysis by confocal laser scanning microscopic method	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(F)c3)cc2-c2ccc3nsnc3c2)n1		CHEMBL4527908		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
Dose-dependent effect	19070801	CHEMBL4361675	Inhibition of ALK5 in human LX2 cells assessed as reduction in TGFbeta-induced alphaSMA production pretreated for 1 hr followed by TGFbeta addition and measured after 12 hrs by DAPI staining based immunocytochemistry analysis by confocal laser scanning microscopic method	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3)cc2-c2cc3cnccc3s2)n1		CHEMBL4576703		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
Active	19070802	CHEMBL4361676	Inhibition of ALK5 in human LX2 cells assessed as reduction in TGFbeta-induced collagen 1 production at 5 uM pretreated for 1 hr followed by TGFbeta addition and measured after 12 hrs by DAPI staining based immunocytochemistry analysis by confocal laser scanning microscopic method	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
Active	19070803	CHEMBL4361677	Inhibition of ALK5 in human LX2 cells assessed as reduction in TGFbeta-induced alphaSMA production at 5 uM pretreated for 1 hr followed by TGFbeta addition and measured after 12 hrs by DAPI staining based immunocytochemistry analysis by confocal laser scanning microscopic method	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
Active	19070804	CHEMBL4361678	Inhibition of ALK5 in human LX2 cells assessed as reduction in TGFbeta-induced collagen 1 protein expression at 1.25 to 5 uM pretreated for 1 hr followed by TGFbeta addition and measured after 12 hrs by Western blot analysis	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(F)c3)cc2-c2ccc3nsnc3c2)n1		CHEMBL4527908		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
Active	19070805	CHEMBL4361678	Inhibition of ALK5 in human LX2 cells assessed as reduction in TGFbeta-induced collagen 1 protein expression at 1.25 to 5 uM pretreated for 1 hr followed by TGFbeta addition and measured after 12 hrs by Western blot analysis	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3)cc2-c2cc3cnccc3s2)n1		CHEMBL4576703		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
Active	19070806	CHEMBL4361679	Inhibition of ALK5 in human LX2 cells assessed as reduction in TGFbeta-induced alphaSMA protein expression at 1.25 to 5 uM pretreated for 1 hr followed by TGFbeta addition and measured after 12 hrs by Western blot analysis	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(F)c3)cc2-c2ccc3nsnc3c2)n1		CHEMBL4527908		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
Active	19070807	CHEMBL4361679	Inhibition of ALK5 in human LX2 cells assessed as reduction in TGFbeta-induced alphaSMA protein expression at 1.25 to 5 uM pretreated for 1 hr followed by TGFbeta addition and measured after 12 hrs by Western blot analysis	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3)cc2-c2cc3cnccc3s2)n1		CHEMBL4576703		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
Active	19070808	CHEMBL4361680	Inhibition of ALK5 in human LX2 cells assessed as reduction in TGFbeta-induced ACTA2 mRNA expression at 1.25 to 5 uM pretreated for 1 hr followed by TGFbeta addition and measured after 12 hrs by RT-PCR analysis	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(F)c3)cc2-c2ccc3nsnc3c2)n1		CHEMBL4527908		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
Active	19070809	CHEMBL4361680	Inhibition of ALK5 in human LX2 cells assessed as reduction in TGFbeta-induced ACTA2 mRNA expression at 1.25 to 5 uM pretreated for 1 hr followed by TGFbeta addition and measured after 12 hrs by RT-PCR analysis	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3)cc2-c2cc3cnccc3s2)n1		CHEMBL4576703		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
Active	19070810	CHEMBL4361681	Inhibition of ALK5 in human LX2 cells assessed as reduction in TGFbeta-induced COL1A1 mRNA expression at 1.25 to 5 uM pretreated for 1 hr followed by TGFbeta addition and measured after 12 hrs by RT-PCR analysis	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(F)c3)cc2-c2ccc3nsnc3c2)n1		CHEMBL4527908		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
Active	19070811	CHEMBL4361681	Inhibition of ALK5 in human LX2 cells assessed as reduction in TGFbeta-induced COL1A1 mRNA expression at 1.25 to 5 uM pretreated for 1 hr followed by TGFbeta addition and measured after 12 hrs by RT-PCR analysis	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3)cc2-c2cc3cnccc3s2)n1		CHEMBL4576703		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
	19090419	CHEMBL4365993	Inhibition of wild-type human partial length TGFBR1 (D179 to M503 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	73.0	CHEMBL4439	Homo sapiens	Activity	%	73.0
	19091812	CHEMBL4366286	Inhibition of human ALK5 at 100 nM using casein as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	0.84	CHEMBL4439	Homo sapiens	INH	%	0.84
	19114719	CHEMBL4371452	Binding affinity to TGFBR1 in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4462318	=	Kd	nM	205.0	CHEMBL4439	Homo sapiens	Kd(free)	uM	0.205
	19138197	CHEMBL4376027	Inhibition of recombinant human N-terminal GST-tagged TGFbeta1 receptor (80 to end residues) expressed in baculovirus infected Sf9 insect cells using casein as substrate measured after 2 hrs by ADP-Glo assay	B	C=C(C)[C@@H]1C/C=C(\C)C(=O)CCC2=C[C@@H]1OC2=O		CHEMBL4533719	=	IC50	nM	14.9	CHEMBL4439	Homo sapiens	IC50	nM	14.9
	19138198	CHEMBL4376027	Inhibition of recombinant human N-terminal GST-tagged TGFbeta1 receptor (80 to end residues) expressed in baculovirus infected Sf9 insect cells using casein as substrate measured after 2 hrs by ADP-Glo assay	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	IC50	nM	67.1	CHEMBL4439	Homo sapiens	IC50	nM	67.1
	19144907	CHEMBL4377923	Inhibition of human TGFBR1 T204D mutant (200 to end residues) at 1 uM using casein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	13.0	CHEMBL4439	Homo sapiens	INH	%	13.0
	19146995	CHEMBL4378797	Inhibition of recombinant human TGFBR1 T204D mutant (200 to end residues) at 10 uM using casein as substrate measured after 40 mins in presence of [gamm33P]ATP by scintillation counting method relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1		CHEMBL4459587	=	Inhibition	%	-2.0	CHEMBL4439	Homo sapiens	INH	%	-2.0
	19148064	CHEMBL4379460	Inhibition of recombinant human TGFBR1 T204D mutant (200 to end residues) using casein as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL4439	Homo sapiens	IC50	uM	10.0
	19159683	CHEMBL4382787	Binding affinity to wild-type human partial length TGFBR1 (D179 to M503 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	18.0	CHEMBL4439	Homo sapiens	Activity	%	18.0
	19181157	CHEMBL4387368	Inhibition of tracer 178 binding to recombinant human GST-tagged TGFBR1 catalytic domain (200 to 503 residues) expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	10.9	CHEMBL4439	Homo sapiens	INH	%	10.9
	19181382	CHEMBL4387368	Inhibition of tracer 178 binding to recombinant human GST-tagged TGFBR1 catalytic domain (200 to 503 residues) expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	16.0	CHEMBL4439	Homo sapiens	INH	%	16.0
	19191324	CHEMBL4389506	Inhibition of wild-type human partial length TGFBR1 (D179 to M503 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	96.0	CHEMBL4439	Homo sapiens	INH	%	96.0
	19192169	CHEMBL4389983	Inhibition of wild-type human partial length TGFBR1 (D179 to M503 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	71.0	CHEMBL4439	Homo sapiens	INH	%	71.0
	19200425	CHEMBL4391609	Binding affinity to wild-type human partial length TGFBR1 (D179 to M503 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	74.0	CHEMBL4439	Homo sapiens	Activity	%	74.0
	19266309	CHEMBL4405259	Inhibition of wild-type human ALK5 (D179 to M503 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL4439	Homo sapiens	INH	%	50.0
	19271597	CHEMBL4406752	Inhibition of human ALK5 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	A	c1ccc2c(-c3cnn4cc(-c5ccc(N6CCNCC6)cc5)cnc34)ccnc2c1		CHEMBL513147	=	IC50	nM	468.0	CHEMBL4439	Homo sapiens	IC50	nM	468.0
	19271598	CHEMBL4406752	Inhibition of human ALK5 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	A	COc1cc(-c2cncc(-c3ccc(N4CCN(C(C)C)CC4)cc3)c2C)cc(OC)c1C(N)=O		CHEMBL4468389	=	IC50	nM	66.0	CHEMBL4439	Homo sapiens	IC50	nM	66.0
	19271599	CHEMBL4406752	Inhibition of human ALK5 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	A	COc1cc(-c2cncc(-c3ccc(N4C[C@H](C)N(C)[C@H](C)C4)cc3)c2C)cc(F)c1C(N)=O		CHEMBL4434717	=	IC50	nM	2910.0	CHEMBL4439	Homo sapiens	IC50	nM	2910.0
	19271600	CHEMBL4406752	Inhibition of human ALK5 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	A	COc1cc(-c2cncc(-c3ccc(N4CCN(C)CC4)cc3)c2C)cc(F)c1C(N)=O		CHEMBL4575655	=	IC50	nM	1050.0	CHEMBL4439	Homo sapiens	IC50	nM	1050.0
	19271601	CHEMBL4406752	Inhibition of human ALK5 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	A	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(F)c1C(N)=O		CHEMBL4440168	=	IC50	nM	1920.0	CHEMBL4439	Homo sapiens	IC50	nM	1920.0
	19271602	CHEMBL4406752	Inhibition of human ALK5 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	A	Cc1c(-c2ccc(C(N)=O)cc2)cncc1-c1ccc(N2CCNCC2)cc1		CHEMBL4572458	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	19271603	CHEMBL4406752	Inhibition of human ALK5 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	A	CNC(=O)c1ccc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc1OC		CHEMBL4437768	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	19271604	CHEMBL4406752	Inhibition of human ALK5 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	A	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)sc1C(N)=O		CHEMBL4552750	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	19271605	CHEMBL4406752	Inhibition of human ALK5 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	A	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)ccc1C(N)=O		CHEMBL4553210	=	IC50	nM	576.0	CHEMBL4439	Homo sapiens	IC50	nM	576.0
	19271625	CHEMBL4406750	Inhibition of human ALK5 using dephosphorylated casein as substrate measured after 45 mins in presence of [gamma33P]ATP by scintillation counting method	A	c1ccc2c(-c3cnn4cc(-c5ccc(N6CCNCC6)cc5)cnc34)ccnc2c1		CHEMBL513147	=	IC50	nM	468.0	CHEMBL4439	Homo sapiens	IC50	nM	468.0
	19271627	CHEMBL4406752	Inhibition of human ALK5 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	A	COc1cc(-c2cncc(-c3ccc(N4C[C@H](C)N(C)[C@H](C)C4)cc3)c2C)cc(OC)c1C(N)=O		CHEMBL4526828	=	IC50	nM	52.0	CHEMBL4439	Homo sapiens	IC50	nM	52.0
	19271628	CHEMBL4406752	Inhibition of human ALK5 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	A	COc1cc(-c2cncc(-c3ccc(N4CCN(C)CC4)cc3)c2C)cc(OC)c1C(N)=O		CHEMBL4435320	=	IC50	nM	75.0	CHEMBL4439	Homo sapiens	IC50	nM	75.0
	19271629	CHEMBL4406752	Inhibition of human ALK5 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	A	COc1cc(-c2cncc(-c3ccc(N4CCN(C(C)C)CC4)cc3)c2C)cc(F)c1C(N)=O		CHEMBL4548795	=	IC50	nM	2144.0	CHEMBL4439	Homo sapiens	IC50	nM	2144.0
	19271630	CHEMBL4406752	Inhibition of human ALK5 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	A	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(OC)c1C(N)=O		CHEMBL4565968	=	IC50	nM	46.0	CHEMBL4439	Homo sapiens	IC50	nM	46.0
	19271631	CHEMBL4406752	Inhibition of human ALK5 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	A	Cc1c(-c2ccc(N3CCNCC3)cc2)cncc1-c1ccc(C(N)=O)c(F)c1		CHEMBL4571351	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	19271632	CHEMBL4406752	Inhibition of human ALK5 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	A	Cc1c(-c2ccc(N3CCNCC3)cc2)cncc1-c1ccc2c(c1)CNC2=O		CHEMBL4575999	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	19271633	CHEMBL4406752	Inhibition of human ALK5 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	A	COc1c(C(N)=O)csc1-c1cncc(-c2ccc(N3CCNCC3)cc2)c1C		CHEMBL4538285	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	19271634	CHEMBL4406752	Inhibition of human ALK5 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	A	COc1cc(C(N)=O)cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)c1		CHEMBL4457642	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	19271639	CHEMBL4406752	Inhibition of human ALK5 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	A	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(Cl)c1C(N)=O		CHEMBL4434694	=	IC50	nM	2080.0	CHEMBL4439	Homo sapiens	IC50	nM	2080.0
	19271640	CHEMBL4406752	Inhibition of human ALK5 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	A	COCc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)ccc1C(N)=O		CHEMBL4440071	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	19271641	CHEMBL4406752	Inhibition of human ALK5 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	A	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)ccc1C(=O)N(C)C		CHEMBL4460268	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	19271642	CHEMBL4406752	Inhibition of human ALK5 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	A	COc1c(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)csc1C(N)=O		CHEMBL4456061	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	19271643	CHEMBL4406752	Inhibition of human ALK5 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	A	COc1ccc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc1C(N)=O		CHEMBL4535685	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	19271646	CHEMBL4406752	Inhibition of human ALK5 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	A	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2)cc(OC)c1OC		CHEMBL3341787	=	IC50	nM	747.0	CHEMBL4439	Homo sapiens	IC50	nM	747.0
	19271647	CHEMBL4406752	Inhibition of human ALK5 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	A	COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2C)cc(OC)c1OC		CHEMBL3341789	>	IC50	nM	2000.0	CHEMBL4439	Homo sapiens	IC50	nM	2000.0
	19271648	CHEMBL4406752	Inhibition of human ALK5 using casein as substrate in presence of 10 uM [gamma33P] ATP by radioactive assay	A	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(OC)c1OC		CHEMBL4517408	=	IC50	nM	1830.0	CHEMBL4439	Homo sapiens	IC50	nM	1830.0
	19271672	CHEMBL4406756	Inhibition of ALK5 (unknown origin) transfected in human HEK293T cells cotransfected with CAGA reporter encoding luciferase by luciferase reporter gene assay	A	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2)cc(OC)c1OC		CHEMBL3341787	=	IC50	nM	240.0	CHEMBL4439	Homo sapiens	IC50	nM	240.0
	19271673	CHEMBL4406756	Inhibition of ALK5 (unknown origin) transfected in human HEK293T cells cotransfected with CAGA reporter encoding luciferase by luciferase reporter gene assay	A	COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2C)cc(OC)c1OC		CHEMBL3341789	=	IC50	nM	3000.0	CHEMBL4439	Homo sapiens	IC50	nM	3000.0
	19271697	CHEMBL4406759	Inhibition of ALK5 (unknown origin) expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter measured after 24 hrs by dual luciferase reporter assay	A	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)ccc1C(N)=O		CHEMBL4553210	=	IC50	nM	704.0	CHEMBL4439	Homo sapiens	IC50	nM	704.0
	19271698	CHEMBL4406759	Inhibition of ALK5 (unknown origin) expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter measured after 24 hrs by dual luciferase reporter assay	A	COc1ccc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc1C(N)=O		CHEMBL4535685	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	19271699	CHEMBL4406759	Inhibition of ALK5 (unknown origin) expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter measured after 24 hrs by dual luciferase reporter assay	A	COc1cc(C(N)=O)cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)c1		CHEMBL4457642	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	19271700	CHEMBL4406759	Inhibition of ALK5 (unknown origin) expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter measured after 24 hrs by dual luciferase reporter assay	A	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)sc1C(N)=O		CHEMBL4552750	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	19271701	CHEMBL4406759	Inhibition of ALK5 (unknown origin) expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter measured after 24 hrs by dual luciferase reporter assay	A	COc1c(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)csc1C(N)=O		CHEMBL4456061	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	19271702	CHEMBL4406759	Inhibition of ALK5 (unknown origin) expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter measured after 24 hrs by dual luciferase reporter assay	A	COc1c(C(N)=O)csc1-c1cncc(-c2ccc(N3CCNCC3)cc2)c1C		CHEMBL4538285	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	19271703	CHEMBL4406759	Inhibition of ALK5 (unknown origin) expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter measured after 24 hrs by dual luciferase reporter assay	A	CNC(=O)c1ccc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc1OC		CHEMBL4437768	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	19271704	CHEMBL4406759	Inhibition of ALK5 (unknown origin) expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter measured after 24 hrs by dual luciferase reporter assay	A	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)ccc1C(=O)N(C)C		CHEMBL4460268	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	19271705	CHEMBL4406759	Inhibition of ALK5 (unknown origin) expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter measured after 24 hrs by dual luciferase reporter assay	A	Cc1c(-c2ccc(N3CCNCC3)cc2)cncc1-c1ccc2c(c1)CNC2=O		CHEMBL4575999	=	IC50	nM	4810.0	CHEMBL4439	Homo sapiens	IC50	nM	4810.0
	19271706	CHEMBL4406759	Inhibition of ALK5 (unknown origin) expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter measured after 24 hrs by dual luciferase reporter assay	A	Cc1c(-c2ccc(C(N)=O)cc2)cncc1-c1ccc(N2CCNCC2)cc1		CHEMBL4572458	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	19271707	CHEMBL4406759	Inhibition of ALK5 (unknown origin) expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter measured after 24 hrs by dual luciferase reporter assay	A	COCc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)ccc1C(N)=O		CHEMBL4440071	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	19271708	CHEMBL4406759	Inhibition of ALK5 (unknown origin) expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter measured after 24 hrs by dual luciferase reporter assay	A	Cc1c(-c2ccc(N3CCNCC3)cc2)cncc1-c1ccc(C(N)=O)c(F)c1		CHEMBL4571351	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	19271709	CHEMBL4406759	Inhibition of ALK5 (unknown origin) expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter measured after 24 hrs by dual luciferase reporter assay	A	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(F)c1C(N)=O		CHEMBL4440168	=	IC50	nM	3554.0	CHEMBL4439	Homo sapiens	IC50	nM	3554.0
	19271710	CHEMBL4406759	Inhibition of ALK5 (unknown origin) expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter measured after 24 hrs by dual luciferase reporter assay	A	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(Cl)c1C(N)=O		CHEMBL4434694	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	19271711	CHEMBL4406759	Inhibition of ALK5 (unknown origin) expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter measured after 24 hrs by dual luciferase reporter assay	A	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(OC)c1C(N)=O		CHEMBL4565968	=	IC50	nM	216.0	CHEMBL4439	Homo sapiens	IC50	nM	216.0
	19271712	CHEMBL4406759	Inhibition of ALK5 (unknown origin) expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter measured after 24 hrs by dual luciferase reporter assay	A	COc1cc(-c2cncc(-c3ccc(N4CCN(C)CC4)cc3)c2C)cc(F)c1C(N)=O		CHEMBL4575655	=	IC50	nM	4297.0	CHEMBL4439	Homo sapiens	IC50	nM	4297.0
	19271713	CHEMBL4406759	Inhibition of ALK5 (unknown origin) expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter measured after 24 hrs by dual luciferase reporter assay	A	COc1cc(-c2cncc(-c3ccc(N4CCN(C(C)C)CC4)cc3)c2C)cc(F)c1C(N)=O		CHEMBL4548795	=	IC50	nM	3900.0	CHEMBL4439	Homo sapiens	IC50	nM	3900.0
	19271714	CHEMBL4406759	Inhibition of ALK5 (unknown origin) expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter measured after 24 hrs by dual luciferase reporter assay	A	COc1cc(-c2cncc(-c3ccc(N4C[C@H](C)N(C)[C@H](C)C4)cc3)c2C)cc(F)c1C(N)=O		CHEMBL4434717	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	19271715	CHEMBL4406759	Inhibition of ALK5 (unknown origin) expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter measured after 24 hrs by dual luciferase reporter assay	A	COc1cc(-c2cncc(-c3ccc(N4CCN(C)CC4)cc3)c2C)cc(OC)c1C(N)=O		CHEMBL4435320	=	IC50	nM	249.0	CHEMBL4439	Homo sapiens	IC50	nM	249.0
	19271716	CHEMBL4406759	Inhibition of ALK5 (unknown origin) expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter measured after 24 hrs by dual luciferase reporter assay	A	COc1cc(-c2cncc(-c3ccc(N4CCN(C(C)C)CC4)cc3)c2C)cc(OC)c1C(N)=O		CHEMBL4468389	=	IC50	nM	276.0	CHEMBL4439	Homo sapiens	IC50	nM	276.0
	19271717	CHEMBL4406759	Inhibition of ALK5 (unknown origin) expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter measured after 24 hrs by dual luciferase reporter assay	A	COc1cc(-c2cncc(-c3ccc(N4C[C@H](C)N(C)[C@H](C)C4)cc3)c2C)cc(OC)c1C(N)=O		CHEMBL4526828	=	IC50	nM	283.0	CHEMBL4439	Homo sapiens	IC50	nM	283.0
	19276150	CHEMBL4408153	Inhibition of recombinant human TGFBR1 (200 to end residues) at 1 uM using casein as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	6.0	CHEMBL4439	Homo sapiens	INH	%	6.0
	19411385	CHEMBL4427615	Inhibition of ALK5 in TGF beta1-stimulated HEK293T cells by SMAD binding element-driven beta lactamase reporter gene assay	B	CCn1c(=O)n(-c2cc(-c3cc(Cl)ccc3F)ncc2C)c2ccncc21		CHEMBL4569690	=	EC50	nM	331.13	CHEMBL4439	Homo sapiens	pEC50		6.48
	19411386	CHEMBL4427615	Inhibition of ALK5 in TGF beta1-stimulated HEK293T cells by SMAD binding element-driven beta lactamase reporter gene assay	B	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21		CHEMBL4564126	=	EC50	nM	234.42	CHEMBL4439	Homo sapiens	pEC50		6.63
	19411387	CHEMBL4427615	Inhibition of ALK5 in TGF beta1-stimulated HEK293T cells by SMAD binding element-driven beta lactamase reporter gene assay	B	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(C)c2cnccc21		CHEMBL4515962	=	EC50	nM	457.09	CHEMBL4439	Homo sapiens	pEC50		6.34
	19411388	CHEMBL4427615	Inhibition of ALK5 in TGF beta1-stimulated HEK293T cells by SMAD binding element-driven beta lactamase reporter gene assay	B	O=c1[nH]c2cnccc2n1-c1cc(-c2cc(Cl)ccc2F)nc2[nH]ccc12		CHEMBL4470706	=	EC50	nM	9.55	CHEMBL4439	Homo sapiens	pEC50		8.02
	19411389	CHEMBL4427615	Inhibition of ALK5 in TGF beta1-stimulated HEK293T cells by SMAD binding element-driven beta lactamase reporter gene assay	B	O=c1[nH]c2cnccc2n1-c1cc(-c2ccc(F)cc2F)nc2[nH]ccc12		CHEMBL4555703	=	EC50	nM	17.78	CHEMBL4439	Homo sapiens	pEC50		7.75
	19411390	CHEMBL4427615	Inhibition of ALK5 in TGF beta1-stimulated HEK293T cells by SMAD binding element-driven beta lactamase reporter gene assay	B	CNCCNC(=O)c1cnccc1Nc1cc(-c2ccc(F)cc2F)nc2[nH]ccc12		CHEMBL4470980	=	EC50	nM	51.29	CHEMBL4439	Homo sapiens	pEC50		7.29
	19411391	CHEMBL4427615	Inhibition of ALK5 in TGF beta1-stimulated HEK293T cells by SMAD binding element-driven beta lactamase reporter gene assay	B	C[C@H](O)CNC(=O)c1cnccc1Nc1cc(-c2cc(Cl)ccc2F)nc2[nH]ccc12		CHEMBL4467267	=	EC50	nM	9.12	CHEMBL4439	Homo sapiens	pEC50		8.04
	19411392	CHEMBL4427615	Inhibition of ALK5 in TGF beta1-stimulated HEK293T cells by SMAD binding element-driven beta lactamase reporter gene assay	B	C[C@H](O)CNC(=O)c1cnccc1Nc1cc(-c2ccc(F)cc2F)nc2[nH]ccc12		CHEMBL4443611	=	EC50	nM	17.78	CHEMBL4439	Homo sapiens	pEC50		7.75
	19411393	CHEMBL4427615	Inhibition of ALK5 in TGF beta1-stimulated HEK293T cells by SMAD binding element-driven beta lactamase reporter gene assay	B	O=C(NC1CC1)c1cnccc1Nc1cc(-c2cc(Cl)ccc2F)nc2[nH]ccc12		CHEMBL4483492	=	EC50	nM	22.39	CHEMBL4439	Homo sapiens	pEC50		7.65
	19411394	CHEMBL4427615	Inhibition of ALK5 in TGF beta1-stimulated HEK293T cells by SMAD binding element-driven beta lactamase reporter gene assay	B	O=C(NC1CC1)c1cnccc1Nc1cc(-c2ccc(F)cc2F)nc2[nH]ccc12		CHEMBL4452818	=	EC50	nM	16.6	CHEMBL4439	Homo sapiens	pEC50		7.78
	19411395	CHEMBL4427615	Inhibition of ALK5 in TGF beta1-stimulated HEK293T cells by SMAD binding element-driven beta lactamase reporter gene assay	B	Fc1cc(F)c(-c2cc(Nc3ccncc3)c3cc[nH]c3n2)cc1Cl		CHEMBL4437930	=	EC50	nM	19.95	CHEMBL4439	Homo sapiens	pEC50		7.7
	19411396	CHEMBL4427615	Inhibition of ALK5 in TGF beta1-stimulated HEK293T cells by SMAD binding element-driven beta lactamase reporter gene assay	B	Fc1ccc(Cl)cc1-c1cc(Nc2ccncc2)c2cc[nH]c2n1		CHEMBL4447510	=	EC50	nM	19.95	CHEMBL4439	Homo sapiens	pEC50		7.7
	19411397	CHEMBL4427615	Inhibition of ALK5 in TGF beta1-stimulated HEK293T cells by SMAD binding element-driven beta lactamase reporter gene assay	B	Cc1cccc(-c2cc(Nc3ccncc3)c3cc[nH]c3n2)n1		CHEMBL4572312	=	EC50	nM	158.49	CHEMBL4439	Homo sapiens	pEC50		6.8
	19411398	CHEMBL4427615	Inhibition of ALK5 in TGF beta1-stimulated HEK293T cells by SMAD binding element-driven beta lactamase reporter gene assay	B	Fc1ccc(-c2cc(Nc3ccncc3)c3cc[nH]c3n2)c(F)c1		CHEMBL4446613	=	EC50	nM	25.12	CHEMBL4439	Homo sapiens	pEC50		7.6
	19411399	CHEMBL4427615	Inhibition of ALK5 in TGF beta1-stimulated HEK293T cells by SMAD binding element-driven beta lactamase reporter gene assay	B	Fc1ccccc1-c1cc(Nc2ccncc2)c2cc[nH]c2n1		CHEMBL4576833	=	EC50	nM	50.12	CHEMBL4439	Homo sapiens	pEC50		7.3
	19411400	CHEMBL4427614	Inhibition of ALK5 (unknown origin) using fluorescein-labeled peptide substrate incubated for 90 mins by TR-FRET assay	B	CCn1c(=O)n(-c2cc(-c3cc(Cl)ccc3F)ncc2C)c2ccncc21		CHEMBL4569690	=	IC50	nM	12.59	CHEMBL4439	Homo sapiens	pIC50		7.9
	19411401	CHEMBL4427614	Inhibition of ALK5 (unknown origin) using fluorescein-labeled peptide substrate incubated for 90 mins by TR-FRET assay	B	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21		CHEMBL4564126	=	IC50	nM	25.12	CHEMBL4439	Homo sapiens	pIC50		7.6
	19411402	CHEMBL4427614	Inhibition of ALK5 (unknown origin) using fluorescein-labeled peptide substrate incubated for 90 mins by TR-FRET assay	B	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(C)c2cnccc21		CHEMBL4515962	=	IC50	nM	31.62	CHEMBL4439	Homo sapiens	pIC50		7.5
	19411403	CHEMBL4427614	Inhibition of ALK5 (unknown origin) using fluorescein-labeled peptide substrate incubated for 90 mins by TR-FRET assay	B	Cn1c(=O)n(-c2cc(-c3cc(Cl)ccc3F)nc3[nH]ccc23)c2ccncc21		CHEMBL4474551	=	IC50	nM	6.31	CHEMBL4439	Homo sapiens	pIC50		8.2
	19411404	CHEMBL4427614	Inhibition of ALK5 (unknown origin) using fluorescein-labeled peptide substrate incubated for 90 mins by TR-FRET assay	B	Cn1c(=O)n(-c2cc(-c3ccc(F)cc3F)nc3[nH]ccc23)c2ccncc21		CHEMBL4513488	=	IC50	nM	19.95	CHEMBL4439	Homo sapiens	pIC50		7.7
	19411405	CHEMBL4427614	Inhibition of ALK5 (unknown origin) using fluorescein-labeled peptide substrate incubated for 90 mins by TR-FRET assay	B	O=c1[nH]c2cnccc2n1-c1cc(-c2cc(Cl)ccc2F)nc2[nH]ccc12		CHEMBL4470706	=	IC50	nM	3.981	CHEMBL4439	Homo sapiens	pIC50		8.4
	19411406	CHEMBL4427614	Inhibition of ALK5 (unknown origin) using fluorescein-labeled peptide substrate incubated for 90 mins by TR-FRET assay	B	O=c1[nH]c2cnccc2n1-c1cc(-c2ccc(F)cc2F)nc2[nH]ccc12		CHEMBL4555703	=	IC50	nM	12.59	CHEMBL4439	Homo sapiens	pIC50		7.9
	19411407	CHEMBL4427614	Inhibition of ALK5 (unknown origin) using fluorescein-labeled peptide substrate incubated for 90 mins by TR-FRET assay	B	CC(C)(N)CNC(=O)c1cnccc1Nc1cc(-c2ccc(F)cc2F)nc2[nH]ccc12		CHEMBL4468495	=	IC50	nM	398.11	CHEMBL4439	Homo sapiens	pIC50		6.4
	19411408	CHEMBL4427614	Inhibition of ALK5 (unknown origin) using fluorescein-labeled peptide substrate incubated for 90 mins by TR-FRET assay	B	CNCCNC(=O)c1cnccc1Nc1cc(-c2ccc(F)cc2F)nc2[nH]ccc12		CHEMBL4470980	=	IC50	nM	12.59	CHEMBL4439	Homo sapiens	pIC50		7.9
	19411409	CHEMBL4427614	Inhibition of ALK5 (unknown origin) using fluorescein-labeled peptide substrate incubated for 90 mins by TR-FRET assay	B	C[C@H](O)CNC(=O)c1cnccc1Nc1cc(-c2cc(Cl)ccc2F)nc2[nH]ccc12		CHEMBL4467267	=	IC50	nM	12.59	CHEMBL4439	Homo sapiens	pIC50		7.9
	19411410	CHEMBL4427614	Inhibition of ALK5 (unknown origin) using fluorescein-labeled peptide substrate incubated for 90 mins by TR-FRET assay	B	C[C@H](O)CNC(=O)c1cnccc1Nc1cc(-c2ccc(F)cc2F)nc2[nH]ccc12		CHEMBL4443611	=	IC50	nM	15.85	CHEMBL4439	Homo sapiens	pIC50		7.8
	19411411	CHEMBL4427614	Inhibition of ALK5 (unknown origin) using fluorescein-labeled peptide substrate incubated for 90 mins by TR-FRET assay	B	O=C(NC1CC1)c1cnccc1Nc1cc(-c2cc(Cl)ccc2F)nc2[nH]ccc12		CHEMBL4483492	=	IC50	nM	19.95	CHEMBL4439	Homo sapiens	pIC50		7.7
	19411412	CHEMBL4427614	Inhibition of ALK5 (unknown origin) using fluorescein-labeled peptide substrate incubated for 90 mins by TR-FRET assay	B	O=C(NC1CC1)c1cnccc1Nc1cc(-c2ccc(F)cc2F)nc2[nH]ccc12		CHEMBL4452818	=	IC50	nM	12.59	CHEMBL4439	Homo sapiens	pIC50		7.9
	19411413	CHEMBL4427614	Inhibition of ALK5 (unknown origin) using fluorescein-labeled peptide substrate incubated for 90 mins by TR-FRET assay	B	Fc1cc(F)c(-c2cc(Nc3ccncc3)c3cc[nH]c3n2)cc1Cl		CHEMBL4437930	=	IC50	nM	39.81	CHEMBL4439	Homo sapiens	pIC50		7.4
	19411414	CHEMBL4427614	Inhibition of ALK5 (unknown origin) using fluorescein-labeled peptide substrate incubated for 90 mins by TR-FRET assay	B	Fc1ccc(Cl)cc1-c1cc(Nc2ccncc2)c2cc[nH]c2n1		CHEMBL4447510	=	IC50	nM	3.162	CHEMBL4439	Homo sapiens	pIC50		8.5
	19411415	CHEMBL4427614	Inhibition of ALK5 (unknown origin) using fluorescein-labeled peptide substrate incubated for 90 mins by TR-FRET assay	B	Cc1cccc(-c2cc(Nc3ccncc3)c3cc[nH]c3n2)n1		CHEMBL4572312	=	IC50	nM	79.43	CHEMBL4439	Homo sapiens	pIC50		7.1
	19411416	CHEMBL4427614	Inhibition of ALK5 (unknown origin) using fluorescein-labeled peptide substrate incubated for 90 mins by TR-FRET assay	B	Fc1ccc(-c2cc(Nc3ccncc3)c3cc[nH]c3n2)cc1F		CHEMBL4526347	=	IC50	nM	63095.73	CHEMBL4439	Homo sapiens	pIC50		4.2
	19411417	CHEMBL4427614	Inhibition of ALK5 (unknown origin) using fluorescein-labeled peptide substrate incubated for 90 mins by TR-FRET assay	B	Fc1ccc(-c2cc(Nc3ccncc3)c3cc[nH]c3n2)c(F)c1		CHEMBL4446613	=	IC50	nM	31.62	CHEMBL4439	Homo sapiens	pIC50		7.5
	19411418	CHEMBL4427614	Inhibition of ALK5 (unknown origin) using fluorescein-labeled peptide substrate incubated for 90 mins by TR-FRET assay	B	Fc1ccccc1-c1cc(Nc2ccncc2)c2cc[nH]c2n1		CHEMBL4576833	=	Kd	nM	10.0	CHEMBL4439	Homo sapiens	pKd		8.0
	19453903	CHEMBL4434537	Inhibition of GST-tagged ALK5 kinase domain (unknown origin) using GST-tagged SMAD3 as substrate in presence of [33P] gammaATP by liquid scintillation counter method	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	IC50	nM	47.0	CHEMBL4439	Homo sapiens	IC50	nM	47.0
	19453904	CHEMBL4434538	Inhibition of ALK5 (unknown origin)	B	CCc1cnn(-c2cccc(C)n2)c1-c1cc2cnccc2s1		CHEMBL3704651	=	IC50	nM	4.3	CHEMBL4439	Homo sapiens	IC50	nM	4.3
	19453905	CHEMBL4434538	Inhibition of ALK5 (unknown origin)	B	Cc1cccc(-c2nc3n(c2-c2cc4cnccc4s2)CCN3)n1		CHEMBL4457492	=	IC50	nM	6.1	CHEMBL4439	Homo sapiens	IC50	nM	6.1
	19453922	CHEMBL4434540	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells using casein as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cc1cccc(-c2[nH]c(CNc3ccccc3)nc2-c2ccc3nsnc3c2)n1		CHEMBL4464656	=	IC50	nM	14.0	CHEMBL4439	Homo sapiens	IC50	uM	0.014
	19453923	CHEMBL4434540	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells using casein as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3nsnc3c2)n1		CHEMBL4453060	=	IC50	nM	11.0	CHEMBL4439	Homo sapiens	IC50	uM	0.011
	19453924	CHEMBL4434540	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells using casein as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cc1cccc(-c2[nH]c(CNc3cccc(F)c3)nc2-c2ccc3nsnc3c2)n1		CHEMBL4519261	=	IC50	nM	8.0	CHEMBL4439	Homo sapiens	IC50	uM	0.008
	19453925	CHEMBL4434540	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells using casein as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cc1cccc(-c2[nH]c(CNc3ccc(F)cc3)nc2-c2ccc3nsnc3c2)n1		CHEMBL4588407	=	IC50	nM	10.0	CHEMBL4439	Homo sapiens	IC50	uM	0.01
	19453926	CHEMBL4434540	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells using casein as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cc1cccc(-c2[nH]c(CNc3ccccc3C)nc2-c2ccc3nsnc3c2)n1		CHEMBL4534375	=	IC50	nM	21.0	CHEMBL4439	Homo sapiens	IC50	uM	0.021
	19453927	CHEMBL4434540	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells using casein as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cc1cccc(NCc2nc(-c3ccc4nsnc4c3)c(-c3cccc(C)n3)[nH]2)c1		CHEMBL4574187	=	IC50	nM	13.0	CHEMBL4439	Homo sapiens	IC50	uM	0.013
	19453928	CHEMBL4434540	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells using casein as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cc1ccc(NCc2nc(-c3ccc4nsnc4c3)c(-c3cccc(C)n3)[nH]2)cc1		CHEMBL4553389	=	IC50	nM	22.0	CHEMBL4439	Homo sapiens	IC50	uM	0.022
	19453929	CHEMBL4434540	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells using casein as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cc1cccc(-c2[nH]c(CNc3ccccc3)nc2-c2cc3cnccc3s2)n1		CHEMBL4447399	=	IC50	nM	25.0	CHEMBL4439	Homo sapiens	IC50	uM	0.025
	19453930	CHEMBL4434540	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells using casein as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2cc3cnccc3s2)n1		CHEMBL4516224	=	IC50	nM	23.0	CHEMBL4439	Homo sapiens	IC50	uM	0.023
	19453931	CHEMBL4434540	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells using casein as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cc1cccc(-c2[nH]c(CNc3cccc(F)c3)nc2-c2cc3cnccc3s2)n1		CHEMBL4576341	=	IC50	nM	17.0	CHEMBL4439	Homo sapiens	IC50	uM	0.017
	19453932	CHEMBL4434540	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells using casein as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cc1cccc(-c2[nH]c(CNc3ccc(F)cc3)nc2-c2cc3cnccc3s2)n1		CHEMBL4533727	=	IC50	nM	42.0	CHEMBL4439	Homo sapiens	IC50	uM	0.042
	19453933	CHEMBL4434540	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells using casein as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cc1cccc(-c2[nH]c(CNc3ccccc3C)nc2-c2cc3cnccc3s2)n1		CHEMBL4474911	=	IC50	nM	14.0	CHEMBL4439	Homo sapiens	IC50	uM	0.014
	19453934	CHEMBL4434540	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells using casein as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cc1cccc(NCc2nc(-c3cc4cnccc4s3)c(-c3cccc(C)n3)[nH]2)c1		CHEMBL4543738	=	IC50	nM	19.0	CHEMBL4439	Homo sapiens	IC50	uM	0.019
	19453935	CHEMBL4434540	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells using casein as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cc1ccc(NCc2nc(-c3cc4cnccc4s3)c(-c3cccc(C)n3)[nH]2)cc1		CHEMBL4519255	=	IC50	nM	43.0	CHEMBL4439	Homo sapiens	IC50	uM	0.043
	19453936	CHEMBL4434540	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells using casein as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	=	IC50	nM	129.0	CHEMBL4439	Homo sapiens	IC50	uM	0.129
	19453937	CHEMBL4434540	Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells using casein as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	IC50	nM	14.0	CHEMBL4439	Homo sapiens	IC50	uM	0.014
	19453954	CHEMBL4434535	Potency index, ratio of IC50 for LY-2157299 to IC50 for test compound for inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells using casein as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cc1cccc(-c2[nH]c(CNc3cccc(F)c3)nc2-c2ccc3nsnc3c2)n1		CHEMBL4519261	=	Ratio IC50		16.1	CHEMBL4439	Homo sapiens	Ratio IC50		16.1
	19453955	CHEMBL4434536	Potency index, ratio of IC50 for EW-7197 to IC50 for test compound for inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells using casein as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cc1cccc(-c2[nH]c(CNc3cccc(F)c3)nc2-c2ccc3nsnc3c2)n1		CHEMBL4519261	=	Ratio IC50		1.8	CHEMBL4439	Homo sapiens	Ratio IC50		1.8
Dose-dependent effect	19453958	CHEMBL4434533	Inhibition of ALK5 in human HepG2 cells assessed as reduction in TGFbeta1-induced Smad2 phosphorylation incubated for 36 hrs by Western blot analysis	B	Cc1cccc(-c2[nH]c(CNc3cccc(F)c3)nc2-c2ccc3nsnc3c2)n1		CHEMBL4519261		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
Dose-dependent effect	19453959	CHEMBL4434533	Inhibition of ALK5 in human HepG2 cells assessed as reduction in TGFbeta1-induced Smad2 phosphorylation incubated for 36 hrs by Western blot analysis	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
Active	19453960	CHEMBL4434543	Inhibition of ALK5 in human SPC-A1 cells assessed as reduction in TGFbeta1-induced Smad2 phosphorylation at 0.1 to 0.5 uM incubated for 36 hrs by Western blot analysis	B	Cc1cccc(-c2[nH]c(CNc3cccc(F)c3)nc2-c2ccc3nsnc3c2)n1		CHEMBL4519261		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
Active	19453961	CHEMBL4434543	Inhibition of ALK5 in human SPC-A1 cells assessed as reduction in TGFbeta1-induced Smad2 phosphorylation at 0.1 to 0.5 uM incubated for 36 hrs by Western blot analysis	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
Active	19453962	CHEMBL4434544	Inhibition of ALK5 in human HUVEC cells assessed as reduction in TGFbeta1-induced cell motility at 10 uM incubated for 0 to 48 hrs by wound healing assay	B	Cc1cccc(-c2[nH]c(CNc3cccc(F)c3)nc2-c2ccc3nsnc3c2)n1		CHEMBL4519261		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
	20612858	CHEMBL4606502	Inhibition of human full-length N-terminal GST-tagged ALK5 (200 to 503 residues) expressed in baculovirus expression system at 1 uM by Lanthascreen assay relative to control	A	Nc1ncnc2c1c(Oc1cc(C(F)(F)F)ccn1)nn2C1CC1		CHEMBL4634455	=	Inhibition	%	50.0	CHEMBL4439	Homo sapiens	INH	%	50.0
	20646117	CHEMBL4614186	Inhibition of recombinant GST-tagged human ALK5 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3)cc2-c2ccnc3ccccc23)n1		CHEMBL4649828	=	Activity	%	2.0	CHEMBL4439	Homo sapiens	Activity	%	2.0
	20646118	CHEMBL4614186	Inhibition of recombinant GST-tagged human ALK5 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3F)cc2-c2ccnc3ccccc23)n1		CHEMBL4643959	=	Activity	%	0.0	CHEMBL4439	Homo sapiens	Activity	%	0.0
	20646119	CHEMBL4614186	Inhibition of recombinant GST-tagged human ALK5 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(F)c3)cc2-c2ccnc3ccccc23)n1		CHEMBL4642941	=	Activity	%	0.0	CHEMBL4439	Homo sapiens	Activity	%	0.0
	20646120	CHEMBL4614186	Inhibition of recombinant GST-tagged human ALK5 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(C#N)c3)cc2-c2ccnc3ccccc23)n1		CHEMBL4637341	=	Activity	%	1.0	CHEMBL4439	Homo sapiens	Activity	%	1.0
	20646121	CHEMBL4614186	Inhibition of recombinant GST-tagged human ALK5 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2c(-c3ccnc4ccccc34)cnn2CC(=O)Nc2ccccc2)n1		CHEMBL4634662	=	Activity	%	71.0	CHEMBL4439	Homo sapiens	Activity	%	71.0
	20646122	CHEMBL4614186	Inhibition of recombinant GST-tagged human ALK5 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2c(-c3ccnc4ccccc34)cnn2CC(=O)Nc2ccccc2F)n1		CHEMBL4637339	=	Activity	%	79.0	CHEMBL4439	Homo sapiens	Activity	%	79.0
	20646123	CHEMBL4614186	Inhibition of recombinant GST-tagged human ALK5 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2c(-c3ccnc4ccccc34)cnn2CC(=O)Nc2cccc(F)c2)n1		CHEMBL4638814	=	Activity	%	39.0	CHEMBL4439	Homo sapiens	Activity	%	39.0
	20646124	CHEMBL4614186	Inhibition of recombinant GST-tagged human ALK5 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2c(-c3ccnc4ccccc34)cnn2CC(=O)Nc2cccc(C#N)c2)n1		CHEMBL4644172	=	Activity	%	17.0	CHEMBL4439	Homo sapiens	Activity	%	17.0
	20646125	CHEMBL4614186	Inhibition of recombinant GST-tagged human ALK5 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2nn(CC(=S)Nc3ccccc3)cc2-c2ccnc3ccccc23)n1		CHEMBL4649639	=	Activity	%	3.0	CHEMBL4439	Homo sapiens	Activity	%	3.0
	20646126	CHEMBL4614186	Inhibition of recombinant GST-tagged human ALK5 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2nn(CC(=S)Nc3ccccc3F)cc2-c2ccnc3ccccc23)n1		CHEMBL4638492	=	Activity	%	2.0	CHEMBL4439	Homo sapiens	Activity	%	2.0
	20646127	CHEMBL4614186	Inhibition of recombinant GST-tagged human ALK5 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(F)c3)cc2-c2ccnc3ccccc23)n1		CHEMBL4638285	=	Activity	%	2.0	CHEMBL4439	Homo sapiens	Activity	%	2.0
	20646128	CHEMBL4614186	Inhibition of recombinant GST-tagged human ALK5 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(C#N)c3)cc2-c2ccnc3ccccc23)n1		CHEMBL4649719	=	Activity	%	2.0	CHEMBL4439	Homo sapiens	Activity	%	2.0
	20646129	CHEMBL4614186	Inhibition of recombinant GST-tagged human ALK5 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3)cc2-c2ccnc(-c3ccccc3)c2)n1		CHEMBL4645374	=	Activity	%	12.0	CHEMBL4439	Homo sapiens	Activity	%	12.0
	20646130	CHEMBL4614186	Inhibition of recombinant GST-tagged human ALK5 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3F)cc2-c2ccnc(-c3ccccc3)c2)n1		CHEMBL4638055	=	Activity	%	20.0	CHEMBL4439	Homo sapiens	Activity	%	20.0
	20646131	CHEMBL4614186	Inhibition of recombinant GST-tagged human ALK5 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(F)c3)cc2-c2ccnc(-c3ccccc3)c2)n1		CHEMBL4648655	=	Activity	%	3.0	CHEMBL4439	Homo sapiens	Activity	%	3.0
	20646132	CHEMBL4614186	Inhibition of recombinant GST-tagged human ALK5 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(C#N)c3)cc2-c2ccnc(-c3ccccc3)c2)n1		CHEMBL4633712	=	Activity	%	18.0	CHEMBL4439	Homo sapiens	Activity	%	18.0
	20646133	CHEMBL4614186	Inhibition of recombinant GST-tagged human ALK5 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2c(-c3ccnc(-c4ccccc4)c3)cnn2CC(=O)Nc2ccccc2)n1		CHEMBL4639727	=	Activity	%	100.0	CHEMBL4439	Homo sapiens	Activity	%	100.0
	20646134	CHEMBL4614186	Inhibition of recombinant GST-tagged human ALK5 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2c(-c3ccnc(-c4ccccc4)c3)cnn2CC(=O)Nc2ccccc2F)n1		CHEMBL4636902	=	Activity	%	102.0	CHEMBL4439	Homo sapiens	Activity	%	102.0
	20646135	CHEMBL4614186	Inhibition of recombinant GST-tagged human ALK5 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2c(-c3ccnc(-c4ccccc4)c3)cnn2CC(=O)Nc2cccc(F)c2)n1		CHEMBL4648311	=	Activity	%	93.0	CHEMBL4439	Homo sapiens	Activity	%	93.0
	20646136	CHEMBL4614186	Inhibition of recombinant GST-tagged human ALK5 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2c(-c3ccnc(-c4ccccc4)c3)cnn2CC(=O)Nc2cccc(C#N)c2)n1		CHEMBL4645318	=	Activity	%	105.0	CHEMBL4439	Homo sapiens	Activity	%	105.0
	20646137	CHEMBL4614186	Inhibition of recombinant GST-tagged human ALK5 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2nn(CC(=S)Nc3ccccc3)cc2-c2ccnc(-c3ccccc3)c2)n1		CHEMBL4648490	=	Activity	%	11.0	CHEMBL4439	Homo sapiens	Activity	%	11.0
	20646138	CHEMBL4614186	Inhibition of recombinant GST-tagged human ALK5 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2nn(CC(=S)Nc3ccccc3F)cc2-c2ccnc(-c3ccccc3)c2)n1		CHEMBL4640708	=	Activity	%	11.0	CHEMBL4439	Homo sapiens	Activity	%	11.0
	20646139	CHEMBL4614186	Inhibition of recombinant GST-tagged human ALK5 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(F)c3)cc2-c2ccnc(-c3ccccc3)c2)n1		CHEMBL4644045	=	Activity	%	6.0	CHEMBL4439	Homo sapiens	Activity	%	6.0
	20646140	CHEMBL4614186	Inhibition of recombinant GST-tagged human ALK5 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(C#N)c3)cc2-c2ccnc(-c3ccccc3)c2)n1		CHEMBL4635582	=	Activity	%	12.0	CHEMBL4439	Homo sapiens	Activity	%	12.0
	20646141	CHEMBL4614186	Inhibition of recombinant GST-tagged human ALK5 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	=	Activity	%	1.0	CHEMBL4439	Homo sapiens	Activity	%	1.0
	20646151	CHEMBL4614188	Inhibition of recombinant GST-tagged human ALK5 expressed in baculovirus infected Sf9 insect cells	B	Cc1cccc(-c2nn(CC(=S)Nc3ccccc3)cc2-c2ccnc3ccccc23)n1		CHEMBL4649639	=	IC50	nM	57.0	CHEMBL4439	Homo sapiens	IC50	uM	0.057
	20646152	CHEMBL4614188	Inhibition of recombinant GST-tagged human ALK5 expressed in baculovirus infected Sf9 insect cells	B	Cc1cccc(-c2nn(CC(=S)Nc3ccccc3F)cc2-c2ccnc3ccccc23)n1		CHEMBL4638492	=	IC50	nM	53.0	CHEMBL4439	Homo sapiens	IC50	uM	0.053
	20646153	CHEMBL4614188	Inhibition of recombinant GST-tagged human ALK5 expressed in baculovirus infected Sf9 insect cells	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(F)c3)cc2-c2ccnc3ccccc23)n1		CHEMBL4638285	=	IC50	nM	43.0	CHEMBL4439	Homo sapiens	IC50	uM	0.043
	20646154	CHEMBL4614188	Inhibition of recombinant GST-tagged human ALK5 expressed in baculovirus infected Sf9 insect cells	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(C#N)c3)cc2-c2ccnc3ccccc23)n1		CHEMBL4649719	=	IC50	nM	69.0	CHEMBL4439	Homo sapiens	IC50	uM	0.069
	20646155	CHEMBL4614188	Inhibition of recombinant GST-tagged human ALK5 expressed in baculovirus infected Sf9 insect cells	B	Cc1cccc(-c2nn(CC(=S)Nc3ccccc3)cc2-c2ccnc(-c3ccccc3)c2)n1		CHEMBL4648490	=	IC50	nM	1689.0	CHEMBL4439	Homo sapiens	IC50	uM	1.689
	20646156	CHEMBL4614188	Inhibition of recombinant GST-tagged human ALK5 expressed in baculovirus infected Sf9 insect cells	B	Cc1cccc(-c2nn(CC(=S)Nc3ccccc3F)cc2-c2ccnc(-c3ccccc3)c2)n1		CHEMBL4640708	=	IC50	nM	2050.0	CHEMBL4439	Homo sapiens	IC50	uM	2.05
	20646157	CHEMBL4614188	Inhibition of recombinant GST-tagged human ALK5 expressed in baculovirus infected Sf9 insect cells	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(F)c3)cc2-c2ccnc(-c3ccccc3)c2)n1		CHEMBL4644045	=	IC50	nM	1560.0	CHEMBL4439	Homo sapiens	IC50	uM	1.56
	20646158	CHEMBL4614188	Inhibition of recombinant GST-tagged human ALK5 expressed in baculovirus infected Sf9 insect cells	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(C#N)c3)cc2-c2ccnc(-c3ccccc3)c2)n1		CHEMBL4635582	=	IC50	nM	2200.0	CHEMBL4439	Homo sapiens	IC50	uM	2.2
	20646159	CHEMBL4614188	Inhibition of recombinant GST-tagged human ALK5 expressed in baculovirus infected Sf9 insect cells	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	=	IC50	nM	119.0	CHEMBL4439	Homo sapiens	IC50	uM	0.119
	20690446	CHEMBL4625363	Inhibition of ALK5 (unknown origin)	B	CC(C)(O)Cn1cc(Nc2cc(Oc3cn(C4CC4)nc3C3CCOCC3)ccn2)cn1		CHEMBL4640043	=	IC50	nM	77.0	CHEMBL4439	Homo sapiens	IC50	nM	77.0
	20690447	CHEMBL4625363	Inhibition of ALK5 (unknown origin)	B	c1cc(Oc2cn(C3CC3)nc2C2CCOCC2)cc(Nc2cnn(C3CCOCC3)c2)n1		CHEMBL4648725	=	IC50	nM	21.0	CHEMBL4439	Homo sapiens	IC50	nM	21.0
	20690448	CHEMBL4625363	Inhibition of ALK5 (unknown origin)	B	CC1(Cn2cc(Nc3cc(Oc4cn(C5CC5)nc4C4CCOCC4)ccn3)cn2)COC1		CHEMBL4637443	=	IC50	nM	32.0	CHEMBL4439	Homo sapiens	IC50	nM	32.0
	20690449	CHEMBL4625363	Inhibition of ALK5 (unknown origin)	B	CC(C)N1CCN(c2cc(Nc3cc(Oc4cn(C5CC5)nc4C4CCOCC4)ccn3)ccn2)CC1		CHEMBL4633398	=	IC50	nM	13.0	CHEMBL4439	Homo sapiens	IC50	nM	13.0
	20690450	CHEMBL4625363	Inhibition of ALK5 (unknown origin)	B	c1cc(Oc2cn(C3CC3)nc2C2CCOCC2)cc(Nc2ccnc(NC3CCOCC3)c2)n1		CHEMBL4647548	=	IC50	nM	17.0	CHEMBL4439	Homo sapiens	IC50	nM	17.0
	20690451	CHEMBL4625363	Inhibition of ALK5 (unknown origin)	B	O=C(O)C1CN(c2cc(Nc3cc(Oc4cn(C5CC5)nc4C4CCOCC4)ccn3)ccn2)C1		CHEMBL4635885	=	IC50	nM	234.0	CHEMBL4439	Homo sapiens	IC50	nM	234.0
	20690452	CHEMBL4625363	Inhibition of ALK5 (unknown origin)	B	CC(C)(O)C(=O)N1CCC(Nc2cc(Oc3cn(C4CC4)nc3C3CCOCC3)ccn2)CC1		CHEMBL4632394	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	nM	1000.0
	20690453	CHEMBL4625363	Inhibition of ALK5 (unknown origin)	B	CC(C)(C(=O)O)N1CCC(Nc2cc(Oc3cn(C4CC4)nc3C3CCOCC3)ccn2)CC1		CHEMBL4636813	>	IC50	nM	1000.0	CHEMBL4439	Homo sapiens	IC50	nM	1000.0
	20690454	CHEMBL4625363	Inhibition of ALK5 (unknown origin)	B	N#Cc1ccc(Nc2cc(Oc3cn(C4CC4)nc3C3CCOCC3)ccn2)cc1N1CC(O)C1		CHEMBL4635820	=	IC50	nM	13.0	CHEMBL4439	Homo sapiens	IC50	nM	13.0
	20690455	CHEMBL4625363	Inhibition of ALK5 (unknown origin)	B	CC1(O)CN(c2cc(Nc3cc(Oc4cn(C5CC5)nc4C4CCOCC4)ccn3)ccc2C#N)C1		CHEMBL4641072	=	IC50	nM	14.0	CHEMBL4439	Homo sapiens	IC50	nM	14.0
	20690456	CHEMBL4625363	Inhibition of ALK5 (unknown origin)	B	CC1(O)CN(C(=O)c2cc(Nc3cc(Oc4cn(C5CC5)nc4C4CCOCC4)ccn3)ccc2C#N)C1		CHEMBL4645653	=	IC50	nM	211.0	CHEMBL4439	Homo sapiens	IC50	nM	211.0
	20690457	CHEMBL4625363	Inhibition of ALK5 (unknown origin)	B	CC1(O)CN(C(=O)c2cc(Nc3cc(Oc4cn(C5CC5)nc4C4CCOCC4)ccn3)ccc2F)C1		CHEMBL4634207	=	IC50	nM	122.0	CHEMBL4439	Homo sapiens	IC50	nM	122.0
	20690458	CHEMBL4625363	Inhibition of ALK5 (unknown origin)	B	O=C(c1cc(Nc2cc(Oc3cn(C4CC4)nc3C3CCOCC3)ccn2)ccc1F)N1CCOCC1		CHEMBL4635214	=	IC50	nM	114.0	CHEMBL4439	Homo sapiens	IC50	nM	114.0
	20690459	CHEMBL4625363	Inhibition of ALK5 (unknown origin)	B	NS(=O)(=O)c1cccc(Nc2cc(Oc3cn(C4CC4)nc3C3CCOCC3)ccn2)c1		CHEMBL4644348	=	IC50	nM	9.1	CHEMBL4439	Homo sapiens	IC50	nM	9.1
	20690460	CHEMBL4625363	Inhibition of ALK5 (unknown origin)	B	CNS(=O)(=O)c1cccc(Nc2cc(Oc3cn(C4CC4)nc3C3CCOCC3)ccn2)c1		CHEMBL4637746	=	IC50	nM	15.0	CHEMBL4439	Homo sapiens	IC50	nM	15.0
	20690461	CHEMBL4625363	Inhibition of ALK5 (unknown origin)	B	CCNS(=O)(=O)c1cccc(Nc2cc(Oc3cn(C4CC4)nc3C3CCOCC3)ccn2)c1		CHEMBL4649726	=	IC50	nM	12.0	CHEMBL4439	Homo sapiens	IC50	nM	12.0
	20690462	CHEMBL4625363	Inhibition of ALK5 (unknown origin)	B	Cc1ccc(Nc2cc(Oc3cn(C4CC4)nc3C3CCOCC3)ccn2)cc1S(N)(=O)=O		CHEMBL4646258	=	IC50	nM	16.0	CHEMBL4439	Homo sapiens	IC50	nM	16.0
	20690463	CHEMBL4625363	Inhibition of ALK5 (unknown origin)	B	NS(=O)(=O)c1cc(Nc2cc(Oc3cn(C4CC4)nc3C3CCOCC3)ccn2)ccc1F		CHEMBL4646566	=	IC50	nM	28.0	CHEMBL4439	Homo sapiens	IC50	nM	28.0
	20690464	CHEMBL4625364	Inhibition of ALK5 (unknown origin) expressed in mouse NIH/3T3 cells by cell-based luciferase assay	B	CC(C)(O)Cn1cc(Nc2cc(Oc3cn(C4CC4)nc3C3CCOCC3)ccn2)cn1		CHEMBL4640043	=	IC50	nM	215.2	CHEMBL4439	Homo sapiens	IC50	nM	215.2
	20690465	CHEMBL4625364	Inhibition of ALK5 (unknown origin) expressed in mouse NIH/3T3 cells by cell-based luciferase assay	B	c1cc(Oc2cn(C3CC3)nc2C2CCOCC2)cc(Nc2cnn(C3CCOCC3)c2)n1		CHEMBL4648725	=	IC50	nM	128.3	CHEMBL4439	Homo sapiens	IC50	nM	128.3
	20690466	CHEMBL4625364	Inhibition of ALK5 (unknown origin) expressed in mouse NIH/3T3 cells by cell-based luciferase assay	B	CC1(Cn2cc(Nc3cc(Oc4cn(C5CC5)nc4C4CCOCC4)ccn3)cn2)COC1		CHEMBL4637443	=	IC50	nM	338.0	CHEMBL4439	Homo sapiens	IC50	nM	338.0
	20690467	CHEMBL4625364	Inhibition of ALK5 (unknown origin) expressed in mouse NIH/3T3 cells by cell-based luciferase assay	B	CC(C)N1CCN(c2cc(Nc3cc(Oc4cn(C5CC5)nc4C4CCOCC4)ccn3)ccn2)CC1		CHEMBL4633398	=	IC50	nM	54.9	CHEMBL4439	Homo sapiens	IC50	nM	54.9
	20690468	CHEMBL4625364	Inhibition of ALK5 (unknown origin) expressed in mouse NIH/3T3 cells by cell-based luciferase assay	B	c1cc(Oc2cn(C3CC3)nc2C2CCOCC2)cc(Nc2ccnc(NC3CCOCC3)c2)n1		CHEMBL4647548	=	IC50	nM	133.4	CHEMBL4439	Homo sapiens	IC50	nM	133.4
Not Determined	20690469	CHEMBL4625364	Inhibition of ALK5 (unknown origin) expressed in mouse NIH/3T3 cells by cell-based luciferase assay	B	O=C(O)C1CN(c2cc(Nc3cc(Oc4cn(C5CC5)nc4C4CCOCC4)ccn3)ccn2)C1		CHEMBL4635885		IC50			CHEMBL4439	Homo sapiens	IC50		
Not Determined	20690470	CHEMBL4625364	Inhibition of ALK5 (unknown origin) expressed in mouse NIH/3T3 cells by cell-based luciferase assay	B	CC(C)(O)C(=O)N1CCC(Nc2cc(Oc3cn(C4CC4)nc3C3CCOCC3)ccn2)CC1		CHEMBL4632394		IC50			CHEMBL4439	Homo sapiens	IC50		
Not Determined	20690471	CHEMBL4625364	Inhibition of ALK5 (unknown origin) expressed in mouse NIH/3T3 cells by cell-based luciferase assay	B	CC(C)(C(=O)O)N1CCC(Nc2cc(Oc3cn(C4CC4)nc3C3CCOCC3)ccn2)CC1		CHEMBL4636813		IC50			CHEMBL4439	Homo sapiens	IC50		
Not Determined	20690472	CHEMBL4625364	Inhibition of ALK5 (unknown origin) expressed in mouse NIH/3T3 cells by cell-based luciferase assay	B	N#Cc1ccc(Nc2cc(Oc3cn(C4CC4)nc3C3CCOCC3)ccn2)cc1N1CC(O)C1		CHEMBL4635820		IC50			CHEMBL4439	Homo sapiens	IC50		
	20690473	CHEMBL4625364	Inhibition of ALK5 (unknown origin) expressed in mouse NIH/3T3 cells by cell-based luciferase assay	B	CC1(O)CN(c2cc(Nc3cc(Oc4cn(C5CC5)nc4C4CCOCC4)ccn3)ccc2C#N)C1		CHEMBL4641072	=	IC50	nM	85.9	CHEMBL4439	Homo sapiens	IC50	nM	85.9
Not Determined	20690474	CHEMBL4625364	Inhibition of ALK5 (unknown origin) expressed in mouse NIH/3T3 cells by cell-based luciferase assay	B	CC1(O)CN(C(=O)c2cc(Nc3cc(Oc4cn(C5CC5)nc4C4CCOCC4)ccn3)ccc2C#N)C1		CHEMBL4645653		IC50			CHEMBL4439	Homo sapiens	IC50		
Not Determined	20690475	CHEMBL4625364	Inhibition of ALK5 (unknown origin) expressed in mouse NIH/3T3 cells by cell-based luciferase assay	B	CC1(O)CN(C(=O)c2cc(Nc3cc(Oc4cn(C5CC5)nc4C4CCOCC4)ccn3)ccc2F)C1		CHEMBL4634207		IC50			CHEMBL4439	Homo sapiens	IC50		
Not Determined	20690476	CHEMBL4625364	Inhibition of ALK5 (unknown origin) expressed in mouse NIH/3T3 cells by cell-based luciferase assay	B	O=C(c1cc(Nc2cc(Oc3cn(C4CC4)nc3C3CCOCC3)ccn2)ccc1F)N1CCOCC1		CHEMBL4635214		IC50			CHEMBL4439	Homo sapiens	IC50		
	20690477	CHEMBL4625364	Inhibition of ALK5 (unknown origin) expressed in mouse NIH/3T3 cells by cell-based luciferase assay	B	NS(=O)(=O)c1cccc(Nc2cc(Oc3cn(C4CC4)nc3C3CCOCC3)ccn2)c1		CHEMBL4644348	=	IC50	nM	167.7	CHEMBL4439	Homo sapiens	IC50	nM	167.7
	20690478	CHEMBL4625364	Inhibition of ALK5 (unknown origin) expressed in mouse NIH/3T3 cells by cell-based luciferase assay	B	CNS(=O)(=O)c1cccc(Nc2cc(Oc3cn(C4CC4)nc3C3CCOCC3)ccn2)c1		CHEMBL4637746	=	IC50	nM	92.7	CHEMBL4439	Homo sapiens	IC50	nM	92.7
Not Determined	20690479	CHEMBL4625364	Inhibition of ALK5 (unknown origin) expressed in mouse NIH/3T3 cells by cell-based luciferase assay	B	CCNS(=O)(=O)c1cccc(Nc2cc(Oc3cn(C4CC4)nc3C3CCOCC3)ccn2)c1		CHEMBL4649726		IC50			CHEMBL4439	Homo sapiens	IC50		
	20690480	CHEMBL4625364	Inhibition of ALK5 (unknown origin) expressed in mouse NIH/3T3 cells by cell-based luciferase assay	B	Cc1ccc(Nc2cc(Oc3cn(C4CC4)nc3C3CCOCC3)ccn2)cc1S(N)(=O)=O		CHEMBL4646258	=	IC50	nM	69.5	CHEMBL4439	Homo sapiens	IC50	nM	69.5
	20690481	CHEMBL4625364	Inhibition of ALK5 (unknown origin) expressed in mouse NIH/3T3 cells by cell-based luciferase assay	B	NS(=O)(=O)c1cc(Nc2cc(Oc3cn(C4CC4)nc3C3CCOCC3)ccn2)ccc1F		CHEMBL4646566	=	IC50	nM	126.4	CHEMBL4439	Homo sapiens	IC50	nM	126.4
	20693925	CHEMBL4626180	Inhibition of human ALK5 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	A	CCc1c(-c2ccc(N3CCNCC3)cc2)cncc1-c1cc(OC)c(OC)c(OC)c1		CHEMBL4641897	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	20693926	CHEMBL4626180	Inhibition of human ALK5 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	A	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C2CC2)cc(OC)c1OC		CHEMBL4646409	=	IC50	nM	4658.0	CHEMBL4439	Homo sapiens	IC50	nM	4658.0
	20693927	CHEMBL4626180	Inhibition of human ALK5 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	A	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2OC)cc(OC)c1OC		CHEMBL4633535	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	20693928	CHEMBL4626180	Inhibition of human ALK5 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	A	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2N)cc(OC)c1OC		CHEMBL4635667	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	20693929	CHEMBL4626180	Inhibition of human ALK5 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	A	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2F)cc(OC)c1OC		CHEMBL4633121	=	IC50	nM	880.0	CHEMBL4439	Homo sapiens	IC50	nM	880.0
	20693930	CHEMBL4626180	Inhibition of human ALK5 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	A	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2Cl)cc(OC)c1OC		CHEMBL4642165	=	IC50	nM	1330.0	CHEMBL4439	Homo sapiens	IC50	nM	1330.0
	20693931	CHEMBL4626180	Inhibition of human ALK5 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	A	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C(F)(F)F)cc(OC)c1OC		CHEMBL4635902	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	20693932	CHEMBL4626180	Inhibition of human ALK5 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	A	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C#N)cc(OC)c1OC		CHEMBL4638273	=	IC50	nM	731.0	CHEMBL4439	Homo sapiens	IC50	nM	731.0
	20693933	CHEMBL4626180	Inhibition of human ALK5 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	A	COc1cc(OC)cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)c1		CHEMBL4637817	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	20693934	CHEMBL4626180	Inhibition of human ALK5 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	A	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(OC)c1F		CHEMBL4636120	=	IC50	nM	2206.0	CHEMBL4439	Homo sapiens	IC50	nM	2206.0
	20693935	CHEMBL4626180	Inhibition of human ALK5 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	A	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C#N)cc(OC)c1F		CHEMBL4646278	=	IC50	nM	487.0	CHEMBL4439	Homo sapiens	IC50	nM	487.0
	20693936	CHEMBL4626180	Inhibition of human ALK5 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	A	COc1cc(-c2cncc(-c3ccc(N4CCN(C)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4643265	=	IC50	nM	4847.0	CHEMBL4439	Homo sapiens	IC50	nM	4847.0
	20693937	CHEMBL4626180	Inhibition of human ALK5 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	A	COc1cc(-c2cncc(-c3ccc(N4CCN(C(C)C)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4644571	=	IC50	nM	2236.0	CHEMBL4439	Homo sapiens	IC50	nM	2236.0
	20693938	CHEMBL4626180	Inhibition of human ALK5 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	A	COc1cc(-c2cncc(-c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)c2C)cc(OC)c1OC		CHEMBL4634857	=	IC50	nM	1050.0	CHEMBL4439	Homo sapiens	IC50	nM	1050.0
	20693939	CHEMBL4626180	Inhibition of human ALK5 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	A	COc1cc(-c2cncc(-c3ccc(N4CCN(CCF)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4647991	=	IC50	nM	3215.0	CHEMBL4439	Homo sapiens	IC50	nM	3215.0
	20693940	CHEMBL4626180	Inhibition of human ALK5 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	A	COc1cc(-c2cncc(-c3ccc(N4CCN(C(C)=O)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4648707	=	IC50	nM	2524.0	CHEMBL4439	Homo sapiens	IC50	nM	2524.0
	20693941	CHEMBL4626180	Inhibition of human ALK5 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	A	COc1cc(-c2cncc(-c3ccc(N4CCN(C(=O)N(C)C)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4641207	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	20693942	CHEMBL4626180	Inhibition of human ALK5 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	A	COc1cc(-c2cncc(-c3ccc(N4CCN(S(C)(=O)=O)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4638544	=	IC50	nM	1983.0	CHEMBL4439	Homo sapiens	IC50	nM	1983.0
	20693943	CHEMBL4626180	Inhibition of human ALK5 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	A	COc1cc(-c2cncc(-c3ccc(N4CCOCC4)cc3)c2C)cc(OC)c1OC		CHEMBL4642622	=	IC50	nM	2356.0	CHEMBL4439	Homo sapiens	IC50	nM	2356.0
	20693944	CHEMBL4626180	Inhibition of human ALK5 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	A	COc1cc(-c2cncc(-c3ccc(N4CCS(=O)(=O)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4648735	=	IC50	nM	1229.0	CHEMBL4439	Homo sapiens	IC50	nM	1229.0
	20693945	CHEMBL4626180	Inhibition of human ALK5 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	A	COc1cc(-c2cncc(-c3ccc(C4CCNCC4)cc3)c2C)cc(OC)c1OC		CHEMBL4635321	=	IC50	nM	1745.0	CHEMBL4439	Homo sapiens	IC50	nM	1745.0
	20693946	CHEMBL4626180	Inhibition of human ALK5 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	A	COc1cc(-c2cncc(-c3ccc(C4CCN(C)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4633241	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	20693947	CHEMBL4626180	Inhibition of human ALK5 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	A	COc1cc(-c2cncc(-c3ccc(C4=CCNCC4)cc3)c2C)cc(OC)c1OC		CHEMBL4641530	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	20693948	CHEMBL4626180	Inhibition of human ALK5 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	A	COc1cc(-c2cncc(-c3ccc(C4=CCN(C)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4646444	=	IC50	nM	2520.0	CHEMBL4439	Homo sapiens	IC50	nM	2520.0
	20693949	CHEMBL4626180	Inhibition of human ALK5 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	A	COc1cc(-c2cncc(-c3ccc(N4CCCNCC4)cc3)c2C)cc(OC)c1OC		CHEMBL4639700	=	IC50	nM	3050.0	CHEMBL4439	Homo sapiens	IC50	nM	3050.0
	20693950	CHEMBL4626180	Inhibition of human ALK5 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	A	COc1cc(-c2cncc(-c3ccc(CN4CCN(C)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4638893	=	IC50	nM	2643.0	CHEMBL4439	Homo sapiens	IC50	nM	2643.0
	20693951	CHEMBL4626180	Inhibition of human ALK5 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	A	COc1cc(-c2cncc(-c3ccc(OC4CCNCC4)cc3)c2C)cc(OC)c1OC		CHEMBL4648102	=	IC50	nM	2854.0	CHEMBL4439	Homo sapiens	IC50	nM	2854.0
	20693952	CHEMBL4626180	Inhibition of human ALK5 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	A	COc1cc(-c2cncc(-c3ccc(OC4CCN(C)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4647724	=	IC50	nM	1650.0	CHEMBL4439	Homo sapiens	IC50	nM	1650.0
	20694011	CHEMBL4626182	Inhibition of recombinant human ALK5 expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter after 24 hrs by dual luciferase reporter assay	A	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(OC)c1OC		CHEMBL4517408	=	IC50	nM	2712.0	CHEMBL4439	Homo sapiens	IC50	nM	2712.0
	20694012	CHEMBL4626182	Inhibition of recombinant human ALK5 expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter after 24 hrs by dual luciferase reporter assay	A	CCc1c(-c2ccc(N3CCNCC3)cc2)cncc1-c1cc(OC)c(OC)c(OC)c1		CHEMBL4641897	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	20694013	CHEMBL4626182	Inhibition of recombinant human ALK5 expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter after 24 hrs by dual luciferase reporter assay	A	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C2CC2)cc(OC)c1OC		CHEMBL4646409	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	20694014	CHEMBL4626182	Inhibition of recombinant human ALK5 expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter after 24 hrs by dual luciferase reporter assay	A	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2OC)cc(OC)c1OC		CHEMBL4633535	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	20694015	CHEMBL4626182	Inhibition of recombinant human ALK5 expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter after 24 hrs by dual luciferase reporter assay	A	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2N)cc(OC)c1OC		CHEMBL4635667	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	20694016	CHEMBL4626182	Inhibition of recombinant human ALK5 expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter after 24 hrs by dual luciferase reporter assay	A	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2F)cc(OC)c1OC		CHEMBL4633121	=	IC50	nM	2183.0	CHEMBL4439	Homo sapiens	IC50	nM	2183.0
	20694017	CHEMBL4626182	Inhibition of recombinant human ALK5 expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter after 24 hrs by dual luciferase reporter assay	A	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2Cl)cc(OC)c1OC		CHEMBL4642165	=	IC50	nM	9454.0	CHEMBL4439	Homo sapiens	IC50	nM	9454.0
	20694018	CHEMBL4626182	Inhibition of recombinant human ALK5 expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter after 24 hrs by dual luciferase reporter assay	A	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C(F)(F)F)cc(OC)c1OC		CHEMBL4635902	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	20694019	CHEMBL4626182	Inhibition of recombinant human ALK5 expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter after 24 hrs by dual luciferase reporter assay	A	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C#N)cc(OC)c1OC		CHEMBL4638273	=	IC50	nM	679.0	CHEMBL4439	Homo sapiens	IC50	nM	679.0
	20694020	CHEMBL4626182	Inhibition of recombinant human ALK5 expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter after 24 hrs by dual luciferase reporter assay	A	COc1cc(OC)cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)c1		CHEMBL4637817	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	20694021	CHEMBL4626182	Inhibition of recombinant human ALK5 expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter after 24 hrs by dual luciferase reporter assay	A	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(OC)c1F		CHEMBL4636120	=	IC50	nM	7475.0	CHEMBL4439	Homo sapiens	IC50	nM	7475.0
	20694022	CHEMBL4626182	Inhibition of recombinant human ALK5 expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter after 24 hrs by dual luciferase reporter assay	A	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C#N)cc(OC)c1F		CHEMBL4646278	=	IC50	nM	1511.0	CHEMBL4439	Homo sapiens	IC50	nM	1511.0
	20694023	CHEMBL4626182	Inhibition of recombinant human ALK5 expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter after 24 hrs by dual luciferase reporter assay	A	COc1cc(-c2cncc(-c3ccc(N4CCN(C)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4643265	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	20694024	CHEMBL4626182	Inhibition of recombinant human ALK5 expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter after 24 hrs by dual luciferase reporter assay	A	COc1cc(-c2cncc(-c3ccc(N4CCN(C(C)C)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4644571	=	IC50	nM	1824.0	CHEMBL4439	Homo sapiens	IC50	nM	1824.0
	20694025	CHEMBL4626182	Inhibition of recombinant human ALK5 expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter after 24 hrs by dual luciferase reporter assay	A	COc1cc(-c2cncc(-c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)c2C)cc(OC)c1OC		CHEMBL4634857	=	IC50	nM	1427.0	CHEMBL4439	Homo sapiens	IC50	nM	1427.0
	20694026	CHEMBL4626182	Inhibition of recombinant human ALK5 expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter after 24 hrs by dual luciferase reporter assay	A	COc1cc(-c2cncc(-c3ccc(N4CCN(CCF)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4647991	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	20694027	CHEMBL4626182	Inhibition of recombinant human ALK5 expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter after 24 hrs by dual luciferase reporter assay	A	COc1cc(-c2cncc(-c3ccc(N4CCN(C(C)=O)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4648707	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	20694028	CHEMBL4626182	Inhibition of recombinant human ALK5 expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter after 24 hrs by dual luciferase reporter assay	A	COc1cc(-c2cncc(-c3ccc(N4CCN(C(=O)N(C)C)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4641207	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	20694029	CHEMBL4626182	Inhibition of recombinant human ALK5 expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter after 24 hrs by dual luciferase reporter assay	A	COc1cc(-c2cncc(-c3ccc(N4CCN(S(C)(=O)=O)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4638544	=	IC50	nM	6392.0	CHEMBL4439	Homo sapiens	IC50	nM	6392.0
	20694030	CHEMBL4626182	Inhibition of recombinant human ALK5 expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter after 24 hrs by dual luciferase reporter assay	A	COc1cc(-c2cncc(-c3ccc(N4CCOCC4)cc3)c2C)cc(OC)c1OC		CHEMBL4642622	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	20694031	CHEMBL4626182	Inhibition of recombinant human ALK5 expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter after 24 hrs by dual luciferase reporter assay	A	COc1cc(-c2cncc(-c3ccc(N4CCS(=O)(=O)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4648735	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	20694032	CHEMBL4626182	Inhibition of recombinant human ALK5 expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter after 24 hrs by dual luciferase reporter assay	A	COc1cc(-c2cncc(-c3ccc(C4CCNCC4)cc3)c2C)cc(OC)c1OC		CHEMBL4635321	=	IC50	nM	3421.0	CHEMBL4439	Homo sapiens	IC50	nM	3421.0
	20694033	CHEMBL4626182	Inhibition of recombinant human ALK5 expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter after 24 hrs by dual luciferase reporter assay	A	COc1cc(-c2cncc(-c3ccc(C4CCN(C)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4633241	=	IC50	nM	3326.0	CHEMBL4439	Homo sapiens	IC50	nM	3326.0
	20694034	CHEMBL4626182	Inhibition of recombinant human ALK5 expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter after 24 hrs by dual luciferase reporter assay	A	COc1cc(-c2cncc(-c3ccc(C4=CCNCC4)cc3)c2C)cc(OC)c1OC		CHEMBL4641530	=	IC50	nM	7532.0	CHEMBL4439	Homo sapiens	IC50	nM	7532.0
	20694035	CHEMBL4626182	Inhibition of recombinant human ALK5 expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter after 24 hrs by dual luciferase reporter assay	A	COc1cc(-c2cncc(-c3ccc(C4=CCN(C)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4646444	=	IC50	nM	7803.0	CHEMBL4439	Homo sapiens	IC50	nM	7803.0
	20694036	CHEMBL4626182	Inhibition of recombinant human ALK5 expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter after 24 hrs by dual luciferase reporter assay	A	COc1cc(-c2cncc(-c3ccc(N4CCCNCC4)cc3)c2C)cc(OC)c1OC		CHEMBL4639700	=	IC50	nM	4531.0	CHEMBL4439	Homo sapiens	IC50	nM	4531.0
	20694037	CHEMBL4626182	Inhibition of recombinant human ALK5 expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter after 24 hrs by dual luciferase reporter assay	A	COc1cc(-c2cncc(-c3ccc(CN4CCN(C)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4638893	>	IC50	nM	5000.0	CHEMBL4439	Homo sapiens	IC50	nM	5000.0
	20694038	CHEMBL4626182	Inhibition of recombinant human ALK5 expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter after 24 hrs by dual luciferase reporter assay	A	COc1cc(-c2cncc(-c3ccc(OC4CCNCC4)cc3)c2C)cc(OC)c1OC		CHEMBL4648102	=	IC50	nM	1908.0	CHEMBL4439	Homo sapiens	IC50	nM	1908.0
	20694039	CHEMBL4626182	Inhibition of recombinant human ALK5 expressed in HEK293 cells transfected with CAGA-luciferase and Renilla luciferase reporter after 24 hrs by dual luciferase reporter assay	A	COc1cc(-c2cncc(-c3ccc(OC4CCN(C)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4647724	=	IC50	nM	2094.0	CHEMBL4439	Homo sapiens	IC50	nM	2094.0
	20694300	CHEMBL4626180	Inhibition of human ALK5 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	A	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(OC)c1OC		CHEMBL4517408	=	IC50	nM	2427.0	CHEMBL4439	Homo sapiens	IC50	nM	2427.0
	22392178	CHEMBL4667273	Inhibition of tracer 178 binding to recombinant human N-terminal GST-tagged TGFBR1 (200 to 503 residues) expressed in baculovirus expression system at 10 uM incubated for 60 mins by Lanthascreen assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	-4.5	CHEMBL4439	Homo sapiens	INH	%	-4.5
	22423833	CHEMBL4674492	Inhibition of human ALK5 using casein as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	99.67	CHEMBL4439	Homo sapiens	Activity	%	99.67
	22423834	CHEMBL4674492	Inhibition of human ALK5 using casein as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	92.62	CHEMBL4439	Homo sapiens	Activity	%	92.62
	22816682	CHEMBL4714986	Inhibition of ALK5 (unknown origin) using biotin-labelled KKKVLTQMGSPSIRCSpSVS substrate in presence of [gamma33P] ATP measured after 40 min	B	c1cc2cc(c1)-c1cnn3ccc(nc13)NCCOCCO2		CHEMBL4783244	=	IC50	nM	4400.0	CHEMBL4439	Homo sapiens	IC50	uM	4.4
	22816683	CHEMBL4714986	Inhibition of ALK5 (unknown origin) using biotin-labelled KKKVLTQMGSPSIRCSpSVS substrate in presence of [gamma33P] ATP measured after 40 min	B	O=C(Nc1ccccc1)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL4752410	=	IC50	nM	18.0	CHEMBL4439	Homo sapiens	IC50	uM	0.018000000000000002
	22816684	CHEMBL4714986	Inhibition of ALK5 (unknown origin) using biotin-labelled KKKVLTQMGSPSIRCSpSVS substrate in presence of [gamma33P] ATP measured after 40 min	B	CNc1ccn2ncc(-c3ccnc(OC)c3)c2n1		CHEMBL4795223	=	IC50	nM	4100.0	CHEMBL4439	Homo sapiens	IC50	uM	4.1
	22816685	CHEMBL4714986	Inhibition of ALK5 (unknown origin) using biotin-labelled KKKVLTQMGSPSIRCSpSVS substrate in presence of [gamma33P] ATP measured after 40 min	B	CNc1nc2c(-c3ccnc(OC)c3)cnn2cc1C		CHEMBL4779579	=	IC50	nM	2000.0	CHEMBL4439	Homo sapiens	IC50	uM	2.0
	22816686	CHEMBL4714986	Inhibition of ALK5 (unknown origin) using biotin-labelled KKKVLTQMGSPSIRCSpSVS substrate in presence of [gamma33P] ATP measured after 40 min	B	C=Cc1cn2ncc(-c3ccnc(OC)c3)c2nc1NC		CHEMBL4741913	=	IC50	nM	1400.0	CHEMBL4439	Homo sapiens	IC50	uM	1.4
	22816687	CHEMBL4714986	Inhibition of ALK5 (unknown origin) using biotin-labelled KKKVLTQMGSPSIRCSpSVS substrate in presence of [gamma33P] ATP measured after 40 min	B	CCc1cn2ncc(-c3ccnc(OC)c3)c2nc1NC		CHEMBL4741185	=	IC50	nM	1900.0	CHEMBL4439	Homo sapiens	IC50	uM	1.9
	22816688	CHEMBL4714986	Inhibition of ALK5 (unknown origin) using biotin-labelled KKKVLTQMGSPSIRCSpSVS substrate in presence of [gamma33P] ATP measured after 40 min	B	CNc1nc2c(-c3ccnc(OC)c3)cnn2cc1C1CC1		CHEMBL4744988	=	IC50	nM	8900.0	CHEMBL4439	Homo sapiens	IC50	uM	8.9
	22816689	CHEMBL4714986	Inhibition of ALK5 (unknown origin) using biotin-labelled KKKVLTQMGSPSIRCSpSVS substrate in presence of [gamma33P] ATP measured after 40 min	B	CNc1nc2c(-c3ccnc(OC)c3)cnn2cc1OC		CHEMBL4752199	=	IC50	nM	710.0	CHEMBL4439	Homo sapiens	IC50	uM	0.71
	22844319	CHEMBL4721182	Inhibition of human ALK5 assessed as residual activity using casein as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	107.97	CHEMBL4439	Homo sapiens	Activity	%	107.97
	22844619	CHEMBL4721294	Inhibition of wild-type human partial length TGFBR1 (D179 to M503 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	96.63	CHEMBL4439	Homo sapiens	Activity	%	96.63
	22884275	CHEMBL4727757	Inhibition of human ALK5 using casein as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(N5CCNCC5)cc4)ccn23)c2ccccc2n1		CHEMBL4740381	=	IC50	nM	1260.0	CHEMBL4439	Homo sapiens	IC50	nM	1260.0
	22884276	CHEMBL4727757	Inhibition of human ALK5 using casein as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(N5CCNCC5)cc4)ccn23)c2cc(F)ccc2n1		CHEMBL4788859	=	IC50	nM	1267.0	CHEMBL4439	Homo sapiens	IC50	nM	1267.0
	22884277	CHEMBL4727757	Inhibition of human ALK5 using casein as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(N5CCNCC5)cc4)ccn23)c2cc(F)cc(F)c2n1		CHEMBL4786529	=	IC50	nM	1285.0	CHEMBL4439	Homo sapiens	IC50	nM	1285.0
	22884278	CHEMBL4727757	Inhibition of human ALK5 using casein as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(C5CNCCN5)cc4)ccn23)c2ccccc2n1		CHEMBL4742906	=	IC50	nM	310.0	CHEMBL4439	Homo sapiens	IC50	nM	310.0
	22884279	CHEMBL4727757	Inhibition of human ALK5 using casein as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(C5CNCCN5)cc4)ccn23)c2cc(F)cc(F)c2n1		CHEMBL4778971	=	IC50	nM	717.0	CHEMBL4439	Homo sapiens	IC50	nM	717.0
	22886505	CHEMBL4728242	Binding affinity to TGFBR1 (unknown origin) assessed as change in melting temperature at 10 uM incubated for 10 mins using SYPRO orange dye by RT-PCR-based fluorescence assay	B	CC(=O)c1cccc(-c2cnc3ccc(NCC4CC4)nn23)c1		CHEMBL200528	>	Delta Tm	degrees C	6.0	CHEMBL4439	Homo sapiens	deltaTm	degrees C	6.0
Not Active	22889564	CHEMBL4729083	Inhibition of wild-type human partial length TGFBR1 (D179 to M503 residues) expressed in bacterial expression system at 1 uM by Kinomescan method	B	COc1cc(OCc2ccnc(Nc3cnn(C)c3)n2)cc2sc(N[C@H]3CCCC[C@@H]3O)nc12		CHEMBL4748740		Inhibition	%		CHEMBL4439	Homo sapiens	INH		
	22934011	CHEMBL4739181	Potency index, ratio of EW-7197 IC50 to test compound IC50 for recombinant human GST-fused ALK5 expressed in baculovirus infected Sf9 cells assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1cccc(-c2[nH]c(CNc3ccccc3)nc2-c2ccc3[nH]ncc3c2)n1		CHEMBL4748823	=	Ratio IC50		3.5	CHEMBL4439	Homo sapiens	Ratio IC50		3.5
	22934012	CHEMBL4739181	Potency index, ratio of EW-7197 IC50 to test compound IC50 for recombinant human GST-fused ALK5 expressed in baculovirus infected Sf9 cells assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1cccc(-c2[nH]c(CNc3cccc(F)c3)nc2-c2ccc3[nH]ncc3c2)n1		CHEMBL4778963	=	Ratio IC50		3.5	CHEMBL4439	Homo sapiens	Ratio IC50		3.5
	22934029	CHEMBL4739183	Inhibition of recombinant human GST-fused ALK5 expressed in baculovirus infected Sf9 cells assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1cccc(-c2[nH]c(CNc3ccccc3)nc2-c2ccc3[nH]ncc3c2)n1		CHEMBL4748823	=	IC50	nM	4.0	CHEMBL4439	Homo sapiens	IC50	uM	0.004
	22934030	CHEMBL4739183	Inhibition of recombinant human GST-fused ALK5 expressed in baculovirus infected Sf9 cells assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3[nH]ncc3c2)n1		CHEMBL4779584	=	IC50	nM	5.0	CHEMBL4439	Homo sapiens	IC50	uM	0.005
	22934031	CHEMBL4739183	Inhibition of recombinant human GST-fused ALK5 expressed in baculovirus infected Sf9 cells assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1cccc(-c2[nH]c(CNc3cccc(F)c3)nc2-c2ccc3[nH]ncc3c2)n1		CHEMBL4778963	=	IC50	nM	4.0	CHEMBL4439	Homo sapiens	IC50	uM	0.004
	22934032	CHEMBL4739183	Inhibition of recombinant human GST-fused ALK5 expressed in baculovirus infected Sf9 cells assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1cccc(-c2[nH]c(CNc3ccc(F)cc3)nc2-c2ccc3[nH]ncc3c2)n1		CHEMBL4780141	=	IC50	nM	6.0	CHEMBL4439	Homo sapiens	IC50	uM	0.006
	22934033	CHEMBL4739183	Inhibition of recombinant human GST-fused ALK5 expressed in baculovirus infected Sf9 cells assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1cccc(-c2[nH]c(CNc3ccccc3C)nc2-c2ccc3[nH]ncc3c2)n1		CHEMBL4747557	=	IC50	nM	5.0	CHEMBL4439	Homo sapiens	IC50	uM	0.005
	22934034	CHEMBL4739183	Inhibition of recombinant human GST-fused ALK5 expressed in baculovirus infected Sf9 cells assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1cccc(NCc2nc(-c3ccc4[nH]ncc4c3)c(-c3cccc(C)n3)[nH]2)c1		CHEMBL4759911	=	IC50	nM	8.0	CHEMBL4439	Homo sapiens	IC50	uM	0.008
	22934035	CHEMBL4739183	Inhibition of recombinant human GST-fused ALK5 expressed in baculovirus infected Sf9 cells assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1ccc(NCc2nc(-c3ccc4[nH]ncc4c3)c(-c3cccc(C)n3)[nH]2)cc1		CHEMBL4798879	=	IC50	nM	9.0	CHEMBL4439	Homo sapiens	IC50	uM	0.009000000000000001
	22934036	CHEMBL4739183	Inhibition of recombinant human GST-fused ALK5 expressed in baculovirus infected Sf9 cells assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1cccc(-c2[nH]c(CNc3ccccc3)nc2-c2ccc3c(cnn3C)c2)n1		CHEMBL4756404	=	IC50	nM	14.0	CHEMBL4439	Homo sapiens	IC50	uM	0.013999999999999999
	22934037	CHEMBL4739183	Inhibition of recombinant human GST-fused ALK5 expressed in baculovirus infected Sf9 cells assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3c(cnn3C)c2)n1		CHEMBL4752915	=	IC50	nM	13.0	CHEMBL4439	Homo sapiens	IC50	uM	0.013000000000000001
	22934038	CHEMBL4739183	Inhibition of recombinant human GST-fused ALK5 expressed in baculovirus infected Sf9 cells assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1cccc(-c2[nH]c(CNc3cccc(F)c3)nc2-c2ccc3c(cnn3C)c2)n1		CHEMBL4794179	=	IC50	nM	11.0	CHEMBL4439	Homo sapiens	IC50	uM	0.011000000000000001
	22934039	CHEMBL4739183	Inhibition of recombinant human GST-fused ALK5 expressed in baculovirus infected Sf9 cells assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1cccc(-c2[nH]c(CNc3ccc(F)cc3)nc2-c2ccc3c(cnn3C)c2)n1		CHEMBL4784124	=	IC50	nM	16.0	CHEMBL4439	Homo sapiens	IC50	uM	0.016
	22934040	CHEMBL4739183	Inhibition of recombinant human GST-fused ALK5 expressed in baculovirus infected Sf9 cells assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1cccc(-c2[nH]c(CNc3ccccc3C)nc2-c2ccc3c(cnn3C)c2)n1		CHEMBL4780013	=	IC50	nM	24.0	CHEMBL4439	Homo sapiens	IC50	uM	0.024
	22934041	CHEMBL4739183	Inhibition of recombinant human GST-fused ALK5 expressed in baculovirus infected Sf9 cells assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1cccc(NCc2nc(-c3ccc4c(cnn4C)c3)c(-c3cccc(C)n3)[nH]2)c1		CHEMBL4788508	=	IC50	nM	10.0	CHEMBL4439	Homo sapiens	IC50	uM	0.01
	22934042	CHEMBL4739183	Inhibition of recombinant human GST-fused ALK5 expressed in baculovirus infected Sf9 cells assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1ccc(NCc2nc(-c3ccc4c(cnn4C)c3)c(-c3cccc(C)n3)[nH]2)cc1		CHEMBL4740767	=	IC50	nM	34.0	CHEMBL4439	Homo sapiens	IC50	uM	0.034
	22934043	CHEMBL4739183	Inhibition of recombinant human GST-fused ALK5 expressed in baculovirus infected Sf9 cells assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	=	IC50	nM	129.0	CHEMBL4439	Homo sapiens	IC50	uM	0.129
	22934044	CHEMBL4739183	Inhibition of recombinant human GST-fused ALK5 expressed in baculovirus infected Sf9 cells assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	IC50	nM	14.0	CHEMBL4439	Homo sapiens	IC50	uM	0.013999999999999999
	22934059	CHEMBL4739194	Potency index, ratio of LY-2157299 IC50 to test compound IC50 for recombinant human GST-fused ALK5 expressed in baculovirus infected Sf9 cells assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1cccc(-c2[nH]c(CNc3ccccc3)nc2-c2ccc3[nH]ncc3c2)n1		CHEMBL4748823	=	Ratio IC50		32.3	CHEMBL4439	Homo sapiens	Ratio IC50		32.3
	22934060	CHEMBL4739194	Potency index, ratio of LY-2157299 IC50 to test compound IC50 for recombinant human GST-fused ALK5 expressed in baculovirus infected Sf9 cells assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3[nH]ncc3c2)n1		CHEMBL4779584	=	Ratio IC50		3.8	CHEMBL4439	Homo sapiens	Ratio IC50		3.8
	22934061	CHEMBL4739194	Potency index, ratio of LY-2157299 IC50 to test compound IC50 for recombinant human GST-fused ALK5 expressed in baculovirus infected Sf9 cells assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1cccc(-c2[nH]c(CNc3cccc(F)c3)nc2-c2ccc3[nH]ncc3c2)n1		CHEMBL4778963	=	Ratio IC50		32.3	CHEMBL4439	Homo sapiens	Ratio IC50		32.3
	22934062	CHEMBL4739194	Potency index, ratio of LY-2157299 IC50 to test compound IC50 for recombinant human GST-fused ALK5 expressed in baculovirus infected Sf9 cells assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1cccc(-c2[nH]c(CNc3ccc(F)cc3)nc2-c2ccc3[nH]ncc3c2)n1		CHEMBL4780141	=	Ratio IC50		3.8	CHEMBL4439	Homo sapiens	Ratio IC50		3.8
	22934063	CHEMBL4739194	Potency index, ratio of LY-2157299 IC50 to test compound IC50 for recombinant human GST-fused ALK5 expressed in baculovirus infected Sf9 cells assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1cccc(-c2[nH]c(CNc3ccccc3C)nc2-c2ccc3[nH]ncc3c2)n1		CHEMBL4747557	=	Ratio IC50		3.8	CHEMBL4439	Homo sapiens	Ratio IC50		3.8
	22934064	CHEMBL4739194	Potency index, ratio of LY-2157299 IC50 to test compound IC50 for recombinant human GST-fused ALK5 expressed in baculovirus infected Sf9 cells assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1cccc(NCc2nc(-c3ccc4[nH]ncc4c3)c(-c3cccc(C)n3)[nH]2)c1		CHEMBL4759911	=	Ratio IC50		3.8	CHEMBL4439	Homo sapiens	Ratio IC50		3.8
	22934065	CHEMBL4739194	Potency index, ratio of LY-2157299 IC50 to test compound IC50 for recombinant human GST-fused ALK5 expressed in baculovirus infected Sf9 cells assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1ccc(NCc2nc(-c3ccc4[nH]ncc4c3)c(-c3cccc(C)n3)[nH]2)cc1		CHEMBL4798879	=	Ratio IC50		3.8	CHEMBL4439	Homo sapiens	Ratio IC50		3.8
	22934066	CHEMBL4739194	Potency index, ratio of LY-2157299 IC50 to test compound IC50 for recombinant human GST-fused ALK5 expressed in baculovirus infected Sf9 cells assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1cccc(-c2[nH]c(CNc3ccccc3)nc2-c2ccc3c(cnn3C)c2)n1		CHEMBL4756404	=	Ratio IC50		3.8	CHEMBL4439	Homo sapiens	Ratio IC50		3.8
	22934067	CHEMBL4739194	Potency index, ratio of LY-2157299 IC50 to test compound IC50 for recombinant human GST-fused ALK5 expressed in baculovirus infected Sf9 cells assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3c(cnn3C)c2)n1		CHEMBL4752915	=	Ratio IC50		3.8	CHEMBL4439	Homo sapiens	Ratio IC50		3.8
	22934068	CHEMBL4739194	Potency index, ratio of LY-2157299 IC50 to test compound IC50 for recombinant human GST-fused ALK5 expressed in baculovirus infected Sf9 cells assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1cccc(-c2[nH]c(CNc3cccc(F)c3)nc2-c2ccc3c(cnn3C)c2)n1		CHEMBL4794179	=	Ratio IC50		3.8	CHEMBL4439	Homo sapiens	Ratio IC50		3.8
	22934069	CHEMBL4739194	Potency index, ratio of LY-2157299 IC50 to test compound IC50 for recombinant human GST-fused ALK5 expressed in baculovirus infected Sf9 cells assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1cccc(-c2[nH]c(CNc3ccc(F)cc3)nc2-c2ccc3c(cnn3C)c2)n1		CHEMBL4784124	=	Ratio IC50		3.8	CHEMBL4439	Homo sapiens	Ratio IC50		3.8
	22934070	CHEMBL4739194	Potency index, ratio of LY-2157299 IC50 to test compound IC50 for recombinant human GST-fused ALK5 expressed in baculovirus infected Sf9 cells assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1cccc(-c2[nH]c(CNc3ccccc3C)nc2-c2ccc3c(cnn3C)c2)n1		CHEMBL4780013	=	Ratio IC50		3.8	CHEMBL4439	Homo sapiens	Ratio IC50		3.8
	22934071	CHEMBL4739194	Potency index, ratio of LY-2157299 IC50 to test compound IC50 for recombinant human GST-fused ALK5 expressed in baculovirus infected Sf9 cells assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1cccc(NCc2nc(-c3ccc4c(cnn4C)c3)c(-c3cccc(C)n3)[nH]2)c1		CHEMBL4788508	=	Ratio IC50		3.8	CHEMBL4439	Homo sapiens	Ratio IC50		3.8
	22934072	CHEMBL4739194	Potency index, ratio of LY-2157299 IC50 to test compound IC50 for recombinant human GST-fused ALK5 expressed in baculovirus infected Sf9 cells assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1ccc(NCc2nc(-c3ccc4c(cnn4C)c3)c(-c3cccc(C)n3)[nH]2)cc1		CHEMBL4740767	=	Ratio IC50		3.8	CHEMBL4439	Homo sapiens	Ratio IC50		3.8
	22944002	CHEMBL4742522	Inhibition of TGFBR1 (unknown origin) assessed as residual ligand binding level at 10000 nM relative to control	B	COCc1cc(C)nc2sc(C(N)=O)c(N)c12		CHEMBL4780986	=	Activity	%	95.0	CHEMBL4439	Homo sapiens	Activity	%	95.0
	22953016	CHEMBL4766953	Inhibition of recombinant human TGFBR1 (200 to end residues) assessed as residual activity at 10 uM using casein as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	109.0	CHEMBL4439	Homo sapiens	Activity	%	109.0
	22966787	CHEMBL4769705	Inhibition of ALK5 (unknown origin) measured after 120 mins of incubation by ADP-Glo kinase assay	B	CC(C)(O)c1cc(Nc2cc(Oc3cn(C4CC4)nc3-c3ccccc3)ccn2)ccn1		CHEMBL4777871	=	IC50	nM	26.2	CHEMBL4439	Homo sapiens	IC50	nM	26.2
	22966788	CHEMBL4769705	Inhibition of ALK5 (unknown origin) measured after 120 mins of incubation by ADP-Glo kinase assay	B	CC(C)(O)c1cc(Nc2cc(Oc3cn(C4CC4)nc3-c3ccc(F)cc3)ccn2)ccn1		CHEMBL4792452	=	IC50	nM	19.7	CHEMBL4439	Homo sapiens	IC50	nM	19.7
	22966789	CHEMBL4769705	Inhibition of ALK5 (unknown origin) measured after 120 mins of incubation by ADP-Glo kinase assay	B	CC(C)(O)c1cc(Nc2cc(Oc3cn(C4CC4)nc3-c3ccc(C#N)cc3)ccn2)ccn1		CHEMBL4790322	=	IC50	nM	31.4	CHEMBL4439	Homo sapiens	IC50	nM	31.4
	22966790	CHEMBL4769705	Inhibition of ALK5 (unknown origin) measured after 120 mins of incubation by ADP-Glo kinase assay	B	CC(C)(O)c1cc(Nc2cc(Oc3cn(C4CC4)nc3-c3ccc(C(N)=O)cc3)ccn2)ccn1		CHEMBL4781452	=	IC50	nM	282.0	CHEMBL4439	Homo sapiens	IC50	nM	282.0
	22966791	CHEMBL4769705	Inhibition of ALK5 (unknown origin) measured after 120 mins of incubation by ADP-Glo kinase assay	B	CC(C)(O)c1cc(Nc2cc(Oc3cn(C4CC4)nc3-c3ccc(C(=O)O)cc3)ccn2)ccn1		CHEMBL4794175	=	IC50	nM	814.0	CHEMBL4439	Homo sapiens	IC50	nM	814.0
	22966792	CHEMBL4769705	Inhibition of ALK5 (unknown origin) measured after 120 mins of incubation by ADP-Glo kinase assay	B	CC(C)(O)c1cc(Nc2cc(Oc3cn(C4CC4)nc3-c3ccc4c(c3)OCO4)ccn2)ccn1		CHEMBL4784194	=	IC50	nM	21.7	CHEMBL4439	Homo sapiens	IC50	nM	21.7
	22966793	CHEMBL4769705	Inhibition of ALK5 (unknown origin) measured after 120 mins of incubation by ADP-Glo kinase assay	B	CC(C)(O)c1cc(Nc2cc(Oc3cn(C4CC4)nc3-c3cccc4c3OCCO4)ccn2)ccn1		CHEMBL4788673	=	IC50	nM	44.2	CHEMBL4439	Homo sapiens	IC50	nM	44.2
	22966794	CHEMBL4769705	Inhibition of ALK5 (unknown origin) measured after 120 mins of incubation by ADP-Glo kinase assay	B	Cc1noc(C)c1-c1nn(C2CC2)cc1Oc1ccnc(Nc2ccnc(C(C)(C)O)c2)c1		CHEMBL4784607	=	IC50	nM	6736.0	CHEMBL4439	Homo sapiens	IC50	nM	6736.0
	22966795	CHEMBL4769705	Inhibition of ALK5 (unknown origin) measured after 120 mins of incubation by ADP-Glo kinase assay	B	Cn1cc(-c2nn(C3CC3)cc2Oc2ccnc(Nc3ccnc(C(C)(C)O)c3)c2)cn1		CHEMBL4781586	=	IC50	nM	30.2	CHEMBL4439	Homo sapiens	IC50	nM	30.2
	22966796	CHEMBL4769705	Inhibition of ALK5 (unknown origin) measured after 120 mins of incubation by ADP-Glo kinase assay	B	CC(C)(O)c1cc(Nc2cc(Oc3cn(C4CC4)nc3-c3ccncc3)ccn2)ccn1		CHEMBL4777610	=	IC50	nM	84.0	CHEMBL4439	Homo sapiens	IC50	nM	84.0
	22966797	CHEMBL4769705	Inhibition of ALK5 (unknown origin) measured after 120 mins of incubation by ADP-Glo kinase assay	B	CC(C)(O)c1cc(Nc2cc(Oc3cn(C4CC4)nc3C3CCC(F)(F)CC3)ccn2)ccn1		CHEMBL4777294	=	IC50	nM	13.2	CHEMBL4439	Homo sapiens	IC50	nM	13.2
	22966798	CHEMBL4769705	Inhibition of ALK5 (unknown origin) measured after 120 mins of incubation by ADP-Glo kinase assay	B	CC1(O)CCC(c2nn(C3CC3)cc2Oc2ccnc(Nc3ccnc(C(C)(C)O)c3)c2)CC1		CHEMBL4797447	=	IC50	nM	8.2	CHEMBL4439	Homo sapiens	IC50	nM	8.2
	22966799	CHEMBL4769705	Inhibition of ALK5 (unknown origin) measured after 120 mins of incubation by ADP-Glo kinase assay	B	CC(C)(O)c1cc(Nc2cc(Oc3cn(C4CC4)nc3C3C4COCC43)ccn2)ccn1		CHEMBL4795823	=	IC50	nM	47.2	CHEMBL4439	Homo sapiens	IC50	nM	47.2
	22966800	CHEMBL4769705	Inhibition of ALK5 (unknown origin) measured after 120 mins of incubation by ADP-Glo kinase assay	B	CC(C)(O)c1cc(Nc2cc(Oc3cn(C4CC4)nc3C3CN(CC(F)(F)F)C3)ccn2)ccn1		CHEMBL4783147	=	IC50	nM	528.0	CHEMBL4439	Homo sapiens	IC50	nM	528.0
	22966801	CHEMBL4769705	Inhibition of ALK5 (unknown origin) measured after 120 mins of incubation by ADP-Glo kinase assay	B	CC(C)(O)c1cc(Nc2cc(Oc3cn(C4CC4)nc3C3CN(C(=O)C4CC4)C3)ccn2)ccn1		CHEMBL4799736	=	IC50	nM	308.0	CHEMBL4439	Homo sapiens	IC50	nM	308.0
	22966802	CHEMBL4769705	Inhibition of ALK5 (unknown origin) measured after 120 mins of incubation by ADP-Glo kinase assay	B	CC(C)(O)c1cc(Nc2cc(Oc3cn(C4CC4)nc3C3CC(O)(C(F)(F)F)C3)ccn2)ccn1		CHEMBL4782867	=	IC50	nM	8.2	CHEMBL4439	Homo sapiens	IC50	nM	8.2
	22966803	CHEMBL4769705	Inhibition of ALK5 (unknown origin) measured after 120 mins of incubation by ADP-Glo kinase assay	B	CC(C)(O)c1cc(Nc2cc(Oc3cn(C4CC4)nc3C3CC(F)(F)C3)ccn2)ccn1		CHEMBL4791815	=	IC50	nM	44.0	CHEMBL4439	Homo sapiens	IC50	nM	44.0
	22966804	CHEMBL4769705	Inhibition of ALK5 (unknown origin) measured after 120 mins of incubation by ADP-Glo kinase assay	B	CC(O)(c1cc(Nc2cc(Oc3cn(C4CC4)nc3C3CC(F)(F)C3)ccn2)ccn1)C(F)(F)F		CHEMBL4778362	=	IC50	nM	34.6	CHEMBL4439	Homo sapiens	IC50	nM	34.6
	22966805	CHEMBL4769705	Inhibition of ALK5 (unknown origin) measured after 120 mins of incubation by ADP-Glo kinase assay	B	OC(c1cc(Nc2cc(Oc3cn(C4CC4)nc3C3CC(F)(F)C3)ccn2)ccn1)C(F)(F)F		CHEMBL4788502	=	IC50	nM	13.2	CHEMBL4439	Homo sapiens	IC50	nM	13.2
	22966806	CHEMBL4769705	Inhibition of ALK5 (unknown origin) measured after 120 mins of incubation by ADP-Glo kinase assay	B	FC1(F)CC(c2nn(C3CC3)cc2Oc2ccnc(Nc3ccnc(N4CCOCC4)c3)c2)C1		CHEMBL4786439	=	IC50	nM	26.0	CHEMBL4439	Homo sapiens	IC50	nM	26.0
	22966807	CHEMBL4769705	Inhibition of ALK5 (unknown origin) measured after 120 mins of incubation by ADP-Glo kinase assay	B	OC1(c2cc(Nc3cc(Oc4cn(C5CC5)nc4C4CC(F)(F)C4)ccn3)ccn2)CCOCC1		CHEMBL4791582	=	IC50	nM	11.4	CHEMBL4439	Homo sapiens	IC50	nM	11.4
	22966808	CHEMBL4769705	Inhibition of ALK5 (unknown origin) measured after 120 mins of incubation by ADP-Glo kinase assay	B	OC1(c2cc(Nc3cc(Oc4cn(C5CC5)nc4C4CC(F)(F)C4)ccn3)ccn2)CCC(F)(F)CC1		CHEMBL4797329	=	IC50	nM	27.5	CHEMBL4439	Homo sapiens	IC50	nM	27.5
	22966809	CHEMBL4769705	Inhibition of ALK5 (unknown origin) measured after 120 mins of incubation by ADP-Glo kinase assay	B	OC1(C(F)(F)F)CCN(c2cc(Nc3cc(Oc4cn(C5CC5)nc4C4CC(F)(F)C4)ccn3)ccn2)CC1		CHEMBL4780548	=	IC50	nM	24.3	CHEMBL4439	Homo sapiens	IC50	nM	24.3
	22966810	CHEMBL4769705	Inhibition of ALK5 (unknown origin) measured after 120 mins of incubation by ADP-Glo kinase assay	B	OC1(c2cc(Nc3cc(Oc4cn(C5CC5)nc4C4CC(F)(F)C4)ccn3)ccn2)COC1		CHEMBL4791955	=	IC50	nM	31.4	CHEMBL4439	Homo sapiens	IC50	nM	31.4
	22966811	CHEMBL4769705	Inhibition of ALK5 (unknown origin) measured after 120 mins of incubation by ADP-Glo kinase assay	B	OC1(c2cc(Nc3cc(Oc4cn(C5CC5)nc4C4CC(F)(F)C4)ccn3)ccn2)CN(CC(F)(F)F)C1		CHEMBL4781326	=	IC50	nM	69.2	CHEMBL4439	Homo sapiens	IC50	nM	69.2
	22966812	CHEMBL4769705	Inhibition of ALK5 (unknown origin) measured after 120 mins of incubation by ADP-Glo kinase assay	B	O=C(C1CC1)N1CC2(C1)CC(O)(c1cc(Nc3cc(Oc4cn(C5CC5)nc4C4CC(F)(F)C4)ccn3)ccn1)C2		CHEMBL4784622	=	IC50	nM	61.3	CHEMBL4439	Homo sapiens	IC50	nM	61.3
	22966813	CHEMBL4769705	Inhibition of ALK5 (unknown origin) measured after 120 mins of incubation by ADP-Glo kinase assay	B	CC1COCC(C)N1Cc1cc(Nc2cc(Oc3cn(C4CC4)nc3C3CC(F)(F)C3)ccn2)ccn1		CHEMBL4795745	=	IC50	nM	416.0	CHEMBL4439	Homo sapiens	IC50	nM	416.0
	22966814	CHEMBL4769705	Inhibition of ALK5 (unknown origin) measured after 120 mins of incubation by ADP-Glo kinase assay	B	CC(C)(O)c1cc(Nc2cc(Oc3cn(C4CC4)nc3C3CCOCC3)ccn2)ccn1		CHEMBL4594432	=	IC50	nM	38.2	CHEMBL4439	Homo sapiens	IC50	nM	38.2
	23122249	CHEMBL4804709	Inhibition of TGFBR1 in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	IC50	nM	84000.0	CHEMBL4439	Homo sapiens	IC50	uM	84.0
	23122250	CHEMBL4804709	Inhibition of TGFBR1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4855730	=	IC50	nM	-20500.0	CHEMBL4439	Homo sapiens	IC50	uM	-20.5
	23122251	CHEMBL4804709	Inhibition of TGFBR1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	IC50	nM	91000.0	CHEMBL4439	Homo sapiens	IC50	uM	91.0
	23122252	CHEMBL4804710	Inhibition of TGFBR1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	75.0	CHEMBL4439	Homo sapiens	INH	%	75.0
	23122253	CHEMBL4804710	Inhibition of TGFBR1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	0.0	CHEMBL4439	Homo sapiens	INH	%	0.0
	23122254	CHEMBL4804710	Inhibition of TGFBR1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	>	Inhibition	%	90.0	CHEMBL4439	Homo sapiens	INH	%	90.0
	23122840	CHEMBL4805191	Inhibition of human TGFBR1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	100.0	CHEMBL4439	Homo sapiens	Activity	%	100.0
	23123535	CHEMBL4805779	Inhibition of human TGFBR1 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	82.0	CHEMBL4439	Homo sapiens	Activity	%	82.0
	23123987	CHEMBL4806231	Inhibition of DNA-tagged human TGFBR1 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	100.0	CHEMBL4439	Homo sapiens	Activity	%	100.0
	23125160	CHEMBL4806796	Inhibition of human TGFBR1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL4439	Homo sapiens	Activity	%	100.0
	23125161	CHEMBL4806796	Inhibition of human TGFBR1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL4439	Homo sapiens	Activity	%	100.0
	23127507	CHEMBL4807639	Inhibition of TGFBR1 (unknown origin) assessed as residual activity at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	=	Activity	%	1.0	CHEMBL4439	Homo sapiens	Activity	%	1.0
	23127508	CHEMBL4807639	Inhibition of TGFBR1 (unknown origin) assessed as residual activity at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	=	Activity	%	28.0	CHEMBL4439	Homo sapiens	Activity	%	28.0
	23127509	CHEMBL4807639	Inhibition of TGFBR1 (unknown origin) assessed as residual activity at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Activity	%	5.0	CHEMBL4439	Homo sapiens	Activity	%	5.0
	23128638	CHEMBL4808021	Inhibition of TGFB-R1 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	<	Activity	%	25.0	CHEMBL4439	Homo sapiens	Activity	%	25.0
	23128639	CHEMBL4808021	Inhibition of TGFB-R1 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	=	Activity	%	25.0	CHEMBL4439	Homo sapiens	Activity	%	25.0
	23128640	CHEMBL4808021	Inhibition of TGFB-R1 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Activity	%	25.0	CHEMBL4439	Homo sapiens	Activity	%	25.0
	23240295	CHEMBL4829095	Inhibition of ALK5 (unknown origin)	B	Oc1cc(Nc2ccnc3cc(-c4ccccc4)ccc23)ccc1Cl		CHEMBL4873767	=	IC50	nM	79.0	CHEMBL4439	Homo sapiens	IC50	nM	79.0
	23240296	CHEMBL4829095	Inhibition of ALK5 (unknown origin)	B	c1ccc(-c2ccc3c(Nc4ccc5scnc5c4)ccnc3c2)cc1		CHEMBL4876135	=	IC50	nM	2500.0	CHEMBL4439	Homo sapiens	IC50	nM	2500.0
	23257256	CHEMBL4832363	Inhibition of TGFBR1 (unknown origin) at 2 uM relative to control	B	c1ccc(CN2CCN(c3nnc(Nc4ccc(N5CCOCC5)cc4)c4ccccc34)CC2)cc1		CHEMBL4856734	=	Inhibition	%	0.0	CHEMBL4439	Homo sapiens	INH	%	0.0
	23257257	CHEMBL4832363	Inhibition of TGFBR1 (unknown origin) at 2 uM relative to control	B	FC(F)(F)c1cccc(CN2CCN(c3nnc(Nc4ccc(N5CCOCC5)cc4)c4ccccc34)CC2)c1		CHEMBL4873715	=	Inhibition	%	0.0	CHEMBL4439	Homo sapiens	INH	%	0.0
	23257258	CHEMBL4832363	Inhibition of TGFBR1 (unknown origin) at 2 uM relative to control	B	CC1COCCN1c1ccc(Nc2nnc(N3CCN(Cc4cccc(C(F)(F)F)c4)CC3)c3ccccc23)cc1		CHEMBL4874645	=	Inhibition	%	0.0	CHEMBL4439	Homo sapiens	INH	%	0.0
	23257259	CHEMBL4832363	Inhibition of TGFBR1 (unknown origin) at 2 uM relative to control	B	CC1CN(c2ccc(Nc3nnc(N4CCN(Cc5cccc(C(F)(F)F)c5)CC4)c4ccccc34)cc2)CCO1		CHEMBL4856263	=	Inhibition	%	0.0	CHEMBL4439	Homo sapiens	INH	%	0.0
	23257260	CHEMBL4832363	Inhibition of TGFBR1 (unknown origin) at 2 uM relative to control	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	=	Inhibition	%	73.0	CHEMBL4439	Homo sapiens	INH	%	73.0
	23257261	CHEMBL4832364	Inhibition of TGFBR1 (unknown origin) at 20 uM relative to control	B	c1ccc(CN2CCN(c3nnc(Nc4ccc(N5CCOCC5)cc4)c4ccccc34)CC2)cc1		CHEMBL4856734	=	Inhibition	%	0.0	CHEMBL4439	Homo sapiens	INH	%	0.0
	23257262	CHEMBL4832364	Inhibition of TGFBR1 (unknown origin) at 20 uM relative to control	B	FC(F)(F)c1cccc(CN2CCN(c3nnc(Nc4ccc(N5CCOCC5)cc4)c4ccccc34)CC2)c1		CHEMBL4873715	=	Inhibition	%	0.0	CHEMBL4439	Homo sapiens	INH	%	0.0
	23257263	CHEMBL4832364	Inhibition of TGFBR1 (unknown origin) at 20 uM relative to control	B	CC1COCCN1c1ccc(Nc2nnc(N3CCN(Cc4cccc(C(F)(F)F)c4)CC3)c3ccccc23)cc1		CHEMBL4874645	=	Inhibition	%	0.0	CHEMBL4439	Homo sapiens	INH	%	0.0
	23257264	CHEMBL4832364	Inhibition of TGFBR1 (unknown origin) at 20 uM relative to control	B	CC1CN(c2ccc(Nc3nnc(N4CCN(Cc5cccc(C(F)(F)F)c5)CC4)c4ccccc34)cc2)CCO1		CHEMBL4856263	=	Inhibition	%	0.0	CHEMBL4439	Homo sapiens	INH	%	0.0
	23257265	CHEMBL4832364	Inhibition of TGFBR1 (unknown origin) at 20 uM relative to control	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	=	Inhibition	%	100.0	CHEMBL4439	Homo sapiens	INH	%	100.0
	23312004	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	Fc1ccc(F)c(-c2cc(Nc3ccnc4ccccc34)ccn2)c1		CHEMBL4877712	=	IC50	nM	20.12	CHEMBL4439	Homo sapiens	IC50	nM	20.12
	23312005	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	Oc1ccc(-c2ccc3c(Nc4ccnc(-c5cc(F)ccc5F)c4)ccnc3c2)cc1		CHEMBL4858091	=	IC50	nM	16.24	CHEMBL4439	Homo sapiens	IC50	nM	16.24
	23312006	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	COc1ccc(-c2ccc3c(Nc4ccnc(-c5cc(F)ccc5F)c4)ccnc3c2)cc1		CHEMBL4857030	=	IC50	nM	21.93	CHEMBL4439	Homo sapiens	IC50	nM	21.93
	23312007	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	COc1ccc(OC)c(-c2ccc3c(Nc4ccnc(-c5cc(F)ccc5F)c4)ccnc3c2)c1		CHEMBL4855865	=	IC50	nM	894.3	CHEMBL4439	Homo sapiens	IC50	nM	894.3
	23312008	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	COc1ccc(-c2ccc3c(Nc4ccnc(-c5cc(F)ccc5F)c4)ccnc3c2)c(OC)c1		CHEMBL4861173	=	IC50	nM	4396.5	CHEMBL4439	Homo sapiens	IC50	nM	4396.5
	23312009	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	COc1cccc(OC)c1-c1ccc2c(Nc3ccnc(-c4cc(F)ccc4F)c3)ccnc2c1		CHEMBL4854040	=	IC50	nM	162.8	CHEMBL4439	Homo sapiens	IC50	nM	162.8
	23312010	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	COc1cc(OC)c(-c2ccc3c(Nc4ccnc(-c5cc(F)ccc5F)c4)ccnc3c2)c(OC)c1		CHEMBL4874250	=	IC50	nM	694.0	CHEMBL4439	Homo sapiens	IC50	nM	694.0
	23312011	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	CN(C)c1ccc(-c2ccc3c(Nc4ccnc(-c5cc(F)ccc5F)c4)ccnc3c2)cn1		CHEMBL4857982	=	IC50	nM	29.4	CHEMBL4439	Homo sapiens	IC50	nM	29.4
	23312012	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	CS(=O)(=O)c1ccc(-c2ccc3c(Nc4ccnc(-c5cc(F)ccc5F)c4)ccnc3c2)cc1		CHEMBL4861887	=	IC50	nM	0.62	CHEMBL4439	Homo sapiens	IC50	nM	0.62
	23312013	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	Fc1ccc(F)c(-c2cc(Nc3ccnc4cc(-c5ccsc5)ccc34)ccn2)c1		CHEMBL4845722	=	IC50	nM	10.95	CHEMBL4439	Homo sapiens	IC50	nM	10.95
	23312014	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	Fc1ccc(F)c(-c2cc(Nc3ccnc4cc(-c5cn[nH]c5)ccc34)ccn2)c1		CHEMBL4857294	=	IC50	nM	5.55	CHEMBL4439	Homo sapiens	IC50	nM	5.55
	23312015	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	Cn1cc(-c2ccc3c(Nc4ccnc(-c5cc(F)ccc5F)c4)ccnc3c2)cn1		CHEMBL4850436	=	IC50	nM	6.18	CHEMBL4439	Homo sapiens	IC50	nM	6.18
	23312016	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	CN(C)CCn1cc(-c2ccc3c(Nc4ccnc(-c5cc(F)ccc5F)c4)ccnc3c2)cn1		CHEMBL4850787	=	IC50	nM	1.03	CHEMBL4439	Homo sapiens	IC50	nM	1.03
	23312017	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	=	IC50	nM	126.6	CHEMBL4439	Homo sapiens	IC50	nM	126.6
	23312018	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	CS(=O)(=O)c1ccc(-c2ccc3c(-n4ccc5cnc(-c6cc(F)ccc6F)nc54)ccnc3c2)cc1		CHEMBL4854673	=	IC50	nM	282.65	CHEMBL4439	Homo sapiens	IC50	nM	282.65
	23312019	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	CN(C)CCn1cc(-c2ccc3c(-n4ccc5cnc(-c6cc(F)ccc6F)nc54)ccnc3c2)cn1		CHEMBL4870460	=	IC50	nM	91.72	CHEMBL4439	Homo sapiens	IC50	nM	91.72
	23312020	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	CS(=O)(=O)c1ccc(-c2ccc3c(-c4cnc5ccc(-c6cc(F)ccc6F)cn45)ccnc3c2)cc1		CHEMBL4861588	=	IC50	nM	2744.0	CHEMBL4439	Homo sapiens	IC50	nM	2744.0
	23312021	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	CN(C)CCn1cc(-c2ccc3c(-c4cnc5ccc(-c6cc(F)ccc6F)cn45)ccnc3c2)cn1		CHEMBL4853270	=	IC50	nM	12.74	CHEMBL4439	Homo sapiens	IC50	nM	12.74
	23312022	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	CN(C)CCn1cc(-c2ccc3c(N4CCn5ccc(-c6cc(F)ccc6F)c54)ccnc3c2)cn1		CHEMBL4865192	=	IC50	nM	621.0	CHEMBL4439	Homo sapiens	IC50	nM	621.0
	23312023	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	CS(=O)(=O)c1ccc(-c2ccc3nccc(Nc4ccnc(-c5cc(F)ccc5F)c4)c3c2)cc1		CHEMBL4875083	=	IC50	nM	18.48	CHEMBL4439	Homo sapiens	IC50	nM	18.48
	23312024	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	CS(=O)(=O)c1ccc(-c2cc(Nc3ccnc(-c4cc(F)ccc4F)c3)ccn2)cc1		CHEMBL4877709	=	IC50	nM	225.9	CHEMBL4439	Homo sapiens	IC50	nM	225.9
	23312025	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	CS(=O)(=O)c1ccc(/C=C/C2CC(Nc3ccnc(-c4cc(F)ccc4F)c3)=CC=N2)cc1		CHEMBL4854949	=	IC50	nM	12.94	CHEMBL4439	Homo sapiens	IC50	nM	12.94
	23312026	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	CS(=O)(=O)c1ccc(-c2ccc3c(Nc4ccnc(-c5ccccc5)c4)ccnc3c2)cc1		CHEMBL4877481	=	IC50	nM	0.88	CHEMBL4439	Homo sapiens	IC50	nM	0.88
	23312027	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	CS(=O)(=O)c1ccc(-c2ccc3c(Nc4ccnc(-c5ccccc5F)c4)ccnc3c2)cc1		CHEMBL4867170	=	IC50	nM	0.67	CHEMBL4439	Homo sapiens	IC50	nM	0.67
	23312028	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	CS(=O)(=O)c1ccc(-c2ccc3c(Nc4ccnc(-c5cccc(F)c5)c4)ccnc3c2)cc1		CHEMBL4874538	=	IC50	nM	1.37	CHEMBL4439	Homo sapiens	IC50	nM	1.37
	23312029	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	CS(=O)(=O)c1ccc(-c2ccc3c(Nc4ccnc(-c5ccc(F)cc5)c4)ccnc3c2)cc1		CHEMBL4853591	=	IC50	nM	1.9	CHEMBL4439	Homo sapiens	IC50	nM	1.9
	23312030	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	Cc1ccccc1-c1cc(Nc2ccnc3cc(-c4ccc(S(C)(=O)=O)cc4)ccc23)ccn1		CHEMBL4874893	=	IC50	nM	0.65	CHEMBL4439	Homo sapiens	IC50	nM	0.65
	23312031	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	Cc1cccc(-c2cc(Nc3ccnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc34)ccn2)c1		CHEMBL4851363	=	IC50	nM	0.79	CHEMBL4439	Homo sapiens	IC50	nM	0.79
	23312032	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	Cc1ccc(-c2cc(Nc3ccnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc34)ccn2)cc1		CHEMBL4874586	=	IC50	nM	132.5	CHEMBL4439	Homo sapiens	IC50	nM	132.5
	23312033	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	CC(C)Oc1ccc(-c2cc(Nc3ccnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc34)ccn2)cc1		CHEMBL4869006	=	IC50	nM	127.3	CHEMBL4439	Homo sapiens	IC50	nM	127.3
	23312034	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	CC(C)c1ccc(-c2cc(Nc3ccnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc34)ccn2)cc1		CHEMBL4859412	=	IC50	nM	7542.0	CHEMBL4439	Homo sapiens	IC50	nM	7542.0
	23312035	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	CC(C)(C)c1ccc(-c2cc(Nc3ccnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc34)ccn2)cc1		CHEMBL4876162	=	IC50	nM	147.7	CHEMBL4439	Homo sapiens	IC50	nM	147.7
	23312036	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	CS(=O)(=O)c1ccc(-c2ccc3c(Nc4ccnc(-c5ccoc5)c4)ccnc3c2)cc1		CHEMBL4872884	=	IC50	nM	0.54	CHEMBL4439	Homo sapiens	IC50	nM	0.54
	23312037	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	CS(=O)(=O)c1ccc(-c2ccc3c(Nc4ccnc(-c5ccsc5)c4)ccnc3c2)cc1		CHEMBL4847064	=	IC50	nM	7.29	CHEMBL4439	Homo sapiens	IC50	nM	7.29
	23312038	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	CN(C)CCn1cc(-c2ccc3c(Nc4ccnc(-c5ccccc5)c4)ccnc3c2)cn1		CHEMBL4877947	=	IC50	nM	0.35	CHEMBL4439	Homo sapiens	IC50	nM	0.35
	23312039	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	CN(C)CCn1cc(-c2ccc3c(Nc4ccnc(-c5ccccc5F)c4)ccnc3c2)cn1		CHEMBL4863867	=	IC50	nM	0.82	CHEMBL4439	Homo sapiens	IC50	nM	0.82
	23312040	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	CN(C)CCn1cc(-c2ccc3c(Nc4ccnc(-c5cccc(F)c5)c4)ccnc3c2)cn1		CHEMBL4872045	=	IC50	nM	0.63	CHEMBL4439	Homo sapiens	IC50	nM	0.63
	23312041	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	CN(C)CCn1cc(-c2ccc3c(Nc4ccnc(-c5ccc(F)cc5)c4)ccnc3c2)cn1		CHEMBL4867342	=	IC50	nM	14.61	CHEMBL4439	Homo sapiens	IC50	nM	14.61
	23312042	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	Cc1ccccc1-c1cc(Nc2ccnc3cc(-c4cnn(CCN(C)C)c4)ccc23)ccn1		CHEMBL4852453	=	IC50	nM	0.32	CHEMBL4439	Homo sapiens	IC50	nM	0.32
	23312043	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	Cc1cccc(-c2cc(Nc3ccnc4cc(-c5cnn(CCN(C)C)c5)ccc34)ccn2)c1		CHEMBL4858177	=	IC50	nM	0.34	CHEMBL4439	Homo sapiens	IC50	nM	0.34
	23312044	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	Cc1ccc(-c2cc(Nc3ccnc4cc(-c5cnn(CCN(C)C)c5)ccc34)ccn2)cc1		CHEMBL4847382	=	IC50	nM	1.65	CHEMBL4439	Homo sapiens	IC50	nM	1.65
	23312045	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	CC(C)Oc1ccc(-c2cc(Nc3ccnc4cc(-c5cnn(CCN(C)C)c5)ccc34)ccn2)cc1		CHEMBL4862355	=	IC50	nM	1476.0	CHEMBL4439	Homo sapiens	IC50	nM	1476.0
	23312046	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	CC(C)c1ccc(-c2cc(Nc3ccnc4cc(-c5cnn(CCN(C)C)c5)ccc34)ccn2)cc1		CHEMBL4875621	=	IC50	nM	2391.0	CHEMBL4439	Homo sapiens	IC50	nM	2391.0
	23312047	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	CN(C)CCn1cc(-c2ccc3c(Nc4ccnc(-c5ccc(C(C)(C)C)cc5)c4)ccnc3c2)cn1		CHEMBL4868742	=	IC50	nM	4295.5	CHEMBL4439	Homo sapiens	IC50	nM	4295.5
	23312048	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	CN(C)CCn1cc(-c2ccc3c(Nc4ccnc(-c5ccoc5)c4)ccnc3c2)cn1		CHEMBL4846578	=	IC50	nM	0.51	CHEMBL4439	Homo sapiens	IC50	nM	0.51
	23312049	CHEMBL4844300	Inhibition of human TGFbeta receptor 1 in human HEK293 cells preincubated for 24 hrs followed by addition of TGFbeta1 and measured after 24 hrs by luciferase based assay	B	CN(C)CCn1cc(-c2ccc3c(Nc4ccnc(-c5ccsc5)c4)ccnc3c2)cn1		CHEMBL4875547	=	IC50	nM	1.53	CHEMBL4439	Homo sapiens	IC50	nM	1.53
Not Active	23317676	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	85.0	CHEMBL4439	Homo sapiens	% Control	%	85.0
Not Active	23318144	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	88.0	CHEMBL4439	Homo sapiens	% Control	%	88.0
Not Active	23318810	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	81.0	CHEMBL4439	Homo sapiens	% Control	%	81.0
Not Active	23319294	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	78.0	CHEMBL4439	Homo sapiens	% Control	%	78.0
Not Active	23319930	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	98.6	CHEMBL4439	Homo sapiens	% Control	%	98.6
Not Active	23320406	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23321084	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	97.0	CHEMBL4439	Homo sapiens	% Control	%	97.0
Not Active	23321552	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23322182	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	64.0	CHEMBL4439	Homo sapiens	% Control	%	64.0
Not Active	23322650	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	64.0	CHEMBL4439	Homo sapiens	% Control	%	64.0
Not Active	23323339	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23323807	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23324661	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	62.4	CHEMBL4439	Homo sapiens	% Control	%	62.4
Not Active	23325296	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	90.0	CHEMBL4439	Homo sapiens	% Control	%	90.0
Not Active	23325764	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23326411	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23326879	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	82.0	CHEMBL4439	Homo sapiens	% Control	%	82.0
Not Active	23327579	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23328047	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	84.0	CHEMBL4439	Homo sapiens	% Control	%	84.0
Not Active	23328634	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	80.0	CHEMBL4439	Homo sapiens	% Control	%	80.0
Not Active	23329102	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	91.0	CHEMBL4439	Homo sapiens	% Control	%	91.0
Not Active	23329550	CHEMBL4881257	TGFBR1(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	81.0	CHEMBL4439	Homo sapiens	% residual kinase activity	%	81.0
Not Active	23330048	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	90.0	CHEMBL4439	Homo sapiens	% Control	%	90.0
Not Active	23330516	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	80.0	CHEMBL4439	Homo sapiens	% Control	%	80.0
Not Active	23331272	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23331740	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23332327	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	98.2	CHEMBL4439	Homo sapiens	% Control	%	98.2
Not Active	23332793	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	74.3	CHEMBL4439	Homo sapiens	% Control	%	74.3
Not Active	23333511	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	99.2	CHEMBL4439	Homo sapiens	% Control	%	99.2
Not Active	23334150	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	74.0	CHEMBL4439	Homo sapiens	% Control	%	74.0
Not Active	23334618	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	80.0	CHEMBL4439	Homo sapiens	% Control	%	80.0
Not Active	23335597	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	81.0	CHEMBL4439	Homo sapiens	% Control	%	81.0
Not Active	23336065	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	93.0	CHEMBL4439	Homo sapiens	% Control	%	93.0
Not Active	23336692	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	97.0	CHEMBL4439	Homo sapiens	% Control	%	97.0
Not Active	23337160	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23337798	CHEMBL4882169	TGFBR1 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	96.0	CHEMBL4439	Homo sapiens	% Ctrl	%	96.0
Not Active	23338241	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23338709	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	97.0	CHEMBL4439	Homo sapiens	% Control	%	97.0
Not Active	23339321	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23339789	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23340426	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23340894	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23341551	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23342019	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23342635	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23343103	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	95.0	CHEMBL4439	Homo sapiens	% Control	%	95.0
Not Active	23343733	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23344201	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	97.0	CHEMBL4439	Homo sapiens	% Control	%	97.0
Not Active	23344839	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23345412	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23345880	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23346456	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	68.4	CHEMBL4439	Homo sapiens	% Control	%	68.4
Not Active	23346925	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	83.0	CHEMBL4439	Homo sapiens	% Control	%	83.0
Not Active	23347525	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23348017	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	60.8	CHEMBL4439	Homo sapiens	% Control	%	60.8
Not Active	23348596	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	82.0	CHEMBL4439	Homo sapiens	% Control	%	82.0
Not Active	23349064	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23349651	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23350269	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23350737	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23351342	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23351810	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23352249	CHEMBL4882938	TGFBR1 (ALK5) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	0.9044	CHEMBL4439	Homo sapiens	% Inhibition	%	0.9044
Not Active	23352834	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23353302	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	89.0	CHEMBL4439	Homo sapiens	% Control	%	89.0
Not Active	23354184	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	81.0	CHEMBL4439	Homo sapiens	% Control	%	81.0
Not Active	23354652	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	89.0	CHEMBL4439	Homo sapiens	% Control	%	89.0
Not Active	23355384	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23355852	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23356488	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	90.0	CHEMBL4439	Homo sapiens	% Control	%	90.0
Not Active	23356956	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	78.0	CHEMBL4439	Homo sapiens	% Control	%	78.0
Not Active	23357565	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	96.0	CHEMBL4439	Homo sapiens	% Control	%	96.0
Not Active	23358212	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	61.0	CHEMBL4439	Homo sapiens	% Control	%	61.0
Not Active	23358680	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23359266	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	83.2	CHEMBL4439	Homo sapiens	% Control	%	83.2
Not Active	23359864	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23360332	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	81.0	CHEMBL4439	Homo sapiens	% Control	%	81.0
Not Active	23360917	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23361385	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23361958	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23362494	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	94.0	CHEMBL4439	Homo sapiens	% Control	%	94.0
Not Active	23362962	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	90.0	CHEMBL4439	Homo sapiens	% Control	%	90.0
Active	23363406	CHEMBL4883282	Lathascreen (Takeda) (TGFBR1)	B	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21		CHEMBL4564126		IC50	nM	25.12	CHEMBL4439	Homo sapiens	pIC50		7.6
Active	23363407	CHEMBL4883283	Enzyme kinetic assays	B	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21		CHEMBL4564126		IC50	nM	25.0	CHEMBL4439	Homo sapiens	IC50	nM	25.0
Active	23363409	CHEMBL4883285	Reporter gene assay (TGFBR1)	B	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21		CHEMBL4564126		IC50	nM	245.0	CHEMBL4439	Homo sapiens	IC50	nM	245.0
Active	23363411	CHEMBL4883287	Radioactive kinase assay (TGFBR1)	B	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21		CHEMBL4564126		IC50	nM	316.23	CHEMBL4439	Homo sapiens	pIC50		6.5
Not Active	23363425	CHEMBL4883294	NanoBRET (SGC Frankfurt) (TGFBR1)	B	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2ccccc21	Non standard unit for type	CHEMBL4543737	>	IC50	µM	10.0	CHEMBL4439	Homo sapiens	IC50	µM	10.0
Not Active	23364604	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	84.0	CHEMBL4439	Homo sapiens	% Control	%	84.0
Not Active	23365072	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	93.0	CHEMBL4439	Homo sapiens	% Control	%	93.0
Not Active	23365811	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23366354	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	96.0	CHEMBL4439	Homo sapiens	% Control	%	96.0
Not Active	23366944	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23367412	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	89.0	CHEMBL4439	Homo sapiens	% Control	%	89.0
Not Active	23367763	CHEMBL4884116	TGFB-R1 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	93.0	CHEMBL4439	Homo sapiens	% Residual activity with Skepinone-L	%	93.0
Not Active	23368290	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	90.0	CHEMBL4439	Homo sapiens	% Control	%	90.0
Not Active	23368758	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	85.0	CHEMBL4439	Homo sapiens	% Control	%	85.0
Not Active	23369357	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	85.0	CHEMBL4439	Homo sapiens	% Control	%	85.0
Not Active	23369825	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23370260	CHEMBL4884499	TGFBR1(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	99.0	CHEMBL4439	Homo sapiens	% residual kinase activity	%	99.0
Not Active	23370793	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	58.0	CHEMBL4439	Homo sapiens	% Control	%	58.0
Not Active	23371261	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23372070	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	84.0	CHEMBL4439	Homo sapiens	% Control	%	84.0
Not Active	23372538	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
	23372914	CHEMBL4884879	TGFbetaR1(TGF1LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL4439	Homo sapiens	pIC50		6.0
	23373323	CHEMBL4885170	TGFbetaR1(TGF1LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL4439	Homo sapiens	pIC50		6.0
	23373677	CHEMBL4885454	TGFbetaR1(TGF1LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL4439	Homo sapiens	pIC50		6.0
Not Active	23375115	CHEMBL4886102	TGFBR1 Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	0.5	CHEMBL4439	Homo sapiens	% Inhibition	%	0.5
Not Active	23375965	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23376433	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23377010	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	97.0	CHEMBL4439	Homo sapiens	% Control	%	97.0
Not Active	23377478	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23378338	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	98.0	CHEMBL4439	Homo sapiens	% Control	%	98.0
Not Active	23378806	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	89.0	CHEMBL4439	Homo sapiens	% Control	%	89.0
Slightly Active	23379973	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	41.0	CHEMBL4439	Homo sapiens	% Control	%	41.0
Not Active	23380441	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	72.0	CHEMBL4439	Homo sapiens	% Control	%	72.0
Not Active	23381135	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23381783	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	82.0	CHEMBL4439	Homo sapiens	% Control	%	82.0
Not Active	23382251	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL4439	Homo sapiens	% Control	%	100.0
Not Active	23382875	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	87.0	CHEMBL4439	Homo sapiens	% Control	%	87.0
Slightly Active	23383343	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	44.0	CHEMBL4439	Homo sapiens	% Control	%	44.0
Not Active	23384016	CHEMBL4887614	TGFBR1 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	94.0	CHEMBL4439	Homo sapiens	% Ctrl	%	94.0
Not Active	23384488	CHEMBL4888083	TGFBR1(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	-0.85	CHEMBL4439	Homo sapiens	% inhibition	%	-0.85
Not Active	23385258	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	94.0	CHEMBL4439	Homo sapiens	% Control	%	94.0
Not Active	23385725	CHEMBL4879982	KinomeScan assay: inhibition of TGFBR1	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	95.0	CHEMBL4439	Homo sapiens	% Control	%	95.0
